
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-16801-17100*
  '("'exTreg'" ".2586+1G" ".3113+1G" ".607+1G" "338-010" "A+g" "A-GFP"
    "A-deficiency" "A-deficient" "A-inhibited" "A-mediated" "A-positive"
    "A-targeted" "A-type" "A0" "A1" "A10-1" "A10-3" "A1003V" "A49T" "A870G"
    "A908G" "A9A2" "AATAAA" "AATAAT" "AAXA" "ABBA" "ABCA13" "ABT-737-treated"
    "AC-TH" "ADAPT-232" "ADCK4" "ADHD" "ADMET" "ADOS-2" "ADP-or" "ADSCs" "AE"
    "AECIDLTGI" "AEW541" "AFAP1" "AFC" "AG-014447" "AG-014699" "AGAC" "AGC"
    "AIRD1A" "AJCC" "AKT-c-JUN" "ALSPAC" "ALST" "AMG479" "AMPKα" "AMSCs"
    "ANK-Luc" "ANK-Luc-based" "ANK-mA-Luc" "ANKRD26" "ANKS6" "ANLN" "ANRIL"
    "AP-1cis-elements" "AP1-Luc" "AP26113" "APC-AXIN-CK1α-CTNNβ-GSK3β" "API"
    "APOBEC3" "AR-014418" "AR-CAG" "AR-null" "ARCaP-E" "ARCaP-M" "ARIEL"
    "ARIEL2" "ARIEL3" "ARK" "ARMC1" "ARMS-PCR" "ARQ" "ARTDs" "ARVs" "ASCIZ"
    "ASCO" "ASP3026" "ASPM" "AT2s" "ATAC-seq" "ATBC" "ATM-S1981" "ATRi-1"
    "ATRi-VE" "ATTG" "ATTTATGG" "AUROC" "AZ13256675" "AZD" "AZD-7762" "AZD0530"
    "Abbvie" "Abcam" "Abelson" "Ac-K-103" "Ac-Suclys-AMC" "Achilles"
    "Acid-induced" "Activated" "Acyl-carnitines" "Ad-CRE" "Ad-Cre" "Ad-SIRT1"
    "AdM" "AdTGF" "AdTGF-β1" "AdTGF-β1-induced" "Adeno" "Adeno–FLAG–Rac" "Adh"
    "Adlanmerini" "AdnL" "Aerts" "Affymetrix" "Africa" "African"
    "African-American" "African-Americans" "Africans" "African–Americans"
    "Age-specific" "Ai" "Aiii" "Aim" "Ak1ΔEC" "Akay" "Akbar" "Akishima" "Akt1"
    "Akt1KO" "Akt1ΔEC" "Akt2KO" "AktKO" "AktX" "Alan" "Aldrich" "Alejandra"
    "Alexa" "Alexa-Fluor" "Alexa488" "Alexa488-PFL" "Alexa568-conjugated"
    "Alexa647" "Algeria" "Alhazzazi" "Alibhai" "Alox" "Alox3e" "Alox8"
    "Alu-PCR" "Alvarez" "Alzheimer" "Alzheimer's" "Alzheimer’s" "AmNogo"
    "AmNogo-B" "Amazon" "America" "American" "Americans" "Amino-acid"
    "Amphiuma" "Anacardiaceae" "Andersen" "Anderson" "Andersson"
    "Andrade-Vieira" "Andreeva" "Androgen-ablation" "Andrzej" "Angeles" "Ann"
    "Antigen-retrieval" "Antonio" "Aplysia" "Apr" "Aptamers" "Aquilano" "Arab"
    "Arabia" "Arf6" "Arg105" "Arhgdia" "Arico" "ArrayExpress" "As-HDAC3" "Asea"
    "Ashcroft" "Ashkenazi" "Ashraf" "Asian" "Asians" "Aspirin-induced" "Astra"
    "Astra-Zeneca" "AstraZeneca" "Augmin" "Augmin–microtubule" "AurAi"
    "Aurora-KO" "Aurora-T288" "Australia" "AutoDock" "Aβ" "Aβ42" "A–S1C"
    "A–S1E" "A–S5D" "B+C" "B-DNA" "B-EGFP" "B-NHL" "B-like" "B-lineage"
    "B-type" "B1" "B23" "B4" "B4-stained" "BALB" "BALB-C" "BAY-11" "BAY-320"
    "BAY-524" "BAY-B320" "BAY-B524" "BB-Cl-amidine" "BB-Cl-amidine–cotreated"
    "BC" "BC-21" "BC-23" "BC23" "BC823" "BCIS" "BCL-2-Aurora" "BCL-family"
    "BCLC" "BD" "BDB" "BFM" "BH3-mimetic" "BH3-only" "BID-1870" "BIO" "BIO-A"
    "BIX02188" "BKRF3" "BLC6" "BMDCCCLCOXCXCLILMDSCNOX1NF" "BME" "BMN"
    "BMS‐754807" "BOLERO-3" "BOT-LGSC" "BOTs" "BPAEC" "BPTES" "BRA" "BRAC1"
    "BRACHYURY" "BRCA1-Δ11" "BRCA1-ΔDBR" "BRCAness" "BRD7+miR-141" "BRONCUS"
    "Baarsma" "Background" "Bahamas" "Balko" "Bangladesh" "Bangladeshi"
    "Bannayan" "Barakat" "Barcelona" "Bargiela" "Bargiela-Iparraguirre"
    "Barksi" "Barr" "Barrett" "Barrett’s" "Bax-immunopositive" "Bayer" "Bcl"
    "Bcl-2" "Bcl-Xl" "Bcl-xl" "Bcl11B-dependent" "Beare" "Beare-Stevenson"
    "Becker" "Becn1" "Becton" "Begg" "Begg's" "Begg’s" "Bel" "Bem1p-1"
    "Ben-Shachar" "Berlin" "Beta-Carotene" "Beta-TC-6" "Bethesda"
    "Between-study" "Bfl-1" "Bhutan" "Bid" "Bim" "Bio-Rad" "BioGRID" "BioMol"
    "Bisubstrate" "Bit1-RNAi" "Bi–iii" "Bi–iv" "Blas" "Blas-Rus"
    "Bloom–Richardson" "Boehringer" "Boltzmann" "Bone-marrow" "Bonferroni"
    "Boolean" "Bouchekioua" "Bouchekioua-Bouzaghou" "Bourgine" "Bourseau"
    "Bourseau-Guilmain" "Bouzaghou" "Boyden" "Braak" "Brachyury" "Brady"
    "Brastianos" "Brazil" "Brazilians" "Brca" "Brca1" "Brca11-Δ11" "BrdUrd"
    "Brodmann" "Broyl" "Broyl's" "Bub1-Plk1-mediated" "Bub1–Plk1-dependent"
    "Bub1–Plk1-mediated" "BubR1N" "BubR1N–Cdc20–Mad2" "BubR1–Plk1-dependent"
    "Buchner" "Bufadienolide" "Bufo" "Burkitt" "Burnett" "Bustraan" "BxN"
    "B‐Raf" "C-CYFRA" "C-ESS" "C-Myc-miR-18b" "C-Src-HDAC3" "C-allele" "C-box"
    "C-finger" "C-palmitate" "C-palmitoyl-carnitine" "C-stimulatory"
    "C-terminally" "C-to-T" "C-type" "C1" "C2" "C214A" "C215A" "C2D1" "C3"
    "C3-Transferase" "C3-transferase" "C4" "C4BS" "C5" "C67V" "CA-II" "CAACTG"
    "CAGE-PKCδ-EGFR" "CAK-β" "CAKUT" "CALGB" "CALs" "CARRAY" "CASTp" "CATGTG"
    "CB-839" "CB17" "CBFA2T3" "CBLB" "CC0–CC3" "CC4" "CCAAT" "CCAT1-L" "CCAT2"
    "CCDN1" "CCEs" "CCND1was" "CCZ1B" "CD120a" "CD28-activated" "CD28-coated"
    "CD28-stimulated" "CD3ɛ" "CD3ɛ-NcK" "CD4-TST887AAA" "CD44s"
    "CD81-dependently" "CD90" "CDDO-Im" "CDK2A" "CDK2B" "CDK4-E2F1-let-7c"
    "CDK4-c-Myc-miR-15a" "CDK4overexpression" "CDKN2BAS" "CENPJ" "CEP-37440"
    "CEP120" "CEP17" "CEP213" "CEU" "CFU-F" "CG1218" "CGGA" "CH5424802"
    "CH7C17" "CHC-binding-independent" "CHC001" "CHD2-β-gal-neomycin" "CHK1i"
    "CHKI" "CHR" "CHZ" "CJ" "CJ-023423" "CK-666" "CK1a" "CKDs" "CLEOPATRA"
    "CLIP-seq" "CM-IL6+Tam" "CMA" "CMAs" "CMKLR1" "CNS2" "CNTN5" "CNVs" "CNX"
    "CNX2006" "CNX‐2006" "COA5" "COA7" "COAD" "COBRA" "COGS" "COLl11A1"
    "COMPASS" "COMPASS-like" "COMPETING" "CONSITE" "COPD-like" "COPD-status"
    "COS-1" "COSM26129" "COX7A2" "COXIV" "COX‐2" "CP-Be" "CPG" "CPM" "CPT1-a"
    "CPT11" "CRAF-A" "CRAF-D" "CRAF-MEK1" "CRISPR" "CRISPR-Cas9" "CRKL–C3G"
    "CS-1008" "CS-pathway" "CSMD1" "CT+CC" "CT-FIRE" "CT-FOXO3a"
    "CT-FOXO3a-overexpressed" "CT-FOXO3a-transfected" "CTCF-K" "CTCF-ΔPAR"
    "CTCFBSDB2.0" "CTG" "CTGF-C-Jun" "CTKD" "CUTTL1" "CXK" "CYB1B1" "CZ" "CaCl"
    "Caco" "Caco-V100" "CalcuSyn" "Cambridge" "Cand" "Capasso" "Carboxy-2"
    "Cardinale" "Carlo" "Carlson" "Caroli" "Caroli's" "Carracedo" "Carretero"
    "Case-control" "Case-only" "Case–control" "Caucasians" "Cd19-cre"
    "Cdc20-pS92" "Cdc20-pT70" "Cdc42" "Cdhl" "Cdk1" "Cdk4" "CellROX"
    "CellTiter" "CellTiter-Blue" "Cercopithecus" "ChAM" "ChIP-PCR" "ChIP-grade"
    "ChIP-on-chip" "ChIP-qPCR" "ChIP-qPCRs" "Chad" "Chalmin" "ChanSu"
    "Chandrika" "Charles" "Chd" "Chd4-NuRD" "Chd4-binding"
    "Chemo-radio-therapy" "Cheong" "Chhabra" "Chi-Square" "Chi-Squared"
    "Chi-square" "Chi-squared" "Chile" "Chilean" "Chilosi" "Chiu" "Chk1"
    "Chmielecki" "Chou" "Chou-Talalay" "Chou’s" "Chugai" "CiRS" "CiRS-7"
    "Cimprich" "Cirone" "Clara" "CldU" "Clear-cell" "Cleland" "ClinTrials"
    "ClinicalTrials" "Clinicopath" "Clinicopath-Ological" "Closed-loop"
    "Clovis" "Clyde" "Cn3D" "CoIP" "Coactivator-1" "Coactivator-1α" "Cochran"
    "Cochrane" "Coffin-Lowry" "Cohen" "Col1a2-EGFP" "Col1α2" "ColXA1" "College"
    "Colon26" "Colonocytes" "Compendia" "Complex" "Conclusions" "Conduritol"
    "Conduritols" "Connecticut" "ConsensusPathDB" "Contente" "Cordenonsi"
    "Cornelia" "Cornelissen" "Corr" "Cou" "Cou-Talalay" "Cowden"
    "Cox-proportional" "CpG106" "CpG42" "CpG53" "CpG85" "Craniopharyngiomas"
    "Cre" "CreERT" "CreERT2" "Crohn" "Crohn’s" "Cross-regulations"
    "Cross-resistance" "Cruz" "Ctgf" "Cu" "Cullin-E3" "Cuningham" "Curie"
    "Cx+Stattic" "Cyclacel" "Cyclo" "Cyclooxygenase‐2" "Cyclosome"
    "Cytokine-treatment" "Cι" "C‐X‐C" "C‐terminal" "C‐terminus" "C–1E"
    "C–Cdc20" "D-X-G" "D-box-dependent" "D-dimer" "D-domain" "D-domains"
    "D-loop" "D-loops" "D-type" "D10G4.1" "D122-Q126" "D13S1698" "D13S171"
    "D158A" "D1D2" "D1D2-(AXA)" "D1–D5" "D2" "D2-AXA" "D210A" "D216A" "D2H4"
    "D3" "D3-AXA" "D3-domain" "D374" "D384" "D4" "D5" "D69E" "DAAs" "DAQ" "DBZ"
    "DCN-like" "DCUN1D1" "DDBl" "DDXD" "DEB" "DED-A" "DED-AB" "DED-B" "DED-DED"
    "DED1" "DED1-DED2-EGFP" "DED2" "DEIS" "DEJL" "DER" "DET11" "DEVD"
    "DEVD-AMC" "DF12+bFGF" "DFO-ZEGFR" "DG" "DHPLC" "DHS-seq" "DIANA"
    "DIG-ddUTP-labelled" "DK" "DLD1" "DMH1" "DMS-79" "DN3a" "DN3b"
    "DNA-BD-fused" "DNA-DNA" "DNA-FISH" "DNA-ICL" "DNA-damage-induced"
    "DNA-protein" "DNAs" "DNA–Gata3" "DNS" "DNaseI" "DOXO" "DQFL" "DR-GFP"
    "DRE" "DREM" "DSBs" "DSS+AOM" "DSV" "DSVs" "DUF2228" "DXA" "DYNAFIT"
    "DYNNL1" "Dand" "Daniels" "Danish" "Danvers" "Darby" "Darmstadt" "Darnell"
    "Dasgupta" "Davalos" "De-etiolated" "De-repression" "DeNicola" "Dead"
    "Dean" "Debeb" "Dekanić" "Del19" "Deletion" "Delta-Like-4" "Demetriades"
    "Denmark" "Denu" "DerSimonian-Laird" "Derolf" "Desorption" "Dianova"
    "Dichens" "Dichens's" "Dick" "Dickinson" "Digitizer" "Dikic" "DiscoveRx"
    "Disheveled‐associated" "Di–v" "Doble" "Dock" "Dock-Rac" "Dock9-Luc"
    "Dohner" "Domenech" "Domingo" "Domingo-Domenech" "Donnell" "Doppler"
    "Doxorubincin" "Droplet" "Du" "Dual-antiplatelet" "Duclos" "Duffy" "Dufour"
    "Dulbecco" "Dulbecco’s" "Dunn" "Dunnett" "Durcan" "Dutta" "Duursma" "D–2E"
    "D–2F" "D–7F" "D–S6I" "D–S7F" "E-64d" "E-BOX" "E-MTAB-3479" "E-MTAB-3480"
    "E-MTAB-3482" "E-MTAB-3483" "E-X-S" "E-box" "E-boxes" "E-low" "E-marker"
    "E-markers" "E-twenty-six" "E-type" "E1F5A" "E1bLuc" "E2-depenedent"
    "E2-procapase-8" "E2-procasapse-8" "E2-procaspase-8" "E201A"
    "E2F-depenedent" "E31" "E6-immortalized" "E74-Like" "EAF20" "EAF30" "EBC"
    "EBPa-saRNA-transfected" "EBPα-saRNA" "EBPα-saRNA-dendrimer"
    "EBPα-saRNA-dendrimer-treated" "EBPα-saRNA-transfected"
    "EBPα-saRNA-treated" "EBP‐α" "ECF" "ECFs" "ECMs" "ECOG" "EGF-Like"
    "EGFR-Family" "EGFR-family" "EGFR-null" "EGFRm" "EGFRvIIIshGBP1"
    "EGFRvIIIshGFP" "EGFR‐TKI" "EGFR‐TKIs" "EGRF" "EIF4E1B" "EJ5-GFP" "EKT"
    "ELCWP" "ELL-associate" "ELL-shRNA-mediated" "ELL-shRNAs" "EMT-TFs"
    "EMT-activator" "EMT-activators" "EMT-inducers" "EMT-like" "EMT-markers"
    "ENSG00000113712" "ENT" "EOT" "EPHs" "ER-CD133-IL6R-IL6-Notch" "ER-ERaptR4"
    "ER-RNA" "ER-RasV12" "ER-group" "ER-positive" "ERE-ER" "ERE-luciferase"
    "ERGFR" "ERK-Gab1-PI3K" "ERRβ" "ERRγ-positivity" "ERSD" "ERaptR" "ERaptR1"
    "ERaptR1-ERaptR18" "ERaptR1-ERaptR5" "ERaptR17" "ERaptR5" "ERα-RNA"
    "ERα-aptamer" "ERα-aptamers" "ERα-random" "ERα-specific" "ERαK303R" "ERαKO"
    "ESA-2" "ESCRT" "ESKD" "ESMO" "ESO" "ESW" "ET=1" "ET=22" "ETGE" "ETOC"
    "ETP-ALL" "ETPs" "ETVl" "EU" "EU-5346" "EU5346" "EUFA1341" "EVTs" "EXII"
    "Eahy926" "Early-onset" "Early-stage" "Easton" "Ebersberg" "Eca"
    "EdU-Alexa488" "Edmondson" "Edmondson–Steiner" "Egger" "Egger's" "Egger’s"
    "Egyptians" "El" "Eleutherococcus" "Elsevier" "Em" "Emission" "End-stage"
    "EndoMT" "Engelbreth" "Engelbreth-Holm" "English" "Ensembl" "Entrez" "Enzo"
    "EpREs" "EpiSCs" "Epithelial-Mesenchymal" "Epithelial-mesenchymal"
    "Epithelial-to-mesenchymal" "Epithelium-like" "Epon" "Epoxomycine" "Eptein"
    "ErB3" "Erb3" "ErbB" "ErbB-family" "ErbB2-driven" "ErbB2-positive"
    "ErbB2-specific" "Essick" "Eucheuma" "Eurofins" "Europe" "European"
    "Europeans" "Evans" "Excitation" "Exon4delRev" "Eμ-Myc" "F-labelled"
    "F-site" "F-sites" "F0" "F0–F3" "F1" "F1-A" "F1-site" "F1-variant" "F114"
    "F114G" "F122" "F122A" "F122G" "F2" "F2-AA" "F2-AA-variants" "F2-site" "F4"
    "F48A" "F5" "FA-N" "FA-O" "FA-R" "FA-like" "FACTORS" "FACT‐C" "FADD-DD"
    "FADD-SLT4" "FADD-his" "FADH" "FADH2" "FAK-null" "FAK397" "FAK–Cas–Rac"
    "FALZ" "FAM19A4" "FAS" "FAS-agonistic" "FASL" "FAST-ACT" "FBCs" "FBS±4"
    "FC-IBC02" "FERM" "FERM-domain" "FEV1" "FEV1.0" "FFLs" "FFP" "FHF" "FIGO"
    "FIRE" "FLAG" "FLAG-C4orf27-associated" "FLAG-MLL5-CD" "FLI‐1" "FLJ22536"
    "FNAB" "FOLFOX" "FOXD2" "FQFP" "FRA1" "FRA17B" "FRB" "FRET-FLIM" "FSIP2"
    "FTI-277" "FTP" "FTYP" "FUNDING" "FXFG" "FXFP" "FXRα" "FYX" "Fagundes"
    "Fasan" "Feldkamp" "Feldman" "Ferreira" "Ferrell" "Ferriman" "Fi"
    "Fifty-seven" "Filomeni" "FinHER" "Finley" "Finnish" "Flachsbart" "Flag"
    "Flag-ERαK235R" "Flag-HBV" "Flag-tag" "Flag‐NAT10" "Flice" "Floess"
    "Flow-cytometric" "FlowJo" "Flp-In" "Flu-like" "Fluor-de-lys"
    "Fluorescent-labeled" "Fluoruracil" "FokI" "Follow-up" "Fon" "Forkhead"
    "Forty-four" "Forty-nine" "Forty-one" "Forty-six" "Forty-three"
    "Fos-family" "Fox" "Fra1" "France" "Francisco" "Franco" "Fraumeni" "French"
    "French-American-British" "FrequentPAX5" "Fridlyand" "Fritsch" "Fujiwara"
    "Full‐length" "Fulv" "Fulv-Toci" "FulvR" "FulvR-Bone-Met" "Furuta"
    "Fyn-deficient" "F–4I" "G+g" "G-banded" "G0" "G1" "G1-S" "G12" "G12C"
    "G12D" "G12V" "G13" "G1–S" "G1–S-phase" "G2" "G3" "G3-like" "G337Afs" "G60"
    "G60-γ-phosphate" "G6PD-kd" "G9a-dependent" "G9a-like" "G9a-recognition"
    "GABPβ1" "GATA3-DNA" "GBC-SD" "GC-box" "GDK" "GDK-100017" "GEF-CA" "GEF-DN"
    "GEF-WT" "GENDAI" "GFP-ATRIP-K32Q" "GFP-ATRIP-K32R" "GFP-BM5" "GFP-E2"
    "GFP-E2-expressing" "GFP-GEF-H1-constitutively" "GFP-GEF-H1-dominant"
    "GFP-Pyk2-WT" "GFP-SIRT7" "GFP-tagged-Pyk2" "GFP‐NAT10" "GG" "GG+AG"
    "GGAAG" "GGAATG" "GGCAGAGCA" "GGGGCATTCC" "GGRNNYYC" "GGT-I" "GGTI-2133"
    "GG " "GI" "GI50" "GIST-1" "GLOBOCAN" "GLuc1-A" "GLuc2-A" "GNA" "GPR68-YAP"
    "GRAMMX" "GRE" "GRK6A" "GS" "GSE10281" "GSE16011" "GSE18229" "GSE21576"
    "GSE30070" "GSE3494" "GSE60662" "GSE6783" "GSE67982" "GSE69280" "GSE69667"
    "GSE70135" "GSE73285" "GSE78916" "GSK-3β-activity" "GSK484" "GST-PAK-CD"
    "GST‐Mdm2" "GST‐p53" "GT-box" "GTAAACA" "GTEx" "GWASs" "Ga" "Gadd45α"
    "Gaidzik" "Gain-of-function" "Gajos" "Gal4-GATA3" "Galindo" "Galluzzi"
    "Garnett" "Garrett" "Gata3" "Gayther" "Gee" "Gel-Pro" "Geltrex" "GenBank"
    "Gene-wide" "GeneBank" "GeneScan" "Genentech" "Genomatix" "Genome-wide"
    "Genotype-Tissue" "Genotype-phenotype" "Genotype–Phenotype"
    "Genotype–phenotype" "Gerhardt" "Germain" "Germany" "Gertler" "GetData"
    "Gibbs" "Gibbs-Seymour" "Gibco" "GibcoBRL" "Giα" "Giα-subunit" "Glasgow"
    "GlaxoSmithKline" "Gleason" "Glenda" "Gli1-3" "Gln559ArgfsTer2"
    "Glu650Stop" "GlutaMAX" "GmbH" "Goldner" "Gosens" "Grb2" "Grb2-SOS"
    "Grinnemo" "Guan" "Guangxi" "Guanylate" "Guarente" "Guilmain" "Gujarati"
    "Gy" "Gymnema" "Gymnemoside" "Gα12" "G–4I" "G–S2I" "H&E" "H-Box" "H-HSQC"
    "H-Ras-GTP" "H-Ras-GppNHp" "H-RasV12" "H-bond" "H-bonding" "H-bonds"
    "H-glucose" "H-labelled" "H1" "H1-YAP" "H1792s" "H187Y" "H1993" "H1K26"
    "H2Bub1" "H3" "H3-T3" "H3.3" "H3K18" "H3K27" "H3K36" "H3K79" "H3K9"
    "H3K9Ac" "H3K9ac" "H3S10" "H4" "H4K16" "H4K16ac" "H4K20" "H538A-K540M"
    "H6SL" "H6SL#8" "H7" "H7D" "H9" "H9-YAP" "H9D" "HA-ATRIP" "HA-ATRIP-K32Q"
    "HA-ATRIP-K32R" "HA-tag" "HADDOCK" "HATS" "HBSMCs" "HCC827CNXR" "HCC827CXR"
    "HCC82CNXR" "HCI" "HCI-002" "HCI-009" "HCVcc" "HCVpp" "HD-BMSC"
    "HD-BMSC-derived" "HD-BMSCs" "HD180" "HD180-1" "HD180-10" "HD35" "HD57"
    "HD58" "HDA1" "HDAC3-CAGE" "HDAC3-CAGE-EGFR" "HDAC3-miR326" "HDAg" "HDLECs"
    "HEBalt" "HECT-domain-containing" "HEK393" "HELF" "HER-positive"
    "HER-therapy" "HER2-immunohistochemistry" "HER2-positive"
    "HER2-upregulation-induced" "HER2IGF‐1RIGFIRMTDRP2DTKIULN" "HER2‐positive"
    "HERVH" "HFF" "HFFs" "HGEc" "HGEc-1" "HGEc1" "HGF‐Low" "HGNC" "HGSCs"
    "HGSOC" "HGSOCs" "HIF-1σ" "HIF-α-subunits" "HIV-N" "HIV-RD" "HIV-Tat" "HJR"
    "HL-7702" "HLA-A2" "HLA-A2-BC" "HME50" "HMLE" "HMVEC" "HMVEC-L" "HNF-1β"
    "HNF-4α-Mut" "HNPCC-register" "HNSCCs" "HONE1-EBV-3188"
    "HONE1-EBV-miR-3188" "HOS-MNNG" "HOTTIP" "HPCs" "HPFx50" "HPRT" "HR-HPV"
    "HR-HPV18" "HR-HPVs" "HR-defective" "HR=1.31" "HR=1.37" "HR=1.46" "HR=1.56"
    "HR=2.39" "HS27A" "HSPB" "HT-therapy-induced" "HT29-tsp53" "HT29tsp53"
    "HTB171" "HTLA" "HTLA-230" "HTR-Bone-Met" "HTR-Bone-Mets" "HTR-Met" "HT‐29"
    "HUPKI" "HVD" "HWE" "HWJ" "Haaften-Day" "Haenszel" "Haigis" "Hainan"
    "Hakko" "Hales" "Hamacher" "Hamacher-Brady" "Hamburg" "Hancock" "HapMap"
    "HapMap2" "HaploReg" "Harders" "Hardy-Weinberg" "Hardy–Weinberg" "Hartman"
    "Hartwell" "Harvard" "Hasasna" "Hawkins" "Hayashi" "HbA1C" "HbA1c" "HbA1c "
    "HeLa-EGFP-EBP50" "HeLa-GFP-DRD3-Flag" "Health‐related" "Heatmaps"
    "Hebenstreit" "Hecc251" "Hedgehog-regulated" "Heidelberg" "Hein" "Heinrich"
    "Hela-S3" "Hematoxillin" "Hep2G" "HepG" "HepG2-hNTCP" "HepG2-sodium"
    "Her2-positive" "Hess" "Heymann" "HiSeq" "Hickey" "Hickson"
    "High-expression" "High-fidelity" "High-level" "High-risk" "Hilden"
    "Hindley" "Hippo" "Hippo-YAP" "Hippo-Yap" "Hippo-pathway" "Hiromura"
    "His-pull-downs" "His-tag" "His-ubiquitin" "His‐p53" "Hodges" "Hodgkin"
    "Hodgkin's" "Hoh" "Holm" "Hong" "Hosokawa" "Houston" "HpaII" "Hrs"
    "Hsa-miRNA-326" "Hsp-like" "HtrA4-GBS" "Huang" "Huggins" "Huh21-5"
    "Huh9-13" "Human-proIAPP-induced" "Hunninghake" "Huntington" "Huntington's"
    "Huntington’s" "Hussain" "Huwe" "Huwe-1" "Huwe-1-dependent" "Hwang"
    "Hwang’s" "Hyper-automodification" "Hyper-proliferation" "Hyperammonemia"
    "Hz" "Hürthle" "I-III" "I-IIIa" "I-IV" "I-associated" "I-type" "I680-Q815"
    "IAA" "IB-IVA" "IBC03" "IC50" "IC50s" "IC50 " "IC90" "ICAT‐positive" "ICCB"
    "ICI" "ICICLE" "ICL-hypersensitivity" "ICM-like" "ICRT14" "IDC-specific"
    "IDR-ERK2" "IETD" "IETD-AFC" "IETDase" "IFN-λ1" "IFNγ-non-producing"
    "IFNγ-producing" "IFO" "IGF-1R-positive" "IGF-IIR" "IGF-ligand" "IGFR-1R"
    "IGF‐1" "IGF‐1R" "IGF‐1‐induced" "IGF‐2" "IGF‐2R" "IGF‐R" "II-1" "II-2"
    "II-3" "II-4" "II-5" "II-6" "II-7" "II-III" "IIA" "IIC" "III+IV" "IIIb-IV"
    "III–IV" "IIX" "IIb" "IKB-α" "IL-18Rα" "IL-28 A" "IL6-Notch"
    "IL6–IL6R–ER-dependent" "ILK-homo-755" "ILKs" "IL‐11" "IMEx" "IMPAKT"
    "INDEL" "INDELs" "INF-γ" "INR" "INSS" "INT" "INVS" "IPEX-like" "IQ" "IQR"
    "IRIF" "IRS-dependent" "IRS-gene" "IRS-null" "IS-like" "ISG" "ISGs" "ISSN"
    "ITAG3" "ITAG5" "ITBG5" "ITC" "ITD" "ITGB1-mu" "ITGB1expression" "ITIDP"
    "IU" "IUAs" "IVA" "IVF" "IVIS" "IVS" "Ib" "Ich-1" "IgG2a-to-IgG1" "Ikkα"
    "Il" "Il-17A" "Illumina" "Imaris" "Immune-histological" "Immune-staining"
    "Impedance" "In-225" "In-ABY-025" "In-Cell" "In-DOTA-ZEGFR" "In-EGF"
    "In-labeled" "In-vitro" "Inc" "Independent-Samples" "Indians" "Ingelheim"
    "Insertion" "Institut" "Insulin-AKT" "Insulin-dependent" "IntAct"
    "Inter-endothelial" "Interferin" "Intra-individual" "Invitrogen"
    "Iodotubercidin" "Ionization-time" "Iparraguirre" "Isertion" "Ishitani"
    "Itahana" "Italians" "Itamochi" "Ivan" "Ivemark" "Iwafuchi" "Iwafuchi-Doi"
    "I–II" "I–III" "I–IV" "I–S4L" "I–talazoparib" "J64" "J7" "J77" "JAK2V617F"
    "JAR" "JE-Renal-TMA" "JFH1" "JIMT-1BR3" "JMJD6-expressing" "JNK-IN-8" "JPT"
    "JQ" "JQ1" "JRL" "JUN-V5" "JUNB" "JUND" "JWY" "JZW" "Jadad" "Jaenisch"
    "Jagged1" "Jagged1KO" "Jan" "Japanese" "Jarde" "Jena" "Jeol" "Jett" "Jeune"
    "Jewish" "Jews" "Jiang" "Jinesh" "Jolad" "Jonathon" "Jordan" "Joseph"
    "Joshi" "Joslin" "Ju" "Jun-family" "JunD-dependent" "Jung" "J–S4L"
    "K-Homology" "K-Ras4B-GDP" "K-Ras4B-GTP–GAP" "K-Ras4B–GTP" "K12"
    "K120‐acetylated" "K19‐Wnt1" "K25" "K266" "K299" "K302" "K303" "K382" "K3R"
    "K51" "K78I-C430S" "KAA-2" "KARD" "KAS" "KD1" "KD2" "KDM5" "KEAP1-mediated"
    "KEGG" "KIFGSLAFL" "KIMs" "KJ" "KM1468" "KMN" "KMTs" "KOs" "KPS" "KRR"
    "KT-MT" "KU" "KW‐2450" "Kabyle" "Kakar" "Kanfi" "Kaplan" "Kaplan-Meier"
    "Kaplan-Meir" "Kaplan-Meyer" "Kaplan–Meier" "Kaposi" "Kaposi's"
    "Kappaphycus" "Karmali" "Karnofsky" "Karnovsky" "Karnovsky’s" "Karrasch"
    "Kassen" "Kathleen" "Kaunas" "Kelch" "Kelliny" "Kerr" "Kg" "Ki-67"
    "Ki-67-dependent" "Ki-67-interacting" "Ki-67-negative" "Ki-67-positive"
    "Kilic" "Kim" "Kimmelman" "Kirin" "Kirsten" "Kit-8" "Klionsky" "Knappskog"
    "Kohno" "Kong" "Konigshoff" "Korea" "Korean" "Kossatz" "Kottmann" "Kou"
    "Kozomara" "Kp1080" "Kp2022" "Kramer" "Kroemer" "Kruppel-like"
    "Kruskal-Wallis" "Krüppel-Like" "Kugel" "Kumawat" "Kuo" "Kupffer" "KvDMR"
    "Kwong" "Ky" "Kyoto" "Kyowa" "L-LTP" "L-Myc" "L-loop" "L1" "L115" "L115G"
    "L123" "L123A" "L123G" "L130G" "L3" "L401A" "L5" "LBK1" "LBY" "LBY135"
    "LC3-I" "LC3BII" "LC3I" "LC3II" "LCSCs" "LCTSGR1" "LDKR" "LDN" "LE"
    "LEQKINNY" "LFZ" "LGSC" "LGSCs" "LIN-11" "LINC00222" "LINC00251"
    "LINC01225" "LIRF" "LKB1-null" "LKB1has" "LLIs" "LMS49" "LMS51" "LMS6"
    "LMS61" "LMS71" "LN-111" "LN-211" "LN-411" "LN-511" "LN-511and" "LN-521"
    "LNM" "LOC101928858" "LOC149086" "LOC728084" "LPS" "LPS-treatment" "LPSs"
    "LP‐1" "LR" "LR-HPV" "LTR" "LUAD" "LV-siNC" "LV-siVEGF-D" "LVNEELKGKV"
    "LVSELK" "LVSI" "LXL" "LXXϕ" "LacO" "Lact" "Lalezari" "Lamalice" "Lange"
    "Lanka" "Lapatinib" "Larkin" "Latin" "Latorre" "Lauren" "Laxman" "Lazenby"
    "LecB" "Lecavalier" "Lef" "Lefort" "Lehmann" "Leica" "Leonard"
    "Leszczynska" "Let-7a" "Let-7f" "Lewy" "Leydig" "Lhermitte" "Li"
    "Li-Fraumeni" "Lieberman" "LigandTracer" "Linher" "Linher-Melville" "Liszt"
    "Liu" "Liu’s" "Live" "Live-cell" "Llanos" "Loboda" "Localisation-dependant"
    "Log-Rank" "Log-rank" "London" "Lorenzo" "Los" "Low-density" "Low-level"
    "Low-power" "Lowenberg" "Lowry" "LoxP" "Ltd" "Lu" "Luc-ITGB1-mu"
    "Luijsterburg" "Lukey" "Luminal-A" "Luminal-B" "Lund" "Lundberg"
    "Lv-Rescue" "Lv-shRNA" "Lv-shRNA2" "LvBr4" "LvBr5-Luc" "Ly" "Lynparza"
    "Lénart" "Løken" "L–1" "M-S-pT" "M-arrest" "M-low" "M-marker" "M-markers"
    "MA07" "MARK1–4" "MATCONT" "MATERIALS" "MB-157" "MB-468" "MBCs"
    "MBP-421-701aa" "MC159" "MC3T3_E1" "MCATs" "MCF-7ATCC" "MCF-7L"
    "MCF7-parental" "MCF7p" "MCL-1S" "MCM2-7" "MDA-IBC03" "MDSC" "MDSCs"
    "MEC-3" "MEM" "MET-RNA2" "MET-mediated" "METIV" "MET‐High" "MET‐Low"
    "MET‐TKI" "MHC" "MHCC97H-Lv-shRNA" "MHCC97H-sh-Hsp27" "MHCp" "MI-63"
    "MI-888" "MI0000479" "MIAT" "MICER" "MIIA" "MIR143HG" "MIR200C" "MIR34A"
    "MIRCHIP2" "MK-0752" "MK-571" "MKI67IP" "ML-141" "ML311" "MLL-ELL-related"
    "MLL5-CD" "MLL5-CD4-S861A" "MLL5-siRNA–transfected" "MLN8327" "MM-PBSA"
    "MMR-defective" "MMSE" "MMTV-Myc-driven" "MMTV-PyMT" "MNK45" "MNase-seq"
    "MNuMG" "MOF-dependent" "MOPD-II" "MOSCATO" "MPO-1-labeled" "MRE" "MRE21"
    "MRE21-1" "MRE21-2" "MREs" "MRLCS19" "MS" "MSC-CAF" "MSs" "MS–MS"
    "MT1-MMP-positive" "MTB-TOM" "MUGA" "MUMBO" "MUSK" "MVECs" "MWG"
    "MYB1-like" "MYCLos" "MYCN-preferential" "MYST‐type" "MZL" "MacDonald´s"
    "Machado" "Machado-Joseph" "Madin" "Madin-Darby" "Maik" "Maldergem"
    "Manassas" "Mantel-Cox" "Mantel-Haenszel" "Marburg" "Marcucci" "Maris"
    "Markevich" "Martinez" "Masahiro" "Massie" "Masson" "Masson’s" "Material"
    "Matos" "Matteucchi" "Mauritius" "Mbp" "McDonnell" "McGovern" "McGuinness"
    "McMullen" "Mdm2‐induced" "Mdm2‐mediated" "Mdm2‐null"
    "Mechanisms-of-action" "Meckel" "Mediterranean" "Medline" "Mehlen" "Meier"
    "Meir" "Melville" "Memory-type" "Mendoza" "Mendoza-Villanueva" "Menendez"
    "Meng" "Meraldi" "Merkel" "MetMS" "MetSyn" "Meta-regression" "MetaCore"
    "Methodology" "Methods" "Mexican" "Meyer" "Mi-3" "MiR-26a-mediated"
    "MiR-326" "MiR-374a" "MiR-494" "MiRanda" "Michael" "Michishita"
    "Micro-irradiation" "MicroRNA-126" "MicroRNA‐21" "Mielgo" "Mikels"
    "Milbrandt" "Millipore" "Minna" "Mir34" "Missing-1" "Mitotracker"
    "Mitsudomi" "Mizushima" "Mll" "Mock-treated" "Moffatt" "Moffatt’s" "Mok"
    "Mon1a–CcZ1" "Monlucon" "Monte" "Morbus" "Moreno" "Morikawa" "Moroccan"
    "Morris" "Mostoslavsky" "Mre11-Rad50-Nbn" "Mtp53" "Multi-cytotoxic"
    "Munich" "Muscarella" "Mxd" "Mxs" "Myc-Pyk2-WT" "Myc-overexpressing"
    "Myc83" "MycER" "Myomegalin" "Mz-Ch-A1" "Müllerian" "N-7" "N-acetyl"
    "N-factors" "N-labelled" "N-loops" "N-region" "N-regulatory" "N0" "N0–N1"
    "N2B27+2iFL" "N7" "NA" "NACUAAY-N1–20-UAAY" "NAFL" "NAP" "NAP-5" "NAT10‐D5"
    "NAT10‐binding" "NAT10‐depleted" "NAT10‐mediated" "NAT10‐specific" "NAs"
    "NBRE" "NBREs" "NCBI" "NCBRF" "NCI" "NCI-H3122" "NCIC" "NCN12" "NCOAs"
    "NC_000011.10" "ND-BE" "NEC" "NEDD4‐1" "NEEC1" "NEK" "NEK8-GFP-WT" "NEO"
    "NF-κΒ" "NF70" "NF‐κB" "NGM" "NH" "NHE1cdt" "NHGRI" "NICU" "NIFK-Ki-67"
    "NIKF" "NK1295" "NKI" "NKI-295" "NKI295" "NL" "NLuc" "NM-001558.3"
    "NOD-like" "NORE1A-dependant" "NOX5-S" "NOXs" "NR4A" "NR4As" "NRF2-HIFα"
    "NRG1-action" "NRSSs" "NS-2" "NS5A-LARP1-Mediated" "NSABP" "NSC2376"
    "NSCCLC" "NSV" "NTUH" "Nabeshima" "Naive-Associated" "NanoLuc" "Narendra"
    "Nbn" "Nck" "Near-native" "Neh4" "Neh5" "Nemo‐like" "NeoSphere"
    "Nestin-reactive" "Netrin" "Netrin-1-Fc" "Netrin-1-Fc-treated"
    "Netrin-EGFR-endogenous" "Netrin’s" "Newcastle" "Newcastle-Ottawa"
    "Next-generation" "Nguyen" "Ni" "Niederer" "Nielsen" "Nilbert@regionh"
    "Nilsson" "Nisonger" "Nogo-A" "Nogo-C" "Non‐small" "Noonan" "Notch"
    "Notch-ERBB" "Notch-dependent" "Notch-induced" "Notch-triggered" "Notch1"
    "Notch3" "Notch3-mediated" "Notch–Jagged1" "Nov" "Novartis" "Novicure"
    "Novosibirsk" "Nrf" "Nrf2" "Nrf2-ARE" "Nrf2-DN" "Nrf2-Trx1"
    "Nrf2-activators" "Nu" "Nur" "NurRE" "Nusse" "Nwasp" "Nwasp-decreased"
    "N + " "N‐acetyltransferases" "N‐terminal" "N‐terminus" "N–S7P" "O-3a"
    "O-glycosylation" "OB-induced" "OB-lineage" "OCP" "OCT3" "OD550" "OGX"
    "OGX-411" "OH" "OIM" "OL2A1" "OLA" "OLA1P1" "OLA1P2-P1"
    "OLA1P2-mutated-treated" "OMIM" "OP9-Delta-like" "OR=0.55" "OR=1.40"
    "OR=1.54" "OR=1.55" "OR=1.75" "OR=2.94" "ORC1-6" "ORR" "ORs" "OR = 0.55"
    "OR = 1.54" "OR = 2.94" "OSI" "OSat" "OTII" "OV011" "OV04" "OV10"
    "Objective" "Ofran" "Okabe" "Okumura" "Oligofectamine" "Onat"
    "Oncogenic-Dbl-induced" "Oncology" "Oncomine" "One-hybrid" "One-shot"
    "One-way" "Operon" "Opti" "Opti-MEM" "OptiPrep" "Oran" "Origene" "Orsenigo"
    "OsO" "Oscillatoria" "Ossenkoppele" "Ostronoff" "Ostrow" "Otomo" "Ottawa"
    "Ou" "Ovar" "Oxnard" "Oxnard’s" "Ozasa" "P1" "P1032Cfs" "P1032Cfs*11"
    "P110α" "P13K" "P2" "P34" "P53A" "P57S" "P7" "P=0.001" "P=0.007" "P=0.011"
    "P=0.013" "P=0.021" "P=0.033" "P=0.034" "P=0.043" "PA-treatment" "PALOMA-1"
    "PALOMA-2" "PALOMA-3" "PANC‐1" "PAPR" "PARP-1-Timless" "PARP-DNA"
    "PARP-PI3K" "PARPi" "PARPi-FL" "PARPis" "PARTICIPANTS" "PAT8988" "PATU8988"
    "PAX5‐transfected" "PB-group" "PBLs" "PC14PE6-LvBr5-Luc" "PC2-like"
    "PCNT-patient" "PCR-DHPLC" "PD0325901+CHIR99021" "PDH-A" "PEG300" "PETACC"
    "PETACC-3" "PF-05212384" "PF-271" "PF-4989216" "PF-562,271" "PF-573,228"
    "PF271" "PFKB3" "PGC1-α" "PGL" "PGL4" "PGL4-154" "PGL4-1621" "PGL4-2148"
    "PGL4-325" "PGL4-444" "PGL4-57" "PGL4-717" "PGL4-988" "PGL4-AP-1mut1"
    "PGL4-AP-1mut2" "PHA" "PHA‐665752" "PHF20-dependent" "PHF20L"
    "PI3K-dependent" "PI3K-specific" "PI3KCA" "PI3K–AKT" "PI3k" "PIDD-C"
    "PIDD-CC" "PIDDosome" "PIKKs" "PINK1-null" "PKC-ζ" "PKCθ" "PKGQ" "PLK1-KM"
    "PLK4-siRNA–transfected" "PMCol" "PMSCs" "PND-1186" "PNS" "PONDR" "PP-242"
    "PPIs" "PROMO" "PSKKR82" "PSalpha" "PT-PCR" "PT1" "PT1cells" "PTBs"
    "PTENandPDCD" "PTENandPDCD4can" "PTEN‐High" "PTEN‐Low" "PTС" "PU" "PV=1"
    "PV=6" "PYZ" "Paget" "Paget's" "Paggetti" "Pakistani" "Pamela" "Paneth"
    "Papandreou" "Paradisi" "Parent´s" "Parkin-mediated" "Parkinson"
    "Parkinson's" "Parkinsonism" "PatchDock" "Patients" "Pattingre" "Patu8988"
    "Pearson" "Pearson’s" "PenH" "Peng" "Pennsylvania" "Pepstatin" "Peptidyl"
    "Per-2" "Perera" "Perham" "Petersen" "Petersen's" "Petri" "Petterson"
    "Pf0-1" "Pfam" "Pfizer" "PgE2" "Phang" "Philadelphia" "Pifithrin-α"
    "Pilpel" "Pl88" "Pl88A" "Planchard" "Plano" "Plk1-null" "Plk1functions"
    "Plk1mitotic" "Plki" "PolII" "Polletta" "Pollyea" "PolyPhen" "PolyPhen-2"
    "Polyphen-2" "Popowicz" "Positron-emission" "Post-operative" "Povlsen"
    "Poxviridae" "Priet" "Principal" "Principal-component" "Pro-Viral" "ProSpC"
    "Probesets" "PrognoScan" "Progression‐free" "Proinsulin" "Promega"
    "Proof-of-principle" "Protein-DNA" "Proten" "Puigserver" "Puigserver’s"
    "Pull-down" "Purkinje" "Purpura" "PyMOL" "Pygo" "Pygopus" "Pyro"
    "P = 0.017" "Q-MSP" "Q166A" "Q4" "Q559RfsTer2" "Q61" "QKI-5" "QKI-6"
    "QKI-7" "QREs" "QSAR" "QT" "QTDT" "QTcF" "QW" "QZ" "QZZ" "Qiagen" "Qingdao"
    "Qiu" "Qk" "Qki5" "Queensland" "R&D" "R-HDAC3-Flag" "R-Rescovitine"
    "R-group" "R0" "R015" "R015I" "R05I" "R1.40" "R105" "R105I" "R105l" "R109K"
    "R111K" "R113K" "R127K" "R175H" "R175L" "R2" "R2-IcD" "R239A" "R249S"
    "R26-Ttf1-Cre" "R26RmT" "R26hAR" "R273H" "R280K" "R2PD" "R41A" "R4K" "R5"
    "R5-tropic" "R5E" "R6" "R65-E69" "R76K" "R789" "RAB-7" "RAB-7-containing"
    "RAD3-related" "RAdM" "RAdnCD40L" "RCB" "RCBIII" "RCD" "RD5A2" "REH-empty"
    "REML" "RERT" "REVIGO" "RFLP" "RFP-Mxd" "RGEc" "RHO-like" "RING"
    "RING-FINGER" "RIP1-DD" "RIPK1-RIPK3-mediated" "RMSD" "RMSF" "RNA"
    "RNA-ERα" "RNA-FISH" "RNA-Recognition-Motif" "RNA-protein" "RNA-pulldown"
    "RNA22" "RNAhybrid" "RNAi-complementation" "RNAse-R" "RNC" "RNU6" "RO-2443"
    "RO4" "ROBO" "ROBO1-activating" "ROBO1-induced" "ROI" "ROR-γT"
    "ROSStatTCGATNF‐αTLR" "RP-Be" "RP2D" "RPA-70" "RPA-ssDNA" "RPMI-1640"
    "RPMI-1788" "RPS6KB" "RR=0.21" "RRAGs" "RRPA" "RRR-AT" "RRR-α-tocopherol"
    "RSV" "RT‐PCR" "RUNX" "RWPE" "RXH" "RXRXXpS" "Rab7b" "Rad3" "Rad3-related"
    "Radiotherapy-induced" "Radoshevich" "Raine" "Random-effect" "Ranjan"
    "Rap-GTPases" "Ras-ERK-dependent" "Ras-GppNHp" "Ras-IP" "Ras-Raf1-MEK"
    "Ras-dependant" "Ras-effector" "Ras-immunoprecipitates" "Ras-like" "Rathke"
    "Rathke’s" "Rb" "Re-addition" "Re-biopsies" "Re-distribution" "Realtime"
    "Redmond" "Refseq" "RegRNA2" "Reichert" "Reichert-Jung" "Reiter" "Reiter’s"
    "Rembrandt" "Renal-Hepatic-Pancreatic" "Renilla" "Renneville"
    "Replication-competent" "Rescovitine" "Respir" "Rh123" "Rho-family" "RhoA"
    "RhoG" "RhoGTPases" "Rhodamine" "Rhodiola" "Rhus" "Richardson" "Riggs"
    "Riley" "Roberts" "Robertsson" "Robinson" "Roesch" "Romero"
    "Romero-Martinez" "Ronnebaum" "Rosa" "Rosa26" "Rosa26-mT" "Rosa26rtTA"
    "Roth" "Rousseau" "Rowe" "Rs2228480" "Rs3798577" "Rsk1" "Ruben"
    "Rubinstein" "Rus" "Rushworth" "Russia" "Rutgers" "Ruvalcaba" "RxL"
    "Rygaard" "Rìos" "Rìos-Moreno" "S-P-x-K" "S-adenosyl" "S-fraction"
    "S-labeled" "S1" "S1-nuclear" "S153A" "S15E" "S1981" "S1C" "S1D" "S1E"
    "S1F" "S1G" "S1H" "S1d" "S1i" "S1–S4" "S2-S3" "S2A" "S2B" "S2C" "S2D" "S2E"
    "S2F" "S2G" "S2H" "S2I" "S2J" "S2K" "S2KO" "S2L" "S2M" "S2N" "S2d–e" "S2e"
    "S2f" "S2f–g" "S2g" "S2–S3" "S3" "S339-340" "S3A-D" "S3C" "S3D" "S3E" "S3F"
    "S3G" "S3d" "S3e" "S3f" "S4-S5" "S4A" "S4B" "S4C" "S4E" "S4F" "S4F10" "S4G"
    "S4H" "S4I" "S4L" "S4a" "S4c" "S4d" "S5A" "S5A-D" "S5B-D" "S5D" "S5E"
    "S5E-G" "S5E-J" "S5F" "S5c" "S6" "S6-double-positive" "S6A-C" "S6F" "S6J"
    "S6L" "S6a" "S7" "S723" "S726" "S72A" "S72E" "S7A" "S7A–C" "S7B" "S7J"
    "S7L" "S8" "S84A" "S8A" "S8B" "S8C" "S9" "S92A" "S96A" "S9A" "S9C" "S9E"
    "S9F" "S9H" "SA-β-Gal-positive" "SAAH" "SAFIR01" "SAKRAS" "SAKRAS " "SALEB"
    "SANT" "SANT-SLIDE" "SBEC" "SBECs" "SCARNA10" "SCARNA13" "SCARNA6" "SCr"
    "SDS–polyacrylamide" "SEREX" "SGC" "SH2-domain" "SH3-domain" "SH3-domains"
    "SI3" "SIFT" "SILAC" "SIRT1-postive" "SIRT3-OE" "SIRT5-substrate" "SIRTs"
    "SISH" "SJZ" "SK-N-DZ" "SKG-IIIa" "SKOV3ip" "SLIT" "SM" "SMARTpool"
    "SMCC7721" "SMCC7721-Lv-shRNA" "SMMC" "SMMC‐7721" "SNAP-IV" "SNORA73A"
    "SNORA73B" "SNP285" "SNP285C" "SNP309G" "SNP309T" "SNP309TG" "SNP309T "
    "SNPs" "SNVs" "SNaPhot" "SPADE" "SPD" "SPD-5" "SPQ" "SPSS" "SR" "SR-11302"
    "SR11302" "SRC-SH3-binding" "SRC-mitogenic" "SRC1-3" "SRC3-C" "SRC3-M"
    "SRC3-N" "SRNS-like" "SS-like" "SSCP" "SSU" "STACs" "STATA" "STCC" "STIL"
    "SU-DHL-1" "SU11333" "SU2C" "SUBSTRATES" "SUN387" "SUNE1-3188"
    "SUNE1-miR-3188" "SUVmax" "SVneo" "SXSW" "SXSW-1489" "SYPRO" "SZ" "Saito"
    "Salisbury" "Salomon" "Sanger" "Sansone" "Sante" "Saquib" "Sasaki"
    "Sathyan" "Satoh" "Saudi" "Saurus" "Sauve" "Saxby" "Schephartz"
    "Schisandra" "Schizosaccharomyces" "Schrödinger" "Schubert" "Schuh"
    "Schwalbach" "Schwann" "Scol" "Sd" "Seckel" "Second-generation"
    "Selleckchem" "Sendai" "Senior-Løken" "Sensenbrenner" "Sept" "Sequence-2"
    "Ser-Ser-X-Ser" "Ser235" "Ser321" "Serum-borne" "Setif" "Seung"
    "Seventy-one" "Seventy-two" "Seymour" "Sgo1" "ShS" "ShS3-HTR" "Shahin"
    "Shakibaei" "Sharma" "Shc" "Shen" "Sherr" "Shh-pathway" "Shima" "Shinde"
    "Shiraishi" "Short-term" "Short‐term" "Shramm" "Sigma-Aldrich" "SigmaStat"
    "Significance" "Simvastain" "Sinclair" "Sinclair’s" "Singh"
    "Single-cell-track" "Single-nucleotide" "Sir2p" "Sirt1-ASO"
    "Sirt1-ASO-induced" "Sirt1-ASO-treated" "Sirt1-SO" "Sirt1-SO-treated"
    "Sirt1-dependent" "Sirt1-mediated" "Sirt1-null" "Skov" "Skpla" "Sladek"
    "Slit-diaphragms" "Sloan" "Sm22a" "Smad" "Smad1" "Smad2" "Smad3"
    "Smad3-mediated" "Smads" "Snail" "Soochow" "Sos" "Souza" "Souza-Fagundes"
    "Sox" "Sox4-4" "Sox4-BEs" "Sp1-dependently" "Spanish" "Spearman"
    "Spearman's" "Spessotto" "Spi-1" "Src" "Src-Rl75L" "Src-W118K"
    "Src-substrate" "Src-ΔSH2" "Src-ΔSH3" "Srebp-1c" "Sri" "Srx-1" "Stallcup"
    "Stanger" "Stat3" "Stata12.0" "States" "Steady-state" "Stefansson"
    "Steiner" "Steroid-sensitive" "Stevenson" "Stf4" "Streaker" "Streptolysin"
    "Stress-induced" "Stupp" "Sub-optimal" "SubG1" "Sunamura" "Sundaresan"
    "Sung" "Super-enhancer" "SurePrint" "Susp" "Switzerland" "Sym" "T-3A"
    "T-P-X-R" "T-Rex" "T-RexB" "T-allele" "T-bet-dependent" "T-cell"
    "T-cell-bead" "T-lineage" "T-lymphoid" "T-sites" "T-ψ" "T1" "T156" "T1D"
    "T1DM" "T1–T2" "T2" "T2-staged" "T202" "T234A" "T238A" "T24R2" "T2D" "T2DB"
    "T2DM" "T2DM-AD" "T2DM-MCI" "T2DM-nMCI" "T2MD-nMCI" "T3" "T3-1.6"
    "T3-staged" "T35-γ-phosphate" "T3–T4" "T4" "T4-staged" "T47D-parental"
    "T47Dp" "T47Dr" "T5" "T70A" "T790M" "T839_K862del" "T87A" "TAK-TAB"
    "TAK1-TAB" "TALEN" "TALENs" "TAM67" "TAMRAD" "TARG" "TATA" "TAZ-TEAD"
    "TAZ4SA" "TCF12alt" "TCFs" "TCH" "TCID" "TD" "TDFA" "TDHA" "TDP222669"
    "TDSCs" "TDSCs " "TEA" "TEAE" "TET-off" "TFARs" "TFBC" "TFBCs" "TFBS"
    "TFBSs" "TFCP2L1" "TFSEARCH" "TFbind" "TGACTCAGCA" "TGAGTCAG"
    "TGF-ß1-treated" "TGF-β1-treatment" "TGFβR1" "TGFβRII" "TGM2#1" "TGM2#2"
    "TGO" "TGTTTAC" "THIIF" "TID" "TKI-naïve" "TL-32711" "TLA100.3"
    "TM-FOXO3a-overexpressing" "TM-FOXO3a-transfected" "TMN" "TMRPSS2" "TMT"
    "TMV" "TMVs" "TNBCs" "TNFRS6B" "TNF‐α" "TNF‐α‐dependent" "TOP-luciferase"
    "TP53-null" "TP53BPS" "TPA" "TRA-1-60" "TRA-1-81" "TRADD" "TRAIL-R"
    "TRAIL-R-agonistic" "TRAIL-R-expression" "TRAIL-R-induced"
    "TRAIL-R-mediated" "TRAIL-R-signaling" "TRAIL-R-stimulation"
    "TRAIL-R-targeting" "TRAIL-R1-IcD" "TRAIL-R4-IcD" "TRAIL-sensitivity"
    "TRAIL-system" "TRIO-22" "TRIO18" "TRIO22" "TRKs" "TRYPHAENA" "TST887"
    "TST887AAA" "TT+CT" "TTAGGG" "TTCA" "TUJ" "TUJ1" "TV" "TV-box" "TWIST1"
    "TWIST1observed" "TWS" "Taiho" "Taiwan" "Taiwanese" "Takahashi" "Takasaka"
    "Talalay" "Tali" "TamR" "TamR-FACS-isolated" "TamR2" "Taqman"
    "Target-specificity" "TargetScan" "TargetScanHuman" "TargetScreen"
    "Taskesen" "Tasmania" "Tat-elicited" "Tat-induced" "Tat-mediated"
    "Tat-treated" "Taz" "Tcf" "Tcf-4" "Tcf4" "Tead-AP1" "Tead-JunD" "Tead1"
    "Tead4" "Tead4-Luc" "Tebaldi" "Tef" "Teff" "Telomerase-positive" "Tetsuya"
    "Texas" "Tg" "Tg19959" "Th17" "Thailand" "Thakur" "Therascreen"
    "Third-generation" "Thirty-four" "Thirty-one" "Thirty-seven" "Thirty-six"
    "Thirty-two" "Thirumurthi" "Thorburn" "Thr-Asp-F-amidine" "Thr180"
    "Thr1989" "Thr202" "Thr839-Lys862" "Thr839_Lys862del"
    "Thr887-Ser888-Thr889" "Thr887-Ser888-Thr889-Pro890" "Thrombin-RNA"
    "Thy1069" "Time-course" "Timless" "Titer-Glo" "Tiwst2" "Toci" "Todd"
    "Tokyo" "Toll-like" "Toll‐like" "Tordjman" "Tramtrack" "TransAm" "Transfac"
    "TrexB" "Trichrome" "TrioN" "Tris-HCl" "Tristeraprolin" "Trp53" "Try204"
    "Tsai" "Tsuchiya" "Ttf" "Ttf1-Cre" "TuRC" "Tukey" "Tukey-Kramer"
    "Tumour-to-organ" "Tunel" "Turkish" "Twenty-eight" "Twenty-five"
    "Twenty-nine" "Twenty-three" "TwinsUK" "Twist1" "Twist2-DNA" "Two-state"
    "Two-way" "Ty1" "Type-2" "Tyr182" "Tyrphostin" "Tyverb" "T " "Tβ4" "U133"
    "U14" "U2-O-S" "U87-DK" "U87-EGFRvIIIshGFP" "U87-parental" "UB" "UCN"
    "UCSC" "UCSs" "UCr" "ULMSs" "UMOD" "UNC" "UNC-01" "UNC337" "UNC5" "UNC5s"
    "UNCX" "UPII-Cre" "USA" "UT-SCC-2" "UTRs" "UV" "UV-A" "UV-C-induced" "UVs"
    "UV‐induced" "UV‐mediated" "UW9920" "Ubiquitination" "Ubiqutin"
    "Ultra-structure" "Ultracut" "Uni-axial" "Unigene" "Uniprot" "Upk" "Uptima"
    "Utah" "Utah-Europeans" "Utx" "U‐box" "V-Ki-ras2" "V-P-E" "V1" "V1-1"
    "V163-A206del" "V2" "V3" "V3a" "V3b" "V5" "V5-conjugated" "V5-tag"
    "V5-tagged" "V5a" "VCAM" "VCAM-I" "VE" "VE-cadherin-CreER" "VE1" "VEGAS2"
    "VEGR2" "VH10" "VH10-SV40" "VLuc" "VNTR" "VPREB" "VPS34-IN1"
    "VPS34-dependent" "VS-5095" "VS-6063" "VSV-G" "VSV-G-pseudotyped"
    "Val163-Ala206del" "Valls" "Vargula" "Vater" "Vav1-creanimals" "Vavl"
    "Vavl-cremice" "Vector" "Veh" "Venice" "Venus" "Verastem" "Verdin"
    "Vernalis" "Vichow" "Vieira" "Villanueva" "Vina" "Virchow" "Vl87" "Vl87A"
    "Vora" "Vps27" "Vuga" "V–VI" "W118K" "W42A" "WBC" "WBCs" "WCLs"
    "WD40-repeat" "WDTCs" "WNT" "WST1" "WT-hECs" "WTp53" "Waals" "Wajapeyee"
    "Wald" "Walle" "Wallis" "WanFang" "Warburg" "Wave1" "Weedon" "Weinberg"
    "Weisdorf" "Western" "Wettstein" "Whitney" "Whole-heart" "Wilcoxon"
    "Willcox" "Wingender" "Withaferin" "Withaferin-A" "Wls" "Wnt3"
    "Wnt3a‐positive" "Wnt5b" "Wnt‐induced" "Wouters" "Wu" "Wuhan" "Wurzel"
    "WxxF" "X-box" "X-inactivation" "X-ray" "X-rays" "X-shape" "X114–based"
    "X4" "X4-tropic" "XC" "XD" "XL" "XL-5" "XL5" "XRCC" "XRCC4-LigIV" "XTT"
    "XTX" "XW" "XX" "XY" "XYZ" "Xa" "XaXa" "Xeloda" "Xia" "Xl" "Xq11-12"
    "Y-labelled" "Y012A" "Y102A" "Y1183Ter" "Y183D" "Y183F" "Y204" "Y2285X"
    "Y238A" "Y551Ter" "Y576" "Y579" "Y8" "Y8D" "YA" "YAP-mediated" "YAP5SA"
    "YASARA" "YCL" "YFPP" "YLSGADLNL" "YRPW" "YU-2" "YZ" "Yamamoto" "Yamanaka"
    "Yamano" "Yamato" "Yang" "Yantai" "Yap" "Yates" "Yeo" "Yes"
    "Yes-associated" "Yeung" "Yin-PSCs" "Yongfu" "Yosef" "Yoshimori" "Younes"
    "Youngjoo" "Yu" "Yufang" "Z-DON" "Z-score" "Z-scores" "ZBTB7A" "ZEB1–YAP"
    "ZEGFR" "ZLJ" "ZM39923" "ZM44739" "ZMP" "ZOOM" "ZR75" "ZT" "Zaret" "Zeiss"
    "Zeman" "Zeneca" "Zhang" "Zhao" "Zhejiang" "Zheng" "Zhong" "Zhou" "Zhu"
    "Zingiber" "Zn" "Zn-finger" "Zou" "Zr" "Zr-DFO-Z" "Zr-DFO-ZEGFR"
    "Zr-DFO-cetuximab" "Zr-cetuximab" "Zschenker" "aCGH" "aERK2" "aMTOC"
    "aMTOCs" "aNHEJ" "aOR" "aa9-44" "abelson" "absentia" "absorbance"
    "absorptiometry" "accumbens" "accurateness" "acetyl-lysine"
    "acetyl-lysines" "acetylated-Lys" "acetylcholine" "acetylgalactosaminide"
    "acetylome" "acid-induced" "acidy" "actin-fragmentation" "actinomycin"
    "actinomyosin" "actin–cytoskeleton-associated" "activator-like"
    "activators" "active-site" "actives" "acyl" "acyl-carnitine"
    "acyl-carnitines" "acyl-lysine" "acylimidate" "adaCP" "adaptogens"
    "adaptor-mediated" "add-back" "add-mix-measure" "adduct" "adducts"
    "adenocarcinomas" "adenoid" "adenomas" "adenosyl" "adenoviral-mediated"
    "adenylyl" "adherens" "adhesiveness" "adhesome" "adhesomes"
    "adipose-derived" "adipose-rich" "ado-trastuzumab"
    "ado-trastuzumab-emtansine" "adults" "advanced-stage" "adventitia" "adw"
    "aeruginosa" "aethiops" "aex-3" "affibody" "affinity-precipitation"
    "affinity-tag" "agar" "agardhii" "age-associated" "age-specific"
    "aggregometer" "aggregometry" "agomir" "agonism" "alarmin" "aldoketo"
    "alecensa" "algal" "algorithm" "algorithms" "alkyl" "alkylimidate"
    "all-time" "alleles" "allelic-specific" "alpelisib" "alpha-methylacyl"
    "alvarezii" "alveoli" "amidite" "amino-acid" "amino-acid-containing"
    "amino-acid-replete" "amino-terminal" "aminonucleoside" "aminopeptidases"
    "amma" "amoeboid" "amoeboid-like" "amoeboid–mesenchymal" "amphotericin"
    "amplicon" "ampulla" "analytes" "ancd2" "and11B3" "and7N" "andAtm" "andI"
    "andIRkinases" "andMCP-1" "andNLK" "andPANC‐1" "andPAX5" "andRobo1"
    "andTrp53" "andVav" "andVav1-cre" "andand" "andp16" "aneuploid"
    "aneuploidy" "annulus" "anoikis-like" "antagomiRs" "antagomir-155"
    "antagomir-NC" "antenna-like" "anterior-posterior" "anterograde"
    "antibodies" "antibody-alternative" "antibody-drug" "antibody-toxin"
    "antigen-23" "antigen-antibody" "antigen-capture" "antigen-retrieval"
    "antimiR" "antimiR-138" "antiplatelet" "antitumour" "anucleate"
    "apical-basal" "aplasia" "apoptososme" "app" "approx" "aptamer-alike"
    "aptamer-likeness" "archicortex" "arisen" "armamentarium" "arrest-inducing"
    "arrhythmia" "arteriole" "arterioles" "arylalkylamine" "as11B3" "asTP53"
    "asialoglycoprotein" "aspirin-FOXD3-OLA1P2-STAT3" "aspirin-induced"
    "aspirin-treated" "asplenia" "astrocitic-like" "at-risk" "at15" "ation"
    "atom-pairs" "atria" "atrium" "atrophins" "atypia" "au-lait" "autoregulate"
    "autoregulations" "autosomal-dominant" "auto‐ubiquitination" "axial" "axon"
    "ayw" "azepino" "azotemia" "azoxymethane" "a–c" "a≥1.5-fold" "b-catenin"
    "b2–b4" "bHLH-PAS" "bafilomycin" "basal-like" "base-exchange"
    "base-substitution" "based-model" "basic-helix-loop-helix-leucine"
    "basic-leucine" "batch-to-batch" "battlefront" "bdSNP" "bead-bound"
    "becauseAtm" "begun" "below-normal" "benzo" "benzodiazepinediones"
    "benzylpyrazole" "beta-oxidation" "beta-strand" "beta-strands"
    "between-studies" "between-study" "between11B3" "bi" "bi-allelic"
    "bi-cistronic" "bi-directional" "bi-substrate" "bifid" "bilayer"
    "bio-marker" "bioassay" "biodis" "biodis-tribution" "biomass" "biomedicine"
    "biomicroscopy" "biomolecules" "biopsies" "biopsy" "biosensors"
    "biospecimens" "biotin-PFL" "birinapant" "bivariate" "blastocyst"
    "blastocysts" "blebbishield" "blebbishields" "bleed-through" "block-1"
    "block-2" "block-3" "blocker" "blockers" "blood-based" "blood-brain"
    "blood-progenitor" "blood–brain" "blue-labeled" "body-mediated"
    "body-specific" "body-wall" "bogginess" "bolus" "bona" "bona-fide"
    "bonafide" "bone-trophic" "botulinum" "botulinumtoxin" "box-1" "bp" "brac"
    "bradycardia" "brain-trophic" "brainstem" "branched-chain" "breakpoint"
    "breakpoints" "brightfield" "broad-spectrum" "broader" "bronchi-alveoli"
    "bronchio" "bronchio-alveolar" "bronchioli" "bronchoscopy" "browser"
    "buf1280" "bufotalin" "butylhydroquinone" "by-products" "b‐positive"
    "c-CYFRA" "c-FLIP-containing" "c-JUN-A" "c-JUN-B" "c-JUN-C"
    "c-Jun-dependent" "c-Met-RNA2" "c-Src-associated" "cDNA-PCR" "cIAPs"
    "cNHEJ" "café" "calcaneus" "callosum" "calorimetry" "calvaria"
    "cancer-cell-cultured" "cancer-like" "cannabinoid" "cap-binding"
    "cap-bound" "cap-dependent" "cap-independent" "capsid" "capsulotomy"
    "carbonyl" "carboxy-H2DCFDA" "carboxyl" "carboxyl-terminal"
    "carboxyl-terminus" "carcinomas" "carciongen" "cardia" "cardiacmyocytes"
    "cardio" "cardiopathy" "caregivers" "cargos" "carnitine"
    "carnitine-palmitoyl" "carnitines" "carotid" "carried-out" "carrier-based"
    "carriers" "case-control" "case-only" "case–control" "casitas"
    "caspase-Glo-3" "caspase-antagonist" "catalytically-competent" "catalyzer"
    "catenein" "catheter" "caudal-related" "caudate" "ccRCC" "ccRCCs" "cdc28"
    "ceRNA" "cecum" "cell-alone" "cell-autonomous" "cell-by-cell"
    "cell-internal" "cell-of-origin" "cell-permeable" "cell-to-cell"
    "cell-type-specific" "cells" "cells-of-origin" "cell‐derived" "cell‐free"
    "cell‐intrinsic" "cenocepacia" "centile" "centriole" "centromere"
    "centrosomal-spindle" "cerebellum" "cerevisiae" "ceruleus" "cesarean"
    "chain-based" "change=0.001" "check-up" "checkpoint-independent"
    "chelator-to-protein" "chemo" "chemo-radiotherapy" "chemo-sensor"
    "chemoattractant" "chemoradiotherapy" "chemoresistance" "chemoresistant"
    "chemoresponse" "chi-square" "chi-squared" "children" "chlorhexidine"
    "chlorodeoxyuridine" "chloroqiune" "cholesterol-rich"
    "chomentotriazolopyrimidines" "chosen" "chromatid" "chromatids"
    "chromatin-immunoprecipitation" "chromatin-remodeling" "chromoplexy"
    "chromosome-end" "chromosome-microtubule" "chromosome-negative" "ciRNA"
    "ciRNAs" "circ-Amotl1" "circ-Foxo3-mediated" "circ-Foxo3-transfected"
    "circ-Foxo3–p21–CDK2" "circFoxo3" "circRNA" "circRNAs" "circuitry"
    "cirrhosis-alcohol-related" "cis-epoxide" "cis-imadazoline"
    "cis-regulatory" "cis-to-trans" "cistrome" "cistromes" "cistrons"
    "classifier" "classifiers" "clearer" "cleavage-stage"
    "clinical-pathological" "clinicians" "clinico" "clinico-pathological"
    "closed-loop" "closely-related" "clover-leaf" "cmlc2" "coIPs"
    "coactivator-1α" "coagulant" "coated-genes" "codepend" "codon12"
    "coelomocytes" "coiled-coil" "colXα1" "colecystitis" "coli"
    "colitis-associated" "coll" "collagens" "collider" "coloc" "colonoscopy"
    "colonosphere" "colony-formation" "colony-forming" "combination-induced"
    "combination-treated" "combo" "community-based" "comorbid" "comorbidities"
    "compartment-specific" "competition-binding" "complex-karyotype"
    "compound-C" "compound-heterozygous" "computer-generated" "concatenates"
    "concentration-dependence" "concentration–time" "conditons"
    "confirmedsignificant" "conformer" "conformers" "confounder" "confounders"
    "consensus-binding" "consenus" "constitutive-phosphorylation" "construsts"
    "containingRobo1" "continuum" "cooperativeness" "coregulators" "coremotif"
    "coria" "coriari" "coriaria" "correlationship" "cortico"
    "cortico-medullary" "corticosteroid" "corticosteroids" "cost-effectiveness"
    "cosubstrate" "counter-clockwise" "counter-intuitive" "counter-regulated"
    "covariants" "covariate" "covariates" "coworkers" "co‐morbidities"
    "craniotabes" "creanimals" "cremice" "crizotinib-naive"
    "cross-contamination" "cross-interfering" "cross-reacted"
    "cross-reactivity" "cross-regulation" "cross-resistance" "cross-road"
    "cross-section" "cross-sectional" "cross-sectioned" "cross-sections"
    "cross-species" "crosstalkes" "cross‐talk" "cryo-EM" "cryo-electron"
    "cryostat" "crypt-villus" "cryptotanshinone" "curettage" "curvelet"
    "cut-off" "cut-offs" "cutis" "cyan" "cyanobacteria" "cyclin‐dependent"
    "cyclohexamide" "cyclooxgenase-2" "cyrtonema" "cystoprostatectomies"
    "cystoprostatectomy" "cytochemistry" "cytology" "cytomembrane"
    "cytosine-guanosine" "cytosine-to-thymine" "cytoskeletal-remodeling"
    "c‐Myc" "c–d" "dFOXO" "dL" "dSH2" "damage-recovery" "damage‐associated"
    "damage‐induced" "dark-stained" "dataset" "datasets" "day-night-shift"
    "dbSNP" "ddPCR" "de-activating" "de-identified" "de-novo" "de-regulation"
    "de-sensitized" "de-sensitizes" "deadenylation-dependent" "death-fold"
    "decarboxylates" "decidua" "decondenses" "deconvolute" "decouples"
    "decreasedin" "deeper" "defactinib" "deficits" "degron" "degrons"
    "dehydroxy" "dehydroxy-methylation" "dehydroyx" "dehydroyx-methylation"
    "delaminate" "deletions" "delta-9-tetrahydrocannbinol"
    "demethylasterriquinone" "dendrograms" "denovo" "density-gradient"
    "density-mediated" "deoxcytidine" "deoxynucleotidyl"
    "deoxynucleotidyltransferase-mediated" "dependent-manner" "derivate"
    "desferoxamine" "destabilise" "deta" "detergent-insoluble" "determinators"
    "detriments" "dextran-FITC" "diacetoxy" "dialysate" "diapause"
    "dichlorofluorescein" "dichlorofluorescin" "dichroism" "dideoxynucleotide"
    "diet-induced-obesity" "differentially-methylated-region"
    "difficult-to-target" "difluorobenzyl" "difluorophenyl" "digluconate"
    "digoxygenin" "dimer-to-monomer" "dimethyl-α-KG" "dimethylammonium"
    "dimethylbenz" "dimethyllysine" "dimmer" "dimorphism" "dinucleotides"
    "dioxygenases" "diphenyltetrazolium" "diphosphate" "diploid" "discrepant"
    "disease-susceptible" "disease‐related" "disk-like" "dithiolthione"
    "dockings" "doi" "domain-1" "domain-2" "domain-B" "domain-domain"
    "dome-like" "domed-colony" "dominant-negative" "donor-derived"
    "donor-to-donor" "dormancy" "dose-dependence" "dose-dependently"
    "dose-escalation" "dose-expansion" "dose-finding" "dose-limiting"
    "dose-proportional" "dose-reduction" "dose-response" "dose‐dependent"
    "dose‐limiting" "dose–dose" "dose–response" "double-blind"
    "double-knockout" "double-layer" "double-mutant" "double-producers"
    "double-site" "double-strand" "double-transgenic" "double‐blinded"
    "down-modulate" "down-stream" "down‐regulated" "down‐regulation" "dox"
    "drawn" "droplets" "dropwise" "drug-efflux" "drug-like" "drug-pump"
    "drug-receptor" "drug-sensitivity" "drug-tolerant" "drug‐related"
    "drug‐resistant" "dsDNA" "dual-antiplatelet" "dual-axis" "dual-energy"
    "dual-mechanism" "dual-reporter" "dual-side" "dual-specific" "dual-tropic"
    "ductal-to-endocrine" "duocarmycin" "duplexes" "dwarfism" "dysglycemia"
    "dysmorphism" "dysplasia" "dyspnea" "d–f" "e-mail" "eGFPCreERT2"
    "eIF4E-binding-defective" "eIF4E-eIF4A-eIF4G1" "eIF4E2-dependent"
    "eIF4E2-depleted" "eIF4E2-eIF4A-eIF4G3" "eIF4E2-impaired" "eIF4F"
    "eIF4G3-depleted" "eLife" "eQTL" "early-onset" "early-passage"
    "early-phase" "early-stage" "echinoderm" "echocardiography"
    "echosonography" "ectoderm" "ectosomes" "edema" "effecter" "eightfold"
    "eighty-two" "eitherVav" "eitherVav1-cre" "eleven–nineteen" "eluates"
    "emboli" "embryoid" "embryonal-type" "emitter" "emphasise" "empty-vector"
    "end-organ" "end-plates" "end-resection" "end-stage" "end-to-end"
    "endoderm" "endometrioid" "endometrium" "endomicroscope" "endomicroscopy"
    "endosteum" "endotamponade" "endothelia" "endothelial-mesenchymal"
    "endothelial-myofibroblast" "endothelial-specific" "endotypes" "endpoint"
    "endpoints" "ene" "enfuvirtide" "engineeredAtm" "enhancedO"
    "enhancer-binding" "enhancer-like" "enhancer-of-split" "enin" "enoyl-CoA"
    "enteropathy" "entity-specific" "entropy" "enzyme-acylimidate"
    "enzyme-acylimidate-nicotinamide" "enzyme-substrate" "enzyme‐dead" "eosin"
    "eosinophil" "eosinophils" "epicanthus" "epidermal-mesenchymal"
    "epidermal-specific" "epidermoid" "epithelia" "epithelial-associated"
    "epithelial-derived" "epithelial-high" "epithelial-like"
    "epithelial-mesenchymal" "epithelial-to-mesenchymal"
    "epithelial–mesenchymal" "epithelioid" "epithelioid-cell" "epithelium"
    "eribulin" "erythema" "erythrocytes" "esophagectomy" "estrogen‐positive"
    "et" "ethnic-matched" "ethnicities" "ethoxyquin" "et " "euploid"
    "ever-smokers" "ex" "ex-vivo" "exTreg" "examinePAX5" "examiner`s"
    "examiner´s" "exibits" "exocrine" "exoenzoyme" "exoenzyme" "exome"
    "exon-11" "exon-intron" "exon1" "exon19del" "exons" "exosome"
    "expressing-cells" "extra-cerebral" "extra-gastrointestinal" "extra-renal"
    "extra-terminal" "extrauterine" "exudate" "e–g" "facies" "factor-2"
    "factor-α" "factor‐κB" "facture" "fail-safe" "far-UV" "far-reaching"
    "farnesyl" "farnesylation-RhoA" "farnesylation-mutant" "fast-migrating"
    "favourable‐risk" "feed-back" "feedback-inhibition"
    "feedback-loop-relevant" "fenestrations" "fenoldopam" "fetal-placental"
    "fibroblast-like" "fibroblastoid" "fibroblasts" "fibrosis-associated"
    "fibrosus" "fide" "fine-tune" "fine-tuning" "finger-like" "finger‐like"
    "first-degree" "first-generation" "first-in-human" "first-line"
    "first-time" "first-trimester" "first‐in‐human" "five-micron"
    "five-parameter" "five-year" "flavonoid" "flavonoids" "fluor-de-lys"
    "fluorescens" "fluoresces" "fluorine-18-flurodeoxyglucose"
    "fluorodeoxyglucose" "fluorography" "fluoromevalonate" "fluoromount"
    "fluorophore" "fluorophores" "fms‐like" "follicle" "follicles"
    "follicular-cell" "follow-up" "follow‐up" "fontanelle" "force-fed"
    "force-generating" "force-sensitive" "forebrain" "four-burner"
    "four-hydroxytamoxifen" "four-marker" "four-site" "frame-shift"
    "frameshift" "free-survival" "from11B3" "from43.2±2.32%" "fromTP53"
    "frozen" "fs" "fs0.01" "fs0.05" "full-body" "full-face" "full-term"
    "full-text" "fulminant" "fumarate" "fumigatus" "functionally-related"
    "funder" "fundus" "furthest" "fusion-constructs" "fusion–positive" "gBRCA"
    "gain-of-function" "galectin" "gallbladder" "gallbladders" "gargarizans"
    "gasses" "gastrectomy" "gastria" "gastro" "gastro-esophageal"
    "gastro-intestinal" "gatekeeper" "gavage" "gel-retardation" "gelatinases"
    "geldamycin" "gelucire" "gender-specific" "gender-typical" "gene-1"
    "gene-annotation" "gene-environmental" "gene-gene" "generalise"
    "genes-like" "genetic-variants" "genitalia" "genome" "genome-scale"
    "genome-wide" "genomes" "genomewide" "genomic_TCGA" "genotype-phenotype"
    "genotype–phenotype" "gens" "gentoype" "gentoypes" "geometry-based"
    "geranylgeranyl" "germline" "gingerdiol" "gingerdione" "gland-originated"
    "glia" "glomeruli" "glomerulonephritis" "glow-type" "glutamic-oxalacetic"
    "glutamylcysteine" "gluteus" "glycans" "glycemia " "glycocalix"
    "glycoconjugates" "glycometabolism" "gm" "goes" "gone" "gonioscopy"
    "good‐risk" "gotten" "grade-specific" "gram-negative" "gravida" "greater"
    "greater-than-additive" "greatest" "growth-suppressive" "gyrata" "h-IAPP"
    "h-IAPP-induced" "h-culture" "h-proIAPP" "hBMSCs" "hDF" "hDFs" "hESC"
    "hESCs" "hLECs" "hMDM" "hMDMs" "hMSCs" "hNHE" "hNHE1-D1-AXA" "hNHE1-D2-AXA"
    "hNHE1-D3-AXA" "hNHE1-ERK1" "hNHE1-F2-AA" "hNHE1-tail" "hNHE1cdt"
    "hNHE1cdt-iaERK2" "hNTCP" "hOlf" "hRAD6A" "hRluc" "hTERT-immortalized"
    "hTERT-miR-29a-ITGB1" "haematuria" "hairpin-forming" "half-life"
    "half-lives" "half-log" "half-site" "half-time" "half-times" "half‐life"
    "hand-held" "haplotype" "haplotypes" "hard-wired" "harzard" "head-to-head"
    "headloop" "headwaters" "healthy-donor" "health‐related" "heat-inactivated"
    "heatmap" "heavier" "helices" "helix" "hematology" "hemizygotes"
    "hemocytometry" "hepatectomy" "hepaticus" "hepatocyes" "hetero"
    "hetero-dimer" "hetero-dimmer" "heteroduplex" "heteropentamer"
    "heterozygote" "heterozygousAtm" "hexahistidine" "hexahistidine-tag"
    "hidden" "hide-then-hit" "high-affinity" "high-contrast" "high-density"
    "high-dose" "high-expression" "high-frequency" "high-glutamine"
    "high-grade" "high-intensity" "high-level" "high-mobility"
    "high-penetrance" "high-penetrant" "high-power" "high-priority"
    "high-quality" "high-resolution" "high-risk" "high-sensitivity"
    "high-serum" "high-stiffness" "high-value" "higher-stiffness" "highgrade"
    "highly-specific" "hilum" "hirsutism" "histo" "histo-pathological"
    "histology" "histomorphology" "histopathology" "histopatology" "histotype"
    "histotypes" "hoc" "homeodomain" "homogenates" "homolog" "homolog-1"
    "homologies" "homologs" "homologus" "homozygote" "homozygotes"
    "horizontal-vertical" "hormonetherapy" "hot-spot" "hotspot" "hotspots" "hr"
    "hsa-449c-5p" "hsa-miR-1275" "hsa-miR-1277" "hsa-miR-146b" "hsa-miR-148a"
    "hsa-miR-148a-3p" "hsa-miR-18a" "hsa-miR-198" "hsa-miR-19a"
    "hsa-miR-19a-3p" "hsa-miR-20a-5p" "hsa-miR-222" "hsa-miR-27a-5p"
    "hsa-miR-27b-5p" "hsa-miR-29a-5p" "hsa-miR-29b" "hsa-miR-33a-5p"
    "hsa-miR-34c-5p" "hsa-miR-3661" "hsa-miR-3662" "hsa-miR-371a"
    "hsa-miR-4485" "hsa-miR-449a" "hsa-miR-449b-5p" "hsa-miR-449c-5p"
    "hsa-miR-4521" "hsa-miR-590-3p" "hsa-miR-7-1-3p" "hsa-miR-9" "hsa-miR-9-5p"
    "hsa-miR-92a-1" "hsa-miRNA29b" "hu1640" "humanIGF‐1R" "hydroelectrolyte"
    "hydroureter" "hydroxy" "hydroxyacyl-coenzyme" "hydroxychinoline"
    "hydroxyestradiol" "hydroxyl" "hydroxymethylcytosine"
    "hydroxymethylglutaryl" "hydroxymethylglutaryl-CoA" "hydroxyprostaglandin"
    "hydroxytamoxifen" "hyper" "hyper-automodification" "hyper-pigmentation"
    "hyper-proliferation" "hyper-reactive" "hyper-sensitivity" "hyper-triploid"
    "hyperandrogenism" "hyperchromasia" "hyperestrogenism" "hyperinsulinemia"
    "hyperoxia" "hyperpolarization-activated" "hyperresponsiveness"
    "hypertriploid" "hyperubiquitinates" "hypo-ADP-ribosylated" "hypochlorite"
    "hypodysplasia" "hypomenorrhea" "hypopharynx" "hypovolemia"
    "hypoxanthine–aminopterin–thymidine" "hypoxemia" "i-67" "i.e.the" "iCOGS"
    "iHBECs" "iNKT" "iTSCs" "iaERK" "iaERK2" "ice-cold" "identifier"
    "identifyNAT10" "idoacetate" "ii" "iii" "ill-defined" "imadazoline"
    "imidazoyl" "imidazoyl-indole" "imido" "immue" "immune-associated"
    "immune-deficient" "immune-mediated" "immune-reactivity" "immuno"
    "immuno-phenotype" "immuno-precipitation" "immunoassay"
    "immunocytochemistry" "immunoelectron" "immunoglobulin" "immunopathology"
    "immunophenotype" "immunotherapy" "import-export" "importin-β1" "in-cell"
    "in-clinic" "in-colorectal-cancer" "in-depth" "in-frame" "in-gel"
    "in-house" "in-line" "in-silico" "in-situ" "in-solution" "in-vitro"
    "in-vivo" "inAtm" "inFig" "inIPF" "inNSCLCthan" "inO" "inRobo1" "ina"
    "inactive-to-active" "includingPTENandPDCD4" "increasesIL" "increasesIL-6"
    "indol" "indol-6-1" "induced-apoptosis" "inefficacy" "inevi"
    "infection-based" "infection‐associated" "infection‐induced"
    "inflammation-associated" "inflammation-induced" "inflammation-inducing"
    "inflammation‐associated" "inhibitedIGF‐1" "inhibites" "inhibiton"
    "inhibitor-of-apoptosis" "inhibitors-5-Aminosalicylic" "inhibitors-UCN-01"
    "inhibitors-rapamycin" "inhibitsNSCLCcell" "inoculum" "insertions"
    "insertless" "insulator-binding" "insulin-dependent" "insulin-producing"
    "insulin-stimulated" "insulinemia" "insulin‐induced" "insulin‐like"
    "insulitis" "integrin-family" "integrin-ligand" "intent-to-treat"
    "inter-dimer" "inter-follicular" "inter-individual" "inter-patient"
    "inter-population" "inter-tumor" "interactome" "interconversions"
    "interdigitate" "intermediate‐risk" "interobserver" "interquartile"
    "interresidue" "interstitium" "interstrand" "intersubject"
    "intestinal-type" "intra" "intra-S" "intra-S-phase" "intra-dimer"
    "intra-individual" "intra-module" "intra-organ" "intra-pathway"
    "intra-patient" "intra-specimen" "intra-tumor" "intra-tumoral"
    "intra-vesicular" "intracardiac" "intractions" "intraobserver"
    "introducedp16" "invadopodia-like" "invaginations" "invariant"
    "invasion-metastasis" "invasion-promoting" "inversus" "iododeoxyuridine"
    "ionic" "iris-ciliary" "irradiation‐induced" "ischemia-reperfusion"
    "isochromatid" "isochromosome" "isodicentrism" "isoenzyme" "isoenzymes"
    "isoform-1" "isoform-2" "isoforms-A" "isolectin" "isomiR" "isomiRNAs"
    "isomiRs" "isopeptide" "isopropanol" "isothiocyante" "isotype" "isozyme"
    "isozymes" "ites" "iv" "ivm" "iv–vi" "i–iii" "i–iv" "i–viii"
    "junction-stabilizing" "juxta" "kConFab" "karyotype" "karyotypes" "kcal"
    "kelch-like" "keratopathy" "kg" "kg " "ki-67" "kinase-2" "kinase-beta"
    "kinase-defective" "kinase-proficient" "kink-turn" "kinome" "knock-down"
    "knock-in" "knockdown-only" "knockdown‐induced" "knocked-down" "knocked-in"
    "knocked-out" "knockin" "knock‐in" "knowckdown" "lac" "lac-operon"
    "lactose" "ladder-like" "lait" "lamba5" "lambda" "lamellae" "laminopathies"
    "lane2" "lane3" "lane5" "laptinib" "large-scale" "large-scaled"
    "laser-generated" "laser-induced" "late-acting" "late-onset" "late-passage"
    "late-phase" "late-stage" "latency–response" "later-line" "lateralis"
    "lavage" "leakiness" "leave-one-out" "lebbishield" "left-right"
    "left-sided" "leftmost" "leg-press" "legume" "lemellipodia" "lenti"
    "lenti-OLA1P2" "lentiviral-GFP-FAK-shRNA" "lentiviral-infected"
    "lentiviral-mediated" "less-than-additive" "let-7a" "let-7a-5p" "let-7c"
    "let-7d-5p" "leukemia-1" "lev" "lev-11" "levels" "leves" "libitum"
    "life-long" "life-time" "lifespan" "lifestyle-induced" "ligand-3"
    "ligand-receptor" "light-polysomal" "ligosome" "like-4" "lineage-specific"
    "lipid-soluble" "lipofectamine" "lipopolysaccha" "lipopolysaccha-ride"
    "lipopolysaccharides" "liposome" "literature-based" "lithotripsy"
    "littermate" "littermates" "live-cell" "lncRNA-CLMAT3" "lncRNA-p21" "lo"
    "lobectomies" "lobules" "locally-advanced" "logFC " "logrank" "long-chain"
    "long-lasting" "long-lived" "long-range" "long-standing" "long-time"
    "long-unanswered" "longer-lasting" "long‐term" "lorlatinib" "loss-of"
    "loss-of-function" "low-density" "low-expression" "low-frequency"
    "low-glutamine" "low-grade" "low-income" "low-level" "low-passage"
    "low-penetrance" "low-penetrant" "low-risk" "low-serum" "low-set"
    "lower-affinity" "lower-stiffness" "loxP" "lpr" "luciferase-reporter"
    "lumens" "luminescence-based" "lymphoblastoid" "lymphoblasts" "lymphoma-2"
    "lymphonepnia" "lysine-coumarin" "lysine-deacetylase" "lysis" "m&hAR"
    "m-IAPP" "m-proIAPP" "mCD40L" "mCPRC" "mCRPC" "mCherry-procasapase-8"
    "mCherry–β-actin-expressing" "mESCs" "mG" "mGFP" "mJ" "mMSCs" "mPheK"
    "mRNA" "mSIRT1" "mT" "mTOR-p70S6K" "mTOR-targeted" "mTORC1-p4E-BP1" "mTeSR"
    "mTeSR+2iFL" "mTeSR+2iFL+LPA" "macro-autophagy" "macro-metastasis"
    "macrodomain" "macrophage-1" "macrophage-like" "male-to-female" "maleimido"
    "malignance" "mammals" "mammography" "mammoplasty" "mammosphere"
    "mammospheres" "markers" "mass-Mito" "mass-action" "mastectomy"
    "matched-15" "maternal-fetal" "maternally-inherited" "mating-type"
    "matrigels" "maximalO" "mean±s" "mechano" "mechanotransduce" "median=11.1%"
    "mediastinum" "medium‐term" "medulla" "melanin" "melanogaster" "mellitus"
    "memory-type" "menses" "mesenchyma" "mesenchymal-amoeboid"
    "mesenchymal-associated" "mesenchymal-epithelial" "mesenchymal-high"
    "mesenchymal-like" "mesenchymal-specific" "mesenchymal-to-epithelial"
    "mesenchymal-type" "mesenchymal–amoeboid" "mesendoderm" "mesoderm" "metERα"
    "meta-adhesome" "meta-regression" "metabolic-induced" "metabolic-stress"
    "metabolisc" "metabolome" "metagene" "metallopeptidase-1"
    "metalloproteinase-9" "metaphase-anaphase"
    "metaplasia-dysplasia-adenocarcinoma" "metastasectomy" "metastasis-private"
    "methanesulfonate" "methods" "methyaldenine" "methyl-β-cyclodextrin"
    "methylacyl" "methylation‐specific" "methylbenzyl" "methylcytosine"
    "methyllysine" "methylome" "mevalonate" "mi-R125b" "miR-100" "miR-103"
    "miR-106b-25" "miR-122" "miR-124" "miR-1260" "miR-1260a" "miR-127"
    "miR-128" "miR-129-a" "miR-133" "miR-134" "miR-135" "miR-138" "miR-138-FAK"
    "miR-138-FAK-ERK1" "miR-139" "miR-139-3p" "miR-139-5p" "miR-141"
    "miR-141-3p" "miR-141-overexpressing" "miR-141P" "miR-143" "miR-143-3p"
    "miR-145" "miR-145-5p" "miR-146a" "miR-146b" "miR-148a" "miR-15" "miR-150"
    "miR-150-3p" "miR-152" "miR-155" "miR-155-induced" "miR-15a" "miR-15b-5p"
    "miR-17" "miR-17-92" "miR-181b" "miR-1827" "miR-183" "miR-184"
    "miR-184-mediated" "miR-187" "miR-18a-5p" "miR-191" "miR-192" "miR-192-3p"
    "miR-193a-3p" "miR-194-3p" "miR-195" "miR-198" "miR-199b" "miR-199b-5p"
    "miR-200" "miR-200b" "miR-200b-5p" "miR-200c-5p" "miR-203" "miR-205"
    "miR-206" "miR-20a" "miR-214" "miR-217" "miR-218-5p-overexpressing"
    "miR-22" "miR-23-mediated" "miR-25" "miR-27a" "miR-28" "miR-2861" "miR-290"
    "miR-29a" "miR-30" "miR-31" "miR-3162-3p" "miR-3188" "miR-3188+5-FU"
    "miR-3188+NS" "miR-3188-inhibited" "miR-3188-mTOR–p-PI3K"
    "miR-3188-mTOR–pPI3K" "miR-3188-mediated" "miR-3188-overexpressing"
    "miR-3188-treated" "miR-32" "miR-326" "miR-326-HDAC3"
    "miR-326-agomir-treated" "miR-326-expressing" "miR-326-expression"
    "miR-326-transfected" "miR-335" "miR-33b" "miR-34" "miR-34-3p" "miR-34a-3p"
    "miR-34a-5p" "miR-34b" "miR-34c" "miR-3661" "miR-373" "miR-375" "miR-378"
    "miR-409-3p" "miR-424" "miR-433" "miR-433-induced" "miR-433-mediated"
    "miR-433-regulated" "miR-433-suppressed" "miR-433-targeting"
    "miR-433-transfected" "miR-449" "miR-449-induced" "miR-449-involved"
    "miR-449a" "miR-449b-5p" "miR-450a" "miR-451" "miR-4521" "miR-486"
    "miR-486-5p-binding" "miR-494" "miR-497" "miR-503" "miR-504" "miR-506"
    "miR-507" "miR-509" "miR-509-5p" "miR-590" "miR-634" "miR-661" "miR-7-1"
    "miR-766" "miR-9-2" "miR-9-3p" "miR-93" "miR-96" "miR-NC-transfected"
    "miR-con" "miR-let-7c-5p" "miR-negative" "miR139-3p" "miR198" "miR31"
    "miRDB" "miRISC" "miRNA" "miRNA-181a" "miRNA-1826" "miRNA-186" "miRNA-195"
    "miRNA-221" "miRNA-29a" "miRNA-34a-5p" "miRNA-378a-5p" "miRNA-495"
    "miRNA-551a" "miR‐21" "miR‐21‐3p" "miR‐21‐induced" "micro-environment"
    "micro-irradiation" "micro-metastasis" "microCT" "microPET" "microRNA"
    "microRNA-126" "microRNA-143" "microRNA-148" "microRNA-155" "microRNA-21"
    "microalbuminuria" "microdomains" "microenvironments" "micrographs"
    "micrometastases" "microplates" "micropore" "micropreparations"
    "microsatellite" "microsatellites" "microscale" "microseconds"
    "microvasculature" "microvessel" "microvessels" "mid-20s" "mid-brain"
    "mid-face" "mid-facial" "midline" "midwest" "milk-producing" "milliseconds"
    "mimic-NC" "mineralocorticoid-receptor" "minifilaments" "minimise"
    "miniprotein" "minireview" "miniscule" "minute-2" "mir" "mir-139" "mir-185"
    "mir-199" "mir-200" "mir-21" "mir-31" "mir2disease" "mircroRNAs"
    "mis-incorporation" "mis-segregation" "misclassifications"
    "mismatch-repair" "missense" "missing-thus" "mitochondrial-defective"
    "mitochondrial-encoded" "mitoses" "mitosis-phase" "mixed-lineage"
    "mixed-type" "ml " "mobilizer" "mock+5-FU" "mock+NS" "mock+miR-3188"
    "mock-transduced" "mock-transfected" "mock-treated"
    "moderately-differentiated" "molecule-1" "mollusks" "mono-allelic"
    "mono-phosphorylated" "mono-therapy" "mono-ubiquitin" "monocyte-derived"
    "monocytoid" "monodisperse" "monolayer" "monomethyl" "monomethylates"
    "monophosphate" "monosialotetrahexosylganglioside" "monosomes"
    "monotherapy" "month-old" "morphants" "morpholino" "morula" "motile"
    "mountant" "mtp53" "mu" "mucinous‐type" "mucoepidermoid" "mucosa"
    "multi-cellular" "multi-center" "multi-database" "multi-databases"
    "multi-differentiation" "multi-effector" "multi-institution" "multi-organ"
    "multi-photon" "multi-protein" "multi-reference" "multi-round"
    "multi-scanner" "multi-step" "multi-subunit" "multi-systemic" "multi-tumor"
    "multicenter" "multicentre" "multidomain" "multidose" "multiforme"
    "multiorgan" "multipass" "multipeptide" "multiphoton" "multipolar-spindle"
    "multiprotein" "multistage" "multisubunit" "multivariate" "murineHT"
    "muscle-invasive" "muscle-specific" "muscularis" "mutant–only" "mutations"
    "myc-tag" "myeloid‐derived" "myocardium" "myocytes"
    "myofibroblast-associated" "myofibroblast-like" "myofibroblasts"
    "myometrium" "myr-Akt1-introduced" "myr-Akt1-mediated"
    "myr-Akt1-transfected" "myristate" "myxoid" "myxovirus" "n-fold" "nAChR"
    "nAChRs" "nCAG-AR" "nCounter" "nEGFR" "nEq" "nMCI" "nPCR" "naive-like"
    "naive-specific" "nano" "nano-LC-MS" "nasopharynx" "nc" "ncomms10438"
    "ncomms10442" "ncomms10498" "ncomms10662" "ncomms10689" "ncomms10734"
    "ncomms10765" "ncomms10810" "ncomms10818" "ncomms10822" "ncomms10960"
    "ncomms10975" "ncomms11057" "ncomms11150" "ncomms11171" "ncomms11190"
    "ncomms11289" "ncomms11309" "ncomms11321" "ncomms11371" "ncomms11389"
    "neXtProt" "near-diploid" "near-infrared" "near-maximal" "near-native"
    "near-total" "nearest" "necrosome" "necrostatin" "negative-stain"
    "neoadjuvant" "neocortex" "neoepitope" "nephrectomy" "nephroapathy"
    "nephron" "nephrons" "nephropathy" "nestin-postive" "neural-crest-derived"
    "neuroendocrine" "neuroephitelium" "neuroepithelium" "neurofibromatosis-2"
    "neuron-like" "neuropathology" "neurosphere" "neutropenia" "never-smokers"
    "new-generation" "new-onset" "newer" "newest" "next-day-imaging"
    "next-generation" "ng⁄mL" "nick-end" "nigricans" "nitro" "nitro-fatty"
    "no-reactive" "no-treatment" "node-positive" "nonbreast" "noncarriers"
    "noncase–control" "nonmalignant" "nonmuscle" "nonobese" "nonprogressors"
    "nonredundant" "nonsense-mediated" "nonsignificant" "nonsmall"
    "nonsmall-cell" "nonsubstrate" "nonvariant" "nonzero" "non‐fasting"
    "non‐human" "non‐malignant" "non‐small" "non‐tumour" "normal-like"
    "normal-shaped" "normal-term" "normally-sized" "normal‐looking" "normo"
    "normo-osmotic" "normoglycemia" "notch-induced" "nt" "nt480-486"
    "nt639–645" "nt86-92" "nt945–950" "nucleases" "nucleates" "nucleo"
    "nucleolus–nucleoplasm" "nuclide" "nuclides" "nutrient-deprivation"
    "obervations" "occluden-1" "occludens" "occupany" "odorant" "oedema"
    "oestrogen" "of11B3" "ofAtm" "ofKW" "ofKW‐2450" "ofNAT10" "ofNSCLCcell"
    "ofPATU8988" "ofPAX5" "ofPTENandPDCD4antagonized" "ofTP53" "ofVav"
    "ofVav1-cre" "off-line" "off-target" "officinale" "offs" "offsprings"
    "often-inaccessible" "oligo" "oligoadenylate" "oligomer-oligomer"
    "oligomycin" "oligonucleo" "oligopyrimidine" "oligos" "oliguria"
    "oltipratz" "olysome" "on-target" "on-treatment" "once-daily" "onco"
    "onco-suppressor" "oncomiR-141" "oncomiRNA" "oncomiRNAs" "oncomir"
    "one-half" "one-hour" "one-hybridization" "one-leg" "one-tailed"
    "one-third" "one-way" "onosome" "onychalgia" "oocyte-to-embryo" "oocytes"
    "oophorectomy" "open-label" "open-loop" "open-source" "operon" "orVav"
    "orVav1-cre" "ordinates" "ordistant" "organelle" "organelles" "organoid"
    "oropharynx" "ortholog" "orthologue" "orthologues" "osmostress"
    "osteoblasts" "osteoid" "osteolineage" "otolaryngology" "over-activated"
    "over-activation" "over-activations" "over-intake" "over-production"
    "over-representation" "overabundance" "overexpresson" "overseen" "overview"
    "oxaliplatin‐based" "oxidases" "oxygenase-1" "p21KO" "p21and" "p21works"
    "p38MAPK-HSP27" "p45S6K" "p4E-BP1" "p4E-BP1-mediated" "p53-centric"
    "p53-defective" "p53-like" "p53-miR-222-MAPK1" "p53-miR-29a-PTEN"
    "p53-miR-34c-BCL2" "p53-null" "p53K120R" "p53K370" "p53KO" "p53MH"
    "p53R156P" "p53_WT" "p53wt" "p53‐Mdm2" "p53‐deficient" "p53‐dependent"
    "p53‐depleted" "p53‐expressing" "p53‐independent" "p53‐mediated"
    "p53‐specific" "p53‐sufficient" "p=0.0" "p=0.00" "p=0.002" "p=0.014"
    "p=0.053" "p=0.076" "p=0.095" "p=0.159" "p=0.186" "p=1.00" "pALK" "pAMPK"
    "pAMPKα" "pCDNA-3.1" "pCDNA-Snail" "pCEFL-AU5-RhoAN19" "pCEFL-AU5-RhoAQL"
    "pCHK1" "pCLE" "pCMV" "pCMV6-Kan" "pCMV6-XL5" "pCR" "pCREB" "pCR " "pCdk1"
    "pDP4" "pEGFGR" "pEGFP" "pEGFR" "pEGR" "pFAK" "pFAK397" "pFN"
    "pFN-promoter-Luc" "pFOXO3a" "pG12V" "pGATA" "pGATA3-FLAG" "pGBM" "pGBMs"
    "pGL3-Basic" "pGL3-Enhancer" "pGL3-F0" "pGL3-basic" "pGSK3" "pGSK3α" "pGal"
    "pGal4-FLAG" "pGal4-GATA3" "pGal4-GATA3-FLAG" "pGal4-GCM1-FLAG"
    "pGal4-VP16" "pH" "pHBV" "pHBV-1.3" "pHDAC1" "pHer2" "pHluorin" "pHs"
    "pHtrA4-1" "pHtrA4-1 " "pIFN-α2-Luc" "pIRS" "pIRS-Grb2-SOS-ERK" "pIRS1"
    "pIRS1→pAKT→pERK→mTOR→pIRS1" "pIRS1→pAKT→pERK→pIRS1" "pIRS→ERK→mTOR→pIRS"
    "pK588Q" "pK591Q" "pKi-67" "pLKO" "pLR25" "pLR35" "pM" "pM-β-cat"
    "pMALc5-E-TEV" "pMAPK" "pMIR-Report-Luciferase" "pMLC" "pMRE21PtenLuc1"
    "pMRE21PtenLuc2" "pMRLC19" "pN0" "pNG2" "pPAS" "pPKCδ" "pPR10" "pPR4"
    "pPR9" "pPax" "pS-P" "pS338" "pS473" "pS9GSK-3β" "pS9GSK3β" "pSILAC"
    "pSIMIR21" "pSTAT" "pSTAT3" "pSTAT5" "pSUPER" "pSUPER-sh2531"
    "pSUPER-sh370" "pSUPER-shNC" "pSX" "pSX95.77YFP-proIAPP" "pSilencer"
    "pSilencer1.0-U6" "pSilencer3.1-H1-neo-Bit1-shRNA"
    "pSilencer3.1-H1-neo-negative-shRNA" "pSmad2" "pStat3" "pSuper-ELL-shRNA-1"
    "pSuper-ELL-shRNA-2" "pT" "pT2" "pT210" "pT2b" "pT3" "pT308" "pT4" "pT77"
    "pT77 " "pTSC2" "pachygyria" "pack-year" "paclitaxol" "pair-wise"
    "pairwise" "palmitoyl" "pan-PAD" "pan-PI3K" "pan-cancer" "pan-class-1"
    "pan-neuronal" "pancreata" "pancreatitis" "pancreatobiliary-type"
    "pan‐cytokeratin" "pap11" "papCP" "papillary‐type" "para-aortic"
    "para-carcinoma" "para-tumor" "para-tumoral" "paracrine" "paradol"
    "paraffine" "paralog" "paralogues" "parenchyma" "parent-of"
    "parent-of-origin" "parent-of-origin-specific" "parent-origin-specific"
    "parent`s" "parotid" "partial-EMT-high" "particels" "particulate"
    "paternally-inherited" "path-breaking" "pathobiology" "pathogen-host"
    "pathologies" "pathomorphology" "pathophysiology" "pathways"
    "pathway‐associated" "pathway‐dependent" "patient-to-patient" "patients"
    "patient‐related" "patritumab" "paxilllin" "pb" "pcDNA3-FLAG-WWP2"
    "pcDNA3-flag-WWP2" "pcDNA3.1" "pcDNA5" "pcDNA5-Myc-KPNA2" "peau"
    "peel-like" "pemetrexed-plus-platinum" "penetrance" "penetrant"
    "pentraxin-3" "peptide-specific" "peptides" "percentege" "perhaps"
    "peri-implantation" "pericardiac" "pericarditis" "period-2"
    "peripheral-blood-derived" "peritoneum" "permeability-increasing"
    "peroxidant" "phagophore" "phallotoxin" "pharmacologically-safe"
    "pharmacopeias" "pharmacophore" "pharyngeal-specific" "phenethyl"
    "phenylhydrazone" "phenylmethylsulfonyl" "phosphate-affinity"
    "phosphate-binding" "phosphate-mimic" "phosphatidylinositol-3-OH"
    "phospho-CAV1" "phospho-Gata3" "phospho-Thr120" "phospho1068"
    "phosphogluconolactone" "phosphoinositol" "phosphomutants" "phosphopeptide"
    "phosphopeptides" "phosphorothioate" "phosphorylation-defective"
    "phosphorylation-dephosphorylation" "phosphorylation–dephosphorylation"
    "phosphosites" "phosphotidylinositol" "photo-activatable" "phyla"
    "physiologically-relevant" "phytopharmaceuticals" "phytyl" "pial"
    "pictilisib" "pigmentosa" "pixel" "pixels" "placebo-treated"
    "placebo‐controlled" "placeholders" "placenta-specific" "plana"
    "platinum-taxane" "pleura" "plexiform" "pll3.7-treated"
    "pluripotency-associated" "plus-tip-tracking" "pmiR-RB-REPORT" "pmirGLO"
    "podocytopathy" "podosome-like" "polo-box" "poly-ADP-ribose"
    "poly-L-lysine" "polyendocrinopathy" "polyglutamine-repeat"
    "polyhydramnios" "polymerase-1" "polymorphism" "polymorphisms" "pombe"
    "poor-prognostic" "poorer" "poorest" "poorly-differentiated" "poor‐risk"
    "population-match" "population-wide" "porpidium" "positively-stained"
    "positron" "post-DRE" "post-Dox" "post-ESW" "post-Golgi" "post-HSCT"
    "post-IVS" "post-PD" "post-PV" "post-RC" "post-Tat" "post-birth"
    "post-delamination" "post-development" "post-diabetes" "post-entry"
    "post-fixation" "post-hoc" "post-implantation" "post-induction"
    "post-infection" "post-injection" "post-irradiation" "post-menopausal"
    "post-natal" "post-operative" "post-replicative" "post-transcriptional"
    "post-transcriptionally" "post-transfection" "post-translational"
    "post-translationally" "post-treatment" "postchemotherapy" "postmortem"
    "post‐dose" "presesnt" "prespread" "preterm" "pre‐dose" "pri-miR-141"
    "pri-miR-150" "pri-miR-21" "pri-miR-34a" "primaryPATU8988" "pro-B-cells"
    "pro-HCV" "pro-IAPP" "pro-NRG1" "pro-angiogenic" "pro-apoptosis"
    "pro-caspase-2" "pro-caspase-8" "pro-death" "pro-drug" "pro-fibrogenic"
    "pro-growth" "pro-heparin" "pro-inflammation" "pro-inflammatory"
    "pro-invasive" "pro-metastatic" "pro-migratory" "pro-mitogenic"
    "pro-motile" "pro-oxidative" "pro-proliferative" "pro-resection"
    "pro-senescence" "pro-survival" "pro-thrombin" "pro-tumor"
    "pro-tumorigenic" "pro-tumoural" "pro-viral" "proSP" "proSP-C" "probands"
    "probeset" "procasapase-8" "procaspase-3" "procaspase-7" "procaspase-8b"
    "procaspase-DED" "procaspases-8" "processome" "procollagen" "prodomain"
    "prodomains" "produced-hypoxic" "product-moment" "proenzymes" "profiler"
    "progenitor-like" "progenitor-specific" "progeny" "program–mediated"
    "progression‐free" "proliferator-activated" "proliferin" "prometa"
    "promoter-proximal" "promoter-reporter" "promoters" "pronephros"
    "proof-of-concept" "proof-of-principle" "propolis" "propria" "proprotein"
    "proproteins" "proresistance" "prostaglandins" "prostatectomies"
    "prostatectomy" "prosurfactant" "proteasome‐dependent" "protein-5"
    "protein-DNA" "protein-RNA" "protein-fragment" "protein-α" "proteins"
    "protein C4orf27" "proteome" "proteome-scale" "proteome-wide" "proteomes"
    "proto-oncogene1" "protooncogene" "protooncogenes" "proven"
    "proximity-induced" "pseudo-death" "pseudogenes" "pseudoparticles" "pts"
    "pubarche" "pull-down" "pull-downs" "pulldown" "pulldowns" "pulled-down"
    "pulling-down" "pulpitis" "pulposus" "punctae" "putamen" "pyridin-4-yl"
    "pyrimidin-4-amine" "p = 0.002" "p≤0.02" "q-value" "q22q32" "qMSP" "qNano"
    "quadriceps" "quadriradials" "quality-control" "quality-of-life"
    "quantile-quantile" "quassinoid" "r-DISC" "r-DISC-associated"
    "r-DISC-mediated" "rAAV" "rDNAs" "rGSK-3β" "rGSK3β" "rHRE" "rHSP70" "rRNA"
    "raclopride" "radiation-enhancing" "radiation-induced" "radiation-mediated"
    "radiation-protective" "radiation–induced" "radio-SDS-PAGE"
    "radio-labelled" "radio-nuclide" "radio-resistance" "radiochemotherapy"
    "radiohalogens" "radioiodine" "radionuclide" "radionuclides"
    "radioresistance" "radioresistant" "radiotherapy-induced"
    "radiotherapy-naive" "radiotherapy-resistance" "raft-mediated" "ramapycin"
    "random-RNAs" "random-effects" "rank-sum" "rapalogs" "rapamycin-only"
    "rapid-signaling" "rasopathies" "rasopathy-like" "re-ChIP" "re-absorbed"
    "re-absorption" "re-absorptions" "re-acquire" "re-acquired" "re-adding"
    "re-addition" "re-analysed" "re-analyzed" "re-association" "re-biopsies"
    "re-biopsy" "re-boosts" "re-checked" "re-elicit" "re-emerged"
    "re-endothelialization" "re-engraftment" "re-enter" "re-entered" "re-entry"
    "re-establishment" "re-evaluate" "re-evaluated" "re-express" "re-expressed"
    "re-expressing" "re-expression" "re-graded" "re-implanted" "re-implanting"
    "re-infecting" "re-injected" "re-introduction" "re-investigated"
    "re-localized" "re-localizes" "re-orientated" "re-performed"
    "re-programming" "re-read" "re-reviewed" "re-routing" "re-sensitizes"
    "re-sequencing" "re-stimulated" "re-stimulation" "re-supplementation"
    "re-writing" "re-written" "reacquire" "read-out" "readout" "readouts"
    "real-time-qPCR" "real-world" "real‐time" "rebiopsy" "receptor-1"
    "receptor-2" "receptor-5" "receptor-ligand" "receptor-α" "receptor-β"
    "receptor-γ" "receptor‐1" "receptor–ligand" "redifferentiate"
    "redox-susceptible" "reduced-miR-3188" "reevaluate" "reflux-induced"
    "refluxate" "regrew" "regrow" "regrowth" "regulations" "regulator-1"
    "regulators" "regulons" "reinitiates" "relatedness" "relocalise"
    "remodeler" "remodelers" "reperfuse" "replication-competent"
    "replication-fork-associated" "replication-independent" "replicon"
    "replicons" "repopulate" "reporter-dependent" "reprogrammes" "residuals"
    "residues" "residues1–200" "resp" "respiratory-chain" "responder-CD8"
    "response-4" "resveratrol-anti-proliferative" "resveratrol-anti-tumor"
    "resveratrol-treated" "retroperitoneum" "retrovirus" "reults"
    "reverse-phase" "reverse-transcription" "revertant" "re‐expression"
    "rhabdovirus" "ribociclib" "ribose" "right-sided" "rigid-body"
    "risk-reducing" "ristocetin" "rle" "robustly-induced" "root-mean" "rosea"
    "rpm" "rs10069690" "rs1011970" "rs1038304" "rs1045288" "rs10491334"
    "rs1050171" "rs1078533" "rs10811661" "rs10885122" "rs10941679" "rs10951982"
    "rs10995190" "rs10997870" "rs11246020" "rs11246029" "rs11249433"
    "rs11267092" "rs11555236" "rs11599176" "rs117039649" "rs11708067"
    "rs11977670" "rs12293349" "rs12413112" "rs12493607" "rs12568456"
    "rs12631593" "rs12778366" "rs13236351" "rs13281615" "rs13431554"
    "rs1430738" "rs1690252" "rs16906252" "rs17130567" "rs1801132" "rs1801278"
    "rs1801516" "rs185277566" "rs1885472" "rs1896832" "rs1896832-rs956115"
    "rs2046210" "rs2077647" "rs2228480" "rs2229066" "rs2234693" "rs2234975"
    "rs2251692" "rs2251692-rs13431554-rs10205923-rs1078533" "rs2272563"
    "rs2273773" "rs2279744" "rs2288586" "rs2288586-rs1801278" "rs231359"
    "rs2363956" "rs2494732" "rs2566752" "rs28362491" "rs2981579" "rs2981582"
    "rs339097" "rs33957861" "rs356665" "rs36009202" "rs369178836" "rs369344513"
    "rs3740051" "rs3757318" "rs3758391" "rs3768716" "rs3783553" "rs3798577"
    "rs3798577and" "rs3803662" "rs3817629" "rs3821902" "rs3903072" "rs3978577"
    "rs41284209" "rs41420046" "rs429358" "rs4506565" "rs4646994" "rs4746720"
    "rs4973768" "rs527616" "rs554219" "rs56312618" "rs576674" "rs62444275"
    "rs6435862" "rs6557156" "rs6678914" "rs678653" "rs6943153" "rs6954996"
    "rs702482" "rs702483" "rs7069102" "rs71019893" "rs72670452" "rs73179023"
    "rs75334237" "rs7585356" "rs75915166" "rs78540526" "rs7896005" "rs79071878"
    "rs8170" "rs836478" "rs836488" "rs865686" "rs889312" "rs9340799" "rs9344"
    "rs9368222" "rs9374" "rs956115" "rtTA" "s12881-016-0293-3"
    "s12885-016-2087-6" "s12885-016-2090-y" "s12885-016-2099-2"
    "s12885-016-2111-x" "s12885-016-2136-1" "s12885-016-2240-2"
    "s12885-016-2277-2" "s12885-016-2302-5" "s12915-016-0252-7"
    "s12929-016-0240-9" "s12933-016-0362-0" "s12943-016-0494-6"
    "s12964-016-0128-z" "s12967-016-0841-9" "s13000-016-0473-7"
    "s13045-016-0260-7" "s13045-016-0269-y" "s13046-016-0311-5"
    "s13058-016-0671-y" "s13058-016-0675-7" "s13058-016-0686-4"
    "s13058-016-0694-4" "s13058-016-0697-1" "s13059-016-0892-5"
    "s13059-016-0897-0" "s13148-016-0205-6" "s13238-016-0257-6"
    "s40478-016-0287-6" "sCD40L" "sMaf" "sRNA" "sRNAs" "saline-injected"
    "salpingo" "salpingo-oophorectomy" "samplings" "sapiens" "sc-7305" "sc-816"
    "sc-990" "sca" "scale-up" "scar-link" "scatterplot" "schizotypy"
    "scramble-saRNA" "scramble-saRNA-dendrimer" "scramble-saRNA-transfected"
    "second-generation" "second-leading" "second-line" "selective-aptamers"
    "self-activated" "self-adaptation" "self-assembling" "self-associate"
    "self-association" "self-digest" "self-examination" "self-oligomerization"
    "self-protective" "self-renew" "self-renewal" "self-renewal-deficient"
    "self-reports" "self-sufficiency" "self-sufficient" "self-unphosphorylated"
    "semi" "semi-quantitative" "semi‐quantitative" "senesce" "sensitise"
    "sensitizer" "senticocus" "sequelae" "sequence-directed"
    "sequence-independent" "sequence-matched" "sequence-recognition"
    "sequence-specific" "sequence-threading" "sequences-GGRNNYYC"
    "sequence‐specific" "serosa" "serra" "sertindole" "set-up" "set-ups"
    "seven-bladed" "seven-member" "seven-week" "sh1-3" "sh6" "shAKA"
    "shAlox15b" "shCDK4-2" "shCDK4-3" "shChk1" "shCtrl" "shERBB3" "shFN"
    "shGFP" "shGSK3A" "shHNF4α" "shLKB1" "shLuc" "shMYCN" "shNC" "shNEK8"
    "shNRF" "shNRF2" "shNRF2-infected" "shNotch1" "shPLK1#2" "shQKI"
    "shRNA-NC-infected" "shRNA-OLA1P2" "shRNA-group" "shRNA1" "shRNA2" "shRPA"
    "shRPA32-tranduced" "shRPA32-transduced" "shRUNX2" "shRobo1" "shS3" "shTSC"
    "shTSC2" "shTSC2-treated" "shTrp53" "shUNG" "shUNG2" "shUNG2-transduced"
    "shake-off" "shao" "shear-fiber" "shockwave" "short-activating"
    "short-hairpin" "short-span" "short-term" "short‐term" "shp16" "shp53"
    "shutoff" "si-5" "si-HIF-2α" "si-NC-transfected" "si-Scramble"
    "si-α5-nAChR" "siAP-1" "siBRCA1" "siCDK4" "siCDK4-2" "siCREB1" "siCon"
    "siEZRIN" "siFOXO1" "siFOXO1s" "siHER2" "siHO-1" "siITGA4" "siKDM5B"
    "siLMP1" "siMCL1" "siMMP" "siMMP-2" "siMMP-9" "siMet" "siNgBR" "siPTTG1"
    "siRNA-ILKs" "siRNA-d" "siRNA-α5-nAChR" "siRNA3" "siRNAs#378" "siRNA‐3"
    "siRNF20" "siSIRT1" "siSIRT3" "side-chain" "side-chains" "side-effect"
    "side-effects" "signal-peptide" "signalling-cascades" "silco" "silico"
    "silicone-lens" "similar-case-only" "simpler" "simplest" "simplex"
    "single-cell" "single-country" "single-domain" "single-gene" "single-locus"
    "single-nucleotide" "single-particle" "single-round" "single-site"
    "single-strand" "sinusoid" "sirtuin" "site-specifically" "sites" "situ"
    "situs" "size-exclusion" "skewness" "skin-derived" "skin-fold"
    "slit-diaphragm" "slit-diaphragms" "slit-lamp" "slow-cycling"
    "slow-migrating" "slower-migrating" "slowest-migrating" "small-cell"
    "small-interfering" "small-molecule" "small-scale" "small-subunit"
    "smokers" "smu" "solenoid" "solid-phase" "solid-type" "solutes"
    "solution-phase" "sothe" "sotope" "source-specific" "spacer"
    "spatially-distinct" "spatio" "spatio-temporal" "spaw" "specific-analytes"
    "spermaduct" "sphere-forming" "sphere-like" "spindle-associated"
    "spindle-cell" "spindle-like" "spinning-disk" "spirooxindoles"
    "spirooxinodole" "splMO" "spot-like" "squamous‐cell" "srep20486"
    "srep20502" "srep20690" "srep20756" "srep20875" "srep20913" "srep21141"
    "srep21144" "srep21285" "srep21371" "srep21374" "srep21408" "srep21519"
    "srep21549" "srep21596" "srep21602" "srep21630" "srep21643" "srep21664"
    "srep21698" "srep21713" "srep21927" "srep21949" "srep21955" "srep22034"
    "srep22455" "srep22528" "srep22628" "srep22787" "srep23208" "srep23965"
    "ss" "stably-integrated" "stage-wise" "stainings" "stand-alone"
    "steady-state" "steady-states" "stem-cell-like" "stem-like" "stem-loop"
    "stemness" "stent" "stepwise" "stereochemistry" "steroid-sensitive"
    "stiffness-dependent" "stiffnesses" "still-born" "stimulated-17OHP"
    "stop-codon" "stress-activated" "stress-induced" "stress-inducible"
    "stress-mediated" "stress-response" "stress-stimulus" "stressful"
    "stressors" "stress‐induced" "stretch-induced" "stromal-derived"
    "stromal–epithelial" "structural-functional" "structure–function" "sub-G1"
    "sub-cellular" "sub-chromosomal" "sub-complex" "sub-fragments"
    "sub-genomic" "sub-lethal" "sub-network" "sub-optimal" "sub-population"
    "sub-set" "sub-stoichiometric" "sub-type" "subcategories" "subclass"
    "subclasses" "subcomplex" "subcomplexes" "subendothelium" "subfield"
    "subfields" "subiculum" "sublines" "submucosa" "subpathways" "subplate"
    "subscale" "subset" "subsets" "substate" "substates" "substudy" "subsystem"
    "subsystems" "subtype" "subunit-B" "succinate" "succinylated-Lys" "sulfide"
    "super-enhancer" "super-enhancer-associated" "super-family"
    "super-physiological" "supergene" "supernatant" "supernatants" "supernate"
    "supershift" "suprabasal-differentiated" "suprabasal-layers" "supress"
    "surface-resident" "surgery-associated" "switch-like" "sylvestre"
    "syn-miR-control" "synapse" "synergism" "systemto" "t-BHQ" "t-BHQ-mediated"
    "t-BHQ-treated" "tAkt" "tBOOH" "tEGFR" "tGSH" "tGSK-3β" "tGSK3β" "tGg"
    "tMAPK" "tagSNP" "tailbud" "tamoxifen+tocilizumab" "tamponade" "tamponades"
    "tandem-repeat" "tannins" "targeted-therapy-induced" "targetome" "tate"
    "tdTomato" "teady" "telencephalon" "telomerase-negative" "telopeptides"
    "temisirolimus" "temperature-sensitive" "ten-day"
    "ten-eleven-translocation" "tendon-bone" "tendon-derived" "tetraacetate"
    "tetracycline-off" "tetrahydro" "tetrahydro-azepino" "tetramethoxystilbene"
    "tetranitro" "tetrazolium" "thanEμ-Myc" "thatNAT10" "thatPATU8988"
    "thatPAX5" "thatRobo1" "the11B3" "theRobo1" "theTrp53" "theTrp53r"
    "theblood" "theblood–brain" "therapy-induced" "thin-layer" "thin-walled"
    "thioflavin" "thioflavin-T" "thionoacyl" "third-generation" "third-round"
    "third‐generation" "thoracotomy" "three-dimensional" "three-level"
    "three-line" "three-part" "three-round" "three-state"
    "threonine-to-alanine" "thrombin-RNA" "thrombocythemia" "thrombus"
    "thymidine-nocodazole" "thymocytes" "tie-1AS" "tight-junction–like"
    "time-cause" "time-course" "time-dependently" "time-lapse" "time-point"
    "time-points" "timeframe" "timelapse" "timepoint" "tissue-autonomous"
    "tissue-specificity" "tissue-to-plasma" "tissue-to-thigh-muscle" "tissues"
    "tissues–including" "tivantinib‐treated" "tm1Awb" "tm1Bei" "tnt-4" "to-GDP"
    "to-GTP" "to29.9" "toTP53" "tocopherols" "toll-like" "toluidine" "toolbox"
    "top-50" "topology" "tozasertib" "to–GDP" "trans-endothelial"
    "trans-factor" "trans-membrane" "trans-regulatory" "trans-well"
    "transactivation-competent" "transcatheter" "transcription-PCR"
    "transcription-incompetent" "transcription-quantitative"
    "transcription–PCR" "transcription–quantitative" "transcriptome"
    "transcriptomes" "transcriptors" "transdifferentiate" "transducer"
    "transfected-cells" "transfections" "transgenes" "translation-competent"
    "translatome" "translatomes" "transmembrane-domain" "transmittance"
    "transporter-1" "transposase-inaccessible" "transposition-permissible"
    "transversions" "transwell" "treasure-trove" "treatd" "treatment-emergent"
    "treatment-naive" "treatment‐emergent" "treatment‐related" "triage"
    "trifluoromethoxy" "trihydroxystilbene" "trimester" "trinucleotide"
    "triphosphate" "triple-epitope" "triple-negative" "triple-transgenic"
    "triploid" "triradials" "trisomies" "trisomy" "trithorax"
    "trophoblast-specific" "ts" "tube-like" "tubular-shaped" "tubular‐type"
    "tubule" "tubules" "tubulo" "tubulo-reticular" "tubulopathy"
    "tumor-invasion" "tumor-nodes-metastasis" "tumor-reactive"
    "tumor-repressive" "tumor-stromal" "tumor-supportive" "tumor-suppressive"
    "tumor-surveillance" "tumors" "tumor‐promoting" "tumour-associated"
    "tumour-bearing" "tumour-derived" "tumour-friendly" "tumour-induced"
    "tumour-initiating" "tumour-promoting" "tumour-specific"
    "tumour-suppressing" "tumour-suppressor" "tumour-to-blood" "tumour-to-bone"
    "tumour-to-kidney" "tumour-to-muscle" "tumour-to-organ"
    "tumour-to-salivary" "tumour-to-spleen" "tumours" "tunica" "turn-over"
    "twenty-eight" "twenty-four" "twenty-nine" "twenty-seven" "twenty-three"
    "twenty-two" "two-chamber" "two-electron" "two-gene" "two-hit" "two-hybrid"
    "two-side" "two-step" "two-substrate" "two-thirds" "two-way" "two-week"
    "txn" "type-1" "type-2" "type-I" "typhimurium" "tyrosine-phosphatase"
    "ubiquitin‐associated" "ug" "uibiquitin" "ulinastatin" "ulse" "ultra-low"
    "ultrahigh" "ultrahigh-throughput" "ultrastructure" "ultrathin" "un"
    "under-developed" "under-differentiating" "under-sample" "underexpress"
    "undergoes" "undergone" "underpinnings" "undertaken" "unfavourable‐risk"
    "uni" "uni-axial" "units" "univariate" "unmet" "unrecombined11B3"
    "untangle" "up-ratio" "up-regualtion" "up-to-date" "upper-limit"
    "up‐regulated" "up‐regulating" "up‐regulation" "uranyl" "urea" "urfaces"
    "urokinase-type" "uroplakin" "uroplakins" "urothelial-specific"
    "urothelium" "usCRP" "users" "usingRobo1" "utero" "v-Ki-ras2" "vIII"
    "vaccine-induced" "vacuoles" "vadilate" "vagal" "values" "vanadium"
    "vanderwaals" "var" "variant-1" "variant-2" "variants" "vastus"
    "vehicle-treated" "vena" "venae" "venosus" "ventilator-associated" "ventro"
    "ventro-dorsal" "vera" "vermis" "versus-deficient" "versusTrp53" "vi"
    "videomicroscopy" "vii" "villi" "villus" "vimentin‐positive"
    "viral-related" "virion-density" "vis-a-vis" "viscera" "vitrectomy" "vitro"
    "viv" "vivo" "viz" "wait-anaphase" "water-soluble" "weakest"
    "web-available" "website" "weeks-old" "well-conserved" "well-defined"
    "well-designed" "well-developed" "well-differentiated" "well-documented"
    "well-explored" "well-matched" "well-moderately" "well-organized"
    "well-powered" "well-prepared" "well-recognized" "well-regulated"
    "well-replicated" "well-tolerated" "whichp16" "whirl-like" "whole-body"
    "whole-cell" "whole-exome" "whole-genome" "whole-heart" "whole-kidney"
    "whole-mount" "whole-organ" "wide-range" "wide-ranging" "wide-type"
    "widely-used" "wild-types" "wildtype" "wild‐type" "withIGF‐1R"
    "withIPFwere" "withTrp53" "withdrawn" "wk" "work-up" "workarounds"
    "workers" "workflow" "workup" "world-wide" "wound‐healing" "written" "wt"
    "wtEGFR" "x-CT" "x-interferon" "x10" "xL" "year-old" "yellow-fluorescent"
    "yr" "zipper-like" "zona" "zykadia" "zymogen" "zymography" " 2"
    "©–secretase" "×10" "×109" "× 10" "× 10" "× 10" "˜10" "Δ10" "Δ1611–1828"
    "Δ205–304" "Δ3" "Δ305–404" "Δ405–465" "Δ5" "ΔC" "ΔC-Box-expressing"
    "ΔC-box" "ΔCt" "ΔCyt-GFP" "ΔEC" "ΔG" "ΔGAT" "ΔGAT-expressing" "ΔH" "ΔIR"
    "ΔIR-expressing" "ΔKinase" "ΔN97–CFP" "ΔPAR" "ΔPE" "ΔPE-GFP" "ΔS" "ΔS45"
    "ΔT" "ΔVpr" "Δkinase" "Δl05–204" "Δlinker" "ΙΙA" "ΦXΦ" "Φ−εΨ" "α-1" "α-2"
    "α-3" "α-4" "α-DG" "α-Dystroglycan" "α-KG" "α-TSC1" "α-TSC2" "α-crystallin"
    "α-dystroglycan" "α-helical" "α-helices" "α-helix" "α-methylacyl"
    "α-solenoid" "α-specific" "α-tocopherylquinone" "α1-β" "α11" "α1–α5" "α2b"
    "α2β1" "α2–α10" "α3" "α3-integrin" "α3β1-integrins" "α4-integrin" "α5"
    "α5-nAChR" "α5-nAChR-specific" "α5-nAChRs" "α5-nAchR" "α5-nicotinic" "α5b"
    "α7-nAChR" "α7-nAChRs" "α7or" "α9" "αGFP-LacR" "αvβ1" "αβ-lineage" "β-1"
    "β-S" "β-adrenoceptors" "β-barrel" "β-ca-tenin" "β-catenein"
    "β-catenin-Tcf" "β-catenin-mediated" "β-catenin–Tcf" "β-dystroglycan"
    "β-galactoside" "β-hairpin" "β-lactam" "β-oxidation" "β-phosphate"
    "β-propellers" "β-related" "β-selection" "β-strands" "β-subunit"
    "β-transducin" "β-γ" "β1–β6" "β3" "β4" "β6" "β8" "β‐catenin" "γ-S" "γ-TuRC"
    "γ-glutamylcysteine" "γ-imido" "γ-phosphate" "γ-phosphates" "γ-phosphorus"
    "γ1" "δ-tocopherols" "ε2" "ε2ε2" "ε2ε3" "ε2ε4" "ε3" "ε3ε3" "ε3ε4" "ε4"
    "ε4ε4" "κB" "μM" "μU" "μg-shRNA" "μg " "μl" "μmol" "μs" "ρmol" "кB" " WT"
    "”-induced" "⁄AP-1" "⁄kg" "⁄mL"
    "、帕妥珠单抗与紫杉醇联合治疗后整体纵向应变和心脏生物标记物水平均无具有临床意义的改变"
    "。整体纵向应变和心脏生物标记物可作为左心室射血分数的辅助检查" "。本研究的发现同时也对密切心脏监测在接受抗" "。本项"
    "。这些结果进一步支持了之前" "。鉴于" "。降低心脏评估的频率可减少不必要的治疗中断" "【2015" "与以紫杉烷类为基础的化疗联用时"
    "信号转导在心脏稳态和应激反应中具有重要作用" "因此非常有必要对" "并且在医疗成本不断增加的大环境下也是一个值得考虑的重要问题" "患者与方法"
    "曲妥珠单抗与帕妥珠单抗的二联抗" "期研究中" "治疗" "研究中报告的" "能够改善"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-16801-17100*
  '("re-association" "RNC" "FRB" "disk-like" "monodisperse" "micrographs"
    "solenoid" "cryo" "PIKKs" "actives" "fenestrations" "glycocalix" "pg/μg"
    "UCr" "HGEc1" "VEGF-A +" "Scr" "pMLC" "TEER" "HGEc-1" "HGEc" "RGEc" "Tg"
    "HSGP" "tubulo" "Thrombotic Thrombocytopenic Purpura"
    "HIV-associated nephropathy (HIVAN)" "Purpura" "HIV+" "R & D" "ΙΙA"
    "COX-2/PGE 2" "NOXs" "oxidases" "monocyte/macrophages"
    "phosphogluconolactone" "monophosphate" "kd" "≤ 0.05" "10.1038/ncomms11309"
    "siLMP1" "-ddUTP-labelled" "nearly gone" "oligonucleo" "digoxygenin"
    "TFBSs" "inhibites" "Dunnett" "RNAhybrid" "miR-3188+5-FU" "mock+NS"
    "miR-3188+NS" "mock+5-FU" "HONE1-EBV-miR-3188" "SXSW" "epithelium (NP)"
    "p-PI3K" "miR-3188 directly targets mTOR" "mean±s" "5-weeks" "5–weeks"
    "P =0.011" "10.1038/ncomms11371" "Guilmain" "Bourseau" "duocarmycin" "LIRF"
    "SLC16A3/MCT-4" "ConsensusPathDB" "Proteome" "neXtProt"
    "a weak co-association" "co-association" "transporter-1"
    "monosialotetrahexosylganglioside" "a clear co-association" "metabolome"
    "the hypoxic 3microenvironment" "Anti-mouse" "1/10" "LC–MS/MS"
    "a ≥1.5-fold" "determining reproductive lifespan" "salpingo" "mid 30s"
    "30s" "Jews" "year-old" "unilateral or bilateral oophorectomy"
    "oophorectomy" "OCP" "timeframe" "female reproductive lifespan"
    "the primordial follicles" "early antral follicles" "follicles" "mid-20s"
    "the reproductive lifespan" "anti-Müllerian" "Western Australia" "Tasmania"
    "Queensland" "NHMRC" "immunoassay" "kConFab" "Cuningham" "Kathleen"
    "reproductive lifespan" "= 0.61" "isothiocyante" "enfuvirtide"
    "macrophage-like" "U/mL" "viral capsid" "capsid" "monocytoid" "hMDMs"
    "hMDM" "RSV" "Kaposi's" "TGACTCAGCA" "mobilizer" "HAART" "oltipratz" "LTR"
    "the Kaposi's" "Kaposi" "anti-HIV" "24-hour" "10.1038/ncomms11389" "spatio"
    "Rus" "Blas" "A-targeted" "neoepitope"
    "Aurora-A-inhibited T cells form normal-shaped lamellae" "co-exist" "J77"
    "CH7C17" "PKCθ" "lamellae" "TCR/CD3" "A-deficiency" "IS-like"
    "MLN8237-treated T-cell" "ɛ" "TCR/CD3 complexes" "RERT" "Imaris"
    "A-inhibited" "+tips" "XYZ" "OTII" "TCR/CD3 complex" "synapse (IS)"
    "synapse" "MHCp" "2C" "β8" "anti-phospho-specific" "Asea" "Chalmin"
    "Bhatnagar et" "Paggetti" "oncomiRNAs" "rHSP70" "0.5–2 " "co-administered"
    "PMSCs" "AMSCs" "Yufang" "AMSC" "long-time" "6 h" "co-injected"
    "myofibroblast-like" "non-malignant" "toll-like" "chemoresponse" "sTILs"
    "COLl11A1" "COLl" "colXa1" "RCBIII" "pCR " "anti- colXα1" "mammoplasty"
    "ColXα1" "non-responding" "TCH" "RCB" "ColXA1" "Collagens" "NeoSphere"
    "TRYPHAENA" "pCR" "more aggressive breast cancer subtypes" "ER+/HER2+"
    "colXα1" "NAC+H" "just begun" "non-responsive" "CD10+" "P  = 0.001" "≥40 "
    "HER2/CEP17" "epidermal growth factor receptor-2" "/HER2+"
    "non-genome-wide" "JPT" "Willcox" "CEU" "Utah" "rs2234975" "rs2273773"
    "rs10997870" "rs1885472" "only five common haplotypes" "Flachsbart"
    "only four common haplotypes" "Pairwise" "rs11599176" "rs12413112"
    "rs33957861" "LLIs" "Hainan" "Guangxi" "Yongfu" "rs4746720"
    "the long-lived Caucasians" "rs7896005" "≤ 0.05" "10.1038/ncomms11321"
    "Lukey" "re-programming" "biomass" "around −200 bp" "PROMO" "SR11302"
    "P493 Burkitt's" "miR-23a/b" "sulfide (BPTES)" "BPTES" "sulfide" "bis" "KG"
    "α/β" "=0.83" "=0.85" "erythrocytes" "Amphiuma" "Perham" "non-cooperative"
    "T202/Y204" "F2-AA-variants" "S723/S726" "D1D2-(AXA)" "D1D2-" "D1D2" "S5a"
    "aERK2" "around iaERK2" "hexahistidine" "microscale" "app"
    "the iaERK2-bound hNHE1cdt" "a relatively extended structure around iaERK2"
    "hNHE1cdt folds or wraps around iaERK2" "iaERK" "e" "FFP" "FTP" "NHE1cdt"
    "mono-phosphorylated" "PKGQ" "iaERK2"
    "The previously described conserved TV-box" "described conserved TV-box"
    "conserved TV-box" "TV-box" "TV" "LEQKINNY" "LVNEELKGKV" "ITIDP" "IDR"
    "hNHE1cdt" "D-domain" "IDRs" "PONDR" "F-site" "FXFG" "FTYP" "FQFP" "FXFP"
    "ΦXΦ" "KIMs" "DEJL" "LXL" "placeholders" "F-sites" "D-domains" "hNHE1"
    "hNHE" "~ 80 %" "μg/ml " "1 mg/mL" "co-regulation" "N-labelled"
    "non-denaturing" "non-tumorigenic"
    "this model displays relatively few CNVs" "MNuMG" "MycER" "88CT1" "Myc83"
    "relatively few CNVs" "recurrent CNVs" "PyMT" "FVB/N" "re-localizes"
    "skin/mucosal" "NICU" "catheter" "otolaryngology" "bogginess" "fontanelle"
    "craniotabes" "gm" "polyhydramnios" "gravida" "cesarean" "workup" "bifid"
    "nigricans" "gyrata" "cutis" "Stevenson" "Beare" "factor‐κB"
    "ROSStatTCGATNF‐αTLR" "cell‐intrinsic" "‐derived" "intestinal epithelia"
    "IL‐11" "inflammation‐associated" "‐intrinsic" "‐23" "Toll‐like"
    "tumor‐promoting" "infection‐associated" "‐elicited" "‐11"
    "TNF‐α‐dependent" "NF‐κB" "TNF‐α" "+VE" "papillary‐type" "‐Wnt1" "24/223"
    "6/223" "tubular‐type" "pathway‐dependent" "‐κB" "‐inflammatory"
    "‐promoting" "COX‐2/PGE 2" "COX‐2" "Cyclooxygenase‐2" "F/F" "Wnt/β‐catenin"
    "TATA" "Unigene" "rs11555236" "_000011.10:g" "rs11246020" "G+g"
    "rs369178836" "rs3817629" "A+g" "JUND" "FOXD2" "YRPW" "_86ins" "_79ins"
    "rs185277566" "rs71019893" "rs11246029" "rs369344513" "rs12293349"
    "one novel heterozygous deletion DSV" "DSV" "Five novel heterozygous DSVs"
    "cardiac ischemia/reperfusion" "non-tissue-autonomous" "urea" "SIRTs"
    "_81ins" "_25del" "Six novel heterozygous DSVs" "DSVs" "14/17" "CpGs"
    "family 1A" "non-cirrhotic" "Non-invasive" "8/9" "3/7" "≥ 60" "anti-HCV"
    "Harders" "Cheong" "cardiacmyocytes" "raclopride" "sertindole"
    "HeLa-GFP-DRD3-Flag" "intra-vesicular pH" "re-localized" "d" "LC3BII"
    "monitor autophagosomal pH" "the vesicular pH" "GlutaMAX" "Polletta"
    "non-traditional" "odorant" "the intra-vesicular pH" "ortholog"
    "hyperammonemia" "autophagosomal pH" "Hyperammonemia" "ExTreg" "pSTAT5"
    "'exTreg'" "a fully demethylated CNS2" "Leonard" "ites" "amma" "Floess"
    "Epoxomycine" "a demethylated CNS2" "exTreg" "Teff" "TSDR" "enteropathy"
    "polyendocrinopathy" "CNS2" "Sequence-2" "2 +" "5 is" "co-stimulatory"
    "HWJ" "QZZ" "XW" "JWY" "YCL" "SJZ" "MZL" "RXH" "JRL" "QW" "CXK" "PYZ" "HJR"
    "CHZ" "LFZ" "SZ" "JZW" "Aβ" "tGSK-3β/pS9GSK-3β" "tGSK-3β" "simpler"
    "pS9GSK-3β" "ε2ε4" "ε2ε3" "ε4ε4" "ε2ε2" "ε3ε3" "ε3ε4" "ε3"
    "fluorodeoxyglucose" "ε4" "rGSK-3β" "ε2" "nMCI" "Wuhan" "CCCRC"
    "Connecticut" "Petersen's" "Petersen" "MMSE" "~ 70%" "= 12"
    "Glycogen synthase kinase-3β" "1.5–2" "HbA1c" "patritumab" "CTG" "NCIC"
    "evaluable stainings" "All assessable HER2 3+" "SISH" "and 3+" "Vater"
    "ampulla" "I-type" "histological subtype" "= 0.031" "/3" "co-existence"
    "rebiopsy" "Codon 12" "rs2228480:A" "rs2228480:G" "rs2077647:T" "TT+CT"
    "CT + CC" "fs" "statistical power greater" "rs3798577" "rs9340799"
    "rs1801132" "rs2234693" "rs2228480" "rs2077647" "Rs2228480" "rs3798577:T"
    "= 0.398" "OR = 1.55" "= 11" "= 0.83" "Hela-S3" "LVSI" "protooncogene"
    "Elsevier" "= 0.00" "= 0.038" "= 2.07" "= 0.0%" "= 0.052" "= 0.083" "= 66"
    "= 0.00001" "Joslin" "pSTAT3 +" "Insulin +" "Seung Kim’s" "Seung"
    "pancreatitis" "redifferentiate" "pSTAT3/DBA" "NGN3/DBA" "BrdU/DBA"
    "insulin +" "insulin+" "double+" "insulitis" "200mg/dl"
    "the ductal epithelium" "normoglycemia" "pSTAT" "non-beta" "Proinsulin/DBA"
    "A/DBA" "10X" "pancreata" "C57BL/6" "Cx+Stattic" "Selleckchem" "|Cx+" "Cx+"
    "48hrs" "brightfield" "72hrs" "exocrine" "interconversions" "≤0.05"
    "simplex" "Barr" "Eptein" "Poxviridae" "WxxF" "Priet" "shRPA32-transduced"
    "shRPA32-tranduced" "ΔVpr" "reevaluate" "non-activated" "T-lymphoid"
    "shLuc-" "shUNG2-" "shUNG2" "shRPA" "shUNG" "co-transduced" "Timless"
    "Y238A/R239A" "U2-O-S/" "anti-poly" "Δ3" "293T/" "interactome" "U2-O-S"
    "mollusks" "Pfam" "protein C4orf27" "CG1218" "more eukaryotic genomes"
    "PBZ" "protein C4orf27" "TARG" "macrodomain" "ARTDs" "Seymour" "Gibbs"
    "1 μg/ml" "MSHSP" "headloop" "16q23" "Wanfang" "OR = 0.55" "95 % CI = 1"
    "95 % CI " "16q" "= 3" "Xl" "miR198" "Oligofectamine" "DIANA"
    "proliferation/differentiation" "MLTC" "IVS" "2 × 10" "°2" "T-cells"
    "Venice" "nonbreast" "Zschenker" "Arabia" "Saudi" "Switzerland" "rs1801516"
    "co-morbidity" "= 2.94" "= 0.0%" "= 0.006" "= 0.005" "leave-one-out"
    "= 0.026" "= 11" "= 3" "= 0.031" "OR = 2.94" "P  = 0.002" "= 66"
    "miR-193a-3p" "miR-218-5p-overexpressing" "/Smads"
    "CCL21 induced mammosphere" "pCDNA" "Rh123" "mammospheres" "DOX"
    "Chemoresistance" "diabetic/severe" "Dick" "nonobese" "Thr180/Tyr182"
    "CD34+" "the mesenchymal subtype" "clinico" "Meir" "HR +" "HR+"
    "expression/activation" "= 0.34" "co-targeting" "BRAC" "PARP/PI3K" "RRPA"
    "PI3K/mTOR" "ΔT/ΔC" "ΔC" "ΔT/" "pictilisib" "pGSK3α/β" "Identifier"
    "an approximately 10-fold lower IC 50" "p≤0.02" "ribose (PAR)" "BMN"
    "≤0.02" "PAPR" "= 0.023" "anti-proliferation" "= 0.034" "p = 0.013"
    "= 0.042" "= 0.022" "shRNA2" "≤1" "6 pS" "pT308" "10.1038/ncomms11289"
    "Hosokawa" "non-producing" "T-bet-dependent" "G3/C4BS" "CGRE" "S/T-3A"
    "anti-phospho-Gata3" "S/T-3D" "C-finger" "NuRD" "Chd" "immunopathology"
    "Anti-Flag" "8-week" "Loss-of-function" "ubiquitin/proteasome"
    "LN-521/LN-411" "LN-411" "9-week" "LN-211" "LN-511 and" "LN-521" "LN-511"
    "GibcoBRL" "Geltrex" "Holm" "Engelbreth" "the cardiogenic mesoderm"
    "venosus" "OFT" "atria" "the pharyngeal mesoderm" "homeodomain" "FHF"
    "Grinnemo" "5B" "CCDN1" "ZBTB7A" "EBPa-saRNA-transfected" "hyperchromasia"
    "C/EBPα-saRNA-dendrimer-treated" "Doble" "gens" "shGSK3A" "H1993" "logrank"
    "harzard" "CARRAY" "NHTBE" "= 111" "= 90" "x 10" "Raine" "French" "GENDAI"
    "ALSPAC" "QTDT" "significantly associated SNPs" "rs4506565" "rs10885122"
    "rs11708067" "rs9368222" "4.60x10" "rs10811661" "4.85x10" "CDKN2A/B" "x10"
    "specifically 0.02–0.06 mmol/L" "EYHS" "Weedon" "Kelliny" "dysglycemia"
    "= 3" "= 0.06" "= 1.22" "= 0.88" "10.1038/ncomms11190" "Yosef" "repopulate"
    "non-senescent" "ABT-737-treated" "senesce" "Renilla" "cistrons"
    "monosomes" "variant-2" "variant-1" "Pilpel" "follicle" "non-autonomous"
    "10.1038/ncomms11171" "Walle" "ETPs" "T/NK cell" "VPREB"
    "human postnatal thymocytes" "TCF12alt" "HEBalt" "difluorophenyl"
    "these input multipotent CB CD34 + HPCs" "ICN" "multipotent HPCs"
    "T-lineage" "HPCs" "T-cell" "CD34 +" "B-lineage" "AMG479" "ClinicalTrials"
    "Ser235/236" "BYL719/AEW541" "AEW541" "T47Dr" "Vora" "GI50" "IC90"
    "Pan-PI3K" "pan-PI3K" "yr" "co-overexpression" "HMLE"
    "forms discrete heterogenous microdomains" "Rab7b" "FTI-277" "farnesyl"
    "Simvastain" "fluoromevalonate" "txn" "shp53/wt" "shp53" "ccRCCs"
    "hydroxymethylglutaryl" "geranylgeranyl" "mevalonate" "Nu/Nu" "22Q" "2 B"
    "10.1038/srep23965" "Jinesh" "IMEx/IntAct" "birinapant" "p70S6K/p45S6K"
    "isoform-2" "isoform-1" "non-sphere-forming" "sphere-forming blebbishields"
    "medium generated blebbishields" "lebbishield" "-pulldown" "3-hour"
    "blebbishields" "blebbishield" "non-Asian" "1.53–3.78" "1.09–2.36"
    "Clinicopath" "1.47–3.18" "1.66–2.86" "1.09–2.21" "1.42–2.42"
    "transdifferentiate" "non-mammals" "HRs" "= 1.87" "non-vascular"
    "Adlanmerini" "vascular endothelia" "endothelia" "Veh" "relatedness" "TFBC"
    "TFBCs" "Eahy926" "_hECs" "COS-1" "DNS" "KRR-" "E2/ERα" "carotid"
    "re-endothelialization" "17β estradiol" "KRR" "pCDNA 3.1" "T-" "pCDNA3.1"
    "Let-7f" "Shao" "the eutopic and ectopic endometrium" "ILKs" "extrauterine"
    "and 3LOH_E" "3LOH_E" "3LOH" "_E" "CASTp"
    "refining physical realism, stereochemistry, and side-chain accurateness"
    "accurateness" "stereochemistry" "YASARA" "Conduritols" "tetranitro"
    "tetraacetate" "ADMET" "QSAR" "pharmacophore" "CADD" "Conduritol"
    "Gymnemoside" "DAQ" "demethylasterriquinone" "vanadium" "arylalkylamine"
    "multidose" "Bangladeshi" "Saquib" "Mauritius" "Bhutan" "Lanka" "Sri"
    "Bangladesh" "sylvestre" "Gymnema" "mellitus (DM)" "Kcal/mol"
    "Huntington's" "Parkinson's" "rDNAs" "polymerase-1" "Aplysia" "NFT"
    "Alzheimer's" "p = 0.017" "methyaldenine" "phagophore" "p62/" "mg/kg/day"
    "XTT" "S15E" "Bem1p-1" "isopeptide" "6 h" "-813" "Netrin’s" "DAAs"
    "concatenates" "the last 15 y" "formation/morphogenesis" "ICCB" "inoculum"
    "HCVpp" "pseudoparticles" "UNC5s" "assembly/morphogenesis"
    "subgenomic HCV replicons" "replicons" "Fc" "TCID" "GUS" "JFH1" "fulminant"
    "japanese" "HBV+" "Uniprot" "Netrin" "Mehlen" "Paradisi" "UNC5" "adeno"
    "HCV+" "non-viral" "1/1000" "R&D" "Anti-E2" "50 /" "non-neural"
    "Pfizer Global R&D" "Ltd" "Vernalis" "Ser/Thr-Pro" "gotten" "Andrzej"
    "Masahiro" "peptidyl" "malignance" "SPSS" "Yantai" "Qingdao" "≤1 " "≥50 "
    "P  = 0.043" "pCdk1" "re-introduction" "+114" "Intestinal epithelium"
    "at 15 " "re-entered" "non-neuronal" "maturation/normalization"
    "Thr 180/Tyr 182" "kinase-2" "MAPKAP" "lemellipodia" "Rousseau" "McMullen"
    "Lamalice" "Gerhardt" "insertless" "reperfuse" "at 15" "p38MAPK" "galectin"
    "Δ5/6/10do" "Δ10" "the intraperitoneal exudate" "RhoG" "#378" "#690" "TMN"
    "ordistant" "normal colon glandular epithelia" "urfaces"
    "the peritoneal exudate" "exudate" "Spearman's" "P = 0.001" "12P"
    "pPAS (AATAAA)" "AATAAA" "pPAS (AATAAT)" "AATAAT" "pPAS" "RNA22" "immue"
    "ISG" "HDAg" "HVD" "HDV" "the same viral genome" "asialoglycoprotein"
    "sinusoid" "TAB" "myxovirus" "oligoadenylate" "ISGs" "Sendai" "shFN" "pFN"
    "pFN-promoter-Luc" "hNTCP" "HepG" "pHBV" "adw" "ayw" "EII" "rhabdovirus"
    "= 50" "3-3" "HNF-4α" "cooperation/coordination"
    "independent thermal unfolding/transitions" "Denu" "-acylimidate"
    "acylimidate" "/K" "isozymes" "Y102A/R105" "ΔS" "ΔH" "ITC" "Y102A/R015I"
    "Guan" "miniscule" "Shramm" "Sauve" "non-competitive" "DYNAFIT"
    "Fluor-de-lys" "Cleland" "Ac-Suclys-AMC" "Bisubstrate" "Boltzmann" "Du"
    "structural similarity/difference" "viz" "-acyl-ADP-ribose" "-alkylimidate"
    "alkylimidate" "peptides/proteins" "physiological/pathological"
    "Y102A/R105I" "1 mg/mL" "tGSH" "6 h" "siHO-1" "INT" "Interferin" "nEq/mg"
    "6h" "glutamylcysteine"
    "the highly chemoresistant neuroblastoma cells HTLA-230" "HTLA-230" "HTLA"
    "dialysate" "aminopeptidases" "nPCR" "3,500g" "IQ" "kg/m 2" "IDWG"
    "diabetic nephropathy" "three possible genotypes" "hydroelectrolyte"
    "SigmaStat" "D-dimer" "usCRP" "I/D" "= 0.067" "= 0.033" "& D"
    "insertion/deletion" "P = 0.033" "Insertion/Deletion" "archicortex" "2011b"
    "headwaters" "the existing Alzheimer’s" "ofAtm" "Most Alzheimer’s" "Lewy"
    "subiculum" "hidden" "Cerebellum" "the dorsal brainstem" "brainstem"
    "ceruleus" "melanin" "the Alzheimer’s" "NL" "Braak" "VI" "subfields"
    "subfield" "the following three Alzheimer’s" "2C1" "Brodmann" "R1.40"
    "tm1Awb" "becauseAtm" "2011a" "inAtm" "cryostat" "heterozygousAtm" "andAtm"
    "∼10%" "engineeredAtm" "CCEs" "Purkinje" "caregivers" "Alzheimer’s"
    "10.1038/ncomms11150" "Yeung" "Bethesda" "ectosomes" "reprogrammes"
    "miR21+/miR21+" "The ovarian cancer cells ALST" "ALST" "SKOV3ip" "amidite"
    "NAs" "exosomal miR21 isomiRs" "isomiR" "isomiRs" "qNano" "Exosomes"
    "colorectal cancer exosomes" "isomiRNAs" "exosomes" "P =0.002" "non-fixed"
    "P =0.007" "acidy" "supress" "co-transplantation" "Warburg" "situ" "ECF"
    "ECFs" "pHs" "Onat" "SNP309T " "SNP309TG" "SNP285C" "SNP285" "Knappskog"
    "SNP309G" "Phang" "Begg's" "1.02–1.83" "1.00–1.68" "1.11–2.20" "1.05–1.46"
    "0.84–1.49" "0.83–1.28" "0.79–1.61" "0.89–1.27" "0.80–1.07" "0.87–1.15"
    "0.75–1.15" "0.87–1.05" "biomedicine" "= 0.87" "21–1" "OR = 1.54" "= 1.31"
    "= 0.33" "= 0.88" "= 0.55" "rs2279744" "= 1.37" "= 1.30" "= 1.57" "= 1.00"
    "Wnt/β-catenin/Tcf4" "or/and" "Tcf" "LCSCs" "and 3 μM" "CellTiter" "ICRT14"
    "BC-21" "FP" "β-catenin/Tcf4" "arrest/progression" "GDK" "paclitaxol"
    "appreciable radioresistance" "BC-23" "Tcf/Lef" "non-cancer cells"
    "chromoplexy" "non-mutation" "Denmark" "Danish" "11/16" "≥4" "5-8 F/BRD7"
    "HNE1/BRD7" "5-8F/BRD7" "oncomiR" "oncomiRNA" "approximately 220–240 bp"
    "1.7-kb" "Enhancer" "anti-pS473" "RNU6" "5-8 F" "tEGFR" "tMAPK" "tAkt"
    "=0.0002" "CJ-023423" "CJ" "pCREB" "pGSK3" "Ras/MAPK" "Live/Dead" "xl"
    "deoxynucleotidyl" "apoptososme" "±0.3" "diphenyltetrazolium" "newer"
    "pMAPK" "hydroxyprostaglandin" "at 15 " "Ras/" "48 h" "10.1038/ncomms11057"
    "overexpression/knockdown" "ESCRTII" "THIIF" "global proteome"
    "pSuper-ELL-shRNA-1" "pSuper" "∼2.8-fold" "K51/52" "K51/52R" "UW9920"
    "weakest" "BioMol" "Mxd" "BM5" "a Burkitt's" "MBII" "anti-Flag"
    "Co-expression" "mg/kg/bid" "VS-6063" "Verastem" "defactinib" "the NCBI’s"
    "units/μg" "IBC03" "emboli" "peau" "non-IBC" "IBC02" "CEP-37440" "8q24"
    "= 0.302" "mg/kg " "7-week" "1 + " "≥ 2" "ina" "exon 19del"
    "confirmedsignificant" "sothe" "65/151" "±10.5" "19del"
    "the bronchial mucosa" "transversions" "FVC" "= 0.015" "FEV1" "= 0.03"
    "FEV 1" "blockers" "anti-platelet" "HbA1C" "mmol/L" "glycemia " "Gajos"
    "HbA1c " "Giα" "AGAC" "block-1" "block-2" "block-3" "rs1896832" "rs1801278"
    "rs2288586" "rs1078533" "rs2251692" "IIb/IIIa" "Rs13431554" "non-DM"
    "tagSNP" "rs956115" "diphosphate (ADP)" "Ferreira" "inefficacy"
    "rs13431554" "diphosphate" "non-HPR" "= 1.22" "= 0.03" "T2DM"
    "decay/degradation" "co-author" "Novicure" "RWPE" "Respir" "Jiang" "pS338"
    "Mielgo" "Reiter’s" "Reiter" "MEK1/2-ERK1/2-Fra1-ZEB1/2" "83-year-old" "TD"
    "micrometastases" "epithelial-like" "ARIEL2" "2b" "ESMO" "CO-338" "ARIEL"
    "Clovis" "exposure/penetration" "PBLs" "intersubject" "minimise" "21-day"
    "⩾12" "HGSOC" "8-Fluoro-2-" "indol" "cd" "azepino" "tetrahydro" "TCGAN"
    "HGSOCs" "antitumour" "PARPis" "HRD" "gBRCA" "⩾24 h" "BRCA-1/2" "=12" "=5"
    "BRCA 1/2" "phosphopeptides" "Lénart" "TuRC" "Augmin" "TST887AAA"
    "CD4-TST887AAA" "rpm" "andand" "aMTOCs" "eluates" "Mll" "7q22" "trithorax"
    "SPD" "aMTOC" "Anti-Mouse" "Anti–mouse" "anti–FLAG" "= 0.012" "anti–rabbit"
    "KIRC" "2-deoxy-glucose" "HOTTIP" "Non-Coding" "2-Deoxy-" "co-deleted"
    "mutation/deletion" "2-deoxy-" "el" "Kilic" "rs429358" "rs339097"
    "nonvariant" "Shahin" "Egyptians" "_phaseII+III" "Angeles" "Mexican"
    "Texas" "Houston" "Gujarati" "Los" "Roth" "Sung"
    "the homozygous genotype GG" "Richardson" "rs3740051" "rs12778366"
    "rs3758391" "= 0.387" "= 0.005" "= 0.205" "= 0.892" "genetic/epigenetic"
    "pathobiology" "collagens" "endometrial curettage"
    "deeply endometrial curettage" "myometrium" "the endometrial curettage"
    "curettage" "procollagen" "TGF- β 1/Smads" "hypomenorrhea" "menses"
    "Fritsch" "Heinrich" "IUAs" "IUA" "noncarriers" "Bahamas" "and 3rd"
    "funder" "Moroccan" "_4068del" "mastectomy" "in 1st" "Kabyle"
    "eastern Algeria" "Setif" "Algeria" "Anti-Cancer"
    "the fibrotic battlefront" "Todd" "diagnostic biopsies"
    "healthy epithelium" "Salomon" "prosurfactant" "vimentin‐positive"
    "stainings" "Ishitani" "Andreeva" "Cirone" "Wnt5b" "‐labeling" "Wnt3/3a"
    "the actual battlefront" "battlefront" "Nusse" "Mikels" "Kumawat" "Gosens"
    "Daniels" "activation/stabilization" "Enzo" "nonfibrotic parenchyma"
    "Nemo‐like" "cells/mm 2" "Vuga" "β ‐catenin‐positive" "‐shaped"
    "Wnt3a‐positive" "‐cytokeratin" "ProSpC" "all diagnostic biopsies"
    "Normal‐looking" "fibrosis/remodeling" "Wnt/Ca 2+" "Baarsma" "Konigshoff"
    "Chilosi" "Hess" "Franco" "Kottmann" "Hunninghake" "inIPF" "normal‐looking"
    "Wnt5a/b" "‐looking" "andNLK" "withIPFwere" "‐fold"
    "fibroblasts/myofibroblasts" "± SD" "= 6" "β ‐catenin" "Hyper" "propolis"
    "TAM67" "pcDNA" "SR-11302" "SR" "phenethyl" "catenein" "48 h" "nasopharynx"
    "miR-18b" "p15/p16/CDK4/E2F1" "p16/CDK4/E2F1" "mt" "shCDK4-2" "5–8 F"
    "siCDK4-2" "siCDK4" "5-8F" "let-7c" "~22-nucleotide" "CCND1 was" "48 h"
    "p16/" "miR-15a" "phospho-IGFR-1R" "Younes" "pg/ml" "Thr202/Try204" "pALK"
    "dideoxynucleotide" "LDKR" "CHR" "NCI" "proto-oncogene1" "CH5424802"
    "hepatocyte nuclear factor 4α" "ng⁄mL" "Vichow" "gallbladders"
    "LV-siVEGF-D" "⁄AP-1" "siAP-1" "PGL4" "PGL" "TFbind" "PGL4-57" "PGL4-325"
    "PGL4-717" "PGL4-154" "PGL4-444" "PGL4-988" "⁄mL" "supernate" "Virchow"
    "LNM" "Gallbladder" "HDLECs" "GBC" "co-culture" "non-mutated" "15/20"
    "± SD" "weeks-old" "tube-like" "95 % of" "ΔG" "workarounds"
    "chomentotriazolopyrimidines" "spirooxinodole" "imidazoyl" "MI-888"
    "spirooxindoles" "1T4E" "TDP222669" "benzodiazepinediones" "imadazoline"
    "Recently Popowicz et" "Popowicz" "Schephartz" "Carlson" "Zhong"
    "the N-terminal amphipathic helix" "overexpresson" "1YCR" "MUMBO"
    "kcal/mol" "Strong IRS-1 Corr" "Corr" "NKI" "UNC337" "YA" "95% CI = 1"
    "normal-like" "P-values" "mg/mL" "oligomerization/activation"
    "its viral homolog MC159" "MC159" "∼1:1:1" "the Burkitt’s" "Burkitt"
    "filaments/spot-like" "H9D" "H7D" "F114G/L115G" "R5E" "Y8D" "DED2" "DED1"
    "necrosome" "procaspase-3/Bid" "non-cleavable" "D374/D384" "procaspase-3"
    "bioassay" "lpr" "procaspase-8b" "recruitment/activation" "prodomains"
    "activation/activity" "the catalytically inactive caspase-8 homolog"
    "TRAIL-R1/R2" "receptor-1" "L/S" "quantitative LC-MS/MS" "non-fluorescent"
    "co-operative" "core protein/gene" "facies" "Lange" "Cornelia"
    "lymphoblasts" "destabilise" "Y1183Ter" "Waals" "der" "Schrödinger" "PyMOL"
    "LVSELK" "C-terminally" "T839_K862del" "Exon4delRev" "EUFA1341" "Y551Ter"
    "Xia" "revertant" "Q559RfsTer2" "_K862del" "II-3" "Thr839_Lys862del"
    ".2586+1G" "Gln559ArgfsTer2" "relocalise" "IRIF" "Nbn" "quadriradials"
    "triradials" "another larger café au lait" "epicanthus" "μg/L"
    "isochromatid" "XX" "gluteus" "centile" "echosonography" "radial aplasia"
    "DOXO" "IFO" "BFM" "CD20+" "emphasise" "ChAM" "paralogs" "_Lys862del"
    "_1677delAAinsG" "1μg/ml" "48H" "S1981" "48h" "FA-like" "LPSs"
    "JQ1/BB-Cl-amidine" "JQ1-" "JQ" "K3R" "GSK484" "BB-Cl-amidine" "R4K" "TDHA"
    "TDFA" "/R" "Peptidyl" "S2D" "pulpitis" "COX2/PGE2" "Il"
    "/activating protein-1" "4,6-diamidino-2-phenylindole" "co-cultured"
    "ROR-γT" "Th17" "K/BxN" "Niederer" "Th1/Th17" "co-cultures" "mSIRT1"
    "P- values" "Wurzel" "Harvard" "ATBC" "phytyl"
    "2,2,5,7,8-pentamethyl-6-chromonol" "PMCol" "hemocytometry"
    "anti-androgenic" "tocopherols" "the androgenic endpoints" "1 mg/ml"
    "sensitise" "AdM" "GGGGCATTCC" "RAdM" "RAdnCD40L" "AdnL" "sCD40L" "mCD40L"
    "1000 bp" "1  μ g/ml" "stress fibers/YAP" "stress fiber/YAP" "siCon" "=3"
    "db/db" "xref  diabetic nephropathy" "ML-141" "non-stimulated"
    "forkhead box O3A" "Clyde" "Glasgow" "SMARTpool" "= 0.011" "= 0.038"
    "arrhythmias" "Ky" "mg/dL" "patients—1" "MUGA" "≥16%"
    "the exploratory cardiac substudy" "substudy" "echocardiography (ECHO)"
    "symptomatic LVSD" "LVSD" "。降低心脏评估的频率可减少不必要的治疗中断" "用于早期发现心脏毒性。本项 II 期研究中"
    "。本项" "。整体纵向应变和心脏生物标记物可作为左心室射血分数的辅助检查" "并且在医疗成本不断增加的大环境下也是一个值得考虑的重要问题"
    "研究中报告的" "期研究中" "因此非常有必要对" "信号转导在心脏稳态和应激反应中具有重要作用" "能够改善" "与以紫杉烷类为基础的化疗联用时"
    "治疗" "曲妥珠单抗与帕妥珠单抗的二联抗" "患者与方法" "CLEOPATRA" "asymptomatic LVEF" "LVEF"
    "Exploratory endpoints" "postchemotherapy" "echocardiography" "0–1" "THP"
    "= 6" "a 3-week" "±SD" "18/25" "P=0.011" "=0.011" "B+C" "U/l" "P=0.001"
    "Transcatheter" "hypoxia-inducible factor-1α" "transcatheter" "=0.007"
    "8/26" "=0.033" "=0.021" "P=0.013" "_clinical" "_HiSeqV2" "_exp" "_TCGA"
    "actinomycin" "T234A/T238A" "deletion/mutant" "CK1a" "NIKF" "Michael"
    "Wajapeyee" "Narendra" "Huwe" "TFSEARCH" "-AXIN-CK1α-CTNNβ-GSK3β"
    "MetaCore" "sh6" "PrognoScan" "MKI67IP" "i-67 (NIFK)" "shRNA1"
    "non-silenced" "Casein kinase 1α" "Furuta" "Pattingre" "Sundaresan" "Kanfi"
    "Arico" "Cardinale" "rAAV" "Essick" "Hayashi" "Ou" "Dutta" "Sharma"
    "Lefort" "Davalos" "Thirumurthi" "Ronnebaum" "conditons" "Domenech"
    "Domingo" "Takasaka" "HBEC" "Filomeni" "Klionsky" "Galluzzi" "Kroemer"
    "box-1" "Mostoslavsky" "Kugel" "Feldman" "Liszt" "Michishita"
    "Ischemia/Reperfusion" "mol/L" "non-HD" "postmortem" "covariate" "euploid"
    "HD180-1" "HD180" "isodicentrism" "isochromosome" "trisomies" "HD57" "HD35"
    "Karyotype" "trisomy" "putamen" "caudate" "neuropathology" "G 0 /G 1" "1/3"
    "= 0.006" "1x10" "~ 80%" "ofVav" "fl/fl" "/Trp53" "eitherVav" "Alox"
    "17p13" "co-suppressing" "and11B3" "andVav" "and 11B3"
    "the conditional 11B3" "orVav" "creanimals" "cremice" "Vavl" "fl/+"
    "the 11B3" "the11B3" "Eμ-Myc" "of 11B3" "Cd" "Scol" "HPRT" "MICER" "CNV"
    "approximately ~50%" "Chromosome 17p" "chromosome 17p" "CNVs" "SNVs"
    "17p13.1" "11B3" "72H" "NIH3T3 cells" "3 +" "non-Hodgkin" "clearer"
    "Hydroxyestradiol" "β-catenin/TCF/LEF" "carcinogenic DNA adducts"
    "hydroxyestradiol" "tetramethoxystilbene (TMS)" "tetramethoxystilbene"
    "dimethylbenz" "β-catenin/" "pcDNA 3.1" "10.1038/srep23208" "Hindley"
    "/CD44 + /CD49d + neural subset" "human neural stemness" "Joshi" "ventro"
    "+ /HNK-1" "neurofibromatosis-2" "+ /CD49d" "SPADE" "neural stemness" "PNS"
    "maintaining neural stemness" "telencephalon" "neurosphere" "TUJ1-" "TUJ"
    "TUJ1" "Lund" "the adjacent β-III-tubulin-" "vagal" "co-ordinates"
    "delaminate" "paralog" "α4" "+ /" "MST1/2" "Hippo/YAP"
    "an important functional polymorphism" "Gayther" "Thakur" "Kuo" "Hussain"
    "A870G" "=0.522" "Medline" "Sathyan" "1q31-32" "rs678653" "=0.159" "=0.381"
    "MOSCATO" "Spanish" "Fridlyand" "Stefansson" "in 1q" "Duffy"
    "organization/DNA" "12q21.1" "8p22" "9q32" "11q" "Alvarez"
    "at least four genes of interest PDE4DIP /Myomegalin" "/Myomegalin"
    "Chilean" "hypermethylation/loss" "DEIS" "Chile" "BRCAness" "Agilent 4x44K"
    "aCGH" "BRCA1 /2" "17p" "FNAB" "TLG" "Multivariate" "cytologic CYFRA 21-1"
    "SUVmax" "21-1" "SCCA" "CYFRA" "= 0.012" "= 0.010" "= 0.996" "= 0.005"
    "FAS/FASL" "insulinemia" "IIR" "12~20%" "Approximately 12~20%"
    "non-diabetics" "non-diabetic" "responder" "Dock/Nck" "abelson" "/high"
    "publicly available clinical datasets" "theRobo1" "LD/HD"
    "a mammary tubule" "eightfold" "SCR" "andRobo1" "∼75%" "HME50" "pFAK397"
    "CMA" "pMRLC19" "NMII" "nonmuscle" "NSC2376" "TrioN" "inRobo1" "wk"
    "SLIT/ROBO" "ofRobo1 +/+" "mechanotransduce" "minifilaments" "MIIA"
    "adhesomes" "CMAs" "Structure/function" "1 +" "acidic autophagic vacuoles"
    "the online databases miRanda" "miRanda" "-triphosphate"
    "fragile site FRA17B" "FRA17B" "caspase-Glo-3" "DEVD"
    "numerous acidic autophagolysosomal vacuoles" "vacuoles" "MRE21"
    "pMIR-Report-Luciferase" "pMRE21PtenLuc2" "pMRE21PtenLuc1" "MRE21-1"
    "HPV16+" "pSilencer 1.0-U6" "pSilencer" "MRE21-2" "oncomir" "sapiens"
    "pSIMIR21" "Let-7a" "PI3K/AKT" "activator-like" "co-transfections" "1X10"
    "the mammalian postnatal forebrain" "forebrain" "isoenzyme"
    "the primitive neuroephitelium" "neuroephitelium"
    "the ventricular neuroepithelium" "subplate" "radial glia"
    "the radial glia" "pial" "β4" "Tβ4" "Radial glia" "neocortex" "NECs"
    "pluripotent hESCs" "IKKi-treated H1 hESCs" "IKKi-Treated hESCs" "OL2A1"
    "7-day" "OI" "BRACHYURY" "IKKi-treated hESCs" "monolayers" "Hong" "1 mg/ml"
    "and 2B" "95% of" "/nuclear" "10.1038/srep22787" "Ranjan"
    "strong co-relation" "vanderwaals" "GRAMMX" "silco" "knowckdown"
    "non-tranfected" "Tali" "porpidium" "procaspase-8/10" "cIAPs"
    "non-apoptotic" "Flice" "8/10" "2 × 10" "NIH 3T3 cells"
    "10.1038/ncomms10960" "Kerr" "Ju" "available and ubiquitous KOs"
    "global double Akt1/Akt2KO" "Akt1/Akt2KO" "matrigels"
    "Jagged1-encoding retrovirus" "AktX" "Jagged1KO" "Jagged1/Notch" "Sm22a"
    "Akt1 KO" "isolectin" "BBB" "theblood" "microCT" "arteriole"
    "mature Akt1ΔEC" "Akt1ΔEC" "AktKO" "KOs" "ΔEC" "Akt2KO" "arterioles" "∼40%"
    "&D" "∼2-fold" "Akt1/2" "fenoldopam" "azotemia" "oliguria" "SCr" "BCL"
    "AKI" "miR-449a" "jck/jck" "RhoGTPases" "fetal renal biopsies"
    "some mature glomeruli" "Streaker" "Anks6" "*16" "_1011del"
    "kidney cystic dysplasia" "ANKS6/NPHP16" "INVS/NPHP2" "tm1Bei"
    "hydroureter" "dilated proximal tubules" "Dysplasia" "infantile NPH"
    "morphants" "morpholino (MO)" "re-expressing" "Ctgf" "non-confluent" "NEK"
    "ciliary ANKS6" "ANKS6" "T87A/p" "isolated infantile NPH" "shNEK8" "pLKO"
    "PT1" "callosum" "syndromic cystic dysplasia" "structure/function" "Meckel"
    "severe syndromic renal cystic dysplasia" "asplenia" "Ivemark"
    "atrophic kidney tubules" "cortico" "CAKUT" "renal cystic dysplasia (RCD)"
    "NPH" "RCD" "aplasia" "vermis" "Løken" "pigmentosa" "multiorgan"
    "renal cystic hypodysplasia" "hypodysplasia"
    "renal cystic dysplasia/hypodysplasia" "cardiopathy" "inversus" "situs"
    "patients/fetuses" "a sensory organelle" "cmlc2" "antenna-like" "Roesch"
    "shERBB3" "laptinib" "shGFP" "Kg" "Titer" "DBZ"
    "publicly available array datasets" "ERBB2/Notch" "co-reactivated"
    "De-identified" "mg/Kg" "T24R2" "Kyoto" "2-3" "Written" "8/15" "6/15"
    "soft tissue peritoneum" "QTcF" "hematology" "pericarditis" "INR" "EPHs"
    "TRKs" "MUSK" "gatekeeper" "member 5B" "ClinTrials" "ASP3026" "ALK+" "≥1"
    "≥5 " "±7 " "3 + " "p = 0.053" "Background/Aim" "liposome" "identifier"
    "gelucire" "PF-271" "BME" "thoracotomy"
    "the resistant parental lines chosen" "= 0.91" "= 0.87" "IC50s" "μg/g"
    "1 x 10" "~80%" "heteroduplex" "Okumura" ".3113+1G"
    "highly homologous unprocessed pseudogenes" "plexiform" "PolyPhen"
    "Frameshift" "dysmorphism" "CALs" "lait" "café" "OMIM" "PolyPhen-2"
    "covariants" "WanFang" "CHKI" "trinucleotide" "Xq11-12" "Leydig" "× 10"
    "exon 1" "blocker" "=0.00007" "=0.00009" "p-p70S6K" "mTOR-p70S6K"
    "Cryptotanshinone" "=0.00004" "=0.00006" "=0.00002" "=0.00000"
    "presence/absence" "non-starved" "=0.00001" "cryptotanshinone" "1 mg/ml"
    "refining uncertain cytology" "cytology" "classifiers" "histopatology"
    "miR-200a/b" "PTС" "pathomorphology" "−144-5p" "144-5p"
    "Follicular subtype" "the developed classifier"
    "well-prepared histological micropreparations" "micropreparations"
    "The diagnostic classifier" "Russia" "Novosibirsk" "miR-146b"
    "10.1038/ncomms10810" "methyllysine" "Stallcup" "H4K16ac" "dimethyllysine"
    "dimethylammonium" "HSQC" "ERαK235R" "ERα K235R" "monomethylates" "E2+"
    "var" "K266/288" "NCOAs" "coregulators" "KMTs" "3P" "H4K20" "∼11%" "H3K36"
    "non-genomic" "non-histone" "H4K16" "10.1038/ncomms10975" "ΔC-box"
    "ΔN97–CFP" "cyan" "Yamano" "lambda" "C-Box" "C-box" "Nilsson" "Hein"
    "Complex/Cyclosome" "A-type" "non-degradable" "Adaptogens" "geldamycin"
    "intra-" "Melanogaster" "proprotein" "prohormone convertase 1/3"
    "proproteins" "thioflavin" "Massie" "NGM" "hypochlorite" "Coelomocytes"
    "aex-3" "coelomocytes" "lev" "pPR10" "pPR9" "pPR4" "pSX95.77YFP-proIAPP"
    "pSX" "Gibco" "Lipofectamine" "XL5" "Origene" "Promega" "Lorenzo"
    "ADAPT-232" "rosea" "Rhodiola" "Schisandra" "senticocus" "Eleutherococcus"
    "stressful" "adaptogens" "co-secreted" "proIAPP" "co-injection" "± SD"
    "3-day" "eosinophils" "eosinophil" "PenH"
    "specifically targets endogenous miR-3162-3p" "nt945–950"
    "anti-miR-3162-3p" "GAD" "publicly available bioinformatics tools miRDB"
    "TargetScreen" "endotypes" "BALF" "lavage"
    "exaggerated bronchial airway hyperresponsiveness (AHR)"
    "hyperresponsiveness (AHR)" "hyperresponsiveness" "antagomir" "MiR-3162-3p"
    "miR-3162-3p" "prevention/treatment" "phytopharmaceuticals" "anti-aging"
    "2/Sirtuin 1" "colonosphere" "resveratrol-promoting anti-tumorigenic"
    "Leica" "mountant" "fluoromount" "-toluidine" "tetrazolium" "nitro"
    "France" "Monlucon" "Uptima" "g/mL" "phenylmethylsulfonyl" "Tokyo"
    "Akishima" "EXII" "Jeol" "Berlin" "uranyl" "Ultrathin" "Darmstadt"
    "Ultracut" "Jung" "Reichert" "ultrathin" "Epon" "Karnovsky’s" "OsO"
    "Karnovsky" "Jena" "Zeiss" "toluidine" "Bio" "Absorbance" "isopropanol"
    "L/mL" "Petri" "Invitrogen" "/mL" "phosphorothioate" "Ebersberg" "Eurofins"
    "Operon" "CaCl" "dropwise" "Shakibaei" "trypsin/EDTA" "Manassas"
    "Salisbury" "Marburg" "Plano" "Dulbecco’s" "Munich" "amphotericin"
    "anti-mouse" "Schwalbach" "Millipore" "Heidelberg" "Dickinson" "Becton"
    "Hamburg" "Dianova" "Inc" "Abcam" "-trihydroxystilbene"
    "trihydroxystilbene" "anti-metastasis" "14-day" "anti-tumorigenic"
    "the large visible droplets" "biomicroscopy" "gonioscopy" "non-randomized"
    "keratopathy" "hLECs" "fundus" "intraocular tamponades" "tamponades" "4+"
    "endotamponade" "Vitrectomy" "tamponade" "capsulotomy" "vitrectomy" "plana"
    "1+" "paxilllin" "Karmali" "Parkinson" "CBLB" "website"
    "pSilencer3.1-H1-neo-Bit1-shRNA" "Stepwise" "the main histological subtype"
    "SurePrint" "= 15" "A 'catalytically" "Thorburn" "Papandreou" "Otomo"
    "Yoshimori" "Mizushima" "Kimmelman" "andp16" "inactivation/RAS"
    "activation/" "Wingender" "TRANSFAC" "Tebaldi" "Jordan" "Contente"
    "Menendez" "Hoh" "p53MH" "Radoshevich" "Rubinstein" "LDN" "CDKN1A/TGM2 #1"
    "TGM2 #2" "TGM 2#1" "chloroqiune" "TGM2#2" "TGM2#1"
    "similarly enlarged yellow punctae" "CQ" "ofTP53" "asTP53" "punctae"
    "shp16" "co-regulator" "TGM2 #1"
    "a publicly available breast cancer expression array dataset" "Itahana"
    "Yeo" "whose loss-of-function" "= 1" "#2" "#1" "PF-05212384" "Lorlatinib"
    "ALTA" "90-mg" "TEAE" "all 137 treated pts" "pt" "pts" "18 evaluable ALK +"
    "dyspnea" "alecensa" "zykadia" "multiforme" "ALK +" "1151Tins"
    "non-dominant" "phospholipase Cγ" "V3a/V3b" "V5a" "juxta" "AP26113"
    "lorlatinib" "HBV/HBx" "tBOOH" "peroxidant" "apurinic/apyrimidinic"
    "HBx-mutated HBV genome" "pcDNA3.1" "dichlorofluorescein"
    "ethical endpoint" "HCI-002" "HCI" "hydroxytamoxifen" "Achilles"
    "the most aggressive subtype" "palmitoyl" "carnitine" "acyl" "carnitines"
    "~1.5" "/µL" "morula" "Taz" "XaXa" "ICM-like" "5i"
    "the proximal enhancer (PE)" "EpiSCs" "the naive PSC datasets" "WGCNA"
    "mTeSR+2iFL+LPA" "HERVH" "Jaenisch" "DF12+bFGF" "karyotypes" "mTeSR+2iFL"
    "mTeSR" "N2B27+2iFL" "adenylyl" "naive-like" "diapause" "TALENs" "systemto"
    "karyotype" "blastocysts" "+2" "Tsuchiya" "domain 1A" "HNF-1β"
    "Hepatocyte nuclear factor-1β" "AT-rich interactive domain 1A"
    "a distinct histologic subtype" "= 0.016" "= 6" "≤1 " "20/26" "= 0.03"
    "= 0.02" "atypia" "GG " "written" "minute-2" "= 0.381" "= 0.85" "95% CI "
    "= 1.08" "= 1" "= 2.07" "95% CI = 1" "= 1.52" "regulons"
    "sequence/structure" "sequence/arrangement" "reinitiates" "REVIGO"
    "Significantly more HA-RNMT T77A co-purified" "co-purified" "pcDNA5" "β-1"
    "α-3" "S-adenosyl" "kinase/min" "pT77 " "RxL" "pT77" "PSKKR82" "SAAH"
    "adenosyl" "α-1" "Co-transcriptional" "RNMT-activating miniprotein (RAM)"
    "miniprotein" "eukaryotic initiation factor 4F" "factor 4F" "CBC" "2 × 10"
    "40 min" "nonsubstrate" "ethoxyquin" "Jolad" "5-acetoxy-" "-paradol"
    "paradol" "-gingerdione" "gingerdione" "diacetoxy-" "diacetoxy"
    "-gingerdiol" "gingerdiol" "flavonoid" "officinale" "Zingiber" "kelch-like"
    "aldoketo" "BJ" "L/min" "OGX" "Dand" "Profiler" "Cand" "vadilate" "viv"
    "inFig" "oncomine" "2×10" "AG/GG" "Latorre" "Capasso" "at least 4941 SNPs"
    "Polymorphisms" "protooncogenes" "2q35" "TG/GG" "95% CI=1.09-2.84"
    "OR=1.75" "III+IV" "95% CI=1.40-6.18" "=2.94" "95% CI=1.04-2.31" "OR=1.55"
    "=0.98-2.00" "OR=1.40" "mediastinum" "INSS" "rs7585356" "Italians"
    "the two most significant SNPs" "6p22" "Maris" "GWASs" "FASL" "medulla"
    "rs3768716" "ISSN" "rs6435862" "=0.55" "P =0.076" "=0.33" "=0.788" "=1.40"
    "hydroxy" "BCLC" "ERRβ" "Steiner" "Barcelona" "=0.049" "10.1038/srep22628"
    "Zhou" "p38 MAPK/p16 INK4a" "OA" "percentege" "IVF" "homolog-1"
    "fibrosus (AF)" "pulposus (NP)" "fibrosus" "annulus" "pulposus" "LVF"
    "tissues/cells" "6 /group" "10.1038/srep22455" "Chandrika" "bio"
    "Pentraxin-3" "induced/" "isoenzymes" "ROI" "UCN" "pentraxin-3" "~0.3"
    "gelatinolytic zymography" "~20–25%" "Temisirolimus" "nucleates"
    "myristate" "temisirolimus" "the NR4A1 distal primed enhancers" "cistrome"
    "heterodimeric intractions" "coremotif" "Nur" "intractions"
    "distal enhancer" "HATS" "PolII" "H3K9ac" "H3K9Ac" "CBFA2T3" "non-DHS"
    "a publically available genome wide DHS-seq dataset" "DHS" "DNaseI" "NBREs"
    "CEAA" "cistromes" "NurRE" "NBRE" "targetome" "NR4As" "NR4A" "co-enriched"
    "stem/progenitor" "1p35.2" "hepatectomy" "=90" "p44/42" "SMCC7721"
    "LINC01225" "LC-MS/MS" "P -value" "P -values" "2 × 10" "Annexin V-FITC/"
    "nu/nu" "7/10" "NSCCLC" "siEZRIN" "gallbladder" "nEGFR" "transducers"
    "synergism" "EGRF" "the important endogenous determinators" "determinators"
    "MiR-150-3p" "neonatal mouse calvaria" "calvaria" "facture" "iNKT"
    "invariant" "GGRNNYYC" "GeneBank" "mature miR-150-3p" "BIX02188"
    "anti-miR-150-3p" "receptor-2" "Paget's" "Paget" "miR-150-3p"
    "co-regulations" "a further 6 h" "alarmin" "far more interstitial edema"
    "more interstitial edema" "activity/signaling" "ischemia/reperfusion"
    "hemorrhage/resuscitation" "lipopolysaccha" "factor-2" "10.1038/srep22528"
    "TGO" "osmiophilic droplets" "droplets" "NAFL" "MetSyn" "hepatocyes"
    "1.02–1.09" "BD" "= 5" "= 0.042" "p  = 0.002" "first-time" "Kassen"
    "Villanueva" "Mendoza" "pre-OB-" "HD-BMSC-" "discrepant" "endosteum" "API"
    "osteolineage" "sequelae" "siMET" "HS27A" "OCs" "vis" "ERK-Gab1-PI3K"
    "ramapycin" "pIRS" "type-2" "pIRS1→pAKT→pERK→mTOR→pIRS1" "EKT"
    "non-inhibited" "nonzero" "chip 1inactivation" "≠0" "pIRS1" "8x10"
    "oocytes" "Ferrell" "switch-like" "exibits" "toolbox" "MATCONT"
    "subsystems" "subsystem" "SOS" "Proten" "Type-2" "= 5" "= 1" "dendrograms"
    "Heatmaps" "NSV" "neuroendocrine (NE)" "mCPRC" "continuum" "mCRPC"
    "oncology" "Intra" "= 0.02" "= 0.21" "nCounter" "benign biopsies" "Laxman"
    "immunocytochemistry" "Pearson’s" "pT2" "copy/μl" "copies/μl"
    "cystoprostatectomies" "Cystoprostatectomy" "prostatectomies (RP)"
    "prostatectomies" "benign prostatic glandular epithelium"
    "alpha-methylacyl" "antigen (PSA)" "DRE"
    "the benign cystoprostatectomy (CP)" "cystoprostatectomy"
    "prostatectomy (RP)" "prostatectomy" "histologically benign biopsies"
    "Kaunas" "actinomyosin" "Uni" "non-stretched" "lipofectamine"
    "specifically ADP-ribosylates RhoA" "botulinum" "Hz" "HBSMCs" "RhoA/ROCK"
    "Nguyen" "cardiac myocytes" "myocytes" "hypertrophy/hyperplasia"
    "RhoA/Rho kinase" "re-orientated" "exoenzoyme" "phallotoxin" "axial" "uni"
    "VE1" "finger-like" "histomorphology" "craniopharyngiomas" "scatterplot"
    "multilayered squamous epithelium" "Subsequent Sanger" "SSCP"
    "residual or recurrent papCP" "Larkin" "Brastianos" "anucleate"
    "palisaded columnar epithelium" "lobules" "non-neuroepithelial" "Rathke’s"
    "Rathke" "well-differentiated squamous epithelium" "AdaCP" "methylome"
    "papCP" "adaCP" "Craniopharyngiomas" "= 12" "= 6" "= 16" "= 5 " "Lieberman"
    "methylacyl" "gastric epithelial dysplasia" "cervical dysplasia"
    "gastric dysplasia" "Partial/non-consensus"
    "three subspecialized GI pathologists independently and blindly re-graded dysplasia"
    "consenus" "re-read" "PCAs" "partial/non-consensus" "non-consensus" "j"
    "S1g" "S1e" "S1c" "re-graded" "columnar epithelium"
    "normal esophageal squamous epithelium" "unnecessary esophagectomy"
    "esophagectomy" "non-dysplastic" "subcategories" "intraobserver"
    "interobserver" "non-dysplastic Barrett’s" "dysplasia (HGD)"
    "dysplasia (LGD)" "= 1 " "GSE69667" "deconvolute" "cell/tissue" "JQ1"
    "M-markers" "E-markers" "S5A" "autoregulations"
    "mesenchymal state regulators/markers" "regulators/markers" "autoregulate"
    "cooperativeness" "a highly modular topology" "topology" "DREM"
    "Hebenstreit" "transcriptome" "JUNB" "SNAI1/2" "ZEB1/2" "non-redundant"
    ".607+1G" "SNaPhot" "rs41284209" "CpG53" "probands" "CpG42" "CpG106"
    "23 developed Rb" "4 developed Rb" "27 developed Rb" "only 3 developed Rb"
    "1960G" "_79dup" "_65dup" "bilateral Rb" "Unilateral Rb" "DER" "Curie"
    "Institut" "CpG85" "almost complete penetrance" "Familial hereditary Rb"
    "Non-hereditary" "13q14" "T / p" "T/p" "1981C" "+1 G" "+1G"
    "parent-of-origin-specific" "titer" "Galindo" "Mi-3" "enin" "COMPASS"
    "COMPASS-like" "_4" "shLuc" "RUNX" "Realtime" "_E1" "mMSCs" "Dunn" "3xFLAG"
    "50 uM" "Co-IP" "H3K79" "an active enhancer" "thermodynamic entropy"
    "entropy" "metagene" "Heatmap" "nearest" "iTSCs" "eukaryotic genomes"
    "Zaret" "Iwafuchi" "Doi" "S4G" "S4F" "S4E" "S3G" "S3F" "S2I" "S2F" "S2G"
    "S2E" "H3K27" "S1F" "polymorphism (RFLP)" "RFLP" "Pamela" "catalyzer"
    "Tsai" "Takahashi" "quassinoid" "Yates" "dithiolthione" "sensitizer"
    "benzo" "adduct" "thionoacyl" "Yamamoto" "Zhao" "Loboda" "Rushworth"
    "Satoh" "DeNicola" "its activator tertiary butylhydroquinone"
    "butylhydroquinone" "brac" "à" "Tramtrack" "Keap1 amino residuals"
    "amino residuals" "residuals" "ETGE" "Muscarella" "Sasaki" "TPM"
    "mucoepidermoid" "minireview" "glycometabolism" "denovo" "anti-initiation"
    "erythroid 2-like" "echinoderm" "19p" "кB" "TMV" "exosome" "50,000xg"
    "a subsequent ELISA" "CHK1/2" "the alternate PIDDosome" "HUPKI" "Venus"
    "0.4uM" "the ATP competitive inhibitor AZD-7762" "AZD-7762" "AZD"
    "PIDDosome" "TMVs" "35-mm" "Δ Ct" "20X" "CHK1 is" "Balko" "anti-BC"
    "hydroxychinoline" "navitoclax/ABT-263" "derivate" "Bcl-2/Bcl-xL"
    "JIMT-1 BR3" "JIMT-1BR3" "eribulin" "Cou" "siHER2" "kD" "Cambridge"
    "ultrahigh" "siMCL1" "±0.44" "B-like" "London" "GlaxoSmithKline"
    "Francisco" "Genentech" "EU-5346" "Δ/null" "EU5346" "EU" "S3e"
    "co-localizes" "Bcl-2/" "= 1" "Basal-like" "videomicroscopy" "timelapse"
    "SYPRO" "flox/" "non-essential" "leftmost" "re-evaluated" "non-spindle"
    "essential Plk1 functions" "methylbenzyl" "non-modifiable" "Plk1 functions"
    "distinct Plk1functions" "nonredundant" "3-MB-PP1" "6P" "=22" "≥16.5%"
    "Univariate" "=1" "=6" "the Pearson's" "×109/L" "Philadelphia" "150g/L"
    "/L" "10×10" "VS" "JAK2V617F" "essential thrombocythemia (ET)" "vera (PV)"
    "thrombocythemia" "vera" "= 12" "≥60" "Valls" "Gertler" "ΔCt" "P-value"
    "offs" "Spearman" "non-tumours" "TTAGGG" "CIMP" "microsatellites" "onco"
    "non-tumour" "T/N" "TL" "i.e. the" "= 0.062" "= 0.086" "P = 0.017"
    "= 0.043" "= 0.021" "non-cancer" "7/16" "Gleason" "pCMV" "GenBank"
    "TGTTTAC" "GTAAACA" "cyclohexamide (CHX)" "cyclohexamide" "pFOXO3a"
    "AKT/DU-145" "CRPC" "Withaferin" "O-3a" "nu / nu" "∼70%"
    "10.1038/ncomms10818" "BubR1N" "mPheK" "pS92" "ΔIR" "ΔKinase" "Meraldi"
    "KARD" "ABBA" "40 min" "hyperinsulinemia" "Oestrogen" "Maldergem"
    "bivariate" "= 0.034–1.19 " "GTEx" "HaploReg" "Genotype" "rs12568456"
    "rs72670452" "rs36009202" "rs1430738" "rs1038304" "rs6557156" "rs62444275"
    "VEGAS2" "5q13.1" "9q22.31" "LINC00222" "2p12" "4p13" "6q21" "10p11.23"
    "11q22.1" "12q21.33" "4q28.1" "6q25.1" "8q13.1" "10q22.3" "TwinsUK"
    "1p31.3" "GENOS" "collider" "covariates" "NHGRI" "BMI"
    "absorptiometry (DXA)" "DXA" "absorptiometry" "eQTL" "rs17130567"
    "rs2566752" "P = 0.002" "12q" "10p" "= 1.00" "5-years" "= 0.034"
    "P = 0.017" "G0/G1" "KDM5" "Hep-3B cells" "shNC" "pSUPER" "treatd"
    "the major histological subtype" "Edmondson" "/G1" "non-tumorous"
    "co-morbid" "5´s" "psychiatric co-morbidity"
    "similar/different biological underpinnings" "hyperactivity/ADHD"
    "Tordjman" "behavioral/emotional" "ADOS-2" "Stanger" "parent`s" "Martinez"
    "Romero" "ADHD-" "examiner´s" "NCBRF" "subscale" "skewness"
    "the biological underpinnings" "examiner`s" "co-varies" "2D:4D" "comorbid"
    "co-occurrence" "distinct biological underpinnings" "Lecavalier" "ADHD"
    "biological underpinnings" "`s" "Nisonger" "= 0.3" "p = 0.002" "= 0.001"
    "= 0.109" "= 0.066" "co-occur" "= 0.007" "the homopentameric α7-nAChRs"
    "α7-nAChRs" "cyclooxgenase-2" "to29.9" "co-treated" "cigarettes/day" "h"
    "nAchR" "α7-nAChR" "heteropentamer" "acetylcholine" "nAChRs" "nAChR" "72h"
    "7/8" "μmol/L" "untangle" "Caroli's" "Caroli" "Jeune" "DDR/replication"
    "subclass" "Plki" "AurAi" "ATRi-VE" "∼2%" "ATRi:VE" "D-loops" "WMISH"
    "atrium" "the left lateral plate mesoderm" "spaw" "pericardiac" "tailbud"
    "ATRi-1" "the characteristic primordial dwarfism" "splMO" "smu"
    "the Kupffer's" "KV" "Kupffer" "re-entry" "Sensenbrenner" "centrioles"
    "Readouts" "formation/signalling" "cause primordial dwarfism" "mechano-"
    "centriole" "STIL" "ASPM" "CENPJ" "MOPD"
    "microcephalic primordial dwarfism (MPD)" "RAD3" "stalling/collapse"
    "dwarfism" "∼50%" "∼80%" "Minna" "anti-oncogene" "histopathology"
    "TargetScanHuman" "EOC" "miR-20a" "10.1038/srep21408" "LR" "α2/α3"
    "characteristic helix/helix" "non-bonded" "non-homotypic" "AFC" "IETD"
    "F122/L123" "DQFL" "α2/α5" "anti-E2" "RWF" "nucleo"
    "using far-UV circular dichroism" "dichroism" "macromolecule/ligand"
    "ionic" "Ni" "lac" "operon" "prodomain" "DEDs" "zymogen" "proenzymes" "DED"
    "α-2" "10.1038/ncomms10822" "Gee" "ESKD" "the glomerulotubular nephropathy"
    "nephrons" "nephron" "pronephros" "Hodgkin's" "Morris" "Arhgdia" "CKDs"
    "lumens" "neuroepithelium" "midline" "morpholino" "tubule" "ultrastructure"
    "tubulointerstitial nephropathy" "RHO-like" "P1032Cfs*11" "P1032Cfs"
    "atrophins" "whose orthologues" "microscopic haematuria"
    "unilateral nephrectomy" "nephrectomy" "non-consanguineous" "Hodgkin"
    "Morbus" "tubulointerstitial nephroapathy" "nephroapathy" "melanogaster"
    "dbSNP" "Arab" "*11" "pachygyria" "Turkish" "∼30%"
    "a glomerulotubular nephropathy" "ANLN" "interdigitate" "oedema"
    "tubulopathy" "haematuria" "CKD" "SRNS" "Non-adherent" "month-old" "∼60%"
    "∼15%" "=11" "10.1038/srep21643" "Ruben" "the visceral endoderm" "Redmond"
    "Tristeraprolin" "Orsenigo" "Evans" "Qk" "intronic regions several QREs"
    "Refseq" "QREs" "QRE" "impedance" "Electric Cell-substrate Impedance"
    "ECIS" "Impedance" "shCtrl-" "non-QKI" "shQKI" "MVECs" "microvasculature"
    "Qki5" "adventitia" "deeper" "‐mRNA" "76/NF70" "MIAT" "adherens" "edema"
    "solutes" "Co-staining" "10.1038/srep21602" "a weak signaling transducer"
    "DMH1" "x" "W/TID" "knockin" "primitive ectoderm" "ectoderm" "mesoderm"
    "mesendoderm" "DDXD" "AAXA" "Smad2/3" "hrs" "Ser-Ser-X-Ser" "endoderm"
    "domain-2" "domain-1" "promoters/enhancers" "SSXS" "Smads" "CRISPR/Cas9"
    "5/8" "deta" "O/E" "Fi" "decarboxylates" "IAA" "idoacetate"
    "phenylhydrazone (FCCP)" "phenylhydrazone" "trifluoromethoxy"
    "-dichlorofluorescin" "dichlorofluorescin" "Aiii" "TFARs" "NLuc/VLuc" "MOI"
    "hDFs" "TGAGTCAG" "embryoid" "Bi" "Ai" "Yamanaka"
    "glycogen synthase kinase-3β" "VLuc" "Vargula" "TFAR" "NLuc" "NanoLuc"
    "hESC" "hDF" "hESCs" "Hawkins" "HIFα"
    "nuclear factor (erythroid-derived 2)-like" "phosphorylation/activation"
    "TPA" "Nrf" "Kelch" "tumor microenvironment-like" "microvessels"
    "3-kinase-" "phosphoinositol" "microenvironmental oxidative stressors"
    "antioxidant-response element-" "Nuclear factor (erythroid-derived 2)-like"
    "N-acetyl-" "a 2 h" "S1D" "NAD(P)H:quinone oxidoreductase" "oxygenase-1"
    "confounder" "corticosteroid" "the placental villi" "hyperoxia"
    "pathophysiology" "~2-fold" "corticosteroids" "resp" "~10-fold" "preterm"
    "umbilical artery Doppler" "umbilical Doppler" "a restrictive subset"
    "Doppler" "fetal hypoxemia" "hypoxemia" "gasses" "Perhaps" "1  μ g/mL"
    "= 0.67" "10.1038/srep21955" "antagomiRs" "construsts" "SGC-7901-" "SGC"
    "GS" "Luc-ITGB1-mu" "mu" "ITGB" "ITGB1 expression" "mircroRNAs"
    "adhesiveness" "10.1038/srep21949" "the active K-Ras4B–GTP" "decouples"
    "active K-Ras4B–GTP" "the conformational substates"
    "the two higher energy inactive substates"
    "the former bearing two inactive substates" "Shima" "NH" "RMSF" "RMSD"
    "H-bonding" "hydroxyl" "carbonyl" "GTP-like" "GDP-like" "G12/P34"
    "interresidue" "two active and inactive conformers" "conformers"
    "K-Ras4B–GTP" "the inactive substate" "P-loop" "inactive substate"
    "substate" "conformer" "the two inactive substates" "PCA" "substates"
    "triphosphate" "imido" "milliseconds" "microseconds"
    "The functional P-loop" "helices" "Overview" "K-Ras4B-GTP" "–GTP" "HVR"
    "GDP-to-GTP" "μs" "-GTP" "1 ps" "10.1038/srep21927" "Ostrow" "vitro"
    "~24.5" "tGg" "non-reoccurring" "NRSSs" "the twelve possible codon 12"
    "PAAD" "COAD" "LUAD" "non-smokers" "10.1038/srep22034" "breakpoints"
    "siSIRT1" "siBRCA1" "Skp2/B" "/HER2 +" "non-homologous" "= 0.007"
    "ER + /PR +" "HER2 +" "•Rho" "the esophageal mucosa" "benign Barrett" "PPI"
    "refluxate" "a metaplastic intestinal-type epithelium"
    "squamous epithelium" "Barrett’s" "Barrett" "1 μg/ml" "-337-3p" "Spessotto"
    "correlationship" "siMMP-2" "siMMP" "RhoA/B/C" "gelatinases" "JAR"
    "at least 7mer" "A/B/C" "exoenzyme" "siITGA4" "PTBs" "HTR-8/SVneo" "Kakar"
    "Maik" "gene-1" "miRNA-378a-5p" "blastocyst" "siPTTG1" "40 min"
    "non-overlapping" "A/B" "1 μg/mL" "10.1038/srep21371" "Kossatz"
    "probe-based confocal laser endomicroscopy" "pCLE" "Larger fluorophores"
    "fluorophores" "fluorophore" "the fluorescent protein tdTomato"
    "endomicroscopy" "a commercial fluorescence endomicroscope"
    "endomicroscope" "coloc" "fluoresces" "Ex" "negligible non-specific" "NPV"
    "classifier" "H&E" "Memorial Sloan" "Sloan" "biospecimens" "Zeneca" "Astra"
    "Lynparza" "PARPi" "1 mg/g" "1 μg/ml" "6/group" "= 0.3" "± 7"
    "10.1038/srep21630" "Chiu" "BDB" "pGATA3" "pGal4" "pGal" "pGATA" "E1bLuc"
    "pHtrA4-1 " "trimester" "proliferin"
    "hematopoietic and nonhematopoietic tissues/cells" "carboxyl" "Missing-1"
    "EVTs" "EVT" "decidua" "placental villi" "villi" "10.1038/srep21549" "Zhu"
    "19q13" "shao" "CONSITE" "Moffatt’s" "Moffatt" "Chad" "NEC" "BIO"
    "the published esophageal cancer dataset (TCGA)" "dataset (TCGA)" "heavier"
    "BrdUrd" "IIa" "adenoid" "= 0.001" "P  = 0.017" "= 0.016"
    "10.1038/ncomms10765" "ESCRT" "LE" "Cι" "the global LE/Ly" "LE/Ly"
    "late endosomes/lysosomes" "pHluorin" "TIRF" "and 3T3-neu" "zymography"
    "invadopodia-like" "ΔGAT" "telopeptides" "TOM1L1−" "TOM" "ERBB2+/ER+"
    "/ER+" "ERBB2+" "ene" "17q12" "17q22" "17q23" "co-amplification" "CHC"
    "Hrs" "co-amplified" "× 10 " "Anti-rabbit" "HER2+" "≥10 " "ER  +" "HER2  +"
    "10.1038/srep21285" "using computational dockings" "LBD"
    "isothermal titration calorimetry" "calorimetry"
    "a flexible docking algorithm" "dockings" "Carlo" "Monte" "nucleases"
    "approx" "chromogenic cytochemistry" "H-bond" "ERaptR5" "ERaptR1"
    "ERaptR17" "all the probable aptamers" "ZT" "selected probable aptamers"
    "H-bonds" "ERaptR" "Z-scores" "Z-score" "Ē" "probable aptamers" "Sym"
    "hairpin-forming EREs" "non-SELEX" "analytes" "smaller aptamers"
    "usually ≥40 nt" "the lengthy aptamers" "cytochemistry" "ERaptR4"
    "PatchDock" "HADDOCK" "Vina" "AutoDock" "aptamer" "aptamers" "EREs" "SELEX"
    "Aptamers" "non-target" "≥40 " "aspirin-FOXD3-OLA1P2-STAT3" "ceRNA"
    "pseudogenes" "MRE" "circuitry" "OLA" "HGNC" "CCAT2" "MYCLos" "OLA1P2" "1P"
    "S8A" "S7A" "S5E" "S4D" "S4C" "S4A" "S3D" "CCAT1-L" "10.1038/srep21713"
    "Kou" "The E-cadherin repressors play important rle" "rle" "Liu’s"
    "libitum" "Yamato" "metabolisc" "Eca" "Okabe" "pHDAC1" "period-2"
    "Digitizer" "GetData" "Xeloda" "Saxby" "Chou’s" "Oncology/College" "IHC 2+"
    "IHC 3+" "2+" "3+" "Antigen" "Egger’s" "0.12–2.14" "Australia" "STATA"
    "Jan" "= 0.55" "95 % CIs" "CHD2 directly deposits H3.3" "KU"
    "laser-induced DSBs" "FokI" "S/G2" "Mbp" "laser-generated DSBs"
    "Multiphoton" "G–4I" "non-permissive" "°C" "ts" "aNHEJ" "cNHEJ" "readout"
    "EJ5" "VH10" "radiation (IR)-induced DSBs" "coIPs" "and 3F" "and 3D" "SANT"
    "ation" "SILAC" "coIP" "LacO" "lactose" "Remodeler" "remodelers" "LigIV"
    "XRCC" "Luijsterburg" "H3.3" "remodeler" "S5D" "S4L" "S3E" "1/2  " "S1E"
    "neuronal damage/death" "fumarate (MMF)" "fumarate" "monomethyl" "Akay"
    "overview" "TransAm" "digluconate (CHL)" "digluconate" "chlorhexidine"
    "EpREs" "sMaf" "ARVs" "glia" "ARV" "6/7" "strong anti-proliferative"
    "Chansu" "Bufadienolide" "robust anti-tumor" "Representative TUNEL"
    "both Broyl's" "Broyl's" "Dichens's" "Dichens" "Broyl" "pcDNA3-flag-WWP2"
    "hyperubiquitinates" "ELISA" "GRE" "MTS" "anti-myeloma" "bufotalin"
    "gargarizans" "Bufo" "parotid" "The Chinese traditional medicine ChanSu"
    "ChanSu" "hu" "GBT" "Roberts" "Sherr" "Carracedo" "FADH" "COA7" "nano"
    "TMT" "CellROX" "Debeb" "the most common histological subtype" "McGovern"
    "Cohen" "ccRCC" "Ashraf" "Haigis" "Finley" "Alhazzazi" "Qiu" "McDonnell"
    "Germain" "Verdin" "Multipeptide" "multipeptide" "ESO" "HLA-A2"
    "Peptide tumour-associated antigens" "2–3" "Chemo" "erythema" "sd"
    "KIFGSLAFL" "YLSGADLNL" "normal colonic mucosa" "antigen (CEA)" "supergene"
    "Several tumour-associated antigens" "antigens" "immunotherapy"
    "hormonetherapy" "at least one antigen" "OC" "1-year" "2/7" "72 h"
    "Alexa 647" "rapalogs" "WBCs" "leukemia-1" "/G 1" "Kit-8"
    "lentiviral-GFP-FAK-shRNA" "non-obese" "breakpoint" "HSCT" "mTOR-" "mTOR"
    "CLL/lymphoma-2" "diabetic/severe combined immunodeficiency" "= 11" "72 h"
    "NOD/SCID" "‐kinase" "progression‐free" "‐Colorectal" "FOLFOX" "‐HCC"
    "growth/metastasis" "multicenter" "‐controlled" "‐based" "‐C" "EOT" "‐drug"
    "febrile neutropenia" "disorder/onychalgia" "Drug‐related"
    "The most frequently reported drug‐related AEs" "drug‐related"
    "bradycardia" "AEs" "hoc" "PTEN‐High" "PTEN‐Low" "MET‐Low" "MET‐High"
    "‐Low" "‐High" "ECOG" "0.55–1.33" "Progression‐free" "follow‐up" "ARQ"
    "Neutropenia" "‐blinded" " WT" "CETIRI" "‐emergent" "≥50" "±7"
    "dose‐limiting" "5‐year" "drug‐resistant" "a known mutational hotspot"
    "SIFT" "3/19" "ANKRD26" "ABCA13" "FSIP2" "mutational hotspots" "hotspots"
    "4/19" "5/19" "6/19" "∼9%" "∼3%" "thalassemia/mental retardation"
    "0.4/100,000" "Exome" "altogether 44 ULMSs" "at least two ULMSs" "ULMS"
    "ULMSs" "≥5" "50/" "13q" "offsprings" "David" "Hales" "non-alcoholic"
    "utero" "NAFLD" "de-identified" "10.1038/srep21144" "Hasasna" "El"
    "iNOS/NOS2" "coria" "increasesIL" "ulinastatin" "Hartman" "Singh"
    "prostaglandins" "anti-invasive" "coriari" "anti-metastatic"
    "targets/pathways" "iNOS" "approximately 110 pg/mL" "pg/mL" "Boyden"
    "non-cytotoxic" "TNBCs" "Rhus coriaria ’s" "tannins" "Mediterranean"
    "Anacardiaceae" "pharmacopeias" "flavonoids" "HMVEC" "TNBC" "coriaria"
    "Rhus" "pSTAT3" "CALGB" "ovary/bladder" "GAC" "codon 12" "Subtype"
    "metastasectomy" "codon12" "PETACC-3" "= 0.137" "non-metastatic" "miR-29a"
    "FFLs" "miR-34c" "10 p53-miRNAs" "BioGRID" "PPIs" "c" "miR-19a"
    "hsa-miR-449a" "hsa-miR-148a" "hsa-miR-27a" "miR-7-1" "DAVID" "MiRanda"
    "TFBS" "14-3-3θ" "HL-7702" "miR-27a" "hsa-miR-20a" "hsa-miR-19a"
    "hsa-miR-34c-5p" "HiSeq" "Illumina" "sRNA" "sRNAs" "co-regulated" "10 p"
    "= 1.40" "miR-18a" "24h" "infectious particels" "supernatant" "particels"
    "Erb3" "respective IgG isotype" "the sub-genomic replicon" "supernatants"
    "the HCV sub-genomic replicon" "un" "HCVcc" "a subgenomic replicon"
    "the subgenomic HCV replicon" "Huh9-13" "the sub-genomic HCV replicon"
    "PHH" "the HCV subgenomic replicon" "Entrez" "ErbBs"
    "extracellular signal-regulated kinase 1/2" "CD"
    "the viral protease NS3/4A" "NS3/4A" "replicon" "Anti-Rabbit" "quadriceps"
    "inO" "enhancedO" "1RM" "1 RM" "lateralis" "vastus" "IIC" "IIX" "IIA"
    "μmol" "2max" "R-group" "l/min" "maximalO" "seven-week" "kg" "Lundberg"
    "Hickson" "= 0.55–0.61" "re-investigated" "± 7" "= 0.55" "Bayer" "gone"
    "DiscoveRx" "McGuinness" "Perera" "re-writing" "Dikic" "Ivan" "Jonathon"
    "B/CPC" "non-mitotic" "centromeres/KTs" "centromere/KT" "hypertriploid"
    "phosphatase 2A" "the bulky ATP analog 2OH-BNPP1" "2OH-BNPP1" "hr"
    "Iodotubercidin" "biosensors" "centromere-" "~50%" "~70%" "chromatids"
    "centromeres" "prometa-" "prometa" "pyrimidin-4-amine" "-5-methoxy-N-"
    "difluorobenzyl" "benzylpyrazole" "pombe" "Schizosaccharomyces"
    "cerevisiae" "Centromere" "KMN" "chromatid" "Schubert" "eLife" "DOI"
    "BAY-524" "BAY-320" "BAY" "IC 50  " "half-times" "anti-proliferative"
    "~40%" "APC/C" "Robinson" "Brca" "422-693aa" "3xFlag" "CPT11" "281-701aa"
    "421-988aa" "421-701aa" "dsDNA" "Δ11" "ΔDBR" "TALEN" "non-labeled"
    "rs2981582" "rs13281615" "5p12" "rs10941679" "NSABP" "rs4973768"
    "rs3821902" "rs10995190" "rs1011970" "BCIS" "rs12493607" "rs3903072" "COGS"
    "rs889312" "rs3803662-" "Easton" "rs3803662" "rs12631593" "rs73179023"
    "rs13236351" "low/highgrade  " "rs554219" "rs75915166" "low/intermediate"
    "≥50  " "BCAC" "ICICLE" "non-genetic" "clinicians" "arisen" "mammography"
    "non-obligate" "iCOGS" "IDC" "= 0.33" "= 0.021" "= 0.17" "22q" "18q"
    "Matteucchi" "pEGFGR" "pEGR" "anti-sense" "Itamochi" "PSalpha"
    "microtubule-targeting anti-cancer" "miR-200b" "SEREX" "cancer/testis"
    "Robertsson" "ERGFR" "β3" "Multi" "pEGFR" "6-week" "nu/ nu" "Anti-cancer"
    "10.1038/srep21596" "ENT" "isozyme" "Joseph" "Machado" "subclasses"
    "absentia" "casitas" "dominant-negative TCFs" "TCFs"
    "-acetylgalactosaminide" "acetylgalactosaminide" "FALZ" "BMFS"
    "intracardiac" "WCLs" "profiler" "adenomatous polyposis coli" "coli"
    "PC14PE6/LvBr4" "β-Catenin/" "Lalezari" "C-allele" "Germany" "Hilden"
    "Qiagen" "Pyro" "Therascreen" "amplicon" "rs16906252" "level/status"
    "T-allele" "alkyl" "immunohistochemistry (IHC)" "Stupp" "qMSP" "= 0.02"
    "p = 0.002" "= 0.006"
    "V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog" "Kirsten"
    "microvessel" "STCC" "nonmalignant" "TSCC" "V-Ki-ras2" "let-7a"
    "Material/Methods" "YZ" "CZ" "XD" "UV‐induced" "‐independent"
    "p53‐sufficient" "‐box" "‐dead" "knock‐in" "p53‐Mdm2" "Lu" "‐depleted"
    "1–3" "‐malignant" "actinomycin D‐induced" "‐sufficient" "damage‐induced"
    "GFP‐NAT10" "p53‐deficient" "p53‐dependent" "‐deficient" "SMMC‐7721"
    "‐expressing" "stress‐induced" "purified bacterial NAT10‐D5" "NAT10‐D5"
    "‐length" "‐D5" "knockdown‐induced" "auto‐ubiquitination" "‐ubiquitination"
    "cell‐free" "SMMC" "‐7721" "Mdm2‐induced" "Mdm2‐mediated" "‐null"
    "K120‐acetylated" "‐acetylated" "NAT10‐mediated" "‐acetyltransferases" "‐G"
    "‐X" "N‐terminus" "Flag‐NAT10" "GST‐Mdm2" "GST‐p53" "‐NAT10" "‐Mdm2" "‐p53"
    "NAT10‐specific" "laminopathies" "‐acetyltransferase" "thymocytes"
    "C‐terminus" "‐terminus" "p53‐mediated" "ofNAT10" "‐to" "Real‐Time"
    "Real‐time" "‐associated" "‐treated" "‐binding" "C‐terminal" "‐mediated"
    "cannabinoid" "Greater" "agonism" "accumbens" "non-intoxicated" "=0.027"
    "=0.043" "=−0.13" "schizotypy" "=0.02" "=0.088" "=1.79" "=0.038"
    "Non-intoxicated" "=0.034" "=2.21" "=0.529" "=0.87" "=0.015" "=0.085"
    "=1.87" "=0.03" "=7.00" "=0.181" "=7.01" "=0.223" "=0.88" "change=0.001"
    "THC/cannabidiol" "SPQ" "=12.40" "=0.17" "=0.795" "=0.067" "=0.001" "=2.07"
    "=0.198 " "gentoype" "=0.792" "=3.14" "=0.136" "=5.54" "=0.484" "=1.45"
    "=95" "=190" "=109" "=0.194" "=3.281" "=0.465" "=1.52" "=0.356" "=2.06"
    "=91" "=197" "=111" "gentoypes" "rs2494732" "P =0.017" "=2.30" "=0.042"
    "=0.017" "=0.031" "=0.167" "=0.902" "C/T" "Midwest" "Brazilians"
    "Northern Brazil" "Europeans" "INDELs" "rs11267092" "European" "ATTG"
    "rs28362491" "A homozygous genotype" "VNTR" "rs79071878" "TTCA" "indel"
    "INDEL" "rs3783553" "the Brazilian Amazon" "Amazon" "Brazil" "midwest"
    "Africans" "Americans" "interleukin 1A" "70 bp" "10.1038/srep21141" "Ozasa"
    "radiochemotherapy" "Petterson" "Kong" "Nabeshima" "RNA2"
    "preoperative KPS" "pGBM" "CGGA" "pGBMs" "7q21–q31" "KPS" "mg/m2"
    "10.1038/srep21374" "non-normal distribution" "BOLERO-3" "Vieira" "FinHER"
    "Carretero" "Melville" "Linher" "pAMPK" "BSS" "NTUH" "Bouzaghou"
    "Bouchekioua" "Shen" "TAMRAD" "Taiwanese" "= 0.039" "P  = 0.014"
    "P  = 0.002" "P  = 0.013" "10.1038/ncomms10498" "Lehmann" "ArrayExpress"
    "co-stimulate" "co-activate" "co-stimulates" "co-activated" "CoIP" "MCATs"
    "co-stimulation" "Dox" "dox" "Cordenonsi" "ZEB1/YAP" "radio/chemotherapy"
    "Alexa647" "72 h" "co-activation" "E-box" "E-boxes" "basal-like"
    "10.1038/srep21664" "Saurus" "podocytopathy" "responders" "Finnish"
    "experimental crescentic glomerulonephritis" "p38 MAPK" "CDK2B" "CDK2A"
    "co-treatment" "mg/mmol" "BALB" "Co-treatment" "aminonucleoside (PA)"
    "aminonucleoside" "tubules" "Hiromura" "Heymann" "re-enter"
    "glomerulonephritis" "nonprogressors" "microalbuminuria" "T1D"
    "lipopolysaccharides" "T2D" "Indians" "glomeruli"
    "diabetic nephropathy (DN)" "nephropathy" "non-toxic" "Toll-like"
    "10.1038/srep21698" "Leszczynska" "DYNNL1" "localization/translocation"
    "PEST" "desferoxamine" "hypoxia/reoxygenation" "methanesulfonate (MMS)"
    "methanesulfonate" "ASCIZ" "6 p" "HCT116 p53 +/+" "regrowth" "ABT-199/CPM"
    "regrow" "regrew" "gavage" "codepend" "overabundance" "Abbvie"
    "an amphipathic alpha helix" "multidomain" "helix"
    "ABT-199/cyclophosphamide" "Co-Immunoprecipitation" "deoxcytidine"
    "co-precipitates" "co-precipitation" "ETVl" "Co-transfection" "uibiquitin"
    "phosphomutants" "and 3l9" "degrons" "non-canonical" "Pl88A" "Vl87A" "P53A"
    "Pl88" "Vl87" "Δ305–404" "degron" "DDBl" "multisubunit" "Skpla" "Cdhl"
    "Ubiqutin" "COP1/DET11" "DET11" "phyla" "GGAAG" "mtp53" "De-etiolated"
    "Mtp53" "co-transfecting" "co-transfection" "b" "effecter" "myxoid" "ICI"
    "straighter" "normal ovarian epithelium" "pDP4" "hOlf" "Epithelium" "FIGO"
    "≤5" "five-year" "Dekanić" "rs1050171" "Haaften-Day" "Fujiwara" "Nielsen"
    "LGSC" "transcriptors" "GCN" "Exons" "serous BOTs" "COSM26129"
    "a heterozygous rs41420046" "rs2229066" "GA" "Lo" "= 0.625" "HGSCs" "LGSCs"
    "BOTs" "Non-specific" "= 0.013" "p= 0.002" "10.1038/ncomms10689" "Shinde"
    "phosphotidylinositol" "CcZ1" "endo/lysosomes" "co-component" "Ccz1"
    "S72E/Y183D" "S72A/Y183F" "alexa" "Duclos" "Lhermitte" "Ruvalcaba" "Riley"
    "Bannayan" "Cowden" "10q23" "anti-Rabbit" "non-hydrolyzable" "10q"
    "10.1038/srep20690" "Sunamura" "Utx" "DMR" "β-catenin/Kp1080" "Kp1080"
    "Kp2022" "Genomatix" "KvDMR" "bdSNP" "casein kinase 1α" "XCI" "ANRIL"
    "11p15.5" "Alexa 488" "N + " "11p" "10.1038/ncomms10662" "Demetriades"
    "complete Dulbecco's" "Dulbecco" "triploid" "aneuploid" "Boolean"
    "aethiops" "Cercopithecus" "African" "ATCC" "GmbH" "Fig. S2F"
    "immunoelectron" "the predominant organelles" "DG" "amino-acid re-addition"
    "re-stimulation" "re-supplementation" "re-addition" "osmostress" "TSC1/2"
    "anti-FLAG" "external dataset" "epithelia" "Shiraishi" "coll" "14q" "9p"
    "8p" "6p" "histotypes" "PI3KCA" "5p" "logFC " "Peng" "Andersen" "20q" "15q"
    "3p" "1p" "Hematoxillin" "Eosin" "Immunohistochemistry" "re-implanted"
    "colecystitis" "pN0" "exome" "Thailand" "10.1038/srep20913" "Zheng" "Mok"
    "Youngjoo" "Chmielecki" "Oxnard’s" "Oxnard" "EGFRm" "re-emerged"
    "mono-therapy" "timepoint" "re-biopsy" "19Dels" "Serial blood samplings"
    "samplings" "Combo" "Apr" "Sept" "Nov" "droplet" "serial tumor re-biopsies"
    "55/117" "ddPCR" "Droplet" "ctDNA" "re-biopsies" "10.1038/srep21519"
    "Iparraguirre" "Bargiela" "gastrectomy" "Meyer"
    "the online software TARGETSCAN" "TARGETSCAN" "MNK45" "pb" "8 Gy"
    "Transfac" "intra" "DSBs" "CalcuSyn" "Talalay" "Chou" "UNC" "DBS" "vs" "Gy"
    "begun" "IVA" "Fluoruracil" "radioresistant" "WB" "´s"
    "10.1038/ncomms10734" "NCBI" "H3K18" "18SE" "normo" "K12/25R" "K12/25Q"
    "2KQ" "K12/25" "non-acetylated" "+650" "the external transcribed spacer"
    "spacer" "fluorography" "SCARNA13" "SCARNA10" "SNORA73A" "nt" "H/ACA" "sca"
    "C/D" "-seq" "seq" "cosubstrate" "Sirtuins" "processome" "SSU" "subcomplex"
    "k" "Co-immunoprecipitation" "500 bp" "N +" "24 h" "Anti-HA" "B/C" "Moreno"
    "Rìos" "Group A1" "2-year" "mitoses" "epithelioid" "11q13" "GIST-1"
    "codons" "succinate" "4q12" "≥ 5 " "= 13" "stent" "antiplatelet"
    "anti-inflammatory" "myocardium" "aggregometry" "ristocetin" "aggregometer"
    "and 2-days-after" "transmittance" "mellitus" "HSPB" "non-valvular" "α2β1"
    "coagulant" "thrombus" "subendothelium" "Xa" "ΔSH2" "R175L/W118K" "ΔSH3"
    "Kohno" "Riggs" "FERM" "re-expressed" "++" "non-receptor tyrosine kinases"
    "GEF-CA" "GEF-DN" "pulldowns" "and 3x-mCherry-EMTB" "Scar1/Wave1"
    "c-Src-associated" "non-receptor tyrosine kinase" "MTs" "shNRF2" "shNRF"
    "OCT3/4" "2-like" "BHQ" "μ g/ml" "μ g" "CD90" "MicroRNA‐21" "decreasedin"
    "miR‐21‐induced" "wound‐healing" "MiR‐21" "lenti" "RT‐PCR"
    "its parental cell line PATU8988" "_miR‐21" "‐miR‐21" "nc" "‐resistance"
    "quantitative RT‐PCR" "‐PCR" "5‐FU‐resistant" "PANC‐1" "PATU8988/5‐FU"
    "PATU8988" "5‐FU" "5‐fluorouracil" "‐FU" "‐FUsensitivity" "PTENandPDCD"
    "proresistance" "‐FUbut" "andPANC‐1" "‐FUresistance" "‐Fu" "miR‐21"
    "‐fluorouracil" "‐21" "‐3" "μ mol/L" "‐healing" "μ g/mL" "× 10"
    "‐resistant" "‐year" "a Kras  G12D -driven GEMM"
    "a constitutively active RhoA" "K78I-C430S" "pixels" "pixel" "FIRE"
    "curvelet" "multiphoton" "cells/spheroid" "pPax" "sites/cell" "pFAK"
    "reacquire" "shLKB1" "amoeboid-like" "H1792s" "GEMM" "orthologue" "NUAK1/2"
    "axon" "missense" "amoeboid" "overseen" "loss-of-function"
    "mesenchymal-like" "10.1038/srep20875" "Hu" "Shockwave" "antimiR" "Schuh"
    "bone-forming osteoblasts" "significantly more osteoid" "ESW-treated TDSCs"
    "osteoid" "Goldner" "promotion/induction" "hBMSCs" "OIM" "hMSCs" "TDSCs "
    "miR-138-FAK-ERK1/2-RUNX2" "mechano" "osteoblasts" "the treated calcaneus"
    "calcaneus" "mJ/mm 2" "lithotripsy" "Extracorporeal shockwave (ESW)"
    "ADSCs" "TDSCs" "ESW" "shockwave" "v/v" "Hodges" "Huggins" "Charles"
    "the sexual dimorphism" "biopsies" "Sexual dimorphism"
    "approximately one-fold greater" "both male and female R 26hAR  LoxP/+"
    "R 26hAR" "BBN-treated R26hAR  LoxP/+"
    "no age-matched female R26hAR  LoxP/+ control littermates developed either non-invasive"
    "LoxP/Cre" "&hAR" "Cruz" "CreER" "uroplakins" "mGFP" "tdTomato" "R26RmT/mG"
    "mT" "Rosa" "Urothelium" "Both male and female R26hAR  LoxP/+"
    "neonatal hemizygotes" "hemizygotes" "eGFPCreERT2" "VUR" "Upk" "Uroplakin"
    "UPII" "uroplakin" "12-weeks" "a clear sexual dimorphism" "dimorphism"
    "ARKO" "naïve" "carciongen" "urothelium" "male and female R26hAR  LoxP/+"
    "both male and female R26hAR  LoxP/+" "UCC" "R26hAR" "GCE/+" "LoxP/+"
    "LoxP" "co-immunofluorescence" "ROSA26" "GRK6A" "BPAEC" "S339-340" "Darby"
    "Madin" "re-stimulated" "the antigenic phosphopeptide" "phosphopeptide"
    "RXRXXpS/T" "S/T" "kinome" "G protein-coupled receptor kinase 6A" "NTKD"
    "CTKD" "AGC" "Mz-Ch-A1" "OH" "XL" "occludens"
    "synthetic LecB-binding glycoconjugates" "glycoconjugates" "α3β1-integrins"
    "Karrasch" "fumigatus" "cenocepacia" "re-establishment" "co-stained"
    "Cyclo" "de-novo" "Lact" "bafilomycin" "TWS" "2A–C" "SubG1" "diploid"
    "FlowJo" "Alexa488" "co-staining" "MFI" "co-incubation" "soluble LecB"
    "typhimurium" "LecB" "aeruginosa" "#21" "24 h" "anti-rabbit" "co-incubated"
    "expression/signaling" "endometrium" "the alveolar epithelium" "pSmad2"
    "viii" "trichrome" "+/" "IU" "ets" "Pennsylvania" "iHBECs" "β6"
    "interstitium" "the pulmonary epithelium" "co-regulatory" "BRONCUS" "ZOOM"
    "non-COPD" "TUNEL" "caspase-3/7" "EBC" "pack-year" "particulate" "mucosa"
    "N-acetyl" "Kramer" "Tukey" "bronchoscopy" "4T07" "non-cancer cell"
    "pulldown" "A/CDK2" "circ-Foxo3–p21–CDK2" "circ-Foxo3–" "non-transfected"
    "circ-Foxo3-transfected" "circ-Foxo3-" "S4d" "circFoxo3" "dimmer" "oligo"
    "p21 and" "p21and" "lysis" "S4c" "S4b" "S3f" "DMEM" "S3d" "S3c" "S2f" "S2c"
    "S2b" "S2a" "S1d" "CiRS" "circRNAs" "ciRNAs" "ciRNA" "circRNA" "N+"
    "co-precipitated" "Non-coding" "rasopathies" "Noonan" "Schwann" "life-time"
    "Markevich" "simplest" "15/20 " "protein/activity" "Streptolysin"
    "activation/deactivation" "Rsk1/2"
    "the ubiquitous guanine nucleotide exchange factor (GEF) Sos" "Lowry" "z"
    "Sos" "the pulmonary parenchyma" "AdTGF" "Wettstein"
    "actively collagen-producing fibroblasts/myofibroblasts"
    "IPF/usual interstitial pneumonia" "Masson’s" "the Ashcroft’s" "Ashcroft"
    "Trichrome" "Masson" "homogenates" "Col1a2-EGFP" "co-localized" "inevi"
    "7AAD" "quantitate" "NMLF" "MEM" "Opti" "IPF" "ß1" "co-localization"
    "proSP" "Non-targeting" "24 h" "transgenes" "histotype"
    "bronchial dysplasia" "dysplasia" "bronchiolar epithelial SBECs" "SBECs"
    "AT2s" "SBEC" "immunophenotype" "FFPE"
    "Clara cells line bronchiolar epithelium" "alveoli" "Clara" "paraffine"
    "bronchio-alveolar adenomas/adenocarcinomas" "tumors/mouse" "tumor/mouse"
    "littermates" "multistage" "Adeno" "bronchioli" "bronchio" "2/6" "5/6"
    "1/6" "Alveolar epithelium" "terminal bronchial epithelium" "histo"
    "littermate" "the bronchial epithelium" "Ttf" "mESCs" "0.6–2"
    "v-Ki-ras2/Kirsten rat sarcoma viral oncogene homolog (KRAS)"
    "homolog (KRAS)" "homolog" "v" "Rosa26" "fide" "bona" "approximately 0.6–2"
    "hotspot" "500bp" "the MYCN -amplified subset" "anti-cancerous"
    "MYCN -driven anti-apoptotic" "CACGTG" "mg/m 2" "Oncology" "S6F" "SK-N-DZ"
    "TORC1/2" "p4E-BP1" "C–1E" "S1G" "S4B" "ABT-199/MLN8237" "tozasertib"
    "CAACTG" "CATGTG" "isotype" "shMYCN" "Garnett" "GDSC" "non-kinase"
    "MYCN -amplified subset" "S1H" "E-BOX" "10.1038/ncomms10442" "Sansone"
    "stepwise" "cell types/pathways" "underpinnings" "Mitotracker" "oligomycin"
    "/Mito" "GSE69280" "-galactosidase-negative" "/OXPHOS" "secondary MSs"
    "MetMS" "MSs" "ShS" "Toci" "Fulv" "FulvR" "IVIS" "combo" "ERE" "TamR"
    "tertiary mammosphere (MS)" "mammary fat pad (MFP) re-engraftment"
    "re-engraftment" "mammosphere" "Wilcoxon" "Wald" "dormancy" "OXPHOS" "lo"
    "70 bp" "U133" "μg " "non-proliferating" "ER +" "generalise"
    "misclassifications" "multicentre" "non–triple-negative" "PR+" "IQR"
    "interquartile" "CIMBA" "micropapillary histology" "post-menopausal FBCs"
    "FBC" "hyperestrogenism" "BRCA1 / 2" "oestrogen" "SEER"
    "the largest available dataset" "FBCs" "MBCs" "BRCA1/2" "MBC" "≥10"
    "10.1038/srep20756" "Meng" "≥40" "CPG" "0.38–2.94" "Haenszel" "Begg’s"
    "the Begg’s" "a Begg’s" "histology" "REML" "Cochran" "English" "3p21.3"
    "CNKI" "protein 1a" "95% CIs" "alpelisib" "lymphonepnia" "Novartis"
    "ribociclib" "3/4" "ASCO" "TRIO18" "PALOMA-1" "PALOMA-2"
    "chemotherapy-associated neutropenia" "Antonio" "IMPAKT"
    "secondary endpoints" "endpoints" "on/1-week"
    "advanced post-menopausal ER+" "furthest" "bolus" "arrhythmia" "Cyclacel"
    "Rescovitine" "severe neutropenia" "neutropenia" "loss/mutation" "Genome"
    "ErbB" "non-catalytic" "goes" "D-type" "Hartwell" "armamentarium" "ER+"
    "= 0.06" "IC50 " "G1/S" "I/II" "histologic subtype" "Hürthle"
    "aggressive histologic subtype" "pT" "AJCC"
    "the most frequent histologic subtype" "WDTCs" "Korea" "Radioiodine"
    "radioiodine" "WDTC" "BRA" "Sanger" "p  = 0.014" "=  0.017" "Wu" "UV"
    "Fagundes" "Souza" "Feldkamp" "S2KO" "co-localize" "CldU"
    "-chlorodeoxyuridine" "chlorodeoxyuridine" "iododeoxyuridine" "Thr1989"
    "anti-acetyl-lysine" "anti-acetyl" "HU" "PIKK" "Guarente" "Duursma" "MRN"
    "DSB" "Seckel" "Cimprich" "Zeman" "Zou" "Rad3" "Zhang" "ETOC" "ssDNA" "RPA"
    "acetylome" "non-treated" "Stem cells (SCs) typically display low H2Bub1"
    "non-cell" "S7B" "RNF20/40" "shutoff" "global H2Bub1" "TCGA" "non-inflamed"
    "propria" "muscularis" "submucosa" "Colonoscopy" "MDSC"
    "This intestinal leakiness" "leakiness" "heterozygotes" "colonoscopy"
    "RNF20/H2Bub1" "small intestinal 3D organoid"
    "viable homozygous knockout progeny" "progeny" "RING" "colonocytes (YAMC)"
    "colonocytes" "Colonocytes" "oligos" "underexpress" "hetero-" "hetero" "UC"
    "MDSCs" "H2Bub1" "&E" "× 10" "non-specific" "μg" "re-ChIP"
    "non-transformed" "H3K9" "efficiency/machinery"
    "adaptive translatomes/proteomes" "proteomes" "broader" "rHRE" "≥2"
    "eIF4E-" "the combined normoxic and hypoxic translatome" "eIF4E2-depleted"
    "eIF" "the normoxic translatome" "KEGG" "the O 2 -regulated translatomes"
    "/T" "=P" "pSILAC" "sotope" "ulse-" "ulse" "ss" "tate" "teady" "NA"
    "olysome" "ligosome" "o" "onosome" "translatome" "IRES" "titrate" "triage"
    "translatomes" "~20%" "co-segregation" "mutations/variants" "nearly 1/3"
    "algorithm" "non-carriers" "greatest" "_7805del370" "Japanese" "12/23"
    "Kwong" "DHPLC" "Jewish" "Ashkenazi" "Africa" "Pakistani" "13/133" "18/133"
    "1-40delGA" "+ 1G " "Genomes" "UVs" "8/16" "31/133" "races/ethnicities"
    "non-synonymous" "_5477del8" "_473delAAGTC" "_4066delAATC" "_3781delAG"
    "breast/ovarian" "Haplotype" "Germline" "+ 1" "receptor‐1" "insulin‐like"
    "‐limiting" "HER2IGF‐1RIGFIRMTDRP2DTKIULN" "AECIDLTGI" "HER2‐positive" "AE"
    "BMS‐754807" "BMS" "‐free" "‐754807" "‐IGF‐1" "IGF‐1R/IR" "Kirin" "Hakko"
    "Kyowa" "‐daily" "‐mg" "first‐in‐human" "non‐fasting" "pre‐dose"
    "post‐dose" "‐dose" "‐h" "half‐life" "RP2D" "‐fasting" "concentration–time"
    "‐life" "‐dependent" "‐R" "IGF‐1‐induced" "HT‐29/GFP" "‐29" "‐induced"
    "KM1468" "IGF‐1" "‐H929" "‐ES‐1" "‐71" "GI" "nmol/L" "‐human" "‐in"
    "IGF‐1R" "‐Raf" "‐talk" "‐agentKW‐2450" "mg/day" "KW‐2450" "andIRkinases"
    "Preclinical activity ofKW‐2450" "ofKW‐2450" "ofKW" "‐2450" "‐1R" "‐1"
    "‐positive" "‐2" "‐like" "multipass" "cargos" "GNA" "cyrtonema" "legume"
    "The autophagic marker LC3II" "LC3II" "Alexa" "ECMs" "anoikis-like" "Pf0-1"
    "ESA-2" "alvarezii" "Kappaphycus" "serra" "Eucheuma" "algal" "agardhii"
    "Oscillatoria" "cyanobacteria" "Desorption/Ionization-time" "glycans"
    "fluorescens" "β1" "× 10" "μg/mL" "supershift" "biotin" "+1" "Sladek"
    "D69E/R76K" "apolipo-protein A-I" "factor 4α" "anti-tumor"
    "radioresistance" "Rembrandt" "Tunel" "eosin" "EGFRvIIIshGFP" "ATTTATGG"
    "Wallis" "retrovirus" "DK" "metallopeptidase-1" "wtEGFR"
    "the classical subtype" "vIII" "Guanylate" "500 bp" "loss-of-" "∼20%"
    "precocious idiopathic pubarche" "idiopathic hirsutism" "XY"
    "the external genitalia" "genitalia" "Hickey" "ovarian hyperandrogenism"
    "premature pubarche" "X-inactivation" "hyperandrogenism" "ng/dL"
    "mild hirsutism" "severe hirsutism" "Ferriman" "Nonclassical genotypes"
    "A49T" "idiopathic precocious pubarche" "17OH-progesterone" "Genotypes"
    "total/severe" "precocious pubarche" "hirsutism" "pubarche" "CAH" "A/C"
    "adolescent/adults" "C/C" "adolescent/adult" "GeneScan" "HpaII" "nCAG"
    "Alan" "Akbar" "Bustraan" "Glenda" "the diagnostic work‐up" "‐up"
    "‐morbidities" "disease‐related" "‐lived" "Marcucci" "Fasan" "Dufour"
    "Wouters" "Renneville" "Taskesen" "14·3" "6·6 " "·3 " "0·0001" "·38"
    "favourable‐risk" "·0001" "poor‐risk" "good‐risk" "·08" "ITD" "WBC" "SM"
    "Ostronoff" "Lazenby" "Becker" "Buchner" "Alibhai" "Weisdorf" "Oran"
    "Lowenberg" "Ossenkoppele" "Pollyea" "Derolf" "≥60 " "long‐term" "‐α"
    "Donnell" "Cornelissen" "Rowe" "Ofran" "Gaidzik" "Dohner" "Burnett"
    "younger" "et " "intermediate‐risk" "‐term" "·6" "·2" "OSat" "·6 " "‐risk"
    "‐terminal" "‐related" "wild‐type" "the long-lived positron" "4.3±0.6%"
    "2.6±0.5%" "Aerts" "re-absorption" "re-absorptions" "re-absorbed"
    "maleimido" "=67.6" "biodis" "MicroPET" "renal re-absorption" "ID/g"
    "160±60" "×10" "LigandTracer" "NAP" "presesnt"
    "a long-lived positron emitter" "=78.4" "radiohalogens" "=109.8"
    "a more long-lived positron emitter" "emitter" "Ga" "T 1/2" "nuclide"
    "In-DOTA-ZEGFR:2377" "Affibody" "the more long-lived 89 Zr" "nuclides"
    "long-lived positron" "Zr" "Cu" "radionuclides" "SPECT" "Positron"
    "co-workers" "Radionuclide" "unmet" "non-invasive" "biopsy"
    "chemoradiotherapy" "microPET" "Zr-DFO-cetuximab" "Zr-DFO-ZEGFR:2377"
    "epidermoid" "pM" "ZEGFR:2377" "pH" "affibody" "positron" "radionuclide"
    "invasion/metastasis" "metastasis/invasion" "biomolecules" "48-hour"
    "Transwell" "cell migration/invasion" "non-epithelial cells" "VCAM"
    "antigen" "immunoglobulin" "extravasate" "pleura" "anterograde" "vena"
    "adrenal gland, and intestine serosa" "spermaduct" "hilum" "parenchyma"
    "hepaticus" "venae" "frozen" "viscera" "mesenchyma" "gastria" "serosa"
    "tunica" "cecum" "Morikawa" "Povlsen" "Rygaard" "CK8/18" "retroperitoneum"
    "peritoneum" "8/18" "undergone" "BALB/C" "10.1038/srep20502" "Huang"
    "amplification/expression" "expression/amplification" "centromere" "#3"
    "fibroblastoid" "micropore" "μg/ml" "AGS/DDP" "MGC803/DDP" "occluden-1"
    "poorer" "EMT-like" "spindle-like" "IC 50" "Pfizer" "Taiho" "Chugai"
    "Ingelheim" "Boehringer" "AstraZeneca" "Mitsudomi" "Tetsuya" "Planchard"
    "monotherapy" "PHA‐665752" "‐665752" "PHA" "HCC827CXR" "Del19" "‐type"
    "HCC827CNXR" "3G‐TKI" "CNX2006" "CNX‐2006" "‐1686" "‐TKIs" "EGFR‐TKIs"
    "‐generation" "‐tyrosine kinase" "EGFR‐TKI" "MET‐TKI" "‐2006" "CNX"
    "sublines" "‐TKI" "vii" "vi" "Yu" "Chhabra" "Liu" "miR-433-mediated"
    "Saito" "5-aza-CdR" "14q32.2" "siCREB1" "siMet" "miR-433-transfected"
    "pmirGLO" "ARMC1" "TGFβR1" "miR-433-" "undertaken" "non-cancerous"
    "miR-409-3p" "=0.340" "=0.029" "non-standardized" "algorithms" "reults"
    "Jarde" "Garrett" "non-significant" "0–2" "48/96" "57/73" "74/81" "168/174"
    "45/96" "116/131" "53/73" "71/81" "170/174" "normal squamous epithelium"
    "perioperative and palliative chemo-" "neoadjuvant" "gastro" "drawn"
    "cardia" "chemo-" "chemo" "stem cell-like" "= 0.016" "p = 0.014"
    "positive/high" "ORs" "Lauren" "1.49–2.73" "Whitney" "ELCWP" "Korean"
    "nonsmall" "Darnell" "GLOBOCAN" "Cochrane" "= 0.083" "S2 B" "S2 A" "= 0.67"
    "P  = 0.014" "both the normal intestinal epithelium" "Pygo" "Pygopus"
    "tamoxifen inducible CreERT2" "CreERT2"
    "Kras -driven Bcl9 / 9l -null intestinal organoids" "sphere-like"
    "intestinal stemness" "ISCs" "intestinal organoids" "CreERT"
    "wild-type intestinal organoids" "Wild-type Intestinal Organoids" "Pre"
    "normal intestinal epithelium" "organoid" "spherical organoids"
    "budding structures resembling normal intestinal organoids" "withdrawn"
    "the small intestinal epithelium"
    "culture and passage intestinal crypt-derived epithelial organoids"
    "Intestinal Organoids" "Organoids" "subtypes (CMS)" "CRCSC" "PETACC"
    "Subtypes" "stemness-" "heatmap" "transcriptomes" "Stemness"
    "microsatellite" "homologs" "a homozygous Bcl" "loxP" "Bcl"
    "azoxymethane (AOM)" "azoxymethane" "the gastrointestinal epithelium" "Wls"
    "stem-cell-like" "Paneth" "ISC" "villus" "poorest"
    "murine oncogenic intestinal organoids" "organoids" "BCL9/9L"
    "the intestinal epithelium" "stemness" "Stem-like" "1 / 2"
    "ubiquitination/degradation" "Gli1-3" "2DG" "ZMP" "paracrine" "cerebellum"
    "R-targeting" "vivo" "ex" "mg/kg" "parental DLD1" "necrostatin"
    "re-expression" "frameshift" "IC50" "A9A2" "A10-3" "A10-1" "LBY"
    "the colorectal cancer cell line DLD1" "DLD1" "endpoint" "KO"
    "the TRAIL-R2-targeting antibody LBY135" "LBY135" "interstrand"
    "anti-apoptotic" "10.1038/srep20486" "anti-phospho-CAV1" "Danvers"
    "Barakat" "Caco" "Aldrich" "OptiPrep" "microplates" "Lipopolysaccharide"
    "Kim" "bilayer" "anti-cancer" "invaginations" "non-small" "QT" "XTX" "QZ"
    "FYX" "XC" "ZLJ" "c‐Myc" "‐Myc" "re‐expression" "‐Aza" "‐tumour" "Oncomine"
    "subtypes" "semi‐quantitative" "β‐catenin" "‐67" "PAX5‐transfected"
    "‐transfected" "monolayer" "absorbance" "semi" "real‐time" "‐quantitative"
    "‐expression" "‐squared" "up‐regulation" "‐specific" "chosen" "‐time"
    "H1975" "USA" "Ann" "Compendia" "squamous‐cell" "down‐regulated"
    "neuroendocrine" "‐cell" "‐cell differentiation" "‐small" "American"
    "‐regulating" "inhibitsNSCLCcell" "‐catenin" "down‐regulation"
    "‐regulation" "inNSCLCthan" "ofNSCLCcell" "ofPAX5" "‐regulated" "Yang"
    "non-adherent" "soft agar" "agar" "shCtrl" "shAKA" "non-targeting" "TrexB"
    "anti-HA" "HA" "SAKRAS " "SALEB" "SAKRAS" "aneuploidy"
    "dual pharmacological inhibiton" "inhibiton" "S3C" "S2C" "S2B" "S1C"
    "Soochow" "et" "Twist1/2" "microenvironments" "perhaps" "si" "8/70" "47/70"
    "cytomembrane" "= 0.017" "5-year" "lymphoblastoid" "ancd2" "Taiwan"
    "smoking/passive" "subsets" "FANCC/E" "subcomplexes" "cases/controls"
    "-by-four" "penetrant" "UB" "the only significant FANCC SNP" "rs356665"
    "both the homozygous variant genotype" "aOR" "DEB" "bulky adducts"
    "adducts" "penetrance" "genotypic polymorphisms" "subpathways" "95 % CI"
    "doi:10.1186" "homologus" "stem-like" "ΔS45" "BEs" "−813 " "A/T " "A/T"
    "H6SL#8" "#8" "H6SL" "fibroblast-like" "S-fraction" "endometrioid" "y"
    "UCSs" "Em" "EMT/CSC" "Sox" "2000 bp" "S2A" "1000 bp" "Bonferroni" "HWE"
    "comorbidities" "Bourgine" "Alejandra" "motile" "non-smoking" "Asian"
    "HapMap" "co-effect" "pairwise" "the global haplotypes" "1.09–1.94"
    "haplotypes" "co-dominant" "confounders" "1.03–1.77" "GG" "CC"
    "heterozygote" "homozygote" "genotypes" "ERSD" "rs836478" "G/A" "Crohn’s"
    "Crohn" "7p22" "Matos" "botulinumtoxin" "UMOD" "UNCX" "GWAS" "genomewide"
    "rs9374" "rs6954996" "rs10951982" "homozygotes" "rs702483" "rs702482"
    "rs836488" "Weinberg" "haplotype" "TaqMan" "SNPs" "polymorphisms" "= 1.57"
    "= 0.029" "= 1.07" "= 1.35" "= 1.46" "leves" "CHX" "Rb" "G1/S phase"
    "siNgBR" "FACS" "Bel/5FU" "chemoresistant" "chemoattractant" "AmNogo"
    "microdomains" "CNS" "Bel7402/5FU" "chemoresistance" "1/2" "= 0.017"
    "P = 0.002" "Mir" "miRISC" "coworkers" "Kozomara" "bonafide" "MIR" "exons"
    "probesets" "Probesets" "probeset" "mir" "intron" "miR-139-5P" "miR-139-5p"
    "pri" "miR-143-3P" "bi" "miR-143-3p" "MREs"
    "The mature double stranded miRNA duplexes" "duplexes" "introns"
    "miR-145-5p" "miR-34a-5p" "Doxorubincin" "Zhejiang" "ISH" "non-tumor"
    "Rutgers" "Taqman" "p53+/+" "HCT116 p53+/+"
    "human colorectal HCT116 p53+/+" "miRDB" "Targetscan" "polymorphism (SNP)"
    "SNP" "polymorphism" "non-stressed" "germline" "Fraumeni" "Li" "BALB/c"
    "co-transfected" "non-coding" "subtype" "univariate" "=0.186" "p=0.002"
    "=0.095" "=0.076" "KAS" "=1.37" "=2.39" "=1.31" "Egger's" "=0.014" "newest"
    "=1.46" "=0.21" "=1.56" "transducer" "0.95-1.30" "0.76-1.02" "=1.00"
    "=0.002" "1.11-1.64" "0.27-1.11" "0.97-1.84" "p=0.0" "1.21-1.61" "=0.0"
    "1.14-1.50" "andI" "=0.053" "1.23-1.74" "=0.0%" "1.17-2.09" "lobectomies"
    "Caucasians" "p=0.00" "Egger" "Begg" "=0.00" "1.39-1.76" "95%CI" "Asians"
    "Jadad" "Ottawa" "Newcastle" "Karnofsky" "codon" "IIIa" "Latin" "America"
    "Europe" "re-performed" "genotype" "95% CI" "95 % CI" "PFS" "ORR" "DFS"
    "pre" "iv" "iii" "ii" "agomir" "pmiR-RB-REPORT" "hRluc" "TargetScan"
    "Pearson" "Meier" "Kaplan" "HELF" "-UTR" "IARC" "-UTRs" "UTRs" "silico"
    "stiffnesses" "phosphosites" "greater" "dSH2" "half-time" "α5" "non-IAC"
    "readouts" "AZD0530/saracatinib" "Susp" "Adh" "nonsignificant" "proteome"
    "seven previously published FN-induced IAC MS datasets" "dataset"
    "workflow" "prespread" "HFF" "PF271" "HFFs" "anti-phosphotyrosine"
    "adhesome" "AZ13256675" "decondenses" "dehydroyx" "pEGFP" "dehydroxy"
    "5-hydroxy-methylcytosine" "ΔPAR" "wildtype" "HTB171" "GGCAGAGCA" "Barksi"
    "ivm" "Affymetrix" "Ovar" "Skov" "p  " "COBRA" "2q11.2" "browser" "UCSC"
    "bp" "5hmC" "hydroxymethylcytosine" "dioxygenases" "methylcytosine" "5mC"
    "dinucleotides" "p53-" "p" "immuno" "Merkel" "10.1038/ncomms10438" "doi"
    "P-S6-double-positive" "multivariate" "proven" "hypopharynx" "oropharynx"
    "immunohistochemistry" "4E-BP1-4A+LM-AA" "non-phosphorylated"
    "Non-phosphorylated" "obervations" "p21KO" "UTR" "shTSC2" "wt" "p53KO"
    "shTSC" "HNSCCs" "oligopyrimidine" "RPS6KB" "RRAGs" "multiprotein"
    "stressors" "Llanos" "hyper" "HNSCC" "co-regulators" "crosstalkes"
    "the invasive melanoma genome" "transwell" "YAP5SA" "RhoA" "co-occupied"
    "YAP/Tead" "SRC1-3" "co-IP" "subset" "Tead-AP1 mediated co-regulation"
    "enhancers" "enhancer" "Tead4 and AP1 genomic co-occupany" "Fra1/2"
    "datasets" "Luc" "AP" "co-occupancy" "activating protein-1" "genomes"
    "KD/KO" "mis" "IHC" "YAP/TAZ" "Sd" "GGAATG" "TEA" "Tead" "co-activator"
    "co-activators" "multi" "dFOXO" "detriments" "an Alzheimer’s" "AD"
    "Alzheimer" "neurodegenerative pathologies" "pathologies" "Huntington’s"
    "Huntington" "non-functional" "Zn" "Parkinsonism" "Sante" "epithelium"
    "cardio" "Hwang’s" "Hwang" "Brady" "Hamacher" "Fon" "Durcan"
    "levels/activity" "Milbrandt" "Dasgupta" "Sinclair’s" "Sinclair" "Hancock"
    "COXIV" "Anderson" "Puigserver’s" "Puigserver" "undergoes" "co-activates"
    "Coactivator-1" "organelle" "organelles" "Aquilano" "sirtuins"
    "coactivator-1α" "κB" "STACs" "lifespan" "orthologues" "paralogues"
    "sirtuin" "genome" "ribose" "homologies" "HDA1" "Coactivator-1α"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-16801-17100*
  '(("ATM and ATM-containing complexes" . SPARSER::COLLECTION)
    ("cysteines" . SPARSER::AMINO-ACID) ("-rapamycin" . SPARSER::DRUG)
    ("The predominant form" . SPARSER::FORM)
    ("ATM and mTOR" . SPARSER::COLLECTION) ("clamps" . SPARSER::PROTEIN-FAMILY)
    ("FAT/kinase/FATC" . SPARSER::COLLECTION)
    ("monomeric ATM" . SPARSER::PROTEIN)
    ("the monomeric ATM" . SPARSER::PROTEIN)
    ("the dimeric state" . SPARSER::BIO-STATE)
    ("the monomeric and dimeric forms" . SPARSER::FORM)
    ("the dimeric ATM" . SPARSER::PROTEIN)
    ("monomeric and dimeric ATM" . SPARSER::PROTEIN)
    ("both the monomeric and dimeric forms" . SPARSER::FORM)
    ("dimeric state" . SPARSER::BIO-STATE)
    ("Raptor and mLST8" . SPARSER::COLLECTION)
    ("cryo-EM" . SPARSER::PROTEIN-PAIR)
    ("FRAP, ATM and TRRAP" . SPARSER::COLLECTION)
    ("protein and protein" . SPARSER::COLLECTION)
    ("FATC" . SPARSER::PROTEIN-FAMILY) ("TRRAP" . SPARSER::PROTEIN)
    ("Monomeric ATM" . SPARSER::PROTEIN) ("PIKK" . SPARSER::KINASE)
    ("dimeric ATM" . SPARSER::PROTEIN) ("inert ATM dimers" . SPARSER::DIMER)
    ("e2" . SPARSER::MOLECULE) ("FK506" . SPARSER::DRUG)
    ("N-terminally" . SPARSER::PROTEIN) ("NKX3.1" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase catalytic subunit" . SPARSER::PROTEIN)
    ("Rho-A, Rac-1 and Src" . SPARSER::COLLECTION)
    ("TNF-α and thrombin" . SPARSER::COLLECTION)
    ("protamine" . SPARSER::PROTEIN)
    ("water and small molecules [ xref – xref ]" . SPARSER::COLLECTION)
    ("a Rho-associated kinase (ROCK)" . SPARSER::KINASE)
    ("actin and myosin" . SPARSER::COLLECTION)
    ("water and small molecules" . SPARSER::COLLECTION)
    ("macromolecules" . SPARSER::MOLECULE)
    ("FGFR and VEGFR2" . SPARSER::COLLECTION)
    ("KDR/Flk-1" . SPARSER::COLLECTION)
    ("FGF receptors (FGFR) and vascular endothelial cell growth factor receptors (VEGFR) [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("receptors (VEGFR)" . SPARSER::RECEPTOR)
    ("receptors (FGFR)" . SPARSER::RECEPTOR)
    ("Rho-A, Rac-1, and Src" . SPARSER::COLLECTION)
    ("viral proteins and heparin binding cytokines" . SPARSER::PROTEIN)
    ("Rho-A, Src, and ROCK" . SPARSER::COLLECTION)
    ("± SD pg/μg urinary creatinine" . SPARSER::PROTEIN)
    ("FGF-2 and VEGF-A" . SPARSER::COLLECTION)
    ("a constitutively active Rho-A (pCEFL-AU5-RhoAQL) or a dominant negative mutant Rho-A (pCEFL-AU5-RhoAN19)"
     . SPARSER::COLLECTION)
    ("the MCherry red fluorescent protein" . SPARSER::PROTEIN)
    ("pCEFL-MCherry" . SPARSER::COLLECTION) ("MCherry" . SPARSER::PROTEIN)
    ("FGF-2 and VEGF- A" . SPARSER::COLLECTION)
    ("Rho-A and Rac-1" . SPARSER::COLLECTION)
    ("Rho-A, pMLC, and c-Src" . SPARSER::COLLECTION)
    ("Rho-A, Scr, and ROCK" . SPARSER::COLLECTION)
    ("FGF-2 or VEGF-A" . SPARSER::COLLECTION)
    ("HSPGs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Heparin" . SPARSER::PROTEIN)
    ("thrombin, and VEGF-A" . SPARSER::COLLECTION)
    ("vWF, VE-cadherin, and CD31" . SPARSER::COLLECTION)
    ("vWF" . SPARSER::PROTEIN) ("protein (TERT)" . SPARSER::PROTEIN)
    ("the simian virus 40-(SV40) T antigen" . SPARSER::MOLECULE)
    ("HGEc-1" . SPARSER::COLLECTION) ("VEGF-A or FGF-2" . SPARSER::COLLECTION)
    ("Vascular Endothelial Growth Factor-A (VEGF-A) and Fibroblast Growth Factor-2 (FGF-2)"
     . SPARSER::COLLECTION)
    ("renal HSPG" . SPARSER::PROTEIN)
    ("viral proteins and heparin binding growth factors"
     . SPARSER::GROWTH-FACTOR)
    ("proteins and heparin" . SPARSER::COLLECTION) ("HSPG" . SPARSER::PROTEIN)
    ("proteoglycans (HSGP)" . SPARSER::PROTEIN)
    ("cytokines and viral proteins" . SPARSER::COLLECTION)
    ("viral proteins" . SPARSER::PROTEIN)
    ("Rho-A and Src" . SPARSER::COLLECTION)
    ("VEGF-A and FGF-2" . SPARSER::COLLECTION)
    ("Rho-A, Src, and Rac-1" . SPARSER::COLLECTION)
    ("two heparin-binding growth factors, Vascular Endothelial Cell Growth Factor-A (VEGF-A) and Fibroblast Growth Factor-2 (FGF-2)"
     . SPARSER::COLLECTION)
    ("REc" . SPARSER::PROTEIN) ("α v β 3" . SPARSER::PROTEIN)
    ("α v β 5" . SPARSER::PROTEIN) ("Flk-1" . SPARSER::PROTEIN)
    ("VEGF- A" . SPARSER::PROTEIN)
    ("Telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("P-2" . SPARSER::PROTEIN)
    ("endothelial cell growth factor" . SPARSER::PROTEIN)
    ("BV6" . SPARSER::MOLECULE) ("CD144" . SPARSER::PROTEIN)
    ("pp60" . SPARSER::PROTEIN) ("Myosin Light Chain 2" . SPARSER::PROTEIN)
    ("B9)" . SPARSER::PROTEIN) ("USP 5" . SPARSER::PROTEIN)
    ("Vascular Endothelial Growth Factor-A" . SPARSER::PROTEIN)
    ("Heparan sulfate" . SPARSER::MOLECULE) ("Rac-1" . SPARSER::PROTEIN)
    ("Rho-A" . SPARSER::PROTEIN)
    ("Fibroblast Growth Factor-2" . SPARSER::PROTEIN)
    ("G6PD and NOX" . SPARSER::COLLECTION)
    ("antiviral cytokines" . SPARSER::PROTEIN)
    ("exogenous PGE 2" . SPARSER::DRUG) ("viral N gene" . SPARSER::GENE)
    ("NOX2 and Duox" . SPARSER::COLLECTION)
    ("p40 phox , p47 phox , and p67 phox" . SPARSER::COLLECTION)
    ("MAPKs and NF-κB" . SPARSER::COLLECTION)
    ("TNF-α/MAPK/NF-κB/COX-2" . SPARSER::COLLECTION)
    ("lucigenin" . SPARSER::DRUG) ("MAPK/NF-κB/COX-2" . SPARSER::COLLECTION)
    ("phospho-p38 and COX-2" . SPARSER::COLLECTION)
    ("Helenalin" . SPARSER::DRUG) ("Tanshinone" . SPARSER::DRUG)
    ("c-JUN and NF-κB" . SPARSER::COLLECTION)
    ("SB203580 (an inhibitor of p38 MAPK) or U0126 (an inhibitor of MEK1/2)"
     . SPARSER::COLLECTION)
    ("celecoxib" . SPARSER::DRUG) ("COX-2 and PGE 2" . SPARSER::COLLECTION)
    ("pro-inflammatory genes" . SPARSER::GENE)
    ("especially membrane-bound NOX" . SPARSER::PROTEIN)
    ("NOX1, NOX2, NOX3, NOX4, NOX5, Duox1 and Duox2" . SPARSER::COLLECTION)
    ("Duox1" . SPARSER::PROTEIN) ("Duox" . SPARSER::PROTEIN)
    ("molecules, and growth factors" . SPARSER::COLLECTION)
    ("a pleiotropic cytokine" . SPARSER::PROTEIN)
    ("NOX/MAPK/NF-κB/COX-2" . SPARSER::COLLECTION)
    ("NOX2-siRNA" . SPARSER::COLLECTION) ("DPI" . SPARSER::PROTEIN)
    ("diphenyleneiodonium" . SPARSER::DRUG)
    ("MAPK (p38 and ERK1/2) and NF-κB" . SPARSER::COLLECTION)
    ("p38 and ERK1/2" . SPARSER::COLLECTION) ("kd" . SPARSER::PROTEIN)
    ("G6PD-kd" . SPARSER::COLLECTION) ("IL-32" . SPARSER::PROTEIN)
    ("p40 phox" . SPARSER::PROTEIN) ("p67  phox" . SPARSER::PROTEIN)
    ("NADP +" . SPARSER::MOLECULE) ("p67 phox" . SPARSER::PROTEIN)
    ("NOX-1" . SPARSER::PROTEIN) ("Duox2" . SPARSER::PROTEIN)
    ("kappa light polypeptide gene" . SPARSER::PROTEIN)
    ("glucose-6-phosphate" . SPARSER::MOLECULE)
    ("Cyclooxygenase-2" . SPARSER::PROTEIN) ("G6PD" . SPARSER::PROTEIN)
    ("Glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("FOXO1, c-JUN and mTOR" . SPARSER::COLLECTION)
    ("mTOR, PI3K/AKT and c-JUN" . SPARSER::COLLECTION)
    ("5-FU and DDP" . SPARSER::COLLECTION)
    ("mTOR, FOXO1 and c-JUN" . SPARSER::COLLECTION)
    ("N2–N3" . SPARSER::COLLECTION) ("NPCs" . SPARSER::MOLECULE)
    ("FOXO1 or both FOXO1 and siFOXO1 ( xref )" . SPARSER::COLLECTION)
    ("FOXO1 and siFOXO1" . SPARSER::COLLECTION)
    ("Ki67 and PCNA" . SPARSER::COLLECTION) ("pSG5-LMP1" . SPARSER::COLLECTION)
    ("first used small-interfering RNAs" . SPARSER::RNA)
    ("CCND1 and c-JUN" . SPARSER::COLLECTION)
    ("c-JUN and G1/S" . SPARSER::COLLECTION)
    ("c-JUN and CCND1" . SPARSER::COLLECTION)
    ("p27 and p21" . SPARSER::COLLECTION)
    ("diamminedichloroplatinum" . SPARSER::MOLECULE)
    ("Ki67 and proliferating cell nuclear antigen" . SPARSER::COLLECTION)
    ("Edu" . SPARSER::DRUG) ("NPC or NP69" . SPARSER::COLLECTION)
    ("mammalian target of rapamycin (mTOR) and FOXO1" . SPARSER::COLLECTION)
    ("AKT-c-JUN" . SPARSER::PROTEIN-PAIR)
    ("the original miRNAs" . SPARSER::PROTEIN)
    ("Cis -diamminedichloroplatinum" . SPARSER::DRUG)
    ("pPI3K" . SPARSER::PROTEIN-FAMILY)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LMP1" . SPARSER::PROTEIN) ("BART1" . SPARSER::PROTEIN)
    ("c-JUN" . SPARSER::PROTEIN)
    ("hypoxia and caveolin-1" . SPARSER::COLLECTION)
    ("bevacizumab" . SPARSER::DRUG)
    ("integrins and RTKs" . SPARSER::COLLECTION)
    ("DDR1, IGFR1, IGF2R and ROR2" . SPARSER::COLLECTION)
    ("HIFs" . SPARSER::PROTEIN)
    ("other macromolecular ligands" . SPARSER::LIGAND)
    ("the identified candidate proteins, CAIX" . SPARSER::PROTEIN)
    ("anti-CAIX–ADC" . SPARSER::COLLECTION)
    ("total cell-associated CAIX" . SPARSER::PROTEIN)
    ("ALPP, CD59, CD109, CDH10, DDR1, IGFR1, IGF2R, IL1RAP, LIRF, PODXL and SCARB1"
     . SPARSER::COLLECTION)
    ("PODXL" . SPARSER::PROTEIN) ("ALPP" . SPARSER::PROTEIN)
    ("SLC2A3/GLUT-3" . SPARSER::COLLECTION)
    ("SLC2A1/GLUT-1" . SPARSER::COLLECTION) ("ENG/CD105" . SPARSER::COLLECTION)
    ("ENG" . SPARSER::PROTEIN) ("CAIX" . SPARSER::PROTEIN)
    ("CD44, CXADR, FOLR1, ITFG3, MAGED2, NPR1, PARK7, SRPRB, SLC43A3 and SLC44A1"
     . SPARSER::COLLECTION)
    ("SRPRB" . SPARSER::PROTEIN) ("CXADR" . SPARSER::PROTEIN)
    ("at least two unique peptides" . SPARSER::PEPTIDE)
    ("biotin-protein" . SPARSER::COLLECTION)
    ("surface-resident proteins" . SPARSER::PROTEIN)
    ("unique surface antigens" . SPARSER::PROTEIN)
    ("increased peripheral caveolin-1-mCherry" . SPARSER::COLLECTION)
    ("caveolin-1-mCherry" . SPARSER::COLLECTION)
    ("acute hypoxia" . SPARSER::PROTEIN)
    ("hypoxia and dynamin" . SPARSER::COLLECTION)
    ("proteins and caveolin-1" . SPARSER::COLLECTION)
    ("Glut-1" . SPARSER::PROTEIN) ("Toxin" . SPARSER::MOLECULE)
    ("endocytic membrane proteins" . SPARSER::PROTEIN)
    ("MCD" . SPARSER::PROTEIN) ("dynasore" . SPARSER::MOLECULE)
    ("biotin and EEA1" . SPARSER::COLLECTION)
    ("the membrane impermeable reducing agent MesNa" . SPARSER::MOLECULE)
    ("MesNa" . SPARSER::MOLECULE)
    ("reversible membrane protein" . SPARSER::PROTEIN)
    ("ADCs" . SPARSER::PROTEIN) ("HGFR" . SPARSER::PROTEIN)
    ("cytotoxin" . SPARSER::PROTEIN) ("dynamin" . SPARSER::PROTEIN)
    ("M+2" . SPARSER::MOLECULE) ("HP-1 " . SPARSER::PROTEIN)
    ("Surface protein" . SPARSER::PROTEIN) ("subunit B" . SPARSER::PROTEIN)
    ("ml –1" . SPARSER::PROTEIN) ("N -hydroxysuccinimide" . SPARSER::DRUG)
    ("ITGA1" . SPARSER::PROTEIN) ("SCARB1" . SPARSER::PROTEIN)
    ("IL1RAP" . SPARSER::PROTEIN) ("IGF2R" . SPARSER::PROTEIN)
    ("DDR1" . SPARSER::PROTEIN) ("CDH10" . SPARSER::PROTEIN)
    ("CD109" . SPARSER::PROTEIN) ("MCT-4" . SPARSER::PROTEIN)
    ("16A" . SPARSER::PROTEIN) ("GLUT-3" . SPARSER::PROTEIN)
    ("SLC2A3" . SPARSER::PROTEIN) ("GLUT-1" . SPARSER::PROTEIN)
    ("SLC2A1" . SPARSER::PROTEIN) ("CD70" . SPARSER::PROTEIN)
    ("SLC44A1" . SPARSER::PROTEIN) ("SLC43A3" . SPARSER::PROTEIN)
    ("PARK7" . SPARSER::PROTEIN) ("NPR1" . SPARSER::PROTEIN)
    ("MAGED2" . SPARSER::PROTEIN) ("ITFG3" . SPARSER::PROTEIN)
    ("FOLR1" . SPARSER::PROTEIN) ("MS–MS" . SPARSER::PROTEIN)
    ("platelet derived growth factor receptor beta" . SPARSER::PROTEIN)
    ("huntingtin-interacting protein 1" . SPARSER::PROTEIN)
    ("carbonic anhydrase IX" . SPARSER::PROTEIN)
    ("new light" . SPARSER::PROTEIN)
    ("BMI, and cigarette" . SPARSER::COLLECTION)
    ("BMI and cigarette" . SPARSER::COLLECTION) ("Cohort" . SPARSER::MOLECULE)
    ("the best currently available biomarker" . SPARSER::MOLECULE)
    ("AMH" . SPARSER::PROTEIN) ("ketone" . SPARSER::MOLECULE)
    ("sulfoxide" . SPARSER::DRUG)
    ("omeprazole, or clopidogrel" . SPARSER::COLLECTION)
    ("omeprazole" . SPARSER::DRUG) ("lactam" . SPARSER::MOLECULE)
    ("GCLM and NQO1" . SPARSER::COLLECTION) ("Mox" . SPARSER::PROTEIN)
    ("phospholipids" . SPARSER::PHOSPHOLIPID)
    ("new viral proteins" . SPARSER::PROTEIN)
    ("DMF and MMF" . SPARSER::COLLECTION)
    ("a viral component" . SPARSER::COMPONENT)
    ("the viral pre-integration complex" . SPARSER::BIO-COMPLEX)
    ("Nrf2, NQO1 or GCLM" . SPARSER::COLLECTION)
    ("NQO1 and GCLM" . SPARSER::COLLECTION)
    ("the IRF3/7/STAT1 and NF-κB anti-viral and inflammatory pathways"
     . SPARSER::COLLECTION)
    ("SAMHD1 or MX2" . SPARSER::COLLECTION) ("Alu" . SPARSER::PROTEIN)
    ("AZT and SFN" . SPARSER::COLLECTION)
    ("Env or VSV-G" . SPARSER::COLLECTION)
    ("Nrf2 and Nrf2" . SPARSER::COLLECTION)
    ("a protein or an RNA" . SPARSER::COLLECTION)
    ("Nrf2, and SFN" . SPARSER::COLLECTION)
    ("A western blot" . SPARSER::PROTEIN)
    ("siRNA and SFN" . SPARSER::COLLECTION)
    ("Neither DMF nor EGCG" . SPARSER::COLLECTION)
    ("the most potent naturally occurring Nrf2 activators"
     . SPARSER::ACTIVATOR)
    ("AZT, SFN, DMF or EGCG" . SPARSER::COLLECTION)
    ("DMSO, AZT, SFN, DMF or EGCG" . SPARSER::COLLECTION)
    ("AZT, DMSO, SFN, DMF or EGCG" . SPARSER::COLLECTION)
    ("the viral promoter" . SPARSER::PROMOTER)
    ("SFN, DMF and EGCG" . SPARSER::COLLECTION)
    ("dimethyl fumarate (DMF) and epigallocatechin gallate (EGCG)"
     . SPARSER::COLLECTION)
    ("exogenous reporter genes" . SPARSER::GENE)
    ("luciferase and GFP" . SPARSER::COLLECTION)
    ("adjacent macrophages" . SPARSER::PROTEIN)
    ("SFN and AZT" . SPARSER::COLLECTION) ("Env" . SPARSER::PROTEIN)
    ("AZT-" . SPARSER::DRUG)
    ("viral capsid protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vpx" . SPARSER::PROTEIN) ("AZT or SFN" . SPARSER::COLLECTION)
    ("5 μM AZT or 10 μM SFN" . SPARSER::COLLECTION)
    ("Blasticidin" . SPARSER::MOLECULE) ("blasticidin" . SPARSER::MOLECULE)
    ("proviral DNA" . SPARSER::DNA) ("env" . SPARSER::PROTEIN)
    ("AZT" . SPARSER::DRUG) ("fungi" . SPARSER::PROTEIN)
    ("SFN and Nrf2" . SPARSER::COLLECTION)
    ("response elements (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("SFN and other Nrf2-activators" . SPARSER::COLLECTION)
    ("myrosinase" . SPARSER::PROTEIN) ("glucoraphanin" . SPARSER::DRUG)
    ("rectal and vaginal macrophages" . SPARSER::PROTEIN)
    ("sulforaphane (SFN)" . SPARSER::DRUG)
    ("a common dietary component" . SPARSER::COMPONENT)
    ("sulforaphane (SFN) and epigallocatechin gallate (EGCG)"
     . SPARSER::COLLECTION)
    ("nitrous oxide" . SPARSER::MOLECULE) ("EGCG" . SPARSER::DRUG)
    ("oxide" . SPARSER::MOLECULE)
    ("neither SAMHD1 nor MX2" . SPARSER::COLLECTION)
    ("SAMHD1 and MX2" . SPARSER::COLLECTION) ("Mx2" . SPARSER::PROTEIN)
    ("Dimethyl Fumarate" . SPARSER::DRUG) ("interleukin-2" . SPARSER::PROTEIN)
    ("interferon-inducible" . SPARSER::PROTEIN) ("IRF3" . SPARSER::PROTEIN)
    ("Dimethyl fumarate" . SPARSER::DRUG) ("VP24" . SPARSER::PROTEIN)
    ("musculoaponeurotic fibrosarcoma" . SPARSER::PROTEIN)
    ("epigallocatechin gallate" . SPARSER::DRUG) ("MX2" . SPARSER::PROTEIN)
    ("SAMHD1" . SPARSER::PROTEIN)
    ("erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("a targetable molecule" . SPARSER::MOLECULE)
    ("associated kinases" . SPARSER::KINASE) ("FLIM" . SPARSER::PROTEIN-FAMILY)
    ("HSP90 and HSP70" . SPARSER::COLLECTION)
    ("IL-2 , CD69 and CD25" . SPARSER::COLLECTION)
    ("A inhibitor MLN8237 and Aurora" . SPARSER::COLLECTION)
    ("proteins and kinases" . SPARSER::COLLECTION)
    ("LAT, PLCγ1 and PKCθ" . SPARSER::COLLECTION) ("NcK" . SPARSER::PROTEIN)
    ("EB1 or HDAC6" . SPARSER::COLLECTION)
    ("the centrosomal MT aster" . SPARSER::BIO-COMPLEX)
    ("aster" . SPARSER::BIO-COMPLEX) ("LAT and PLC" . SPARSER::COLLECTION)
    ("antigen-" . SPARSER::PROTEIN) ("superantigen" . SPARSER::MOLECULE)
    ("Nck and actin" . SPARSER::COLLECTION) ("CD4-" . SPARSER::PROTEIN)
    ("Cyt" . SPARSER::MOLECULE) ("CD4-Lck" . SPARSER::COLLECTION)
    ("Lck-GFP" . SPARSER::COLLECTION) ("ITAMs" . SPARSER::PROTEIN)
    ("doxycycline and IL-7" . SPARSER::COLLECTION) ("tetO" . SPARSER::PROTEIN)
    ("CD3ζ (Y83), LAT (Y132), PLCγ1 (Y783), PKCθ (T538) and ERK1/2 (T202/Y204)"
     . SPARSER::COLLECTION)
    ("MLN8237 and AZD1152" . SPARSER::COLLECTION) ("APCs" . SPARSER::PROTEIN)
    ("SEB" . SPARSER::PROTEIN) ("Staphylococcal" . SPARSER::PROTEIN)
    ("haemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD3ζ (Y83), LAT (Linker for Activation of T cell; Y132), PLCγ1 (Phospholipase C; Y783), PKCθ (T538) and ERK1/2 (T202/Y204)"
     . SPARSER::COLLECTION)
    ("Linker" . SPARSER::LINKER) ("LAT" . SPARSER::PROTEIN)
    ("the peripheral SMAC" . SPARSER::PROTEIN)
    ("mCherry–β-actin" . SPARSER::COLLECTION) ("MLN" . SPARSER::PROTEIN)
    ("CRIB" . SPARSER::DRUG) ("CD3ζ–Nck" . SPARSER::COLLECTION)
    ("the actin–cytoskeleton-associated protein Nck" . SPARSER::PROTEIN)
    ("DMSO or MLN8237" . SPARSER::COLLECTION)
    ("CD3ζ-mCherry" . SPARSER::COLLECTION)
    ("MLN8237 or dimethyl sulfoxide" . SPARSER::COLLECTION)
    ("anti-CD3/CD28" . SPARSER::COLLECTION)
    ("tamoxifen and IL-7" . SPARSER::COLLECTION)
    ("ert/ert" . SPARSER::COLLECTION) ("lox/lox" . SPARSER::COLLECTION)
    ("ert" . SPARSER::PROTEIN) ("lox" . SPARSER::PROTEIN)
    ("Aurka" . SPARSER::PROTEIN)
    ("the pericentrosomal matrix" . SPARSER::PROTEIN-FAMILY)
    ("EB1" . SPARSER::PROTEIN) ("enterotoxin" . SPARSER::PROTEIN)
    ("staphylococcal" . SPARSER::PROTEIN)
    ("stimulatory anti-CD3 and anti-CD28 antibodies" . SPARSER::ANTIBODY)
    ("anti-CD3 and anti-CD28" . SPARSER::COLLECTION)
    ("CD69, CD25 and interleukin" . SPARSER::COLLECTION)
    ("Bora, Tpx2, Ajuba and PAK1" . SPARSER::COLLECTION)
    ("Tpx2" . SPARSER::PROTEIN) ("Essential proteins" . SPARSER::PROTEIN)
    ("Lck and Fyn" . SPARSER::COLLECTION) ("SMAC" . SPARSER::PROTEIN)
    ("the central supramolecular activating complex" . SPARSER::BIO-COMPLEX)
    ("its associated molecules" . SPARSER::MOLECULE)
    ("receptor (TCR)" . SPARSER::RECEPTOR)
    ("IL-2, CD25 and CD69" . SPARSER::COLLECTION)
    ("Reverse transcriptase" . SPARSER::PROTEIN) ("A-V" . SPARSER::MOLECULE)
    ("pRC3" . SPARSER::PROTEIN) ("CD16" . SPARSER::PROTEIN)
    ("A ‘" . SPARSER::PROTEIN) ("SSH1" . SPARSER::PROTEIN)
    ("HDAC6" . SPARSER::PROTEIN) ("NEDD1" . SPARSER::PROTEIN)
    ("CAM1" . SPARSER::PROTEIN) ("Col1a1" . SPARSER::PROTEIN)
    ("Aurora-A" . SPARSER::PROTEIN) ("AZD1152" . SPARSER::DRUG)
    ("PLCγ1" . SPARSER::PROTEIN) ("CD3 complex" . SPARSER::PROTEIN)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("CD3ζ" . SPARSER::PROTEIN) ("exosomal surface HSP70" . SPARSER::PROTEIN)
    ("TLR2/NF-κB" . SPARSER::COLLECTION)
    ("Tumor exosomal miR-21 and miR-29a" . SPARSER::COLLECTION)
    ("miR-21 and miR-29a" . SPARSER::COLLECTION)
    ("Exosomal miRNAs" . SPARSER::PROTEIN)
    ("plasma exosome-associated Hsp72 and microRNA" . SPARSER::COLLECTION)
    ("Hsp72 and microRNA" . SPARSER::COLLECTION)
    ("exosomal RNAs" . SPARSER::RNA)
    ("Some others thought stress-induced Hsp72"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TLR2 and its adaptor MyD88" . SPARSER::COLLECTION)
    ("mice tumor-derived exosomal HSP72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT, ERK1/2, CREB, and GSK3α/β" . SPARSER::COLLECTION)
    ("exosomal TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("H-ras and K-ras" . SPARSER::COLLECTION)
    ("proteins (HSP)" . SPARSER::PROTEIN) ("Versican" . SPARSER::PROTEIN)
    ("IL-6, IL-8 and MCP-1" . SPARSER::COLLECTION)
    ("single-stranded viral RNA" . SPARSER::RNA)
    ("lipopeptides" . SPARSER::PROTEIN) ("TLR7 or TLR8" . SPARSER::COLLECTION)
    ("TLR7 and TLR8" . SPARSER::COLLECTION)
    ("TLR2, TLR7, and TLR8" . SPARSER::COLLECTION) ("PDTC" . SPARSER::DRUG)
    ("JNK, ERK, and p38" . SPARSER::COLLECTION)
    ("NFκB, JNK, and p38" . SPARSER::COLLECTION)
    ("pro-inflammatory MSCs" . SPARSER::PROTEIN) ("DiO" . SPARSER::MOLECULE)
    ("AMSC" . SPARSER::PROTEIN)
    ("various pro-inflammatory genes" . SPARSER::GENE)
    ("about MSCs immuno-phenotype changes often use pre-conditioned MSCs"
     . SPARSER::PROTEIN)
    ("reprogramming MSCs" . SPARSER::PROTEIN) ("MSC (BMSC)" . SPARSER::PROTEIN)
    ("adipose-derived MSCs (AMSC)" . SPARSER::PROTEIN)
    ("proteins, mRNA, miRNAs, and DNAs" . SPARSER::COLLECTION)
    ("cytokines, chemokines, and growth factors" . SPARSER::COLLECTION)
    ("adipocytes, osteoblasts, and chondrocytes" . SPARSER::COLLECTION)
    ("siRNA and TLR2-neutralizing antibody" . SPARSER::COLLECTION)
    ("IL-6, IL-8, and MCP-1" . SPARSER::COLLECTION)
    ("exosomes-treated MSCs" . SPARSER::PROTEIN)
    ("exosome-treated MSCs" . SPARSER::PROTEIN)
    ("inflammation-associated cytokines" . SPARSER::PROTEIN)
    ("proteins, lipids, and miRNA/mRNA/DNAs" . SPARSER::COLLECTION)
    ("IKKα" . SPARSER::PROTEIN) ("Rnase A" . SPARSER::PROTEIN)
    ("HSP72" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TLR8" . SPARSER::PROTEIN)
    ("5–2 " . SPARSER::PROTEIN) ("Ikkα" . SPARSER::PROTEIN)
    ("Toll-like receptor 2" . SPARSER::PROTEIN) ("/HER2+" . SPARSER::PROTEIN)
    ("a positive prognostic biomarker" . SPARSER::MOLECULE)
    ("sTILs" . SPARSER::PROTEIN)
    ("hypertrophic chondrocytes" . SPARSER::PROTEIN)
    ("COL3A1 and COL14A1" . SPARSER::COLLECTION)
    ("tenascin, fibronectin and collagen" . SPARSER::COLLECTION)
    ("taxane and platinum" . SPARSER::COLLECTION)
    ("TGFB3 and MAPK3" . SPARSER::COLLECTION) ("TGFB" . SPARSER::PROTEIN)
    ("Col12A1 and Col11A1" . SPARSER::COLLECTION)
    ("Col11A1" . SPARSER::PROTEIN)
    ("CXCL10 (Fc 1.8, p  = 0.01) and IL7R" . SPARSER::COLLECTION)
    ("Fc " . SPARSER::PROTEIN)
    ("Col10A1, Col14A1, and COL3A1" . SPARSER::COLLECTION)
    ("NES " . SPARSER::PROTEIN) ("ERBB4 and TGFB3" . SPARSER::COLLECTION)
    ("Col10A1, Col14A1, and Col3A1" . SPARSER::COLLECTION)
    ("Col3A1" . SPARSER::PROTEIN) ("Col14A1" . SPARSER::PROTEIN)
    ("HTA" . SPARSER::PROTEIN) ("mRNA and NAC" . SPARSER::COLLECTION)
    ("doxorubicin and cyclophosphamide" . SPARSER::COLLECTION)
    ("paclitaxel and trastuzumab" . SPARSER::COLLECTION)
    ("docetaxel, carboplatin and trastuzumab" . SPARSER::COLLECTION)
    ("genes and pathways" . SPARSER::COLLECTION)
    ("responders" . SPARSER::PROTEIN) ("ER-" . SPARSER::PROTEIN)
    ("ER-/HER2+" . SPARSER::COLLECTION)
    ("trastuzumab and either lapatinib or pertuzumab" . SPARSER::COLLECTION)
    ("lapatinib or pertuzumab" . SPARSER::COLLECTION)
    ("NAC+H" . SPARSER::PROTEIN) ("immune-associated genes" . SPARSER::GENE)
    ("pre-NAC+H" . SPARSER::PROTEIN-PAIR)
    ("novel predictive biomarkers" . SPARSER::MOLECULE)
    ("immunohistochemistry" . SPARSER::PROTEIN) ("COL14A1" . SPARSER::PROTEIN)
    ("syndecan-1" . SPARSER::PROTEIN) ("MAPK3" . SPARSER::PROTEIN)
    ("Col12A1" . SPARSER::PROTEIN) ("GPX8" . SPARSER::PROTEIN)
    ("COL10A1" . SPARSER::PROTEIN) ("PD-L1" . SPARSER::PROTEIN)
    ("Col10A1" . SPARSER::PROTEIN)
    ("SIRT1 and its regulators" . SPARSER::COLLECTION)
    ("CAMKIV" . SPARSER::PROTEIN)
    ("SIRT1 as well as allelic variants" . SPARSER::COLLECTION)
    ("allelic variants" . SPARSER::VARIANT)
    ("allele and haplotype" . SPARSER::COLLECTION)
    ("genotype or haplotype" . SPARSER::COLLECTION)
    ("gene and human" . SPARSER::COLLECTION) ("SNP 3" . SPARSER::PROTEIN)
    ("SNP 2" . SPARSER::PROTEIN) ("SNP 1" . SPARSER::PROTEIN)
    ("PGC1" . SPARSER::PROTEIN) ("coactivator 1" . SPARSER::PROTEIN)
    ("Jun- and Fos-family" . SPARSER::COLLECTION)
    ("JunB or JunD" . SPARSER::COLLECTION)
    ("Jun-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Jun-Fos" . SPARSER::COLLECTION)
    ("c-Jun, JunB and JunD" . SPARSER::COLLECTION)
    ("c-Fos, Fra-1, Fra-2 and FosB" . SPARSER::COLLECTION)
    ("FosB" . SPARSER::PROTEIN) ("a dimeric complex" . SPARSER::BIO-COMPLEX)
    ("Jun–Fos" . SPARSER::COLLECTION) ("Jun–Jun" . SPARSER::COLLECTION)
    ("which targets c-Jun" . SPARSER::PROTEIN)
    ("the cellular homologue" . SPARSER::PROTEIN)
    ("elevated mitochondrial glutaminase activity" . SPARSER::PROTEIN)
    ("the c-Jun N-terminal kinase (JNK) and the oncogenic transcription factor c-Jun"
     . SPARSER::COLLECTION)
    ("glucose and glutamine" . SPARSER::COLLECTION)
    ("an exogenous glutamine" . SPARSER::AMINO-ACID)
    ("GLS, c-Jun and V5-tag" . SPARSER::COLLECTION)
    ("GLS and c-Jun" . SPARSER::COLLECTION)
    ("-TGAGTCA-3" . SPARSER::COLLECTION) ("-TGACACA-3" . SPARSER::COLLECTION)
    ("-TGACTCC-3" . SPARSER::COLLECTION) ("TGA" . SPARSER::PROTEIN)
    ("The GLS promoter directly binds c-Jun" . SPARSER::PROTEIN)
    ("three previously reported regulators" . SPARSER::REGULATOR)
    ("c-Myc and STAT1" . SPARSER::COLLECTION)
    ("JNK1 and JNK2" . SPARSER::COLLECTION)
    ("c-Jun and GLS" . SPARSER::COLLECTION)
    ("phospho-c-Jun and GLS" . SPARSER::COLLECTION)
    ("JNK1, JNK2 or JNK3" . SPARSER::COLLECTION)
    ("JNK and c-Jun" . SPARSER::COLLECTION) ("MKK/JNK" . SPARSER::COLLECTION)
    ("MKK" . SPARSER::PROTEIN-FAMILY)
    ("the archetypal substrate c-Jun" . SPARSER::PROTEIN)
    ("inhibitor, and whole-cell" . SPARSER::COLLECTION)
    ("ROCK, p38 and JNK" . SPARSER::COLLECTION)
    ("Y-27632, SB203580 and SP600125" . SPARSER::COLLECTION)
    ("mTORC1-S6K" . SPARSER::COLLECTION)
    ("The JNK kinase MKK7 and the Jun-family members JunB and JunD"
     . SPARSER::COLLECTION)
    ("JunB and JunD" . SPARSER::COLLECTION) ("JunB" . SPARSER::PROTEIN)
    ("MKK4/c-Jun" . SPARSER::COLLECTION)
    ("a guanine nucleotide exchange factor and potent activator"
     . SPARSER::COLLECTION)
    ("oncogenic-Dbl, a guanine nucleotide exchange factor and potent activator"
     . SPARSER::COLLECTION)
    ("Dbl" . SPARSER::PROTEIN)
    ("mitochondrial glutaminase activity" . SPARSER::PROTEIN)
    ("c-Myc and GLS" . SPARSER::COLLECTION)
    ("c-Myc and glutamine" . SPARSER::COLLECTION)
    ("complex and tissue" . SPARSER::COLLECTION) ("bis" . SPARSER::PROTEIN)
    ("glutaminase and glutaminase" . SPARSER::COLLECTION)
    ("GLS and GLS2" . SPARSER::COLLECTION)
    ("glutaminase (GLS)" . SPARSER::PROTEIN)
    ("an anaplerotic substrate" . SPARSER::SUBSTRATE)
    ("glutaminase" . SPARSER::PROTEIN) ("Set 3" . SPARSER::PROTEIN)
    ("Set 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Set 1" . SPARSER::PROTEIN)
    ("mix 1" . SPARSER::PROTEIN) ("tween 20" . SPARSER::MOLECULE)
    ("MEK7" . SPARSER::PROTEIN) ("MEK4" . SPARSER::PROTEIN)
    ("S19" . SPARSER::PROTEIN) ("SEK1" . SPARSER::PROTEIN)
    ("Fra-2" . SPARSER::PROTEIN) ("v-Jun" . SPARSER::PROTEIN)
    ("and −1" . SPARSER::PROTEIN) ("p54" . SPARSER::PROTEIN)
    ("p46" . SPARSER::PROTEIN) ("GLUD1" . SPARSER::PROTEIN)
    ("JNK3" . SPARSER::PROTEIN) ("MLC 2" . SPARSER::PROTEIN)
    ("miR-23a" . SPARSER::MOLECULE) ("glutaminase activity" . SPARSER::PROTEIN)
    ("IDR-ERK2" . SPARSER::PROTEIN-PAIR) ("Tpr" . SPARSER::PROTEIN)
    ("IDP or IDR" . SPARSER::COLLECTION) ("IDP" . SPARSER::PROTEIN)
    ("MEKs, phosphatases, and substrates" . SPARSER::COLLECTION)
    ("MEKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G protein-coupled receptors (GPCRs) and growth factor receptors"
     . SPARSER::COLLECTION)
    ("Many soluble scaffold proteins" . SPARSER::PROTEIN)
    ("substrates and intermediates" . SPARSER::COLLECTION)
    ("a fuzzy complex" . SPARSER::BIO-COMPLEX)
    ("ERK2 and NHE1" . SPARSER::COLLECTION)
    ("NHE1 and ERK2" . SPARSER::COLLECTION)
    ("ERK1/2-NHE1" . SPARSER::COLLECTION) ("hNHE1s" . SPARSER::PROTEIN)
    ("hNHE1 and D1D2-(AXA)" . SPARSER::COLLECTION)
    ("hNHE1 and D1D2-" . SPARSER::COLLECTION) ("S6b" . SPARSER::PROTEIN)
    ("hNHE1-ERK2" . SPARSER::COLLECTION)
    ("the self-unphosphorylated state, and vice versa" . SPARSER::PROTEIN)
    ("state, and vice" . SPARSER::COLLECTION)
    ("TR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("linkers" . SPARSER::LINKER)
    ("LTV" . SPARSER::PROTEIN-FAMILY) ("S3a–c" . SPARSER::COLLECTION)
    ("AXA" . SPARSER::MOLECULE) ("HePTP and re-analysed" . SPARSER::COLLECTION)
    ("HePTP" . SPARSER::PROTEIN) ("NHE1-ERK" . SPARSER::COLLECTION)
    ("NHE1 and ERK1/2" . SPARSER::COLLECTION)
    ("hNHE1 and ERK1/2" . SPARSER::COLLECTION)
    ("ERK1/2 and NHE1" . SPARSER::COLLECTION) ("ia" . SPARSER::MOLECULE)
    ("IDPs" . SPARSER::PROTEIN) ("NHE1-MAPK" . SPARSER::COLLECTION)
    ("ERK1/2 and p38 MAPK" . SPARSER::COLLECTION)
    ("ERK1/2, p38 MAPK, and c-Jun" . SPARSER::COLLECTION)
    ("receptor tyrosine kinases or GTP-binding protein-coupled receptors"
     . SPARSER::COLLECTION)
    ("Elk-1 (FQFP) [ xref ] and c-Fos (FTYP) [ xref ]" . SPARSER::COLLECTION)
    ("Elk-1 (FQFP)" . SPARSER::PROTEIN) ("c-Fos (FTYP)" . SPARSER::PROTEIN)
    ("nucleoporin" . SPARSER::PROTEIN)
    ("the transcription factor Elk-1 and p90 ribosomal S kinase"
     . SPARSER::KINASE)
    ("Elk-1 and p90" . SPARSER::COLLECTION) ("RSK1-3" . SPARSER::COLLECTION)
    ("ERK and JNK" . SPARSER::COLLECTION)
    ("targets and regulators" . SPARSER::COLLECTION)
    ("proteins and receptors" . SPARSER::COLLECTION)
    ("Ras (KSR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JNK-interacting protein (JIP)" . SPARSER::PROTEIN)
    ("JIP" . SPARSER::PROTEIN) ("KSR" . SPARSER::PROTEIN)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("hNHE1 and ERK2" . SPARSER::COLLECTION) ("hNHE1" . SPARSER::PROTEIN)
    ("hNHE1-ERK1/2" . SPARSER::COLLECTION)
    ("currently no membrane proteins" . SPARSER::PROTEIN)
    ("i.e. S" . SPARSER::MOLECULE) ("PTP-SL" . SPARSER::PROTEIN)
    ("p21 CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Fus3" . SPARSER::PROTEIN)
    ("Ste5" . SPARSER::PROTEIN-FAMILY)
    ("in Chinese hamster" . SPARSER::PROTEIN) ("p38 MAPK" . SPARSER::PROTEIN)
    ("SLC9A1" . SPARSER::PROTEIN) ("NHE1" . SPARSER::PROTEIN)
    ("PEA-15" . SPARSER::PROTEIN)
    ("phosphoprotein enriched in astrocytes" . SPARSER::PROTEIN)
    ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("β-arrestin" . SPARSER::PROTEIN)
    ("IQGAP1" . SPARSER::PROTEIN)
    ("IQ motif containing GTPase activating protein 1" . SPARSER::PROTEIN)
    ("JNK-interacting protein" . SPARSER::PROTEIN)
    ("Extracellular signal-regulated kinase 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JMJD6 and the Myc proto-oncogene" . SPARSER::COLLECTION)
    ("Src and PI3K" . SPARSER::COLLECTION) ("Myc-JMJD6" . SPARSER::COLLECTION)
    ("active genes" . SPARSER::GENE) ("distant enhancers" . SPARSER::PROTEIN)
    ("Brd4-JMJD6" . SPARSER::COLLECTION) ("U2AF65" . SPARSER::PROTEIN)
    ("a transcriptional activator and transcriptional repressor"
     . SPARSER::COLLECTION)
    ("p19ARF or p53" . SPARSER::COLLECTION)
    ("Erbb2, PyMT, or BRCA1" . SPARSER::COLLECTION) ("CNV" . SPARSER::VARIANT)
    ("JMJD6/Myc" . SPARSER::COLLECTION)
    ("Snail and Twist1" . SPARSER::COLLECTION)
    ("vimentin and Slug" . SPARSER::COLLECTION)
    ("V5-conjugated agarose" . SPARSER::MOLECULE)
    ("LacZ, JMJD6, and JMJD6" . SPARSER::COLLECTION)
    ("JMJD6 and JMJD6" . SPARSER::COLLECTION)
    ("JMJD6 and p19ARF" . SPARSER::COLLECTION)
    ("JMJD6 and the inducible MycER TM" . SPARSER::COLLECTION)
    ("its Ser18 phosphorylated form as well as p21 proteins"
     . SPARSER::COLLECTION)
    ("p19ARF and p53" . SPARSER::COLLECTION)
    ("its mutated form" . SPARSER::FORM)
    ("caspase 3 and PARP" . SPARSER::COLLECTION)
    ("histone and non-histone" . SPARSER::COLLECTION)
    ("iron-" . SPARSER::MOLECULE)
    ("JMJD6 and an inducible c-Myc" . SPARSER::COLLECTION)
    ("etoposide or glucose" . SPARSER::COLLECTION)
    ("JMJD6, Tnrc6c, and Ube2o" . SPARSER::COLLECTION)
    ("FBF1, Ube2o, TK1, Birc5, Sumo2, Tnrc6c, and JMJD6" . SPARSER::COLLECTION)
    ("Tnrc6c" . SPARSER::PROTEIN) ("Ube2o" . SPARSER::PROTEIN)
    ("Sumo" . SPARSER::PROTEIN) ("MMTV-HRas" . SPARSER::COLLECTION)
    ("HRas" . SPARSER::PROTEIN) ("PyMT" . SPARSER::PROTEIN)
    ("the distal part" . SPARSER::COMPONENT)
    ("identified previously reported copy number variants (CNVs) and chromosomal aberrations"
     . SPARSER::COLLECTION)
    ("the predominant responder" . SPARSER::PROTEIN)
    ("responder" . SPARSER::PROTEIN) ("GEM" . SPARSER::PROTEIN)
    ("haploid" . SPARSER::PROTEIN) ("variants (CNV)" . SPARSER::VARIANT)
    ("relevant oncogenes" . SPARSER::ONCOGENE)
    ("WAP-Myc" . SPARSER::COLLECTION) ("MMTV-PyMT" . SPARSER::COLLECTION)
    ("WAP" . SPARSER::PROTEIN) ("Erbb2" . SPARSER::PROTEIN)
    ("GEMs" . SPARSER::PROTEIN) ("Myc and JMJD6" . SPARSER::COLLECTION)
    ("JMJD6 and Myc" . SPARSER::COLLECTION) ("MMTV-Myc" . SPARSER::COLLECTION)
    ("qter" . SPARSER::DRUG) ("MMTV" . SPARSER::PROTEIN)
    ("Bcl-W" . SPARSER::PROTEIN) ("Caspase3" . SPARSER::PROTEIN)
    ("long form" . SPARSER::PROTEIN) ("VegfR1" . SPARSER::PROTEIN)
    ("U2AF" . SPARSER::BIO-COMPLEX) ("p21 proteins" . SPARSER::PROTEIN)
    ("Bmi1" . SPARSER::PROTEIN) ("S6B" . SPARSER::PROTEIN)
    ("Myc protein" . SPARSER::PROTEIN) ("beta-estradiol" . SPARSER::MOLECULE)
    ("CT1" . SPARSER::PROTEIN) ("TK1" . SPARSER::PROTEIN)
    ("FBF1" . SPARSER::PROTEIN) ("Arg3" . SPARSER::PROTEIN)
    ("H4R" . SPARSER::PROTEIN) ("JMJD6" . SPARSER::PROTEIN)
    ("versican or high mobility group box 1" . SPARSER::COLLECTION)
    ("versican" . SPARSER::PROTEIN) ("NOX1/ROS" . SPARSER::COLLECTION)
    ("TLR2 and TLR4" . SPARSER::COLLECTION)
    ("CXCL1 and CXCL2" . SPARSER::COLLECTION)
    ("phosphatase and tensin homolog and SHP2" . SPARSER::COLLECTION)
    ("CD44 , Prom1 , Sox9 , and Noxo1" . SPARSER::COLLECTION)
    ("Tnf" . SPARSER::PROTEIN) ("Trim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD44 , Sox2 , Noxo1 , Cd14 , Ephb2 , Cxcr4 , Sox9 , and Prom1"
     . SPARSER::COLLECTION)
    ("Cxcr4" . SPARSER::PROTEIN) ("Ephb2" . SPARSER::PROTEIN)
    ("Cd14" . SPARSER::PROTEIN) ("Noxo1" . SPARSER::PROTEIN)
    ("WNT3 and CTNNB1" . SPARSER::COLLECTION)
    ("the respective histological types" . TYPE)
    ("APC and the β‐catenin gene ( CTNNB1 )" . SPARSER::COLLECTION)
    ("APC or CTNNB1" . SPARSER::COLLECTION) ("Gan" . SPARSER::PROTEIN)
    ("prostaglandin" . SPARSER::PROTEIN) ("TLR2/MyD88" . SPARSER::COLLECTION)
    ("TLR2" . SPARSER::PROTEIN) ("TLR/MyD88" . SPARSER::COLLECTION)
    ("CD44, Prom1, and Sox9" . SPARSER::COLLECTION)
    ("Prom1" . SPARSER::PROTEIN) ("CXCL2, and CXCL5" . SPARSER::COLLECTION)
    ("high mobility group box 1" . SPARSER::PROTEIN)
    ("gp130" . SPARSER::PROTEIN) ("Interleukin‐11" . SPARSER::PROTEIN)
    ("SHP2" . SPARSER::PROTEIN) ("WNT3" . SPARSER::PROTEIN)
    ("Krt19" . SPARSER::PROTEIN)
    ("prostaglandin E synthase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("K19" . SPARSER::PROTEIN) ("Myd88" . SPARSER::PROTEIN)
    ("CXCL2" . SPARSER::PROTEIN) ("interleukin‐11" . SPARSER::PROTEIN)
    ("PGE 2" . SPARSER::DRUG)
    ("SIRT3 gene promoter and change SIRT3 level" . SPARSER::COLLECTION)
    ("human very long-chain acyl-CoA dehydrogenase" . SPARSER::PROTEIN)
    ("SIRT3-FOXO1" . SPARSER::COLLECTION) ("cyclophilin" . SPARSER::PROTEIN)
    ("mitochondrial aldehyde dehydrogenase" . SPARSER::PROTEIN)
    ("SOD2 and catalase" . SPARSER::COLLECTION)
    ("isocitrate" . SPARSER::PROTEIN)
    ("Nuclear respiratory factor 2" . SPARSER::PROTEIN)
    ("early growth response protein 1, KLF16, SP1, SP2 and SP3"
     . SPARSER::COLLECTION)
    ("ZIC1 (zinc finger transcription factor 1) and ZIC4"
     . SPARSER::COLLECTION)
    ("SP1, SP2, KLF5 and KLF16" . SPARSER::COLLECTION)
    ("KLF14 (Kruppel-like factor 14) and SP8" . SPARSER::COLLECTION)
    ("FOS" . SPARSER::PROTEIN)
    ("ETS transcription factor and THAP domain-containing protein 1"
     . SPARSER::COLLECTION)
    ("neurogenic differentiation factor 2" . SPARSER::PROTEIN)
    ("GCMb" . SPARSER::PROTEIN)
    ("caudal-related homeobox transcription factor 1" . SPARSER::PROTEIN)
    ("insulinoma-associated 1, MEIS1 and SOX10" . SPARSER::COLLECTION)
    ("HLTF (helicase-like transcription factor) and MEIS1"
     . SPARSER::COLLECTION)
    ("hypoxia-inducible factor 1-alpha and aryl hydrocarbon receptor nuclear translocator"
     . SPARSER::COLLECTION)
    ("HLTF" . SPARSER::PROTEIN)
    ("estrogen-related receptor beta and nuclear receptor subfamily 4 group A member 2"
     . SPARSER::COLLECTION)
    ("SPIB" . SPARSER::PROTEIN) ("circadian clock" . SPARSER::PROTEIN)
    ("ins" . SPARSER::PROTEIN) ("synthase 2" . SPARSER::PROTEIN)
    ("IDH2" . SPARSER::PROTEIN) ("ZF5" . SPARSER::PROTEIN)
    ("SP3" . SPARSER::PROTEIN)
    ("early growth response protein 1" . SPARSER::PROTEIN)
    ("ZIC4" . SPARSER::PROTEIN) ("TFAP2C" . SPARSER::PROTEIN)
    ("TFAP2B" . SPARSER::PROTEIN) ("AP-2 alpha" . SPARSER::PROTEIN)
    ("TFAP2A" . SPARSER::PROTEIN) ("KLF16" . SPARSER::PROTEIN)
    ("KLF5" . SPARSER::PROTEIN)
    ("E2F transcription factor 6" . SPARSER::PROTEIN)
    ("KLF14" . SPARSER::PROTEIN) ("SP4" . SPARSER::PROTEIN)
    ("zinc finger protein 263" . SPARSER::PROTEIN)
    ("NKX6-2" . SPARSER::PROTEIN)
    ("NK6 transcription factor related" . SPARSER::PROTEIN)
    ("NKX6-1" . SPARSER::PROTEIN) ("homeobox 1" . SPARSER::PROTEIN)
    ("transcription factor 1" . SPARSER::PROTEIN)
    ("insulinoma-associated 1" . SPARSER::PROTEIN)
    ("helicase-like transcription factor" . SPARSER::PROTEIN)
    ("doublesex and Mab-3 related transcription factor 3" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor nuclear translocator" . SPARSER::PROTEIN)
    ("nuclear receptor subfamily 4 group A member 2" . SPARSER::PROTEIN)
    ("estrogen-related receptor beta" . SPARSER::PROTEIN)
    ("myeloid zinc finger 1" . SPARSER::PROTEIN) ("Spi-1" . SPARSER::PROTEIN)
    ("Spi-B transcription factor" . SPARSER::PROTEIN)
    ("HCC and an attractive molecular target" . SPARSER::COLLECTION)
    ("an attractive molecular target" . SPARSER::TARGET-PROTEIN)
    ("DNMTs" . SPARSER::PROTEIN) ("Brazilian HCC" . SPARSER::PROTEIN)
    ("several genes and geographical area" . SPARSER::COLLECTION)
    ("folate" . SPARSER::MOLECULE) ("HCCs" . SPARSER::PROTEIN)
    ("HCC-" . SPARSER::PROTEIN) ("HCC and non-HCC" . SPARSER::COLLECTION)
    ("HCC and a potential molecular target" . SPARSER::COLLECTION)
    ("a valuable biomarker" . SPARSER::MOLECULE)
    ("RASSF1A and DOK1" . SPARSER::COLLECTION) ("DOK1" . SPARSER::PROTEIN)
    ("ammonia and Rapamycin" . SPARSER::COLLECTION)
    ("possibly other membrane receptors" . SPARSER::RECEPTOR)
    ("Eng" . SPARSER::PROTEIN)
    ("especially other Dopamine receptors" . SPARSER::RECEPTOR)
    ("a dopaminergic neurotoxin" . SPARSER::PROTEIN)
    ("amino acids as well as other nutrients" . SPARSER::COLLECTION)
    ("EM" . SPARSER::PROTEIN) ("MTOR and ammonia" . SPARSER::COLLECTION)
    ("the ammonia’s" . SPARSER::MOLECULE) ("RAPTOR" . SPARSER::PROTEIN)
    ("both Rapamycin and starvation treatment increase autophagosomes"
     . SPARSER::COLLECTION)
    ("inducer and inhibitor" . SPARSER::COLLECTION)
    ("CHO-GFP-DRD3-Flag" . SPARSER::COLLECTION)
    ("GFP-DRD3-FLAG" . SPARSER::COLLECTION)
    ("the commercially available antibodies" . SPARSER::ANTIBODY)
    ("DRD3 and GAPDH" . SPARSER::COLLECTION) ("CHO" . SPARSER::PROTEIN)
    ("LC3 ( xref ) or DRD3 ( xref )" . SPARSER::COLLECTION)
    ("significantly more GFP fragment" . SPARSER::FRAGMENT)
    ("full length GFP-LC3 and GFP-DRD3 protein ( xref )" . SPARSER::COLLECTION)
    ("LC3 and DRD3" . SPARSER::COLLECTION)
    ("LC3 or DRD3" . SPARSER::COLLECTION)
    ("autophagic flux inhibitors" . SPARSER::INHIBITOR)
    ("PIK3C3/VPS34" . SPARSER::COLLECTION) ("Pepstatin" . SPARSER::DRUG)
    ("an autophagic flux inhibitor" . SPARSER::INHIBITOR)
    ("The autophagic flux inhibitors Chloroquine and Bafilomycin A1"
     . SPARSER::COLLECTION)
    ("Chloroquine and Bafilomycin A1" . SPARSER::COLLECTION)
    ("dopamine or Rapamycin" . SPARSER::COLLECTION)
    ("mCherry-" . SPARSER::PROTEIN) ("mCherry and EGFP" . SPARSER::COLLECTION)
    ("mCherry-EGFP-LC3" . SPARSER::COLLECTION)
    ("fragment and LC3B" . SPARSER::COLLECTION)
    ("GFP-DRD3" . SPARSER::COLLECTION) ("hydrochloride" . SPARSER::MOLECULE)
    ("GFP-LC3-Flag" . SPARSER::COLLECTION) ("BII" . SPARSER::PROTEIN)
    ("the consequent ammonia" . SPARSER::MOLECULE)
    ("S6K as well as EIF4EBP1" . SPARSER::COLLECTION)
    ("GFP-DRD3-Flag" . SPARSER::COLLECTION)
    ("ions and photons [ xref – xref ]" . SPARSER::COLLECTION)
    ("the largest membrane receptor family" . SPARSER::PROTEIN-FAMILY)
    ("Receptors" . SPARSER::RECEPTOR) ("T1R1 and T1R3" . SPARSER::COLLECTION)
    ("Bafilomycin A1, Chloroquine or ammonium chloride" . SPARSER::COLLECTION)
    ("their less essential components" . SPARSER::COMPONENT)
    ("Various exogenous cues" . SPARSER::PROTEIN-FAMILY)
    ("DRD3 and MTOR" . SPARSER::COLLECTION) ("Glutamine" . SPARSER::AMINO-ACID)
    ("ammonia" . SPARSER::MOLECULE) ("Ammonia" . SPARSER::MOLECULE)
    ("MPP+" . SPARSER::MOLECULE)
    ("N-methyl-4-phenylpyridinium" . SPARSER::MOLECULE)
    ("dopamine receptor D2" . SPARSER::PROTEIN)
    ("dopamine receptor D3" . SPARSER::PROTEIN)
    ("V-ATPase" . SPARSER::PROTEIN-FAMILY)
    ("Acridine Orange" . SPARSER::MOLECULE) ("LC3A" . SPARSER::PROTEIN)
    ("pS6K" . SPARSER::PROTEIN) ("H4A" . SPARSER::PROTEIN)
    ("LAMP1" . SPARSER::PROTEIN) ("EIF4EBP1" . SPARSER::PROTEIN)
    ("G-Protein Coupled" . SPARSER::PROTEIN) ("MTORC1" . SPARSER::PROTEIN)
    ("T1R3" . SPARSER::PROTEIN) ("T1R1" . SPARSER::PROTEIN)
    ("Bafilomycin A1" . SPARSER::DRUG) ("Atg8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAP1LC3" . SPARSER::PROTEIN-FAMILY)
    ("mechanistic target of Rapamycin" . SPARSER::PROTEIN)
    ("VPS34" . SPARSER::PROTEIN) ("PIK3C3" . SPARSER::PROTEIN)
    ("Dopamine receptor D3" . SPARSER::PROTEIN) ("DRD3" . SPARSER::PROTEIN)
    ("G protein-coupled receptor" . SPARSER::PROTEIN)
    ("IL-2/IL-2R" . SPARSER::COLLECTION) ("stabilizer" . SPARSER::MOLECULE)
    ("at least one miR" . SPARSER::PROTEIN)
    ("a crucial transcription factor" . SPARSER::PROTEIN)
    ("pias-1" . SPARSER::PROTEIN) ("Eos" . SPARSER::PROTEIN)
    ("pias" . SPARSER::PROTEIN-FAMILY) ("furin" . SPARSER::PROTEIN)
    ("Pias-1" . SPARSER::PROTEIN) ("Pias" . SPARSER::PROTEIN-FAMILY)
    ("ubiquitinase" . SPARSER::UBIQUITINASE)
    ("deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("Foxp3-GFP" . SPARSER::COLLECTION) ("JAK2 and JAK3" . SPARSER::COLLECTION)
    ("Tyrphostin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JAK3/STAT-5" . SPARSER::COLLECTION)
    ("IL-2/CD122/JAK3/STAT-5" . SPARSER::COLLECTION)
    ("IL-2/JAK3/STAT-5" . SPARSER::COLLECTION) ("STAT5b" . SPARSER::PROTEIN)
    ("ST5" . SPARSER::PROTEIN) ("SK3" . SPARSER::PROTEIN)
    ("mIL-2" . SPARSER::PROTEIN) ("β-Mercaptoethanol" . SPARSER::MOLECULE)
    ("IL-2R" . SPARSER::PROTEIN) ("ikzf4" . SPARSER::PROTEIN)
    ("Ets-1" . SPARSER::PROTEIN) ("IFN- G" . SPARSER::PROTEIN)
    ("STAT1" . SPARSER::PROTEIN) ("STUB1" . SPARSER::PROTEIN)
    ("USP7" . SPARSER::PROTEIN) ("AG-490" . SPARSER::DRUG)
    ("CD122" . SPARSER::PROTEIN) ("foxp3" . SPARSER::PROTEIN)
    ("STAT-5" . SPARSER::PROTEIN) ("GPL" . SPARSER::PROTEIN)
    ("LF" . SPARSER::PROTEIN) ("YG" . SPARSER::MOLECULE)
    ("HHL" . SPARSER::PROTEIN) ("ZPX and JZW" . SPARSER::COLLECTION)
    ("ZPX" . SPARSER::PROTEIN) ("neurotransmitters" . SPARSER::MOLECULE)
    ("an early diagnostic biomarker" . SPARSER::MOLECULE)
    ("ɛ2, ɛ3 and ɛ4" . SPARSER::COLLECTION)
    ("Arg or Cys" . SPARSER::COLLECTION) ("ɛ2 and ɛ3" . SPARSER::COLLECTION)
    ("Potential Diagnostic Biomarkers" . SPARSER::MOLECULE)
    ("group, and T2DM-MCI" . SPARSER::COLLECTION)
    ("a clinical diagnostic biomarker" . SPARSER::MOLECULE)
    ("glycogen" . SPARSER::PROTEIN) ("CSF" . SPARSER::PROTEIN)
    ("MR" . SPARSER::PROTEIN)
    ("peripheral circulating GSK-3β" . SPARSER::PROTEIN)
    ("ApoE" . SPARSER::PROTEIN) ("ɛ3" . SPARSER::MOLECULE)
    ("ɛ2" . SPARSER::MOLECULE) ("apolipoprotein E" . SPARSER::PROTEIN)
    ("dimers and ligands" . SPARSER::COLLECTION)
    ("HER2-immunohistochemistry" . SPARSER::PROTEIN-PAIR)
    ("antibodies, and algorithms" . SPARSER::COLLECTION)
    ("HER2-HER3" . SPARSER::COLLECTION)
    ("potential predictive biomarkers" . SPARSER::MOLECULE)
    ("pancreatobiliary type" . TYPE) ("a longer RFS" . SPARSER::PROTEIN)
    ("a significantly shorter RFS" . SPARSER::PROTEIN)
    ("peripancreatic fat" . SPARSER::PROTEIN)
    ("formaldehyde" . SPARSER::MOLECULE)
    ("PB- and I-type" . SPARSER::COLLECTION) ("PB-" . SPARSER::PROTEIN)
    ("EGFR, HER2 and HER3 and HER2" . SPARSER::COLLECTION)
    ("HER3 and HER2" . SPARSER::COLLECTION)
    ("KRAS, NRAS and BRAF" . SPARSER::COLLECTION)
    ("HER3 (ErbB-3) and HER4 (ErbB-4)" . SPARSER::COLLECTION)
    ("EGFR (HER1, ErbB-1), HER2 (Neu, ErbB-2), HER3 (ErbB-3) and HER4 (ErbB-4)"
     . SPARSER::COLLECTION)
    ("four closely related transmembranous molecules" . SPARSER::MOLECULE)
    ("Neu" . SPARSER::PROTEIN) ("PB" . SPARSER::PROTEIN)
    ("EGFR, HER2 and HER3, and HER2" . SPARSER::COLLECTION)
    ("HER3, and HER2" . SPARSER::COLLECTION)
    ("EGFR, HER2 and HER3" . SPARSER::COLLECTION) ("HR 3" . SPARSER::PROTEIN)
    ("ErbB-1" . SPARSER::PROTEIN)
    ("both monoclonal antibodies" . SPARSER::ANTIBODY)
    ("type or vice" . SPARSER::COLLECTION)
    ("type and vice" . SPARSER::COLLECTION)
    ("a heterogeneous complex" . SPARSER::BIO-COMPLEX)
    ("RAS/MAPK" . SPARSER::COLLECTION) ("CR or PR" . SPARSER::COLLECTION)
    ("Variety" . SPARSER::VARIETY)
    ("male and 22 female patients" . SPARSER::COLLECTION)
    ("K-ras and EGFR" . SPARSER::COLLECTION)
    ("echinoderm microtubule-associated protein-like 4 ( EML4 ) and the anaplastic lymphoma kinase [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("Another important predictive and therapeutic biomarker"
     . SPARSER::MOLECULE)
    ("drugable oncogene" . SPARSER::ONCOGENE)
    ("different histological subtypes" . SPARSER::PROTEIN)
    ("ARMS" . SPARSER::PROTEIN) ("EGFR and K-ras" . SPARSER::COLLECTION)
    ("ESR1 and a synonymous variant" . SPARSER::COLLECTION)
    ("a synonymous variant" . SPARSER::VARIANT)
    ("estrogen-" . SPARSER::MOLECULE) ("mRNA or mRNA" . SPARSER::COLLECTION)
    ("the SNP and BC risk" . SPARSER::COLLECTION)
    ("the rs2228480 ESR1 genetic variant and BC risk" . SPARSER::COLLECTION)
    ("genetic variants and environmental factors" . SPARSER::COLLECTION)
    ("ER- α" . SPARSER::PROTEIN) ("IIIa" . SPARSER::PROTEIN)
    ("the cervical cancer cell line SKG-IIIa" . SPARSER::PROTEIN-PAIR)
    ("SKG-IIIa" . SPARSER::COLLECTION) ("SKG" . SPARSER::PROTEIN)
    ("cancer cell histologic type" . TYPE) ("HGF/c-Met" . SPARSER::COLLECTION)
    ("HGF and its receptor" . SPARSER::COLLECTION)
    ("a hepatocyte growth factor (HGF) receptor and a protooncogene"
     . SPARSER::COLLECTION)
    ("HGF receptor" . SPARSER::PROTEIN) ("c-met" . SPARSER::PROTEIN)
    ("pancreatic regenerative medicine" . SPARSER::DRUG)
    ("the most critical proinflammatory cytokines" . SPARSER::PROTEIN)
    ("TNFα, IL-1β, and IFNγ" . SPARSER::COLLECTION)
    ("immune cell-derived inflammatory cytokines" . SPARSER::PROTEIN)
    ("proinsulin and Chromogranin" . SPARSER::COLLECTION)
    ("proinflammatory cytokine" . SPARSER::PROTEIN)
    ("EGF and CNTF" . SPARSER::COLLECTION)
    ("STAT3 and NGN3" . SPARSER::COLLECTION) ("CNTF" . SPARSER::PROTEIN)
    ("/NGN3" . SPARSER::COLLECTION)
    ("Eotaxin ( xref ) and cytokine" . SPARSER::COLLECTION)
    ("Eotaxin" . SPARSER::PROTEIN)
    ("TNFα, IL-1β and IFNγ" . SPARSER::COLLECTION)
    ("C-peptide and glucagon" . SPARSER::COLLECTION)
    ("glucagon" . SPARSER::PROTEIN) ("Proinsulin" . SPARSER::PROTEIN)
    ("proinsulin" . SPARSER::PROTEIN) ("Chromogranin" . SPARSER::PROTEIN)
    ("Stattic [5μM] or Cx+Stattic [5μM]" . SPARSER::COLLECTION)
    ("Stattic" . SPARSER::DRUG)
    ("the three proinflammatory cytokines" . SPARSER::PROTEIN)
    ("TNFα and IL-1β" . SPARSER::COLLECTION)
    ("NKX6.1 and HNF6" . SPARSER::COLLECTION) ("Cx−" . SPARSER::PROTEIN-FAMILY)
    ("NGN3 , NKX6.1 or HNF6" . SPARSER::COLLECTION)
    ("NKX6.1 ( xref ) and HNF6 ( xref )" . SPARSER::COLLECTION)
    ("Proinflammatory cytokines" . SPARSER::PROTEIN)
    ("anhydrase" . SPARSER::PROTEIN) ("Cytokine" . SPARSER::PROTEIN)
    ("CHOP" . SPARSER::PROTEIN) ("Cx" . SPARSER::PROTEIN-FAMILY)
    ("the three proinflammatory cytokines, TNFα, IL-1β, and IFNγ"
     . SPARSER::COLLECTION)
    ("cytokines, TNFα, IL-1β, and IFNγ" . SPARSER::COLLECTION)
    ("Inflammatory cytokines" . SPARSER::PROTEIN)
    ("the human ductal epithelial cell line PANC-1" . SPARSER::PROTEIN)
    ("digestive enzyme" . SPARSER::ENZYME) ("delta" . SPARSER::PROTEIN)
    ("endocrine and exocrine" . SPARSER::COLLECTION)
    ("inflammatory cytokine" . SPARSER::PROTEIN)
    ("C-peptide" . SPARSER::MOLECULE) ("secretory granule" . SPARSER::PROTEIN)
    ("IFN γ R" . SPARSER::PROTEIN) ("IL-1 R" . SPARSER::PROTEIN)
    ("TNF α" . SPARSER::PROTEIN) ("HNF6" . SPARSER::PROTEIN)
    ("NKX6.1" . SPARSER::PROTEIN) ("SNAIL2" . SPARSER::PROTEIN)
    ("e-cadherin" . SPARSER::PROTEIN) ("NGN3" . SPARSER::PROTEIN)
    ("UNG2 and RPA" . SPARSER::COLLECTION)
    ("cellular UNG2 and RPA32" . SPARSER::COLLECTION)
    ("the negative viral DNA" . SPARSER::DNA)
    ("Vpr and UNG2" . SPARSER::COLLECTION) ("APOBEC" . SPARSER::BIO-COMPLEX)
    ("the single strand viral DNA" . SPARSER::DNA)
    ("the RPA trimeric complex" . SPARSER::BIO-COMPLEX)
    ("cellular UNG2" . SPARSER::PROTEIN)
    ("UNG2 and viral-related UNG proteins" . SPARSER::COLLECTION)
    ("viral-related UNG proteins" . SPARSER::PROTEIN)
    ("RPA32 and UNG2" . SPARSER::COLLECTION)
    ("RPA70 and RPA14" . SPARSER::COLLECTION)
    ("Vpr and RPA32" . SPARSER::COLLECTION) ("UNG" . SPARSER::PROTEIN)
    ("UNG2 and the RPA32 subunit" . SPARSER::COLLECTION)
    ("viral p24" . SPARSER::PROTEIN) ("MDM" . SPARSER::PROTEIN)
    ("UNG2- or -RPA32-depleted" . SPARSER::COLLECTION)
    ("the viral Vpr protein" . SPARSER::PROTEIN)
    ("vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the total viral DNA" . SPARSER::DNA)
    ("total viral DNA reverse transcripts 7 h" . SPARSER::PROTEIN)
    ("monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("endogenous UNG2 as well as RPA32" . SPARSER::COLLECTION)
    ("the viral p24 capsid protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RPA32 and Vpr" . SPARSER::COLLECTION) ("HA-UNG2" . SPARSER::COLLECTION)
    ("HA-RPA32" . SPARSER::COLLECTION) ("HA-Vpr" . SPARSER::COLLECTION)
    ("-Sepharose" . SPARSER::MOLECULE) ("GST-RPA32" . SPARSER::COLLECTION)
    ("GST-UNG2" . SPARSER::COLLECTION) ("UNG2 and GST" . SPARSER::COLLECTION)
    ("Vpr, UNG2 and RPA32" . SPARSER::COLLECTION)
    ("Refs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SHM" . SPARSER::DRUG)
    ("proliferating cell nuclear antigen (PCNA)" . SPARSER::PROTEIN)
    ("complex (RPA)" . SPARSER::BIO-COMPLEX)
    ("cross-complementing" . SPARSER::PROTEIN)
    ("the newly synthesized viral DNA" . SPARSER::DNA)
    ("the viral DNA" . SPARSER::DNA)
    ("the only HIV-1 auxiliary protein" . SPARSER::PROTEIN)
    ("Vpu" . SPARSER::PROTEIN) ("Vif" . SPARSER::PROTEIN)
    ("monocytes and macrophages" . SPARSER::COLLECTION)
    ("UNG2 and RPA32" . SPARSER::COLLECTION) ("UNG2-" . SPARSER::PROTEIN)
    ("UNG2 or RPA32" . SPARSER::COLLECTION) ("MDMs" . SPARSER::PROTEIN)
    ("UNG2 and the p32 subunit (RPA32)" . SPARSER::COLLECTION)
    ("a trimolecular complex" . SPARSER::BIO-COMPLEX)
    ("uracil" . SPARSER::DRUG) ("Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-globin" . SPARSER::PROTEIN) ("U5" . SPARSER::PROTEIN)
    ("1 µL" . SPARSER::PROTEIN) ("UNG1" . SPARSER::PROTEIN)
    ("RPA3" . SPARSER::PROTEIN) ("M-CSF" . SPARSER::PROTEIN)
    ("colony-stimulating factor" . SPARSER::PROTEIN)
    ("cytidine deaminase" . SPARSER::PROTEIN) ("APOBEC3G" . SPARSER::PROTEIN)
    ("centromere protein A" . SPARSER::PROTEIN) ("RPA14" . SPARSER::PROTEIN)
    ("as 2 " . SPARSER::PROTEIN) ("NL4" . SPARSER::PROTEIN)
    ("capsid protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("X-ray repair" . SPARSER::PROTEIN) ("Pr55Gag" . SPARSER::PROTEIN)
    ("CCR5" . SPARSER::PROTEIN) ("p32" . SPARSER::PROTEIN)
    ("UNG2" . SPARSER::PROTEIN)
    ("the previously uncharacterized protein HPF1" . SPARSER::PROTEIN)
    ("Timeless-PARP-1" . SPARSER::COLLECTION)
    ("PARP-1-Timeless" . SPARSER::COLLECTION)
    ("Timeless" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HPF1-PARP-1" . SPARSER::COLLECTION)
    ("hypo-ADP-ribosylated PARP-1" . SPARSER::PROTEIN)
    ("automodified PARP-1 or ADP-ribosylated histones" . SPARSER::COLLECTION)
    ("WT C4orf27 and the Y238A/R239A mutant ( xref F)" . SPARSER::COLLECTION)
    ("octamer" . SPARSER::PROTEIN) ("FLAG-histone H2B" . SPARSER::COLLECTION)
    ("C4orf27/PARP-1" . SPARSER::COLLECTION) ("Parp-1" . SPARSER::PROTEIN)
    ("Parp" . SPARSER::PROTEIN) ("PARP-1/PARP-2" . SPARSER::COLLECTION)
    ("PARP-1 and histones" . SPARSER::COLLECTION)
    ("APLF and PARP-1" . SPARSER::COLLECTION) ("APLF" . SPARSER::PROTEIN)
    ("PARP-1 and C4orf27" . SPARSER::COLLECTION)
    ("iGFP-C4orf27" . SPARSER::COLLECTION)
    ("C4orf27 and histones" . SPARSER::COLLECTION)
    ("C4orf27-histone" . SPARSER::COLLECTION)
    ("C4orf27 primarily binds PARP-1" . SPARSER::PROTEIN)
    ("C4orf27 and PARP-1" . SPARSER::COLLECTION)
    ("C4orf27 and PARP-2" . SPARSER::COLLECTION)
    ("PARP-1, PARP-2, or PARP-3" . SPARSER::COLLECTION)
    ("C4orf27-PARP-1" . SPARSER::COLLECTION)
    ("FLAG-C4orf27" . SPARSER::COLLECTION)
    ("PARP-1 and the core histones (H2A, H2B, H3, and H4)"
     . SPARSER::COLLECTION)
    ("FLAG-C4orf27-associated proteins" . SPARSER::PROTEIN)
    ("interactors" . SPARSER::PROTEIN) ("YFP-C4orf27" . SPARSER::COLLECTION)
    ("orthologs" . SPARSER::PROTEIN) ("metazoans" . SPARSER::PROTEIN-FAMILY)
    ("enzymes, and proteases" . SPARSER::COLLECTION)
    ("eukaryotic proteins" . SPARSER::PROTEIN) ("PBZ" . SPARSER::PROTEIN)
    ("C4orf27/HPF1" . SPARSER::COLLECTION)
    ("HPF1 and PARP-1" . SPARSER::COLLECTION) ("orf" . SPARSER::PROTEIN)
    ("histones and other chromatin-associated proteins ( xref )"
     . SPARSER::COLLECTION)
    ("other chromatin-associated proteins" . SPARSER::PROTEIN)
    ("PARP-1 extensively poly(ADP-ribosyl)ates" . SPARSER::PROTEIN)
    ("ates" . SPARSER::PROTEIN)
    ("the enzymatic process whereby adenosine diphosphate ribose (ADPr) molecules"
     . SPARSER::MOLECULE)
    ("ADPr" . SPARSER::PROTEIN) ("adenosine" . SPARSER::PROTEIN)
    ("DNA " . SPARSER::DNA) ("a robust protein complex" . SPARSER::BIO-COMPLEX)
    ("HPF1/C4orf27" . SPARSER::COLLECTION) ("guide RNA" . SPARSER::RNA)
    ("MacroD2" . SPARSER::PROTEIN) ("ALC1 " . SPARSER::PROTEIN)
    ("ALC1" . SPARSER::PROTEIN) ("PARP-3" . SPARSER::PROTEIN)
    ("yeast)" . SPARSER::PROTEIN) ("protein C" . SPARSER::PROTEIN)
    ("nicotinamide adenine dinucleotide " . SPARSER::MOLECULE)
    ("C4orf27" . SPARSER::PROTEIN) ("HPF1" . SPARSER::PROTEIN)
    ("histone PARylation factor 1" . SPARSER::PROTEIN)
    ("tumor suppressor genes and hypomethylation" . SPARSER::COLLECTION)
    ("two essential components" . SPARSER::COMPONENT)
    ("- 1" . SPARSER::PROTEIN)
    ("CDH1 and tumor histology" . SPARSER::COLLECTION)
    ("epithelial cadherin (E-cadherin) and cadherin-1" . SPARSER::COLLECTION)
    ("tumor suppressor gene (TSG)" . SPARSER::PROTEIN)
    ("LMP" . SPARSER::PROTEIN) ("- 2" . SPARSER::PROTEIN)
    ("cadherin-1" . SPARSER::PROTEIN)
    ("epithelial cadherin" . SPARSER::PROTEIN)
    ("regulatory miRs" . SPARSER::PROTEIN)
    ("miR29b and miR198" . SPARSER::COLLECTION)
    ("Bcl-2, MCL-1, and Bcl-Xl" . SPARSER::COLLECTION)
    ("JAK/STAT" . SPARSER::COLLECTION)
    ("Anti-hsa-miRNA198" . SPARSER::COLLECTION)
    ("directly address miR-29b" . SPARSER::MOLECULE)
    ("b and c" . SPARSER::COLLECTION)
    ("expressed high miR-29b and miR-198 levels" . SPARSER::COLLECTION)
    ("Anti-hsa-miRNAs" . SPARSER::COLLECTION) ("Reagent" . SPARSER::MOLECULE)
    ("miR16" . SPARSER::PROTEIN) ("PITA" . SPARSER::PROTEIN)
    ("miR-29b and miR-198" . SPARSER::COLLECTION)
    ("responder-CD8" . SPARSER::PROTEIN-PAIR)
    ("a complete HLA" . SPARSER::PROTEIN)
    ("radical or partial" . SPARSER::COLLECTION)
    ("MCL-1 and JAK3" . SPARSER::COLLECTION)
    ("JAK3 and MCL - 1" . SPARSER::COLLECTION)
    ("a pro-apoptotic state" . SPARSER::BIO-STATE)
    ("JAK3 and MCL-1" . SPARSER::COLLECTION)
    ("anti-apoptotic and proliferation-associated" . SPARSER::COLLECTION)
    ("pre- and post-IVS" . SPARSER::COLLECTION)
    ("IFN-alpha" . SPARSER::PROTEIN) ("miR29b" . SPARSER::RNA)
    ("B-6" . SPARSER::PROTEIN) ("MCL - 1" . SPARSER::PROTEIN)
    ("STAT5" . SPARSER::PROTEIN) ("JAK3" . SPARSER::PROTEIN)
    ("proliferation-associated" . SPARSER::PROTEIN)
    ("ROR " . SPARSER::PROTEIN-FAMILY) ("PRISMA" . SPARSER::DRUG)
    ("EGFR and small-molecule TKIs" . SPARSER::COLLECTION)
    ("specifically target EGFR" . SPARSER::PROTEIN)
    ("miRNAs or oligonucleotides" . SPARSER::COLLECTION)
    ("small-molecule inhibitors and antisense oligonucleotides"
     . SPARSER::COLLECTION)
    ("anti-proliferative and anti-migratory" . SPARSER::COLLECTION)
    ("NATs" . SPARSER::PROTEIN)
    ("suppressors or oncogenes" . SPARSER::COLLECTION)
    ("19-24-nucleotide-long non-coding RNAs" . SPARSER::RNA)
    ("gefitinib, erlotinib and afatinib" . SPARSER::COLLECTION)
    ("two major histological types" . TYPE)
    ("further experimentally validated miR-218-5" . SPARSER::PROTEIN)
    ("either tumor oncogenes or tumor suppressors" . SPARSER::COLLECTION)
    ("JAK/Stat3" . SPARSER::COLLECTION)
    ("5-FU and mammosphere" . SPARSER::COLLECTION)
    ("CCL21, CCL19, and its receptor" . SPARSER::COLLECTION)
    ("PD98059, SB431542, SB203580, AG490, LY294002, or BAY"
     . SPARSER::COLLECTION)
    ("AKT, NF-kappaB, Smad-2, Stat3, β -catenin, and GSK-3 β"
     . SPARSER::COLLECTION)
    ("pCDNA-Snail" . SPARSER::PROTEIN-PAIR) ("si-Snail" . SPARSER::COLLECTION)
    ("pluripotent markers Bmi-1, Nanog, and Oct-4" . SPARSER::COLLECTION)
    ("Bmi-1, Nanog, and Oct-4" . SPARSER::COLLECTION)
    ("Rh" . SPARSER::MOLECULE)
    ("P-gp, Bmi-1, Nanog, and Oct-4" . SPARSER::COLLECTION)
    ("drug and disease" . SPARSER::COLLECTION)
    ("metabolites and xenobiotics" . SPARSER::COLLECTION)
    ("Sox2, Lin28, Bmi-1, Oct-4, and Nanog" . SPARSER::COLLECTION)
    ("CCR7/CCL19/CCL21" . SPARSER::COLLECTION)
    ("CCL19 and CCL21" . SPARSER::COLLECTION) ("Chemokine" . SPARSER::PROTEIN)
    ("Chemokines" . SPARSER::PROTEIN)
    ("P-gp, Bmi-1, Nanog, and OCT-4" . SPARSER::COLLECTION)
    ("/Snail" . SPARSER::COLLECTION) ("AKT and GSK-3 β" . SPARSER::COLLECTION)
    ("AKT/GSK-3 β" . SPARSER::COLLECTION)
    ("Bmi-1, Nanog, and OCT-4" . SPARSER::COLLECTION)
    ("Basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("LY 294002" . SPARSER::MOLECULE) ("Smad-2" . SPARSER::PROTEIN)
    ("CXCL13" . SPARSER::PROTEIN) ("PGL3" . SPARSER::PROTEIN)
    ("AG490" . SPARSER::DRUG) ("membrane protein" . SPARSER::PROTEIN)
    ("Oct-4" . SPARSER::PROTEIN) ("Lin28" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD38" . SPARSER::PROTEIN) ("CCR7" . SPARSER::PROTEIN)
    ("CCL19" . SPARSER::PROTEIN) ("CX 3" . SPARSER::PROTEIN)
    ("OCT-4" . SPARSER::PROTEIN) ("P-gp" . SPARSER::PROTEIN)
    ("CCL21" . SPARSER::PROTEIN)
    ("carboplatin[ xref ] and ixabepilone[ xref ]" . SPARSER::COLLECTION)
    ("ixabepilone" . SPARSER::DRUG)
    ("cisplatin or cisplatin" . SPARSER::COLLECTION)
    ("anti-EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("EGFR and p-EGFR" . SPARSER::COLLECTION)
    ("cMET and HGF" . SPARSER::COLLECTION)
    ("a more aggressive form" . SPARSER::FORM)
    ("HGF and cMET" . SPARSER::COLLECTION) ("favorable RFS" . SPARSER::PROTEIN)
    ("both cMET and p-cMET" . SPARSER::COLLECTION)
    ("TN and HER2" . SPARSER::COLLECTION) ("Thy" . SPARSER::MOLECULE)
    ("p-EGFR/cMET" . SPARSER::COLLECTION) ("EGFR/cMET" . SPARSER::COLLECTION)
    ("cMET and EGFR" . SPARSER::COLLECTION)
    ("EGFR, ERBB2 and insulin like growth factor 1 receptor"
     . SPARSER::COLLECTION)
    ("Ras-Erk/MAPK" . SPARSER::COLLECTION)
    ("the receptor tyrosine kinase (RTK) and its ligand" . SPARSER::COLLECTION)
    ("receptor tyrosine kinase (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HGF/SF" . SPARSER::COLLECTION) ("SF" . SPARSER::PROTEIN)
    ("neither cMET nor EGFR expression/activation" . SPARSER::COLLECTION)
    ("cMET/p-cMET" . SPARSER::COLLECTION) ("EGFR/p-EGFR" . SPARSER::COLLECTION)
    ("higher cMET and p-cMET (cMET p = 0.023;p-cMET p<0.001)"
     . SPARSER::COLLECTION)
    ("p-EGFRs" . SPARSER::COLLECTION) ("p-cMET" . SPARSER::COLLECTION)
    ("HR and TN" . SPARSER::COLLECTION)
    ("cMET and their phosphorylated proteins" . SPARSER::COLLECTION)
    ("EGFR, cMET and their phosphorylated proteins" . SPARSER::COLLECTION)
    ("EGFR and cMET" . SPARSER::COLLECTION) ("cMET" . SPARSER::PROTEIN)
    ("TGFα" . SPARSER::PROTEIN)
    ("insulin like growth factor 1 receptor" . SPARSER::PROTEIN)
    ("scatter factor" . SPARSER::PROTEIN)
    ("which targets PI3K and ATR" . SPARSER::COLLECTION)
    ("PI3K and ATR" . SPARSER::COLLECTION)
    ("both BKM-120 and the talazoparib + BKM-120 combination"
     . SPARSER::COLLECTION)
    ("talazoparib or BKM-120" . SPARSER::COLLECTION)
    ("P110α (5nm vs 52nM [ xref , xref ]) and BKM-120" . SPARSER::COLLECTION)
    ("a PARP inhibitor and a PI3K inhibitor" . SPARSER::COLLECTION)
    ("metformin" . SPARSER::DRUG) ("MO25 and STRAD" . SPARSER::COLLECTION)
    ("STRAD" . SPARSER::PROTEIN)
    ("Talazoparib and BKM-120" . SPARSER::COLLECTION)
    ("talazoparib (PARP inhibitor) and BKM-120 (PI3K inhibitor)"
     . SPARSER::COLLECTION)
    ("BKM-120 and talazoparib" . SPARSER::COLLECTION)
    ("BKM-120 or P110α" . SPARSER::COLLECTION)
    ("AKT and p-BAD (p<0.001)" . SPARSER::COLLECTION)
    ("our previously published PI3K" . SPARSER::PROTEIN-FAMILY)
    ("p-BAD" . SPARSER::COLLECTION) ("p-AMPKα" . SPARSER::COLLECTION)
    ("p-cMyc" . SPARSER::COLLECTION) ("cMyc" . SPARSER::PROTEIN)
    ("146 total or phosphorylated proteins" . SPARSER::PROTEIN)
    ("AKT2 , RICTOR , and MTOR" . SPARSER::COLLECTION)
    ("PI3Kα" . SPARSER::PROTEIN) ("ATP–an" . SPARSER::ATP)
    ("LKB1/AMPK/mTOR" . SPARSER::COLLECTION) ("available ATP" . SPARSER::ATP)
    ("ATP-intensive" . SPARSER::ATP) ("ADP-ribose (PAR)" . SPARSER::MOLECULE)
    ("pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("olaparib or rucaparib" . SPARSER::COLLECTION)
    ("Talazoparib" . SPARSER::DRUG)
    ("137 total and phosphorylated proteins" . SPARSER::PROTEIN)
    ("RPPA" . SPARSER::PROTEIN)
    ("PIK3CA , PTEN , AKT2 , AKT3 , RICTOR , or MTOR" . SPARSER::COLLECTION)
    ("RICTOR" . SPARSER::PROTEIN) ("-AKT" . SPARSER::COLLECTION)
    ("olaparib and veliparib" . SPARSER::COLLECTION)
    ("veliparib" . SPARSER::DRUG) ("poly-ADP" . SPARSER::PROTEIN)
    ("the most aggressive form" . SPARSER::FORM)
    ("talazoparib (the most potent PARP inhibitor in SCLC clinical testing) and BKM-120"
     . SPARSER::COLLECTION)
    ("talazoparib" . SPARSER::DRUG) ("cMYC" . SPARSER::PROTEIN)
    ("PARP and PI3K" . SPARSER::COLLECTION)
    ("LKB1 and its targets AMPK and TSC" . SPARSER::COLLECTION)
    ("AMPK and TSC" . SPARSER::COLLECTION)
    ("olaparib and rucaparib" . SPARSER::COLLECTION) ("BEZ235" . SPARSER::DRUG)
    ("1-8" . SPARSER::PROTEIN) ("AZD5363" . SPARSER::DRUG)
    ("αSNAP" . SPARSER::PROTEIN) ("MO25" . SPARSER::PROTEIN)
    ("BKM120" . SPARSER::DRUG) ("S21" . SPARSER::PROTEIN)
    ("p-ACC" . SPARSER::PROTEIN) ("P110" . SPARSER::PROTEIN)
    ("P110α" . SPARSER::PROTEIN) ("p-S6" . SPARSER::PROTEIN)
    ("ADP-Ribose" . SPARSER::MOLECULE) ("—3" . SPARSER::PROTEIN)
    ("PIK75" . SPARSER::DRUG) ("AG 014699" . SPARSER::DRUG)
    ("AZD2281" . SPARSER::DRUG) ("BKM-120" . SPARSER::DRUG)
    ("deafness" . SPARSER::PROTEIN) ("hypoparathyroidism" . SPARSER::PROTEIN)
    ("co-receptors or cytokine" . SPARSER::COLLECTION)
    ("non-producing" . SPARSER::PROTEIN)
    ("Gata3 and T-bet" . SPARSER::COLLECTION)
    ("Foxo1, CREB, Gata1 and Gata2" . SPARSER::COLLECTION)
    ("Itk" . SPARSER::PROTEIN) ("IFNγ-non-producing" . SPARSER::PROTEIN-PAIR)
    ("phospho-GATA3 and T-BET" . SPARSER::COLLECTION)
    ("IL-4/IFNγ" . SPARSER::COLLECTION) ("ionomycin" . SPARSER::DRUG)
    ("phorbol" . SPARSER::DRUG) ("IL-4 and IFNγ" . SPARSER::COLLECTION)
    ("Antigen" . SPARSER::PROTEIN)
    ("the Gata3 complex and the derepression" . SPARSER::COLLECTION)
    ("Gata3 and myr-Akt1" . SPARSER::COLLECTION)
    ("the unphosphorylatable Gata3 S/T-3A mutant" . SPARSER::MUTANT)
    ("Gata3/Chd4-NuRD" . SPARSER::COLLECTION) ("NuRD" . SPARSER::PROTEIN)
    ("Gata3 and Akt1" . SPARSER::COLLECTION)
    ("around 55 kDa" . SPARSER::PROTEIN)
    ("The Gata3-associated molecules" . SPARSER::MOLECULE)
    ("GST-Gata3" . SPARSER::COLLECTION)
    ("Gata3-associated molecules" . SPARSER::MOLECULE)
    ("the Gata3/Chd4-NuRD repressive complex" . SPARSER::BIO-COMPLEX)
    ("Chd4-NuRD" . SPARSER::PROTEIN-PAIR) ("Gata3/p300" . SPARSER::COLLECTION)
    ("Gata3 and S/T-3A" . SPARSER::COLLECTION)
    ("Tbx21, Ifng and Il4" . SPARSER::COLLECTION) ("Il4" . SPARSER::PROTEIN)
    ("Gata3 and Myc-tagged" . SPARSER::COLLECTION)
    ("Chd4 or Hdac2" . SPARSER::COLLECTION)
    ("Chd4 and p300" . SPARSER::COLLECTION)
    ("Hdac2 or HA-tagged p300" . SPARSER::COLLECTION)
    ("an unphosphorylatable Ala and phosphate-mimic Asp (Gata3 S/T-3A and S/T-3D, respectively)"
     . SPARSER::COLLECTION)
    ("an unphosphorylatable Ala" . SPARSER::AMINO-ACID)
    ("drosophila" . SPARSER::PROTEIN) ("Flag-Gata3" . SPARSER::COLLECTION)
    ("Chd4 and Hdac2" . SPARSER::COLLECTION)
    ("the Chd4-NuRD repressive complex" . SPARSER::BIO-COMPLEX)
    ("repressive Gata3" . SPARSER::PROTEIN)
    ("the distinct Gata3" . SPARSER::PROTEIN)
    ("repressive complexes" . SPARSER::BIO-COMPLEX)
    ("T-bet" . SPARSER::PROTEIN) ("IL-5, IL-17 or IFNγ" . SPARSER::COLLECTION)
    ("IL-4 and IL-13" . SPARSER::COLLECTION)
    ("Tbx21 and IFN γ" . SPARSER::COLLECTION)
    ("bet" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tbx21 and Ifng" . SPARSER::COLLECTION) ("Tbx21" . SPARSER::PROTEIN)
    ("Ifng" . SPARSER::PROTEIN) ("Tbx" . SPARSER::PROTEIN-FAMILY)
    ("the Gata3/Chd4 repressive complex" . SPARSER::BIO-COMPLEX)
    ("Gata3/Chd4" . SPARSER::COLLECTION) ("Hdac2" . SPARSER::PROTEIN)
    ("IL-4, IL-5 and IL-13" . SPARSER::COLLECTION) ("Thy1" . SPARSER::PROTEIN)
    ("IL12" . SPARSER::PROTEIN-FAMILY) ("TCRβ" . SPARSER::PROTEIN)
    ("Foxo1" . SPARSER::PROTEIN) ("Foxp3" . SPARSER::PROTEIN)
    ("T-BET" . SPARSER::PROTEIN) ("Histone deacetylase 2" . SPARSER::PROTEIN)
    ("Gata1" . SPARSER::PROTEIN) ("STAT6" . SPARSER::PROTEIN)
    ("IFN γ" . SPARSER::PROTEIN) ("Chd4" . SPARSER::PROTEIN)
    ("IL-13" . SPARSER::PROTEIN) ("IL-5" . SPARSER::PROTEIN)
    ("KDR, NKX2.5, c-KIT, and SSEA-1" . SPARSER::COLLECTION)
    ("either Wnt3a or LN-based matrix" . SPARSER::COLLECTION)
    ("exogenous PDGF-BB and TGF-β" . SPARSER::COLLECTION)
    ("PDGF-BB and TGF-β" . SPARSER::COLLECTION)
    ("growth factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("ISL1, NKX2.5, PDGFR-α, SSEA-1, KDR, and c-KIT" . SPARSER::COLLECTION)
    ("TnT" . SPARSER::PROTEIN) ("Expanded cardiac MSCs" . SPARSER::PROTEIN)
    ("The human fetal cardiac MSCs" . SPARSER::PROTEIN)
    ("culture matrix (Geltrex) and molecules" . SPARSER::COLLECTION)
    ("fetal cardiac MSCs" . SPARSER::PROTEIN)
    ("KDR, c-KIT, or SSEA-1" . SPARSER::COLLECTION)
    ("the mesodermal progenitor marker TBX18" . SPARSER::PROTEIN)
    ("Cardiac MSCs" . SPARSER::PROTEIN)
    ("MYH11 and myocardin ( MYOCD )" . SPARSER::COLLECTION)
    ("heavy chain (MYH)" . SPARSER::PROTEIN)
    ("MYH11 and myocardin" . SPARSER::COLLECTION) ("MYOCD" . SPARSER::PROTEIN)
    ("MYH" . SPARSER::PROTEIN)
    ("cardiogenic bone morphogenic proteins" . SPARSER::PROTEIN)
    ("the cultured cardiac MSCs" . SPARSER::PROTEIN)
    ("NKX2.5 and mesoderm" . SPARSER::COLLECTION)
    ("ISL1-GATA4" . SPARSER::COLLECTION)
    ("PDGFR-α and the stemness markers KDR , SSEA-1 , and KIT ( xref A)"
     . SPARSER::COLLECTION)
    ("mesodermal markers TBX6 , TBX1/Brachyury , and TBX18"
     . SPARSER::COLLECTION)
    ("the human fetal cardiac MSCs" . SPARSER::PROTEIN)
    ("TBX6 , TBX1/Brachyury , and TBX18" . SPARSER::COLLECTION)
    ("KDR , SSEA-1 , and KIT" . SPARSER::COLLECTION)
    ("Cultured Cardiac MSCs" . SPARSER::PROTEIN)
    ("HLA-DR and the hematopoietic lineage markers CD14" . SPARSER::COLLECTION)
    ("HLA-1" . SPARSER::COLLECTION)
    ("the fetal cardiac MSCs" . SPARSER::PROTEIN)
    ("troponin" . SPARSER::PROTEIN) ("Wnt3a or Geltrex" . SPARSER::COLLECTION)
    ("the initial adherent cell fraction" . SPARSER::COMPONENT)
    ("Dvl3" . SPARSER::PROTEIN)
    ("the cardiac progenitor markers ISL1 , KDR , and NKX2.5"
     . SPARSER::COLLECTION)
    ("ISL1 , KDR , and NKX2.5" . SPARSER::COLLECTION)
    ("Fetal Cardiac MSCs" . SPARSER::PROTEIN)
    ("The fetal cardiac MSCs" . SPARSER::PROTEIN)
    ("laminins" . SPARSER::PROTEIN-FAMILY)
    ("stage-specific embryonic antigen" . SPARSER::PROTEIN)
    ("receptor (KDR)" . SPARSER::RECEPTOR)
    ("ISL1, PDGFR-α, and NKX2.5" . SPARSER::COLLECTION)
    ("the adherent cell fraction" . SPARSER::COMPONENT)
    ("this study cardiac MSCs" . SPARSER::PROTEIN)
    ("cardiac MSCs" . SPARSER::PROTEIN)
    ("TBX5 as well as NKX2.5 ( xref , xref )" . SPARSER::COLLECTION)
    ("SHF" . SPARSER::PROTEIN) ("human fetal cardiac MSCs" . SPARSER::PROTEIN)
    ("the cardiac MSCs" . SPARSER::PROTEIN)
    ("PDGFR-α, ISL1, and NKX2.5" . SPARSER::COLLECTION)
    ("TBX18, KDR, c-KIT, and SSEA-1" . SPARSER::COLLECTION)
    ("laminin (LN)" . SPARSER::PROTEIN)
    ("ISL1 , OCT4 , KDR , and NKX2.5" . SPARSER::COLLECTION)
    ("I.E.S" . SPARSER::MOLECULE)
    ("endothelial differentiation" . SPARSER::PROTEIN)
    ("Fluo-4" . SPARSER::DRUG) ("MYH11" . SPARSER::PROTEIN)
    ("VCAM1" . SPARSER::PROTEIN) ("MESP1" . SPARSER::PROTEIN)
    ("FGF8" . SPARSER::PROTEIN) ("FOXH1" . SPARSER::PROTEIN)
    ("TBX1" . SPARSER::PROTEIN) ("TBX6" . SPARSER::PROTEIN)
    ("TNNT2" . SPARSER::PROTEIN) ("FLK1" . SPARSER::PROTEIN)
    ("derived growth factor receptor-alpha" . SPARSER::PROTEIN)
    ("Islet-1" . SPARSER::PROTEIN) ("TBX5" . SPARSER::PROTEIN)
    ("HCN4" . SPARSER::PROTEIN) ("SSEA-1" . SPARSER::PROTEIN)
    ("c-KIT" . SPARSER::PROTEIN) ("TBX18" . SPARSER::PROTEIN)
    ("NKX2.5" . SPARSER::PROTEIN) ("ISL1" . SPARSER::PROTEIN)
    ("cardiac muscle" . SPARSER::PROTEIN)
    ("C/EBPα and EGFR/β-catenin" . SPARSER::COLLECTION)
    ("the adherent junction complex" . SPARSER::BIO-COMPLEX)
    ("EGFR, and β-catenin" . SPARSER::COLLECTION)
    ("N-cadherin, Slug, and Vimentin" . SPARSER::COLLECTION)
    ("C/EBPα and promoter" . SPARSER::COLLECTION)
    ("c-Myc, Axin2, CCDN1, and Lgr5" . SPARSER::COLLECTION)
    ("EGFR, ADAM17 and β-catenin" . SPARSER::COLLECTION)
    ("CTNNB1 (encoding β-catenin) and EGFR" . SPARSER::COLLECTION)
    ("EGFR and β-catenin" . SPARSER::COLLECTION)
    ("N-Cadherin, Slug, and Vimentin" . SPARSER::COLLECTION)
    ("C/EBPα and albumin" . SPARSER::COLLECTION)
    ("Hematoxylin and eosin staining" . SPARSER::COLLECTION)
    ("generated short-activating RNAs (saRNA) molecules" . SPARSER::MOLECULE)
    ("cirrhosis/HCC" . SPARSER::COLLECTION)
    ("EGFR/β-catenin" . SPARSER::COLLECTION)
    ("glutamic-oxalacetic transaminase (AST)" . SPARSER::PROTEIN)
    ("aminotransferase (ALT)" . SPARSER::PROTEIN)
    ("short-activating RNAs" . SPARSER::RNA) ("saRNA" . SPARSER::DRUG)
    ("CCAAT" . SPARSER::PROTEIN) ("ZBTB7" . SPARSER::PROTEIN)
    ("nuclease activity" . SPARSER::PROTEIN)
    ("ADAM metallopeptidase domain 17" . SPARSER::PROTEIN)
    ("G-protein coupled receptor 5" . SPARSER::PROTEIN)
    ("Axin2" . SPARSER::PROTEIN)
    ("Axis inhibition protein 2" . SPARSER::PROTEIN)
    ("β-catenin and AXIN2" . SPARSER::COLLECTION)
    ("an active regulator" . SPARSER::REGULATOR)
    ("EDN1, CYP19A1, HMOX1, WT1, and BIRC2" . SPARSER::COLLECTION)
    ("MYC , WT1 , BIRC2 , IL-9 , HMOX1 , and TERT" . SPARSER::COLLECTION)
    ("IKK-NF-κB" . SPARSER::COLLECTION)
    ("CREB and its co-activators" . SPARSER::COLLECTION)
    ("valproate" . SPARSER::DRUG) ("/p300" . SPARSER::COLLECTION)
    ("GSK-3α or cyclin B1" . SPARSER::COLLECTION)
    ("cyclin A2, cyclin B1, cyclin D1, and cyclin E2" . SPARSER::COLLECTION)
    ("siRNAs or shRNAs" . SPARSER::COLLECTION) ("forskolin" . SPARSER::PROTEIN)
    ("NS-1, NS-2, and NS-3" . SPARSER::COLLECTION)
    ("antibody and IgG" . SPARSER::COLLECTION)
    ("GSK-3α or GSK-3β" . SPARSER::COLLECTION)
    ("GSK-3 or GSK-3β" . SPARSER::COLLECTION)
    ("GSK-3α and GSK-3β" . SPARSER::COLLECTION)
    ("tracheobronchial" . SPARSER::PROTEIN)
    ("The transcription factor cyclic AMP-response element-binding protein (CREB)"
     . SPARSER::PROTEIN)
    ("CREB-GSK-3α" . SPARSER::COLLECTION)
    ("cyclic AMP-response element-binding protein (CREB)" . SPARSER::PROTEIN)
    ("CYP19A1" . SPARSER::PROTEIN) ("HMOX1" . SPARSER::PROTEIN)
    ("IL-9" . SPARSER::PROTEIN) ("MEIS1" . SPARSER::PROTEIN)
    ("NS-3" . SPARSER::PROTEIN) ("NS-1" . SPARSER::PROTEIN)
    ("CREB binding" . SPARSER::PROTEIN-FAMILY) ("GSK3A" . SPARSER::PROTEIN)
    ("GSK-3α" . SPARSER::PROTEIN) ("relevant genes" . SPARSER::GENE)
    ("MTNR1B , GCK , and SLC30A8" . SPARSER::COLLECTION)
    ("TCF7L2 and ADRA2A" . SPARSER::COLLECTION)
    ("TCF7L2 , ADRA2A , CDKN2A/B , and GRB10" . SPARSER::COLLECTION)
    ("CDKAL1 and ADCY5" . SPARSER::COLLECTION)
    ("TCF7L2 , ADCY5 , CDKAL1 , ADRA2A , CDKN2A/B , and GRB10"
     . SPARSER::COLLECTION)
    ("KL" . SPARSER::PROTEIN) ("FAMILY" . SPARSER::PROTEIN-FAMILY)
    ("MTNR1B , GCK , G6PC2 , and SLC30A8 and FPG" . SPARSER::COLLECTION)
    ("SLC30A8 and FPG" . SPARSER::COLLECTION) ("GCK" . SPARSER::PROTEIN)
    ("glucose (FPG)" . SPARSER::MOLECULE) ("FPG" . SPARSER::PROTEIN-FAMILY)
    ("ADCY5 , ADRA2A , CDKAL1 , CDKN2A/B , GRB10 , and TCF7L2"
     . SPARSER::COLLECTION)
    ("GLIS3" . SPARSER::PROTEIN) ("SLC30A8" . SPARSER::PROTEIN)
    ("G6PC2" . SPARSER::PROTEIN) ("MTNR1B" . SPARSER::PROTEIN)
    ("TCF7L2" . SPARSER::PROTEIN) ("GRB10" . SPARSER::PROTEIN)
    ("CDKAL1" . SPARSER::PROTEIN) ("ADRA2A" . SPARSER::PROTEIN)
    ("ADCY5" . SPARSER::PROTEIN) ("senolytic drugs" . SPARSER::DRUG)
    ("polysome" . SPARSER::BIO-COMPLEX) ("/CD49f" . SPARSER::COLLECTION)
    ("K5-rtTA/tet-p14" . SPARSER::COLLECTION) ("tet" . SPARSER::PROTEIN)
    ("ABT-737, BCL-XL and BCL-W" . SPARSER::COLLECTION)
    ("Fluc/Rluc" . SPARSER::COLLECTION) ("Rluc" . SPARSER::PROTEIN)
    ("BCL-W and BCL-XL protein" . SPARSER::COLLECTION)
    ("BCL-W or BCL-XL protein" . SPARSER::COLLECTION)
    ("translation initiation factor 4E-binding proteins (4EBPs) and S6 kinases (S6K1 and S6K2)"
     . SPARSER::COLLECTION)
    ("S6K1 and S6K2" . SPARSER::COLLECTION)
    ("heavier polysomal fractions" . SPARSER::COMPONENT)
    ("the ribosomal fractions" . SPARSER::COMPONENT)
    ("GAPDH and actin" . SPARSER::COLLECTION)
    ("the different ribosomal fractions" . SPARSER::COMPONENT)
    ("polyribosomes" . SPARSER::BIO-COMPLEX)
    ("BCL-XL and BCL-W" . SPARSER::COLLECTION)
    ("BCL-W or BCL-XL" . SPARSER::COLLECTION) ("Obatoclax" . SPARSER::DRUG)
    ("obatoclax" . SPARSER::DRUG) ("PARP and caspase-3" . SPARSER::COLLECTION)
    ("BCL-W, BCL-XL and BCl-2" . SPARSER::COLLECTION)
    ("BCL-2, BCL-XL and BCL-W" . SPARSER::COLLECTION)
    ("BCL-W, BCL-XL and BCL-2" . SPARSER::COLLECTION)
    ("BCL-W, BCL-XL, BCL-2 and MCL-1" . SPARSER::COLLECTION)
    ("the essential regulators" . SPARSER::REGULATOR)
    ("polymerase (PARP)" . SPARSER::PROTEIN) ("ICAD" . SPARSER::PROTEIN)
    ("DIS" . SPARSER::PROTEIN)
    ("BCL-2, BCL-W and BCL-XL" . SPARSER::COLLECTION)
    ("siRNAs or the small-molecule ABT-737" . SPARSER::COLLECTION)
    ("BCL-W and BCL-XL" . SPARSER::COLLECTION) ("CK14" . SPARSER::PROTEIN)
    ("K14" . SPARSER::PROTEIN) ("G15" . SPARSER::PROTEIN)
    ("p14  ARF" . SPARSER::PROTEIN) ("K5" . SPARSER::PROTEIN)
    ("S6K2" . SPARSER::PROTEIN) ("S6 kinases" . SPARSER::PROTEIN-FAMILY)
    ("4EBPs" . SPARSER::PROTEIN) ("initiation factor 4E" . SPARSER::PROTEIN)
    ("BCL-XL protein" . SPARSER::PROTEIN) ("ABT-737-" . SPARSER::DRUG)
    ("caspase-activated DNase" . SPARSER::PROTEIN)
    ("p14 ARF" . SPARSER::PROTEIN) ("BCL-W" . SPARSER::PROTEIN)
    ("a multipotent state" . SPARSER::BIO-STATE)
    ("lineage-specific genes" . SPARSER::GENE)
    ("negative downstream mediators" . SPARSER::PROTEIN)
    ("LMO2 , MEF2C , TAL1 , PU1 and BCL11A" . SPARSER::COLLECTION)
    ("incompletely knocked-down GATA3" . SPARSER::PROTEIN)
    ("ETP" . SPARSER::PROTEIN) ("at least parts" . SPARSER::COMPONENT)
    ("TCF7 and BCL11B" . SPARSER::COLLECTION)
    ("essential genes" . SPARSER::GENE)
    ("GATA3 and DTX1" . SPARSER::COLLECTION)
    ("Notch-triggered CD34 + CD1" . SPARSER::PROTEIN)
    ("RASAL1 and OAS2" . SPARSER::COLLECTION)
    ("MEF2C , ETV5 , VPREB , LMO2 and TCF4" . SPARSER::COLLECTION)
    ("CD7 and LYL1" . SPARSER::COLLECTION)
    ("IGLL1 (coding for lamba5) and ETV6" . SPARSER::COLLECTION)
    ("RUNX3 , IGLL1 (coding for lamba5) and ETV6" . SPARSER::COLLECTION)
    ("early Notch-dependent genes" . SPARSER::GENE)
    ("ID2 , IL7RA and MYC" . SPARSER::COLLECTION) ("CD300A" . SPARSER::PROTEIN)
    ("ID2 and RUNX3" . SPARSER::COLLECTION)
    ("TCF7 , DNTT , IKZF2 , BCL11B and TCF12" . SPARSER::COLLECTION)
    ("RUNX1 and ETS1" . SPARSER::COLLECTION)
    ("NFIL3, NCAM1, GZMB and GZMH" . SPARSER::COLLECTION)
    ("GZMH" . SPARSER::PROTEIN) ("GZMB" . SPARSER::PROTEIN)
    ("FcERI" . SPARSER::PROTEIN) ("mast cell" . SPARSER::PROTEIN)
    ("bright" . SPARSER::PROTEIN) ("dim" . SPARSER::PROTEIN-FAMILY)
    ("LMO2 , MEF2C and SPI1" . SPARSER::COLLECTION)
    ("DTX1 ( xref and xref and xref ) and RUNX3 ( xref )"
     . SPARSER::COLLECTION)
    ("MYC and HES1" . SPARSER::COLLECTION) ("DNTT" . SPARSER::PROTEIN)
    ("-s-phenyl-glycine" . SPARSER::COLLECTION)
    ("these Notch-dependent genes" . SPARSER::GENE)
    ("the most significant Notch-dependent genes" . SPARSER::GENE)
    ("IGFR1 and RUNX3" . SPARSER::COLLECTION)
    ("DTX1 and NRARP" . SPARSER::COLLECTION)
    ("TCF7 and GATA3" . SPARSER::COLLECTION)
    ("DTX1 and HES1" . SPARSER::COLLECTION)
    ("GATA3 and TCF7" . SPARSER::COLLECTION)
    ("the most immature human CD34 + CD1a" . SPARSER::PROTEIN)
    ("simultaneous GATA3" . SPARSER::PROTEIN)
    ("DTX1 , NOTCH3 , CD3E , RUNX3 , IL7R and TCF7" . SPARSER::COLLECTION)
    ("CD3E" . SPARSER::PROTEIN) ("Exogenous GATA3" . SPARSER::PROTEIN)
    ("Notch target genes as well as T-cell genes" . SPARSER::COLLECTION)
    ("HES1 , DTX1 and TCF7" . SPARSER::COLLECTION)
    ("human child thymus-derived intrathymic CD34 + CD1" . SPARSER::PROTEIN)
    ("HES1 and DTX1" . SPARSER::COLLECTION) ("CD1" . SPARSER::PROTEIN)
    ("DLL1, DLL4 or JAG2" . SPARSER::COLLECTION)
    ("two essential regulatory proteins" . SPARSER::PROTEIN)
    ("TCF1 and GATA3" . SPARSER::COLLECTION)
    ("NRARP and DTX1" . SPARSER::COLLECTION)
    ("HES1 and MYC" . SPARSER::COLLECTION) ("NRARP" . SPARSER::PROTEIN)
    ("DP" . SPARSER::PROTEIN) ("TPSAB1" . SPARSER::PROTEIN)
    ("FLT3-L" . SPARSER::PROTEIN)
    ("FMS-like tyrosine kinase 3" . SPARSER::PROTEIN)
    ("p8" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD28" . SPARSER::PROTEIN)
    ("BCL11A" . SPARSER::PROTEIN) ("PU1" . SPARSER::PROTEIN)
    ("TAL1" . SPARSER::PROTEIN) ("IL2RG" . SPARSER::PROTEIN)
    ("IL7" . SPARSER::PROTEIN) ("LYL1" . SPARSER::PROTEIN)
    ("ETV6" . SPARSER::PROTEIN) ("IGLL1" . SPARSER::PROTEIN)
    ("IL7RA" . SPARSER::PROTEIN) ("IRp60" . SPARSER::PROTEIN)
    ("GATA-3" . SPARSER::PROTEIN) ("NCAM1" . SPARSER::PROTEIN)
    ("repressor of GATA" . SPARSER::PROTEIN) ("IL15" . SPARSER::PROTEIN)
    ("ID2" . SPARSER::PROTEIN) ("EBF1" . SPARSER::PROTEIN)
    ("CD79A" . SPARSER::PROTEIN) ("SPI1" . SPARSER::PROTEIN)
    ("LMO2" . SPARSER::PROTEIN) ("TCF12" . SPARSER::PROTEIN)
    ("BCL11B" . SPARSER::PROTEIN) ("GFI1B" . SPARSER::PROTEIN)
    ("IKZF2" . SPARSER::PROTEIN) ("t-butyl" . SPARSER::MOLECULE)
    ("IGFR1" . SPARSER::PROTEIN) ("CD1a" . SPARSER::PROTEIN)
    ("NOTCH3" . SPARSER::PROTEIN) ("TCF7" . SPARSER::PROTEIN)
    ("JAG2" . SPARSER::PROTEIN) ("DLL4" . SPARSER::PROTEIN)
    ("HLA-DR" . SPARSER::PROTEIN) ("CD7" . SPARSER::PROTEIN)
    ("CD5" . SPARSER::PROTEIN) ("Jagged2" . SPARSER::PROTEIN)
    ("DLL1" . SPARSER::PROTEIN) ("Delta-" . SPARSER::PROTEIN)
    ("E-protein" . SPARSER::PROTEIN) ("DTX1" . SPARSER::PROTEIN)
    ("an excellent biomarker" . SPARSER::MOLECULE)
    ("p110α/p110β" . SPARSER::COLLECTION) ("p110α/IGF1R" . SPARSER::COLLECTION)
    ("AMG" . SPARSER::PROTEIN) ("RAF and RAS" . SPARSER::COLLECTION)
    ("PI3K and IGF1R" . SPARSER::COLLECTION) ("IGFR" . SPARSER::PROTEIN)
    ("G protein coupled receptor (GPCR)" . SPARSER::PROTEIN)
    ("AKT and mTOR" . SPARSER::COLLECTION)
    ("mTORC [ xref ] or CDK4/6 [ xref ]" . SPARSER::COLLECTION)
    ("dual PI3K/mTOR inhibitors" . SPARSER::INHIBITOR)
    ("BCL2, epidermal growth factor, and IGF1R" . SPARSER::COLLECTION)
    ("MEK/ERK/RSK" . SPARSER::COLLECTION)
    ("appropriate biomarkers" . SPARSER::MOLECULE)
    ("α-specific PI3K inhibitors" . SPARSER::INHIBITOR)
    ("dual PI3K/mTOR or pan-PI3K inhibitors" . SPARSER::INHIBITOR)
    ("the most attractive therapeutic targets and numerous inhibitors"
     . SPARSER::COLLECTION)
    ("the most attractive therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("IRS/p110β/p85" . SPARSER::COLLECTION) ("p110β/p85" . SPARSER::COLLECTION)
    ("p85 and IRS" . SPARSER::COLLECTION)
    ("IGF1R/IRS/p85" . SPARSER::COLLECTION)
    ("IRS and p85" . SPARSER::COLLECTION) ("kinases (SFK)" . SPARSER::PROTEIN)
    ("IGF1R, p110β, PDK1, AKT, or mTOR" . SPARSER::COLLECTION)
    ("p110δ, MEK, or Src" . SPARSER::COLLECTION)
    ("p110α and IGF1R" . SPARSER::COLLECTION)
    ("PI and Annexin V" . SPARSER::COLLECTION)
    ("BYL719 and the IGF1R inhibitor AEW541" . SPARSER::COLLECTION)
    ("IRS1, IRS2 and p85" . SPARSER::COLLECTION)
    ("IGF1R/IRS" . SPARSER::COLLECTION)
    ("IRS1, IRS2, or p85" . SPARSER::COLLECTION)
    ("IRS1 and IRS2" . SPARSER::COLLECTION)
    ("IGF1R, IRS1, IRS2, and p85" . SPARSER::COLLECTION)
    ("IGF1R, IRS, and p85" . SPARSER::COLLECTION)
    ("/S6K" . SPARSER::COLLECTION)
    ("AKT/mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("molecules and pathways" . SPARSER::COLLECTION)
    ("PI3K α-specific inhibitors" . SPARSER::INHIBITOR)
    ("the α-specific inhibitor BYL719" . SPARSER::DRUG)
    ("Isoform" . SPARSER::ISOFORM) ("PDK1 and AKT" . SPARSER::COLLECTION)
    ("p110α and p110β" . SPARSER::COLLECTION)
    ("the regulatory p85" . SPARSER::PROTEIN) ("IA" . SPARSER::MOLECULE)
    ("IGF1R or p110β" . SPARSER::COLLECTION)
    ("IGF1R/p110β/AKT/mTOR" . SPARSER::COLLECTION)
    ("mTOR/S6K" . SPARSER::COLLECTION) ("AKT/mTOR/S6K" . SPARSER::COLLECTION)
    ("IGF1R/IRS/p85/p110β" . SPARSER::COLLECTION)
    ("IRS1/IRS2" . SPARSER::COLLECTION)
    ("G protein coupled receptor" . SPARSER::PROTEIN)
    ("PRAS40" . SPARSER::PROTEIN) ("GSK2636771" . SPARSER::DRUG)
    ("Reducing Agent" . SPARSER::MOLECULE) ("TiO 2" . SPARSER::MOLECULE)
    ("CAL101" . SPARSER::DRUG) ("GSK2334470" . SPARSER::DRUG)
    ("AZD6482" . SPARSER::DRUG) ("MEK162" . SPARSER::DRUG)
    ("RAD001" . SPARSER::DRUG) ("pERK1/2" . SPARSER::PROTEIN)
    ("pS6" . SPARSER::PROTEIN) ("p110" . SPARSER::PROTEIN)
    ("PI3Ks" . SPARSER::PROTEIN) ("IRS2" . SPARSER::PROTEIN)
    ("Arf6 and AMAP1" . SPARSER::COLLECTION)
    ("therapeutics and perhaps" . SPARSER::COLLECTION)
    ("A genotype (12%) and the luminal B genotype (29%; xref )"
     . SPARSER::COLLECTION)
    ("Arf6 and its signaling proteins" . SPARSER::COLLECTION)
    ("EPB41L5 and HMGCR" . SPARSER::COLLECTION)
    ("GEP100 , Arf6 , AMAP1 , EPB41L5 , and EGFR" . SPARSER::COLLECTION)
    ("Gemcitabine and Temsirolimus" . SPARSER::COLLECTION)
    ("Temsirolimus" . SPARSER::DRUG)
    ("mesenchymal-specific EPB41L5" . SPARSER::PROTEIN)
    ("mesenchymal genes" . SPARSER::GENE)
    ("MVP and Rab11b" . SPARSER::COLLECTION)
    ("MVP and Rab11" . SPARSER::COLLECTION)
    ("sphingolipids" . SPARSER::MOLECULE) ("SREBP" . SPARSER::PROTEIN-FAMILY)
    ("the detergent-insoluble membrane fraction" . SPARSER::COMPONENT)
    ("the soluble fraction" . SPARSER::COMPONENT)
    ("HA-Rab11b" . SPARSER::COLLECTION) ("detergent" . SPARSER::MOLECULE)
    ("Triton" . SPARSER::MOLECULE) ("Arf6-EGFP" . SPARSER::COLLECTION)
    ("Rab11a and Rab11b" . SPARSER::COLLECTION)
    ("Rab3b or Rab7b" . SPARSER::COLLECTION)
    ("TGFβ1, HGF, and EGF" . SPARSER::COLLECTION)
    ("Rab3b, Rab5c, Rab7b, Rab11a, and Rab11b" . SPARSER::COLLECTION)
    ("Rab3b" . SPARSER::PROTEIN) ("external ligands" . SPARSER::LIGAND)
    ("FTI" . SPARSER::DRUG) ("GGTI" . SPARSER::PROTEIN)
    ("GGT and farnesyl" . SPARSER::COLLECTION) ("GGT" . SPARSER::PROTEIN)
    ("MVP as well as mutant p53" . SPARSER::COLLECTION)
    ("p53 and geranylgeranyl" . SPARSER::COLLECTION)
    ("decarboxylase" . SPARSER::PROTEIN) ("Mevastatin" . SPARSER::DRUG)
    ("Simvastatin" . SPARSER::DRUG) ("RTKs and Akt" . SPARSER::COLLECTION)
    ("EGF and HGF" . SPARSER::COLLECTION)
    ("These exogenous p53 proteins" . SPARSER::PROTEIN)
    ("normal p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Met and GEP100" . SPARSER::COLLECTION)
    ("Gab1 and c-Met" . SPARSER::COLLECTION)
    ("Arf6 and its signaling components" . SPARSER::COLLECTION)
    ("the mesenchymal-specific EPB41L5" . SPARSER::PROTEIN)
    ("The small GTPase Arf6 and its signaling proteins" . SPARSER::COLLECTION)
    ("SREBP-1 and SREBP-2" . SPARSER::COLLECTION)
    ("fatty acid and sterol" . SPARSER::COLLECTION) ("statins" . SPARSER::DRUG)
    ("HMGCR" . SPARSER::PROTEIN) ("Statins" . SPARSER::MOLECULE)
    ("Ras and Rho family" . SPARSER::COLLECTION)
    ("Arf6 and mesenchymal proteins" . SPARSER::COLLECTION)
    ("mesenchymal proteins" . SPARSER::PROTEIN)
    ("MVP and GGT-II" . SPARSER::COLLECTION)
    ("Arf6 and components" . SPARSER::COLLECTION)
    ("GGT-II and Rab11b" . SPARSER::COLLECTION) ("MVP" . SPARSER::PROTEIN)
    ("Flotillin-1" . SPARSER::PROTEIN) ("G protein–coupled" . SPARSER::PROTEIN)
    ("Rab25" . SPARSER::PROTEIN) ("Rab11c" . SPARSER::PROTEIN)
    ("Rab11a" . SPARSER::PROTEIN) ("Rab5c" . SPARSER::PROTEIN)
    ("Rab3" . SPARSER::PROTEIN) ("Rab family" . SPARSER::PROTEIN)
    ("p53s" . SPARSER::HUMAN-PROTEIN-FAMILY) ("1 L" . SPARSER::PROTEIN)
    ("1 K" . SPARSER::PROTEIN) ("E–H" . SPARSER::PROTEIN)
    ("PHA665752" . SPARSER::MOLECULE) ("EPB41L5" . SPARSER::PROTEIN)
    ("AMAP1" . SPARSER::PROTEIN) ("EFA6" . SPARSER::PROTEIN)
    ("BRAG2" . SPARSER::PROTEIN) ("GEP100" . SPARSER::PROTEIN)
    ("SREBP-2" . SPARSER::PROTEIN) ("SREBP-1" . SPARSER::PROTEIN)
    ("Rab11b" . SPARSER::PROTEIN) ("GGT-II" . SPARSER::DRUG)
    ("Rab11" . SPARSER::PROTEIN) ("TNF-α or BI-D1870" . SPARSER::COLLECTION)
    ("ROS, and ROS" . SPARSER::COLLECTION)
    ("rapidly screen combination therapeutics" . SPARSER::THERAPEUTICS)
    ("functional TNF-α" . SPARSER::PROTEIN)
    ("the N-terminal 298 amino acids of p47 phox" . SPARSER::PROTEIN)
    ("TL32711 and BI-D1870" . SPARSER::COLLECTION)
    ("CD44 and c-Kit" . SPARSER::COLLECTION)
    ("N-terminal 298 amino acids of p47 phox fused" . SPARSER::PROTEIN)
    ("GST-" . SPARSER::PROTEIN) ("BI-D1870 or TNF-α" . SPARSER::COLLECTION)
    ("GST-p47 phox" . SPARSER::COLLECTION)
    ("caspase-3 and caspase-8" . SPARSER::COLLECTION)
    ("BI-D1870 and TNF-α" . SPARSER::COLLECTION)
    ("TNF-α or TL-32711" . SPARSER::COLLECTION)
    ("TNF-α and BI-D1870" . SPARSER::COLLECTION) ("Smac" . SPARSER::PROTEIN)
    ("Neutrophils" . SPARSER::PROTEIN) ("BCG" . SPARSER::DRUG)
    ("muscle invasive subtypes" . SPARSER::PROTEIN)
    ("ROS and the PKC-ζ" . SPARSER::COLLECTION) ("p47phox" . SPARSER::PROTEIN)
    ("CL4" . SPARSER::PROTEIN) ("FL-1" . SPARSER::PROTEIN)
    ("IGFBP-3" . SPARSER::PROTEIN) ("PAK-1" . SPARSER::PROTEIN)
    ("TL32711" . SPARSER::DRUG) ("p26" . SPARSER::PROTEIN)
    ("Non-muscle" . SPARSER::PROTEIN) ("p47 phox" . SPARSER::PROTEIN)
    ("14 eligible studies met" . SPARSER::AMINO-ACID)
    ("K63" . SPARSER::PROTEIN) ("par-4" . SPARSER::PROTEIN)
    ("serine/threonine kinase 11" . SPARSER::PROTEIN)
    ("triple point mutant ERα" . SPARSER::PROTEIN) ("EDCs" . SPARSER::MOLECULE)
    ("dendrimer" . SPARSER::MOLECULE) ("AMPK and eNOS" . SPARSER::COLLECTION)
    ("Akt and ERK" . SPARSER::COLLECTION) ("Ctrl-hECs" . SPARSER::COLLECTION)
    ("striatin-ER" . SPARSER::COLLECTION)
    ("inhibitors or activators" . SPARSER::COLLECTION)
    ("FOXO [ xref ] and SRF [ xref , xref ]" . SPARSER::COLLECTION)
    ("MEF2 [ xref – xref ] and TBP [ xref , xref ]" . SPARSER::COLLECTION)
    ("TBP" . SPARSER::PROTEIN) ("PTGS2/Cyclooxygenase 2" . SPARSER::COLLECTION)
    ("phosphofructokinase" . SPARSER::PROTEIN) ("PDGFB" . SPARSER::PROTEIN)
    ("ERα and ERβ" . SPARSER::COLLECTION)
    ("ER and the critical adaptor molecule striatin [ xref ]"
     . SPARSER::COLLECTION)
    ("inflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("inflammatory cytokines and adhesion molecules (mRNA and protein)"
     . SPARSER::COLLECTION)
    ("CEBP and SRF" . SPARSER::COLLECTION) ("SRF" . SPARSER::PROTEIN)
    ("CEBP" . SPARSER::PROTEIN) ("too few downregulated genes" . SPARSER::GENE)
    ("Ctrl or KRR" . SPARSER::COLLECTION) ("only 10 genes" . SPARSER::GENE)
    ("bearing KRR mutant ERα" . SPARSER::PROTEIN) ("hECs" . SPARSER::PROTEIN)
    ("Akt, ERK and eNOS" . SPARSER::COLLECTION)
    ("ERα:striatin" . SPARSER::BIO-COMPLEX)
    ("ERα as well as ERβ" . SPARSER::COLLECTION) ("wire" . SPARSER::PROTEIN)
    ("ERα and ERβ and striatin" . SPARSER::COLLECTION)
    ("ERβ and striatin" . SPARSER::COLLECTION)
    ("ERα or ERβ" . SPARSER::COLLECTION) ("ER-striatin" . SPARSER::COLLECTION)
    ("striatin" . SPARSER::PROTEIN)
    ("c-Src, PI3-kinase, Akt and ERK1/2" . SPARSER::COLLECTION)
    ("cellular ERα" . SPARSER::PROTEIN)
    ("a central pathophysiologic component" . SPARSER::COMPONENT)
    ("vascular SMCs" . SPARSER::PROTEIN) ("SMCs" . SPARSER::PROTEIN)
    ("cytokines and neutrophil" . SPARSER::COLLECTION)
    ("GPR30" . SPARSER::PROTEIN) ("Ly294002" . SPARSER::MOLECULE)
    ("Cyclooxygenase 2" . SPARSER::PROTEIN) ("ICI182780" . SPARSER::DRUG)
    ("estrogen-receptor" . SPARSER::PROTEIN) ("MEF2A" . SPARSER::PROTEIN)
    ("MEF2" . SPARSER::PROTEIN) ("RGS4" . SPARSER::PROTEIN)
    ("PTGS2" . SPARSER::PROTEIN) ("HAVCR2" . SPARSER::PROTEIN)
    ("COS1" . SPARSER::PROTEIN) ("ERβ" . SPARSER::PROTEIN)
    ("β estradiol" . SPARSER::MOLECULE) ("Drugs" . SPARSER::DRUG)
    ("Yan and Shao" . SPARSER::COLLECTION) ("Yan" . SPARSER::PROTEIN)
    ("siRNA-ILK" . SPARSER::COLLECTION) ("slug and Zeb1" . SPARSER::COLLECTION)
    ("kinase (ILK)" . SPARSER::KINASE)
    ("a secretory extracellular matrix protein" . SPARSER::PROTEIN)
    ("Periostin" . SPARSER::PROTEIN) ("ILK-Akt" . SPARSER::COLLECTION)
    ("slug, Zeb1, N-cadherin, and vimentin" . SPARSER::COLLECTION)
    ("slug, and Zeb1" . SPARSER::COLLECTION) ("Zeb1" . SPARSER::PROTEIN)
    ("Zeb" . SPARSER::PROTEIN) ("slug" . SPARSER::PROTEIN)
    ("periostin" . SPARSER::PROTEIN)
    ("the candidate drugs as well as candidate drugs" . SPARSER::COLLECTION)
    ("known antidiabetic drugs" . SPARSER::DRUG)
    ("predicted ideal antidiabetic drugs" . SPARSER::DRUG)
    ("bioavailable oral drugs" . SPARSER::DRUG)
    ("potential oral antidiabetic drug" . SPARSER::DRUG)
    ("Glut-4" . SPARSER::PROTEIN)
    ("the active site amino acid of the IR (Figures xref , xref , and xref )"
     . SPARSER::PROTEIN)
    ("antidiabetic drugs" . SPARSER::DRUG)
    ("Importantly no drug" . SPARSER::DRUG) ("IR protein's" . SPARSER::PROTEIN)
    ("ligands and chains" . SPARSER::COLLECTION)
    ("IR protein and all the six drugs" . SPARSER::COLLECTION)
    ("the novel antidiabetic drugs" . SPARSER::DRUG)
    ("ligand and ADMET" . SPARSER::COLLECTION) ("epoxide" . SPARSER::MOLECULE)
    ("effective antidiabetic drugs" . SPARSER::DRUG)
    ("insulin receptor and candidate drugs [ xref , xref – xref , xref – xref ]"
     . SPARSER::COLLECTION)
    ("type 1 and type 2" . SPARSER::COLLECTION)
    ("VII and Gymnemoside" . SPARSER::COLLECTION) ("VII" . SPARSER::PROTEIN)
    ("strong IR activators" . SPARSER::ACTIVATOR) ("salts" . SPARSER::DRUG)
    ("insulin receptor (IR)" . SPARSER::PROTEIN)
    ("Chronic hyperglycemia" . SPARSER::PROTEIN) ("sugar" . SPARSER::MOLECULE)
    ("new therapeutics and alternatives" . SPARSER::COLLECTION)
    ("the active site amino acids of IR" . SPARSER::PROTEIN)
    ("NO 2" . SPARSER::MOLECULE) ("protein 3" . SPARSER::PROTEIN)
    ("GS4" . SPARSER::PROTEIN) ("β -cell" . SPARSER::PROTEIN)
    ("Type 1" . SPARSER::PROTEIN) ("β  2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the inferior parietal lobe" . SPARSER::PROTEIN)
    ("subregions" . SPARSER::PROTEIN) ("lobe" . SPARSER::PROTEIN)
    ("LTP" . SPARSER::PROTEIN)
    ("fibrillarin and other nucleolar proteins" . SPARSER::COLLECTION)
    ("PARP-1 and fibrillarin" . SPARSER::COLLECTION)
    ("dentate" . SPARSER::PROTEIN)
    ("hippocampal regions CA1–4" . SPARSER::PROTEIN)
    ("nucleolar PARP-1" . SPARSER::PROTEIN)
    ("CA1 and CA4" . SPARSER::COLLECTION)
    ("immediate early genes [ xref ] and ribosomal RNA genes (rDNAs)"
     . SPARSER::COLLECTION)
    ("ribosomal RNA genes" . SPARSER::GENE)
    ("polymerases, ligases, and histones" . SPARSER::COLLECTION)
    ("extracellular beta-amyloid" . SPARSER::PROTEIN)
    ("both PARP-1 and the nucleolar marker fibrillarin" . SPARSER::COLLECTION)
    ("the nucleolar marker fibrillarin" . SPARSER::PROTEIN)
    ("Nucleolar PARP-1" . SPARSER::PROTEIN) ("anti-PAR" . SPARSER::DRUG)
    ("beta-amyloid" . SPARSER::PROTEIN)
    ("an mTOR 1/2 dual inhibitor" . SPARSER::INHIBITOR)
    ("polyubiquitinated" . SPARSER::PROTEIN)
    ("Polyubiquitination" . SPARSER::PROTEIN)
    ("TGase 2 and p53" . SPARSER::COLLECTION)
    ("doxorubicin (1 mg/kg/day) and GK921 (2 mg/kg/day)" . SPARSER::COLLECTION)
    ("a possible therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("the triple complex" . SPARSER::BIO-COMPLEX)
    ("p53–TGase 2–p62" . SPARSER::COLLECTION)
    ("SQSTM1 and TGM2" . SPARSER::COLLECTION)
    ("5-FU (8 mg/kg/day) and sorafenib (15 mg/kg/day)" . SPARSER::COLLECTION)
    ("doxorubicin and GK921" . SPARSER::COLLECTION)
    ("p-p53" . SPARSER::COLLECTION)
    ("GK921 and doxorubicin" . SPARSER::COLLECTION)
    ("TGase 2 and doxorubicin" . SPARSER::COLLECTION)
    ("SRB" . SPARSER::PROTEIN-FAMILY)
    ("p21, BAD, BAX and PUMA" . SPARSER::COLLECTION)
    ("the protein's" . SPARSER::PROTEIN)
    ("p53 as well as p62" . SPARSER::COLLECTION)
    ("TGase 2–p62" . SPARSER::COLLECTION)
    ("the insoluble fraction" . SPARSER::COMPONENT)
    ("TGase 2, p53, and p62" . SPARSER::COLLECTION)
    ("polymers" . SPARSER::MOLECULE)
    ("glutamines and lysines" . SPARSER::COLLECTION)
    ("glutamines" . SPARSER::AMINO-ACID)
    ("p53 (S15E) and an inactive form (S15A)" . SPARSER::COLLECTION)
    ("Doxorubicin or etoposide" . SPARSER::COLLECTION)
    ("doxorubicin or etoposide" . SPARSER::COLLECTION)
    ("TGM2 and HDM2" . SPARSER::COLLECTION)
    ("TGM2 and chloroquine" . SPARSER::COLLECTION)
    ("both an siRNA and either chloroquine or MG132" . SPARSER::COLLECTION)
    ("chloroquine or MG132" . SPARSER::COLLECTION)
    ("HDM2 and TGase 2" . SPARSER::COLLECTION)
    ("TGase 2 and HDM2" . SPARSER::COLLECTION)
    ("TGase 2 and p62" . SPARSER::COLLECTION)
    ("ubiquitin and polyubiquitin" . SPARSER::COLLECTION)
    ("p53 or TGase 2" . SPARSER::COLLECTION) ("UBA" . SPARSER::PROTEIN)
    ("TGase 2 only uses calcium" . SPARSER::CALCIUM)
    ("glutamine and lysine" . SPARSER::COLLECTION)
    ("p62, p53 and TGase 2" . SPARSER::COLLECTION)
    ("Phox and Bem1p-1" . SPARSER::COLLECTION) ("Phox" . SPARSER::PROTEIN)
    ("PB1" . SPARSER::PROTEIN) ("p53 and p62" . SPARSER::COLLECTION)
    ("inhibitor 1 " . SPARSER::PROTEIN) ("P62" . SPARSER::PROTEIN)
    ("S15A" . SPARSER::PROTEIN) ("Nutlin3a" . SPARSER::DRUG)
    ("NBR1" . SPARSER::PROTEIN) ("MAPK kinase" . SPARSER::PROTEIN)
    ("microtubule-associated protein 1 light chain 3 alpha" . SPARSER::PROTEIN)
    ("sequestosome 1" . SPARSER::PROTEIN) ("GK921" . SPARSER::DRUG)
    ("p-1" . SPARSER::PROTEIN) ("Bem1" . SPARSER::PROTEIN)
    ("HDM2" . SPARSER::PROTEIN) ("TGase 2" . SPARSER::PROTEIN)
    ("antivirals" . SPARSER::DRUG)
    ("EGFR and the dimerization inducer HER-3" . SPARSER::COLLECTION)
    ("EGFR and its main dimerization partner HER-3 (ErbB-3)"
     . SPARSER::COLLECTION)
    ("intrahepatic Netrin-1" . SPARSER::PROTEIN)
    ("an HCV virion candidate component and an EGFR activator"
     . SPARSER::COLLECTION)
    ("Claudin-1/CD81" . SPARSER::COLLECTION)
    ("NS5A and LARP1" . SPARSER::COLLECTION)
    ("siRNA and Netrin-1" . SPARSER::COLLECTION)
    ("EEA1 and EGFR" . SPARSER::COLLECTION)
    ("EGFR and EEA1" . SPARSER::COLLECTION)
    ("anti-Netrin-1 (siRNA) or a Netrin-1" . SPARSER::COLLECTION)
    ("VSV" . SPARSER::PROTEIN)
    ("plasma membrane-associated CD81" . SPARSER::PROTEIN)
    ("Netrin-1 and EGFR" . SPARSER::COLLECTION)
    ("DCC and UNC5" . SPARSER::COLLECTION)
    ("Netrin-1 (compared with the same heat-inactivated receptor) and two distinct anti-Netrin-1 antibodies (compared with their respective isotypic IgG controls)"
     . SPARSER::COLLECTION)
    ("DCC" . SPARSER::PROTEIN)
    ("intracellular HCV RNA ( xref ) and a 5-fold decrease"
     . SPARSER::COLLECTION)
    ("a distinct recombinant soluble Netrin-1" . SPARSER::PROTEIN)
    ("Netrin-1-FLAG" . SPARSER::COLLECTION) ("Fc" . SPARSER::PROTEIN)
    ("Netrin-1-Fc" . SPARSER::COLLECTION) ("Netrin-1-" . SPARSER::PROTEIN)
    ("Netrin-1-HA" . SPARSER::COLLECTION) ("VR1-HA" . SPARSER::COLLECTION)
    ("vanilloid" . SPARSER::DRUG)
    ("this subcellular fraction" . SPARSER::COMPONENT)
    ("LARP1 and Netrin-1" . SPARSER::COLLECTION) ("puromycin" . SPARSER::DRUG)
    ("LARP1 and calnexin" . SPARSER::COLLECTION)
    ("calnexin" . SPARSER::PROTEIN) ("LARP1 and NS5A" . SPARSER::COLLECTION)
    ("NS4A, and NS4B" . SPARSER::COLLECTION)
    ("VAPA, GRB2, RAF1, PITX1, and TP53" . SPARSER::COLLECTION)
    ("NS5A-LARP1" . SPARSER::COLLECTION) ("VAPA" . SPARSER::PROTEIN)
    ("LARP1 and HCV NS5A ( xref )" . SPARSER::COLLECTION)
    ("GLuc" . SPARSER::PROTEIN) ("proteins and LARP1" . SPARSER::COLLECTION)
    ("the glucuronidase ( GUS) and phosphomannomutase 1 ( PMM1) mRNAs"
     . SPARSER::COLLECTION)
    ("membrane-bound and free polysomes" . SPARSER::COLLECTION)
    ("glucuronidase ( GUS)" . SPARSER::PROTEIN)
    ("glucuronidase" . SPARSER::PROTEIN)
    ("a hepatocytic Netrin-1 inducer" . SPARSER::MOLECULE)
    ("Netrin-1 and the HCV E2 envelope glycoprotein antigens"
     . SPARSER::COLLECTION)
    ("interferon and ribavirin" . SPARSER::COLLECTION)
    ("ribavirin" . SPARSER::DRUG)
    ("Netrin-1 mRNA and HCV RNA" . SPARSER::COLLECTION)
    ("Acc" . SPARSER::PROTEIN)
    ("Netrin-1 and its main receptors" . SPARSER::COLLECTION)
    ("reciprocal inducers" . SPARSER::MOLECULE)
    ("NS5A-La-related protein 1" . SPARSER::COLLECTION)
    ("CPP32" . SPARSER::PROTEIN) ("siRNA-Mediated" . SPARSER::PROTEIN)
    ("Membrane-Bound" . SPARSER::PROTEIN) ("DNAse I" . SPARSER::PROTEIN)
    ("ErbB-3" . SPARSER::PROTEIN) ("HER-3" . SPARSER::PROTEIN)
    ("Q15075" . SPARSER::PROTEIN) ("P60033" . SPARSER::PROTEIN)
    ("P00533" . SPARSER::PROTEIN) ("Q6ZN44" . SPARSER::PROTEIN)
    ("UNC5C" . SPARSER::PROTEIN) ("SiRNA-mediated" . SPARSER::PROTEIN)
    ("VR1" . SPARSER::PROTEIN) ("NS4B" . SPARSER::PROTEIN)
    ("NS4A" . SPARSER::PROTEIN) ("NS2" . SPARSER::PROTEIN)
    ("PITX1" . SPARSER::PROTEIN) ("RAF1" . SPARSER::PROTEIN)
    ("RPS18" . SPARSER::PROTEIN) ("ribosomal protein S18" . SPARSER::PROTEIN)
    ("Q6PKG0" . SPARSER::PROTEIN) ("PMM1" . SPARSER::PROTEIN)
    ("phosphomannomutase 1" . SPARSER::PROTEIN)
    ("envelope glycoprotein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("O95631" . SPARSER::PROTEIN) ("UNC5A" . SPARSER::PROTEIN)
    ("LARP1" . SPARSER::PROTEIN) ("La-related protein 1" . SPARSER::PROTEIN)
    ("Netrin-1" . SPARSER::PROTEIN)
    ("the informed consent form" . SPARSER::FORM)
    ("Ras [ xref ] and cytokine NF-κB [ xref ]" . SPARSER::COLLECTION)
    ("Pin1 and cyclin D1" . SPARSER::COLLECTION)
    ("mRNA and Pin1" . SPARSER::COLLECTION)
    ("β-catenin and cyclin D1" . SPARSER::COLLECTION)
    ("micro-PTCs" . SPARSER::PROTEIN)
    ("phosphothreonine-proline" . SPARSER::COLLECTION)
    ("phosphoserine-proline" . SPARSER::COLLECTION)
    ("cis-trans isomerase" . SPARSER::COLLECTION)
    ("phosphothreonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("iodine, and TSH" . SPARSER::COLLECTION) ("TSH" . SPARSER::PROTEIN)
    ("the most common histological type" . TYPE)
    ("Thr-Pro" . SPARSER::MOLECULE) ("trans isomerase" . SPARSER::PROTEIN)
    ("deacetylases and acetyl-transferases" . SPARSER::COLLECTION)
    ("Cyclin D1 and E1" . SPARSER::COLLECTION)
    ("at least 14 h" . SPARSER::PROTEIN)
    ("Cyclin B1/Cdk1" . SPARSER::COLLECTION)
    ("Cyclin A2/Cdk1" . SPARSER::COLLECTION)
    ("Cyclin D1 and Cyclin E1" . SPARSER::COLLECTION)
    ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("16 h and 20 h" . SPARSER::COLLECTION)
    ("both Kv10.1 (20 h) and Cyclin A2 promoters (16 and 20 h)"
     . SPARSER::COLLECTION)
    ("Kv10.1 or Cyclin A2" . SPARSER::COLLECTION)
    ("E2F1 and the Cyclin A2 promoter" . SPARSER::COLLECTION)
    ("E2F1 and the Kv10.1 promoter" . SPARSER::COLLECTION)
    ("Kv10.1 and cyclin A2" . SPARSER::COLLECTION)
    ("Kv10.1 and Cyclin A2" . SPARSER::COLLECTION)
    ("E2F1 as well as HPV-E7" . SPARSER::COLLECTION)
    ("Prof" . SPARSER::PROTEIN) ("Kv10.1 and Cyclin B1" . SPARSER::COLLECTION)
    ("Cyclin A2 and Cyclin B1" . SPARSER::COLLECTION)
    ("pRb/E2F1" . SPARSER::COLLECTION) ("Triton X- 100" . SPARSER::MOLECULE)
    ("a 15 " . SPARSER::PROTEIN) ("Kv10.2" . SPARSER::PROTEIN)
    ("acetyl-transferases" . SPARSER::PROTEIN)
    ("Retinoblastoma protein" . SPARSER::PROTEIN) ("Eag1" . SPARSER::PROTEIN)
    ("KCNH1" . SPARSER::PROTEIN) ("Kv10.1" . SPARSER::PROTEIN)
    ("the angiogenic cue" . SPARSER::PROTEIN-FAMILY)
    ("cue" . SPARSER::PROTEIN-FAMILY)
    ("the only Ras protein" . SPARSER::PROTEIN)
    ("genes and proteins" . SPARSER::COLLECTION)
    ("p38MAPK and HSP27" . SPARSER::COLLECTION)
    ("VEGFR2-p38MAPK-HSP27" . SPARSER::COLLECTION)
    ("Unstimulated mock-transduced control cells exhibited actin filaments"
     . SPARSER::PROTEIN-FAMILY)
    ("VEGF-HSP27" . SPARSER::COLLECTION)
    ("CD31 and phospho-HSP27" . SPARSER::COLLECTION)
    ("VEGFR2 and p38MAPK" . SPARSER::COLLECTION)
    ("VEGFR2-p38MAPK" . SPARSER::COLLECTION)
    ("VEGF-p38MAPK" . SPARSER::COLLECTION)
    ("H-Ras and Rap1" . SPARSER::COLLECTION)
    ("PHD2/HIF-2" . SPARSER::COLLECTION)
    ("K-Ras and H-Ras" . SPARSER::COLLECTION)
    ("Raf-MAP kinase" . SPARSER::COLLECTION)
    ("p38MAPK-Hsp27" . SPARSER::COLLECTION) ("p38MAPK" . SPARSER::PROTEIN)
    ("p38MAPK-HSP27" . SPARSER::COLLECTION)
    ("stress-activated protein kinase-2/p38" . SPARSER::COLLECTION)
    ("MAPKAPK-2" . SPARSER::PROTEIN)
    ("Mitogen-activated-protein kinase" . SPARSER::PROTEIN)
    ("MK2" . SPARSER::PROTEIN)
    ("MAPK-activated protein kinase 2" . SPARSER::PROTEIN)
    ("Rap1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HIF-2" . SPARSER::PROTEIN)
    ("PHD2" . SPARSER::PROTEIN) ("SAPK2" . SPARSER::PROTEIN)
    ("stress-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("R-Ras" . SPARSER::PROTEIN) ("actin-myosin" . SPARSER::COLLECTION)
    ("chemical and physical signals" . SPARSER::COLLECTION)
    ("galectin-9/Tim-3" . SPARSER::COLLECTION)
    ("soluble rh-galectin-9" . SPARSER::PROTEIN)
    ("galectin-9 and rh-galectin-9" . SPARSER::COLLECTION)
    ("Rho family ( xref ) and ROCK1( xref )" . SPARSER::COLLECTION)
    ("Rho and ROCK" . SPARSER::COLLECTION) ("RhoT1" . SPARSER::PROTEIN)
    ("RhoT" . SPARSER::PROTEIN) ("RhoH" . SPARSER::PROTEIN)
    ("RhoF" . SPARSER::PROTEIN) ("a pivotal regulator" . SPARSER::REGULATOR)
    ("mRNA, and protein" . SPARSER::COLLECTION) ("HPF" . SPARSER::PROTEIN)
    ("galectins" . SPARSER::PROTEIN) ("galactoside" . SPARSER::MOLECULE)
    ("Galectins" . SPARSER::PROTEIN) ("Rho/ROCK1" . SPARSER::COLLECTION)
    ("rh" . SPARSER::MOLECULE) ("galectin-9 and CD56" . SPARSER::COLLECTION)
    ("galectin-8" . SPARSER::PROTEIN) ("gal-9" . SPARSER::PROTEIN)
    ("Tim-3" . SPARSER::PROTEIN) ("ROCK1 protein" . SPARSER::PROTEIN)
    ("IL-12" . SPARSER::PROTEIN) ("CD56" . SPARSER::PROTEIN)
    ("galectin-9" . SPARSER::PROTEIN) ("Galectin-9" . SPARSER::PROTEIN)
    ("a recurrent FGFR3" . SPARSER::PROTEIN)
    ("CCND1 or CCND1" . SPARSER::COLLECTION)
    ("the full-length (FL- CCND1 ) or the truncated CCND1"
     . SPARSER::COLLECTION)
    ("Tr-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MRCK chimeric mRNA" . SPARSER::PROTEIN)
    ("the myotonic dystrophy kinase-related Cdc42-binding kinase ( MRCK ) gene"
     . SPARSER::GENE)
    ("RACE" . SPARSER::PROTEIN) ("CCND1/MRCK" . SPARSER::COLLECTION)
    ("cyclin D1 ( CCND1 ) and a 3" . SPARSER::COLLECTION)
    ("myotonic dystrophy kinase-related Cdc42-binding kinase"
     . SPARSER::KINASE)
    ("MRCK" . SPARSER::PROTEIN) ("MCL" . SPARSER::PROTEIN)
    ("alpha tubulin" . SPARSER::PROTEIN) ("x104" . SPARSER::PROTEIN)
    ("Not1" . SPARSER::PROTEIN) ("7SK" . SPARSER::RNA)
    ("TACC3" . SPARSER::PROTEIN)
    ("HNF-4α, PPARα, and RXRα" . SPARSER::COLLECTION)
    ("Cellular FN" . SPARSER::PROTEIN)
    ("heparin and fibrin" . SPARSER::COLLECTION)
    ("FN and the TAK-TAB complex" . SPARSER::COLLECTION)
    ("FN and the TAK1-TAB complex" . SPARSER::COLLECTION)
    ("FN, and TAK1" . SPARSER::COLLECTION)
    ("IFN-α and ISG" . SPARSER::COLLECTION)
    ("the most severe forms" . SPARSER::FORM)
    ("HBeAg or HBV DNA" . SPARSER::COLLECTION)
    ("HBeAg and HBV DNA" . SPARSER::COLLECTION)
    ("receptor and FN" . SPARSER::COLLECTION)
    ("receptor, FN, and HBsAg" . SPARSER::COLLECTION)
    ("HNF-4α" . SPARSER::PROTEIN) ("HNF-4α-Mut and EII" . SPARSER::COLLECTION)
    ("HNF-4α-Mut" . SPARSER::COLLECTION) ("FXR" . SPARSER::PROTEIN)
    ("Sev" . SPARSER::PROTEIN) ("FN-TAK1" . SPARSER::COLLECTION)
    ("transmembrane protein or the intracellular FN" . SPARSER::COLLECTION)
    ("the extracellular FN" . SPARSER::PROTEIN)
    ("FN and TAB3" . SPARSER::COLLECTION)
    ("surface protein (HBL)" . SPARSER::PROTEIN)
    ("myc-TAB3" . SPARSER::COLLECTION) ("HBL" . SPARSER::PROTEIN)
    ("both HBsAg and the TAK1-TAB complex" . SPARSER::COLLECTION)
    ("HBsAg and TAB3" . SPARSER::COLLECTION)
    ("FN and TAK-TAB" . SPARSER::COLLECTION) ("TAK" . SPARSER::PROTEIN)
    ("exogenous FN" . SPARSER::PROTEIN)
    ("TAB2, and TAB3" . SPARSER::COLLECTION)
    ("IkBα or NEMO" . SPARSER::COLLECTION)
    ("TAB2, TAB3, IkBα, and NF-κB" . SPARSER::COLLECTION)
    ("RelB or NF-κB-inducing kinase (NIK)" . SPARSER::COLLECTION)
    ("kinase (NIK)" . SPARSER::KINASE) ("NIK" . SPARSER::PROTEIN)
    ("endogenous IFN-α and downstream ISGs" . SPARSER::COLLECTION)
    ("siRNA-NC" . SPARSER::COLLECTION) ("siRNA-IFNAR1" . SPARSER::COLLECTION)
    ("IFN-α and ISGs" . SPARSER::COLLECTION) ("si-FN" . SPARSER::COLLECTION)
    ("IFN-α and IFN-stimulated genes (ISGs)" . SPARSER::COLLECTION)
    ("RNA-dependent protein kinase (PKR)" . SPARSER::PROTEIN)
    ("synthetase (OAS)" . SPARSER::PROTEIN)
    ("the direct antiviral effectors" . SPARSER::EFFECTOR)
    ("MxA" . SPARSER::PROTEIN) ("SeV" . SPARSER::PROTEIN)
    ("IFN-α and IFN-Stimulated Genes" . SPARSER::COLLECTION)
    ("viral genes" . SPARSER::GENE) ("HBsAg and HBV" . SPARSER::COLLECTION)
    ("FN-specific shRNA or irrelevant shRNA" . SPARSER::COLLECTION)
    ("irrelevant shRNA" . SPARSER::PROTEIN) ("NC-KD" . SPARSER::COLLECTION)
    ("FN-KD" . SPARSER::COLLECTION) ("shFN-2" . SPARSER::COLLECTION)
    ("HBeAg, HBsAg, and HBV" . SPARSER::COLLECTION)
    ("shFN-1" . SPARSER::COLLECTION) ("HBeAg and HBsAg" . SPARSER::COLLECTION)
    ("HBeAg" . SPARSER::PROTEIN) ("NTCP" . SPARSER::PROTEIN)
    ("fetal hepatocytes" . SPARSER::PROTEIN) ("viral DNA" . SPARSER::DNA)
    ("IRAKs" . SPARSER::PROTEIN) ("TLRs" . SPARSER::PROTEIN-FAMILY)
    ("an insoluble matrix" . SPARSER::PROTEIN-FAMILY)
    ("a soluble protein dimer" . SPARSER::DIMER)
    ("collagen, fibrin, and heparan sulfate" . SPARSER::COLLECTION)
    ("insoluble cellular FN" . SPARSER::PROTEIN)
    ("soluble plasma FN" . SPARSER::PROTEIN)
    ("two nearly identical polypeptide" . SPARSER::PROTEIN)
    ("disulfide" . SPARSER::MOLECULE) ("HBsAg" . SPARSER::DRUG)
    ("NF-κB/p65" . SPARSER::COLLECTION) ("taurocholate" . SPARSER::MOLECULE)
    ("Fibronectin" . SPARSER::PROTEIN) ("LRH1" . SPARSER::PROTEIN)
    ("receptor homolog" . SPARSER::PROTEIN)
    ("farnesoid X receptor" . SPARSER::PROTEIN) ("PPARα" . SPARSER::PROTEIN)
    ("surface protein" . SPARSER::PROTEIN) ("IkBα" . SPARSER::PROTEIN)
    ("IFN-α2" . SPARSER::PROTEIN) ("IFNAR1" . SPARSER::PROTEIN)
    ("RNA-dependent protein kinase" . SPARSER::PROTEIN)
    ("activating transcription factor 2" . SPARSER::PROTEIN)
    ("sp1" . SPARSER::PROTEIN) ("TAB3" . SPARSER::PROTEIN)
    ("TAB2" . SPARSER::PROTEIN)
    ("hepatocyte nuclear factor 4 alpha" . SPARSER::PROTEIN)
    ("TRAF6" . SPARSER::PROTEIN) ("TLR9" . SPARSER::PROTEIN)
    ("IFNα" . SPARSER::PROTEIN)
    ("receptor proteins" . SPARSER::RECEPTOR-PROTEIN)
    ("TAK1" . SPARSER::PROTEIN) ("IFN-α" . SPARSER::PROTEIN)
    ("extracellular matrix protein" . SPARSER::PROTEIN)
    ("the native conformational state" . SPARSER::BIO-STATE)
    ("melts" . SPARSER::DRUG)
    ("wild-type SIRT5 as well as Y102A mutant enzymes" . SPARSER::COLLECTION)
    ("two slowly interconvertible protein conformations"
     . SPARSER::BIO-CONFORMATION)
    ("the global conformational states" . SPARSER::BIO-STATE)
    ("competitive inhibitor" . SPARSER::INHIBITOR)
    ("the wild-type SIRT5 and its Y012A mutant" . SPARSER::COLLECTION)
    ("structurally similar fluorogenic substrates" . SPARSER::SUBSTRATE)
    ("the substrate(s) and NAD +" . SPARSER::COLLECTION)
    ("the enzyme-substrate-NAD + ternary complex" . SPARSER::BIO-COMPLEX)
    ("SIRT1 and SIRT5, and SIRT5" . SPARSER::COLLECTION)
    ("SIRT5, and SIRT5" . SPARSER::COLLECTION) ("TCEP" . SPARSER::MOLECULE)
    ("glycerol" . SPARSER::PROTEIN) ("HEPES" . SPARSER::MOLECULE)
    ("Y102A/R105I" . SPARSER::PROTEIN) ("fluor" . SPARSER::MOLECULE)
    ("both SIRT1 (deacetylation) and SIRT5 (desuccinylation)"
     . SPARSER::COLLECTION)
    ("Isonicotinamide" . SPARSER::DRUG) ("isonicotinamide" . SPARSER::DRUG)
    ("the enzyme’s" . SPARSER::ENZYME) ("SIRT1 or SIRT5" . SPARSER::COLLECTION)
    ("sirtuins, Sauve and Shramm" . SPARSER::COLLECTION)
    ("certain sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("the latter enzyme" . SPARSER::ENZYME)
    ("the former enzyme" . SPARSER::ENZYME)
    ("only weak deacetylase activity" . SPARSER::PROTEIN)
    ("strong deacetylase activity" . SPARSER::PROTEIN)
    ("the fluorogenic substrates instead of using physiologically relevant peptide substrates"
     . SPARSER::COLLECTION)
    ("using physiologically relevant peptide substrates" . SPARSER::SUBSTRATE)
    ("the fluorogenic substrates" . SPARSER::SUBSTRATE)
    ("coumarin" . SPARSER::DRUG) ("the former substrate" . SPARSER::SUBSTRATE)
    ("lys" . SPARSER::PROTEIN)
    ("the wild-type SIRT5 ( xref ) and its Y102A mutant variant ( xref )"
     . SPARSER::COLLECTION)
    ("wild-type SIRT5 and Y102A mutant enzyme" . SPARSER::COLLECTION)
    ("Met or Leu" . SPARSER::COLLECTION)
    ("SIRT5 and SIRT1" . SPARSER::COLLECTION)
    ("nicotinamide and EX527" . SPARSER::COLLECTION)
    ("Ala and Ile" . SPARSER::COLLECTION)
    ("SIRT1 and SIRT5" . SPARSER::COLLECTION) ("-OAADPr" . SPARSER::MOLECULE)
    ("OAADPr" . SPARSER::MOLECULE) ("the associated enzymes" . SPARSER::ENZYME)
    ("SIRT4 and SIRT6" . SPARSER::COLLECTION)
    ("SIRT1-SIRT6" . SPARSER::COLLECTION)
    ("SIRT3, SIRT4 and SIRT5" . SPARSER::COLLECTION)
    ("SIRT1-SIRT7" . SPARSER::COLLECTION)
    ("Sir 2 or sirtuin" . SPARSER::COLLECTION)
    ("EX527 and nicotinamide" . SPARSER::COLLECTION)
    ("activators and inhibitors" . SPARSER::COLLECTION)
    ("M -1" . SPARSER::PROTEIN)
    ("6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide" . SPARSER::DRUG)
    ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("min -1" . SPARSER::PROTEIN)
    ("SIRT4" . SPARSER::PROTEIN) ("Sir 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EX527" . SPARSER::DRUG) ("SIRT5" . SPARSER::PROTEIN)
    ("ATRA or Nrf2-DN" . SPARSER::COLLECTION)
    ("BSO and HO-1" . SPARSER::COLLECTION)
    ("HO-1 and x-CT" . SPARSER::COLLECTION)
    ("RARalpha and RXR" . SPARSER::COLLECTION) ("RARalpha" . SPARSER::PROTEIN)
    ("an essential cofactor" . SPARSER::MOLECULE) ("Brahma" . SPARSER::PROTEIN)
    ("β1, β2 and β5" . SPARSER::COLLECTION)
    ("other chemotherapeutic drugs" . SPARSER::DRUG)
    ("uric acid [ xref ] or bilirubin [ xref , xref ]" . SPARSER::COLLECTION)
    ("ATRA and BTZ" . SPARSER::COLLECTION)
    ("E1, GCLM and x-CT" . SPARSER::COLLECTION)
    ("-Retinoic acid (ATRA)" . SPARSER::MOLECULE)
    ("GCLM (+58.3% vs CTR, xref ) and x-CT (+88.5% vs CTR, xref )"
     . SPARSER::COLLECTION)
    ("E2, GCLM and x-CT" . SPARSER::COLLECTION)
    ("E1 and E2" . SPARSER::COLLECTION)
    ("HO-1, GCLM and x-CT" . SPARSER::COLLECTION)
    ("BTZ and BSO" . SPARSER::COLLECTION) ("siHO-1" . SPARSER::COLLECTION)
    ("CTR" . SPARSER::PROTEIN) ("BSO" . SPARSER::DRUG)
    ("prot" . SPARSER::PROTEIN) ("GCLM and x-CT" . SPARSER::COLLECTION)
    ("GCLM ( xref ) and x-CT ( xref )" . SPARSER::COLLECTION)
    ("γ-glutamylcysteine ligase (both modulatory GCLM, and catalytic GCLC subunits) and the transporter"
     . SPARSER::COLLECTION)
    ("β2 (PSMB7) and β5 (PSMB5)" . SPARSER::COLLECTION)
    ("the proteolytic core subunits β1 (PSMB6), β2 (PSMB7) and β5 (PSMB5)"
     . SPARSER::COLLECTION)
    ("Trypan" . SPARSER::DRUG) ("Retinoic acid (ATRA)" . SPARSER::MOLECULE)
    ("HO-1 and GSH" . SPARSER::COLLECTION) ("chemosensitizer" . SPARSER::DRUG)
    ("Bortezomib" . SPARSER::DRUG)
    ("Toxic molecules and oxidative insults" . SPARSER::COLLECTION)
    ("ligase (GCL)" . SPARSER::LIGASE) ("Toxic molecules" . SPARSER::MOLECULE)
    ("ferritin [ xref ] and carbon monoxide [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("ferritin" . SPARSER::PROTEIN) ("Glutathione" . SPARSER::DRUG)
    ("toxic molecules" . SPARSER::MOLECULE)
    ("Nrf2, HO-1 and GSH" . SPARSER::COLLECTION)
    ("-Retinoic acid" . SPARSER::MOLECULE)
    ("γ-glutamylcysteine ligase (GCLM) and the transporter"
     . SPARSER::COLLECTION)
    ("ligase (GCLM)" . SPARSER::LIGASE)
    ("the modulatory subunit" . SPARSER::FRAGMENT) ("BTZ" . SPARSER::PROTEIN)
    ("bortezomib" . SPARSER::DRUG) ("BRG-1" . SPARSER::PROTEIN)
    ("uric acid" . SPARSER::MOLECULE) ("PSMB5" . SPARSER::PROTEIN)
    ("PSMB7" . SPARSER::PROTEIN) ("PSMB6" . SPARSER::PROTEIN)
    ("β5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N-ethylmaleimide" . SPARSER::MOLECULE)
    ("chymotrypsin-like" . SPARSER::PROTEIN) ("Leu-Val" . SPARSER::MOLECULE)
    ("buthionine sulfoximine" . SPARSER::DRUG) ("CUL3" . SPARSER::PROTEIN)
    ("Keap-1" . SPARSER::PROTEIN) ("carbon monoxide" . SPARSER::MOLECULE)
    ("Retinoic acid" . SPARSER::MOLECULE)
    ("various proinflamatory cytokines" . SPARSER::PROTEIN)
    ("CPR" . SPARSER::PROTEIN) ("ACE and PAI-1" . SPARSER::COLLECTION)
    ("the ACE D allele and DD genotype" . SPARSER::COLLECTION)
    ("Salt" . SPARSER::MOLECULE) ("water and salt" . SPARSER::COLLECTION)
    ("salt and water" . SPARSER::COLLECTION) ("BMI" . SPARSER::DRUG)
    ("a multifunctional cytokine" . SPARSER::PROTEIN)
    ("an insertion (I) allele or a deletion (D) allele" . SPARSER::COLLECTION)
    ("Angiotensin" . SPARSER::PROTEIN) ("Renin" . SPARSER::PROTEIN)
    ("ultrassensible C-reactive protein" . SPARSER::PROTEIN)
    ("PAI-1, D-dimer and TGF-β1" . SPARSER::COLLECTION)
    ("ACE" . SPARSER::PROTEIN) ("Ang I" . SPARSER::PROTEIN)
    ("Plasminogen activator inhibitor 1" . SPARSER::PROTEIN)
    ("Angiotensin-Converting enzyme" . SPARSER::PROTEIN)
    ("Ang II" . SPARSER::PROTEIN) ("C-reactive protein" . SPARSER::PROTEIN)
    ("Angiotensin-Converting Enzyme" . SPARSER::PROTEIN)
    ("Chloroquine" . SPARSER::PROTEIN) ("gene or genes" . SPARSER::COLLECTION)
    ("Atm" . SPARSER::PROTEIN) ("α-synuclein and Lewy" . SPARSER::COLLECTION)
    ("PHF1 or AT8" . SPARSER::COLLECTION)
    ("phospho-tau and HDAC4" . SPARSER::COLLECTION)
    ("HDAC4 and tau" . SPARSER::COLLECTION)
    ("ATM and phospho-tau" . SPARSER::COLLECTION)
    ("HDAC4 and cyclin" . SPARSER::COLLECTION)
    ("neuronal cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HDAC4 and H3K27me3" . SPARSER::COLLECTION)
    ("H3K27me3 and HDAC4" . SPARSER::COLLECTION)
    ("the most prominent H3K27me3" . SPARSER::PROTEIN)
    ("CDR" . SPARSER::PROTEIN) ("CA3 and CA4" . SPARSER::COLLECTION)
    ("CA1" . SPARSER::PROTEIN) ("midfrontal gyrus" . SPARSER::PROTEIN)
    ("HDAC4 and ATM" . SPARSER::COLLECTION) ("gyrus" . SPARSER::PROTEIN)
    ("APP and PSEN1" . SPARSER::COLLECTION) ("PS/APP" . SPARSER::COLLECTION)
    ("MAPT" . SPARSER::PROTEIN) ("APP" . SPARSER::PROTEIN)
    ("Neuronal ATM" . SPARSER::PROTEIN)
    ("a hypomorphic allele" . SPARSER::ALLELE) ("CA4" . SPARSER::PROTEIN)
    ("CA3" . SPARSER::PROTEIN) ("neuronal 2" . SPARSER::PROTEIN)
    ("presenilin-1" . SPARSER::PROTEIN) ("PHF1" . SPARSER::PROTEIN)
    ("AT8" . SPARSER::PROTEIN) ("PSEN1" . SPARSER::PROTEIN)
    ("enhancer of zeste homolog 2" . SPARSER::PROTEIN)
    ("β-amyloid" . SPARSER::MOLECULE)
    ("histone deacetylase 4" . SPARSER::PROTEIN)
    ("A-T mutated" . SPARSER::PROTEIN) ("Bank" . SPARSER::PROTEIN)
    ("cytochrome c and dATP" . SPARSER::COLLECTION) ("dATP" . SPARSER::DATP)
    ("gemcitabine, 5-fluorouracil and docetaxel" . SPARSER::COLLECTION)
    ("PTEN , PDCD4 and p21" . SPARSER::COLLECTION)
    ("tamoxifen, faslodex and topotecan" . SPARSER::COLLECTION)
    ("topotecan" . SPARSER::DRUG) ("faslodex" . SPARSER::DRUG)
    ("MiR21" . SPARSER::PROTEIN)
    ("-GACATGGAAACTGAAGAAGTTG-3" . SPARSER::COLLECTION)
    ("miR21 and APAF1" . SPARSER::COLLECTION)
    ("stromal miR21" . SPARSER::PROTEIN) ("complete media" . SPARSER::PROTEIN)
    ("chemoresistance-associated genes" . SPARSER::GENE)
    ("miR21+/miR21+ MEFs (miR21-MEF) or miR21−/miR21− MEFs (MEFs)"
     . SPARSER::COLLECTION)
    ("the mature miR21" . SPARSER::PROTEIN)
    ("exosomal miR21" . SPARSER::PROTEIN)
    ("MEFs and miR21+/miR21+" . SPARSER::COLLECTION)
    ("transfectants" . SPARSER::PROTEIN) ("calcein" . SPARSER::MOLECULE)
    ("pre-miR21" . SPARSER::COLLECTION) ("miR21-MEF" . SPARSER::COLLECTION)
    ("miR21−" . SPARSER::PROTEIN) ("pre-miR" . SPARSER::COLLECTION)
    ("both normal adipocytes" . SPARSER::PROTEIN)
    ("microdissected normal adipocytes" . SPARSER::PROTEIN)
    ("primary normal adipocytes" . SPARSER::PROTEIN) ("NFs" . SPARSER::PROTEIN)
    ("miRNA-seq" . SPARSER::COLLECTION)
    ("variant and precursor" . SPARSER::COLLECTION)
    ("-TAGCTTATCAGACTGATGTTGACTA-3" . SPARSER::COLLECTION)
    ("-miR21" . SPARSER::COLLECTION)
    ("-TAGCTTATCAGACTGATGTTGA-3" . SPARSER::COLLECTION)
    ("-TAGCTTATCAGACTGATGTTGACA-3" . SPARSER::COLLECTION)
    ("-miR-21" . SPARSER::COLLECTION)
    ("miR21 and its variants" . SPARSER::COLLECTION)
    ("miRNAs and isomiRs" . SPARSER::COLLECTION)
    ("-nucleotide" . SPARSER::NUCLEOTIDE)
    ("each miRNA and their variants" . SPARSER::COLLECTION)
    ("normal omental adipocytes" . SPARSER::PROTEIN)
    ("the exosomal markers CD63 and HSP70" . SPARSER::COLLECTION)
    ("CD63 and HSP70" . SPARSER::COLLECTION)
    ("normal adipocytes" . SPARSER::PROTEIN) ("Ion" . SPARSER::MOLECULE)
    ("these exosomal miRNAs" . SPARSER::PROTEIN)
    ("proteins and lipids" . SPARSER::COLLECTION)
    ("soluble mediators" . SPARSER::PROTEIN)
    ("platinum- and taxane-based chemotherapy" . SPARSER::COLLECTION)
    ("stromal-derived miR21" . SPARSER::PROTEIN) ("miR21" . SPARSER::PROTEIN)
    ("cancer-associated adipocytes" . SPARSER::PROTEIN)
    ("Apaf1" . SPARSER::PROTEIN) ("per 1" . SPARSER::PROTEIN)
    ("local MSCs" . SPARSER::PROTEIN) ("local hypoxia" . SPARSER::PROTEIN)
    ("GTPases and ROCK" . SPARSER::COLLECTION)
    ("1B and 1C" . SPARSER::COLLECTION) ("naive MSCs" . SPARSER::PROTEIN)
    ("DKK1 and oncostatin M" . SPARSER::COLLECTION)
    ("CXCL8, CXCL12, and epidermal growth factor" . SPARSER::COLLECTION)
    ("tenascin" . SPARSER::PROTEIN)
    ("G-protein-coupled receptor (GPCR)" . SPARSER::PROTEIN)
    ("CAFs" . SPARSER::PROTEIN) ("GPR132" . SPARSER::PROTEIN)
    ("GPR65" . SPARSER::PROTEIN) ("GPR4" . SPARSER::PROTEIN)
    ("CSPG4" . SPARSER::PROTEIN) ("oncostatin M" . SPARSER::PROTEIN)
    ("DKK1" . SPARSER::PROTEIN) ("CXCL12" . SPARSER::PROTEIN)
    ("FSP1" . SPARSER::PROTEIN) ("αSMA" . SPARSER::PROTEIN)
    ("Yes-associated protein 1" . SPARSER::PROTEIN)
    ("G-protein-coupled receptor" . SPARSER::PROTEIN)
    ("GPR68" . SPARSER::PROTEIN) ("TG or GG" . SPARSER::COLLECTION)
    ("ALLELE And SUBGROUP" . SPARSER::COLLECTION) ("ALLELE" . SPARSER::ALLELE)
    ("severe DNA" . SPARSER::DNA)
    ("a key tumor suppressor protein" . SPARSER::PROTEIN)
    ("Stata" . SPARSER::PROTEIN) ("MdM2" . SPARSER::PROTEIN)
    ("double minute 2" . SPARSER::PROTEIN)
    ("nucleus-localized β-catenin–Tcf complex" . SPARSER::BIO-COMPLEX)
    ("followed 1 h" . SPARSER::PROTEIN) ("Tef" . SPARSER::PROTEIN)
    ("cyclin D1 and c-Myc" . SPARSER::COLLECTION)
    ("c-Myc and cyclin D1 and β-catenin" . SPARSER::COLLECTION)
    ("cyclin D1 and β-catenin" . SPARSER::COLLECTION)
    ("wnt/β-catenin" . SPARSER::COLLECTION)
    ("the aliphatic parts" . SPARSER::COMPONENT)
    ("naphthoquinone" . SPARSER::MOLECULE)
    ("Tcf4 and β-catenin" . SPARSER::COLLECTION)
    ("Renilla-luciferase" . SPARSER::COLLECTION)
    ("β-catenin and an FITC-labeled Tcf4 (8–30)" . SPARSER::COLLECTION)
    ("β-catenin-Tcf/Lef" . SPARSER::PROTEIN-PAIR)
    ("β-catenin and Tcf4" . SPARSER::COLLECTION)
    ("Wnt 1, Wnt 2, and β-catenin" . SPARSER::COLLECTION)
    ("Tcf4, Wnt1, and Wnt2" . SPARSER::COLLECTION)
    ("Wnt/beta-catenin" . SPARSER::COLLECTION) ("x-ray" . SPARSER::COLLECTION)
    ("enhancer" . SPARSER::PROTEIN) ("S-G 2" . SPARSER::PROTEIN)
    ("Tcf-4" . SPARSER::PROTEIN) ("Wnt 2" . SPARSER::PROTEIN)
    ("Wnt 1" . SPARSER::PROTEIN) ("Wnt2" . SPARSER::PROTEIN)
    ("beta-catenin" . SPARSER::PROTEIN) ("ClN 3" . SPARSER::PROTEIN)
    ("Tcf4" . SPARSER::PROTEIN) ("Frequent MMR" . SPARSER::PROTEIN)
    ("MSS and MMR" . SPARSER::COLLECTION) ("MSS" . SPARSER::PROTEIN)
    ("the respective MMR proteins" . SPARSER::PROTEIN)
    ("MLH1 ( n  = 8) and MSH6 ( n  = 6)" . SPARSER::COLLECTION)
    ("MSH2 ( n  = 14), MLH1 ( n  = 8) and MSH6 ( n  = 6)"
     . SPARSER::COLLECTION)
    ("MLH1, MSH2, MSH6 or PMS2" . SPARSER::COLLECTION)
    ("MLH1 and MSH3" . SPARSER::COLLECTION)
    ("the respective mismatch repair protein" . SPARSER::PROTEIN)
    ("MSH2, MLH1 and MSH6" . SPARSER::COLLECTION) ("MLH1" . SPARSER::PROTEIN)
    ("HNPCC" . SPARSER::PROTEIN) ("PD-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PMS2" . SPARSER::PROTEIN) ("MSH3" . SPARSER::PROTEIN)
    ("mismatch repair protein" . SPARSER::PROTEIN)
    ("p27, CCND1 and caspase-9" . SPARSER::COLLECTION)
    ("the western blot" . SPARSER::PROTEIN) ("c-PARP" . SPARSER::COLLECTION)
    ("miR-NC" . SPARSER::COLLECTION) ("Enhancer" . SPARSER::PROTEIN)
    ("pGL3-Enhancer" . SPARSER::COLLECTION) ("pri" . SPARSER::PROTEIN)
    ("exogenous BRD7" . SPARSER::PROTEIN)
    ("E2F and PI3K/AKT" . SPARSER::COLLECTION)
    ("Bromodomain" . SPARSER::PROTEIN) ("leading form" . SPARSER::FORM)
    ("PTEN/AKT" . SPARSER::COLLECTION) ("the mature forms" . SPARSER::FORM)
    ("Drosha and Dicer" . SPARSER::COLLECTION)
    ("3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("JNK2" . SPARSER::PROTEIN) ("BIRC2" . SPARSER::PROTEIN)
    ("Bromodomain containing 7" . SPARSER::PROTEIN)
    ("cellular β -catenin" . SPARSER::PROTEIN)
    ("Akt and GSK3 β" . SPARSER::COLLECTION)
    ("Akt, MAPK and GSK3 β" . SPARSER::COLLECTION)
    ("EP4, COX-2 and VEGF" . SPARSER::COLLECTION)
    ("competitive EP4 prostanoid receptor antagonist" . SPARSER::MOLECULE)
    ("COX-2, pAkt, pMAPK and pEGFR" . SPARSER::COLLECTION)
    ("EGFR, Akt, PKA and MAPK" . SPARSER::COLLECTION)
    ("a competitive EP4 antagonist" . SPARSER::MOLECULE)
    ("ambient PGE2" . SPARSER::DRUG)
    ("VEGF, COX-2 and PGE2" . SPARSER::COLLECTION)
    ("Akt/GSK3 β" . SPARSER::COLLECTION)
    ("EGFR, Ras, Akt, GSK3 β and MAPK" . SPARSER::COLLECTION)
    ("EP4/CREB" . SPARSER::COLLECTION)
    ("PKA or adenylyl" . SPARSER::COLLECTION)
    ("PKA and CREB" . SPARSER::COLLECTION)
    ("EGFR/Akt/GSK3 β" . SPARSER::COLLECTION)
    ("EP4/PKA/CREB" . SPARSER::COLLECTION)
    ("receptor and HIF1 α" . SPARSER::COLLECTION)
    ("p-vascular endothelial" . SPARSER::COLLECTION)
    ("secretory VEGF" . SPARSER::PROTEIN)
    ("PGE2 and VEGF" . SPARSER::COLLECTION)
    ("COX-2, PGE2, EP4 and VEGF" . SPARSER::COLLECTION)
    ("proteins, Bcl-2, Bcl-xl and XIAP" . SPARSER::COLLECTION)
    ("BAX and apoptosis-inducing" . SPARSER::COLLECTION)
    ("pro-apoptotic protein BAX" . SPARSER::PROTEIN)
    ("Rhodamine" . SPARSER::PROTEIN) ("ME" . SPARSER::PROTEIN)
    ("GPCRs and EGFR" . SPARSER::COLLECTION)
    ("complex and context" . SPARSER::COLLECTION)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TCF-" . SPARSER::PROTEIN)
    ("EP2 and EP4" . SPARSER::COLLECTION)
    ("COX-2 and PGE2" . SPARSER::COLLECTION)
    ("viral antigens E6 and E7" . SPARSER::COLLECTION)
    ("EP4/EGFR" . SPARSER::COLLECTION)
    ("pAkt, pMAPK, pEGFR and COX-2" . SPARSER::COLLECTION)
    ("CREB and β -catenin" . SPARSER::COLLECTION)
    ("growth factor and c-myc" . SPARSER::COLLECTION)
    ("EP4 and EGFR" . SPARSER::COLLECTION)
    ("a highly selective competitive EP4 antagonist" . SPARSER::MOLECULE)
    ("prostanoid" . SPARSER::MOLECULE)
    ("cyclooxygenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β Catenin" . SPARSER::PROTEIN) ("p-Ras" . SPARSER::PROTEIN)
    ("Anti-angiogenic" . SPARSER::DRUG) ("HIF1 α" . SPARSER::PROTEIN)
    ("PEG2" . SPARSER::PROTEIN) ("adenosine monophosphate" . SPARSER::MOLECULE)
    ("cyclase activity" . SPARSER::PROTEIN) ("EP4 receptor" . SPARSER::PROTEIN)
    ("CYP19" . SPARSER::PROTEIN) ("EP2" . SPARSER::PROTEIN)
    ("GSK3 β" . SPARSER::PROTEIN)
    ("cAMP response element-binding protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GW627368X" . SPARSER::DRUG) ("EP4" . SPARSER::PROTEIN)
    ("a well-defined metastasis-promoting gene" . SPARSER::GENE)
    ("metastasis-associated genes" . SPARSER::GENE)
    ("Akt/PDK-1/mTOR" . SPARSER::COLLECTION)
    ("siRNA or shRNA" . SPARSER::COLLECTION)
    ("some metastasis-associated proteins" . SPARSER::PROTEIN)
    ("S100A4, MARCKSL1 and BAG4" . SPARSER::COLLECTION)
    ("classic tumour suppressors" . SPARSER::SUPPRESSOR)
    ("p53 and pVHL" . SPARSER::COLLECTION)
    ("oncogene or a tumour suppressor xref" . SPARSER::COLLECTION)
    ("mediating ELL's" . SPARSER::PROTEIN)
    ("c-Myc or c-Myc" . SPARSER::COLLECTION)
    ("ELL or ELL(C595A) mutant as well as ELL-shRNA" . SPARSER::COLLECTION)
    ("wild-type c-Myc (c-Myc-shRNA resistant) or c-Myc(4K/R) mutant"
     . SPARSER::COLLECTION)
    ("two well-defined c-Myc down-stream target genes" . SPARSER::GENE)
    ("Skp2 and HectH9" . SPARSER::COLLECTION)
    ("a well-defined tumour suppressor" . SPARSER::SUPPRESSOR)
    ("Vps 22 and Vps" . SPARSER::COLLECTION) ("Vps" . SPARSER::PROTEIN)
    ("proteins (EAP)" . SPARSER::PROTEIN)
    ("EAP45, EAF30 and EAF20" . SPARSER::COLLECTION)
    ("EAF" . SPARSER::PROTEIN-FAMILY) ("EAP" . SPARSER::PROTEIN)
    ("HECT and RBR-domain E3 ligases" . SPARSER::COLLECTION)
    ("typical E3 ligases" . SPARSER::LIGASE)
    ("these metastasis-associated genes" . SPARSER::GENE)
    ("S100A4 , MARCKSL1 and BAG4" . SPARSER::COLLECTION)
    ("a commercially available antibody" . SPARSER::PROTEIN)
    ("S100A4 , MARCKSL1 , BCAM , BAG4 , IPO4 and CPSF7" . SPARSER::COLLECTION)
    ("BCAM" . SPARSER::PROTEIN) ("ribs" . SPARSER::DRUG)
    ("c-Myc and Max" . SPARSER::COLLECTION)
    ("the wild-type c-Myc or the c-Myc(4K/R) mutant ( xref )"
     . SPARSER::COLLECTION)
    ("c-Myc-shRNA" . SPARSER::COLLECTION) ("MLL-ELL" . SPARSER::COLLECTION)
    ("ELL and ELL" . SPARSER::COLLECTION) ("ELL or ELL" . SPARSER::COLLECTION)
    ("hTERT and E2F2" . SPARSER::COLLECTION)
    ("ELL-shRNA" . SPARSER::COLLECTION)
    ("two well-defined c-Myc target genes" . SPARSER::GENE)
    ("two single-site mutants (K397R, K430R) and one double-site mutant (K51/52R)"
     . SPARSER::COLLECTION)
    ("4K/R" . SPARSER::PROTEIN)
    ("a typical E3 ubiquitin ligase" . SPARSER::PROTEIN)
    ("His6-ELL(C595A) and His6-c-Myc" . SPARSER::COLLECTION)
    ("His6-ELL, His6-ELL(C595A) and His6-c-Myc" . SPARSER::COLLECTION)
    ("UbcH8, UbcH6 and UbcH5b" . SPARSER::COLLECTION)
    ("ELL, and UbcH8" . SPARSER::COLLECTION)
    ("the HECT and RBR-domain E3 ligases" . SPARSER::COLLECTION)
    ("RBR" . SPARSER::PROTEIN-FAMILY) ("only one cysteine" . SPARSER::MOLECULE)
    ("AICAR (macro-autophagy inhibitor) and MG132 (proteasome inhibitor)"
     . SPARSER::COLLECTION)
    ("ELL and c-Myc" . SPARSER::COLLECTION)
    ("glutathione S-transferase (GST)-pull-down assays using GST-tagged c-Myc and His-tagged ELL"
     . SPARSER::COLLECTION)
    ("Flag-ELL" . SPARSER::COLLECTION) ("RFP-Max" . SPARSER::COLLECTION)
    ("Max" . SPARSER::PROTEIN) ("GFP-BM5" . SPARSER::PROTEIN-PAIR)
    ("GFP-ELL" . SPARSER::COLLECTION) ("RFP-c-Myc" . SPARSER::COLLECTION)
    ("HA-c-Myc" . SPARSER::COLLECTION) ("HA-ELL" . SPARSER::COLLECTION)
    ("Myc-ELL" . SPARSER::COLLECTION)
    ("the classic oncogenes" . SPARSER::ONCOGENE)
    ("heterotypic polyubiquitin" . SPARSER::PROTEIN)
    ("Fbw7" . SPARSER::PROTEIN)
    ("a multifunctional transcription factor" . SPARSER::PROTEIN)
    ("E2F1 and the TFIIH complex" . SPARSER::COLLECTION)
    ("steroid receptors, hypoxia-inducible factor 1-alpha (HIF-1α), E2F1 and the TFIIH complex"
     . SPARSER::COLLECTION)
    ("snRNA" . SPARSER::RNA)
    ("the super elongation complex (SEC) and the little elongation complex (LEC) xref  xref  xref"
     . SPARSER::COLLECTION)
    ("complex (SEC)" . SPARSER::BIO-COMPLEX)
    ("two distinct elongation" . SPARSER::PROTEIN)
    ("c-Myc and a potential tumour suppressor" . SPARSER::COLLECTION)
    ("Cysteine" . SPARSER::AMINO-ACID)
    ("an E3 ubiquitin ligase and targets c-Myc" . SPARSER::COLLECTION)
    ("transcriptional elongation" . SPARSER::PROTEIN)
    ("Ell" . SPARSER::PROTEIN) ("ELL" . SPARSER::PROTEIN)
    ("Colon cancer" . SPARSER::PROTEIN) ("Ubc13" . SPARSER::PROTEIN)
    ("UbcH7" . SPARSER::PROTEIN) ("UbcH5c" . SPARSER::PROTEIN)
    ("UbcH5a" . SPARSER::PROTEIN) ("s 5A" . SPARSER::PROTEIN)
    ("PDK-1" . SPARSER::PROTEIN) ("calcium-binding protein" . SPARSER::PROTEIN)
    ("Vps 22" . SPARSER::PROTEIN) ("EAP45" . SPARSER::PROTEIN)
    ("CPSF7" . SPARSER::PROTEIN) ("IPO4" . SPARSER::PROTEIN)
    ("BAG4" . SPARSER::PROTEIN) ("MARCKSL1" . SPARSER::PROTEIN)
    ("S100A4" . SPARSER::PROTEIN) ("Gadd45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GAL4" . SPARSER::PROTEIN) ("UbcH5b" . SPARSER::PROTEIN)
    ("UbcH6" . SPARSER::PROTEIN) ("E. coli )" . SPARSER::PROTEIN)
    ("co-localized" . SPARSER::PROTEIN) ("P57" . SPARSER::PROTEIN)
    ("HectH9" . SPARSER::PROTEIN) ("E6-AP" . SPARSER::PROTEIN)
    ("UbcH5" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor 1-alpha" . SPARSER::PROTEIN)
    ("UbcH8" . SPARSER::PROTEIN) ("PND" . SPARSER::PROTEIN)
    ("the most attractive tyrosine kinase" . SPARSER::PROTEIN)
    ("Phospholipid" . SPARSER::PHOSPHOLIPID)
    ("FAK1 and ALK" . SPARSER::COLLECTION)
    ("BIK (2.3-fold) and KDR (2.3-fold)" . SPARSER::COLLECTION)
    ("KDR" . SPARSER::PROTEIN) ("-ALK" . SPARSER::COLLECTION)
    ("FAK1/μg" . SPARSER::COLLECTION)
    ("FAK1 and phospho-FAK1" . SPARSER::COLLECTION)
    ("FAK1 (enzymatic IC 50 : 2.3 nM, cellular IC 50 : 88 nM) and anaplastic lymphoma kinase (ALK) (enzymatic IC 50 : 3.5 nM, cellular IC 50 : 40 nM, cellular IC 50 in 75 % human plasma: 120 nM)"
     . SPARSER::COLLECTION)
    ("anaplastic lymphoma kinase (ALK)" . SPARSER::PROTEIN)
    ("a potent ATP-competitive" . SPARSER::ATP)
    ("potent ATP-competitive" . SPARSER::ATP)
    ("vascular epidermal growth factor receptor (VEGFR)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Src, PI-3 kinase, and Grb-7" . SPARSER::COLLECTION)
    ("FAK1 or PTK2" . SPARSER::COLLECTION) ("a very aggressive type" . TYPE)
    ("bid" . SPARSER::PROTEIN) ("IBC02" . SPARSER::PROTEIN)
    ("FC-IBC02" . SPARSER::COLLECTION)
    ("ALK and phospho-ALK" . SPARSER::COLLECTION)
    ("FAK1 and anaplastic lymphoma kinase" . SPARSER::COLLECTION)
    ("an aggressive type" . TYPE) ("GSK2256098" . SPARSER::DRUG)
    ("VS-4718" . SPARSER::DRUG) ("PIK3" . SPARSER::PROTEIN)
    ("TAE226" . SPARSER::DRUG) ("ISG15" . SPARSER::PROTEIN)
    ("MX1" . SPARSER::PROTEIN) ("OAS1" . SPARSER::PROTEIN)
    ("OAS3" . SPARSER::PROTEIN) ("OAS2" . SPARSER::PROTEIN)
    ("IL23A" . SPARSER::PROTEIN) ("IL32" . SPARSER::PROTEIN)
    ("CCL5" . SPARSER::PROTEIN) ("IRF7" . SPARSER::PROTEIN)
    ("IFI35" . SPARSER::PROTEIN) ("IFI6" . SPARSER::PROTEIN)
    ("IFI27" . SPARSER::PROTEIN)
    ("phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("Grb-7" . SPARSER::PROTEIN) ("PI-3 kinase" . SPARSER::PROTEIN)
    ("FAK1" . SPARSER::PROTEIN) ("focal adhesion kinase 1" . SPARSER::PROTEIN)
    ("COPD, or cigarette" . SPARSER::COLLECTION)
    ("many pro-inflammatory chemokines and growth factors"
     . SPARSER::COLLECTION)
    ("chemokines and growth factors" . SPARSER::COLLECTION)
    ("CYP1A1 and CYP1B1" . SPARSER::COLLECTION)
    ("COPD and type" . SPARSER::COLLECTION) ("KRAS/EGFR" . SPARSER::COLLECTION)
    ("Males" . SPARSER::MOLECULE) ("HRM" . SPARSER::PROTEIN-FAMILY)
    ("male and 151 (46.5%) female" . SPARSER::COLLECTION)
    ("GOLD" . SPARSER::MOLECULE) ("HR 2" . SPARSER::PROTEIN)
    ("Variant" . SPARSER::VARIANT) ("prasugrel" . SPARSER::DRUG)
    ("CYP" . SPARSER::PROTEIN) ("mRNA and miRNAs" . SPARSER::COLLECTION)
    ("miRNA and its target mRNA" . SPARSER::COLLECTION)
    ("the external validation cohort" . SPARSER::MOLECULE)
    ("AG " . SPARSER::PROTEIN) ("AA, AG and GG" . SPARSER::COLLECTION)
    ("AA, AG, and GG" . SPARSER::COLLECTION)
    ("HPR and non-HPR" . SPARSER::COLLECTION) ("clopidogrel" . SPARSER::DRUG)
    ("Adenosine" . SPARSER::PROTEIN) ("HPR" . SPARSER::PROTEIN)
    ("P2Y12" . SPARSER::PROTEIN) ("HbA1" . SPARSER::PROTEIN)
    ("CD61" . SPARSER::PROTEIN) ("CD62P" . SPARSER::PROTEIN)
    ("P2Y 12" . SPARSER::PROTEIN) ("PAC-1" . SPARSER::PROTEIN)
    ("P-selectin" . SPARSER::PROTEIN)
    ("insulin receptor substrate-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGFβ and EGF" . SPARSER::COLLECTION)
    ("PLK1 and re-expression" . SPARSER::COLLECTION)
    ("PLK1 and CRAF" . SPARSER::COLLECTION) ("Med" . SPARSER::PROTEIN)
    ("ERK/FRA1/ZEB" . SPARSER::COLLECTION)
    ("ARCaP, ARCaP-E and ARCaP-M" . SPARSER::COLLECTION)
    ("Flag-PLK1" . SPARSER::COLLECTION) ("CRAF/ERK" . SPARSER::COLLECTION)
    ("currently available drugs" . SPARSER::DRUG)
    ("anoikis, and oncogene" . SPARSER::COLLECTION)
    ("ERK/Fra1/ZEB" . SPARSER::COLLECTION)
    ("an essential downstream effector" . SPARSER::EFFECTOR)
    ("MEK1/2-ERK1/2-Fra1-ZEB1/2" . SPARSER::PROTEIN)
    ("Ras as well as various kinases" . SPARSER::COLLECTION)
    ("Src, PKC, and PAK" . SPARSER::COLLECTION)
    ("CRAF-MEK1/2-ERK1/2" . SPARSER::COLLECTION)
    ("relapsed metastatic PCa" . SPARSER::PROTEIN)
    ("CRAF-MEK1/2-ERK1/2-Fra1-ZEB1/2" . SPARSER::COLLECTION)
    ("an established mitotic kinase" . SPARSER::KINASE)
    ("a 15-h" . SPARSER::COLLECTION)
    ("either WT PLK1 or its constitutively active TD mutant ( xref )"
     . SPARSER::COLLECTION)
    ("WT CRAF or the phospho-mimetic mutant (CRAF-D/E)" . SPARSER::COLLECTION)
    ("the phospho-mimetic mutant" . SPARSER::MUTANT)
    ("GST or the GST-PBD mutant ( xref )" . SPARSER::COLLECTION)
    ("PLK1-CRAF" . SPARSER::COLLECTION)
    ("MEK1/2 and ERK1/2" . SPARSER::COLLECTION)
    ("Fra1, ZEB1, and ZEB2" . SPARSER::COLLECTION)
    ("a retroviral oncogene" . SPARSER::ONCOGENE)
    ("ARAF and BRAF" . SPARSER::COLLECTION)
    ("further downstream effectors" . SPARSER::EFFECTOR)
    ("ARAF, BRAF, and CRAF" . SPARSER::COLLECTION) ("ARAF" . SPARSER::PROTEIN)
    ("RPWE-1–PLK1" . SPARSER::COLLECTION) ("ERK/ZEB" . SPARSER::COLLECTION)
    ("MEK and its upstream kinase" . SPARSER::COLLECTION)
    ("a highly selective dual inhibitor" . SPARSER::INHIBITOR)
    ("ERK1/2 and its upstream kinase MEK1/2 ( xref )" . SPARSER::COLLECTION)
    ("MEK1/2-ERK1/2" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase/extracellular signal-regulated kinase"
     . SPARSER::COLLECTION)
    ("ERK1/2-Fra1" . SPARSER::COLLECTION)
    ("ZEB1 or ZEB2" . SPARSER::COLLECTION)
    ("N-cadherin, fibronectin, and vimentin" . SPARSER::COLLECTION)
    ("ZEB1 and/or ZEB2" . SPARSER::COLLECTION)
    ("transforming growth factor β1 (TGF-β1) and epidermal growth factor (EGF)"
     . SPARSER::COLLECTION)
    ("physiologically-relevant EMT" . SPARSER::PROTEIN)
    ("ARCaP" . SPARSER::PROTEIN) ("yet another shRNA" . SPARSER::PROTEIN)
    ("kinase-defective KM PLK1" . SPARSER::PROTEIN)
    ("the perijunctional F-actin" . SPARSER::BIO-COMPLEX)
    ("IIB" . SPARSER::PROTEIN)
    ("junctional adhesion molecule (JAM)" . SPARSER::PROTEIN)
    ("kinase-defective (KM) PLK1" . SPARSER::PROTEIN)
    ("active (TD)" . SPARSER::ACTIVE)
    ("E-cadherin and cytokeratin" . SPARSER::COLLECTION)
    ("N-cadherin, vimentin, fibronectin, and SM22" . SPARSER::COLLECTION)
    ("total PLK1 or its active form" . SPARSER::COLLECTION)
    ("CRAF" . SPARSER::PROTEIN) ("v-Ras" . SPARSER::PROTEIN)
    ("collagen-I" . SPARSER::PROTEIN) ("JAM-A" . SPARSER::PROTEIN)
    ("anti−ERK" . SPARSER::PROTEIN) ("SM22α" . SPARSER::PROTEIN)
    ("anti−" . SPARSER::ANTIBODY) ("RasG12V" . SPARSER::PROTEIN)
    ("v-RAF" . SPARSER::PROTEIN) ("Fra-1" . SPARSER::PROTEIN)
    ("RO5126766" . SPARSER::DRUG) ("Snail2" . SPARSER::PROTEIN)
    ("Snail1" . SPARSER::PROTEIN) ("FoxM1" . SPARSER::PROTEIN)
    ("non-muscle" . SPARSER::PROTEIN) ("SM22" . SPARSER::PROTEIN)
    ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("high tumour genomic loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("oral continuous rucaparib" . SPARSER::DRUG)
    ("CR/PR/SD" . SPARSER::COLLECTION) ("CBR" . SPARSER::PROTEIN)
    ("longest PFI" . SPARSER::PROTEIN) ("PARP-" . SPARSER::PROTEIN)
    ("longer PFI" . SPARSER::PROTEIN) ("BRCA-" . SPARSER::PROTEIN-FAMILY)
    ("rucaparib and sustained inhibition ⩾24 h" . SPARSER::COLLECTION)
    ("a well-tolerated potent inhibitor" . SPARSER::INHIBITOR)
    ("type and BRCA" . SPARSER::COLLECTION) ("PFI" . SPARSER::PROTEIN)
    ("platinum-" . SPARSER::MOLECULE)
    ("preclinical models AG014699" . SPARSER::DRUG)
    ("camphorsulphonic acid salt" . SPARSER::MOLECULE)
    ("PARP5A and PARP5B" . SPARSER::COLLECTION)
    ("tankyrases" . SPARSER::PROTEIN)
    ("PARP-1 and PARP-2" . SPARSER::COLLECTION)
    ("ATM , CHEK2 , RAD51 and MRE11A" . SPARSER::COLLECTION)
    ("genes or pathways" . SPARSER::COLLECTION)
    ("gene or pathway" . SPARSER::COLLECTION) ("PARPs" . SPARSER::MOLECULE)
    ("continuous rucaparib" . SPARSER::DRUG) ("CR/PR" . SPARSER::COLLECTION)
    ("PS" . SPARSER::PROTEIN) ("rucaparib" . SPARSER::DRUG)
    ("an orally available potent selective small-molecule inhibitor"
     . SPARSER::INHIBITOR)
    ("Rucaparib" . SPARSER::DRUG) ("CA125" . SPARSER::DRUG)
    ("BRCA 1" . SPARSER::PROTEIN) ("XRCC3" . SPARSER::PROTEIN)
    ("AG014699" . SPARSER::DRUG) ("PARP5B" . SPARSER::PROTEIN)
    ("TANK1" . SPARSER::PROTEIN) ("PARP-2" . SPARSER::PROTEIN)
    ("PF-01367338" . SPARSER::DRUG) ("MRE11A" . SPARSER::PROTEIN)
    ("BRCA-1" . SPARSER::PROTEIN) ("PLK2 and PLK4" . SPARSER::COLLECTION)
    ("other centrosomal kinases" . SPARSER::KINASE)
    ("phosphoproteins" . SPARSER::PROTEIN) ("Bora" . SPARSER::PROTEIN)
    ("PLK1 and partial" . SPARSER::COLLECTION)
    ("PLK1 and its interacting proteins" . SPARSER::COLLECTION)
    ("nocodazole or monastrol" . SPARSER::COLLECTION)
    ("centrosomal protein Numb" . SPARSER::PROTEIN) ("Numb" . SPARSER::PROTEIN)
    ("Nedd1 and Hice1" . SPARSER::COLLECTION) ("Hice1" . SPARSER::PROTEIN)
    ("less soluble PLK1" . SPARSER::PROTEIN)
    ("either S888A single mutant or S861A-S888A double mutant"
     . SPARSER::COLLECTION)
    ("wild-type MLL5 or S861A mutant" . SPARSER::COLLECTION)
    ("the centrosomal PLK1" . SPARSER::PROTEIN)
    ("S888A (key PBD binding residue) single mutant or S861A-S888A double mutant"
     . SPARSER::COLLECTION)
    ("wild-type MLL5 and S861A (phospho-site) mutant" . SPARSER::COLLECTION)
    ("centrosomal FLAG-MLL5" . SPARSER::COLLECTION)
    ("pericentrin and MLL5" . SPARSER::COLLECTION)
    ("monastrol" . SPARSER::DRUG) ("a further 8 h" . SPARSER::PROTEIN)
    ("MLL5-CD4" . SPARSER::COLLECTION) ("FLAG-MLL5-CD4" . SPARSER::COLLECTION)
    ("the CD4-TST887AAA triple alanine mutant" . SPARSER::MUTANT)
    ("TST" . SPARSER::PROTEIN) ("MLL5-CD9" . SPARSER::COLLECTION)
    ("two smaller FLAG-MLL5" . SPARSER::COLLECTION)
    ("CD6 and CD9" . SPARSER::COLLECTION)
    ("wild-type PLK1 or kinase-dead PLK1 (D194A)" . SPARSER::COLLECTION)
    ("LSL and HSL" . SPARSER::COLLECTION) ("HSL" . SPARSER::PROTEIN)
    ("HA-PLK1" . SPARSER::COLLECTION) ("NC-shRNA" . SPARSER::COLLECTION)
    ("PLK4 and MLL5" . SPARSER::COLLECTION)
    ("siRNA/shRNA" . SPARSER::COLLECTION)
    ("NC- or MLL5-shRNA" . SPARSER::COLLECTION)
    ("MLL5-shRNA" . SPARSER::COLLECTION)
    ("NC- or PLK4-siRNA–transfected" . SPARSER::COLLECTION)
    ("PLK4-siRNA" . SPARSER::COLLECTION) ("PLK4-KD" . SPARSER::COLLECTION)
    ("first depleted centrosomal MLL5" . SPARSER::PROTEIN)
    ("centrosomal MLL5" . SPARSER::PROTEIN)
    ("centrin-2 and PLK1" . SPARSER::COLLECTION)
    ("pericentrin and PLK1" . SPARSER::COLLECTION)
    ("NC- and MLL5-siRNA–transfected" . SPARSER::COLLECTION)
    ("NC-" . SPARSER::PROTEIN) ("PLK1 and MLL5" . SPARSER::COLLECTION)
    ("supernumerary foci" . SPARSER::PROTEIN)
    ("pericentrin and γ-tubulin" . SPARSER::COLLECTION)
    ("PCM proteins and the centrioles" . SPARSER::COLLECTION)
    ("anti-pericentrin and anti–α-tubulin" . SPARSER::COLLECTION)
    ("MLL5-siRNA" . SPARSER::COLLECTION) ("NC-siRNA" . SPARSER::COLLECTION)
    ("PHD/SET domain" . SPARSER::COLLECTION)
    ("FLAG-MLL5" . SPARSER::COLLECTION)
    ("known centrosomal proteins" . SPARSER::PROTEIN)
    ("anti-MLL5 or anti–rabbit" . SPARSER::COLLECTION)
    ("centrosomal fractions" . SPARSER::COMPONENT)
    ("MLL5 and γ-tubulin" . SPARSER::COLLECTION)
    ("sucrose" . SPARSER::MOLECULE)
    ("a centrosomal protein" . SPARSER::PROTEIN)
    ("a SET domain and a PHD zinc finger" . SPARSER::COLLECTION)
    ("PHD" . SPARSER::PROTEIN)
    ("PLK1 or its centrosomal substrates ( xref ; xref ; xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("its centrosomal substrates" . SPARSER::SUBSTRATE)
    ("pericentrin and Nedd1" . SPARSER::COLLECTION)
    ("Nedd1" . SPARSER::PROTEIN) ("Cnn" . SPARSER::PROTEIN)
    ("PCM" . SPARSER::PROTEIN) ("MLL5-KD" . SPARSER::COLLECTION)
    ("MLL5 and PLK1" . SPARSER::COLLECTION)
    ("MLL5 and PLK" . SPARSER::COLLECTION) ("PLK" . SPARSER::PROTEIN)
    ("90K" . SPARSER::PROTEIN) ("α-Tubulin" . SPARSER::PROTEIN)
    ("Nek2" . SPARSER::PROTEIN) ("PLK2" . SPARSER::PROTEIN)
    ("SENP6" . SPARSER::PROTEIN) ("CD9" . SPARSER::PROTEIN)
    ("CD6" . SPARSER::PROTEIN) ("A-K" . SPARSER::PROTEIN)
    ("centrin-2" . SPARSER::PROTEIN) ("MLL5" . SPARSER::PROTEIN)
    ("proteins or RNAs" . SPARSER::COLLECTION) ("lincRNA" . SPARSER::RNA)
    ("a catalytic α subunit and two regulatory β and γ subunits"
     . SPARSER::COLLECTION)
    ("active (CA)" . SPARSER::ACTIVE) ("SAMS" . SPARSER::PROTEIN)
    ("bacterial purified GST-ACC" . SPARSER::COLLECTION)
    ("GST-ACC" . SPARSER::COLLECTION) ("NBR2 and LKB1" . SPARSER::COLLECTION)
    ("AMPK-LKB1" . SPARSER::COLLECTION)
    ("AMPK and mTORC1" . SPARSER::COLLECTION) ("AMPK-" . SPARSER::PROTEIN)
    ("at least three splicing isoforms" . SPARSER::ISOFORM)
    ("purified AMPK α and in vitro -synthesized biotinylated NBR2"
     . SPARSER::COLLECTION)
    ("NBR2 and AMPK α" . SPARSER::COLLECTION)
    ("NBR2 and endogenous AMPK β and γ subunits ( xref )"
     . SPARSER::COLLECTION)
    ("endogenous AMPK β and γ subunits ( xref )" . SPARSER::COLLECTION)
    ("a heterotrimeric complex which consists of a catalytic α subunit and two regulatory β and γ subunits  xref"
     . SPARSER::COLLECTION)
    ("a heterotrimeric complex" . SPARSER::BIO-COMPLEX)
    ("phosphorylatable" . SPARSER::PROTEIN) ("Glucose" . SPARSER::PROTEIN)
    ("-AMPK" . SPARSER::COLLECTION)
    ("AMPK, ACC and Raptor" . SPARSER::COLLECTION)
    ("AMPK, or AMPK" . SPARSER::COLLECTION)
    ("AMPK-mTORC1" . SPARSER::COLLECTION) ("hexokinase" . SPARSER::PROTEIN)
    ("the long intergenic noncoding RNAs" . SPARSER::RNA)
    ("lincRNAs" . SPARSER::RNA)
    ("energy stress-induced lncRNAs" . SPARSER::RNA)
    ("an energy stress-induced lncRNA" . SPARSER::RNA)
    ("AMPK and its downstream effectors" . SPARSER::COLLECTION)
    ("both the upstream kinase Lkb1 and downstream effectors"
     . SPARSER::COLLECTION)
    ("TSC1 and TSC2" . SPARSER::COLLECTION)
    ("protein and lipid" . SPARSER::COLLECTION)
    ("Raptor, a component of mTORC1, and the TSC1-TSC2 complex"
     . SPARSER::COLLECTION)
    ("TSC1-TSC2" . SPARSER::COLLECTION) ("Raptor" . SPARSER::PROTEIN)
    ("all chromatin-associated lncRNAs" . SPARSER::RNA)
    ("ACC 1" . SPARSER::PROTEIN) ("E-9" . SPARSER::PROTEIN)
    ("p70 S6 kinase α" . SPARSER::PROTEIN) ("AMPKβ" . SPARSER::PROTEIN)
    ("AMPK α1" . SPARSER::PROTEIN) ("AMPK β" . SPARSER::PROTEIN)
    ("AMPK α" . SPARSER::PROTEIN-FAMILY) ("compound C" . SPARSER::MOLECULE)
    ("A769662" . SPARSER::DRUG) ("LKB1-AMPK" . SPARSER::PROTEIN)
    ("gene 2" . SPARSER::PROTEIN) ("NBR2" . SPARSER::PROTEIN)
    ("SIRT1 gene or other tumor-related genes [ xref ]" . SPARSER::COLLECTION)
    ("PR and ER" . SPARSER::COLLECTION) ("AG and GG" . SPARSER::COLLECTION)
    ("APOE" . SPARSER::PROTEIN) ("CYP2C9" . SPARSER::PROTEIN)
    ("CALU" . SPARSER::PROTEIN) ("Los" . SPARSER::MOLECULE)
    ("systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("the TT genotype and the T allele" . SPARSER::COLLECTION)
    ("genotype and allele" . SPARSER::COLLECTION)
    ("N2 and N3" . SPARSER::COLLECTION)
    ("CC and CT carriers" . SPARSER::COLLECTION)
    ("the heterozygous genotype AG" . SPARSER::PROTEIN)
    ("ALP (p = 0.892) and bilirubin (p = 0.785)" . SPARSER::COLLECTION)
    ("bilirubin" . SPARSER::MOLECULE) ("opt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("class O (FOXO)" . SPARSER::PROTEIN) ("CYP4F2" . SPARSER::PROTEIN)
    ("CYP2" . SPARSER::PROTEIN) ("N3" . SPARSER::PROTEIN)
    ("naringenin" . SPARSER::DRUG) ("Smad3 and type I" . SPARSER::COLLECTION)
    ("/Smad" . SPARSER::COLLECTION) ("porcine TGF- β 1" . SPARSER::PROTEIN)
    ("Smad3 and Smad7" . SPARSER::COLLECTION)
    ("the regulatory Smad3 and inhibitory Smad7" . SPARSER::COLLECTION)
    ("the regulatory Smad3" . SPARSER::PROTEIN)
    ("mediators, Smad2 and Smad3" . SPARSER::COLLECTION)
    ("a multifunctional regulatory cytokine" . SPARSER::PROTEIN)
    ("fibrous tissue mRNA Smad3, Smad7 and protein" . SPARSER::COLLECTION)
    ("Smad3, Smad7 and protein" . SPARSER::COLLECTION)
    ("Smad3, P-Smad3, Smad7, and TGF- β 1" . SPARSER::COLLECTION)
    ("Smad3, P-Smad3, and TGF β 1" . SPARSER::COLLECTION)
    ("Smad3, P-Smad3, and TGF- β 1" . SPARSER::COLLECTION)
    ("p-Smad3" . SPARSER::COLLECTION) ("prolactin" . SPARSER::PROTEIN)
    ("FSH" . SPARSER::DRUG)
    ("TGF- β 1, Smad3, and Smad7" . SPARSER::COLLECTION)
    ("TGF- β 1/Smad3" . SPARSER::COLLECTION)
    ("T β RI and Smads" . SPARSER::COLLECTION)
    ("TGF- β 1 and Smad3" . SPARSER::COLLECTION)
    ("collagen and fibronectin" . SPARSER::COLLECTION)
    ("LTBPs" . SPARSER::PROTEIN-FAMILY)
    ("latency associated peptide (LAP) and a molecule" . SPARSER::COLLECTION)
    ("protein (LTBP)" . SPARSER::PROTEIN)
    ("an inactive tripartite complex" . SPARSER::BIO-COMPLEX)
    ("LTBP" . SPARSER::PROTEIN-FAMILY) ("LAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGF- β 1/Smad3/smad7" . SPARSER::COLLECTION)
    ("smad3 and TGF- β 1" . SPARSER::COLLECTION)
    ("Smad3, Smad7, and TGF- β 1" . SPARSER::COLLECTION)
    ("Smurf2" . SPARSER::PROTEIN) ("β 1" . SPARSER::PROTEIN)
    ("T β RI" . SPARSER::PROTEIN) ("TGF β 1" . SPARSER::PROTEIN)
    ("latency associated peptide" . SPARSER::PROTEIN)
    ("smad7" . SPARSER::PROTEIN) ("smad3" . SPARSER::PROTEIN)
    ("SIS3" . SPARSER::MOLECULE) ("TGF- β 1" . SPARSER::PROTEIN)
    ("Smad7" . SPARSER::PROTEIN) ("receptor and HER2" . SPARSER::COLLECTION)
    ("Nonpathogenic and unclassified variants" . SPARSER::VARIANT)
    ("the heterozygous germline BRCA1 c" . SPARSER::PROTEIN)
    ("the heterozygous germline BRCA2 c" . SPARSER::PROTEIN)
    ("valine" . SPARSER::AMINO-ACID) ("isoleucine" . SPARSER::AMINO-ACID)
    ("abnormal mRNA" . SPARSER::PROTEIN)
    ("The heterozygous germline BRCA1 mutation c" . SPARSER::PROTEIN)
    ("BRCA2 protein" . SPARSER::PROTEIN) ("S11" . SPARSER::PROTEIN)
    ("ICAT and NLK" . SPARSER::COLLECTION)
    ("Neither DAAM1 nor NLK" . SPARSER::COLLECTION)
    ("Wnt5a and 5b" . SPARSER::COLLECTION)
    ("Wnt5a and Wnt5b" . SPARSER::COLLECTION)
    ("Wnt3 and Wnt5" . SPARSER::COLLECTION)
    ("Smad3 and β ‐catenin" . SPARSER::COLLECTION)
    ("kinase (NLK)" . SPARSER::KINASE) ("Nemo" . SPARSER::PROTEIN)
    ("junctional complexes" . SPARSER::BIO-COMPLEX)
    ("NLK (Fig.  xref D) and ICAT (Fig.  xref F)" . SPARSER::COLLECTION)
    ("Wnt5a" . SPARSER::PROTEIN) ("ICAT" . SPARSER::PROTEIN)
    ("protein C" . SPARSER::DRUG) ("Wnt3" . SPARSER::PROTEIN)
    ("G–H" . SPARSER::PROTEIN) ("Protein C" . SPARSER::DRUG)
    ("morphogenesis 1" . SPARSER::PROTEIN) ("Wnt5" . SPARSER::PROTEIN)
    ("MAD3 (a mutated IκBα gene) or TAM67 (a dominant negative mutant of c-Jun)"
     . SPARSER::COLLECTION)
    ("CAPE (a specific NF-κB inhibitor) or SR-11302 (a selective AP-1 inhibitor)"
     . SPARSER::COLLECTION)
    ("MAD3 or TAM67" . SPARSER::COLLECTION)
    ("CAPE or SR-11302" . SPARSER::COLLECTION) ("retinoid" . SPARSER::PROTEIN)
    ("oncogenes (β-catenin, c-myc) and hyperproliferation"
     . SPARSER::COLLECTION)
    ("β-catenin or c-myc" . SPARSER::COLLECTION)
    ("CAPE and SR-11302" . SPARSER::COLLECTION)
    ("MAD3 and TAM67" . SPARSER::COLLECTION)
    ("IκBα ( MAD3 ) and c-Jun ( TAM67 )" . SPARSER::COLLECTION)
    ("a specific NF-κB inhibitor caffeic acid phenethyl ester (CAPE)"
     . SPARSER::MOLECULE)
    ("ester (CAPE)" . SPARSER::MOLECULE) ("CAPE" . SPARSER::PROTEIN)
    ("oncogenes and hyperproliferation" . SPARSER::COLLECTION)
    ("NF-κB and AP-1" . SPARSER::COLLECTION)
    ("β-catenin and c-myc" . SPARSER::COLLECTION) ("IκB-α" . SPARSER::PROTEIN)
    ("nicotinamide adenine dinucleotide phosphate oxidase" . SPARSER::PROTEIN)
    ("MAD3" . SPARSER::PROTEIN) ("CDK4/E2F1/c-Myc" . SPARSER::COLLECTION)
    ("C-Myc-miR-18b" . SPARSER::PROTEIN-PAIR)
    ("CTGF-C-Jun" . SPARSER::PROTEIN-PAIR)
    ("CDK4, c-Myc, and E2F1" . SPARSER::COLLECTION)
    ("miR-15a directly targets Cripto, Bmi-1, CCNE1, RECK, VEGF, CCND1, and BCL-2"
     . SPARSER::COLLECTION)
    ("Cripto, Bmi-1, CCNE1, RECK, VEGF, CCND1, and BCL-2"
     . SPARSER::COLLECTION)
    ("Cripto" . SPARSER::PROTEIN) ("DLEU2 and miR-15a" . SPARSER::COLLECTION)
    ("CCND1, CDK6, p21, and pRB" . SPARSER::COLLECTION)
    ("mRNA and miR-15a" . SPARSER::COLLECTION)
    ("NPC and NP" . SPARSER::COLLECTION)
    ("CCND1 and miR-15a" . SPARSER::COLLECTION)
    ("the directly target gene" . SPARSER::GENE)
    ("its directly target gene" . SPARSER::GENE)
    ("c-Myc, CDK4 and E2F1" . SPARSER::COLLECTION)
    ("directly target CCND1" . SPARSER::PROTEIN)
    ("CCND1,CDK6, and E2F1" . SPARSER::COLLECTION)
    ("siRNA-CDK4" . SPARSER::COLLECTION)
    ("c-Myc and Bcl-2" . SPARSER::COLLECTION)
    ("PTEN, LATS2, and TGFBR2" . SPARSER::COLLECTION)
    ("important tumor-associated genes" . SPARSER::GENE)
    ("proteins and cyclin dependent kinases" . SPARSER::COLLECTION)
    ("CDK4 and miR-15a" . SPARSER::COLLECTION)
    ("c-Myc/CCND1/CDK4/E2F1" . SPARSER::COLLECTION) ("NPC" . SPARSER::MOLECULE)
    ("C-Jun" . SPARSER::PROTEIN) ("Bmi-1" . SPARSER::PROTEIN)
    ("Sox5" . SPARSER::PROTEIN) ("DLEU2" . SPARSER::PROTEIN)
    ("C-Myc" . SPARSER::PROTEIN) ("ARF5" . SPARSER::PROTEIN)
    ("cyclin dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phospho-ALK and alternative RTKs" . SPARSER::COLLECTION)
    ("afatinib and ALK" . SPARSER::COLLECTION)
    ("clinically developed small-molecule inhibitors" . SPARSER::INHIBITOR)
    ("NTS" . SPARSER::PROTEIN)
    ("a ALK/EGFR dual inhibitor" . SPARSER::INHIBITOR)
    ("ALK/EGFR" . SPARSER::COLLECTION) ("EGFR-HER3" . SPARSER::COLLECTION)
    ("p-HER2" . SPARSER::COLLECTION) ("HER3 and NRG1" . SPARSER::COLLECTION)
    ("EGF and IGF" . SPARSER::COLLECTION)
    ("NRG1, EGF, and IGF" . SPARSER::COLLECTION)
    ("ligand (HGF)" . SPARSER::MOLECULE)
    ("EGFR, KIT, and IGF-1R" . SPARSER::COLLECTION)
    ("a dual inhibitor" . SPARSER::INHIBITOR)
    ("afatinib or afatinib" . SPARSER::COLLECTION)
    ("alectinib and afatinib" . SPARSER::COLLECTION)
    ("EGFR, HER2, and HER3" . SPARSER::COLLECTION)
    ("NPM-ALK" . SPARSER::COLLECTION) ("HER3-EGFR" . SPARSER::COLLECTION)
    ("NRG1-EGFR-HER3" . SPARSER::COLLECTION)
    ("p-HER3 in either the presence or absence of NRG1 ( xref  A and B )"
     . SPARSER::PROTEIN)
    ("exogenous NRG1" . SPARSER::PROTEIN) ("HER3-AKT" . SPARSER::COLLECTION)
    ("EGF, amphiregulin, or IGF" . SPARSER::COLLECTION)
    ("ligand (IGF)" . SPARSER::MOLECULE)
    ("EGF and amphiregulin" . SPARSER::COLLECTION)
    ("amphiregulin" . SPARSER::PROTEIN) ("p-AXL" . SPARSER::COLLECTION)
    ("ALK, EGFR, HER3, and IGF-1R" . SPARSER::COLLECTION)
    ("p-IGF-1R" . SPARSER::COLLECTION) ("p-HER3" . SPARSER::COLLECTION)
    ("HER3 and IGF-1R" . SPARSER::COLLECTION)
    ("mRNA, and IGF-1R" . SPARSER::COLLECTION) ("RTKs" . SPARSER::PROTEIN)
    ("phospho-IGF-1R and phospho-HER3" . SPARSER::COLLECTION)
    ("p-ALK" . SPARSER::COLLECTION)
    ("alectinib or ceritinib" . SPARSER::COLLECTION)
    ("protein and phospho-ALK" . SPARSER::COLLECTION)
    ("their respective ALK inhibitor" . SPARSER::INHIBITOR)
    ("Alectinib and Ceritinib" . SPARSER::COLLECTION)
    ("Ros" . SPARSER::PROTEIN) ("particular afatinib" . SPARSER::DRUG)
    ("NRG1-HER3-EGFR" . SPARSER::COLLECTION)
    ("phospho-ALK and alternative receptor tyrosine kinases"
     . SPARSER::COLLECTION)
    ("phospho-EGFR, phospho-HER3, and phospho-IGFR-1R" . SPARSER::COLLECTION)
    ("alectinib and ceritinib" . SPARSER::COLLECTION)
    ("Alectinib and ceritinib" . SPARSER::COLLECTION)
    ("AZD8931" . SPARSER::DRUG) ("Tyrosine Kinase" . SPARSER::PROTEIN)
    ("C – E" . SPARSER::PROTEIN) ("Phospho-Kinase" . SPARSER::PROTEIN)
    ("neuregulin-1" . SPARSER::PROTEIN) ("PF06463922" . SPARSER::DRUG)
    ("AZD 8931" . SPARSER::DRUG) ("B-Raf" . SPARSER::PROTEIN)
    ("IGFR-1" . SPARSER::PROTEIN) ("NF-κB/VEGF-C" . SPARSER::COLLECTION)
    ("“TNF-α/ERK1/2/AP-1/VEGF-D" . SPARSER::COLLECTION)
    ("TNFR and ERK1/2" . SPARSER::COLLECTION)
    ("Ras family and K-ras" . SPARSER::COLLECTION)
    ("guanosine triphosphate (GTP)" . SPARSER::MOLECULE)
    ("ERK1/2/AP-1" . SPARSER::COLLECTION)
    ("reagents, SP600125, SB203580 and PD98059" . SPARSER::COLLECTION)
    ("JNK or p38 MAPK" . SPARSER::COLLECTION)
    ("TNF-α and its receptor" . SPARSER::COLLECTION)
    ("NF-κB or AP-1" . SPARSER::COLLECTION)
    ("COUP-TF1 and COUP-TF2" . SPARSER::COLLECTION)
    ("ovalbumin" . SPARSER::PROTEIN)
    ("lentiviral-mediated shRNA" . SPARSER::PROTEIN)
    ("LVD" . SPARSER::MOLECULE) ("h, and 24 h" . SPARSER::COLLECTION)
    ("GBC-SD, LV-siVEGF-D and LV-siNC" . SPARSER::COLLECTION)
    ("DiI" . SPARSER::MOLECULE) ("TNF-α and VEGF-D" . SPARSER::COLLECTION)
    ("a GBC-SD cell line (Fig.  xref ) stably expressing lentiviral VEGF-D shRNA"
     . SPARSER::PROTEIN)
    ("TNF-α/AP-1" . SPARSER::COLLECTION) ("SP600125-" . SPARSER::PROTEIN)
    ("SB203580 (20 μM) or PD98059 (50 μM)" . SPARSER::COLLECTION)
    ("JNK, p38 or ERK1/2" . SPARSER::COLLECTION)
    ("p-AP-1" . SPARSER::COLLECTION) ("siNC" . SPARSER::DRUG)
    ("siAP-1" . SPARSER::COLLECTION)
    ("TNF-α/ERK1/2/AP-1" . SPARSER::COLLECTION)
    ("AP-1 and NF-κB" . SPARSER::COLLECTION)
    ("the VEGF-D gene promoter and the firefly luciferase report gene (named PGL4-2148, PGL4-1621, PGL4-988, PGL4-717, PGL4-444, PGL4-325, PGL4-154, and PGL4-57)"
     . SPARSER::COLLECTION)
    ("pRL-TK" . SPARSER::COLLECTION) ("pRL" . SPARSER::PROTEIN)
    ("VEGF-D and TNF-α" . SPARSER::COLLECTION)
    ("a key pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("TNF-α, IL-1, and IL-6" . SPARSER::COLLECTION)
    ("Cytokines" . SPARSER::PROTEIN)
    ("ERK1/2/AP-1/VEGF-D" . SPARSER::COLLECTION)
    ("TNF-α-VEGF-D" . SPARSER::COLLECTION) ("GBC" . SPARSER::PROTEIN)
    ("JNK, p38 MAPK and ERK1/2" . SPARSER::COLLECTION)
    ("exogenous TNF-α" . SPARSER::PROTEIN) ("GBC-SD" . SPARSER::PROTEIN-PAIR)
    ("ASK1" . SPARSER::PROTEIN) ("MAP3K" . SPARSER::PROTEIN)
    ("COUP-TF2" . SPARSER::PROTEIN) ("COUP-TF1" . SPARSER::PROTEIN)
    ("HNF-4" . SPARSER::PROTEIN)
    ("hepatocyte nuclear factor 4" . SPARSER::PROTEIN)
    ("AP-1 transcription factor" . SPARSER::PROTEIN) ("RD1" . SPARSER::PROTEIN)
    ("LYVE-1" . SPARSER::PROTEIN) ("VEGF-C" . SPARSER::PROTEIN)
    ("Tumor necrosis factor" . SPARSER::PROTEIN) ("VEGF-D" . SPARSER::PROTEIN)
    ("Vascular endothelial" . SPARSER::PROTEIN)
    ("Tumor necrosis factor-alpha" . SPARSER::PROTEIN)
    ("overactive p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and MDM2" . SPARSER::COLLECTION)
    ("its respective wild type residue type" . TYPE)
    ("licorice" . SPARSER::DRUG)
    ("many high affinity competitive inhibitors" . SPARSER::INHIBITOR)
    ("rational drug" . SPARSER::DRUG)
    ("multiple excellent MDM2 inhibitors" . SPARSER::INHIBITOR)
    ("MDM2 and MDMX" . SPARSER::COLLECTION) ("RO" . SPARSER::PROTEIN)
    ("tightly binding highly specific inhibitors" . SPARSER::INHIBITOR)
    ("five drugs representative examples" . SPARSER::EXAMPLE)
    ("val" . SPARSER::AMINO-ACID) ("flap" . SPARSER::PROTEIN)
    ("MDMX" . SPARSER::PROTEIN) ("indole" . SPARSER::DRUG)
    ("oxindole" . SPARSER::DRUG) ("TDP" . SPARSER::TDP)
    ("nutlin" . SPARSER::DRUG) ("nutlins" . SPARSER::DRUG)
    ("their alanine scanning and molecular dynamics" . SPARSER::COLLECTION)
    ("peptidomimetic inhibitors" . SPARSER::INHIBITOR) ("PBSA" . SPARSER::DRUG)
    ("nitrogen" . SPARSER::MOLECULE) ("hyperactive MDM2" . SPARSER::PROTEIN)
    ("competitive inhibitors" . SPARSER::INHIBITOR)
    ("novel competitive inhibitors" . SPARSER::INHIBITOR)
    ("Nutlin-3" . SPARSER::DRUG)
    ("receptor and adaptor protein" . SPARSER::COLLECTION)
    ("potential predictive clinical biomarkers" . SPARSER::MOLECULE)
    ("SLC7A11 or xCT" . SPARSER::COLLECTION) ("xCT" . SPARSER::PROTEIN)
    ("an important predictive biomarker" . SPARSER::MOLECULE)
    ("ganitumab" . SPARSER::DRUG) ("a weak IRS-1" . SPARSER::PROTEIN)
    ("a strong IRS-1" . SPARSER::PROTEIN) ("poor RFS" . SPARSER::PROTEIN)
    ("TGFβ1 or TGFβ2" . SPARSER::COLLECTION) ("SH-EP" . SPARSER::PROTEIN)
    ("alternate IRS" . SPARSER::PROTEIN) ("isoform-" . SPARSER::ISOFORM)
    ("IRS-1 and IRS-2" . SPARSER::COLLECTION)
    ("functional IGF-1R" . SPARSER::PROTEIN)
    ("PI3K and MAPK" . SPARSER::COLLECTION)
    ("monoclonal antibodies and tyrosine kinase inhibitors"
     . SPARSER::INHIBITOR)
    ("antibodies and tyrosine kinase" . SPARSER::COLLECTION)
    ("TGFb2" . SPARSER::PROTEIN) ("IRS-1 or IRS-2" . SPARSER::COLLECTION)
    ("IGF1R and its two adaptor proteins" . SPARSER::COLLECTION)
    ("predictive biomarkers" . SPARSER::MOLECULE) ("RPLP0" . SPARSER::PROTEIN)
    ("SLC7A11" . SPARSER::PROTEIN) ("MYBL2" . SPARSER::PROTEIN)
    ("HEMA3" . SPARSER::PROTEIN) ("TGFβ2" . SPARSER::PROTEIN)
    ("IRS-2" . SPARSER::PROTEIN)
    ("insulin-like growth factor receptor" . SPARSER::PROTEIN)
    ("RIPK1-RIPK3" . SPARSER::COLLECTION) ("/p10" . SPARSER::COLLECTION)
    ("TRAIL and CD95" . SPARSER::COLLECTION) ("DISCs" . SPARSER::BIO-COMPLEX)
    ("the active DISC" . SPARSER::BIO-COMPLEX)
    ("CD95/TRAIL" . SPARSER::COLLECTION) ("-caspase-8" . SPARSER::COLLECTION)
    ("caspase-8 or c-FLIP" . SPARSER::COLLECTION)
    ("caspase-8 and c-FLIP" . SPARSER::COLLECTION)
    ("full-length recombinant proteins and structure-guided DED mutants"
     . SPARSER::COLLECTION)
    ("FKBP" . SPARSER::PROTEIN)
    ("either an activator or an inhibitor of caspase-8 activation"
     . SPARSER::COLLECTION)
    ("FADD:caspase-8:c-FLIP" . SPARSER::BIO-COMPLEX)
    ("previously whereby multiple procaspase-8 molecules" . SPARSER::MOLECULE)
    ("FADD:caspase-8" . SPARSER::BIO-COMPLEX)
    ("approximately 6-fold more caspase-8" . SPARSER::PROTEIN)
    ("FADD and c-FLIP" . SPARSER::COLLECTION)
    ("FADD, caspase-8, and c-FLIP" . SPARSER::COLLECTION)
    ("procaspase-8 and p43/41" . SPARSER::COLLECTION)
    ("TRAIL or CD95" . SPARSER::COLLECTION)
    ("TRAIL or CD95L" . SPARSER::COLLECTION) ("-EGFP" . SPARSER::COLLECTION)
    ("caspase-8, caspase-10, or FADD" . SPARSER::COLLECTION)
    ("procaspase-8 or c-FLIP" . SPARSER::COLLECTION)
    ("caspase-8:c-FLIP" . SPARSER::BIO-COMPLEX)
    ("the next procaspase-8 molecule" . SPARSER::MOLECULE)
    ("phenylalanine/leucine" . SPARSER::COLLECTION)
    ("phenylalanine" . SPARSER::AMINO-ACID)
    ("c-FLIP and procaspase-8" . SPARSER::COLLECTION)
    ("exogenous procaspase-8" . SPARSER::PROTEIN) ("Jurkat" . SPARSER::PROTEIN)
    ("TRAIL-R1 or CD95" . SPARSER::COLLECTION)
    ("procaspase-8 and c-FLIP" . SPARSER::COLLECTION)
    ("c-FLIP and Procaspase-8" . SPARSER::COLLECTION)
    ("/procaspase-8" . SPARSER::COLLECTION)
    ("ripoptosome" . SPARSER::BIO-COMPLEX)
    ("/Procaspase-8" . SPARSER::COLLECTION)
    ("procaspase-8/c-FLIP" . SPARSER::COLLECTION)
    ("p43/p12" . SPARSER::COLLECTION)
    ("p43 fragment and a C-terminal p12 fragment ( xref B)"
     . SPARSER::COLLECTION)
    ("p41/p10" . SPARSER::COLLECTION)
    ("exogenous DISC substrates" . SPARSER::SUBSTRATE)
    ("r-FADD" . SPARSER::COLLECTION)
    ("FADD, procaspase-8, and c-FLIP" . SPARSER::COLLECTION)
    ("a highly active heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("IAPs" . SPARSER::PROTEIN) ("Ripoptosome" . SPARSER::BIO-COMPLEX)
    (":procaspase-8" . SPARSER::BIO-COMPLEX)
    ("activator or inhibitor" . SPARSER::COLLECTION)
    ("CD95 or TRAIL-R1/R2" . SPARSER::COLLECTION)
    ("receptors (DR)" . SPARSER::RECEPTOR)
    ("receptors-1/-2" . SPARSER::COLLECTION) ("Fas/Apo1" . SPARSER::COLLECTION)
    ("procaspase-8:c-FLIP" . SPARSER::BIO-COMPLEX)
    ("/c-FLIP" . SPARSER::COLLECTION) ("Amino acids" . SPARSER::AMINO-ACID)
    ("TOP 3" . SPARSER::PROTEIN) ("CD95L" . SPARSER::PROTEIN)
    ("caspase-10" . SPARSER::PROTEIN) ("c- FLIP" . SPARSER::PROTEIN)
    ("p43" . SPARSER::PROTEIN) ("p10" . SPARSER::PROTEIN)
    ("TRAIL-R4" . SPARSER::PROTEIN) ("RIPK3" . SPARSER::PROTEIN)
    ("Fas-associated death domain protein" . SPARSER::PROTEIN)
    ("TNFR superfamily" . SPARSER::PROTEIN) ("TNF-R1" . SPARSER::PROTEIN)
    ("TNF-related apoptosis-inducing ligand" . SPARSER::PROTEIN)
    ("Apo1" . SPARSER::PROTEIN) ("ATM and NBN" . SPARSER::COLLECTION)
    ("NBN" . SPARSER::PROTEIN) ("typical FA" . SPARSER::PROTEIN)
    ("FA-D1 or FA-N" . SPARSER::COLLECTION)
    ("the Q559RfsTer2 patient-associated mutant PALB2 protein"
     . SPARSER::PROTEIN)
    ("BRCA1-PALB2" . SPARSER::COLLECTION) ("PALB2-BRCA2" . SPARSER::COLLECTION)
    ("Rad51 and the Rad51 paralogs" . SPARSER::COLLECTION)
    ("BRCA2, Rad51 and the Rad51 paralogs" . SPARSER::COLLECTION)
    ("Asn" . SPARSER::AMINO-ACID)
    ("a seven-bladed beta-propeller" . SPARSER::PROTEIN-FAMILY)
    ("propeller" . SPARSER::PROTEIN-FAMILY) ("MMC or IR" . SPARSER::COLLECTION)
    ("the FLAG-tagged exogenous PALB2" . SPARSER::PROTEIN)
    ("WT PALB2 and the revertant" . SPARSER::COLLECTION)
    ("the induced FLAG-tagged exogenous PALB2" . SPARSER::PROTEIN)
    ("FLAG tagged WT PALB2" . SPARSER::PROTEIN) ("Flp" . SPARSER::PROTEIN)
    ("our atypical FA-N family" . SPARSER::PROTEIN-FAMILY)
    ("The smaller protein" . SPARSER::PROTEIN)
    ("BRCA2 or RAD51" . SPARSER::COLLECTION)
    ("BRCA1, BRCA2, PALB2 and Rad51" . SPARSER::COLLECTION)
    ("our unusual DNA repair deficient family" . SPARSER::PROTEIN-FAMILY)
    ("PALB2 , BRCA2 or RAD51" . SPARSER::COLLECTION)
    ("IR or MMC" . SPARSER::COLLECTION) ("residual foci" . SPARSER::PROTEIN)
    ("MDC1, 53BP1, BRCA1, FANCD2 and RPA2" . SPARSER::COLLECTION)
    ("Smc" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IR and MMC" . SPARSER::COLLECTION) ("CBC" . SPARSER::BIO-COMPLEX)
    ("IgM" . SPARSER::PROTEIN) ("MTX" . SPARSER::DRUG) ("VCR" . SPARSER::DRUG)
    ("CD3, CD45RO, CD15, CD30, ALK and EMA" . SPARSER::COLLECTION)
    ("previously identified patient-associated mutant PALB2 proteins"
     . SPARSER::PROTEIN)
    ("FA-D1, FA-N, FA-S, FA-O and FA-R" . SPARSER::COLLECTION)
    ("mitomycin C (MMC) and diepoxybutane" . SPARSER::COLLECTION)
    ("gonadal" . SPARSER::PROTEIN-FAMILY) ("microphthalmia" . SPARSER::PROTEIN)
    ("BRCA2 [ xref – xref ] and PALB2 [ xref – xref ]" . SPARSER::COLLECTION)
    ("BRCA1 [ xref , xref ] and Rad51C [ xref ]" . SPARSER::COLLECTION)
    ("RAD51C [ xref ] and RAD51D [ xref ]" . SPARSER::COLLECTION)
    ("PALB2 and Rad51" . SPARSER::COLLECTION)
    ("BRCA1 and PALB2" . SPARSER::COLLECTION)
    ("RAP80, MERIT40, Abraxas, BRCC36/45, CtIP or FANCJ" . SPARSER::COLLECTION)
    ("CtIP" . SPARSER::PROTEIN) ("Abraxas" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRCA2-Rad51" . SPARSER::COLLECTION)
    ("simultaneously binding both BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("Rad51 and the Rad51 paralogs form" . SPARSER::COLLECTION)
    ("BRCA2, PALB2, BRCA1, Rad51 and the Rad51 paralogs form"
     . SPARSER::COLLECTION)
    ("one hypomorphic allele" . SPARSER::ALLELE)
    ("Homologous Recombination Repair (HRR) proteins BRCA1, BRCA2 and Rad51"
     . SPARSER::COLLECTION)
    ("BRCA1, BRCA2 and Rad51" . SPARSER::COLLECTION)
    ("a hypomorphic PALB2 allele" . SPARSER::ALLELE)
    ("a very mild form" . SPARSER::FORM) ("a severe form" . SPARSER::FORM)
    ("Fanconi" . SPARSER::PROTEIN-FAMILY) ("Chk2" . SPARSER::PROTEIN)
    ("CHK2" . SPARSER::PROTEIN) ("KAP-1" . SPARSER::PROTEIN)
    ("SMC1" . SPARSER::PROTEIN) ("I-2" . SPARSER::PROTEIN)
    ("I-1" . SPARSER::PROTEIN) ("core protein" . SPARSER::PROTEIN)
    ("90kD" . SPARSER::PROTEIN) ("RPA2" . SPARSER::PROTEIN)
    ("MDC1" . SPARSER::PROTEIN) ("FA-A" . SPARSER::PROTEIN)
    ("ARA-C" . SPARSER::DRUG) ("CD30" . SPARSER::PROTEIN)
    ("CD45RO" . SPARSER::PROTEIN) ("CD 10" . SPARSER::PROTEIN)
    ("CD79a" . SPARSER::PROTEIN) ("CD20" . SPARSER::PROTEIN)
    ("FA-S" . SPARSER::PROTEIN) ("FA-D1" . SPARSER::PROTEIN)
    ("Rad51C" . SPARSER::PROTEIN) ("RAD51D" . SPARSER::PROTEIN)
    ("BRCC36" . SPARSER::PROTEIN) ("MERIT40" . SPARSER::PROTEIN)
    ("RAP80" . SPARSER::PROTEIN) ("PAD4–E2F-1" . SPARSER::COLLECTION)
    ("TNFα and IL-6" . SPARSER::COLLECTION)
    ("E2F-1 and BD1" . SPARSER::COLLECTION)
    ("E2F-1/BRD4" . SPARSER::COLLECTION) ("GSK" . SPARSER::PROTEIN)
    ("DMSO and TNFα" . SPARSER::COLLECTION) ("chemokine" . SPARSER::PROTEIN)
    ("PAD4 and E2F-1" . SPARSER::COLLECTION) ("HL60" . SPARSER::PROTEIN)
    ("E2F-1 ( xref ) and PAD4 ( xref )" . SPARSER::COLLECTION)
    ("amidine" . SPARSER::MOLECULE) ("exogenous PAD4" . SPARSER::PROTEIN)
    ("TP73 and CDC6" . SPARSER::COLLECTION)
    ("E2F-1 and PAD4" . SPARSER::COLLECTION) ("Arginine" . SPARSER::AMINO-ACID)
    ("E2F-1, and PAD4" . SPARSER::COLLECTION)
    ("E2F-1 and BRD4" . SPARSER::COLLECTION)
    ("NETs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E2F-1, and PAD4 and BRD4" . SPARSER::COLLECTION)
    ("PAD4 and BRD4" . SPARSER::COLLECTION) ("citrulline" . SPARSER::MOLECULE)
    ("CD3ε" . SPARSER::PROTEIN) ("NT3" . SPARSER::PROTEIN)
    ("DNA Polymerase" . SPARSER::PROTEIN) ("C20" . SPARSER::PROTEIN)
    ("CD11B" . SPARSER::PROTEIN) ("K3" . SPARSER::PROTEIN)
    ("BD2" . SPARSER::PROTEIN) ("BD1" . SPARSER::PROTEIN)
    ("interleukin-1β" . SPARSER::PROTEIN) ("C-C motif" . SPARSER::PROTEIN)
    ("CCL3" . SPARSER::PROTEIN) ("CDC6" . SPARSER::PROTEIN)
    ("TP73" . SPARSER::PROTEIN) ("PRMT1" . SPARSER::PROTEIN)
    ("bromodomain-containing protein 4" . SPARSER::PROTEIN)
    ("Peptidyl arginine deiminase 4" . SPARSER::PROTEIN)
    ("E2F-1" . SPARSER::PROTEIN) ("PAD4" . SPARSER::PROTEIN)
    ("C-Fos and c-Jun" . SPARSER::COLLECTION)
    ("c-jun and c-fos" . SPARSER::COLLECTION)
    ("COX2 or PGE2" . SPARSER::COLLECTION)
    ("the JNK inhibitor SP600125 or the p38 inhibitor SB203580 (Fig.  xref a)"
     . SPARSER::COLLECTION)
    ("exogenous IL-17A" . SPARSER::PROTEIN)
    ("TNF-α and IFNγ" . SPARSER::COLLECTION)
    ("IL-6 and PGE2" . SPARSER::COLLECTION)
    ("c-Fos and c-Jun" . SPARSER::COLLECTION)
    ("P38 and JNK" . SPARSER::COLLECTION)
    ("AP-1, c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("p38 and JNK" . SPARSER::COLLECTION) ("P38/c-Fos" . SPARSER::COLLECTION)
    ("P38, JNK and ERK" . SPARSER::COLLECTION)
    ("SB203580 and SP600125" . SPARSER::COLLECTION)
    ("JNK/MAPK" . SPARSER::COLLECTION) ("P38/MAPK" . SPARSER::COLLECTION)
    ("ERK/MAPK" . SPARSER::COLLECTION)
    ("JNK, p-ERK1/2 and ERK1/2" . SPARSER::COLLECTION)
    ("p-JNK" . SPARSER::COLLECTION) ("JNK-MAPK" . SPARSER::COLLECTION)
    ("MAPK/AP-1" . SPARSER::COLLECTION)
    ("c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK)"
     . SPARSER::COLLECTION)
    ("three major MAPKs, p38 kinase, c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK)"
     . SPARSER::COLLECTION)
    ("three major MAPKs" . SPARSER::PROTEIN)
    ("CCL20/CCR6" . SPARSER::COLLECTION)
    ("PGE2 and COX2" . SPARSER::COLLECTION)
    ("COX1 and COX2" . SPARSER::COLLECTION)
    ("TNF-α, IL-6, and PGE2" . SPARSER::COLLECTION) ("LBP" . SPARSER::PROTEIN)
    ("JNK/c-Jun" . SPARSER::COLLECTION) ("p38/c-Fos" . SPARSER::COLLECTION)
    ("kinase and Jun" . SPARSER::COLLECTION)
    ("COX2 and PGE2" . SPARSER::COLLECTION)
    ("MAPK or AP-1" . SPARSER::COLLECTION) ("C-Fos" . SPARSER::PROTEIN)
    ("c-fos" . SPARSER::PROTEIN) ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti-ERK" . SPARSER::PROTEIN) ("p-ERK" . SPARSER::PROTEIN)
    ("Activator protein-1" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CCR6" . SPARSER::PROTEIN) ("CCL20" . SPARSER::PROTEIN)
    ("COX1" . SPARSER::PROTEIN) ("cyclo-oxygenase" . SPARSER::PROTEIN)
    ("tumour necrosis factor" . SPARSER::PROTEIN) ("IL-1α" . SPARSER::PROTEIN)
    ("interleukin-1α" . SPARSER::PROTEIN) ("PGE2" . SPARSER::DRUG)
    ("IL-17A" . SPARSER::PROTEIN)
    ("CIA and co-cultivated" . SPARSER::COLLECTION)
    ("co-stimulatory molecules and pro-inflammatory cytokines"
     . SPARSER::COLLECTION)
    ("proinflammatory cytokines and MMPs" . SPARSER::COLLECTION)
    ("cytokines and MMPs" . SPARSER::COLLECTION)
    ("TNF and IL-6" . SPARSER::COLLECTION)
    ("IL-1, IL-6 and IL-12p70" . SPARSER::COLLECTION)
    ("both inflammatory cytokines and ROR-γT" . SPARSER::COLLECTION)
    ("cytokines and ROR-γT" . SPARSER::COLLECTION)
    ("NF-κB and activator protein-1" . SPARSER::COLLECTION)
    ("p65 and phospho-c-jun" . SPARSER::COLLECTION)
    ("IL-12p70, IL-1β and IL-6" . SPARSER::COLLECTION)
    ("pro- and anti-inflammatory" . SPARSER::COLLECTION)
    ("CD86 and the MHC class II molecule" . SPARSER::COLLECTION)
    ("CD80, CD86 and the MHC class II molecule" . SPARSER::COLLECTION)
    ("macrophages and osteoclasts" . SPARSER::COLLECTION)
    ("IFN-γ and IL-17" . SPARSER::COLLECTION)
    ("CIA and re-stimulated" . SPARSER::COLLECTION)
    ("autoantibody" . SPARSER::PROTEIN)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-1β, IL-6, IL-17 and IL-23" . SPARSER::COLLECTION)
    ("chemoattractant protein-1, MMP-3 and MMP-13" . SPARSER::COLLECTION)
    ("IFN-γ, IL-17 and IL-23" . SPARSER::COLLECTION)
    ("macrophages and neutrophils" . SPARSER::COLLECTION)
    ("Myeloid" . SPARSER::PROTEIN)
    ("pathogenic autoantibodies" . SPARSER::PROTEIN)
    ("autoantibodies" . SPARSER::PROTEIN) ("Gao" . SPARSER::PROTEIN)
    ("suppressor or promoter" . SPARSER::COLLECTION)
    ("FLSs" . SPARSER::PROTEIN)
    ("metalloproteinases and ROR-γT" . SPARSER::COLLECTION)
    ("CD80-" . SPARSER::PROTEIN) ("ROR" . SPARSER::PROTEIN-FAMILY)
    ("CIA" . SPARSER::PROTEIN) ("SIRT-1" . SPARSER::PROTEIN)
    ("IL-27" . SPARSER::PROTEIN) ("IL-1" . SPARSER::PROTEIN)
    ("activator protein-1" . SPARSER::PROTEIN) ("IL-23" . SPARSER::PROTEIN)
    ("MMP-13" . SPARSER::PROTEIN) ("MMP-3" . SPARSER::PROTEIN)
    ("chemoattractant protein-1" . SPARSER::PROTEIN)
    ("lamin B" . SPARSER::PROTEIN-FAMILY) ("p-65" . SPARSER::PROTEIN)
    ("c-jun" . SPARSER::PROTEIN) ("IL-4" . SPARSER::PROTEIN)
    ("granulocyte-macrophage colony-stimulating factor" . SPARSER::PROTEIN)
    ("anti-CD28" . SPARSER::PROTEIN) ("brefeldin A" . SPARSER::MOLECULE)
    ("IL-17" . SPARSER::PROTEIN) ("IL-10" . SPARSER::PROTEIN)
    ("IL-12p70" . SPARSER::PROTEIN)
    ("glucose-6-phosphate isomerase" . SPARSER::PROTEIN)
    ("factor-κB" . SPARSER::PROTEIN) ("CD86" . SPARSER::PROTEIN)
    ("CD80" . SPARSER::PROTEIN)
    ("the primary substrates for NQO1’s" . SPARSER::SUBSTRATE)
    ("nucleophiles" . SPARSER::MOLECULE)
    ("quinone and phytyl" . SPARSER::COLLECTION)
    ("the Selenium and Vitamin E Cancer Prevention Trial (SELECT) [ xref ]"
     . SPARSER::COLLECTION)
    ("Selenium" . SPARSER::MOLECULE) ("Carotene" . SPARSER::MOLECULE)
    ("at least part" . SPARSER::COMPONENT) ("esterases" . SPARSER::PROTEIN)
    ("androgenic ligands" . SPARSER::LIGAND)
    ("testosterone or dihydrotestosterone" . SPARSER::COLLECTION)
    ("genes or gene" . SPARSER::COLLECTION)
    ("androgen and TQ" . SPARSER::COLLECTION)
    ("phosphatase , NKX3 . 1 , and prostate specific membrane antigen"
     . SPARSER::COLLECTION)
    ("mRNA and AR" . SPARSER::COLLECTION)
    ("these distinct antioxidants" . SPARSER::DRUG)
    ("cellular redox" . SPARSER::PROTEIN)
    ("The antioxidants N-acetylcysteine (NAC) and AT" . SPARSER::COLLECTION)
    ("N-acetylcysteine (NAC)" . SPARSER::DRUG)
    ("AR or FOXA1" . SPARSER::COLLECTION)
    ("25 μM TQ or AT" . SPARSER::COLLECTION)
    ("phosphatase , NKX3 . 1 and prostate specific membrane antigen"
     . SPARSER::COLLECTION)
    ("prostein" . SPARSER::PROTEIN)
    ("either 30 μM TQ or AT ( xref )" . SPARSER::COLLECTION)
    ("TQ or AT" . SPARSER::COLLECTION) ("Antioxidants" . SPARSER::DRUG)
    ("analogs and derivatives" . SPARSER::COLLECTION)
    ("a more water soluble ester derivative" . SPARSER::DERIVATIVE)
    ("gonadotropin" . SPARSER::PROTEIN)
    ("a bioactive quinone" . SPARSER::PROTEIN)
    ("chromanol" . SPARSER::MOLECULE) ("tocopherylquinone" . SPARSER::DRUG)
    ("-tocotrienols" . SPARSER::MOLECULE) ("RRR" . SPARSER::PROTEIN)
    ("tocotrienols" . SPARSER::MOLECULE)
    ("TM4SF1, KLK2, and PSA" . SPARSER::COLLECTION)
    ("the Multifunctional Androgen Receptor" . SPARSER::PROTEIN)
    ("TQ" . SPARSER::DRUG) ("Tocopherylquinone" . SPARSER::DRUG)
    ("CSS 1" . SPARSER::PROTEIN) ("120 kD" . SPARSER::PROTEIN)
    ("RP-18" . SPARSER::PROTEIN) ("Alpha-Tocopherol" . SPARSER::MOLECULE)
    ("transmembrane 4 L six family member 1" . SPARSER::PROTEIN)
    ("pro-oxidant" . SPARSER::MOLECULE) ("RXRα" . SPARSER::PROTEIN)
    ("retinoid X receptor" . SPARSER::PROTEIN)
    ("prostate specific membrane antigen" . SPARSER::PROTEIN)
    ("NKX3 . 1" . SPARSER::PROTEIN) ("kallikrein 2" . SPARSER::PROTEIN)
    ("CYP17A1" . SPARSER::PROTEIN) ("α-tocopherol" . SPARSER::MOLECULE)
    ("KLK2" . SPARSER::PROTEIN) ("TM4SF1" . SPARSER::PROTEIN)
    ("DU145" . SPARSER::PROTEIN) ("alpha-tocopherol" . SPARSER::MOLECULE)
    ("SC-514 and BMS-345541" . SPARSER::COLLECTION)
    ("MAP kinase, ERK, PI3K/Akt or JNK" . SPARSER::COLLECTION)
    ("the ERK inhibitor (PD98059) or the JNK inhibitor (SP600125)"
     . SPARSER::COLLECTION)
    ("MAPK/JNK" . SPARSER::COLLECTION)
    ("annexin V and propidium" . SPARSER::COLLECTION)
    ("anti-RNA polymerase II (Pol II) or rabbit isotype antibodies"
     . SPARSER::COLLECTION)
    ("an anti-c-Rel" . SPARSER::ANTIBODY)
    ("either SC-514 (35  μ M) or BMS-345541 (8  μ M)" . SPARSER::COLLECTION)
    ("AKT, ERK and JNK" . SPARSER::COLLECTION)
    ("p65 and IK" . SPARSER::COLLECTION) ("IK" . SPARSER::PROTEIN)
    ("JNK, p38, AKT and ERK" . SPARSER::COLLECTION)
    ("RASSF" . SPARSER::PROTEIN-FAMILY) ("CD40L/CD154" . SPARSER::COLLECTION)
    ("NORE1A/Rassf5" . SPARSER::COLLECTION)
    ("soluble CD40L" . SPARSER::PROTEIN) ("Ribonuclease A" . SPARSER::PROTEIN)
    ("TNF -α" . SPARSER::PROTEIN) ("I κ B α" . SPARSER::PROTEIN)
    ("IKK2" . SPARSER::PROTEIN) ("D2H" . SPARSER::PROTEIN)
    ("BMS-345541" . SPARSER::DRUG) ("SC-514" . SPARSER::PROTEIN)
    ("Ras-binding" . SPARSER::PROTEIN) ("RASSF5" . SPARSER::PROTEIN)
    ("CD154" . SPARSER::PROTEIN) ("Rassf5" . SPARSER::PROTEIN)
    ("NORE1A" . SPARSER::PROTEIN) ("mCD40" . SPARSER::PROTEIN)
    ("CD40L" . SPARSER::PROTEIN) ("Membrane-bound" . SPARSER::PROTEIN)
    ("HG, or LPS or ADR" . SPARSER::COLLECTION)
    ("endogenic Cdc42 gene" . SPARSER::GENE)
    ("Annexin V, and propidium" . SPARSER::COLLECTION)
    ("HG, LPS and ADR" . SPARSER::COLLECTION)
    ("Cdc42 and Nwasp" . SPARSER::COLLECTION) ("LatA" . SPARSER::DRUG)
    ("Phalloidin" . SPARSER::MOLECULE)
    ("HG, LPS or ADR-injured podocytes" . SPARSER::COLLECTION)
    ("HG or LPS or ADR" . SPARSER::COLLECTION)
    ("Bax and Bcl2" . SPARSER::COLLECTION) ("HG or LPS" . SPARSER::COLLECTION)
    ("LPS or ADR" . SPARSER::COLLECTION)
    ("massive neonatal proteinuria" . SPARSER::PROTEIN)
    ("HG, LPS or ADR-injured podocytes in vitro and in vivo"
     . SPARSER::COLLECTION)
    ("mannitol (MA)" . SPARSER::DRUG) ("mannitol" . SPARSER::PROTEIN)
    ("HG, LPS or ADR" . SPARSER::COLLECTION)
    ("LPS or ADR-induced proteinuria and podocytopathy" . SPARSER::COLLECTION)
    ("proteinuria and podocytopathy" . SPARSER::COLLECTION)
    ("glucose (HG)" . SPARSER::MOLECULE)
    ("insufficient Cdc42 or neuronal Wiskott–Aldrich syndrome protein (Nwasp)"
     . SPARSER::COLLECTION)
    ("neuronal Wiskott–Aldrich syndrome protein" . SPARSER::PROTEIN)
    ("insufficient Cdc42" . SPARSER::PROTEIN)
    ("increased pro-apoptotic Bax" . SPARSER::PROTEIN)
    ("Cdc42/Nwasp" . SPARSER::COLLECTION)
    ("insufficient Cdc42 or Nwasp" . SPARSER::COLLECTION)
    ("Cdc42 or Nwasp" . SPARSER::COLLECTION) ("Nwasp" . SPARSER::PROTEIN)
    ("lipopolysaccharide-" . SPARSER::PROTEIN) ("glucose-" . SPARSER::PROTEIN)
    ("doxorubicin hydrochloride" . SPARSER::DRUG)
    ("anti-Histone" . SPARSER::PROTEIN) ("IFN- γ" . SPARSER::PROTEIN)
    ("G-protein" . SPARSER::PROTEIN) ("WT-1" . SPARSER::PROTEIN)
    ("Wiskott–Aldrich syndrome protein" . SPARSER::PROTEIN)
    ("pro-HB-EGF and FOXO" . SPARSER::COLLECTION) ("BLC" . SPARSER::PROTEIN)
    ("claudin-1 and other genes" . SPARSER::COLLECTION)
    ("miR-155 targets FOXO3 , SOCS1 , claudin-1 and other genes"
     . SPARSER::COLLECTION)
    ("SOCS1-STAT3" . SPARSER::COLLECTION)
    ("BCL6 and its downstream gene cyclin D2" . SPARSER::COLLECTION)
    ("BCL6 and cyclin D2" . SPARSER::COLLECTION)
    ("antagomir" . SPARSER::PROTEIN) ("antagomir-NC" . SPARSER::COLLECTION)
    ("NOK-SI" . SPARSER::COLLECTION) ("SI" . SPARSER::PROTEIN)
    ("NOK" . SPARSER::PROTEIN)
    ("-epidermal growth factor (EGF)" . SPARSER::COLLECTION)
    ("-epidermal growth factor" . SPARSER::COLLECTION)
    ("cyclin D2 and various chemokines ( xref )" . SPARSER::COLLECTION)
    ("suppressor of cytokine signaling 1 (SOCS1) and signal transducer and activator of transcription 3 (STAT3)"
     . SPARSER::COLLECTION)
    ("miRNAs or miRs" . SPARSER::COLLECTION)
    ("BCL6/cyclin D2" . SPARSER::COLLECTION)
    ("its target gene B-cell CLL/lymphoma 6 ( BCL6 ) and downstream gene cyclin D2 ( CCND2 )"
     . SPARSER::COLLECTION)
    ("pro-HB-EGF" . SPARSER::PROTEIN) ("FOXO3" . SPARSER::PROTEIN)
    ("C/EBPβ" . SPARSER::PROTEIN) ("forkhead box O3" . SPARSER::PROTEIN)
    ("Cyclin D2" . SPARSER::PROTEIN) ("CDC73" . SPARSER::PROTEIN)
    ("cell division cycle 73" . SPARSER::PROTEIN)
    ("claudin-1" . SPARSER::PROTEIN) ("SOCS1" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling 1" . SPARSER::PROTEIN)
    ("CCND2" . SPARSER::PROTEIN) ("B-cell CLL/lymphoma 6" . SPARSER::PROTEIN)
    ("suppressor or enhancer" . SPARSER::COLLECTION)
    ("the smaller cohort" . SPARSER::MOLECULE)
    ("FAK and DSS" . SPARSER::COLLECTION)
    ("Lyn and paxillin" . SPARSER::COLLECTION)
    ("Lyn and downstream paxillin" . SPARSER::COLLECTION)
    ("Dasatinib and saracatinib" . SPARSER::COLLECTION)
    ("Lyn and Paxillin" . SPARSER::COLLECTION)
    ("Lyn or Paxillin" . SPARSER::COLLECTION)
    ("VHL-PTP1B-Src kinase" . SPARSER::COLLECTION) ("Lck" . SPARSER::PROTEIN)
    ("Hck" . SPARSER::PROTEIN) ("Fgr" . SPARSER::PROTEIN)
    ("Blk" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR TKi, such as sunitinib, pazopanib and axitinib) and inhibitors"
     . SPARSER::COLLECTION)
    ("sunitinib, pazopanib and axitinib" . SPARSER::COLLECTION)
    ("everolimus or temsirolimus" . SPARSER::COLLECTION)
    ("temsirolimus" . SPARSER::DRUG) ("axitinib" . SPARSER::DRUG)
    ("pazopanib" . SPARSER::DRUG) ("Dasatinib" . SPARSER::DRUG)
    ("Lyn" . SPARSER::PROTEIN)
    ("dasatinib and saracatinib" . SPARSER::COLLECTION)
    ("Elk-1" . SPARSER::PROTEIN) ("regulated kinase" . SPARSER::PROTEIN)
    ("src kinase" . SPARSER::PROTEIN) ("beta tubulin" . SPARSER::PROTEIN)
    ("PTP1B" . SPARSER::PROTEIN) ("less intensive LVEF" . SPARSER::COMPONENT)
    ("TnI or BNP" . SPARSER::COLLECTION)
    ("elevated cardiac biomarkers" . SPARSER::MOLECULE)
    ("cardiac biomarker" . SPARSER::MOLECULE)
    ("significant asymptomatic LVEF" . SPARSER::COMPONENT)
    ("paclitaxel, trastuzumab, and lapatinib" . SPARSER::COLLECTION)
    ("subsequent LVEF" . SPARSER::COMPONENT)
    ("ultrasensitive TnI" . SPARSER::PROTEIN)
    ("doxorubicin and trastuzumab" . SPARSER::COLLECTION)
    ("an abnormal GLS" . SPARSER::PROTEIN)
    ("significant asymptomatic grade 2 LVEF" . SPARSER::COMPONENT)
    ("paclitaxel and dual anti-HER2 therapy" . SPARSER::COLLECTION)
    ("symptomatic HF" . SPARSER::PROTEIN)
    ("a significant asymptomatic LVEF" . SPARSER::COMPONENT)
    ("—1" . SPARSER::PROTEIN) ("Cardiac Biomarkers" . SPARSER::MOLECULE)
    ("an asymptomatic LVEF" . SPARSER::COMPONENT)
    ("Abnormal GLS" . SPARSER::PROTEIN)
    ("asymptomatic and subsequent follow-up LVEF" . SPARSER::COMPONENT)
    ("carvedilol (25 mg twice daily) and lisinopril (20 mg once daily) therapy"
     . SPARSER::COLLECTION)
    ("lisinopril" . SPARSER::DRUG) ("carvedilol" . SPARSER::DRUG)
    ("asymptomatic LVEF" . SPARSER::COMPONENT)
    ("Cardiac biomarkers" . SPARSER::MOLECULE) ("LVEF" . SPARSER::COMPONENT)
    ("pertuzumab and trastuzumab" . SPARSER::COLLECTION)
    ("Pertuzumab" . SPARSER::DRUG)
    ("left ventricular ejection fraction (LVEF)" . SPARSER::COMPONENT)
    ("fraction (LVEF)" . SPARSER::COMPONENT)
    ("anthracycline" . SPARSER::MOLECULE) ("Trastuzumab" . SPARSER::DRUG)
    ("cardiac biomarkers" . SPARSER::MOLECULE)
    ("trastuzumab and pertuzumab" . SPARSER::COLLECTION)
    ("pre- and postchemotherapy" . SPARSER::COLLECTION)
    ("GLS, and TnI and BNP" . SPARSER::COLLECTION)
    ("TnI and BNP" . SPARSER::COLLECTION)
    ("paclitaxel, trastuzumab, and pertuzumab" . SPARSER::COLLECTION)
    ("BNP" . SPARSER::PROTEIN) ("TnI" . SPARSER::PROTEIN)
    ("GLS" . SPARSER::PROTEIN) ("natriuretic peptide" . SPARSER::PROTEIN)
    ("troponin-I" . SPARSER::PROTEIN)
    ("Vimentin and Snail" . SPARSER::COLLECTION)
    ("h and 24 h" . SPARSER::COLLECTION)
    ("HIF-1α, COX-2 and EMT" . SPARSER::COLLECTION)
    ("Snail, Vimentin and E-cadherin" . SPARSER::COLLECTION)
    ("HIF-1α/COX-2" . SPARSER::COLLECTION) ("AFP" . SPARSER::PROTEIN)
    ("EMT and HIF-1" . SPARSER::COLLECTION)
    ("EMT and HIF-1α" . SPARSER::COLLECTION)
    ("endotoxin and hormones ( xref , xref )" . SPARSER::COLLECTION)
    ("COX-1 and COX-2" . SPARSER::COLLECTION)
    ("Cyclooxygenase" . SPARSER::PROTEIN)
    ("HIF-1α and HIF-1α" . SPARSER::COLLECTION)
    ("Snail and Vimentin" . SPARSER::COLLECTION)
    ("HIF-1α and COX-2" . SPARSER::COLLECTION) ("TACE" . SPARSER::PROTEIN)
    ("Hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("NIFK, RUNX1 and CK1alpha" . SPARSER::COLLECTION)
    ("NIFK and CK1alpha" . SPARSER::COLLECTION) ("exp" . SPARSER::PROTEIN)
    ("Pro" . SPARSER::AMINO-ACID) ("RUNX1 and CK1alpha" . SPARSER::COLLECTION)
    ("CK1α/β-catenin" . SPARSER::COLLECTION)
    ("TCF/β–catenin" . SPARSER::COLLECTION)
    ("NIFK-CK1α-β-catenin" . SPARSER::COLLECTION)
    ("Axin and GSK3-β" . SPARSER::COLLECTION)
    ("Dvl" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-catenin and APC" . SPARSER::COLLECTION)
    ("APC, Axin, CK1α, and GSK3β" . SPARSER::COLLECTION)
    ("Hklp2/KIF15" . SPARSER::COLLECTION)
    ("NIFK ( MKI67IP ) and CK1α ( CSNK1A1 )" . SPARSER::COLLECTION)
    ("NIFK and RUNX1 or CK1α" . SPARSER::COLLECTION)
    ("RUNX1 or CK1α" . SPARSER::COLLECTION)
    ("RUNX1 and CK1α" . SPARSER::COLLECTION) ("CdxA" . SPARSER::PROTEIN)
    ("SRY and RUNX1" . SPARSER::COLLECTION)
    ("RUNX1 and SRY" . SPARSER::COLLECTION)
    ("TCF4, CD44, CCND1 and MMP7" . SPARSER::COLLECTION)
    ("NIFK-CK1α" . SPARSER::COLLECTION) ("NIFK/CK1α" . SPARSER::COLLECTION)
    ("TCF/β-catenin" . SPARSER::COLLECTION)
    ("CK1α and the adenomatous polyposis coli (APC)-AXIN-CK1α-CTNNβ-GSK3β complex"
     . SPARSER::COLLECTION)
    ("the adenomatous polyposis coli (APC)-AXIN-CK1α-CTNNβ-GSK3β complex"
     . SPARSER::BIO-COMPLEX)
    ("IPA" . SPARSER::MOLECULE) ("CK1α and Wnt" . SPARSER::COLLECTION)
    ("the previously characterized NIFK" . SPARSER::PROTEIN)
    ("MMP7, MYC, TCF4, CCND1 and CD44" . SPARSER::COLLECTION)
    ("NIFK and Ki-67" . SPARSER::COLLECTION)
    ("cyclin-dependent kinase 1 (CDK1) and glycogen synthase kinase GSK-3 ( xref )"
     . SPARSER::COLLECTION)
    ("N ucleolar protein" . SPARSER::PROTEIN)
    ("TCF4/β-catenin" . SPARSER::COLLECTION)
    ("Nucleolar protein" . SPARSER::PROTEIN) ("NIFK" . SPARSER::PROTEIN)
    ("pKi" . SPARSER::PROTEIN-FAMILY) ("FHA" . SPARSER::PROTEIN-FAMILY)
    ("CK1 α" . SPARSER::PROTEIN) ("CK1alpha" . SPARSER::PROTEIN)
    ("β–catenin" . SPARSER::PROTEIN) ("Runx-1" . SPARSER::PROTEIN)
    ("tumor antigen" . SPARSER::DRUG) ("KIF15" . SPARSER::PROTEIN)
    ("Hklp2" . SPARSER::PROTEIN) ("MKI67" . SPARSER::PROTEIN)
    ("GSK-3" . SPARSER::PROTEIN) ("CSNK1A1" . SPARSER::PROTEIN)
    ("IGF-AKT" . SPARSER::COLLECTION) ("SIRT6 and AKT" . SPARSER::COLLECTION)
    ("miR-34a and miR-766 (Davalos et al., xref ; Lefort et al., xref ; Sharma et al., xref )"
     . SPARSER::COLLECTION)
    ("peptidase" . SPARSER::PROTEIN) ("myristoylated" . SPARSER::PROTEIN)
    ("A–C, S1C and S1D" . SPARSER::COLLECTION)
    ("AKT/mTOR" . SPARSER::COLLECTION)
    ("the autophagic puncta" . SPARSER::PROTEIN)
    ("EGFP-LC3" . SPARSER::COLLECTION)
    ("B–D, S1C and S1D" . SPARSER::COLLECTION) ("DHE" . SPARSER::DRUG)
    ("2 h and 6 h" . SPARSER::COLLECTION) ("h and 24 h" . SPARSER::COLLECTION)
    ("unnecessary cellular components or dysfunctional organelles"
     . SPARSER::COLLECTION)
    ("unnecessary cellular components" . SPARSER::COMPONENT)
    ("cerebral ischemia" . SPARSER::PROTEIN)
    ("oxygen and glucose" . SPARSER::COLLECTION)
    ("ADP-ribosyltransferase and NAD +" . SPARSER::COLLECTION)
    ("ischemia and oxygen/glucose" . SPARSER::COLLECTION)
    ("OGD" . SPARSER::PROTEIN) ("beta-Tubulin" . SPARSER::PROTEIN)
    ("Sirt6" . SPARSER::PROTEIN) ("Hydrogen peroxide" . SPARSER::MOLECULE)
    ("USP10" . SPARSER::PROTEIN) ("Ubiquitin ligase" . SPARSER::PROTEIN)
    ("DNA-damage and DNA-damage" . SPARSER::COLLECTION)
    ("phosphorylated p53(S15) and p53 protein" . SPARSER::COLLECTION)
    ("An example western blot" . SPARSER::PROTEIN)
    ("Neocarzinostatin" . SPARSER::PROTEIN)
    ("karyotypically normal HD" . SPARSER::PROTEIN)
    ("H2AX or ATM" . SPARSER::COLLECTION)
    ("neocarzinostatin" . SPARSER::PROTEIN)
    ("p53 and ataxia telangiectasia mutated (ATM)" . SPARSER::COLLECTION)
    ("Ku70 and MRE11" . SPARSER::COLLECTION)
    ("p53 and ataxia telangiectasia mutated" . SPARSER::COLLECTION)
    ("rays" . SPARSER::PROTEIN) ("HD, and variants" . SPARSER::COLLECTION)
    ("hypersensitive DNA" . SPARSER::DNA)
    ("p53 and H2AX" . SPARSER::COLLECTION) ("ATM-p53" . SPARSER::COLLECTION)
    ("S15" . SPARSER::PROTEIN) ("p11" . SPARSER::PROTEIN)
    ("1-2" . SPARSER::PROTEIN) ("TWEEN 20" . SPARSER::MOLECULE)
    ("T-antigen" . SPARSER::PROTEIN) ("BET-protein" . SPARSER::COLLECTION)
    ("an aggressive form" . SPARSER::FORM)
    ("Nf1 and Mll3" . SPARSER::COLLECTION) ("Kmt2c" . SPARSER::PROTEIN)
    ("Mll3" . SPARSER::PROTEIN) ("Nf1" . SPARSER::PROTEIN)
    ("Alox12b" . SPARSER::PROTEIN) ("exogenous AA" . SPARSER::MOLECULE)
    ("-sh" . SPARSER::COLLECTION) ("HSPCs" . SPARSER::PROTEIN)
    ("the latter gene" . SPARSER::GENE)
    ("TP53 and E1F5A" . SPARSER::COLLECTION)
    ("GFP and mCherry" . SPARSER::COLLECTION)
    ("Eif5a and Sco1/Alox12" . SPARSER::COLLECTION)
    ("loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("the DNA-damaging chemotherapeutic drug adriamycin (ADR)" . SPARSER::DRUG)
    ("adriamycin (ADR)" . SPARSER::DRUG) ("Cdkn1a" . SPARSER::PROTEIN)
    ("ADR" . SPARSER::PROTEIN) ("a more mature B-cell type" . TYPE)
    ("Mx1-cre or Vav1-cre alleles ( xref )" . SPARSER::COLLECTION)
    ("Vav1-cre" . SPARSER::COLLECTION)
    ("the cre transgene and an unrecombined11B3 fl allele"
     . SPARSER::COLLECTION)
    ("Ella-cre" . SPARSER::COLLECTION) ("cis and trans" . SPARSER::COLLECTION)
    ("-cre" . SPARSER::COLLECTION) ("aminopterin" . SPARSER::DRUG)
    ("hypoxanthine" . SPARSER::DRUG) ("Alox12 and Scol" . SPARSER::COLLECTION)
    ("Alox12" . SPARSER::PROTEIN) ("Eif5a and Alox15b" . SPARSER::COLLECTION)
    ("Alox15b" . SPARSER::PROTEIN) ("Eif5a" . SPARSER::PROTEIN)
    ("IL-3" . SPARSER::PROTEIN) ("EIF5A" . SPARSER::PROTEIN)
    ("ALOX12" . SPARSER::PROTEIN) ("Q-R" . SPARSER::PROTEIN)
    ("IL-7" . SPARSER::PROTEIN) ("c-Kit" . SPARSER::PROTEIN)
    ("3-F" . SPARSER::PROTEIN) ("Vav1" . SPARSER::PROTEIN)
    ("Chromosome 17" . SPARSER::PROTEIN)
    ("Sp1 and other key proteins" . SPARSER::COLLECTION)
    ("Cyp1b1" . SPARSER::PROTEIN) ("Cyp" . SPARSER::PROTEIN)
    ("MMP13 and MMP9" . SPARSER::COLLECTION)
    ("MMP1 and MMP14" . SPARSER::COLLECTION)
    ("MMP1 , MMP9 , and MMP14" . SPARSER::COLLECTION)
    ("Sp1 and SNAIL" . SPARSER::COLLECTION)
    ("PCNA and Sp1" . SPARSER::COLLECTION)
    ("an auxiliary component" . SPARSER::COMPONENT)
    ("CYP1B1 L432V or N203S polymorphic genes" . SPARSER::GENE)
    ("proteins and Sp1" . SPARSER::COLLECTION)
    ("The allelic variants" . SPARSER::VARIANT)
    ("Sp1, β-catenin, c-Myc, cyclin D1, PCNA, ZEB2, SNAI1, and vimentin"
     . SPARSER::COLLECTION)
    ("CTNNB1 and MYC" . SPARSER::COLLECTION)
    ("β-catenin, ZEB1, and TWIST1" . SPARSER::COLLECTION)
    ("PCNA, ZEB2, and β-catenin" . SPARSER::COLLECTION)
    ("β-catenin, c-Myc, cyclin D1, ZEB2, vimentin, and SNAI1"
     . SPARSER::COLLECTION)
    ("DMBA and mithramycin" . SPARSER::COLLECTION)
    ("β-catenin, c-Myc, cyclin D1, ZEB2, SNAI1, and vimentin"
     . SPARSER::COLLECTION)
    ("CYB" . SPARSER::PROTEIN) ("TMS or siRNA" . SPARSER::COLLECTION)
    ("ZEB2, SNAI1, and vimentin" . SPARSER::COLLECTION)
    ("TMS or CYP1B1-specific siRNA ( xref )" . SPARSER::COLLECTION)
    ("E-cadherin and α-catenin" . SPARSER::COLLECTION)
    ("N-cadherin, α-SMA, vimentin, fibronectin, and integrin"
     . SPARSER::COLLECTION)
    ("c-Myc and cyclin D1" . SPARSER::COLLECTION)
    ("MMP1 , MMP9 , MMP13 , and MMP14" . SPARSER::COLLECTION)
    ("DMBA and TMS" . SPARSER::COLLECTION)
    ("E-cadherin-catenin-actin" . SPARSER::COLLECTION)
    ("SNAIL, ZEB1/2, and TWIST" . SPARSER::COLLECTION)
    ("SNAIL" . SPARSER::PROTEIN)
    ("tight junctions using cell membrane glycoproteins" . SPARSER::PROTEIN)
    ("CYP1A1 and CYP1A2" . SPARSER::COLLECTION)
    ("a major metabolite" . SPARSER::MOLECULE) ("OHE" . SPARSER::MOLECULE)
    ("mithramycin" . SPARSER::DRUG)
    ("CTNNB1 , ZEB2 , SNAI1 , and TWIST1" . SPARSER::COLLECTION)
    ("β-catenin, c-Myc, ZEB2, and matrix" . SPARSER::COLLECTION)
    ("anthracene (DMBA)" . SPARSER::DRUG) ("TMS" . SPARSER::PROTEIN)
    ("DMBA" . SPARSER::MOLECULE) ("anthracene" . SPARSER::DRUG)
    ("1B1" . SPARSER::PROTEIN) ("PCNA-associated factor" . SPARSER::PROTEIN)
    ("Proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("P450" . SPARSER::PROTEIN-FAMILY) ("P-40" . SPARSER::PROTEIN)
    ("murine leukemia virus" . SPARSER::PROTEIN) ("Texas Red" . SPARSER::DRUG)
    ("mitomycin C" . SPARSER::DRUG) ("E-cadherins" . SPARSER::PROTEIN)
    ("CYP1A2" . SPARSER::PROTEIN) ("CYP1A1" . SPARSER::PROTEIN)
    ("CYP1" . SPARSER::PROTEIN) ("E 2" . SPARSER::MOLECULE)
    ("hyaluronic acid and integrin" . SPARSER::COLLECTION)
    ("soluble signaling molecules" . SPARSER::MOLECULE)
    ("CD44 and CD49d" . SPARSER::COLLECTION)
    ("CD44 and SOX9" . SPARSER::COLLECTION)
    ("antigen, or α4-integrin" . SPARSER::COLLECTION)
    ("α4-integrin" . SPARSER::PROTEIN-PAIR)
    ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY) ("peripherin" . SPARSER::PROTEIN)
    ("neural EMT" . SPARSER::PROTEIN) ("Wnt1-cre" . SPARSER::COLLECTION)
    ("kinases and inhibitor" . SPARSER::COLLECTION)
    ("the chemotactic receptor CD184 (CXCR4) and CD57 (HNK-1)"
     . SPARSER::COLLECTION)
    ("the chemotactic receptor CD184" . SPARSER::PROTEIN)
    ("CD15, CD44 and CD49d" . SPARSER::COLLECTION)
    ("mature neural crest derivatives" . SPARSER::DERIVATIVE)
    ("SLUG" . SPARSER::PROTEIN) ("doublecortin" . SPARSER::PROTEIN)
    ("nestin" . SPARSER::PROTEIN) ("RA" . SPARSER::PROTEIN)
    ("CD49f" . SPARSER::PROTEIN) ("Mg 2 + " . SPARSER::MOLECULE)
    ("Ca 2 + " . SPARSER::CALCIUM-ION) ("5–2 " . SPARSER::PROTEIN)
    ("p200" . SPARSER::PROTEIN)
    ("Brain-Derived Neurotrophic Factor" . SPARSER::PROTEIN)
    ("L- ornithine" . SPARSER::DRUG) ("neurotrophic factor" . SPARSER::PROTEIN)
    ("L-ornithine" . SPARSER::DRUG) ("hyaluronic acid" . SPARSER::MOLECULE)
    ("CD44 antigen" . SPARSER::PROTEIN) ("ZIC1" . SPARSER::PROTEIN)
    ("CD271" . SPARSER::PROTEIN) ("p75" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Wnt1" . SPARSER::PROTEIN) ("NF2" . SPARSER::PROTEIN)
    ("PAX3" . SPARSER::PROTEIN) ("HNK-1" . SPARSER::PROTEIN)
    ("CD57" . SPARSER::PROTEIN) ("CD184" . SPARSER::PROTEIN)
    ("CD49d" . SPARSER::PROTEIN) ("CD15" . SPARSER::DRUG)
    ("v-myc" . SPARSER::PROTEIN) ("MAP-2" . SPARSER::PROTEIN)
    ("essential mediators" . SPARSER::PROTEIN)
    ("3 D" . SPARSER::PROTEIN-FAMILY) ("PI3K and EGF" . SPARSER::COLLECTION)
    ("PI3K and EGFR" . SPARSER::COLLECTION)
    ("PIK3CA and FGF receptors and ligands" . SPARSER::COLLECTION)
    ("AKT, PIK3CA and FGF receptors and ligands" . SPARSER::COLLECTION)
    ("receptors and ligands" . SPARSER::COLLECTION)
    ("FGFR and FGF ligands" . SPARSER::COLLECTION)
    ("AKT, PIK3CA and IGF1R" . SPARSER::COLLECTION)
    ("immunogenic peptides" . SPARSER::PEPTIDE)
    ("PLEKHO1 and GDF11" . SPARSER::COLLECTION)
    ("a highly relevant glycoprotein" . SPARSER::PROTEIN)
    ("DARC and DAG1" . SPARSER::COLLECTION)
    ("DARC (Duffy antigen receptor for chemokines) and DAG1 (α-Dystroglycan)"
     . SPARSER::COLLECTION)
    ("two relevant genes" . SPARSER::GENE) ("Dystroglycan" . SPARSER::PROTEIN)
    ("mainly gains involving genes" . SPARSER::GENE)
    ("oncogenes LGR5 (leucine-rich repeat containing G protein-coupled receptor 5) and RAB21 (RAB21, member RAS oncogene family)"
     . SPARSER::COLLECTION)
    ("TUSC3, DLC1, ZDHHC2 and MTUS1" . SPARSER::COLLECTION)
    ("at least six candidate tumor suppressor genes" . SPARSER::GENE)
    ("BRCA2 and BRCAX" . SPARSER::COLLECTION)
    ("at least three genes" . SPARSER::GENE)
    ("NEK1, POSH and ANX10A" . SPARSER::COLLECTION) ("ANX" . SPARSER::PROTEIN)
    ("POSH" . SPARSER::PROTEIN)
    ("IL20 [ xref – xref ] and FAIM3 [ xref – xref ]" . SPARSER::COLLECTION)
    ("SSBP1 [ xref ] and CADM1 [ xref ]" . SPARSER::COLLECTION)
    ("PSMB8 [ xref ], HLA-DMB [ xref ], SSBP1 [ xref ] and CADM1 [ xref ]"
     . SPARSER::COLLECTION)
    ("a negative regulator of the mitogenic PI3K/AKT signaling pathway and APH1A [ xref ]"
     . SPARSER::COLLECTION)
    ("BRCAX" . SPARSER::PROTEIN) ("genes and oncogenes" . SPARSER::COLLECTION)
    ("PLEKHO1, GDF11, DARC, DAG1 and CD63" . SPARSER::COLLECTION)
    ("DARC" . SPARSER::PROTEIN) ("type and amount" . SPARSER::COLLECTION)
    ("x" . SPARSER::PROTEIN) ("chemokine receptor" . SPARSER::PROTEIN)
    ("RAB21, member RAS oncogene family" . SPARSER::PROTEIN)
    ("RAB21" . SPARSER::PROTEIN)
    ("G protein-coupled receptor 5" . SPARSER::PROTEIN)
    ("MTUS1" . SPARSER::PROTEIN) ("ZDHHC2" . SPARSER::PROTEIN)
    ("DLC1" . SPARSER::PROTEIN) ("TUSC3" . SPARSER::PROTEIN)
    ("NEK1" . SPARSER::PROTEIN) ("E2F6" . SPARSER::PROTEIN)
    ("FAIM3" . SPARSER::PROTEIN) ("IL20" . SPARSER::PROTEIN)
    ("IL19" . SPARSER::PROTEIN) ("PDE4DIP" . SPARSER::PROTEIN)
    ("CADM1" . SPARSER::PROTEIN) ("SSBP1" . SPARSER::PROTEIN)
    ("HLA-DMB" . SPARSER::PROTEIN) ("PSMB8" . SPARSER::PROTEIN)
    ("APH1A" . SPARSER::PROTEIN) ("18 h" . SPARSER::PROTEIN)
    ("F11" . SPARSER::PROTEIN) ("DAG1" . SPARSER::PROTEIN)
    ("GDF11" . SPARSER::PROTEIN) ("PLEKHO1" . SPARSER::PROTEIN)
    ("adenocarcinoma histologic type" . TYPE) ("Mak" . SPARSER::PROTEIN)
    ("c-SCCA" . SPARSER::COLLECTION) ("c-CEA" . SPARSER::COLLECTION)
    ("s-SCCA" . SPARSER::COLLECTION) ("s-CEA" . SPARSER::COLLECTION)
    ("s-CYFRA" . SPARSER::COLLECTION) ("SCCA" . SPARSER::PROTEIN)
    ("antigen (SCCA)" . SPARSER::PROTEIN) ("antigen (CEA)" . SPARSER::PROTEIN)
    ("antigen" . SPARSER::PROTEIN)
    ("The cytologic tumor marker c-CYFRA" . SPARSER::COLLECTION)
    ("CYFRA" . SPARSER::PROTEIN) ("c-CYFRA" . SPARSER::COLLECTION)
    ("SUV" . SPARSER::PROTEIN) ("FDG" . SPARSER::PROTEIN)
    ("CK 19" . SPARSER::PROTEIN) ("or 2 " . SPARSER::MOLECULE)
    ("1–2 " . SPARSER::PROTEIN) ("IGF-I/IGF-IR" . SPARSER::COLLECTION)
    ("IGFBP-6 and IGF-I or IGF-IR" . SPARSER::COLLECTION)
    ("IGF-I or IGF-IR" . SPARSER::COLLECTION)
    ("Subsequent studies shed light" . SPARSER::PROTEIN)
    ("proteins, IGF-IR, and IGF-I" . SPARSER::COLLECTION)
    ("IGF-I and IGF-II" . SPARSER::COLLECTION)
    ("polypeptides" . SPARSER::PROTEIN) ("IIR" . SPARSER::PROTEIN)
    ("IGF-I, IGF-IR and IGFBP-6" . SPARSER::COLLECTION)
    ("IGF-I, IGF-IR, and IGFBP-6" . SPARSER::COLLECTION)
    ("IGF-II, IGF-IR, and IGF-IIR" . SPARSER::COLLECTION)
    ("IGFBP-2 and IGFBP-6" . SPARSER::COLLECTION)
    ("IGF-IIR" . SPARSER::COLLECTION)
    ("relevant receptors IGF-IR and IGF-IIR" . SPARSER::COLLECTION)
    ("IGF-IR and IGF-IIR" . SPARSER::COLLECTION)
    ("certain unique biological molecules" . SPARSER::MOLECULE)
    ("IGF-I and IGF-IR" . SPARSER::COLLECTION) ("IGFs" . SPARSER::PROTEIN)
    ("IGFBP-2" . SPARSER::PROTEIN) ("IGFBP-5" . SPARSER::PROTEIN)
    ("IGF-II" . SPARSER::PROTEIN) ("IGFBP-6" . SPARSER::PROTEIN)
    ("IGF-IR" . SPARSER::PROTEIN)
    ("a mechanoresponsive receptor" . SPARSER::RECEPTOR)
    ("well-known mechanoresponsive receptors" . SPARSER::PROTEIN)
    ("larger FAs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GEF, Sos, and PAK" . SPARSER::COLLECTION)
    ("PAK" . SPARSER::PROTEIN-FAMILY)
    ("three domains, and ROBO4" . SPARSER::COLLECTION)
    ("CCO" . SPARSER::PROTEIN) ("proteins and GEFs" . SPARSER::COLLECTION)
    ("PAKs" . SPARSER::PROTEIN-FAMILY)
    ("HD and LD collagen" . SPARSER::COLLECTION)
    ("rigid SAP" . SPARSER::PROTEIN) ("SAP" . SPARSER::PROTEIN)
    ("acini" . SPARSER::PROTEIN)
    ("synthetic self-assembling peptides" . SPARSER::PEPTIDE)
    ("SAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("collagen-integrin" . SPARSER::COLLECTION)
    ("PXN and ROBO1" . SPARSER::COLLECTION)
    ("FAK and ROBO1" . SPARSER::COLLECTION) ("PXN" . SPARSER::PROTEIN)
    ("bicistronic Robo1 shRNA-GFP" . SPARSER::COLLECTION)
    ("shRNA-GFP" . SPARSER::COLLECTION)
    ("peripheral puncta" . SPARSER::PROTEIN)
    ("significantly larger FAs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("peripheral pFAK397-positive puncta" . SPARSER::PROTEIN)
    ("a key mechanosensory protein" . SPARSER::PROTEIN)
    ("mechanosensitive receptors" . SPARSER::PROTEIN)
    ("ROBO1/Rac" . SPARSER::COLLECTION) ("MRLC" . SPARSER::PROTEIN)
    ("Rho or ROCK" . SPARSER::COLLECTION)
    ("Rho (C3 Transferase) and ROCK (Y27632) inhibitors" . SPARSER::COLLECTION)
    ("NSC23766, Sos1 , and Ctl" . SPARSER::COLLECTION)
    ("the myosin regulatory light chain" . SPARSER::PROTEIN)
    ("Rac and Rho" . SPARSER::COLLECTION)
    ("SLIT2/ROBO1/Rac" . SPARSER::COLLECTION)
    ("Rho/ROCK" . SPARSER::COLLECTION)
    ("compliant collagen" . SPARSER::PROTEIN) ("Ctl" . SPARSER::PROTEIN)
    ("Sos1" . SPARSER::PROTEIN) ("myoepithelial fraction" . SPARSER::COMPONENT)
    ("Rho and Rac" . SPARSER::COLLECTION) ("Rac/Cdc42" . SPARSER::COLLECTION)
    ("chronic SLIT2" . SPARSER::PROTEIN) ("the rigid ECM" . SPARSER::PROTEIN)
    ("resident MECs" . SPARSER::PROTEIN)
    ("a compliant 3D ECM" . SPARSER::PROTEIN) ("MECs" . SPARSER::PROTEIN)
    ("compliant matrices" . SPARSER::PROTEIN-FAMILY)
    ("Rac and FAK" . SPARSER::COLLECTION)
    ("FAs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Nck" . SPARSER::PROTEIN)
    ("ROBOs" . SPARSER::PROTEIN-FAMILY) ("ROBO" . SPARSER::PROTEIN-FAMILY)
    ("collagen-XV/XVIII" . SPARSER::COLLECTION) ("XVIII" . SPARSER::PROTEIN)
    ("proteoglycans" . SPARSER::PROTEIN) ("sulfate" . SPARSER::MOLECULE)
    ("heparin" . SPARSER::PROTEIN)
    ("integrins and other collagen receptors" . SPARSER::COLLECTION)
    ("integrins and other ECM receptors" . SPARSER::COLLECTION)
    ("stromal collagen" . SPARSER::PROTEIN)
    ("collagen and other extracellular components" . SPARSER::COLLECTION)
    ("SLIT2/ROBO1" . SPARSER::COLLECTION)
    ("mechanical cues" . SPARSER::PROTEIN-FAMILY) ("E-Cad" . SPARSER::PROTEIN)
    ("heavy chain" . SPARSER::PROTEIN) ("ROBO4" . SPARSER::PROTEIN)
    ("ROBO3" . SPARSER::PROTEIN) ("ROBO2" . SPARSER::PROTEIN)
    ("Robo2" . SPARSER::PROTEIN) ("3 d" . SPARSER::PROTEIN-FAMILY)
    ("light chain" . SPARSER::PROTEIN) ("Son of Sevenless" . SPARSER::PROTEIN)
    ("NSC23766" . SPARSER::DRUG) ("Cytokeratin-14" . SPARSER::PROTEIN)
    ("immunoglobulin superfamily" . SPARSER::PROTEIN)
    ("Robo1" . SPARSER::PROTEIN) ("ROBO1" . SPARSER::PROTEIN)
    ("SLIT2" . SPARSER::PROTEIN) ("a given mRNA" . SPARSER::PROTEIN)
    ("protein-mRNA" . SPARSER::COLLECTION)
    ("the short internal nucleotide" . SPARSER::NUCLEOTIDE)
    ("SiRNAs" . SPARSER::PROTEIN)
    ("acridine orange and propidium" . SPARSER::COLLECTION)
    ("the lysomotropic agent acridine orange" . SPARSER::MOLECULE)
    ("a unique tumor suppressor" . SPARSER::SUPPRESSOR)
    ("phosphatase and protein tyrosine phosphatase activity"
     . SPARSER::COLLECTION)
    ("tumor-repressive PTEN" . SPARSER::PROTEIN)
    ("miR-21-PTEN" . SPARSER::COLLECTION)
    ("p53 and miR-21" . SPARSER::COLLECTION)
    ("p53 and activators" . SPARSER::COLLECTION)
    ("JMY, TOPORS, TP53BPS and DAXX" . SPARSER::COLLECTION)
    ("TOPORS" . SPARSER::PROTEIN) ("JMY" . SPARSER::PROTEIN)
    ("p53 or its downstream effectors" . SPARSER::COLLECTION)
    ("its principal component" . SPARSER::COMPONENT)
    ("miR-21 and Let-7a" . SPARSER::COLLECTION)
    ("a relevant part" . SPARSER::COMPONENT)
    ("the principal regulatory target" . SPARSER::TARGET-PROTEIN)
    ("siRNAs and TALEN" . SPARSER::COLLECTION)
    ("a luminogenic caspase-3/7 substrate" . SPARSER::SUBSTRATE)
    ("tetrapeptide" . SPARSER::MOLECULE) ("this microRNA’s" . SPARSER::RNA)
    ("condensation" . SPARSER::PROTEIN-FAMILY)
    ("pre-miR-21" . SPARSER::COLLECTION)
    ("AP-1, c-Myc, E2F, NF-kB, pRb, and p53" . SPARSER::COLLECTION)
    ("heterogeneous nuclear ribonucleoprotein K (HNRPK) and TAp63 [ xref ]"
     . SPARSER::COLLECTION)
    ("HNRPK" . SPARSER::PROTEIN) ("tropomyosin" . SPARSER::PROTEIN)
    ("maspin" . SPARSER::PROTEIN) ("RECK" . SPARSER::PROTEIN)
    ("pri-miR-21" . SPARSER::PROTEIN-PAIR) ("whose gene" . SPARSER::GENE)
    ("hsa-miR-21" . SPARSER::COLLECTION) ("PTEN-3" . SPARSER::COLLECTION)
    ("miR-21 and PTEN" . SPARSER::COLLECTION)
    ("protein tyrosine phosphatase activity" . SPARSER::PROTEIN)
    ("SESN1" . SPARSER::PROTEIN) ("APAF1" . SPARSER::PROTEIN)
    ("ACTA2" . SPARSER::PROTEIN) ("FAM3C" . SPARSER::PROTEIN)
    ("MiR-21" . SPARSER::PROTEIN) ("beta-gal" . SPARSER::PROTEIN)
    ("beta-galactosidase activity" . SPARSER::PROTEIN)
    ("CC-3" . SPARSER::PROTEIN) ("caspases-3" . SPARSER::PROTEIN)
    ("TAp63" . SPARSER::PROTEIN)
    ("heterogeneous nuclear ribonucleoprotein K" . SPARSER::PROTEIN)
    ("cysteine-rich protein" . SPARSER::PROTEIN)
    ("programmed cell death 4" . SPARSER::PROTEIN)
    ("TMEM49" . SPARSER::PROTEIN) ("ligand (SCF)" . SPARSER::MOLECULE)
    ("a crucial cytoskeletal component" . SPARSER::COMPONENT)
    ("PAX2 and Sox2" . SPARSER::COLLECTION)
    ("NSE, CD117 and WT1" . SPARSER::COLLECTION)
    ("NSE and CD117" . SPARSER::COLLECTION)
    ("PAX2, WT1 and Sox2" . SPARSER::COLLECTION)
    ("WT1, Sox2, Nestin and Vimentin" . SPARSER::COLLECTION)
    ("Vimentin and Nestin" . SPARSER::COLLECTION)
    ("Pax5, GFAP, Synaptophysin, CD133 and Cyclin D1" . SPARSER::COLLECTION)
    ("Thymosin" . SPARSER::PROTEIN)
    ("CD117, S100B and Sox2" . SPARSER::COLLECTION)
    ("xref  S100B protein  xref  Pax6 16 and GFAP" . SPARSER::COLLECTION)
    ("Fibroblast Growth Factors (FGF)" . SPARSER::PROTEIN-FAMILY)
    ("Sonic Hedgehog (SH)" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor (EGF)" . SPARSER::PROTEIN)
    ("SH" . SPARSER::PROTEIN-FAMILY) ("aRG" . SPARSER::AMINO-ACID)
    ("microglia" . SPARSER::PROTEIN) ("PAX2 and NSE" . SPARSER::COLLECTION)
    ("NSE" . SPARSER::PROTEIN)
    ("Vimentin, Nestin and WT1" . SPARSER::COLLECTION)
    ("CD44, CD133, Synaptophysin and Cyclin D1" . SPARSER::COLLECTION)
    ("Synaptophysin" . SPARSER::PROTEIN) ("Nestin" . SPARSER::PROTEIN)
    ("GFAP" . SPARSER::PROTEIN) ("C-kit" . SPARSER::PROTEIN)
    ("c-kit" . SPARSER::PROTEIN)
    ("Glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("intermediate filament protein" . SPARSER::PROTEIN)
    ("S-100" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Pax5" . SPARSER::PROTEIN)
    ("Pax2" . SPARSER::PROTEIN) ("BMI-1" . SPARSER::PROTEIN)
    ("MSI-1" . SPARSER::PROTEIN) ("Pax6" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor" . SPARSER::PROTEIN)
    ("Fibroblast Growth Factors" . SPARSER::PROTEIN-FAMILY)
    ("neuronal migration" . SPARSER::PROTEIN) ("PAX2" . SPARSER::PROTEIN)
    ("S100B" . SPARSER::PROTEIN) ("functional MSCs" . SPARSER::PROTEIN)
    ("mESC" . SPARSER::PROTEIN) ("multipotent MSCs" . SPARSER::PROTEIN)
    ("adipogenic marker genes" . SPARSER::GENE)
    ("adipogenic induction media" . SPARSER::PROTEIN)
    ("PPAR-γ and LPL" . SPARSER::COLLECTION) ("LPL" . SPARSER::PROTEIN)
    ("the chondrogenic marker genes" . SPARSER::GENE)
    ("SOX9 and COL2A1" . SPARSER::COLLECTION)
    ("the osteogenic marker genes" . SPARSER::GENE)
    ("significantly more MSCs" . SPARSER::PROTEIN)
    ("the endodermal marker FOXA2 and two mesodermal markers PDGFR-α and BRACHYURY"
     . SPARSER::COLLECTION)
    ("the ectodermal marker PAX6" . SPARSER::PROTEIN)
    ("the endodermal marker FOXA2" . SPARSER::PROTEIN)
    ("the pluripotent markers NANOG , OCT4 , and SOX2" . SPARSER::COLLECTION)
    ("cIAP2 , IL-6 , and IL-8" . SPARSER::COLLECTION)
    ("SOX9 and C OL2A1" . SPARSER::COLLECTION)
    ("chondrogenic marker genes" . SPARSER::GENE)
    ("glycosaminoglycans" . SPARSER::MOLECULE)
    ("RUNX2 and BGLAP" . SPARSER::COLLECTION) ("BGLAP" . SPARSER::PROTEIN)
    ("a larger CD73 + CD90 + CD146 + CD45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD73 and CD146" . SPARSER::COLLECTION)
    ("The endodermal marker FOXA2" . SPARSER::PROTEIN)
    ("mesodermal markers PDGFR-α and BRACHYURY" . SPARSER::COLLECTION)
    ("p100 and p52" . SPARSER::COLLECTION)
    ("p65 and IκBα" . SPARSER::COLLECTION) ("MSCs " . SPARSER::PROTEIN)
    ("CD51 and CD90" . SPARSER::COLLECTION)
    ("CD34 and CD45" . SPARSER::COLLECTION)
    ("the endodermal marker gene FOXA2 and two mesodermal markers PDGFR-α and BRACHYURY"
     . SPARSER::COLLECTION)
    ("two mesodermal markers PDGFR-α and BRACHYURY" . SPARSER::COLLECTION)
    ("the endodermal marker gene FOXA2" . SPARSER::PROTEIN)
    ("the ectodermal marker gene PAX6" . SPARSER::PROTEIN)
    ("PDGFR-α and BRACHYURY" . SPARSER::COLLECTION)
    ("NANOG , OCT4 , and SOX2" . SPARSER::COLLECTION)
    ("IKKi" . SPARSER::PROTEIN)
    ("p65, p50, IκBα, and IκBβ" . SPARSER::COLLECTION)
    ("p50 and p65/RelA proteins" . SPARSER::COLLECTION)
    ("The classical NF-κB" . SPARSER::PROTEIN)
    ("p65/RelA" . SPARSER::COLLECTION)
    ("bone regenerative medicine" . SPARSER::DRUG)
    ("PPAR-γ" . SPARSER::PROTEIN) ("COL2A1" . SPARSER::PROTEIN)
    ("OL2" . SPARSER::PROTEIN) ("p100" . SPARSER::PROTEIN)
    ("CD146" . SPARSER::PROTEIN) ("CD51" . SPARSER::PROTEIN)
    ("PDGFR-α" . SPARSER::PROTEIN) ("PAX6" . SPARSER::PROTEIN)
    ("IκBβ" . SPARSER::PROTEIN) ("IκBs" . SPARSER::PROTEIN)
    ("ROS and JNK" . SPARSER::COLLECTION)
    ("RIP1 and FADD" . SPARSER::COLLECTION)
    ("FADD, procaspases-8 and RIP1" . SPARSER::COLLECTION)
    ("stimulant" . SPARSER::DRUG)
    ("both extrinsic and intrinsic caspases" . SPARSER::PROTEIN)
    ("FADD (FADD-DD) and mutant" . SPARSER::COLLECTION)
    ("TNF-α and NF-κB" . SPARSER::COLLECTION)
    ("c-FLIP and vice versa" . SPARSER::COLLECTION)
    ("FADD, casper and caspases-8" . SPARSER::COLLECTION)
    ("casper" . SPARSER::PROTEIN)
    ("FADD, cFLIP and caspases-8" . SPARSER::COLLECTION)
    ("MAPK/ERK1" . SPARSER::COLLECTION)
    ("procaspase-8 and cFLIP" . SPARSER::COLLECTION)
    ("pro-apoptotic functional protein FADD and caspases-8"
     . SPARSER::COLLECTION)
    ("protein FADD and caspases-8" . SPARSER::COLLECTION)
    ("cysteine (NAC)" . SPARSER::MOLECULE)
    ("ROS and JNK1" . SPARSER::COLLECTION)
    ("JNK1 and ubiquitin ligase" . SPARSER::COLLECTION)
    ("JNK1 and ITCH" . SPARSER::COLLECTION)
    ("RIP1 and complex" . SPARSER::COLLECTION) ("–versa" . SPARSER::COLLECTION)
    ("PPI" . SPARSER::INHIBITOR)
    ("FADD (FADD-DD) and RIP1-DD" . SPARSER::COLLECTION)
    ("FADD-RIP1-caspase-8" . SPARSER::COLLECTION)
    ("RIP1-FADD" . SPARSER::COLLECTION)
    ("procaspase-8 (row 2) and FADD (row 3)" . SPARSER::COLLECTION)
    ("cFLIP-siRNA" . SPARSER::COLLECTION)
    ("FADD, RIP1 and procaspase-8" . SPARSER::COLLECTION)
    ("FADD and RIP1" . SPARSER::COLLECTION)
    ("FADD, RIP1 and caspase-8" . SPARSER::COLLECTION)
    ("LDH" . SPARSER::PROTEIN) ("pcDNA-FADD" . SPARSER::COLLECTION)
    ("caspase-8 and caspase-3" . SPARSER::COLLECTION)
    ("GFP-cytochrome c" . SPARSER::COLLECTION)
    ("cytometry and Tali" . SPARSER::COLLECTION)
    ("p65 and wt" . SPARSER::COLLECTION) ("FADD-SLT2" . SPARSER::COLLECTION)
    ("FADD and wt" . SPARSER::COLLECTION) ("FADD " . SPARSER::PROTEIN)
    ("p65 and NF-κB" . SPARSER::COLLECTION)
    ("p65 and cFLIP" . SPARSER::COLLECTION) ("XIAPs" . SPARSER::PROTEIN)
    ("cIAP2 and cFLIP" . SPARSER::COLLECTION)
    ("JNK1 and E3" . SPARSER::COLLECTION)
    ("NF-κB and JNK1" . SPARSER::COLLECTION)
    ("NF-κB and JNK" . SPARSER::COLLECTION)
    ("NF-κB and cFLIP" . SPARSER::COLLECTION)
    ("NF- κB and cFLIP" . SPARSER::COLLECTION) ("c-IAP" . SPARSER::COLLECTION)
    ("hILP" . SPARSER::PROTEIN) ("XIAP" . SPARSER::PROTEIN)
    ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FADD and procaspase-8" . SPARSER::COLLECTION)
    ("TRADD, TRAF2, cIAPs and RIP1" . SPARSER::COLLECTION)
    ("TRADD" . SPARSER::PROTEIN)
    ("two sequential complexes" . SPARSER::BIO-COMPLEX)
    ("FADD and cFLIP" . SPARSER::COLLECTION) ("TNFR" . SPARSER::PROTEIN)
    ("a multifunctional protein and its Fas ligand" . SPARSER::COLLECTION)
    ("apical caspases" . SPARSER::PROTEIN)
    ("Fas (CD95/Apo) and tumor necrosis factor receptor 1 (TNFR1)"
     . SPARSER::COLLECTION)
    ("CD95/Apo" . SPARSER::COLLECTION) ("Apo" . SPARSER::PROTEIN)
    ("DRs" . SPARSER::MOLECULE) ("receptor (DR)" . SPARSER::RECEPTOR)
    ("a pivotal signaling component" . SPARSER::COMPONENT)
    ("ITCH" . SPARSER::PROTEIN) ("RIP1 and procaspase-8" . SPARSER::COLLECTION)
    ("cellular inhibitor of apoptosis protein 2 (cIAP2) and Bcl-2"
     . SPARSER::COLLECTION)
    ("cellular inhibitor of apoptosis protein 2" . SPARSER::PROTEIN)
    ("cFLIP and NF-κB" . SPARSER::COLLECTION) ("O6" . SPARSER::PROTEIN)
    ("Caspase 8" . SPARSER::PROTEIN) ("procaspase-9" . SPARSER::PROTEIN)
    ("thymidine kinase" . SPARSER::PROTEIN) ("NBP1" . SPARSER::PROTEIN)
    ("Cytochrome c" . SPARSER::PROTEIN) ("Procaspase-9" . SPARSER::PROTEIN)
    ("MitoTracker Red" . SPARSER::MOLECULE) ("cIAP1" . SPARSER::PROTEIN)
    ("necrostatin-1" . SPARSER::MOLECULE) ("c-FLIP" . SPARSER::PROTEIN)
    ("protein FADD" . SPARSER::PROTEIN) ("Necrostatin-1" . SPARSER::MOLECULE)
    ("SLT2" . SPARSER::PROTEIN) ("TNF-α " . SPARSER::PROTEIN)
    ("IKKβ" . SPARSER::PROTEIN) ("NF- κB" . SPARSER::PROTEIN)
    ("complex I" . SPARSER::PROTEIN) ("p55" . SPARSER::PROTEIN)
    ("TNFR1" . SPARSER::PROTEIN) ("CD95" . SPARSER::PROTEIN)
    ("RIP1" . SPARSER::PROTEIN) ("cIAP2" . SPARSER::PROTEIN)
    ("inhibitor of apoptosis protein 2" . SPARSER::PROTEIN)
    ("caspases-8" . SPARSER::PROTEIN)
    ("cellular FLICE-like inhibitory protein" . SPARSER::PROTEIN)
    ("mature vasculature" . SPARSER::PROTEIN)
    ("fully developed vasculature" . SPARSER::PROTEIN)
    ("Hes1 , Hey2 and Dll4" . SPARSER::COLLECTION)
    ("Akt1 and PI3K" . SPARSER::COLLECTION) ("quiescent EC" . SPARSER::PROTEIN)
    ("VEGF–VEGFR2" . SPARSER::COLLECTION)
    ("Akts" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pSer" . SPARSER::PROTEIN)
    ("supporting patent vasculature" . SPARSER::PROTEIN)
    ("coronary vasculature" . SPARSER::PROTEIN)
    ("Jagged1 and Hes1" . SPARSER::COLLECTION)
    ("mTOR/STAT3/p63" . SPARSER::COLLECTION)
    ("Stat3 and p63" . SPARSER::COLLECTION)
    ("PI3K, Akt and mTOR" . SPARSER::COLLECTION)
    ("p63 and STAT3" . SPARSER::COLLECTION)
    ("Jagged1 and Hey2" . SPARSER::COLLECTION)
    ("pAkt" . SPARSER::PROTEIN-FAMILY)
    ("mTOR, or LY294002 or wortmannin" . SPARSER::COLLECTION)
    ("LY294002 or wortmannin" . SPARSER::COLLECTION)
    ("wortmannin" . SPARSER::PROTEIN)
    ("Akt2KO retinal vasculature" . SPARSER::PROTEIN)
    ("Hes1 , Hey2 , Notch3 , Notch1 and Notch4" . SPARSER::COLLECTION)
    ("Hes1 , Hey2 , Dll4 and Notch3" . SPARSER::COLLECTION)
    ("Hes1 and Hey2" . SPARSER::COLLECTION) ("pimonidazole" . SPARSER::DRUG)
    ("∼6-fold increased perivascular cleaved caspase 3" . SPARSER::PROTEIN)
    ("CD31 or isolectin" . SPARSER::COLLECTION) ("NG2-" . SPARSER::PROTEIN)
    ("patent vasculature" . SPARSER::PROTEIN) ("seizures" . SPARSER::PROTEIN)
    ("patent or perfused vasculature" . SPARSER::PROTEIN)
    ("functional cardiac vasculature" . SPARSER::PROTEIN)
    ("lymphatic vasculature" . SPARSER::PROTEIN)
    ("endothelial Akt1" . SPARSER::PROTEIN) ("vasodilator" . SPARSER::PROTEIN)
    ("bin" . SPARSER::PROTEIN) ("arterial vasculature" . SPARSER::PROTEIN)
    ("actin (SMA)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD31 and smooth muscle" . SPARSER::COLLECTION)
    ("Akt1 and Akt2" . SPARSER::COLLECTION)
    ("An essential part" . SPARSER::COMPONENT)
    ("Akt/mTOR" . SPARSER::COLLECTION) ("A 20" . SPARSER::PROTEIN)
    ("potassium chloride" . SPARSER::MOLECULE)
    ("VE-Cadherin" . SPARSER::PROTEIN) ("p110alpha" . SPARSER::PROTEIN)
    ("Angiopoietin2" . SPARSER::PROTEIN) ("Jagged 1" . SPARSER::PROTEIN)
    ("VEGFR2" . SPARSER::PROTEIN) ("Notch4" . SPARSER::PROTEIN)
    ("Pdgfrβ" . SPARSER::PROTEIN) ("Dll4" . SPARSER::PROTEIN)
    ("Hey2" . SPARSER::PROTEIN) ("Hes1" . SPARSER::PROTEIN)
    ("Akt3" . SPARSER::PROTEIN) ("MK2206" . SPARSER::DRUG)
    ("NG2" . SPARSER::PROTEIN) ("Myh11" . SPARSER::PROTEIN)
    ("LYVE1" . SPARSER::PROTEIN) ("Akt2" . SPARSER::PROTEIN)
    ("p53/BAX" . SPARSER::COLLECTION)
    ("mitochondria and cytochrome C" . SPARSER::COLLECTION)
    ("volatile cigarette smoke" . SPARSER::MOLECULE)
    ("a widely-used antitumor drug" . SPARSER::DRUG)
    ("SIRT1 and downstream p53 and BAX" . SPARSER::COLLECTION)
    ("online database microRNA" . SPARSER::RNA)
    ("its possible target sirtuin 1 (SIRT1) and downstream factors tumor protein p53 and BCL2-associated X protein (BAX)"
     . SPARSER::COLLECTION)
    ("downstream factors tumor protein p53 and BCL2-associated X protein (BAX)"
     . SPARSER::COLLECTION)
    ("BCL2-associated X protein (BAX)" . SPARSER::PROTEIN)
    ("its possible target sirtuin 1" . SPARSER::PROTEIN)
    ("SIRT1/p53/BAX" . SPARSER::COLLECTION)
    ("p53 and BAX" . SPARSER::COLLECTION)
    ("p53, and BAX" . SPARSER::COLLECTION)
    ("BCL-associated X protein (BAX)" . SPARSER::PROTEIN)
    ("cytochrome C" . SPARSER::PROTEIN)
    ("Tumor protein p53" . SPARSER::PROTEIN)
    ("transcription factor E2F1" . SPARSER::PROTEIN)
    ("CA-3" . SPARSER::PROTEIN) ("Reverse Transcriptase" . SPARSER::PROTEIN)
    ("a 15" . SPARSER::PROTEIN) ("tumor protein p53" . SPARSER::PROTEIN)
    ("interleukin-18" . SPARSER::PROTEIN)
    ("neutrophil gelatinase-associated lipocalin" . SPARSER::PROTEIN)
    ("cystatin C" . SPARSER::PROTEIN)
    ("a multifunctional protein" . SPARSER::PROTEIN)
    ("CCN" . SPARSER::PROTEIN-FAMILY) ("soft matrix" . SPARSER::PROTEIN-FAMILY)
    ("GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NEK8 and TAZ" . SPARSER::COLLECTION)
    ("kinase and RCC1" . SPARSER::COLLECTION)
    ("NEK8 and ANKS6" . SPARSER::COLLECTION)
    ("NEK8 or ANKS6" . SPARSER::COLLECTION) ("Fetuses" . SPARSER::PROTEIN)
    ("hpf" . SPARSER::PROTEIN) ("mutated NEK8-GFP RNA" . SPARSER::RNA)
    ("Ankrd1" . SPARSER::PROTEIN)
    ("JAG1 as well as the downstream target HES1" . SPARSER::COLLECTION)
    ("CYR61 , CTGF and TEAD4" . SPARSER::COLLECTION)
    ("YAP-myc and NEK8-GFP-WT" . SPARSER::COLLECTION)
    ("HEK" . SPARSER::PROTEIN) ("ciliary NEK8" . SPARSER::PROTEIN)
    ("axonemal" . SPARSER::PROTEIN) ("inversin" . SPARSER::PROTEIN)
    ("the wild-type protein (WT) or the missense variants"
     . SPARSER::COLLECTION)
    ("protein (WT)" . SPARSER::PROTEIN) ("endogeneous NEK8" . SPARSER::PROTEIN)
    ("*/p" . SPARSER::COLLECTION)
    ("compound heterozygous mutations p" . SPARSER::PROTEIN)
    ("paternally-inherited p" . SPARSER::PROTEIN)
    ("consanguineous family 4" . SPARSER::PROTEIN)
    ("a maternally-inherited heterozygous variant" . SPARSER::VARIANT)
    ("a maternally-inherited c" . SPARSER::PROTEIN)
    ("a paternally-inherited c" . SPARSER::PROTEIN)
    ("family 2 and his" . SPARSER::COLLECTION)
    ("two distinct cohorts" . SPARSER::MOLECULE)
    ("the proximal part" . SPARSER::COMPONENT)
    ("NIMA" . SPARSER::PROTEIN-FAMILY) ("ciliary proteins" . SPARSER::PROTEIN)
    ("canonical Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Wnt/PCP" . SPARSER::COLLECTION) ("Joubert" . SPARSER::PROTEIN-FAMILY)
    ("Inversin" . SPARSER::PROTEIN) ("Verteporfin" . SPARSER::DRUG)
    ("NEK8-GFP" . SPARSER::COLLECTION) ("NEK8/NPHP9" . SPARSER::COLLECTION)
    ("1200 ciliary genes" . SPARSER::GENE) ("fetuses" . SPARSER::PROTEIN)
    ("cyr61" . SPARSER::PROTEIN) ("tead4" . SPARSER::PROTEIN)
    ("MST1" . SPARSER::PROTEIN) ("HES1" . SPARSER::PROTEIN)
    ("TEAD4" . SPARSER::PROTEIN) ("SAV1" . SPARSER::PROTEIN)
    ("MTS1" . SPARSER::PROTEIN) ("PT5" . SPARSER::PROTEIN)
    ("family1" . SPARSER::PROTEIN) ("family 5" . SPARSER::PROTEIN)
    ("family 4" . SPARSER::PROTEIN) ("family 1" . SPARSER::PROTEIN)
    ("family 2" . SPARSER::PROTEIN) ("family 3" . SPARSER::PROTEIN)
    ("NPHP4" . SPARSER::PROTEIN) ("NPHP16" . SPARSER::PROTEIN)
    ("NPHP3" . SPARSER::PROTEIN) ("NPHP2" . SPARSER::PROTEIN)
    ("RCC1" . SPARSER::PROTEIN)
    ("Regulator of Chromosome Condensation 1" . SPARSER::PROTEIN)
    ("nek8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Nek8" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NPHP9" . SPARSER::PROTEIN)
    ("NEK8" . SPARSER::PROTEIN) ("HEY1 and HEY2" . SPARSER::COLLECTION)
    ("Notch1 and JARID1B" . SPARSER::COLLECTION)
    ("Notch1 or ERBB3" . SPARSER::COLLECTION) ("Part" . SPARSER::COMPONENT)
    ("lapatinib and DBZ" . SPARSER::COLLECTION)
    ("available inhibitors" . SPARSER::INHIBITOR)
    ("lapatinib (50mg/Kg) or a combination" . SPARSER::COLLECTION)
    ("Titer-Glo" . SPARSER::PROTEIN-PAIR) ("Glo" . SPARSER::PROTEIN)
    ("GSI and lapatinib" . SPARSER::COLLECTION)
    ("AKT, ERK and NFκB" . SPARSER::COLLECTION)
    ("effectively hampers p-ERBB3" . SPARSER::COLLECTION)
    ("p-EGFR" . SPARSER::COLLECTION) ("EGFR and ERBB2" . SPARSER::COLLECTION)
    ("dibenzazepine" . SPARSER::DRUG) ("p-ERBB2" . SPARSER::COLLECTION)
    ("p-ERBB3" . SPARSER::COLLECTION)
    ("active Notch1 (NIC) and active (phosphorylated) ERBB3 and ERBB2"
     . SPARSER::COLLECTION)
    ("Notch1 (NIC)" . SPARSER::PROTEIN)
    ("Notch1 and active" . SPARSER::COLLECTION) ("GSI" . SPARSER::PROTEIN)
    ("ERBB3/ERBB2" . SPARSER::COLLECTION)
    ("ERBB2 and Notch1" . SPARSER::COLLECTION)
    ("ERBB3 (HER3) and ERBB4 (HER4)" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR), ERBB2 (HER2), ERBB3 (HER3) and ERBB4 (HER4)"
     . SPARSER::COLLECTION)
    ("AKT and NFκB" . SPARSER::COLLECTION)
    ("Notch1 and ERBB3" . SPARSER::COLLECTION)
    ("active Notch1 (Notch1 NIC ) and active (phosphorylated) ERBB3 and ERBB2"
     . SPARSER::COLLECTION)
    ("ERBB3 and ERBB2" . SPARSER::COLLECTION) ("ERBB" . SPARSER::PROTEIN)
    ("Lamin-B1" . SPARSER::PROTEIN) ("M 2" . SPARSER::MOLECULE)
    ("P65" . SPARSER::PROTEIN) ("HEY2" . SPARSER::PROTEIN)
    ("PLX4720" . SPARSER::DRUG) ("ERBB4" . SPARSER::PROTEIN)
    ("JARID1B" . SPARSER::PROTEIN) ("γ-secretase" . SPARSER::PROTEIN)
    ("small interfering RNA or small RNA" . SPARSER::COLLECTION)
    ("CCNE1 and MCM7" . SPARSER::COLLECTION)
    ("BCL2, CCNE1 and MCM7" . SPARSER::COLLECTION)
    ("CDK6, CYCS, ORC5, MCM7, and PRKAR2B" . SPARSER::COLLECTION)
    ("BCL2, CCNE1 and MCM7, CDK6, CYCS, ORC5, MCM7, and PRKAR2B"
     . SPARSER::COLLECTION)
    ("MCM7, CDK6, CYCS, ORC5, MCM7, and PRKAR2B" . SPARSER::COLLECTION)
    ("the putative replicative helicase" . SPARSER::PROTEIN)
    ("MCM" . SPARSER::PROTEIN) ("CDC7, ORC2 and ORC5" . SPARSER::COLLECTION)
    ("genes and plays" . SPARSER::COLLECTION) ("NPAT" . SPARSER::PROTEIN)
    ("CDK6 and ORC5" . SPARSER::COLLECTION)
    ("the apoptosome and the activation of caspase-9" . SPARSER::COLLECTION)
    ("apoptosome" . SPARSER::BIO-COMPLEX)
    ("BCL2, CCNE1, CDK6, CYCS, ORC5, MCM7, and PRKAR2B" . SPARSER::COLLECTION)
    ("sugars" . SPARSER::MOLECULE) ("antimetabolites" . SPARSER::DRUG)
    ("maps" . SPARSER::PROTEIN) ("BCL2, CCNE1, and MCM7" . SPARSER::COLLECTION)
    ("CR-related genes and molecular pathways using microarray methods"
     . SPARSER::COLLECTION)
    ("methotrexate, vinblastine, doxorubicin and cisplatin, or gemcitabine and cisplatin"
     . SPARSER::COLLECTION)
    ("cisplatin, or gemcitabine and cisplatin" . SPARSER::COLLECTION)
    ("gemcitabine and cisplatin" . SPARSER::COLLECTION)
    ("vinblastine" . SPARSER::DRUG) ("methotrexate" . SPARSER::DRUG)
    ("BCL2 , MCM7 , and CCNE1" . SPARSER::COLLECTION)
    ("BCL2, MCM7, and CCNE1" . SPARSER::COLLECTION)
    ("PRKAR2A , PRKAR2B , CYCS , BCL2 , BIRC3 , DFFB , CASP6 , CDK6 , CCNE1 , STEAP3 , MCM7 , ORC2 , ORC5 , ANAPC1 , and ANAPC7 , CDC7 , CDC27 , and SKP1"
     . SPARSER::COLLECTION)
    ("ANAPC7 , CDC7 , CDC27 , and SKP1" . SPARSER::COLLECTION)
    ("DFFB" . SPARSER::PROTEIN) ("CYCS" . SPARSER::PROTEIN)
    ("Genes and Genomes" . SPARSER::COLLECTION)
    ("cAMP-dependent" . SPARSER::PROTEIN) ("pre-RC" . SPARSER::BIO-COMPLEX)
    ("MCM2" . SPARSER::PROTEIN) ("Cyclin E" . SPARSER::PROTEIN)
    ("Apaf-1" . SPARSER::PROTEIN)
    ("apoptotic protease activating factor" . SPARSER::PROTEIN)
    ("minichromosome maintenance complex component 7" . SPARSER::PROTEIN)
    ("Cytochrome c, somatic" . SPARSER::PROTEIN)
    ("subunit 5" . SPARSER::PROTEIN)
    ("origin recognition complex" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 6" . SPARSER::PROTEIN)
    ("Beta-actin" . SPARSER::PROTEIN) ("SKP1" . SPARSER::PROTEIN)
    ("CDC27" . SPARSER::PROTEIN) ("CDC7" . SPARSER::PROTEIN)
    ("ANAPC7" . SPARSER::PROTEIN) ("ANAPC1" . SPARSER::PROTEIN)
    ("ORC5" . SPARSER::PROTEIN) ("ORC2" . SPARSER::PROTEIN)
    ("MCM7" . SPARSER::PROTEIN) ("STEAP3" . SPARSER::PROTEIN)
    ("CASP6" . SPARSER::PROTEIN) ("BIRC3" . SPARSER::PROTEIN)
    ("PRKAR2B" . SPARSER::PROTEIN) ("PRKAR2A" . SPARSER::PROTEIN)
    ("MTD and R2PD" . SPARSER::COLLECTION) ("PR and SD" . SPARSER::COLLECTION)
    ("ALK-" . SPARSER::PROTEIN) ("gastrointestinal AEs" . SPARSER::PROTEIN)
    ("ceritinib and alectinib" . SPARSER::COLLECTION)
    ("approximately 3 h" . SPARSER::PROTEIN)
    ("Serious AEs (SAE)" . SPARSER::PROTEIN)
    ("aminotransferase and drug" . SPARSER::COLLECTION)
    ("ACK, TNK1, and EGFR" . SPARSER::COLLECTION)
    ("MET, RON, LCK, JAK2, MUSK, TRKs, TYRO3, AXL, MER, and EPHs"
     . SPARSER::COLLECTION)
    ("MER" . SPARSER::PROTEIN) ("LCK" . SPARSER::PROTEIN)
    ("RON" . SPARSER::PROTEIN) ("FRK" . SPARSER::PROTEIN)
    ("ALK, ROS1, and ACK" . SPARSER::COLLECTION) ("ACK" . SPARSER::PROTEIN)
    ("a relevant biomarker" . SPARSER::MOLECULE)
    ("transaminase" . SPARSER::PROTEIN) ("ASP" . SPARSER::PROTEIN)
    ("TYRO3" . SPARSER::PROTEIN) ("TNK1" . SPARSER::PROTEIN)
    ("member 5" . SPARSER::PROTEIN) ("EML-4" . SPARSER::PROTEIN)
    ("echinoderm microtubule-associated protein-like 4" . SPARSER::PROTEIN)
    ("complex and variable" . SPARSER::COLLECTION)
    ("ER, PR and AR" . SPARSER::COLLECTION)
    ("the hormonal receptors" . SPARSER::PROTEIN)
    ("lactating" . SPARSER::MOLECULE)
    ("an inactive LKB1/STK11 gene" . SPARSER::GENE)
    ("cationic liposome-delivered shRNAs" . SPARSER::RNA)
    ("FAK and EGFR" . SPARSER::COLLECTION)
    ("gefitinib and the mTOR inhibitor everolimus [ xref ]"
     . SPARSER::COLLECTION)
    ("TKI and erlotinib" . SPARSER::COLLECTION)
    ("integrin-FAK" . SPARSER::COLLECTION) ("dasatinib" . SPARSER::DRUG)
    ("CD-1" . SPARSER::PROTEIN)
    ("erlotinib and 5 μM PF-228" . SPARSER::COLLECTION)
    ("LKB1-FAK" . SPARSER::COLLECTION) ("LKB1/STK11" . SPARSER::COLLECTION)
    ("ERK and Akt" . SPARSER::COLLECTION)
    ("erlotinib or PF-228" . SPARSER::COLLECTION)
    ("erlotinib or FAK" . SPARSER::COLLECTION)
    ("erlotinib and PF-228" . SPARSER::COLLECTION)
    ("erlotinib (1–25 μM) or PF-228 (1–10 μM)" . SPARSER::COLLECTION)
    ("FAK, EGFR or β1" . SPARSER::COLLECTION) ("H1975" . SPARSER::PROTEIN)
    ("reasonable examples" . SPARSER::EXAMPLE)
    ("cell line H1975" . SPARSER::PROTEIN)
    ("EGFR and FAK" . SPARSER::COLLECTION)
    ("EGFR or c-MET" . SPARSER::COLLECTION)
    ("erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("erlotinib and FAK" . SPARSER::COLLECTION) ("NaVO 3" . SPARSER::MOLECULE)
    ("PF-228" . SPARSER::DRUG) ("CEL" . SPARSER::PROTEIN)
    ("the largest genes" . SPARSER::GENE)
    ("premature translation termination codons" . SPARSER::PROTEIN)
    ("CG" . SPARSER::PROTEIN) ("type or location" . SPARSER::COLLECTION)
    ("Lisch" . SPARSER::PROTEIN)
    ("cardiovascular malformations" . SPARSER::PROTEIN)
    ("the gene's" . SPARSER::GENE) ("AR-GGN" . SPARSER::COLLECTION)
    ("GGC " . SPARSER::PROTEIN) ("GGN" . SPARSER::PROTEIN)
    ("relevant gene" . SPARSER::GENE)
    ("polyglutamine and polyglycine" . SPARSER::COLLECTION)
    ("polyglycine" . SPARSER::MOLECULE) ("GGC" . SPARSER::PROTEIN)
    ("introns" . SPARSER::PROTEIN) ("SMD " . SPARSER::DRUG)
    ("SMD" . SPARSER::DRUG) ("VIP" . SPARSER::PROTEIN)
    ("IL10 and cryptotanshinone" . SPARSER::COLLECTION)
    ("STAT3 and mTOR" . SPARSER::COLLECTION)
    ("IL10/AKT-mTOR" . SPARSER::COLLECTION)
    ("starvation-treated HSFs" . SPARSER::PROTEIN) ("-IFN" . SPARSER::DRUG)
    ("x-interferon" . SPARSER::PROTEIN-PAIR)
    ("autophagic protein" . SPARSER::PROTEIN)
    ("kDa, and LC3-II" . SPARSER::COLLECTION)
    ("LY294002/cryptotanshinone almost completely abolished p-AKT"
     . SPARSER::COLLECTION)
    ("p-mTOR/mTOR" . SPARSER::COLLECTION) ("p-AKT/AKT" . SPARSER::COLLECTION)
    ("p-STAT3/STAT3" . SPARSER::COLLECTION)
    ("IL10/IL10R-STAT3" . SPARSER::COLLECTION)
    ("STAT3 and STAT3" . SPARSER::COLLECTION)
    ("AKT and STAT3" . SPARSER::COLLECTION)
    ("HSFs and NSFs" . SPARSER::COLLECTION) ("NSFs" . SPARSER::PROTEIN)
    ("that IL10's" . SPARSER::PROTEIN) ("herein shed light" . SPARSER::PROTEIN)
    ("STAT3, AKT, and mTOR" . SPARSER::COLLECTION)
    ("IL10-AKT-mTOR" . SPARSER::COLLECTION)
    ("IL10-IL10R-STAT3" . SPARSER::COLLECTION)
    ("AKT-mTOR" . SPARSER::COLLECTION) ("IL10R-STAT3" . SPARSER::COLLECTION)
    ("p-mTOR" . SPARSER::PROTEIN-PAIR) ("p-AKT" . SPARSER::COLLECTION)
    ("HSFs" . SPARSER::PROTEIN) ("Atg12" . SPARSER::PROTEIN)
    ("μ g" . SPARSER::PROTEIN) ("P70S6K" . SPARSER::PROTEIN)
    ("Tyk2" . SPARSER::PROTEIN) ("JAK1" . SPARSER::PROTEIN)
    ("IL-29" . SPARSER::PROTEIN) ("IL-28 A" . SPARSER::PROTEIN)
    ("IL-26" . SPARSER::PROTEIN) ("IL-22" . SPARSER::PROTEIN)
    ("α -chain" . SPARSER::PROTEIN) ("Interleukin-10" . SPARSER::PROTEIN)
    ("IL10RB" . SPARSER::PROTEIN) ("IL10R" . SPARSER::PROTEIN)
    ("alpha-chain" . SPARSER::PROTEIN) ("IL10" . SPARSER::PROTEIN)
    ("classical PTC and its follicular variant" . SPARSER::COLLECTION)
    ("PAX8-PPARγ" . SPARSER::COLLECTION) ("ATA" . SPARSER::MOLECULE)
    ("its follicular variant" . SPARSER::VARIANT)
    ("FA and FTC" . SPARSER::COLLECTION) ("RET-PTC" . SPARSER::COLLECTION)
    ("FA, FTC, or FVPTC" . SPARSER::COLLECTION)
    ("ETC. and FA" . SPARSER::COLLECTION)
    ("BRAF and RAS" . SPARSER::COLLECTION) ("PAX8/PPARγ" . SPARSER::COLLECTION)
    ("RET/PTC" . SPARSER::COLLECTION) ("follicular form" . SPARSER::FORM)
    ("the only translocation variant" . SPARSER::VARIANT)
    ("BRAF(V600E)-negative PTCs" . SPARSER::PROTEIN)
    ("classical PTC" . SPARSER::PROTEIN)
    ("the most informative miRNAs" . SPARSER::PROTEIN)
    ("miR-21 and -181b" . SPARSER::COLLECTION)
    ("FTC and FA" . SPARSER::COLLECTION) ("PAX8-PPAR γ" . SPARSER::COLLECTION)
    ("MTC" . SPARSER::PROTEIN) ("ATC" . SPARSER::DRUG)
    ("RET-PTC1" . SPARSER::COLLECTION) ("RET" . SPARSER::PROTEIN)
    ("ETC." . SPARSER::PROTEIN) ("5-2" . SPARSER::PROTEIN)
    ("- 2 " . SPARSER::PROTEIN) ("U9" . SPARSER::PROTEIN)
    ("– 2 " . SPARSER::PROTEIN) ("C – 2 " . SPARSER::PROTEIN)
    ("DNA glycosylase" . SPARSER::PROTEIN) ("miR-221-3p" . SPARSER::MOLECULE)
    ("PPAR γ" . SPARSER::PROTEIN) ("PAX8" . SPARSER::PROTEIN)
    ("PTC1" . SPARSER::PROTEIN) ("G9a/GLP" . SPARSER::COLLECTION)
    ("enzymes or remodelers" . SPARSER::COLLECTION)
    ("methylated lysines" . SPARSER::AMINO-ACID)
    ("p53 and pRb" . SPARSER::COLLECTION) ("pontin" . SPARSER::PROTEIN)
    ("CARM1 and p300" . SPARSER::COLLECTION)
    ("glucocorticoid receptor, androgen receptor and ERα"
     . SPARSER::COLLECTION)
    ("ERα target genes and PHF20-mediated H4K16 acetylation"
     . SPARSER::COLLECTION)
    ("PHF20 or PHF20/MOF-dependent H4K16ac" . SPARSER::COLLECTION)
    ("all commercial antibodies" . SPARSER::ANTIBODY)
    ("MOF and PHF20" . SPARSER::COLLECTION) ("KMT" . SPARSER::PROTEIN)
    ("PHF20 and PHF20L" . SPARSER::COLLECTION)
    ("ERα or ERαK235R" . SPARSER::COLLECTION) ("ERαK235R" . SPARSER::PROTEIN)
    ("PHF20 and the ERα K235R mutant ( xref )" . SPARSER::COLLECTION)
    ("ERα K235R" . SPARSER::PROTEIN) ("PHF20 and ERα" . SPARSER::COLLECTION)
    ("PHF20–ERα" . SPARSER::COLLECTION) ("amide" . SPARSER::MOLECULE)
    ("biotin-labelled methylated ERα or histone peptides" . SPARSER::PEPTIDE)
    ("ERα or histone" . SPARSER::COLLECTION)
    ("histones and non-histone" . SPARSER::COLLECTION)
    ("SPF30 and PHF20" . SPARSER::COLLECTION)
    ("Flag-ERαK235R" . SPARSER::PROTEIN-PAIR)
    ("Flag-ERα" . SPARSER::COLLECTION)
    ("unmethylated ERα or the ERα K235R mutant ( xref )" . SPARSER::COLLECTION)
    ("WT ERα and the K235R mutant" . SPARSER::COLLECTION)
    ("-luciferase" . SPARSER::COLLECTION)
    ("ERα and several other nuclear receptors" . SPARSER::COLLECTION)
    ("RK" . SPARSER::PROTEIN)
    ("Methylation assays using smaller protein" . SPARSER::PROTEIN)
    ("GREB1 and PR" . SPARSER::COLLECTION) ("E2−" . SPARSER::MOLECULE)
    ("a 2-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GREB1, PR and TFF1" . SPARSER::COLLECTION)
    ("GREB1 , PR and TFF1" . SPARSER::COLLECTION)
    ("GREB1 and TFF1" . SPARSER::COLLECTION)
    ("coactivator-associated arginine methyltransferase 1 (CARM1) and p300"
     . SPARSER::COLLECTION)
    ("NCOA2, coactivator-associated arginine methyltransferase 1 (CARM1) and p300"
     . SPARSER::COLLECTION)
    ("G9a and GLP" . SPARSER::COLLECTION) ("G9a or GLP" . SPARSER::COLLECTION)
    ("G9a and its closely-related paralogue" . SPARSER::COLLECTION)
    ("its closely-related paralogue" . SPARSER::PROTEIN)
    ("G9a and G9a-like" . SPARSER::COLLECTION) ("aka" . SPARSER::PROTEIN)
    ("GLP" . SPARSER::PROTEIN) ("H3K4 and H3K36" . SPARSER::COLLECTION)
    ("lysine methyltransferases (KMTs) and lysine demethylases"
     . SPARSER::COLLECTION)
    ("‘reader' proteins and their associated chromatin regulators"
     . SPARSER::COLLECTION)
    ("their associated chromatin regulators" . SPARSER::REGULATOR)
    ("PHF20/MOF" . SPARSER::COLLECTION) ("MOF" . SPARSER::PROTEIN)
    ("euchromatin" . SPARSER::BIO-COMPLEX) ("AF1" . SPARSER::PROTEIN)
    ("L3MBTL1" . SPARSER::PROTEIN) ("EZH2" . SPARSER::PROTEIN)
    ("SPF30" . SPARSER::PROTEIN) ("S -adenosylmethionine" . SPARSER::DRUG)
    ("AF-1" . SPARSER::PROTEIN) ("MAGE-A2" . SPARSER::PROTEIN)
    ("BIX-01294" . SPARSER::DRUG) ("Group C" . SPARSER::PROTEIN)
    ("pS2" . SPARSER::PROTEIN) ("TFF1" . SPARSER::PROTEIN)
    ("GREB1" . SPARSER::PROTEIN) ("CARM1" . SPARSER::PROTEIN)
    ("coactivator-associated arginine methyltransferase 1" . SPARSER::PROTEIN)
    ("NCOA2" . SPARSER::PROTEIN) ("SET domain" . SPARSER::PROTEIN)
    ("SMYD2" . SPARSER::PROTEIN)
    ("protein arginine methyltransferase 1" . SPARSER::PROTEIN)
    ("SET7/9" . SPARSER::PROTEIN) ("PHF20" . SPARSER::PROTEIN)
    ("G9a" . SPARSER::PROTEIN) ("mitotic entry cyclin A2" . SPARSER::PROTEIN)
    ("cyan fluorescent protein (cyclin B1 L45A–CFP xref ) or non-degradable cyclin A2 (cyclin A2 ΔN97–CFP xref )"
     . SPARSER::COLLECTION)
    ("cyan fluorescent protein" . SPARSER::PROTEIN) ("CFP" . SPARSER::PROTEIN)
    ("quantitative western blot" . SPARSER::PROTEIN)
    ("cyclin B1, cyclin A2 and securin" . SPARSER::COLLECTION)
    ("YFP–Cdc20 Ala and YFP–Cdc20 Asp" . SPARSER::COLLECTION)
    ("APC/C and Cdc20" . SPARSER::COLLECTION)
    ("mCherry–Cdc20" . SPARSER::COLLECTION) ("GFP–PCNA" . SPARSER::COLLECTION)
    ("PCNA" . SPARSER::PROTEIN) ("the last thymidine" . SPARSER::MOLECULE)
    ("Cdc20 and YFP–Cdc20 protein" . SPARSER::COLLECTION)
    ("YFP–Cdc20" . SPARSER::COLLECTION)
    ("Cdc20 Ala and Cdc20 Asp" . SPARSER::COLLECTION)
    ("Ala or Asp" . SPARSER::COLLECTION) ("Asp" . SPARSER::AMINO-ACID)
    ("cyclin A2–Cdk1" . SPARSER::COLLECTION)
    ("Cdk1 and Cdk2" . SPARSER::COLLECTION)
    ("Cyclin B1–Cdk1" . SPARSER::COLLECTION)
    ("Cyclin A2–Cdk2" . SPARSER::COLLECTION)
    ("APC3 and BubR1" . SPARSER::COLLECTION) ("PPase" . SPARSER::PROTEIN)
    ("Cdc20 T59A and Cdc20 T70A" . SPARSER::COLLECTION)
    ("yellow-fluorescent protein (YFP)-tagged Cdc20" . SPARSER::PROTEIN)
    ("TP" . SPARSER::PROTEIN) ("cyclin A2 and cyclin B1" . SPARSER::COLLECTION)
    ("APC/C–Cdh1" . SPARSER::COLLECTION)
    ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin A2 (the major A-type cyclin in human somatic cells) and cyclin B1"
     . SPARSER::COLLECTION)
    ("Cyclin A2–CDK2" . SPARSER::COLLECTION)
    ("cyclin B1 and A2" . SPARSER::COLLECTION)
    ("cyclin A2–Cdk2" . SPARSER::COLLECTION) ("APC/C" . SPARSER::PROTEIN)
    ("APC/C–Cdc20" . SPARSER::COLLECTION) ("Cdh1" . SPARSER::PROTEIN)
    ("Cdh" . SPARSER::PROTEIN) ("Cyclosome" . SPARSER::PROTEIN)
    ("μg " . SPARSER::PROTEIN) ("1–1" . SPARSER::PROTEIN)
    ("1-2 " . SPARSER::PROTEIN) ("PP1γ" . SPARSER::PROTEIN)
    ("PP1α" . SPARSER::PROTEIN) ("PP1 gamma" . SPARSER::PROTEIN)
    ("APC7" . SPARSER::PROTEIN) ("APC1" . SPARSER::PROTEIN)
    ("5P" . SPARSER::PROTEIN) ("Calyculin A" . SPARSER::MOLECULE)
    ("X-R" . SPARSER::PROTEIN) ("protein phosphatase 2" . SPARSER::PROTEIN)
    ("RO3306" . SPARSER::DRUG) ("Emi1" . SPARSER::PROTEIN)
    ("Cyclin A2" . SPARSER::PROTEIN)
    ("curcumin, geldanamycin and radicicol" . SPARSER::COLLECTION)
    ("geldanamycin" . SPARSER::DRUG) ("radicicol" . SPARSER::DRUG)
    ("HSP70 and HSP90" . SPARSER::COLLECTION)
    ("toxic oligomers" . SPARSER::PROTEIN)
    ("TRiC" . SPARSER::HUMAN-PROTEIN-FAMILY) ("chaperonin" . SPARSER::PROTEIN)
    ("h-IAPP toxic oligomers" . SPARSER::PROTEIN)
    ("the highly amyloidogenic h-proIAPP form" . SPARSER::FORM)
    ("Amyloid" . SPARSER::PROTEIN) ("a mature IAPP form" . SPARSER::FORM)
    ("EGL" . SPARSER::PROTEIN) ("kpc-2/egl-3" . SPARSER::COLLECTION)
    ("the COOH-terminal dibasic amino acids" . SPARSER::AMINO-ACID)
    ("an amino terminal signal peptide" . SPARSER::PROTEIN)
    ("all individuals secret amyloidogenic IAPP" . SPARSER::PROTEIN)
    ("proIAPP:IAPP" . SPARSER::BIO-COMPLEX)
    ("the predominantly existing form" . SPARSER::FORM)
    ("COOH" . SPARSER::MOLECULE)
    ("highly amyloidogenic proIAPP" . SPARSER::PROTEIN)
    ("pharyngeal promoter and pan-neuronal promoter" . SPARSER::COLLECTION)
    ("a muscle promoter, pharyngeal promoter and pan-neuronal promoter"
     . SPARSER::COLLECTION)
    ("a potentially secretable form" . SPARSER::FORM)
    ("pan-neuronal promoter" . SPARSER::PROMOTER)
    ("pharyngeal promoter" . SPARSER::PROMOTER) ("azide" . SPARSER::MOLECULE)
    ("YFP and Hsp72" . SPARSER::COLLECTION)
    ("proIAPP and pBX1" . SPARSER::COLLECTION)
    ("immobile protein" . SPARSER::PROTEIN) ("hsp-16-2" . SPARSER::PROTEIN)
    ("the aex-3 pan-neuronal promoter" . SPARSER::PROMOTER)
    ("the pharyngeal-specific tnt-4 promoter" . SPARSER::PROMOTER)
    ("tnt" . SPARSER::PROTEIN)
    ("the muscle-specific lev-11 promoter" . SPARSER::PROMOTER)
    ("pPR3, pPR4 and pPR5" . SPARSER::COLLECTION)
    ("pLR22, pLR25 and pLR35" . SPARSER::COLLECTION)
    ("pPR3, pPR4 and pPR5 and m-proIAPP" . SPARSER::COLLECTION)
    ("pPR5 and m-proIAPP" . SPARSER::COLLECTION)
    ("pPR8, pPR9 and pPR10" . SPARSER::COLLECTION) ("pPR5" . SPARSER::PROTEIN)
    ("pPR" . SPARSER::PROTEIN-FAMILY) ("pLR" . SPARSER::PROTEIN)
    ("pNG1 and pNG2" . SPARSER::COLLECTION) ("pNG1" . SPARSER::PROTEIN)
    ("pNG" . SPARSER::PROTEIN) ("YFP" . SPARSER::PROTEIN)
    ("Hsp72::EGFP" . SPARSER::BIO-COMPLEX)
    ("human proIAPP (vector pCMV6-XL5; Origene) and mouse proIAPP (vector pCMV6-Kan/NEO, Origene)"
     . SPARSER::COLLECTION)
    ("DsRed-h-IAPP" . SPARSER::COLLECTION) ("DsRed" . SPARSER::PROTEIN)
    ("Hsp72 (HspA1A) and Hsp25 (HspB1)" . SPARSER::COLLECTION)
    ("trypan" . SPARSER::DRUG) ("exogenous h-IAPP" . SPARSER::COLLECTION)
    ("food" . SPARSER::MOLECULE) ("the stress-inducible form" . SPARSER::FORM)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("ProIAPP" . SPARSER::PROTEIN) ("pre-proIAPP" . SPARSER::COLLECTION)
    ("a 22 amino-acid signal peptide and two short flanking peptides"
     . SPARSER::COLLECTION)
    ("a 22 amino-acid signal peptide" . SPARSER::PROTEIN)
    ("prohormone" . SPARSER::MOLECULE) ("amylin" . SPARSER::PROTEIN)
    ("proIAPP" . SPARSER::PROTEIN) ("h-Hsp72" . SPARSER::COLLECTION)
    ("h-proIAPP" . SPARSER::COLLECTION) ("h" . SPARSER::PROTEIN)
    ("h-IAPP" . SPARSER::COLLECTION) ("IAPP" . SPARSER::PROTEIN)
    ("Hsp-16" . SPARSER::PROTEIN) ("alpha-synuclein" . SPARSER::PROTEIN)
    ("KPC2" . SPARSER::PROTEIN) ("carboxypeptidase E" . SPARSER::PROTEIN)
    ("prohormone convertase 1" . SPARSER::PROTEIN)
    ("hsp-16" . SPARSER::PROTEIN) ("HspB1" . SPARSER::PROTEIN)
    ("HspA1A" . SPARSER::PROTEIN) ("pBX1" . SPARSER::PROTEIN)
    ("pPR3" . SPARSER::PROTEIN) ("neuronal)" . SPARSER::PROTEIN)
    ("Hsp25" . SPARSER::PROTEIN) ("C . elegans )" . SPARSER::PROTEIN)
    ("HSPA1A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hsp72" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("islet amyloid polypeptide" . SPARSER::PROTEIN)
    ("β-cell" . SPARSER::PROTEIN) ("Type 2" . SPARSER::PROTEIN)
    ("a particular miRNA" . SPARSER::PROTEIN)
    ("IL-6 and NF-κB" . SPARSER::COLLECTION)
    ("β-catenin and miR-3162-3p" . SPARSER::COLLECTION)
    ("Only five proteins" . SPARSER::PROTEIN)
    ("around ten miRNAs" . SPARSER::PROTEIN) ("HDM-" . SPARSER::PROTEIN)
    ("EOS" . SPARSER::PROTEIN) ("syn" . SPARSER::PROTEIN)
    ("allergen" . SPARSER::MOLECULE) ("WNT/β-catenin" . SPARSER::COLLECTION)
    ("TDI" . SPARSER::MOLECULE) ("Akt/GSK-3β/β-catenin" . SPARSER::COLLECTION)
    ("a vital component" . SPARSER::COMPONENT) ("HDM" . SPARSER::PROTEIN)
    ("antigens" . SPARSER::PROTEIN) ("AHR" . SPARSER::PROTEIN)
    ("dual-Luciferase" . SPARSER::PROTEIN) ("Oligo 2" . SPARSER::PROTEIN)
    ("c-3" . SPARSER::PROTEIN) ("hsa-let-7" . SPARSER::RNA)
    ("WNT-5A" . SPARSER::PROTEIN) ("toluene diisocyanate" . SPARSER::MOLECULE)
    ("Let-7" . SPARSER::RNA) ("miR-106a" . SPARSER::MOLECULE)
    ("glucuronide" . SPARSER::MOLECULE)
    ("resveratrol and Sirt1-ASO" . SPARSER::COLLECTION)
    ("resveratrol or co-treatment" . SPARSER::COLLECTION)
    ("controversial complex" . SPARSER::BIO-COMPLEX)
    ("cyclooxygenase" . SPARSER::PROTEIN)
    ("anti-proliferative and anti-metastasis" . SPARSER::COLLECTION)
    ("p53, NF-κB, Ku70 and FoxOs" . SPARSER::COLLECTION)
    ("FoxOs" . SPARSER::PROTEIN-FAMILY)
    ("regulating resveratrol’s" . SPARSER::PROTEIN)
    ("NF-κB and Sirt1" . SPARSER::COLLECTION)
    ("anti-tumor and anti-proliferative" . SPARSER::COLLECTION)
    ("anti-proliferative" . SPARSER::PROTEIN) ("anti-tumor" . SPARSER::PROTEIN)
    ("CXCR4 and MMP-9" . SPARSER::COLLECTION)
    ("resveratrol/Sirt1" . SPARSER::COLLECTION)
    ("Sirt1-NF-κB" . SPARSER::COLLECTION) ("p50/p65" . SPARSER::COLLECTION)
    ("p-NF-κB" . SPARSER::COLLECTION) ("Sirt1 and NF-κB" . SPARSER::COLLECTION)
    ("oligonucleotide (ASO)" . SPARSER::MOLECULE)
    ("resveratrol-anti-tumor" . SPARSER::PROTEIN-PAIR)
    ("Quantitative Western blot" . SPARSER::PROTEIN)
    ("resveratrol-anti-proliferative" . SPARSER::PROTEIN-PAIR)
    ("resveratrol and Sirt1-SO" . SPARSER::COLLECTION)
    ("p53 (HCT116) and mutant (SW480)" . SPARSER::COLLECTION)
    ("MSI and p53" . SPARSER::COLLECTION) ("phenylindole" . SPARSER::MOLECULE)
    ("rhodamine-coupled secondary antibodies" . SPARSER::ANTIBODY)
    ("PBS/BSA" . SPARSER::COLLECTION) ("aqua" . SPARSER::MOLECULE)
    ("rhodamine" . SPARSER::PROTEIN)
    ("bovine serum albumin (BSA)" . SPARSER::PROTEIN)
    ("BSA" . SPARSER::PROTEIN) ("glass" . SPARSER::MOLECULE)
    ("ice-cold PBS" . SPARSER::PROTEIN)
    ("antigen-antibody" . SPARSER::PROTEIN-PAIR) ("bromo" . SPARSER::MOLECULE)
    ("alkaline phosphatase-conjugated secondary antibodies"
     . SPARSER::ANTIBODY)
    ("trans-blot" . SPARSER::COLLECTION) ("nitrocellulose" . SPARSER::MOLECULE)
    ("mercaptoethanol" . SPARSER::MOLECULE)
    ("bovine serum albumin" . SPARSER::PROTEIN) ("PMSF" . SPARSER::MOLECULE)
    ("leupeptin" . SPARSER::DRUG) ("pepstatin" . SPARSER::DRUG)
    ("aprotinin" . SPARSER::DRUG) ("pyrophosphate" . SPARSER::MOLECULE)
    ("orthovanadate" . SPARSER::MOLECULE) ("Tris" . SPARSER::MOLECULE)
    ("methanol" . SPARSER::MOLECULE)
    ("resveratrol (1, 5, 10 µM) or co-treated" . SPARSER::COLLECTION)
    ("resveratrol (1, 5, 10 µM) and co-treated" . SPARSER::COLLECTION)
    ("Lipofectin" . SPARSER::DRUG)
    ("-TGTCTGTTTCATGTGGAATAC-3" . SPARSER::COLLECTION)
    ("-GTATTCCACATGAAACAGACA-3" . SPARSER::COLLECTION)
    ("sterile" . SPARSER::PROTEIN-FAMILY) ("alginate" . SPARSER::MOLECULE)
    ("EDTA" . SPARSER::MOLECULE) ("VA" . SPARSER::MOLECULE)
    ("Alginate" . SPARSER::MOLECULE)
    ("1% essential amino acids and 1% glutamine" . SPARSER::COLLECTION)
    ("1% essential amino acids" . SPARSER::AMINO-ACID)
    ("streptomycin" . SPARSER::DRUG)
    ("sheep anti-rabbit secondary antibodies" . SPARSER::ANTIBODY)
    ("EMD" . SPARSER::PROTEIN) ("β-actin and Ki-67" . SPARSER::COLLECTION)
    ("Antibodies" . SPARSER::ANTIBODY)
    ("Monoclonal poly(ADP-ribose) polymerase (PARP) antibodies"
     . SPARSER::ANTIBODY)
    ("secondary antibodies" . SPARSER::ANTIBODY)
    ("Anti-phospho-specific p65 (NF-κB) and anti-phospho-specific p50 (NFκB)"
     . SPARSER::COLLECTION)
    ("Sirt1 and CXCR4" . SPARSER::COLLECTION)
    ("oligonucleotides (ASO)" . SPARSER::MOLECULE)
    ("Apparently some genes" . SPARSER::GENE)
    ("subcellular target histone deacetylase Sirt1" . SPARSER::PROTEIN)
    ("histone/protein" . SPARSER::COLLECTION) ("stilbenes" . SPARSER::MOLECULE)
    ("NF-κB, and resveratrol" . SPARSER::COLLECTION)
    ("promoter and suppressor" . SPARSER::COLLECTION)
    ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Sirt-1" . SPARSER::PROTEIN)
    ("Triton x-100" . SPARSER::MOLECULE) ("sirtuin-1" . SPARSER::PROTEIN)
    ("Ac-K" . SPARSER::PROTEIN) ("sirtuin1" . SPARSER::PROTEIN)
    ("Bax/bal-2" . SPARSER::COLLECTION)
    ("antiapoptotic proteins (e.g., Bcl-2, Bcl-XL, and Mcl-1) and proapoptotic proteins (e.g., Bax, Bak, and Bad)"
     . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-XL, and Mcl-1" . SPARSER::COLLECTION)
    ("Bax, Bak, and Bad" . SPARSER::COLLECTION)
    ("Bax/Bcl-2" . SPARSER::COLLECTION)
    ("Bax and caspase-3" . SPARSER::COLLECTION)
    ("galactose" . SPARSER::MOLECULE) ("Bax and Bcl-2" . SPARSER::COLLECTION)
    ("ARC" . SPARSER::PROTEIN) ("Silicone" . SPARSER::MOLECULE)
    ("Bax, Bcl-2, and Caspase-3" . SPARSER::COLLECTION)
    ("silicone" . SPARSER::MOLECULE) ("Bcl-XL" . SPARSER::PROTEIN)
    ("Bit1-FAK-paxillin" . SPARSER::COLLECTION)
    ("paxillin and its related protein FAK" . SPARSER::COLLECTION)
    ("an oncogene or a tumor suppressor" . SPARSER::COLLECTION)
    ("oncogene and suppressor" . SPARSER::COLLECTION)
    ("mRNA and protein" . SPARSER::COLLECTION) ("paxillin " . SPARSER::PROTEIN)
    ("paxillin and FAK" . SPARSER::COLLECTION)
    ("FAK and Paxillin" . SPARSER::COLLECTION)
    ("16 upregulated genes (AKAP9, ARHGEF4, RUNX1, FGF18, PARVB, PRDX4, RPS6KA2, ADORA2A, IL1R1, CRP, WNT, IL-2RA, IFN, ARAP1, IFNA6 and VLDLR) and 23 downregulated genes (CMKLR1, SLA2, HNF1A, PPP1R1C, ZNF423, FAM19A4, TLE1, NLRP3, PAXILLIN, BAX, CBLB, MLLT4, ERBB3, MEF2C, ATF2, TALIN, PDGFRA, TIAM1, CAMK4, EIF4E1B, ERCC5, TLR7 and IL-6)"
     . SPARSER::COLLECTION)
    ("AKAP9, ARHGEF4, RUNX1, FGF18, PARVB, PRDX4, RPS6KA2, ADORA2A, IL1R1, CRP, WNT, IL-2RA, IFN, ARAP1, IFNA6 and VLDLR"
     . SPARSER::COLLECTION)
    ("PI3K-Akt" . SPARSER::PROTEIN) ("TALIN" . SPARSER::PROTEIN)
    ("PAXILLIN" . SPARSER::PROTEIN) ("FAM" . SPARSER::PROTEIN)
    ("VLDLR" . SPARSER::PROTEIN) ("IFN" . SPARSER::DRUG)
    ("CRP" . SPARSER::PROTEIN) ("PARVB" . SPARSER::PROTEIN)
    ("μg" . SPARSER::PROTEIN) ("IOD" . SPARSER::MOLECULE)
    ("μg-shRNA" . SPARSER::COLLECTION)
    ("Bit1, Bcl-2 and MMP-2" . SPARSER::COLLECTION)
    ("Bit1-shRNA" . SPARSER::COLLECTION)
    ("peptidyl-tRNA" . SPARSER::COLLECTION) ("tRNA" . SPARSER::PROTEIN)
    ("ECA" . SPARSER::PROTEIN) ("Bcl-2 and MMP-2" . SPARSER::COLLECTION)
    ("Bit1 and FAK" . SPARSER::COLLECTION)
    ("FAK-paxillin" . SPARSER::COLLECTION)
    ("3- (4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("TLR7" . SPARSER::PROTEIN) ("ERCC5" . SPARSER::PROTEIN)
    ("EIF4E1" . SPARSER::PROTEIN) ("CAMK4" . SPARSER::PROTEIN)
    ("TIAM1" . SPARSER::PROTEIN) ("ATF2" . SPARSER::PROTEIN)
    ("MLLT4" . SPARSER::PROTEIN) ("NLRP3" . SPARSER::PROTEIN)
    ("TLE1" . SPARSER::PROTEIN) ("19A" . SPARSER::PROTEIN)
    ("PPP1R1C" . SPARSER::PROTEIN) ("HNF1A" . SPARSER::PROTEIN)
    ("SLA2" . SPARSER::PROTEIN) ("IFNA6" . SPARSER::PROTEIN)
    ("ARAP1" . SPARSER::PROTEIN) ("IL-2RA" . SPARSER::PROTEIN)
    ("IL1R1" . SPARSER::PROTEIN) ("ADORA2A" . SPARSER::PROTEIN)
    ("RPS6KA2" . SPARSER::PROTEIN) ("PRDX4" . SPARSER::PROTEIN)
    ("FGF18" . SPARSER::PROTEIN) ("ARHGEF4" . SPARSER::PROTEIN)
    ("AKAP9" . SPARSER::PROTEIN) ("N2 " . SPARSER::PROTEIN)
    ("N1 " . SPARSER::PROTEIN) ("N  2  " . SPARSER::PROTEIN)
    ("N  1  " . SPARSER::PROTEIN)
    ("Bcl-2 inhibitor of transcription" . SPARSER::PROTEIN)
    ("Bit1" . SPARSER::PROTEIN) ("ATG5 and ATG12" . SPARSER::COLLECTION)
    ("ATG12, ATG5 , or BECN1" . SPARSER::COLLECTION)
    ("ATG5, ATG12, or BECN1" . SPARSER::COLLECTION)
    ("ATG12 and TGM2" . SPARSER::COLLECTION)
    ("autophagosome elongation (Kimmelman, 2011) and BECN1"
     . SPARSER::COLLECTION)
    ("BECN1 or ATG5" . SPARSER::COLLECTION)
    ("BECN1/Beclin 1" . SPARSER::COLLECTION) ("Tgm2" . SPARSER::PROTEIN)
    ("ER-RAS" . SPARSER::COLLECTION)
    ("co-factors or repressors" . SPARSER::COLLECTION)
    ("p53-MDM2" . SPARSER::COLLECTION) ("TGM2-p53" . SPARSER::COLLECTION)
    ("at least two other essential autophagy regulators" . SPARSER::REGULATOR)
    ("RB/TP53" . SPARSER::COLLECTION)
    ("a direct p53 target gene or not" . SPARSER::COLLECTION)
    ("-p53" . SPARSER::COLLECTION)
    ("the multifunctional protein transglutaminase 2" . SPARSER::PROTEIN)
    ("the TP53-dependent tumor suppressive barrier" . SPARSER::PROTEIN)
    ("TP53 and TGM2" . SPARSER::COLLECTION)
    ("ATG12, ATG5 , and BECN1" . SPARSER::COLLECTION)
    ("TP53 and mutant" . SPARSER::COLLECTION)
    ("BAX, BAD , and BNIP3" . SPARSER::COLLECTION)
    ("BBC3/PUMA" . SPARSER::COLLECTION)
    ("SESN2/SESTRIN2" . SPARSER::COLLECTION)
    ("C12orf5/TIGAR" . SPARSER::COLLECTION) ("BAD" . SPARSER::PROTEIN)
    ("TIGAR" . SPARSER::PROTEIN) ("Atg7" . SPARSER::PROTEIN)
    ("Atg5" . SPARSER::PROTEIN) ("Atg" . SPARSER::DRUG)
    ("GTP/GDP" . SPARSER::PROTEIN-PAIR)
    ("CASP3/Caspase 3" . SPARSER::COLLECTION)
    ("a pleiotropic enzyme" . SPARSER::ENZYME)
    ("RARA/RAR-alpha" . SPARSER::COLLECTION)
    ("TGFB1/TGF-beta" . SPARSER::COLLECTION)
    ("NFKB1/NF-κB" . SPARSER::COLLECTION) ("RARA" . SPARSER::PROTEIN)
    ("SQSTM1 and LC3-I" . SPARSER::COLLECTION)
    ("a multifunctional enzyme" . SPARSER::ENZYME)
    ("TGM2/BECN1" . SPARSER::COLLECTION) ("TGM2/ATG5" . SPARSER::COLLECTION)
    ("shRNA or BECN1" . SPARSER::COLLECTION)
    ("TGM2/ATG12" . SPARSER::COLLECTION)
    ("shRNA and ATG12" . SPARSER::COLLECTION)
    ("ATG5 or BECN1" . SPARSER::COLLECTION)
    ("ATG5, BECN1, or ATG12" . SPARSER::COLLECTION)
    ("autophagosome elongation ( xref ) and BECN1" . SPARSER::COLLECTION)
    ("ATG5 and BECN1" . SPARSER::COLLECTION)
    ("ATG12 and CDKN1A" . SPARSER::COLLECTION)
    ("TERT/ST" . SPARSER::COLLECTION) ("TP53/CDKN1A" . SPARSER::COLLECTION)
    ("CDKN1A and TP53" . SPARSER::COLLECTION)
    ("TGM2 or CDKN1A" . SPARSER::COLLECTION)
    ("CDKN1A and TGM2" . SPARSER::COLLECTION) ("Lysotracker" . SPARSER::DRUG)
    ("SQSTM1/p62" . SPARSER::COLLECTION) ("CQ" . SPARSER::PROTEIN)
    ("phosphatidylethanolamine" . SPARSER::MOLECULE)
    ("chloroquine (CQ)" . SPARSER::PROTEIN) ("H2B-GFP" . SPARSER::COLLECTION)
    ("TERT-H2B-GFP" . SPARSER::COLLECTION)
    ("RFP-GFP-LC3" . SPARSER::COLLECTION)
    ("the TGM2 promoter, which does not contain" . SPARSER::PROMOTER)
    ("MH" . SPARSER::MOLECULE) ("TP53-MDM2" . SPARSER::COLLECTION)
    ("not an upstream regulator or a co-factor of TP53" . SPARSER::COLLECTION)
    ("CDKN1A and MDM2" . SPARSER::COLLECTION)
    ("shp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("at least two independent shRNAs" . SPARSER::RNA)
    ("hydrocortisone" . SPARSER::DRUG) ("ER-HRAS" . SPARSER::COLLECTION)
    ("/p16" . SPARSER::COLLECTION) ("RB1/pRb" . SPARSER::COLLECTION)
    ("TGM2 and CDKN1A" . SPARSER::COLLECTION)
    ("INK4A/p16" . SPARSER::COLLECTION) ("RB1/pRB" . SPARSER::COLLECTION)
    ("Cdkn1A" . SPARSER::PROTEIN)
    ("other p53’s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TP53, and TGM2" . SPARSER::COLLECTION) ("A '" . SPARSER::PROTEIN)
    ("C11" . SPARSER::PROTEIN) ("LC3B" . SPARSER::PROTEIN)
    ("BNIP3" . SPARSER::PROTEIN) ("BBC3" . SPARSER::PROTEIN)
    ("ULK2" . SPARSER::PROTEIN) ("ULK1" . SPARSER::PROTEIN)
    ("SESTRIN2" . SPARSER::PROTEIN) ("SESN2" . SPARSER::PROTEIN)
    ("DAPK1" . SPARSER::PROTEIN) ("C12orf5" . SPARSER::PROTEIN)
    ("DRAM1" . SPARSER::PROTEIN) ("Beclin- 1" . SPARSER::PROTEIN)
    ("CASP3" . SPARSER::PROTEIN) ("RAR-alpha" . SPARSER::PROTEIN)
    ("TGF-beta" . SPARSER::PROTEIN) ("Beclin 1" . SPARSER::PROTEIN)
    ("BECN1" . SPARSER::PROTEIN) ("TGM 2" . SPARSER::PROTEIN)
    ("LC3-II" . SPARSER::PROTEIN) ("MAP1LC3A" . SPARSER::PROTEIN)
    ("GFP-LC3" . SPARSER::PROTEIN) ("Nutlin-3a" . SPARSER::DRUG)
    ("INK4a" . SPARSER::PROTEIN) ("4-Hydroxy-Tamoxifen" . SPARSER::DRUG)
    ("small T antigen" . SPARSER::PROTEIN)
    ("tissue transglutaminase" . SPARSER::PROTEIN) ("BRD7" . SPARSER::PROTEIN)
    ("p14ARF" . SPARSER::PROTEIN) ("Transglutaminase 2" . SPARSER::PROTEIN)
    ("TGM2" . SPARSER::PROTEIN) ("transglutaminase 2" . SPARSER::PROTEIN)
    ("ALK as well as EGFRm and ROS1" . SPARSER::COLLECTION)
    ("dual inhibitors" . SPARSER::INHIBITOR)
    ("crizotinib and ceritinib" . SPARSER::COLLECTION)
    ("ALK and ROS1" . SPARSER::COLLECTION)
    ("ALK L1196M and EGFR T790M mutants" . SPARSER::COLLECTION)
    ("a potent dual inhibitor" . SPARSER::INHIBITOR)
    ("ALK and EGFR" . SPARSER::COLLECTION) ("Brigatinib" . SPARSER::DRUG)
    ("creatinine" . SPARSER::PROTEIN) ("Alectinib" . SPARSER::DRUG)
    ("Ceritinib" . SPARSER::DRUG) ("GFR" . SPARSER::PROTEIN)
    ("a newly developed ALK inhibitor" . SPARSER::INHIBITOR)
    ("variant or fusion" . SPARSER::COLLECTION)
    ("ALK or other partner genes [ xref ]" . SPARSER::COLLECTION)
    ("Crizotinib-associated AEs" . SPARSER::PROTEIN)
    ("cisplatin or carboplatin" . SPARSER::COLLECTION)
    ("aminotransferase" . SPARSER::PROTEIN)
    ("vs intravenous pemetrexed or docetaxel" . SPARSER::COLLECTION)
    ("pemetrexed or docetaxel" . SPARSER::COLLECTION)
    ("pemetrexed" . SPARSER::DRUG) ("c-MET and ROS1" . SPARSER::COLLECTION)
    ("xalkori" . SPARSER::DRUG) ("sonic hedgehog (SHH)" . SPARSER::PROTEIN)
    ("kinase (JAK)" . SPARSER::KINASE)
    ("GTPase, and MAPK" . SPARSER::COLLECTION) ("JAK" . SPARSER::PROTEIN)
    ("KIF5B, KLC1, TFG, TPR, HIP1, STRN, DCTN1, SQSTM1, and BIRC6"
     . SPARSER::COLLECTION)
    ("TPR" . SPARSER::PROTEIN)
    ("the juxta membranous part" . SPARSER::COMPONENT)
    ("intramembranous parts" . SPARSER::COMPONENT) ("-t" . SPARSER::COLLECTION)
    ("ATIC" . SPARSER::PROTEIN)
    ("ALK gene and the roles in oncogenesis" . SPARSER::COLLECTION)
    ("brigatinib" . SPARSER::DRUG) ("ceritinib" . SPARSER::DRUG)
    ("alectinib" . SPARSER::DRUG) ("Crizotinib" . SPARSER::DRUG)
    ("GDC0032" . SPARSER::DRUG) ("GDC0941" . SPARSER::DRUG)
    ("LDK378" . SPARSER::DRUG) ("IGF-1R" . SPARSER::PROTEIN)
    ("ROS1" . SPARSER::PROTEIN) ("PF-02341066" . SPARSER::DRUG)
    ("RAP1" . SPARSER::PROTEIN) ("RAPGEF1" . SPARSER::PROTEIN)
    ("JUN-B" . SPARSER::PROTEIN) ("PLCγ" . SPARSER::PROTEIN-FAMILY)
    ("BIRC6" . SPARSER::PROTEIN) ("DCTN1" . SPARSER::PROTEIN)
    ("HIP1" . SPARSER::PROTEIN) ("KLC1" . SPARSER::PROTEIN)
    ("CLTCL1" . SPARSER::PROTEIN) ("TPM3" . SPARSER::PROTEIN)
    ("p23" . SPARSER::PROTEIN) ("PF-06463922" . SPARSER::DRUG)
    ("monocytes/macrophages" . SPARSER::COLLECTION)
    ("peroxynitrite" . SPARSER::MOLECULE) ("MnTBAP" . SPARSER::DRUG)
    ("thiol" . SPARSER::MOLECULE)
    ("metabolic associated proteins" . SPARSER::PROTEIN)
    ("the viral protein HBx" . SPARSER::PROTEIN)
    ("mitochondrially associated HBx" . SPARSER::PROTEIN)
    ("STAT-3 and NF-κB" . SPARSER::COLLECTION) ("anion" . SPARSER::MOLECULE)
    ("a key viral protein" . SPARSER::PROTEIN)
    ("oxidative components" . SPARSER::COMPONENT)
    ("southern blot" . SPARSER::PROTEIN)
    ("H 2 O 2 and NAC" . SPARSER::COLLECTION)
    ("SIRT3 or HBx" . SPARSER::COLLECTION)
    ("purines and pyrimidines" . SPARSER::COLLECTION)
    ("SSBs" . SPARSER::PROTEIN) ("pyrimidines" . SPARSER::DRUG)
    ("purines" . SPARSER::DRUG) ("oxidative DNA" . SPARSER::DNA)
    ("protein or DNA" . SPARSER::COLLECTION) ("GSSG" . SPARSER::DRUG)
    ("peroxiredoxin" . SPARSER::PROTEIN)
    ("mitochondrial ROS" . SPARSER::PROTEIN) ("MitoSOX" . SPARSER::DRUG)
    ("SIRT3 and HBx" . SPARSER::COLLECTION)
    ("Flag-SIRT3" . SPARSER::COLLECTION) ("Flag-HBx" . SPARSER::COLLECTION)
    ("Viral protein HBV X protein" . SPARSER::PROTEIN)
    ("Carboxy" . SPARSER::MOLECULE)
    ("nicotinamide adenine dinucleotide (NAD)" . SPARSER::MOLECULE)
    ("protein and DNA" . SPARSER::COLLECTION)
    ("These studies shed new light" . SPARSER::PROTEIN)
    ("N-acetyl-L-cysteine (NAC)" . SPARSER::MOLECULE)
    ("viral protein HBx" . SPARSER::PROTEIN)
    ("pathological states" . SPARSER::BIO-STATE) ("HBx" . SPARSER::PROTEIN)
    ("STAT-3" . SPARSER::PROTEIN) ("HVDAC3" . SPARSER::PROTEIN)
    ("voltage-dependent" . SPARSER::PROTEIN) ("H 2 AX" . SPARSER::PROTEIN)
    ("Peroxiredoxin 1" . SPARSER::PROTEIN) ("H2DCFDA" . SPARSER::DRUG)
    ("H 2 DCFDA" . SPARSER::DRUG)
    ("tert-butyl hydroperoxide" . SPARSER::MOLECULE)
    ("γ-H 2 AX" . SPARSER::PROTEIN) ("OGG1" . SPARSER::PROTEIN)
    ("8-oxoguanine-DNA glycosylase 1" . SPARSER::PROTEIN)
    ("N-acetyl-L-cysteine" . SPARSER::MOLECULE) ("γH 2 AX" . SPARSER::PROTEIN)
    ("40 or 60 mg/kg etomoxir or vehicle" . SPARSER::COLLECTION)
    ("40 mg/kg etomoxir or vehicle" . SPARSER::COLLECTION)
    ("UDP" . SPARSER::UDP) ("UTP" . SPARSER::MOLECULE) ("UMP" . SPARSER::UMP)
    ("a four-hydroxytamoxifen (TAM)-inducible MYC-ER fusion protein (HMEC MYC-ER ) and two RP"
     . SPARSER::COLLECTION)
    ("MYC-ER" . SPARSER::COLLECTION) ("TN and MYC" . SPARSER::COLLECTION)
    ("RP or TN" . SPARSER::COLLECTION) ("Etomoxir" . SPARSER::DRUG)
    ("etomoxir" . SPARSER::DRUG) ("malonyl" . SPARSER::PROTEIN)
    ("TN and RP" . SPARSER::COLLECTION)
    ("FASN and ACACB" . SPARSER::COLLECTION) ("ACACB" . SPARSER::PROTEIN)
    ("TN" . SPARSER::PROTEIN) ("palmitate" . SPARSER::PROTEIN)
    ("AC" . SPARSER::PROTEIN) ("Metabolite" . SPARSER::MOLECULE)
    ("naïve" . SPARSER::PROTEIN) ("TOM" . SPARSER::PROTEIN)
    ("MTB-TOM" . SPARSER::COLLECTION) ("MTB" . SPARSER::PROTEIN)
    ("estrogen, progesterone and human epidermal growth factor 2 receptor-positive (RP) breast tumors xref"
     . SPARSER::COLLECTION)
    ("Fatty acid" . SPARSER::MOLECULE) ("BBOX1" . SPARSER::PROTEIN)
    ("α-ketoglutarate" . SPARSER::MOLECULE) ("MYC protein" . SPARSER::PROTEIN)
    ("CPT2" . SPARSER::PROTEIN) ("CPT1B" . SPARSER::PROTEIN)
    ("oleic acid" . SPARSER::MOLECULE) ("ACC1" . SPARSER::PROTEIN)
    ("PGC1α" . SPARSER::PROTEIN) ("acyl-CoAs" . SPARSER::MOLECULE)
    ("a pluripotent state" . SPARSER::BIO-STATE)
    ("bFGF and TGF-β" . SPARSER::COLLECTION)
    ("TGF-β/activin" . SPARSER::COLLECTION)
    ("GDF3, NODAL, LEFTY2, SPP1, and CER1" . SPARSER::COLLECTION)
    ("basic fibroblast growth factor (bFGF) and TGF-β" . SPARSER::COLLECTION)
    ("a stable naive state" . SPARSER::BIO-STATE)
    ("sub-optimal culture media" . SPARSER::PROTEIN)
    ("the naive PSC state" . SPARSER::BIO-STATE)
    ("naive media" . SPARSER::PROTEIN)
    ("active β-catenin ( xref ) and Wnt target genes ( xref )"
     . SPARSER::COLLECTION)
    ("only one inhibitor" . SPARSER::INHIBITOR)
    ("the Human Naive State" . SPARSER::BIO-STATE)
    ("inhibitors and growth factors" . SPARSER::COLLECTION)
    ("OCT4-" . SPARSER::PROTEIN)
    ("heterochromatin, and H3K9" . SPARSER::COLLECTION)
    ("B2M and HLA" . SPARSER::COLLECTION) ("HLA" . SPARSER::PROTEIN)
    ("OTX2, DNMT3B, B2M, HLA-A, HLA-B, HLA-H, and HLA-DOA"
     . SPARSER::COLLECTION)
    ("FST" . SPARSER::PROTEIN) ("NODAL" . SPARSER::PROTEIN)
    ("the human naive PSC state" . SPARSER::BIO-STATE)
    ("NANOG, OCT4, and REX1" . SPARSER::COLLECTION)
    ("GP130, SOCS3, and TBX3" . SPARSER::COLLECTION)
    ("LIF-STAT3" . SPARSER::COLLECTION) ("sterol" . SPARSER::PROTEIN)
    ("FC" . SPARSER::PROTEIN) ("PC1" . SPARSER::PROTEIN)
    ("LATS1 and LATS2" . SPARSER::COLLECTION)
    ("trypsinized" . SPARSER::PROTEIN)
    ("OCT4, and NANOG" . SPARSER::COLLECTION) ("SSEA" . SPARSER::PROTEIN)
    ("trypsinization" . SPARSER::PROTEIN)
    ("alkaline phosphatase (AP)" . SPARSER::PROTEIN-FAMILY)
    ("Forskolin and human LIF (N2B27+2iFL)" . SPARSER::COLLECTION)
    ("Forskolin" . SPARSER::PROTEIN) ("bFGF" . SPARSER::PROTEIN)
    ("a Naive State" . SPARSER::BIO-STATE)
    ("a small molecule inhibitor of the Hippo pathway and an activator"
     . SPARSER::COLLECTION)
    ("Yes-associated protein (YAP)" . SPARSER::PROTEIN)
    ("the naive pluripotent state" . SPARSER::BIO-STATE)
    ("NANOG and KLF2" . SPARSER::COLLECTION)
    ("growth factors and small molecules" . SPARSER::COLLECTION)
    ("the mouse naive state" . SPARSER::BIO-STATE)
    ("alternative pluripotent states" . SPARSER::BIO-STATE)
    ("a naive state" . SPARSER::BIO-STATE)
    ("pluripotent state" . SPARSER::BIO-STATE)
    ("a naive ICM-like state" . SPARSER::BIO-STATE)
    ("the human naive state" . SPARSER::BIO-STATE)
    ("the naive state" . SPARSER::BIO-STATE)
    ("The human naive pluripotent stem cell (PSC) state" . SPARSER::BIO-STATE)
    ("EF1 α" . SPARSER::PROTEIN) ("beta-mercaptoethanol" . SPARSER::MOLECULE)
    ("F 12" . SPARSER::PROTEIN) ("KLF4" . SPARSER::PROTEIN)
    ("P28" . SPARSER::PROTEIN) ("Yap/Taz" . SPARSER::PROTEIN)
    ("CER1" . SPARSER::PROTEIN) ("LEFTY2" . SPARSER::PROTEIN)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("SOX1" . SPARSER::PROTEIN) ("SOX17" . SPARSER::PROTEIN)
    ("Histone 3" . SPARSER::PROTEIN) ("histone 3" . SPARSER::PROTEIN)
    ("HLA-DOA" . SPARSER::PROTEIN) ("HLA-H" . SPARSER::PROTEIN)
    ("HLA-B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DNMT3B" . SPARSER::PROTEIN)
    ("OTX2" . SPARSER::PROTEIN) ("IDI1" . SPARSER::PROTEIN)
    ("DHCR7" . SPARSER::PROTEIN) ("DHCR24" . SPARSER::PROTEIN)
    ("NLRP7" . SPARSER::PROTEIN) ("DNMT3L" . SPARSER::PROTEIN)
    ("GDF3" . SPARSER::PROTEIN) ("TBX3" . SPARSER::PROTEIN)
    ("GP130" . SPARSER::PROTEIN) ("TFCP2" . SPARSER::PROTEIN)
    ("REX1" . SPARSER::PROTEIN) ("LATS2" . SPARSER::PROTEIN)
    ("LATS1" . SPARSER::PROTEIN) ("TRA-1" . SPARSER::PROTEIN)
    ("SSEA3" . SPARSER::MOLECULE) ("Lysophosphatidic acid" . SPARSER::LPA)
    ("bank" . SPARSER::PROTEIN) ("the possible biomarkers" . SPARSER::MOLECULE)
    ("The histologic subtypes" . SPARSER::PROTEIN)
    ("ARID1A and PIK3CA" . SPARSER::COLLECTION) ("CA 125" . SPARSER::DRUG)
    ("HNF-1" . SPARSER::PROTEIN)
    ("Hepatocyte nuclear factor" . SPARSER::PROTEIN)
    ("ARID1A" . SPARSER::PROTEIN) ("domain 1" . SPARSER::PROTEIN)
    ("the trimolecular protein EBNA-5–MDM2–P53" . SPARSER::COLLECTION)
    ("protein, and MDM2" . SPARSER::COLLECTION)
    ("EBNA-5–MDM2–P53" . SPARSER::COLLECTION) ("t  " . SPARSER::PROTEIN)
    ("bearing T allele" . SPARSER::ALLELE) ("MTHFR" . SPARSER::PROTEIN)
    ("toxic substances" . SPARSER::SUBSTANCE) ("HNC" . SPARSER::PROTEIN)
    ("latent membrane protein 1" . SPARSER::PROTEIN)
    ("EBNA-5" . SPARSER::PROTEIN) ("CYP1B1" . SPARSER::PROTEIN)
    ("EPHX1" . SPARSER::PROTEIN) ("productive elongation" . SPARSER::PROTEIN)
    ("family or gene" . SPARSER::COLLECTION)
    ("The predominant kinase" . SPARSER::KINASE)
    ("functional mRNA" . SPARSER::PROTEIN)
    ("the mRNA cap N-7 methyltransferase enzymic subunit RNMT"
     . SPARSER::PROTEIN)
    ("T77A-GFP and GFP" . SPARSER::COLLECTION)
    ("RNMT-GFP" . SPARSER::COLLECTION) ("FLAG-RAM" . SPARSER::COLLECTION)
    ("RNMT and RAM" . SPARSER::COLLECTION)
    ("BOP1, TOMM70A, and Skp2" . SPARSER::COLLECTION)
    ("BOP1, TOMM70A, DDX18, and Skp2" . SPARSER::COLLECTION)
    ("Roscovitine" . SPARSER::DRUG)
    ("western blot and cap methyltransferase activity" . SPARSER::COLLECTION)
    ("GST-KPNA2" . SPARSER::COLLECTION)
    ("RO-3306 or roscovitine" . SPARSER::COLLECTION)
    ("RNMT " . SPARSER::PROTEIN)
    ("endogenous RNMT and HA-RNMT (lanes 2–4, xref A)" . SPARSER::COLLECTION)
    ("GST-RNMT" . SPARSER::COLLECTION) ("-KPNA2" . SPARSER::COLLECTION)
    ("Tubulin" . SPARSER::PROTEIN) ("RNMT and KPNA2" . SPARSER::COLLECTION)
    ("pcDNA5 Myc-tagged KPNA2 (Myc-KPNA2) or pcDNA5" . SPARSER::COLLECTION)
    ("Myc-KPNA2" . SPARSER::COLLECTION)
    ("approximately 150 and 90 kDa" . SPARSER::PROTEIN)
    ("Peptides" . SPARSER::PEPTIDE) ("cellular RNMT" . SPARSER::PROTEIN)
    ("TLC" . SPARSER::PROTEIN) ("methionine (SAM)" . SPARSER::MOLECULE)
    ("SAM" . SPARSER::MOLECULE) ("methionine" . SPARSER::AMINO-ACID)
    ("RNMT and histone" . SPARSER::COLLECTION)
    ("cyclin B1 and CDK3" . SPARSER::COLLECTION)
    ("CDK1 and cyclin E1" . SPARSER::COLLECTION)
    ("CDK and cyclin" . SPARSER::COLLECTION)
    ("CDK3 and cyclin E1" . SPARSER::COLLECTION)
    ("CDK1 and cyclin B1" . SPARSER::COLLECTION)
    ("CDK3-cyclin E1" . SPARSER::COLLECTION)
    ("the predominant cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDK1-Cyclin B1" . SPARSER::COLLECTION)
    ("cyclin B1, E1/2, and A2" . SPARSER::COLLECTION)
    ("roscovitine and RO-3306" . SPARSER::COLLECTION)
    ("CDK1 or CDK2" . SPARSER::COLLECTION)
    ("the RNA pol II CTD kinases" . SPARSER::PROTEIN)
    ("DRB" . SPARSER::PROTEIN)
    ("the RNA pol II-associated CDKs" . SPARSER::PROTEIN)
    ("inhibitor " . SPARSER::INHIBITOR)
    ("which targets CDK1 and CDK2" . SPARSER::COLLECTION)
    ("which targets CDK1, CDK2, CDK5, CDK7, and CDK9, and RO-3306"
     . SPARSER::COLLECTION)
    ("CDK1, CDK2, CDK5, CDK7, and CDK9, and RO-3306" . SPARSER::COLLECTION)
    ("CDK9, and RO-3306" . SPARSER::COLLECTION)
    ("CDK1 and CDK2" . SPARSER::COLLECTION)
    ("transcription-associated kinases" . SPARSER::KINASE)
    ("Inhibitors" . SPARSER::INHIBITOR) ("RNMT and RNMT" . SPARSER::COLLECTION)
    ("HA-RNMT" . SPARSER::COLLECTION) ("-RNMT" . SPARSER::COLLECTION)
    ("orthophosphate" . SPARSER::ORTHOPHOSPHATE)
    ("hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the repressive methylation byproduct S-adenosyl homocysteine (SAH)"
     . SPARSER::MOLECULE)
    ("homocysteine (SAH)" . SPARSER::MOLECULE)
    ("hydrolase (SAAH)" . SPARSER::PROTEIN) ("SAH" . SPARSER::MOLECULE)
    ("homocysteine" . SPARSER::MOLECULE) ("TFIIH" . SPARSER::PROTEIN)
    ("Importin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a separate complex" . SPARSER::BIO-COMPLEX)
    ("RNMT-RAM" . SPARSER::COLLECTION) ("RAM" . SPARSER::PROTEIN)
    ("RNGTT" . SPARSER::PROTEIN) ("triphosphatase" . SPARSER::PROTEIN)
    ("complex (CBC)" . SPARSER::BIO-COMPLEX)
    ("exonucleases" . SPARSER::PROTEIN) ("pol" . SPARSER::PROTEIN)
    ("CDK1-cyclin B1" . SPARSER::COLLECTION) ("RNMT" . SPARSER::PROTEIN)
    ("translation-competent mRNA" . SPARSER::PROTEIN)
    ("CE4" . SPARSER::PROTEIN) ("DDX18" . SPARSER::PROTEIN)
    ("TOMM70A" . SPARSER::PROTEIN) ("BOP1" . SPARSER::PROTEIN)
    ("KPNB1" . SPARSER::PROTEIN) ("KPNA4" . SPARSER::PROTEIN)
    ("KPNA3" . SPARSER::PROTEIN)
    ("Methyltransferase Activity" . SPARSER::PROTEIN)
    ("CDK5" . SPARSER::PROTEIN) ("Amino acid" . SPARSER::AMINO-ACID)
    ("Spt5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("methyltransferase activity" . SPARSER::PROTEIN)
    ("KPNA2" . SPARSER::PROTEIN)
    ("RNA guanine-7 methyltransferase" . SPARSER::PROTEIN)
    ("m7G" . SPARSER::MOLECULE) ("7-methylguanosine" . SPARSER::MOLECULE)
    ("c-Jun N-terminal kinase (JNK) and TNF receptor-associated factor 2 (TRAF2)"
     . SPARSER::COLLECTION)
    ("the TNF receptor-associated factor protein" . SPARSER::PROTEIN)
    ("electrophilic substrates" . SPARSER::SUBSTRATE)
    ("p38-MAPK" . SPARSER::COLLECTION)
    ("Nrf2 and its downstream effectors" . SPARSER::COLLECTION)
    ("both Nrf2 and its downstream target effector GSTP1 enzyme"
     . SPARSER::COLLECTION)
    ("-shogaol" . SPARSER::DRUG) ("-gingerol" . SPARSER::DRUG)
    ("acetoxy" . SPARSER::MOLECULE)
    ("their derivatives and plant flavonoid quercetin as well as other dietary plant phenolic compounds"
     . SPARSER::COLLECTION)
    ("plant flavonoid quercetin as well as other dietary plant phenolic compounds"
     . SPARSER::COLLECTION)
    ("shogaol" . SPARSER::DRUG) ("gingerol" . SPARSER::DRUG)
    ("this complex and activation of Nrf2 [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("its cytosolic repressor kelch-like ECH-associated protein 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Nrf2-KEAP1" . SPARSER::COLLECTION)
    ("glutamate-cysteine ligase, and glutathione-S-transferase"
     . SPARSER::COLLECTION)
    ("oxidoreductase" . SPARSER::PROTEIN)
    ("enzymes and antioxidants" . SPARSER::COLLECTION)
    ("Subsequent western blot" . SPARSER::PROTEIN)
    ("phenylpropanoids and quercetin" . SPARSER::COLLECTION)
    ("quercetin" . SPARSER::MOLECULE)
    ("Quercetin and phenylpropanoids" . SPARSER::COLLECTION)
    ("phenylpropanoids" . SPARSER::MOLECULE) ("Quercetin" . SPARSER::MOLECULE)
    ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRAF2" . SPARSER::PROTEIN)
    ("TNF receptor-associated factor 2" . SPARSER::PROTEIN)
    ("butylated hydroxyanisole" . SPARSER::MOLECULE)
    ("anti- β" . SPARSER::PROTEIN) ("β -mercaptoethanol" . SPARSER::MOLECULE)
    ("target cell" . SPARSER::PROTEIN)
    ("glutathione-S-transferase" . SPARSER::PROTEIN)
    ("oligonucleotides or siRNA" . SPARSER::COLLECTION)
    ("ITGA7 or MMP2" . SPARSER::COLLECTION)
    ("Akt/GSK3β/β-catenin" . SPARSER::COLLECTION)
    ("differentially expressed metastasis-related genes" . SPARSER::GENE)
    ("AMPK and JNK" . SPARSER::COLLECTION)
    ("p38α, AMPKα1, JNK, and Akt" . SPARSER::COLLECTION)
    ("clinically translatable Hsp27 inhibitor OGX427" . SPARSER::DRUG)
    ("ITGA7 and MMP2" . SPARSER::COLLECTION)
    ("p38α, AMPKα1, Akt, or JNK" . SPARSER::COLLECTION)
    ("BIRB796, Dorsomorphin, SP600125, and LY294002" . SPARSER::COLLECTION)
    ("Dorsomorphin" . SPARSER::MOLECULE)
    ("p38α, AMPKα1, Akt, and JNK" . SPARSER::COLLECTION)
    ("metastatic foci" . SPARSER::PROTEIN) ("sh-Hsp27" . SPARSER::COLLECTION)
    ("A-B" . SPARSER::PROTEIN) ("EGF, HGF and IL-6" . SPARSER::COLLECTION)
    ("a prometastatic protein" . SPARSER::PROTEIN)
    ("siRNA or OGX-427" . SPARSER::COLLECTION)
    ("its different associated partner proteins" . SPARSER::PROTEIN)
    ("Hsp27 client proteins" . SPARSER::PROTEIN)
    ("200 client proteins" . SPARSER::PROTEIN) ("TCTP" . SPARSER::PROTEIN)
    ("Hsp110" . SPARSER::PROTEIN) ("clusterin" . SPARSER::PROTEIN)
    ("MMP2 and ITGA7" . SPARSER::COLLECTION) ("Hsp 27" . SPARSER::PROTEIN)
    ("G-H" . SPARSER::PROTEIN) ("F-H" . SPARSER::PROTEIN)
    ("BIRB796" . SPARSER::DRUG) ("AMPKα1" . SPARSER::PROTEIN)
    ("p38α" . SPARSER::PROTEIN) ("C-D" . SPARSER::PROTEIN)
    ("G-I" . SPARSER::PROTEIN) ("E-F" . SPARSER::PROTEIN)
    ("C-E" . SPARSER::PROTEIN) ("B-D" . SPARSER::PROTEIN)
    ("OGX427" . SPARSER::DRUG) ("Phospho-kinase" . SPARSER::PROTEIN)
    ("phospho-kinase" . SPARSER::PROTEIN) ("PKC beta" . SPARSER::PROTEIN)
    ("translationally controlled tumor protein" . SPARSER::PROTEIN)
    ("Hsp70" . SPARSER::PROTEIN) ("Hsp60" . SPARSER::PROTEIN)
    ("Hsp40" . SPARSER::PROTEIN) ("ITGA7" . SPARSER::PROTEIN)
    ("Hsp27" . SPARSER::PROTEIN) ("Cys" . SPARSER::AMINO-ACID)
    ("a classically tumor suppressor" . SPARSER::SUPPRESSOR)
    ("their respective wide-type genotypes" . SPARSER::PROTEIN)
    ("AG or AA" . SPARSER::COLLECTION) ("AG" . SPARSER::PROTEIN)
    ("BRCA1 associated RING domain 1" . SPARSER::PROTEIN)
    ("BARD1" . SPARSER::PROTEIN) ("p21-" . SPARSER::PROTEIN)
    ("ERRγ and a 4-hydroxy tamoxifen analog" . SPARSER::COLLECTION)
    ("ERRα or ERα" . SPARSER::COLLECTION)
    ("advanced TNM and BCLC stage" . SPARSER::COLLECTION)
    ("cellular ROS" . SPARSER::PROTEIN) ("cellular GSK5182" . SPARSER::DRUG)
    ("p-pRb" . SPARSER::COLLECTION) ("DY" . SPARSER::MOLECULE)
    ("WAF1 and p27 Kip1" . SPARSER::COLLECTION)
    ("p21 or p27" . SPARSER::COLLECTION)
    ("natural estrogen" . SPARSER::MOLECULE)
    ("ERRα, ERRβ, and ERRγ" . SPARSER::COLLECTION)
    ("ERRγ (siRNA-ERRγ) or an ERRγ inverse agonist" . SPARSER::COLLECTION)
    ("siRNA-ERRγ" . SPARSER::COLLECTION) ("Plk2" . SPARSER::PROTEIN)
    ("N -acetylcysteine" . SPARSER::DRUG) ("CM-H" . SPARSER::MOLECULE)
    ("XCT790" . SPARSER::DRUG)
    ("Cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NR3B" . SPARSER::PROTEIN) ("ERRα" . SPARSER::PROTEIN)
    ("GSK5182" . SPARSER::DRUG) ("ERRγ" . SPARSER::PROTEIN)
    ("mature IVDs" . SPARSER::PROTEIN) ("IVDs" . SPARSER::PROTEIN)
    ("DNA and stress" . SPARSER::COLLECTION)
    ("camptothecin and cisplatin" . SPARSER::COLLECTION)
    ("Chondrocytes" . SPARSER::PROTEIN)
    ("pro-inflammatory mediators and matrix" . SPARSER::COLLECTION)
    ("mediators and matrix" . SPARSER::COLLECTION)
    ("Pifithrin" . SPARSER::DRUG) ("p38 and p16" . SPARSER::COLLECTION)
    ("/p16 INK4a" . SPARSER::COLLECTION) ("cip" . SPARSER::PROTEIN)
    ("Representative MRI" . SPARSER::PROTEIN)
    ("mature discs" . SPARSER::BIO-COMPLEX) ("discs" . SPARSER::BIO-COMPLEX)
    ("NP" . SPARSER::PROTEIN) ("p53/p21" . SPARSER::COLLECTION)
    ("DDD" . SPARSER::MOLECULE) ("IVD" . SPARSER::PROTEIN)
    ("disc" . SPARSER::BIO-COMPLEX) ("interleukin-1" . SPARSER::PROTEIN)
    ("histone-H 3" . SPARSER::PROTEIN) ("p16 INK4a" . SPARSER::PROTEIN)
    ("p38 mitogen activated protein kinase" . SPARSER::PROTEIN)
    ("MMP13" . SPARSER::PROTEIN) ("Col2A1" . SPARSER::PROTEIN)
    ("β-Gal" . SPARSER::PROTEIN) ("FLNA" . SPARSER::PROTEIN)
    ("Filamin" . SPARSER::PROTEIN-FAMILY) ("mTOR-raptor" . SPARSER::COLLECTION)
    ("integrins and growth factor" . SPARSER::COLLECTION)
    ("Akt/mTORC1" . SPARSER::COLLECTION)
    ("VEGF and growth factor" . SPARSER::COLLECTION)
    ("anti-VEGF and PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("p65 and PKC-α" . SPARSER::COLLECTION)
    ("mTORC1 (RAP and TEM) as well as inhibitors" . SPARSER::COLLECTION)
    ("TIMP-1 or -2" . SPARSER::COLLECTION)
    ("MMPs and Tissue inhibitor" . SPARSER::COLLECTION)
    ("Raf/ERK" . SPARSER::COLLECTION)
    ("PI 3-kinase/Akt/mTOR" . SPARSER::COLLECTION)
    ("NFκB and AP-1cis-elements" . SPARSER::COLLECTION)
    ("Ras/ERK" . SPARSER::COLLECTION)
    ("metalloproteinases, MMP-9 and MMP-2" . SPARSER::COLLECTION)
    ("hypoxia and ROI" . SPARSER::COLLECTION) ("TAM" . SPARSER::PROTEIN)
    ("inflammatory mediators and leukocytes" . SPARSER::COLLECTION)
    ("mediators and leukocytes" . SPARSER::COLLECTION)
    ("paxillin and actin" . SPARSER::COLLECTION)
    ("Paxillin" . SPARSER::PROTEIN)
    ("paxillin and F-actin" . SPARSER::COLLECTION)
    ("ASA and BAY" . SPARSER::COLLECTION) ("-MMP-9" . SPARSER::COLLECTION)
    ("constitutively expressed MMP-2 and PMA induced- MMP-2"
     . SPARSER::PROTEIN)
    ("TNFα and PMA-" . SPARSER::COLLECTION)
    ("MMP-2 and PMA" . SPARSER::COLLECTION) ("STS" . SPARSER::PROTEIN)
    ("staurosporin" . SPARSER::MOLECULE) ("ASA" . SPARSER::PROTEIN)
    ("NFκB and PKC" . SPARSER::COLLECTION)
    ("TNFα ( xref ) and PMA ( xref )" . SPARSER::COLLECTION)
    ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cathepsin-B (3.5 fold) and NOS-2 (2 fold) and the mTOR inhibitors"
     . SPARSER::COLLECTION)
    ("NOS-2 (2 fold) and the mTOR inhibitors" . SPARSER::COLLECTION)
    ("cathepsin-B and NOS-2" . SPARSER::COLLECTION)
    ("NOS-2" . SPARSER::PROTEIN) ("Nitric Oxide (NO)" . SPARSER::MOLECULE)
    ("Growth Factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("inducible NOS-2" . SPARSER::COLLECTION)
    ("PMA- induced phospho p65" . SPARSER::PROTEIN) ("PMA-" . SPARSER::PROTEIN)
    ("a major transcription factor" . SPARSER::PROTEIN)
    ("NFκB and PKC-α" . SPARSER::COLLECTION)
    ("TIMP-1, m-RNA and protein" . SPARSER::COLLECTION)
    ("TIMPs" . SPARSER::PROTEIN) ("MMP-2 and IL1β-" . SPARSER::COLLECTION)
    ("IL1β-" . SPARSER::PROTEIN)
    ("an inflammatory cytokine" . SPARSER::PROTEIN)
    ("pro-active and active" . SPARSER::COLLECTION)
    ("TOR and PP242" . SPARSER::COLLECTION)
    ("secretory MMPs" . SPARSER::PROTEIN)
    ("MMP-9 and MMP-2" . SPARSER::COLLECTION)
    ("a classical activator" . SPARSER::ACTIVATOR)
    ("NFκB and TNFα" . SPARSER::COLLECTION)
    ("the induced- gelatinolytic MMPs" . SPARSER::PROTEIN)
    ("TNFα or PMA" . SPARSER::COLLECTION)
    ("more aggressive traits" . SPARSER::PROTEIN)
    ("Torin and PP242" . SPARSER::COLLECTION) ("Torin" . SPARSER::PROTEIN)
    ("(Ser473) in LN-18 cells confirming" . SPARSER::COLLECTION)
    ("-S6K" . SPARSER::COLLECTION) ("p70-s6kinase" . SPARSER::COLLECTION)
    ("TNFα and tumor promoter PMA" . SPARSER::COLLECTION)
    ("mTORC1 as well as mTORC2" . SPARSER::COLLECTION)
    ("PP" . SPARSER::PROTEIN) ("TORKinibs" . SPARSER::DRUG)
    ("Barrier" . SPARSER::PROTEIN)
    ("a water-soluble ester derivative" . SPARSER::DERIVATIVE)
    ("ester" . SPARSER::MOLECULE) ("PI3K and ERK" . SPARSER::COLLECTION)
    ("Sin-1 and mLST8" . SPARSER::COLLECTION) ("Sin-1" . SPARSER::PROTEIN)
    ("Ribosomal protein S6 kinase beta-1 (S6K1) and eukaryotic initiation factor 4E-binding protein 1 (4EBP1)"
     . SPARSER::COLLECTION)
    ("mTOR, raptor and mLST8" . SPARSER::COLLECTION)
    ("the highly predominant form" . SPARSER::FORM)
    ("cathepsin-B and paxillin" . SPARSER::COLLECTION)
    ("pentraxin-3" . SPARSER::COLLECTION) ("-VEGF" . SPARSER::COLLECTION)
    ("TNFα-" . SPARSER::PROTEIN) ("TNFα and PMA" . SPARSER::COLLECTION)
    ("torin-1 (TOR) and PP242" . SPARSER::COLLECTION)
    ("TNFα and IL1β" . SPARSER::COLLECTION) ("PMA" . SPARSER::PROTEIN)
    ("Phorbol" . SPARSER::DRUG) ("TOR" . SPARSER::PROTEIN)
    ("the most aggressive type" . TYPE) ("of 45" . SPARSER::PROTEIN)
    ("S6kinase" . SPARSER::PROTEIN-FAMILY) ("UCN01" . SPARSER::DRUG)
    ("Interleukin1β" . SPARSER::PROTEIN) ("anti-VEGF" . SPARSER::DRUG)
    ("PI 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IGF-I" . SPARSER::PROTEIN)
    ("Phorbol-12-myristate-13-acetate" . SPARSER::DRUG)
    ("non-selective" . SPARSER::PROTEIN) ("inducible NOS" . SPARSER::PROTEIN)
    ("Nitric oxide synthase" . SPARSER::PROTEIN) ("m-RNA" . SPARSER::RNA)
    ("TIMP-1" . SPARSER::PROTEIN) ("m-TOR" . SPARSER::PROTEIN)
    ("s6kinase" . SPARSER::PROTEIN-FAMILY) ("p70" . SPARSER::PROTEIN)
    ("G-1" . SPARSER::PROTEIN) ("FKBP12" . SPARSER::PROTEIN)
    ("Akt/PKB" . SPARSER::PROTEIN) ("Protein kinase B" . SPARSER::PROTEIN)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("Ribosomal protein S6 kinase beta-1" . SPARSER::PROTEIN)
    ("mLST8" . SPARSER::PROTEIN)
    ("mammalian Target of Rapamycin" . SPARSER::PROTEIN)
    ("Receptor Tyrosine Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cathepsin-B" . SPARSER::PROTEIN) ("PKC-α" . SPARSER::PROTEIN)
    ("TNFα" . SPARSER::PROTEIN) ("Tumor Necrosis Factor" . SPARSER::PROTEIN)
    ("PP242" . SPARSER::DRUG) ("ETS and RUNX1" . SPARSER::COLLECTION)
    ("retinoic acid (ATRA)" . SPARSER::MOLECULE)
    ("RARa/RXR" . SPARSER::COLLECTION) ("RXR" . SPARSER::PROTEIN)
    ("ATRA" . SPARSER::DRUG)
    ("vitamin D receptor and the orphan nuclear receptor TR4 [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("the monomeric NBRE response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("chondrocytes" . SPARSER::PROTEIN)
    ("NFkB activated inflammatory gene" . SPARSER::GENE)
    ("corepressors" . SPARSER::PROTEIN)
    ("the 6984 unique genes" . SPARSER::GENE)
    ("ERG, FLI-1, and TEL" . SPARSER::COLLECTION) ("TEL" . SPARSER::PROTEIN)
    ("distal NR4A1" . SPARSER::PROTEIN) ("p300/CBP" . SPARSER::COLLECTION)
    ("NRs" . SPARSER::PROTEIN) ("p300 and CBP" . SPARSER::COLLECTION)
    ("IL7R and FLT3" . SPARSER::COLLECTION)
    ("IL7R , FLT3 and BCL6" . SPARSER::COLLECTION)
    ("H3K27ac or H3K27me3" . SPARSER::COLLECTION)
    ("c-MYC , BCL2 , CBFA2T3 , and CSF1R" . SPARSER::COLLECTION)
    ("IL7R , FLT3 , and BCL6" . SPARSER::COLLECTION)
    ("lineage developmental and proliferative target genes" . SPARSER::GENE)
    ("ERG or FLI-1" . SPARSER::COLLECTION)
    ("IL7R , FLT3 , and SDPR" . SPARSER::COLLECTION) ("DHS" . SPARSER::PROTEIN)
    ("DHS-seq" . SPARSER::PROTEIN-PAIR) ("ERG/FLI-1" . SPARSER::COLLECTION)
    ("the 6982 unique genes" . SPARSER::GENE)
    ("proto-oncogenes and 239 downregulated genes that were enriched"
     . SPARSER::COLLECTION)
    ("an entirely distinct cohort" . SPARSER::MOLECULE)
    ("CEAA" . SPARSER::PROTEIN) ("NR4A1 CEAA" . SPARSER::PROTEIN)
    ("wild type NR4A1 (NR4A1 WT ) and NR4A1" . SPARSER::COLLECTION)
    ("14,712 high confidence peaks representing 6,984 unique genes"
     . SPARSER::GENE)
    ("NR4A1, NR4A2, or NR4A3" . SPARSER::COLLECTION)
    ("HSCs" . SPARSER::PROTEIN) ("ETO" . SPARSER::PROTEIN)
    ("NR4A1 or NR4A3" . SPARSER::COLLECTION) ("LICs" . SPARSER::PROTEIN)
    ("NR4A1 and NR4A3" . SPARSER::COLLECTION) ("NFkB" . SPARSER::PROTEIN)
    ("ERG and FLI-1" . SPARSER::COLLECTION)
    ("distal enhancers" . SPARSER::PROTEIN)
    ("NR4A1 and ETS" . SPARSER::COLLECTION)
    ("retinoic acid" . SPARSER::MOLECULE) ("TR4" . SPARSER::PROTEIN)
    ("vitamin D" . SPARSER::MOLECULE) ("p15Ink4B" . SPARSER::PROTEIN)
    ("p15INK4b" . SPARSER::PROTEIN) ("TSHZ1" . SPARSER::PROTEIN)
    ("CSF1R" . SPARSER::PROTEIN) ("CD83" . SPARSER::PROTEIN)
    ("BCL6" . SPARSER::PROTEIN) ("CLEC5A" . SPARSER::PROTEIN)
    ("CBFA2" . SPARSER::PROTEIN) ("IL7R" . SPARSER::PROTEIN)
    ("ENO3" . SPARSER::PROTEIN) ("H3K27me3" . SPARSER::PROTEIN)
    ("β2m" . SPARSER::PROTEIN) ("H3K27Ac" . SPARSER::MOLECULE)
    ("NR4A3" . SPARSER::PROTEIN) ("NR4A2" . SPARSER::PROTEIN)
    ("FLI-1" . SPARSER::PROTEIN) ("NR4A1" . SPARSER::PROTEIN)
    ("GO and KEGG" . SPARSER::COLLECTION)
    ("kinases, Ras, Raf-1, MEK and MAPK" . SPARSER::COLLECTION)
    ("HCC, and re-expression" . SPARSER::COLLECTION)
    ("activated MEK (mitogen-activated protein kinase/p44/42 kinase) and MAPK"
     . SPARSER::COLLECTION)
    ("EGFR/MAPK" . SPARSER::COLLECTION)
    ("Hematoxylin and eosin (H&E) staining" . SPARSER::COLLECTION)
    ("Hematoxylin" . SPARSER::MOLECULE) ("Lv" . SPARSER::MOLECULE)
    ("SMCC" . SPARSER::PROTEIN)
    ("a potential diagnostic biomarker" . SPARSER::MOLECULE)
    ("EGFR/Ras/Raf-1/MEK/MAPK" . SPARSER::COLLECTION)
    ("RNA-Binding Protein" . SPARSER::PROTEIN) ("p-Raf-1" . SPARSER::PROTEIN)
    ("EGFR-PDGFR" . SPARSER::COLLECTION) ("EGFR–c-MET" . SPARSER::COLLECTION)
    ("monotherapeutic drugs" . SPARSER::DRUG)
    ("phospho-null Y146F mutant" . SPARSER::MUTANT)
    ("HGF and Src" . SPARSER::COLLECTION) ("unique ezrin" . SPARSER::PROTEIN)
    ("proteins, ERK and STAT3" . SPARSER::COLLECTION)
    ("EGFR and a small molecule inhibitor" . SPARSER::COLLECTION)
    ("Ras, Akt, and VEGFR" . SPARSER::COLLECTION) ("VEGFR" . SPARSER::PROTEIN)
    ("EGFR and its signaling components" . SPARSER::COLLECTION)
    ("wt ezrin (Ezrin wt ) and mutant" . SPARSER::COLLECTION)
    ("myc" . SPARSER::PROTEIN) ("Etoposide" . SPARSER::PROTEIN)
    ("Compu-Syn" . SPARSER::COLLECTION) ("Syn" . SPARSER::PROTEIN)
    ("NSC305787 and erlotinib" . SPARSER::COLLECTION)
    ("Ezrin and Erlotinib" . SPARSER::COLLECTION) ("Erlotinib" . SPARSER::DRUG)
    ("AURKA and COX-2" . SPARSER::COLLECTION)
    ("AURKA , COX-2 , and iNOS" . SPARSER::COLLECTION)
    ("STAT3 and ERK" . SPARSER::COLLECTION)
    ("Ezrin-EGFR" . SPARSER::COLLECTION)
    ("ezrin and EGFR" . SPARSER::COLLECTION)
    ("dystroglycan" . SPARSER::PROTEIN) ("H-K-ATPase" . SPARSER::COLLECTION)
    ("adrenergic" . SPARSER::PROTEIN)
    ("proteins and actin" . SPARSER::COLLECTION)
    ("Ezrin-Radixin-Moesin" . SPARSER::COLLECTION)
    ("Moesin" . SPARSER::PROTEIN) ("Radixin" . SPARSER::PROTEIN)
    ("Aurora kinase A ( AURKA )" . SPARSER::PROTEIN)
    ("protein, and GRP78" . SPARSER::COLLECTION)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("transducers" . SPARSER::PROTEIN) ("Ras and PI3K" . SPARSER::COLLECTION)
    ("Ligand" . SPARSER::LIGAND)
    ("EGFR and downstream target proteins" . SPARSER::COLLECTION)
    ("AURKA , COX-2 , cyclin D1 , and iNOS" . SPARSER::COLLECTION)
    ("ERK and STAT3" . SPARSER::COLLECTION)
    ("ezrin and EGRF" . SPARSER::COLLECTION)
    ("ezrin-EGFR" . SPARSER::COLLECTION) ("Tyrosine kinase" . SPARSER::PROTEIN)
    ("COX2" . SPARSER::PROTEIN) ("ddH 2" . SPARSER::PROTEIN)
    ("C-11" . SPARSER::PROTEIN) ("ERM-1" . SPARSER::PROTEIN)
    ("H-K" . SPARSER::PROTEIN) ("NHE3" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("GRP78" . SPARSER::PROTEIN) ("B-Myb" . SPARSER::PROTEIN)
    ("Aurora kinase A" . SPARSER::PROTEIN) ("β1" . SPARSER::PROTEIN)
    ("phospholipase C" . SPARSER::PROTEIN) ("NSC305787" . SPARSER::DRUG)
    ("β-catenin and miR-150-3p" . SPARSER::COLLECTION)
    ("IκBα and β-catenin" . SPARSER::COLLECTION)
    ("β-catenin and TNF-α" . SPARSER::COLLECTION)
    ("TNF-α/IKK/NF-κB" . SPARSER::COLLECTION)
    ("Runx2/Osterix" . SPARSER::COLLECTION)
    ("ALR and ALP" . SPARSER::COLLECTION)
    ("Runx2 and Osterix" . SPARSER::COLLECTION) ("ALR" . SPARSER::PROTEIN)
    ("pyrimidine" . SPARSER::DRUG) ("TPCA-1 or NF-κB" . SPARSER::COLLECTION)
    ("IKK/NF-κB" . SPARSER::COLLECTION)
    ("SP600125 and IKK" . SPARSER::COLLECTION)
    ("hBM-MSC" . SPARSER::COLLECTION) ("Mut-3" . SPARSER::COLLECTION)
    ("Luciferase" . SPARSER::PROTEIN)
    ("endothelial nitric oxide synthase (eNOS) and β-catenin [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("peroxisome proliferator-activated receptor alpha (PPAR-α), intercellular adhesion molecule 2 (ICAM2), growth hormone receptor (GHR), CRH receptor-2 (CRH-R2), endothelial nitric oxide synthase (eNOS) and β-catenin [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("endothelial nitric oxide synthase" . SPARSER::PROTEIN)
    ("eNOS" . SPARSER::PROTEIN) ("CRH" . SPARSER::PROTEIN)
    ("GHR" . SPARSER::PROTEIN)
    ("positive markers CD29, CD105, CD90 and negative marker CD45 [ xref ]"
     . SPARSER::COLLECTION)
    ("miR-29, which targets extracellular matrix proteins [ xref ], and the negative regulators of osteogenic differentiation"
     . SPARSER::COLLECTION)
    ("which targets extracellular matrix proteins" . SPARSER::PROTEIN)
    ("Runx2 or Smad" . SPARSER::COLLECTION)
    ("Wnt and TNF-α" . SPARSER::COLLECTION)
    ("TNF-α or other proinflammatory cytokines" . SPARSER::COLLECTION)
    ("other proinflammatory cytokines" . SPARSER::PROTEIN)
    ("a major proinflammatory cytokine" . SPARSER::PROTEIN)
    ("IKK" . SPARSER::PROTEIN) ("hBM-MSCs" . SPARSER::COLLECTION)
    ("MiR-200a" . SPARSER::MOLECULE) ("MyD88" . SPARSER::PROTEIN)
    ("IκBα" . SPARSER::PROTEIN) ("c-Myb" . SPARSER::PROTEIN)
    ("TPCA-1" . SPARSER::DRUG) ("CRH-R" . SPARSER::PROTEIN)
    ("growth hormone receptor" . SPARSER::PROTEIN) ("ICAM2" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule 2" . SPARSER::PROTEIN)
    ("PPAR-α" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor alpha" . SPARSER::PROTEIN)
    ("p -nitrophenyl" . SPARSER::MOLECULE)
    ("Alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("CD29" . SPARSER::PROTEIN) ("BMP2" . SPARSER::PROTEIN)
    ("a novel late-acting inflammatory cytokine" . SPARSER::PROTEIN)
    ("circulatory HMGB1" . SPARSER::PROTEIN)
    ("these pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("classical innate inflammatory cytokines" . SPARSER::PROTEIN)
    ("intracellular and extracellular ROS" . SPARSER::PROTEIN)
    ("cytokine and alarmin" . SPARSER::COLLECTION)
    ("IL-6, IL-1β, and TNF-α" . SPARSER::COLLECTION)
    ("key cytokines" . SPARSER::PROTEIN)
    ("IL-6, IL-1β and TNF-α" . SPARSER::COLLECTION)
    ("IL-6 and TNF-α" . SPARSER::COLLECTION)
    ("an essential leucine zipper redox-susceptible transcription factor"
     . SPARSER::PROTEIN)
    ("neutrophils and macrophages" . SPARSER::COLLECTION)
    ("neutrophils" . SPARSER::PROTEIN)
    ("peritoneal mouse macrophages" . SPARSER::PROTEIN)
    ("pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("MPO" . SPARSER::PROTEIN) ("myeloperoxidase" . SPARSER::PROTEIN)
    ("peripheral leukocytes" . SPARSER::PROTEIN)
    ("bZIP" . SPARSER::PROTEIN-FAMILY) ("nrf2" . SPARSER::PROTEIN)
    ("HMGB1" . SPARSER::PROTEIN) ("p45" . SPARSER::PROTEIN)
    ("NF-E2" . SPARSER::PROTEIN) ("Hepatocytes" . SPARSER::PROTEIN)
    ("triglyceride" . SPARSER::MOLECULE) ("TGP" . SPARSER::PROTEIN)
    ("aminotransferases" . SPARSER::PROTEIN) ("aspartate" . SPARSER::PROTEIN)
    ("both fat and osmiophilic droplets" . SPARSER::COLLECTION)
    ("-mRNA" . SPARSER::COLLECTION) ("fpG" . SPARSER::PROTEIN-FAMILY)
    ("RPL19" . SPARSER::PROTEIN) ("Murine Leukemia Virus" . SPARSER::PROTEIN)
    ("CK-18" . SPARSER::PROTEIN) ("low-density lipoprotein" . SPARSER::PROTEIN)
    ("gamma-glutamyl" . SPARSER::MOLECULE)
    ("high-density lipoprotein cholesterol" . SPARSER::MOLECULE)
    ("stress-responsive protein 27" . SPARSER::PROTEIN)
    ("cytokeratin 18" . SPARSER::PROTEIN) ("exogenous HGF" . SPARSER::PROTEIN)
    ("CD166 and RUNX2" . SPARSER::COLLECTION)
    ("INCB28060 or siMET suppressed HGF-induced migration of both MDA-MB231 and HCC-1954 cells ( xref , xref )"
     . SPARSER::COLLECTION)
    ("INCB28060 as well as siRNA-mediated knockdown of MET gene (siMET)"
     . SPARSER::COLLECTION)
    ("an orally available specific small molecule inhibitor"
     . SPARSER::INHIBITOR)
    ("pre-OBS" . SPARSER::COLLECTION) ("OBS" . SPARSER::PROTEIN)
    ("RUNX2 , OSX and CD166" . SPARSER::COLLECTION)
    ("OPN and ALP" . SPARSER::COLLECTION) ("OSX/SP7" . SPARSER::COLLECTION)
    ("RUNX2 and OSX" . SPARSER::COLLECTION) ("Mature OBs" . SPARSER::PROTEIN)
    ("osteogenic media" . SPARSER::PROTEIN) ("HGF/MET" . SPARSER::COLLECTION)
    ("RUNX2 and CD166/Activated" . SPARSER::COLLECTION)
    ("ALCAM" . SPARSER::PROTEIN) ("CCL2 and RANKL" . SPARSER::COLLECTION)
    ("RANKL" . SPARSER::PROTEIN) ("MET-" . SPARSER::PROTEIN)
    ("pre-OB" . SPARSER::COLLECTION) ("HGF-" . SPARSER::PROTEIN)
    ("mature OBs" . SPARSER::PROTEIN) ("media (CM)" . SPARSER::PROTEIN)
    ("Pre-OBs" . SPARSER::COLLECTION) ("OSX" . SPARSER::PROTEIN)
    ("OB" . SPARSER::PROTEIN) ("pre-OBs" . SPARSER::COLLECTION)
    ("hepatocyte growth factor (HGF)" . SPARSER::PROTEIN)
    ("OBs" . SPARSER::PROTEIN) ("OCs" . SPARSER::PROTEIN)
    ("adhesion molecule" . SPARSER::PROTEIN) ("P10" . SPARSER::PROTEIN)
    ("p-nitrophenyl" . SPARSER::MOLECULE) ("Anti-ERK" . SPARSER::PROTEIN)
    ("Adhesion Molecule" . SPARSER::PROTEIN) ("INCB28060" . SPARSER::DRUG)
    ("CD166" . SPARSER::PROTEIN) ("vis" . SPARSER::DRUG)
    ("AKT and AKT" . SPARSER::COLLECTION)
    ("the AKT [ xref , xref ] and MAPK [ xref , xref ]" . SPARSER::COLLECTION)
    ("ERK, and pAKT" . SPARSER::COLLECTION)
    ("ERK, pIRS and pAKT" . SPARSER::COLLECTION)
    ("AKT-MAPK" . SPARSER::COLLECTION) ("SOS" . SPARSER::PROTEIN)
    ("FB ( k  1 , k  3 ) and FB ( k  1 , k  2 )" . SPARSER::COLLECTION)
    ("IRS1 and pAKT" . SPARSER::COLLECTION)
    ("ERK-mTOR-AKT" . SPARSER::COLLECTION) ("pAKT’s" . SPARSER::PROTEIN-FAMILY)
    ("the internal feedback gain k  5" . SPARSER::PROTEIN)
    ("the bistable AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK-RAS" . SPARSER::COLLECTION)
    ("AKT (i.e. higher pAKT) and ERK" . SPARSER::COLLECTION)
    ("pAKT-ERK" . SPARSER::COLLECTION) ("k  3 and k  4" . SPARSER::COLLECTION)
    ("RAF and ERK" . SPARSER::COLLECTION)
    ("p53 and p 21" . SPARSER::COLLECTION) ("chip 1" . SPARSER::PROTEIN)
    ("RAF, and ERK" . SPARSER::COLLECTION)
    ("k  3 or ERK" . SPARSER::COLLECTION) ("FB" . SPARSER::PROTEIN)
    ("growth factors, NGF and EGF" . SPARSER::COLLECTION)
    ("the internal negative feedback gain k  5" . SPARSER::PROTEIN)
    ("chip1" . SPARSER::PROTEIN) ("inactive and active" . SPARSER::COLLECTION)
    ("pAKT and glucose" . SPARSER::COLLECTION)
    ("insulin-AKT and MAPK" . SPARSER::COLLECTION)
    ("AKT and MAPK" . SPARSER::COLLECTION)
    ("RAF-MEK-ERK" . SPARSER::COLLECTION) ("EGF and NGF" . SPARSER::COLLECTION)
    ("NGF" . SPARSER::PROTEIN) ("Grb2-SOS" . SPARSER::COLLECTION)
    ("pERK" . SPARSER::PROTEIN) ("Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("Shc" . SPARSER::PROTEIN) ("MAPK/ERK" . SPARSER::COLLECTION)
    ("k  1" . SPARSER::PROTEIN) ("k  2" . SPARSER::PROTEIN)
    ("k  4" . SPARSER::PROTEIN) ("k  3" . SPARSER::PROTEIN)
    ("p 21" . SPARSER::PROTEIN) ("k  5" . SPARSER::PROTEIN)
    ("E 1" . SPARSER::MOLECULE) ("Gab1" . SPARSER::PROTEIN)
    ("GAB1" . SPARSER::PROTEIN) ("IRS-1" . SPARSER::PROTEIN)
    ("extracellular signal regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pIRS1" . SPARSER::PROTEIN) ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("serine residue" . SPARSER::MOLECULE) ("Grb2" . SPARSER::PROTEIN)
    ("its receptor" . SPARSER::PROTEIN) ("GLUT-4" . SPARSER::PROTEIN)
    ("metastatic PC" . SPARSER::PROTEIN)
    ("abiraterone or enzalutamide" . SPARSER::COLLECTION)
    ("enzalutamide" . SPARSER::DRUG) ("abiraterone" . SPARSER::DRUG)
    ("other metastatic foci" . SPARSER::PROTEIN) ("olaparib" . SPARSER::DRUG)
    ("the genotoxic drug carboplatin" . SPARSER::DRUG)
    ("FANCA , BRCA2 and PALB2" . SPARSER::COLLECTION)
    ("FANCA , FANCI , FANCD2 , BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("LNCaP" . SPARSER::PROTEIN) ("CCP" . SPARSER::PROTEIN)
    ("TMPRSS2 and ERG" . SPARSER::COLLECTION)
    ("TMPRSS2-ERG" . SPARSER::COLLECTION) ("CNAs" . SPARSER::PROTEIN)
    ("NR3C1 and ESR1" . SPARSER::COLLECTION) ("PGR" . SPARSER::PROTEIN)
    ("chromogranin" . SPARSER::PROTEIN) ("CNA" . SPARSER::PROTEIN)
    ("PCs" . SPARSER::PROTEIN) ("MSH2 and MSH6" . SPARSER::COLLECTION)
    ("ZBTB16/PLZF" . SPARSER::COLLECTION) ("PLZF" . SPARSER::PROTEIN)
    ("SPOP" . SPARSER::PROTEIN) ("ERG" . SPARSER::PROTEIN)
    ("FA complex genes or ATM" . SPARSER::COLLECTION)
    ("CGH and RNA" . SPARSER::COLLECTION) ("RPL13A" . SPARSER::PROTEIN)
    ("Androgen Receptor" . SPARSER::PROTEIN) ("SLX4" . SPARSER::PROTEIN)
    ("γ–H2AX" . SPARSER::PROTEIN) ("TMPRSS2" . SPARSER::PROTEIN)
    ("NCOR2" . SPARSER::PROTEIN) ("NR3C1" . SPARSER::PROTEIN)
    ("MSH6" . SPARSER::PROTEIN) ("MSH2" . SPARSER::PROTEIN)
    ("ZBTB16" . SPARSER::PROTEIN) ("matrices" . SPARSER::PROTEIN-FAMILY)
    ("the cancerous foci" . SPARSER::PROTEIN)
    ("some weak AMACR" . SPARSER::PROTEIN)
    ("Strong positive AMACR" . SPARSER::PROTEIN)
    ("AMACR , AR and KLK3" . SPARSER::COLLECTION)
    ("AMACR or AR" . SPARSER::COLLECTION)
    ("AR and AMACR" . SPARSER::COLLECTION) ("AR or KLK3" . SPARSER::COLLECTION)
    ("AR and KLK3" . SPARSER::COLLECTION)
    ("AMACR, AR and KLK3" . SPARSER::COLLECTION)
    ("incidental PCa" . SPARSER::PROTEIN)
    ("PCa as well as castration resistant PCa" . SPARSER::COLLECTION)
    ("p63 or 34βE12" . SPARSER::COLLECTION) ("PSA" . SPARSER::PROTEIN)
    ("PIN" . SPARSER::PROTEIN) ("AMACR/KLK3" . SPARSER::COLLECTION)
    ("Peptidase" . SPARSER::PROTEIN) ("Kallikrein" . SPARSER::PROTEIN)
    ("three cross-sectioned RP" . SPARSER::PROTEIN)
    ("AMACR and AR" . SPARSER::COLLECTION) ("RP-PCa" . SPARSER::COLLECTION)
    ("PCa" . SPARSER::PROTEIN) ("keratin 5" . SPARSER::PROTEIN)
    ("KLK 3" . SPARSER::PROTEIN) ("P504S" . SPARSER::PROTEIN)
    ("a 2 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("KLK3" . SPARSER::PROTEIN)
    ("at least four substrates" . SPARSER::SUBSTRATE)
    ("mDia" . SPARSER::PROTEIN)
    ("actin filaments and cell surface proteins [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("cofilin" . SPARSER::PROTEIN)
    ("polymerized type II myosin" . SPARSER::PROTEIN-FAMILY)
    ("activin" . SPARSER::PROTEIN)
    ("lysophosphatidic acid (LPA)" . SPARSER::LPA) ("LPA" . SPARSER::LPA)
    ("integrins or mechanosensitive ion channels [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("mechanosensitive ion channels" . SPARSER::PROTEIN-FAMILY)
    ("noradrenaline [ xref ] and acetylcholine [ xref ]" . SPARSER::COLLECTION)
    ("noradrenaline" . SPARSER::PROTEIN) ("cellular actin" . SPARSER::PROTEIN)
    ("Y-27632 and SP600125" . SPARSER::COLLECTION) ("Pre" . SPARSER::PROTEIN)
    ("asparagine" . SPARSER::AMINO-ACID) ("myogenic" . SPARSER::PROTEIN)
    ("kinase (ROCK)" . SPARSER::KINASE)
    ("an active GTP-bound form and an inactive GDP-bound form"
     . SPARSER::COLLECTION)
    ("kinase (JNK)" . SPARSER::KINASE) ("angiotensin" . SPARSER::PROTEIN)
    ("Fluor" . SPARSER::MOLECULE) ("cytochalasin D" . SPARSER::DRUG)
    ("Na + /H +" . SPARSER::PROTEIN) ("α-actinin" . SPARSER::PROTEIN)
    ("immediate early" . SPARSER::PROTEIN) ("MEKK1" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase kinase 1" . SPARSER::PROTEIN)
    ("MKK4" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase 4" . SPARSER::PROTEIN)
    ("Angiotensin II" . SPARSER::PROTEIN)
    ("lysophosphatidic acid" . SPARSER::LPA)
    ("ion channels" . SPARSER::PROTEIN-FAMILY) ("JNK1" . SPARSER::PROTEIN)
    ("ion channel" . SPARSER::PROTEIN-FAMILY)
    ("mitogen activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Y-27632" . SPARSER::MOLECULE) ("pap" . SPARSER::MOLECULE)
    ("GLI2 , PTCH1 and SHH" . SPARSER::COLLECTION)
    ("CD133 and CD44" . SPARSER::COLLECTION)
    ("TNC and MAP2" . SPARSER::COLLECTION)
    ("CTNNB1 and BRAFV600E" . SPARSER::COLLECTION) ("BRAFV" . SPARSER::PROTEIN)
    ("AXIN2 (Wnt pathway) as well as GLI2 and PTCH1 (SHH pathway)"
     . SPARSER::COLLECTION)
    ("GLI2 and PTCH1" . SPARSER::COLLECTION)
    ("CD44 and Claudin 1" . SPARSER::COLLECTION) ("TNC" . SPARSER::PROTEIN)
    ("Tenascin" . SPARSER::PROTEIN)
    ("PTCH1 as well as SHH (Additional file xref : Figure S1)"
     . SPARSER::COLLECTION)
    ("GLI2 , PTCH1 as well as SHH (Additional file xref : Figure S1)"
     . SPARSER::COLLECTION)
    ("LEF1 and AXIN2" . SPARSER::COLLECTION)
    ("serine or threonine" . SPARSER::COLLECTION) ("Codon" . SPARSER::PROTEIN)
    ("the largest cohorts" . SPARSER::MOLECULE)
    ("Vemurafenib and Dabrafenib" . SPARSER::COLLECTION)
    ("Trametinib" . SPARSER::DRUG) ("Dabrafenib" . SPARSER::DRUG)
    ("Vemurafenib" . SPARSER::DRUG) ("EGFR- and SHH" . SPARSER::COLLECTION)
    ("EGFR-" . SPARSER::PROTEIN) ("CPs" . SPARSER::PROTEIN)
    ("the respective CP variants" . SPARSER::VARIANT)
    ("Wnt- and SHH" . SPARSER::COLLECTION)
    ("Wnt-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SHH" . SPARSER::PROTEIN)
    ("a comprehensive cohort" . SPARSER::MOLECULE)
    ("further insights distinguishing CP variants" . SPARSER::VARIANT)
    ("CTNNB1 and BRAF" . SPARSER::COLLECTION) ("CLDN1" . SPARSER::PROTEIN)
    ("Claudin 1" . SPARSER::PROTEIN) ("PROM1" . SPARSER::PROTEIN)
    ("MAP2" . SPARSER::PROTEIN) ("p5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAS5" . SPARSER::PROTEIN) ("LGD or HGD" . SPARSER::COLLECTION)
    ("AMACR" . SPARSER::PROTEIN)
    ("clinically validated IHC reagents" . SPARSER::MOLECULE)
    ("CDX2 and p120ctn" . SPARSER::COLLECTION) ("Tp53" . SPARSER::PROTEIN)
    ("PCAs" . SPARSER::PROTEIN) ("principal component" . SPARSER::COMPONENT)
    ("sentinel" . SPARSER::DRUG)
    ("the first principal component" . SPARSER::COMPONENT)
    ("LGD/HGD/EAC" . SPARSER::COLLECTION)
    ("LGD, HGD, or EAC" . SPARSER::COLLECTION)
    ("these two pathologic states" . SPARSER::BIO-STATE)
    ("Membranous p120ctn" . SPARSER::PROTEIN)
    ("Partial and non-consensus" . SPARSER::COLLECTION)
    ("Partial" . SPARSER::PROTEIN)
    ("HGD ( n  = 24) and EAC ( n  = 29)" . SPARSER::COLLECTION)
    ("LGD ( n  = 23), HGD ( n  = 24) and EAC ( n  = 29)" . SPARSER::COLLECTION)
    ("LGD, HGD, and EAC" . SPARSER::COLLECTION)
    ("LGD, HGD and EAC" . SPARSER::COLLECTION)
    ("c-Myc and Jagged1" . SPARSER::COLLECTION)
    ("HGD and EAC" . SPARSER::COLLECTION)
    ("the predominant form" . SPARSER::FORM)
    ("larger patient cohorts" . SPARSER::MOLECULE)
    ("CDX2, p120ctn, c-Myc, and Jagged1" . SPARSER::COLLECTION)
    ("LGD and HGD" . SPARSER::COLLECTION) ("HGD/EAC" . SPARSER::COLLECTION)
    ("CDX2, p120ctn, c-Myc and Jagged1" . SPARSER::COLLECTION)
    ("EAC" . SPARSER::PROTEIN) ("HGD" . SPARSER::PROTEIN)
    ("LGD" . SPARSER::PROTEIN) ("p120-catenin" . SPARSER::PROTEIN)
    ("Jagged1" . SPARSER::PROTEIN) ("p120ctn" . SPARSER::PROTEIN)
    ("CDX2" . SPARSER::PROTEIN)
    ("FOXP1 and the mesenchymal marker gene (CDH2)" . SPARSER::COLLECTION)
    ("the mesenchymal marker gene" . SPARSER::GENE)
    ("specifically target ETS2, HNF4A and JUNB associated super-enhancers"
     . SPARSER::PROTEIN)
    ("HNF4A or ETS2" . SPARSER::COLLECTION)
    ("ETS2, HNF4A, JUNB, EGFR and VIM" . SPARSER::COLLECTION)
    ("EST2, HNF4A and JUNB" . SPARSER::COLLECTION)
    ("a recently developed BRD4 inhibitor" . SPARSER::INHIBITOR)
    ("BET" . SPARSER::PROTEIN) ("bromodomain" . SPARSER::PROTEIN)
    ("120 EMT-associated genes" . SPARSER::GENE)
    ("HNF4A and JUNB" . SPARSER::COLLECTION)
    ("ETS2, HNF4a or JUNB" . SPARSER::COLLECTION) ("trio" . SPARSER::PROTEIN)
    ("ETS2, HNF4A or JUNB" . SPARSER::COLLECTION)
    ("ETS2, HNF4, JUNB, FOXP1 and CDH2" . SPARSER::COLLECTION)
    ("mRNAs and proteins" . SPARSER::COLLECTION)
    ("the dynamic GRN" . SPARSER::PROTEIN)
    ("CDH1 and CDH2" . SPARSER::COLLECTION)
    ("further establishing ETS2, HNF4A and JUNB" . SPARSER::COLLECTION)
    ("SMAD3 or ELF3" . SPARSER::COLLECTION)
    ("SMAD3, ELF3 and HMGA2" . SPARSER::COLLECTION)
    ("a dynamic GRN" . SPARSER::PROTEIN)
    ("ETS2, HNF4a and JUNB" . SPARSER::COLLECTION) ("GRN" . SPARSER::PROTEIN)
    ("ETS2, HNF4A, JUNB and FOXP1" . SPARSER::COLLECTION)
    ("the mesenchymal state" . SPARSER::BIO-STATE)
    ("proximal enhancers" . SPARSER::PROTEIN)
    ("SMAD3 and ELF3" . SPARSER::COLLECTION)
    ("epithelial-high, partial-EMT-high and mesenchymal-high genes"
     . SPARSER::GENE)
    ("SNAI1 (5.58 TPM) and SNAI2 (4.11 TPM)" . SPARSER::COLLECTION)
    ("the mesenchymal-high genes" . SPARSER::GENE)
    ("the partial-EMT-high gene" . SPARSER::GENE)
    ("early-wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The epithelial-high genes" . SPARSER::GENE)
    ("a smaller gene" . SPARSER::GENE)
    ("mesenchymal-associated genes" . SPARSER::GENE)
    ("VIM, FN1 and N-cadherin" . SPARSER::COLLECTION)
    ("VIM" . SPARSER::PROTEIN)
    ("known epithelial-associated genes" . SPARSER::GENE)
    ("SMAD3, ELF3 and E-cadherin" . SPARSER::COLLECTION)
    ("the human small cell lung cancer cell line A549 underwent EMT"
     . SPARSER::PROTEIN)
    ("super-enhancer-associated master regulators" . SPARSER::REGULATOR)
    ("EMT-associated genes and the synergistic action" . SPARSER::COLLECTION)
    ("the beginning epithelial state or the ending mesenchymal state"
     . SPARSER::COLLECTION)
    ("the ending mesenchymal state" . SPARSER::BIO-STATE)
    ("beginning epithelial state" . SPARSER::BIO-STATE)
    ("SMADs" . SPARSER::PROTEIN) ("GRNs" . SPARSER::PROTEIN)
    ("super-enhancers" . SPARSER::PROTEIN)
    ("EMT-associated genes" . SPARSER::GENE)
    ("ETS2, HNF4A and JUNB" . SPARSER::COLLECTION)
    ("partial-EMT" . SPARSER::COLLECTION) ("EST2" . SPARSER::PROTEIN)
    ("HNF4" . SPARSER::PROTEIN) ("HNF4a" . SPARSER::PROTEIN)
    ("ZNF703" . SPARSER::PROTEIN) ("WNT5B" . SPARSER::PROTEIN)
    ("WNT5A" . SPARSER::PROTEIN) ("WNT11" . SPARSER::PROTEIN)
    ("TWIST2" . SPARSER::PROTEIN) ("TWIST1" . SPARSER::PROTEIN)
    ("TPM1" . SPARSER::PROTEIN) ("TIMP1" . SPARSER::PROTEIN)
    ("TGFB3" . SPARSER::PROTEIN) ("TGFB2" . SPARSER::PROTEIN)
    ("TGFB1" . SPARSER::PROTEIN) ("TFPI2" . SPARSER::PROTEIN)
    ("TCF3" . SPARSER::PROTEIN) ("SPP1" . SPARSER::PROTEIN)
    ("SOX4" . SPARSER::PROTEIN) ("SOX10" . SPARSER::PROTEIN)
    ("SIX1" . SPARSER::PROTEIN) ("SERPINE1" . SPARSER::PROTEIN)
    ("RGS2" . SPARSER::PROTEIN) ("PTK2" . SPARSER::PROTEIN)
    ("PRX1" . SPARSER::PROTEIN) ("PRDX1" . SPARSER::PROTEIN)
    ("PPPDE2" . SPARSER::PROTEIN) ("PLEK2" . SPARSER::PROTEIN)
    ("PDK4" . SPARSER::PROTEIN) ("NUDT13" . SPARSER::PROTEIN)
    ("NOTCH1" . SPARSER::PROTEIN) ("MAP1B" . SPARSER::PROTEIN)
    ("KRT7" . SPARSER::PROTEIN) ("KRT14" . SPARSER::PROTEIN)
    ("KLF8" . SPARSER::PROTEIN) ("JAG1" . SPARSER::PROTEIN)
    ("IGFBP4" . SPARSER::PROTEIN) ("HMGA2" . SPARSER::PROTEIN)
    ("GSK3B" . SPARSER::PROTEIN) ("GNG11" . SPARSER::PROTEIN)
    ("GATA6" . SPARSER::PROTEIN) ("FOXQ1" . SPARSER::PROTEIN)
    ("FOXF1" . SPARSER::PROTEIN) ("FOXC2" . SPARSER::PROTEIN)
    ("F11R" . SPARSER::PROTEIN) ("DSC2" . SPARSER::PROTEIN)
    ("CTNNB1" . SPARSER::PROTEIN) ("COL5A2" . SPARSER::PROTEIN)
    ("COL3A1" . SPARSER::PROTEIN) ("CD59" . SPARSER::PROTEIN)
    ("CAV2" . SPARSER::PROTEIN) ("CAMK2" . SPARSER::PROTEIN)
    ("CALD1" . SPARSER::PROTEIN) ("BMP7" . SPARSER::PROTEIN)
    ("TSPAN13" . SPARSER::PROTEIN) ("STEAP1" . SPARSER::PROTEIN)
    ("SIP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RAB27B" . SPARSER::PROTEIN)
    ("PTP4A1" . SPARSER::PROTEIN) ("MST1R" . SPARSER::PROTEIN)
    ("KRT19" . SPARSER::PROTEIN) ("IL1RN" . SPARSER::PROTEIN)
    ("GDF15" . SPARSER::PROTEIN) ("FZD7" . SPARSER::PROTEIN)
    ("FOXO3A" . SPARSER::PROTEIN) ("FOXA2" . SPARSER::PROTEIN)
    ("FGFBP1" . SPARSER::PROTEIN) ("ELF5" . SPARSER::PROTEIN)
    ("ELF3" . SPARSER::PROTEIN) ("CXCL5" . SPARSER::PROTEIN)
    ("COL1A2" . SPARSER::PROTEIN) ("FOXP1" . SPARSER::PROTEIN)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("BRD4" . SPARSER::PROTEIN) ("HNF4A" . SPARSER::PROTEIN)
    ("a weak promoter" . SPARSER::PROMOTER)
    ("both parental alleles" . SPARSER::ALLELE)
    ("normal retina" . SPARSER::DRUG) ("the mutated allele" . SPARSER::ALLELE)
    ("2 normal retinas" . SPARSER::DRUG) ("retinas" . SPARSER::DRUG)
    ("the paternal RB1 allele" . SPARSER::ALLELE)
    ("the maternal RB1 allele" . SPARSER::ALLELE)
    ("dup" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNAs and RNAs" . SPARSER::COLLECTION)
    ("the maternal allele" . SPARSER::ALLELE)
    ("the contralateral paternal allele" . SPARSER::ALLELE)
    ("the paternal allele" . SPARSER::ALLELE)
    ("the maternal c" . SPARSER::PROTEIN) ("Trp" . SPARSER::AMINO-ACID)
    ("MED4" . SPARSER::PROTEIN) ("p53 and RB" . SPARSER::COLLECTION)
    ("directly target MYC" . SPARSER::PROTEIN)
    ("RUNX2/MYC" . SPARSER::COLLECTION)
    ("mutant p53 (HOS-MNNG) or even wild type p53 gene (U2OS)"
     . SPARSER::COLLECTION)
    ("even wild type p53 gene" . SPARSER::GENE)
    ("p53 or mutant" . SPARSER::COLLECTION)
    ("Mi-2 and Mi-3" . SPARSER::COLLECTION)
    ("Menin and MLL1" . SPARSER::COLLECTION) ("Wdr5" . SPARSER::PROTEIN)
    ("RUNX2 and Menin" . SPARSER::COLLECTION)
    ("MLL1 and Menin" . SPARSER::COLLECTION)
    ("Menin and other subunits [ xref ]" . SPARSER::COLLECTION)
    ("MLL1, Menin and other subunits [ xref ]" . SPARSER::COLLECTION)
    ("Complexes" . SPARSER::BIO-COMPLEX) ("exogenous MYC" . SPARSER::PROTEIN)
    ("RUNX2 or CBFB" . SPARSER::COLLECTION)
    ("a transcriptional cofactor" . SPARSER::MOLECULE)
    ("cor" . SPARSER::PROTEIN-FAMILY)
    ("RUNX1, RUNX2 and RUNX3" . SPARSER::COLLECTION)
    ("SP7 (also known as Osterix ) and ALPL" . SPARSER::COLLECTION)
    ("RUNX2, SP7 (also known as Osterix ) and ALPL" . SPARSER::COLLECTION)
    ("ALPL" . SPARSER::PROTEIN) ("Osterix" . SPARSER::PROTEIN)
    ("CBFB and RUNX2" . SPARSER::COLLECTION)
    ("RUNX2/CBFB" . SPARSER::COLLECTION)
    ("RUNX2 and CBFB" . SPARSER::COLLECTION)
    ("FLAG-RUNX2" . SPARSER::COLLECTION) ("CBFB" . SPARSER::PROTEIN)
    ("Exon" . SPARSER::PROTEIN) ("NSG" . SPARSER::PROTEIN-FAMILY)
    ("PARP and propidium" . SPARSER::COLLECTION)
    ("Menin/MLL" . SPARSER::COLLECTION)
    ("a p53-repressed target in OS and bone marrow-derived MSCs [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("Nutlin and RITA" . SPARSER::COLLECTION) ("RITA" . SPARSER::PROTEIN)
    ("Nutlin" . SPARSER::DRUG) ("RUNX2/Menin/MLL1/MYC" . SPARSER::COLLECTION)
    ("Menin/MLL1" . SPARSER::COLLECTION) ("Menin" . SPARSER::PROTEIN)
    ("H2O2" . SPARSER::DRUG) ("Mi-2" . SPARSER::PROTEIN)
    ("RUNX1" . SPARSER::PROTEIN) ("SP7" . SPARSER::PROTEIN)
    ("core binding factor beta" . SPARSER::PROTEIN) ("_WT" . SPARSER::PROTEIN)
    ("leukemia 1" . SPARSER::PROTEIN) ("MLL1" . SPARSER::PROTEIN)
    ("GATA3/nucleosome" . SPARSER::COLLECTION)
    ("a transposition-permissible state" . SPARSER::BIO-STATE)
    ("inaccessible chromatin" . SPARSER::PROTEIN)
    ("GATA3 and BRG1" . SPARSER::COLLECTION)
    ("BRG1 and GATA3" . SPARSER::COLLECTION)
    ("GATA1 and GATA4" . SPARSER::COLLECTION)
    ("BRG1/SMARCA4" . SPARSER::COLLECTION)
    ("versions co-localized" . SPARSER::PROTEIN)
    ("wild-type GATA3 and the TA1 mutant (Fig.  xref ; Additional file xref : Figure S4G)"
     . SPARSER::COLLECTION)
    ("601-based DNAs" . SPARSER::DNA) ("DNAs" . SPARSER::DNA)
    ("An appreciable structural barrier" . SPARSER::PROTEIN)
    ("‘GATA’" . SPARSER::PROTEIN) ("DNase-seq" . SPARSER::COLLECTION)
    ("DNase" . SPARSER::PROTEIN)
    ("KRT8, KRT18, CDH1, and CLDN3" . SPARSER::COLLECTION)
    ("TSS distal GATA3" . SPARSER::PROTEIN) ("seq" . SPARSER::PROTEIN)
    ("transposase" . SPARSER::PROTEIN) ("ATAC-seq" . SPARSER::COLLECTION)
    ("ATAC" . SPARSER::PROTEIN)
    ("previously ‘closed’ chromatin" . SPARSER::BIO-COMPLEX)
    ("a mesenchymal state" . SPARSER::BIO-STATE)
    ("FOXA1 and estrogen receptor-α" . SPARSER::COLLECTION)
    ("nucleosomal DNA" . SPARSER::DNA) ("around genes" . SPARSER::GENE)
    ("accessible chromatin" . SPARSER::PROTEIN)
    ("previously inaccessible chromatin" . SPARSER::PROTEIN)
    ("previously closed chromatin" . SPARSER::BIO-COMPLEX)
    ("GATA4" . SPARSER::PROTEIN) ("SMARCA4" . SPARSER::PROTEIN)
    ("chromatin remodeling factor" . SPARSER::PROTEIN)
    ("TA1" . SPARSER::PROTEIN) ("CLDN3" . SPARSER::PROTEIN)
    ("KRT18" . SPARSER::PROTEIN) ("KRT8" . SPARSER::PROTEIN)
    ("Both activators and antagonists" . SPARSER::COLLECTION)
    ("homozygous SNP genotype" . SPARSER::PROTEIN) ("PH" . SPARSER::PROTEIN)
    ("Nrf2, Nqo1, and Ki-67" . SPARSER::COLLECTION)
    ("brusatol" . SPARSER::DRUG) ("Ren" . SPARSER::PROTEIN)
    ("Brusatol" . SPARSER::DRUG) ("aflatoxin" . SPARSER::MOLECULE)
    ("a synthetic oleanolic triterpenoids" . SPARSER::MOLECULE)
    ("triterpenoids" . SPARSER::MOLECULE) ("CDDO" . SPARSER::DRUG)
    ("Lida" . SPARSER::DRUG) ("Oltipraz" . SPARSER::DRUG)
    ("a classical Nrf2 signal activator" . SPARSER::ACTIVATOR)
    ("Curcumin" . SPARSER::DRUG) ("pyrene" . SPARSER::PROTEIN)
    ("isothiocyanate" . SPARSER::MOLECULE) ("Thiols" . SPARSER::MOLECULE)
    ("Sulforaphane" . SPARSER::PROTEIN)
    ("typical activators" . SPARSER::ACTIVATOR)
    ("Activators" . SPARSER::ACTIVATOR)
    ("Typical activators and antagonists" . SPARSER::COLLECTION)
    ("Typical activators" . SPARSER::ACTIVATOR) ("oltipraz" . SPARSER::DRUG)
    ("NICD" . SPARSER::PROTEIN)
    ("Notch signal activation upregulated Nrf2 and cytoprotective genes"
     . SPARSER::COLLECTION)
    ("cytoprotective genes" . SPARSER::GENE)
    ("Notch1 and Notch3" . SPARSER::COLLECTION)
    ("Nrf2 and Notch1" . SPARSER::COLLECTION)
    ("IL-8 and Ho-1" . SPARSER::COLLECTION)
    ("a key transcription factor" . SPARSER::PROTEIN)
    ("Nrf2 and HIF-1α" . SPARSER::COLLECTION)
    ("p50 and p65" . SPARSER::COLLECTION)
    ("Nrf2 and its downstream genes [ xref ]" . SPARSER::COLLECTION)
    ("Nrf2 and NF-kappa" . SPARSER::COLLECTION)
    ("Nrf2 and vice versa [ xref ]" . SPARSER::COLLECTION)
    ("Nrf2 and Sirt1" . SPARSER::COLLECTION)
    ("ER-α and Nrf2" . SPARSER::COLLECTION)
    ("Nrf2 and ER-α" . SPARSER::COLLECTION) ("arsenite" . SPARSER::DRUG)
    ("Ho-1 and its substrates heme [ xref ]" . SPARSER::COLLECTION)
    ("Nrf2 and ARE" . SPARSER::COLLECTION)
    ("Nrf2 and Bach1" . SPARSER::COLLECTION)
    ("response element (TRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("TRE" . SPARSER::PROTEIN)
    ("Tao [ xref ] and DeNicola et al. [ xref ]" . SPARSER::COLLECTION)
    ("Nrf2 and K-ras" . SPARSER::COLLECTION)
    ("a classical oncogenic gene" . SPARSER::GENE)
    ("Nrf2 and PI3K" . SPARSER::COLLECTION)
    ("PI3K and K-ras" . SPARSER::COLLECTION)
    ("water-soluble form" . SPARSER::FORM) ("hydroquinone" . SPARSER::MOLECULE)
    ("Ho-1" . SPARSER::PROTEIN) ("Gst" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Gclm" . SPARSER::PROTEIN)
    ("c-Jun [ xref ] and small Maf [ xref ]" . SPARSER::COLLECTION)
    ("electrophiles and xenobiotics" . SPARSER::COLLECTION)
    ("xenobiotics" . SPARSER::MOLECULE) ("electrophiles" . SPARSER::MOLECULE)
    ("Cullin" . SPARSER::PROTEIN-FAMILY) ("DLG" . SPARSER::PROTEIN)
    ("Keap1 and Nrf2" . SPARSER::COLLECTION) ("Tobacco" . SPARSER::DRUG)
    ("Nrf2 and Keap1" . SPARSER::COLLECTION) ("purine" . SPARSER::DRUG)
    ("various cytoprotective genes" . SPARSER::GENE)
    ("/Cullin3" . SPARSER::COLLECTION) ("this common pathological type" . TYPE)
    ("long non-coding RNAs HOTAIR [ xref ] and GAS5 [ xref ] and potential oncogenes Notch1 [ xref ]"
     . SPARSER::COLLECTION)
    ("GAS5 [ xref ] and potential oncogenes Notch1 [ xref ]"
     . SPARSER::COLLECTION)
    ("NLK" . SPARSER::PROTEIN) ("main pathological types" . TYPE)
    ("EML4-ALK" . SPARSER::COLLECTION)
    ("DNA and protein" . SPARSER::COLLECTION)
    ("Keap1/Nrf2" . SPARSER::COLLECTION) ("DT-diaphorase" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor repressor" . SPARSER::PROTEIN)
    ("miR-1" . SPARSER::PROTEIN) ("miR-200a" . SPARSER::MOLECULE)
    ("Rbpjκ" . SPARSER::PROTEIN) ("prolyl hydroxylase" . SPARSER::PROTEIN)
    ("B subunit" . SPARSER::PROTEIN)
    ("CREB-binding protein" . SPARSER::PROTEIN) ("ER-α" . SPARSER::PROTEIN)
    ("NVP-BKM120" . SPARSER::DRUG) ("Bach1" . SPARSER::PROTEIN)
    ("Multidrug resistance-associated protein 1" . SPARSER::PROTEIN)
    ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("Nqo1" . SPARSER::PROTEIN)
    ("glutamate-cysteine ligase modifier subunit" . SPARSER::PROTEIN)
    ("Broad complex" . SPARSER::PROTEIN) ("Cullin3" . SPARSER::PROTEIN)
    ("alpha-enolase" . SPARSER::PROTEIN) ("GAS5" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("microtubule-associated protein" . SPARSER::PROTEIN)
    ("factor 2" . SPARSER::PROTEIN) ("erythroid 2" . SPARSER::PROTEIN)
    ("chemokines, cytokines and growth factors" . SPARSER::COLLECTION)
    ("IL6, VEGF and BMP4" . SPARSER::COLLECTION)
    ("the DDR and WT p53" . SPARSER::COLLECTION)
    ("VEGF (Figure xref ) and BMP4 (Figure xref )" . SPARSER::COLLECTION)
    ("IL6 (Figure xref ), VEGF (Figure xref ) and BMP4 (Figure xref )"
     . SPARSER::COLLECTION)
    ("BMP4 (Figure xref ) and VEGF (Figure xref )" . SPARSER::COLLECTION)
    ("IL6 (Figure xref ), BMP4 (Figure xref ) and VEGF (Figure xref )"
     . SPARSER::COLLECTION)
    ("soluble proteins" . SPARSER::PROTEIN)
    ("NF-κB and NF-κB-regulated cytokines and chemokines"
     . SPARSER::COLLECTION)
    ("BMP4 and IL6" . SPARSER::COLLECTION)
    ("IL8 (Interleukin-8) and the cytokines IL-6 (Interleukin-6) and BMP4 (Bone Morphogenetic Protein 4)"
     . SPARSER::COLLECTION)
    ("the cytokines IL-6 (Interleukin-6) and BMP4 (Bone Morphogenetic Protein 4)"
     . SPARSER::COLLECTION)
    ("the predominant fragment" . SPARSER::FRAGMENT) ("IKB" . SPARSER::PROTEIN)
    ("CS-caspase-2" . SPARSER::COLLECTION)
    ("CHK1 and the CS-pathway" . SPARSER::COLLECTION)
    ("CHK1-caspase-2" . SPARSER::COLLECTION)
    ("DDR and p53" . SPARSER::COLLECTION)
    ("p53 and CHK1" . SPARSER::COLLECTION)
    ("CHK1 and caspase-2" . SPARSER::COLLECTION)
    ("caspase-2 and NF- κ B" . SPARSER::COLLECTION)
    ("CHK1 and p53" . SPARSER::COLLECTION)
    ("a complex and interconnected signaling network" . SPARSER::COLLECTION)
    ("chemokines and cytokines" . SPARSER::COLLECTION)
    ("a separate PIDDosome complex" . SPARSER::BIO-COMPLEX)
    ("RAIDD and caspase-2" . SPARSER::COLLECTION)
    ("RIPK1 and NEMO" . SPARSER::COLLECTION) ("/IKK γ" . SPARSER::COLLECTION)
    ("NEMO" . SPARSER::PROTEIN)
    ("PIDD (p53-induced death domain protein) and RAIDD (RIP associated Ich-1/CED homologous protein with death domain)"
     . SPARSER::COLLECTION)
    ("three proteins, PIDD (p53-induced death domain protein) and RAIDD (RIP associated Ich-1/CED homologous protein with death domain)"
     . SPARSER::COLLECTION)
    ("RAIDD" . SPARSER::PROTEIN)
    ("a serine/threonine kinase and an effector" . SPARSER::COLLECTION)
    ("IKB-alpha" . SPARSER::PROTEIN) ("caspase 2" . SPARSER::PROTEIN)
    ("Arf6" . SPARSER::PROTEIN) ("TGF-B" . SPARSER::PROTEIN)
    ("Bone Morphogenetic Protein 4" . SPARSER::PROTEIN)
    ("BMP4" . SPARSER::PROTEIN) ("Interleukin-6" . SPARSER::PROTEIN)
    ("Interleukin-8" . SPARSER::PROTEIN) ("CXCL10" . SPARSER::PROTEIN)
    ("IKK γ" . SPARSER::PROTEIN) ("RIPK1" . SPARSER::PROTEIN)
    ("NF- κ B" . SPARSER::PROTEIN) ("Ich-1" . SPARSER::PROTEIN)
    ("p53-induced death domain protein" . SPARSER::PROTEIN)
    ("Caspase-2" . SPARSER::PROTEIN) ("caspase-2" . SPARSER::PROTEIN)
    ("ABT-199, and navitoclax" . SPARSER::COLLECTION)
    ("paclitaxel and gemcitabine" . SPARSER::COLLECTION)
    ("paclitaxel [ xref ] and gemcitabine [ xref ]" . SPARSER::COLLECTION)
    ("Mcl-1 and EU-5346" . SPARSER::COLLECTION)
    ("available Bcl-2 family inhibitors" . SPARSER::INHIBITOR)
    ("ABT-737, navitoclax, and ABT-199" . SPARSER::COLLECTION)
    ("Bcl-2/Bcl-xL inhibitor ABT-737 [ xref ] and its oral derivate navitoclax/ABT-263 [ xref ]"
     . SPARSER::COLLECTION)
    ("trastuzumab and lapatinib" . SPARSER::COLLECTION)
    ("AlamarBlue" . SPARSER::DRUG)
    ("prohibitin-1 and α-tubulin" . SPARSER::COLLECTION)
    ("hypoxia and E-twenty-six" . SPARSER::COLLECTION)
    ("wt/wt and Mcl-1" . SPARSER::COLLECTION)
    ("the Bcl-2-specific BH3-mimetic navitoclax" . SPARSER::DRUG)
    ("Mcl-1/Bim" . SPARSER::COLLECTION)
    ("hydroxyquinoline" . SPARSER::MOLECULE)
    ("pro-apoptotic oncogenes" . SPARSER::ONCOGENE)
    ("2 inhibitors trastuzumab (Fig.  xref ) and lapatinib (Fig.  xref )"
     . SPARSER::COLLECTION)
    ("pVHL, and proteasomal" . SPARSER::COLLECTION) ("pVHL" . SPARSER::PROTEIN)
    ("iron" . SPARSER::MOLECULE) ("proteins, and Mcl-1" . SPARSER::COLLECTION)
    ("-thymidine" . SPARSER::COLLECTION) ("MCF-10A" . SPARSER::PROTEIN)
    ("a promising novel anti-Mcl-1" . SPARSER::ANTIBODY)
    ("paclitaxel [ xref ] and gemcitabine [ xref ] as well as early clinical BH3 mimetic drugs"
     . SPARSER::COLLECTION)
    ("gemcitabine [ xref ] as well as early clinical BH3 mimetic drugs"
     . SPARSER::COLLECTION)
    ("early clinical BH3 mimetic drugs" . SPARSER::DRUG)
    ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("their respective receptors" . SPARSER::PROTEIN)
    ("epidermal growth factor and estrogen" . SPARSER::COLLECTION)
    ("the Bcl-2 homology 3 (BH3)-only protein NOXA"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bak or Bim" . SPARSER::COLLECTION) ("Bak and Bim" . SPARSER::COLLECTION)
    ("proline, glutamic acid, serine, and threonine (PEST)"
     . SPARSER::COLLECTION)
    ("proline, glutamic acid, serine, and threonine" . SPARSER::COLLECTION)
    ("Hif" . SPARSER::PROTEIN-FAMILY)
    ("capecitabine and T-DM1" . SPARSER::COLLECTION)
    ("Kadcyla" . SPARSER::DRUG) ("emtansine" . SPARSER::DRUG)
    ("ado" . SPARSER::PROTEIN) ("Perjeta" . SPARSER::DRUG)
    ("pertuzumab" . SPARSER::DRUG) ("Tykerb" . SPARSER::DRUG)
    ("coreceptor" . SPARSER::PROTEIN)
    ("the HER2 gene and other genes" . SPARSER::COLLECTION)
    ("STARD3 and GRB7" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR) and HER2 [ xref ]"
     . SPARSER::COLLECTION)
    ("KI67 and cyclin B1" . SPARSER::COLLECTION)
    ("ESR1 , GATA3 , FOXA1 , XBP1 , and MYB" . SPARSER::COLLECTION)
    ("progesterone receptor (PR)" . SPARSER::PROTEIN)
    ("estrogen receptor (ER)" . SPARSER::PROTEIN) ("Mcl-1-" . SPARSER::PROTEIN)
    ("fraction and form" . SPARSER::COLLECTION) ("130 kD" . SPARSER::PROTEIN)
    ("prohibitin-1" . SPARSER::PROTEIN) ("MCL1" . SPARSER::PROTEIN)
    ("Prohibitin-1" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("z-VAD-fmk" . SPARSER::DRUG) ("Lapatinib ditosylate" . SPARSER::DRUG)
    ("T-DM1" . SPARSER::PROTEIN) ("GRB7" . SPARSER::PROTEIN)
    ("STARD3" . SPARSER::PROTEIN) ("KI67" . SPARSER::PROTEIN)
    ("XBP1" . SPARSER::PROTEIN) ("FOXA1" . SPARSER::PROTEIN)
    ("c-erbB2" . SPARSER::PROTEIN) ("Hif-1α" . SPARSER::PROTEIN)
    ("Mcl-1 protein" . SPARSER::PROTEIN) ("wt/wt" . SPARSER::PROTEIN)
    ("other mitotic protein kinases" . SPARSER::PROTEIN)
    ("Chemical" . SPARSER::MOLECULE) ("essential proteins" . SPARSER::PROTEIN)
    ("10% residual Plk1" . SPARSER::PROTEIN)
    ("protein and re-expressed" . SPARSER::COLLECTION)
    ("other non-catalytic mitotic proteins" . SPARSER::PROTEIN)
    ("auxin" . SPARSER::MOLECULE) ("trans-" . SPARSER::PROTEIN-FAMILY)
    ("other mitotic kinases" . SPARSER::KINASE)
    ("other mitotic proteins" . SPARSER::PROTEIN)
    ("a single mitotic protein" . SPARSER::PROTEIN)
    ("mitotic proteins" . SPARSER::PROTEIN)
    ("Kin and Plk1" . SPARSER::COLLECTION)
    ("an essential component" . SPARSER::COMPONENT)
    ("fluorescent H2B" . SPARSER::PROTEIN) ("Kin" . SPARSER::PROTEIN)
    ("kinases, ERK1 and ERK2" . SPARSER::COLLECTION)
    ("a major mitotic regulator" . SPARSER::REGULATOR)
    ("DSF" . SPARSER::PROTEIN) ("monoclonal PLK1" . SPARSER::PROTEIN)
    ("Plk1 T210V and Plk1 T214V" . SPARSER::COLLECTION)
    ("flox" . SPARSER::PROTEIN)
    ("most singly non-modifiable mutants" . SPARSER::MUTANT)
    ("Flag-Plk1" . SPARSER::COLLECTION) ("complementing" . SPARSER::PROTEIN)
    ("pyrazolopyrimidine" . SPARSER::MOLECULE)
    ("GFP-Plk1" . SPARSER::COLLECTION)
    ("previously established Plk1" . SPARSER::PROTEIN)
    ("34 singly non-modifiable Plk1 mutants" . SPARSER::MUTANT)
    ("a bulky ATP-analog inhibitor" . SPARSER::INHIBITOR)
    ("a modified analog-sensitive Plk1 (Plk1 AS ) and complemented"
     . SPARSER::COLLECTION)
    ("HCO3" . SPARSER::MOLECULE) ("Kinase activity" . SPARSER::PROTEIN)
    ("AA1" . SPARSER::PROTEIN) ("F-8" . SPARSER::PROTEIN)
    ("gag-pol" . SPARSER::PROTEIN) ("Orc2" . SPARSER::PROTEIN)
    ("MPS1" . SPARSER::PROTEIN) ("ERK2" . SPARSER::PROTEIN)
    ("Cdc5" . SPARSER::PROTEIN) ("S . cerevisiae" . SPARSER::PROTEIN)
    ("yeast homolog" . SPARSER::PROTEIN)
    ("polo-like kinase 1" . SPARSER::PROTEIN)
    ("PP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("particularly polymorphonuclear leukocytes-" . SPARSER::PROTEIN)
    ("leukocytes-" . SPARSER::PROTEIN)
    ("MDS or leukemia" . SPARSER::COLLECTION) ("MDS" . SPARSER::PROTEIN)
    ("PV and 15.02×10" . SPARSER::COLLECTION)
    ("male and 90" . SPARSER::COLLECTION) ("haemoglobin" . SPARSER::MOLECULE)
    ("Janus" . SPARSER::PROTEIN-FAMILY) ("PMF" . SPARSER::PROTEIN)
    ("HGB" . SPARSER::PROTEIN) ("hemoglobin" . SPARSER::MOLECULE)
    ("PV" . SPARSER::PROTEIN) ("TRAP" . SPARSER::PROTEIN)
    ("Dr" . SPARSER::MOLECULE)
    ("tumour type and others (e.g. gastric cancer)" . SPARSER::COLLECTION)
    ("new biomarkers" . SPARSER::MOLECULE)
    ("new predictive and prognostic biomarkers" . SPARSER::MOLECULE)
    ("Rank" . SPARSER::PROTEIN)
    ("telomerase activity and CRC" . SPARSER::COLLECTION)
    ("132 CRCs and their corresponding non-tumour" . SPARSER::COLLECTION)
    ("independent prognostic biomarkers" . SPARSER::MOLECULE)
    ("repetitive DNA" . SPARSER::DNA) ("Shelterin" . SPARSER::PROTEIN)
    ("Mismatch" . SPARSER::PROTEIN) ("MSI" . SPARSER::PROTEIN)
    ("fish" . SPARSER::PROTEIN)
    ("telomerase activity and TERT" . SPARSER::COLLECTION)
    ("Telomerase activity" . SPARSER::PROTEIN)
    ("Cyclophilin A" . SPARSER::PROTEIN)
    ("AKT/FOXO3a/Par-4" . SPARSER::COLLECTION)
    ("various pro-apoptotic genes" . SPARSER::GENE) ("PLA" . SPARSER::PROTEIN)
    ("Par-4 and pAKT" . SPARSER::COLLECTION)
    ("AKT and Par-4" . SPARSER::COLLECTION) ("PKA" . SPARSER::PROTEIN)
    ("pAKT and Par-4" . SPARSER::COLLECTION)
    ("activated AKT and more nuclear-localized Par-4 ( xref )"
     . SPARSER::COLLECTION)
    ("AKT and pAKT" . SPARSER::COLLECTION) ("AKT-Par-4" . SPARSER::COLLECTION)
    ("codon" . SPARSER::PROTEIN) ("caspase-9, and PARP" . SPARSER::COLLECTION)
    ("FOXO3a protein as well as Par-4" . SPARSER::COLLECTION)
    ("FOXO3a or pFOXO3a" . SPARSER::COLLECTION)
    ("FOXO3a or Par-4" . SPARSER::COLLECTION)
    ("DBM-FOXO3a" . SPARSER::COLLECTION) ("TM-FOXO3a" . SPARSER::COLLECTION)
    ("DBM" . SPARSER::PROTEIN)
    ("their pro-apoptotic function both proteins" . SPARSER::PROTEIN)
    ("either transiently transfected myr-AKT or stably transfected total AKT"
     . SPARSER::COLLECTION)
    ("myr" . SPARSER::MOLECULE) ("PAWR" . SPARSER::PROTEIN)
    ("FasL" . SPARSER::PROTEIN)
    ("which makes AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CREB and NF-KB" . SPARSER::COLLECTION)
    ("FOXO3a, and Par-4" . SPARSER::COLLECTION)
    ("FOXO3a and Par-4" . SPARSER::COLLECTION)
    ("a small herbal molecule" . SPARSER::MOLECULE) ("WA" . SPARSER::MOLECULE)
    ("pro-apoptotic signaling molecules" . SPARSER::MOLECULE)
    ("transcription factor and caspase" . SPARSER::COLLECTION)
    ("anti-Par" . SPARSER::DRUG) ("β -actin" . SPARSER::PROTEIN)
    ("actinomycin-D" . SPARSER::MOLECULE) ("AKT-induced" . SPARSER::PROTEIN)
    ("tumor-suppressor protein" . SPARSER::PROTEIN)
    ("Fas ligand" . SPARSER::PROTEIN) ("NF-KB" . SPARSER::PROTEIN)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("Par-4" . SPARSER::PROTEIN) ("protein kinase-B" . SPARSER::PROTEIN)
    ("Bub1 and Bub1-bound Plk1" . SPARSER::COLLECTION)
    ("Bub1–Bub3" . SPARSER::COLLECTION)
    ("PP2A or other phosphatases" . SPARSER::COLLECTION)
    ("this heterodimeric Bub1–Plk1 kinase complex" . SPARSER::BIO-COMPLEX)
    ("the associated kinase Plk1" . SPARSER::PROTEIN)
    ("kinase and non-kinase" . SPARSER::COLLECTION)
    ("Mad1–Mad2" . SPARSER::COLLECTION)
    ("Cdc20 and Ube2S" . SPARSER::COLLECTION)
    ("the heterodimeric Bub1–Plk1 kinase complex" . SPARSER::BIO-COMPLEX)
    ("Mad2 and BubR1N" . SPARSER::COLLECTION)
    ("either securin ( xref ) or cyclin B1 ( xref )" . SPARSER::COLLECTION)
    ("Mad2 or BubR1N" . SPARSER::COLLECTION)
    ("Cdc20 and an N-terminal fragment" . SPARSER::COLLECTION)
    ("recombinant human Mad2, Cdc20 and an N-terminal fragment"
     . SPARSER::COLLECTION)
    ("the residual MCC" . SPARSER::PROTEIN) ("Mad2-" . SPARSER::PROTEIN)
    ("Bub1 and Cdc20" . SPARSER::COLLECTION)
    ("Flag-Cdc20" . SPARSER::COLLECTION) ("also less active" . SPARSER::ACTIVE)
    ("UbcH10 and Ube2S" . SPARSER::COLLECTION) ("Ube2S" . SPARSER::PROTEIN)
    ("Cdc20–Bub1–Plk1" . SPARSER::COLLECTION)
    ("GFP-Bub1" . SPARSER::COLLECTION) ("Bub1–Cdc20" . SPARSER::COLLECTION)
    ("Cdc20 and Plk1" . SPARSER::COLLECTION)
    ("siRNA or BI 2536" . SPARSER::COLLECTION)
    ("The Mps1 inhibitor reversine and the Aurora B inhibitor ZM447439"
     . SPARSER::COLLECTION)
    ("reversine" . SPARSER::DRUG) ("Cdc20 and PP2A" . SPARSER::COLLECTION)
    ("Mad2 and BubR1" . SPARSER::COLLECTION)
    ("BubR1–Plk1" . SPARSER::COLLECTION)
    ("BubR1 or Mad2" . SPARSER::COLLECTION)
    ("BI 2536 or Bub1" . SPARSER::COLLECTION)
    ("Bub1/BubR1–Plk1" . SPARSER::COLLECTION)
    ("the three mitotic kinases" . SPARSER::KINASE)
    ("Bub1 and two other mitotic kinases, Cdk1 and Mps1" . SPARSER::COLLECTION)
    ("two other mitotic kinases, Cdk1 and Mps1" . SPARSER::COLLECTION)
    ("kinases, Cdk1 and Mps1" . SPARSER::COLLECTION)
    ("Cdc20-pS92" . SPARSER::PROTEIN-PAIR) ("–Plk1" . SPARSER::COLLECTION)
    ("cyclin B1–Cdk1" . SPARSER::COLLECTION) ("–Bub3" . SPARSER::COLLECTION)
    ("Bub1 and Plk1" . SPARSER::COLLECTION) ("poisons" . SPARSER::MOLECULE)
    ("BI 2536 and Bub1" . SPARSER::COLLECTION)
    ("siRNA and BI 2536" . SPARSER::COLLECTION)
    ("BI 2536 or GSK461364" . SPARSER::COLLECTION)
    ("several important mitotic regulators" . SPARSER::REGULATOR)
    ("siRNA-c" . SPARSER::COLLECTION) ("siRNA-b" . SPARSER::COLLECTION)
    ("a multifunctional component" . SPARSER::COMPONENT)
    ("Plk1 and Bub1" . SPARSER::COLLECTION)
    ("Plk1 and Cdc20" . SPARSER::COLLECTION)
    ("Bub1 and BubR1" . SPARSER::COLLECTION) ("STP" . SPARSER::PROTEIN)
    ("a stoichiometric inhibitor" . SPARSER::INHIBITOR)
    ("Mad2–Cdc20" . SPARSER::COLLECTION)
    ("BubR1 and Mad2" . SPARSER::COLLECTION)
    ("Cdc20 and Mad2" . SPARSER::COLLECTION)
    ("BubR1–Bub3" . SPARSER::COLLECTION) ("Phe" . SPARSER::AMINO-ACID)
    ("KEN" . SPARSER::PROTEIN) ("securin and cyclin B1" . SPARSER::COLLECTION)
    ("diffusible anaphase inhibitors" . SPARSER::INHIBITOR)
    ("The mitotic checkpoint complex (MCC)" . SPARSER::BIO-COMPLEX)
    ("Mad2 or BubR1" . SPARSER::COLLECTION) ("Bub1–Plk1" . SPARSER::COLLECTION)
    ("the mitotic checkpoint complex (MCC)" . SPARSER::BIO-COMPLEX)
    ("anaphase-promoting complex or cyclosome" . SPARSER::COLLECTION)
    ("APC3" . SPARSER::PROTEIN) ("N protein" . SPARSER::PROTEIN)
    ("Mono-Q" . SPARSER::DRUG) ("L -glutamine" . SPARSER::MOLECULE)
    ("p31 comet" . SPARSER::PROTEIN-FAMILY) ("UbcH10" . SPARSER::PROTEIN)
    ("ZM447439" . SPARSER::DRUG) ("GSK461364" . SPARSER::DRUG)
    ("BI 2536" . SPARSER::DRUG) ("Ndc80" . SPARSER::PROTEIN)
    ("Cdk1" . SPARSER::PROTEIN) ("Bub3" . SPARSER::PROTEIN)
    ("GENOS" . SPARSER::MOLECULE)
    ("only age and gender using two family-based cohorts" . SPARSER::MOLECULE)
    ("Esr1" . SPARSER::PROTEIN) ("gene and forearm" . SPARSER::COLLECTION)
    ("Ctnna2" . SPARSER::PROTEIN) ("Van" . SPARSER::PROTEIN)
    ("only 380,000 variants" . SPARSER::VARIANT)
    ("related traits" . SPARSER::PROTEIN)
    ("the maximally associated variant" . SPARSER::VARIANT)
    ("the maximally associated variants" . SPARSER::VARIANT)
    ("GERP" . SPARSER::PROTEIN) ("Genotype" . SPARSER::PROTEIN)
    ("DNAse" . SPARSER::PROTEIN) ("HOXC5 and HOXC6" . SPARSER::COLLECTION)
    ("The maximally associated variants" . SPARSER::VARIANT)
    ("p12" . SPARSER::PROTEIN) ("LINC" . SPARSER::PROTEIN)
    ("cohort (GENOS)" . SPARSER::MOLECULE) ("adiponectin" . SPARSER::PROTEIN)
    ("leptin" . SPARSER::PROTEIN)
    ("a strong genetic component" . SPARSER::COMPONENT)
    ("intestinal and renal calcium" . SPARSER::CALCIUM)
    ("CCDC170/ESR1" . SPARSER::COLLECTION)
    ("an intronic variant" . SPARSER::VARIANT) ("WLS" . SPARSER::PROTEIN)
    ("α-catenin" . SPARSER::PROTEIN)
    ("catenin (cadherin-associated protein)" . SPARSER::PROTEIN)
    ("FAT atypical cadherin 4" . SPARSER::PROTEIN) ("SOX6" . SPARSER::PROTEIN)
    ("GPR177" . SPARSER::PROTEIN) ("HOXC6" . SPARSER::PROTEIN)
    ("HOXC5" . SPARSER::PROTEIN) ("ROR2" . SPARSER::PROTEIN)
    ("PIK3R1" . SPARSER::PROTEIN) ("LYZL2" . SPARSER::PROTEIN)
    ("PHOX2B" . SPARSER::PROTEIN) ("CTNNA2" . SPARSER::PROTEIN)
    ("KCNMA1" . SPARSER::PROTEIN) ("CCZ1" . SPARSER::PROTEIN)
    ("1–L" . SPARSER::PROTEIN) ("CCDC170" . SPARSER::PROTEIN)
    ("wntless Wnt ligand secretion mediator" . SPARSER::PROTEIN)
    ("p16 and p14" . SPARSER::COLLECTION) ("Jumonji" . SPARSER::PROTEIN)
    ("modifiers" . SPARSER::MOLECULE) ("p27-" . SPARSER::PROTEIN)
    ("CDKI" . SPARSER::DRUG) ("p14 and p16" . SPARSER::COLLECTION)
    ("CDKIs" . SPARSER::DRUG) ("pSUPER-shRNA" . SPARSER::COLLECTION)
    ("kdm5B" . SPARSER::PROTEIN)
    ("the most obvious up-regulated histone demethylase" . SPARSER::PROTEIN)
    ("HCC and KDM5B" . SPARSER::COLLECTION)
    ("KDM5B and transcription factors E2F1 and E2F2" . SPARSER::COLLECTION)
    ("several cancer-associated genes" . SPARSER::GENE)
    ("E2F1 and E2F2" . SPARSER::COLLECTION)
    ("an attractive novel target" . SPARSER::TARGET-PROTEIN)
    ("demethylases and methyltransferases" . SPARSER::COLLECTION)
    ("demethylases" . SPARSER::PROTEIN) ("tri-" . SPARSER::PROTEIN)
    ("tri" . SPARSER::PROTEIN) ("TIEG1" . SPARSER::PROTEIN)
    ("P27" . SPARSER::PROTEIN) ("demethylase activity" . SPARSER::PROTEIN)
    ("p14" . SPARSER::PROTEIN) ("H3-K4" . SPARSER::PROTEIN)
    ("E2F2" . SPARSER::PROTEIN) ("KDM5B" . SPARSER::PROTEIN)
    ("postnatal androgen" . SPARSER::PROTEIN)
    ("ASD and ADHD" . SPARSER::COLLECTION)
    ("ASD as well as their families" . SPARSER::COLLECTION)
    ("testosterone and AR" . SPARSER::COLLECTION)
    ("plasmatic testosterone" . SPARSER::MOLECULE) ("SNAP-" . SPARSER::PROTEIN)
    ("ADOS-2" . SPARSER::COLLECTION)
    ("increased prenatal testosterone" . SPARSER::MOLECULE)
    ("non ASD [ xref , xref ] and ASD [ xref , xref ]" . SPARSER::COLLECTION)
    ("gene-" . SPARSER::GENE)
    ("ASD (e.g. [ xref – xref ]) or ADHD (e.g. [ xref – xref ])"
     . SPARSER::COLLECTION)
    ("autistic traits" . SPARSER::PROTEIN) ("Testosterone" . SPARSER::MOLECULE)
    ("prenatal testosterone" . SPARSER::MOLECULE) ("ASD-" . SPARSER::PROTEIN)
    ("possible subtypes" . SPARSER::PROTEIN) ("DSM" . SPARSER::MOLECULE)
    ("Form" . SPARSER::FORM) ("ASD" . SPARSER::PROTEIN)
    ("Androgen receptor" . SPARSER::PROTEIN) ("K2" . SPARSER::PROTEIN)
    ("ADI-R" . SPARSER::PROTEIN) ("Survivin and Bcl-2" . SPARSER::COLLECTION)
    ("cisplatin and nicotine" . SPARSER::COLLECTION)
    ("cisplatin-" . SPARSER::DRUG) ("adrenoceptors" . SPARSER::PROTEIN)
    ("caspase-3 and Bax" . SPARSER::COLLECTION)
    ("proteins, Bcl-2 and Survivin" . SPARSER::COLLECTION)
    ("the prosurvival protein Bcl-2 and Survivin" . SPARSER::COLLECTION)
    ("si-CHRNA5" . SPARSER::COLLECTION) ("AnnexinV" . SPARSER::PROTEIN)
    ("nicotine and cisplatin" . SPARSER::COLLECTION)
    ("the scrambled nonspecific control siRNA" . SPARSER::PROTEIN)
    ("si-NC" . SPARSER::COLLECTION)
    ("a α5-nAChR-specific siRNA" . SPARSER::PROTEIN) ("CCK" . SPARSER::PROTEIN)
    ("cigarettes" . SPARSER::DRUG) ("Bcl-2 and Survivin" . SPARSER::COLLECTION)
    ("Bax and Caspase-3" . SPARSER::COLLECTION)
    ("PKC/ERK" . SPARSER::COLLECTION)
    ("chemotherapeutic agent cisplatin" . SPARSER::MOLECULE)
    ("nicotinic acetylcholine receptors" . SPARSER::RECEPTOR)
    ("Bcl-2, Bax, Survivin and Caspase-3" . SPARSER::COLLECTION)
    ("α5-nicotinic acetylcholine receptor" . SPARSER::PROTEIN)
    ("Nicotine" . SPARSER::DRUG) ("anti- apoptotic" . SPARSER::PROTEIN)
    ("Annexin-V" . SPARSER::PROTEIN) ("CHRNA5" . SPARSER::PROTEIN)
    ("glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("S-P" . SPARSER::PROTEIN) ("acetylcholine receptor" . SPARSER::PROTEIN)
    ("entirely separate ATR's" . SPARSER::PROTEIN)
    ("entirely separate ATR" . SPARSER::PROTEIN)
    ("a protein that promotes ATR's" . SPARSER::PROTEIN)
    ("an essential protein" . SPARSER::PROTEIN) ("PCNT-" . SPARSER::PROTEIN)
    ("ATR-" . SPARSER::PROTEIN) ("ATR , PCNT and ORC1" . SPARSER::COLLECTION)
    ("PCNT and ORC1" . SPARSER::COLLECTION)
    ("a centriolar protein" . SPARSER::PROTEIN)
    ("MRE11 , ZNF423 and CEP164" . SPARSER::COLLECTION)
    ("associated microcephaly" . SPARSER::PROTEIN)
    ("that ATR's" . SPARSER::PROTEIN) ("kinase or PLK1" . SPARSER::COLLECTION)
    ("defective ATR" . SPARSER::PROTEIN)
    ("tubulin and SMO" . SPARSER::COLLECTION) ("1k" . SPARSER::PROTEIN)
    ("cardiac myosin light chain 2" . SPARSER::PROTEIN)
    ("functional Atr" . SPARSER::PROTEIN) ("ATRi" . SPARSER::MOLECULE)
    ("atr" . SPARSER::PROTEIN) ("puma and p21" . SPARSER::COLLECTION)
    ("puma" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ctrl" . SPARSER::PROTEIN)
    ("SAG" . SPARSER::PROTEIN)
    ("reverse transcriptase–polymerase" . SPARSER::COLLECTION)
    ("GLI1 , PTCH1 and HHIP" . SPARSER::COLLECTION) ("HHIP" . SPARSER::PROTEIN)
    ("actively signalling receptors" . SPARSER::RECEPTOR)
    ("PDGF-AA or -BB" . SPARSER::COLLECTION)
    ("PDGF-AA and -BB" . SPARSER::COLLECTION) ("-BB" . SPARSER::MOLECULE)
    ("BB" . SPARSER::MOLECULE)
    ("IFT43, WDR35, PCNT or ATR" . SPARSER::COLLECTION)
    ("bromodeoxyuridine" . SPARSER::DRUG)
    ("IFT43 or WDR35" . SPARSER::COLLECTION)
    ("A-T and PCNT-patient" . SPARSER::COLLECTION) ("MOPD" . SPARSER::PROTEIN)
    ("elevated supernumerary centrosomes" . SPARSER::PROTEIN)
    ("supernumerary centrosomes" . SPARSER::PROTEIN)
    ("MOPD-type II" . SPARSER::PROTEIN-PAIR) ("ORC" . SPARSER::BIO-COMPLEX)
    ("spikes" . SPARSER::PROTEIN) ("POC1A and PLK4" . SPARSER::COLLECTION)
    ("MCPH1 , CENPJ/CPAP , CEP213/CDK5RAP2 , ASPM , WDR62 , CEP135 , CEP63 and STIL"
     . SPARSER::COLLECTION)
    ("CPAP" . SPARSER::PROTEIN)
    ("SS or primary microcephaly (MCPH)" . SPARSER::COLLECTION)
    ("microcephaly (MCPH)" . SPARSER::PROTEIN)
    ("CEP152 and CENPJ" . SPARSER::COLLECTION)
    ("pericentrin (PCNT)" . SPARSER::PROTEIN)
    ("the centrosomal protein" . SPARSER::PROTEIN)
    ("microcephalic osteodysplastic primordial (MOPD)-type II"
     . SPARSER::COLLECTION)
    ("-type II" . SPARSER::COLLECTION) ("pericentrin" . SPARSER::PROTEIN)
    ("PCNT" . SPARSER::PROTEIN) ("centrosomal proteins" . SPARSER::PROTEIN)
    ("MPD" . SPARSER::PROTEIN) ("microcephaly" . SPARSER::PROTEIN)
    ("protein (ATR)" . SPARSER::PROTEIN) ("MIM" . SPARSER::PROTEIN)
    ("Ataxia" . SPARSER::PROTEIN) ("Atr" . SPARSER::PROTEIN)
    ("growth factor and Sonic hedgehog" . SPARSER::COLLECTION)
    ("ATR-SS" . SPARSER::COLLECTION) ("ataxia" . SPARSER::PROTEIN)
    ("B-1" . SPARSER::PROTEIN) ("beta-2-microglobulin" . SPARSER::PROTEIN)
    ("BI2536" . SPARSER::DRUG) ("Polo-like kinase" . SPARSER::PROTEIN)
    ("VE-821" . SPARSER::DRUG) ("AT1" . SPARSER::PROTEIN)
    ("BR3" . SPARSER::PROTEIN) ("ZNF423" . SPARSER::PROTEIN)
    ("single-strand DNA binding protein" . SPARSER::PROTEIN)
    ("PLK1" . SPARSER::PROTEIN) ("A–D" . SPARSER::PROTEIN)
    ("myosin light chain 2" . SPARSER::PROTEIN) ("gli1" . SPARSER::PROTEIN)
    ("PTCH1" . SPARSER::PROTEIN) ("GLI1" . SPARSER::PROTEIN)
    ("GLI2" . SPARSER::PROTEIN) ("PTCH-1" . SPARSER::PROTEIN)
    ("PDGF-BB" . SPARSER::PROTEIN) ("PDGFRβ" . SPARSER::PROTEIN)
    ("PDGF-AA" . SPARSER::PROTEIN) ("PDGFR α" . SPARSER::PROTEIN)
    ("PDGF receptor" . SPARSER::PROTEIN) ("ORC1" . SPARSER::PROTEIN)
    ("WDR35" . SPARSER::PROTEIN) ("IFT43" . SPARSER::PROTEIN)
    ("A-T" . SPARSER::PROTEIN) ("POC1A" . SPARSER::PROTEIN)
    ("sonic hedgehog" . SPARSER::PROTEIN) ("PLK4" . SPARSER::PROTEIN)
    ("CEP63" . SPARSER::PROTEIN) ("CEP135" . SPARSER::PROTEIN)
    ("WDR62" . SPARSER::PROTEIN) ("CDK5RAP2" . SPARSER::PROTEIN)
    ("MCPH1" . SPARSER::PROTEIN) ("CEP152" . SPARSER::PROTEIN)
    ("Sonic hedgehog" . SPARSER::PROTEIN)
    ("a tumor-suppressive miRNA" . SPARSER::PROTEIN)
    ("c-Myc or mutant" . SPARSER::COLLECTION)
    ("ligand (TRAIL)" . SPARSER::MOLECULE) ("MiRNAs" . SPARSER::PROTEIN)
    ("dual luciferase" . SPARSER::PROTEIN) ("miR-19a" . SPARSER::PROTEIN)
    ("FADD-procaspase-8" . SPARSER::COLLECTION)
    ("receptor/FADD" . SPARSER::COLLECTION)
    ("FADD or caspase-8" . SPARSER::COLLECTION) ("cFLIP" . SPARSER::PROTEIN)
    ("apoptotic-inducer" . SPARSER::PROTEIN)
    ("protein or inhibitor" . SPARSER::COLLECTION)
    ("RWF mutant" . SPARSER::MUTANT) ("RWF" . SPARSER::MUTANT)
    ("mCherry-fused FADD or endogenous FADD ( xref )" . SPARSER::COLLECTION)
    ("E2 and FADD" . SPARSER::COLLECTION)
    ("E2 and adaptor protein" . SPARSER::COLLECTION)
    ("mCherry-fused" . SPARSER::COLLECTION) ("DEF" . SPARSER::PROTEIN)
    ("filaments" . SPARSER::PROTEIN-FAMILY)
    ("the available DED family complex" . SPARSER::BIO-COMPLEX)
    ("procaspase-8 and GFP-E2" . SPARSER::COLLECTION)
    ("E2 triple mutant" . SPARSER::MUTANT)
    ("procaspase-8 and E2" . SPARSER::COLLECTION)
    ("E2 and caspase-8" . SPARSER::COLLECTION)
    ("mCherry-procaspase-8" . SPARSER::COLLECTION)
    ("E2 or caspase-8" . SPARSER::COLLECTION) ("E2-" . SPARSER::MOLECULE)
    ("macromolecule" . SPARSER::MOLECULE)
    ("E2 and procaspase-8" . SPARSER::COLLECTION)
    ("alanine" . SPARSER::AMINO-ACID) ("MBP-fused" . SPARSER::COLLECTION)
    ("prey" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Fas–FADD" . SPARSER::COLLECTION)
    ("IDA" . SPARSER::PROTEIN) ("amylose" . SPARSER::MOLECULE)
    ("-fused" . SPARSER::COLLECTION) ("maltose" . SPARSER::MOLECULE)
    ("DEDs, DED-A, DED-B and E2" . SPARSER::COLLECTION)
    ("detergents" . SPARSER::MOLECULE)
    ("the minimal HPV18 E2" . SPARSER::MOLECULE)
    ("the receptor or adaptor proteins" . SPARSER::COLLECTION)
    ("DEDs" . SPARSER::PROTEIN) ("an active DISC" . SPARSER::BIO-COMPLEX)
    ("Fas or TRAIL" . SPARSER::COLLECTION)
    ("receptor and FADD" . SPARSER::COLLECTION)
    ("apical caspase-8" . SPARSER::PROTEIN) ("E6 and E7" . SPARSER::COLLECTION)
    ("Caspase-8" . SPARSER::PROTEIN) ("Procaspase-8" . SPARSER::PROTEIN)
    ("Brd4" . SPARSER::PROTEIN)
    ("Bromodomain-containing protein 4" . SPARSER::PROTEIN)
    ("Z-VAD-FMK" . SPARSER::DRUG) ("iminodiacetic acid" . SPARSER::MOLECULE)
    ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY) ("procaspase-8" . SPARSER::PROTEIN)
    ("caspase-8" . SPARSER::PROTEIN)
    ("Yes-associated protein" . SPARSER::PROTEIN)
    ("RHOA and RAC1" . SPARSER::COLLECTION) ("Scott" . SPARSER::PROTEIN)
    ("ARHGAP24 or ARHGDIA" . SPARSER::COLLECTION)
    ("multiple different monogenic forms" . SPARSER::FORM)
    ("renal tubular elongation" . SPARSER::PROTEIN)
    ("Fat4 and Fat1" . SPARSER::COLLECTION)
    ("at least one hypomorphic allele" . SPARSER::ALLELE)
    ("Wt1b::GFP" . SPARSER::BIO-COMPLEX)
    ("CDC42 and RAC1" . SPARSER::COLLECTION)
    ("GST–Rhotekin" . SPARSER::COLLECTION) ("Rhotekin" . SPARSER::PROTEIN)
    ("proteins and RHO" . SPARSER::COLLECTION)
    ("homozygous Fat1  −/− mutants" . SPARSER::MUTANT)
    ("podocyte- Fat1 heterozygous mutants" . SPARSER::MUTANT)
    ("homozygous podocyte-specific Fat1  −/− mutants" . SPARSER::MUTANT)
    ("dl" . SPARSER::MOLECULE) ("−1" . SPARSER::PROTEIN)
    ("heterozygous Fat1 mutants" . SPARSER::MUTANT)
    ("progressive proteinuria" . SPARSER::PROTEIN)
    ("electron" . SPARSER::MOLECULE) ("Pod-Cre" . SPARSER::COLLECTION)
    ("NPHS2/podocin" . SPARSER::COLLECTION) ("Pod" . SPARSER::PROTEIN)
    ("podocin" . SPARSER::PROTEIN) ("perinatal" . SPARSER::PROTEIN)
    ("GST–PAK1" . SPARSER::COLLECTION) ("GST–rhotekin" . SPARSER::COLLECTION)
    ("rhotekin" . SPARSER::PROTEIN) ("RAC/CDC42" . SPARSER::COLLECTION)
    ("multiple monogenic SRNS genes" . SPARSER::GENE)
    ("HOMER1–HOMER3" . SPARSER::COLLECTION) ("PCP" . SPARSER::PROTEIN)
    ("scribble" . SPARSER::PROTEIN) ("VASP" . SPARSER::PROTEIN)
    ("FAT1–FAT4" . SPARSER::COLLECTION) ("cyclosporine" . SPARSER::DRUG)
    ("the homozygous state" . SPARSER::BIO-STATE)
    ("FAT1 and EHD1" . SPARSER::COLLECTION)
    ("a homozygous protein" . SPARSER::PROTEIN)
    ("FAT1 , PIDD and DZIP1" . SPARSER::COLLECTION) ("PIDD" . SPARSER::PROTEIN)
    ("proteinuria and haematuria" . SPARSER::COLLECTION)
    ("Virchow–Robin" . SPARSER::COLLECTION) ("Robin" . SPARSER::PROTEIN)
    ("identified monogenic SRNS genes" . SPARSER::GENE)
    ("homozygosity mapping (HM) and whole-exome" . SPARSER::COLLECTION)
    ("novel monogenic SRNS genes" . SPARSER::GENE)
    ("mapping (HM)" . SPARSER::PROTEIN) ("monogenic forms" . SPARSER::FORM)
    ("RHOA, RAC1 and CDC42" . SPARSER::COLLECTION) ("RHOA" . SPARSER::PROTEIN)
    ("caveolin" . SPARSER::PROTEIN) ("Calcium" . SPARSER::CALCIUM)
    ("WT1 and SMARCAL1" . SPARSER::COLLECTION)
    ("COQ2, COQ6, PDSS2 and ADCK4" . SPARSER::COLLECTION)
    ("LAMB2 and ITGA3" . SPARSER::COLLECTION)
    ("Integrin/laminin" . SPARSER::COLLECTION) ("laminin" . SPARSER::PROTEIN)
    ("RHO/RAC/CDC42" . SPARSER::COLLECTION) ("ARHGDIA" . SPARSER::PROTEIN)
    ("RAC" . SPARSER::PROTEIN) ("RHO" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ACTN4, INF2, MYO1E and ANLN" . SPARSER::COLLECTION)
    ("a worldwide cohort" . SPARSER::MOLECULE)
    ("the early-onset developmental variant" . SPARSER::VARIANT)
    ("DMS" . SPARSER::DRUG) ("mapping and whole-exome" . SPARSER::COLLECTION)
    ("fat1" . SPARSER::PROTEIN) ("RAC1 and CDC42" . SPARSER::COLLECTION)
    ("Fat1" . SPARSER::PROTEIN) ("Fat" . SPARSER::PROTEIN)
    ("RAC1/CDC42" . SPARSER::COLLECTION) ("CEP164" . SPARSER::PROTEIN)
    ("Beta-Catenin" . SPARSER::PROTEIN) ("FLP1" . SPARSER::PROTEIN)
    ("signal peptide" . SPARSER::PROTEIN) ("zFat1" . SPARSER::PROTEIN)
    ("Phenol Red" . SPARSER::DRUG) ("Fat4" . SPARSER::PROTEIN)
    ("Wt1b" . SPARSER::PROTEIN) ("KANK2" . SPARSER::PROTEIN)
    ("HOMER3" . SPARSER::PROTEIN) ("HOMER1" . SPARSER::PROTEIN)
    ("FAT4" . SPARSER::PROTEIN) ("EHD1" . SPARSER::PROTEIN)
    ("FAT atypical cadherin 1" . SPARSER::PROTEIN) ("DZIP1" . SPARSER::PROTEIN)
    ("RHO family" . SPARSER::PROTEIN) ("EMP2" . SPARSER::PROTEIN)
    ("TRPC6" . SPARSER::PROTEIN) ("SMARCAL1" . SPARSER::PROTEIN)
    ("PDSS2" . SPARSER::PROTEIN) ("COQ6" . SPARSER::PROTEIN)
    ("COQ2" . SPARSER::PROTEIN) ("Coenzyme Q 10" . SPARSER::DRUG)
    ("ITGA3" . SPARSER::PROTEIN) ("LAMB2" . SPARSER::PROTEIN)
    ("KANK1" . SPARSER::PROTEIN) ("ARHGAP24" . SPARSER::PROTEIN)
    ("MYO1E" . SPARSER::PROTEIN) ("INF2" . SPARSER::PROTEIN)
    ("ACTN4" . SPARSER::PROTEIN) ("PLCE1" . SPARSER::PROTEIN)
    ("CD2AP" . SPARSER::PROTEIN) ("NPHS2" . SPARSER::PROTEIN)
    ("NPHS1" . SPARSER::PROTEIN) ("FAT1" . SPARSER::PROTEIN)
    ("β-catenin and VE-cadherin" . SPARSER::COLLECTION)
    ("BDKRB1 and BDKRB2" . SPARSER::COLLECTION)
    ("Bradykinin" . SPARSER::BRADYKININ)
    ("VE-cadherin or β-catenin" . SPARSER::COLLECTION)
    ("QRE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("QKI-antibody" . SPARSER::COLLECTION)
    ("Response Element (QRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("the previously published gene" . SPARSER::GENE)
    ("the QKI mRNA (shQKI) and a non-QKI" . SPARSER::COLLECTION)
    ("a functional KLF2" . SPARSER::PROTEIN)
    ("ECs showed well organized VE-cadherin" . SPARSER::PROTEIN)
    ("Nos3 and Krüppel-Like" . SPARSER::COLLECTION) ("Klf2" . SPARSER::PROTEIN)
    ("QKI-protein" . SPARSER::COLLECTION) ("MECA" . SPARSER::PROTEIN-FAMILY)
    ("glial" . SPARSER::PROTEIN)
    ("QKI-5, QKI-6 and QKI-7" . SPARSER::COLLECTION)
    ("Nos3" . SPARSER::PROTEIN) ("Qki" . SPARSER::PROTEIN)
    ("VE-cadherin-CreER" . SPARSER::PROTEIN-PAIR)
    ("myocardin" . SPARSER::PROTEIN)
    ("QKI-5, QKI-6, and QKI-7" . SPARSER::COLLECTION)
    ("QKI" . SPARSER::PROTEIN) ("HuR" . SPARSER::PROTEIN)
    ("endoglin" . SPARSER::PROTEIN) ("Homology" . SPARSER::PROTEIN)
    ("RBPs" . SPARSER::PROTEIN)
    ("essential post-transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("proteins (RBP)" . SPARSER::PROTEIN) ("RBP" . SPARSER::PROTEIN)
    ("p120-catenins" . SPARSER::COLLECTION)
    ("catenins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a vital barrier" . SPARSER::PROTEIN) ("bradykinin" . SPARSER::BRADYKININ)
    ("VE-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("SDF-1" . SPARSER::PROTEIN) ("autosomal recessive" . SPARSER::PROTEIN)
    ("MBP-1" . SPARSER::PROTEIN) ("Forkhead Box O1" . SPARSER::PROTEIN)
    ("Hnrnpa1" . SPARSER::PROTEIN) ("BDKRB2" . SPARSER::PROTEIN)
    ("BDKRB1" . SPARSER::PROTEIN) ("pre-mRNA" . SPARSER::RNA)
    ("Response Element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("NOS3" . SPARSER::PROTEIN) ("Factor 2" . SPARSER::PROTEIN)
    ("Sirtuin 1" . SPARSER::PROTEIN) ("splicing factor" . SPARSER::PROTEIN)
    ("pre-mRNAs" . SPARSER::RNA) ("TUG1" . SPARSER::PROTEIN)
    ("tie-1" . SPARSER::PROTEIN) ("p120" . SPARSER::PROTEIN)
    ("KLF2" . SPARSER::PROTEIN) ("RNA-binding protein" . SPARSER::PROTEIN)
    ("relaying extracellular TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BMP and TGFβ" . SPARSER::COLLECTION)
    ("the static state" . SPARSER::BIO-STATE)
    ("Smad4 and the Smad2/Smad4 oligomer" . SPARSER::COLLECTION)
    ("–AGAC-3" . SPARSER::COLLECTION)
    ("neural genes or endoderm genes" . SPARSER::COLLECTION)
    ("mesodermal gene Mixl1" . SPARSER::PROTEIN)
    ("neural gene Nkx2.1" . SPARSER::PROTEIN) ("neural genes" . SPARSER::GENE)
    ("Sox2 and Nkx2.1" . SPARSER::COLLECTION)
    ("Mixl1, CXCR4, Pdx1 and Hnf1b" . SPARSER::COLLECTION)
    ("Hnf1b" . SPARSER::PROTEIN)
    ("E-Cadherin and N-Cadherin" . SPARSER::COLLECTION)
    ("Smad2 −/− or Smad3 −/− mouse ESCs" . SPARSER::COLLECTION)
    ("a weak downstream effector" . SPARSER::EFFECTOR)
    ("Smad4 and Smad3" . SPARSER::COLLECTION)
    ("R-Smads/Smad4" . SPARSER::COLLECTION)
    ("Smad2 and the mutant Smad3" . SPARSER::COLLECTION)
    ("GAG and TID" . SPARSER::COLLECTION) ("GAG" . SPARSER::PROTEIN)
    ("TID" . SPARSER::PROTEIN) ("Activin or TGFβ1" . SPARSER::COLLECTION)
    ("Smad2 or Smad3" . SPARSER::COLLECTION)
    ("Flag-Smad3" . SPARSER::COLLECTION) ("Flag-Smad2" . SPARSER::COLLECTION)
    ("Agonist" . SPARSER::AGONIST) ("TGFβ/BMP" . SPARSER::COLLECTION)
    ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HEF" . SPARSER::PROTEIN)
    ("GFP-Smad3" . SPARSER::COLLECTION) ("GFP-Smad2" . SPARSER::COLLECTION)
    ("TGFβ or BMP" . SPARSER::COLLECTION)
    ("NUP214 and NUP153" . SPARSER::COLLECTION)
    ("importin-β1" . SPARSER::PROTEIN-PAIR)
    ("Smad3/Smad4" . SPARSER::COLLECTION) ("Smad2/Smad4" . SPARSER::COLLECTION)
    ("DNA-interaction" . SPARSER::DNA)
    ("TGFβ/Activin/Nodal" . SPARSER::COLLECTION)
    ("BMPs/GDFs" . SPARSER::COLLECTION) ("BMP" . SPARSER::PROTEIN)
    ("bone morphogenetic proteins" . SPARSER::PROTEIN)
    ("TGF-β superfamily agonists TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GDFs" . SPARSER::PROTEIN) ("BMPs" . SPARSER::PROTEIN)
    ("Nodal" . SPARSER::PROTEIN) ("Activin" . SPARSER::PROTEIN)
    ("TGFβ/Smad2" . SPARSER::COLLECTION)
    ("Smad2 and Smad3" . SPARSER::COLLECTION) ("1–2 " . SPARSER::PROTEIN)
    ("Protein-G" . SPARSER::PROTEIN) ("PD0325901" . SPARSER::DRUG)
    ("CHIR99021" . SPARSER::MOLECULE)
    ("leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("Oct 4" . SPARSER::PROTEIN) ("Lamin A/C" . SPARSER::PROTEIN)
    ("β-Tubulin" . SPARSER::PROTEIN) ("Pdx1" . SPARSER::PROTEIN)
    ("Mixl1" . SPARSER::PROTEIN) ("Nkx2.1" . SPARSER::PROTEIN)
    ("FGF5" . SPARSER::PROTEIN) ("LDN193189" . SPARSER::DRUG)
    ("SB431542" . SPARSER::DRUG) ("NUP153" . SPARSER::PROTEIN)
    ("NUP214" . SPARSER::PROTEIN) ("nuclear pore" . SPARSER::BIO-COMPLEX)
    ("MH1" . SPARSER::PROTEIN) ("R-Smads" . SPARSER::PROTEIN)
    ("Smad4" . SPARSER::PROTEIN)
    ("safe and efficacious regenerative medicine" . SPARSER::DRUG)
    ("HIFα" . SPARSER::PROTEIN) ("one predominant form" . SPARSER::FORM)
    ("NRF2-HIFα" . SPARSER::PROTEIN-PAIR) ("NADPH" . SPARSER::PROTEIN)
    ("NRF2 and HIFα" . SPARSER::COLLECTION)
    ("NF-κB and HIFα" . SPARSER::COLLECTION) ("sham" . SPARSER::DRUG)
    ("the pluripotent state" . SPARSER::BIO-STATE)
    ("/ICAM1" . SPARSER::COLLECTION) ("Nanog" . SPARSER::PROTEIN)
    ("lactate" . SPARSER::LACTATE) ("NONOate" . SPARSER::MOLECULE)
    ("LNT" . SPARSER::MOLECULE) ("-glucose" . SPARSER::COLLECTION)
    ("FCCP" . SPARSER::MOLECULE)
    ("the autophagy-associated ATG5 protein" . SPARSER::PROTEIN)
    ("the autophagy-associated p62 protein" . SPARSER::PROTEIN)
    ("diacetate" . SPARSER::MOLECULE)
    ("HIF1α and its glycolytic target GLUT1" . SPARSER::COLLECTION)
    ("NF-κB, AP-1, NRF2, and HIFα" . SPARSER::COLLECTION)
    ("FOXO and ICAM1" . SPARSER::COLLECTION) ("NFAT" . SPARSER::PROTEIN)
    ("relevant pathway agonists" . SPARSER::AGONIST)
    ("unique non-overlapping substrates" . SPARSER::SUBSTRATE)
    ("Dii" . SPARSER::MOLECULE)
    ("either c-Fos/c-Jun heterodimers or c-Jun/c-Jun homodimers ( xref )"
     . SPARSER::COLLECTION)
    ("c-Jun/c-Jun" . SPARSER::COLLECTION) ("c-Fos/c-Jun" . SPARSER::COLLECTION)
    ("Aii" . SPARSER::PROTEIN) ("p62/SQSTM1" . SPARSER::COLLECTION)
    ("Kelch-like ECH-associated protein 1 (KEAP1) and β-TrCP"
     . SPARSER::COLLECTION)
    ("a reproducible temporal wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("secreted NanoLuc luciferase (NLuc) and eGFP" . SPARSER::COLLECTION)
    ("human dermal fibroblast (hDF) mitochondria" . SPARSER::PROTEIN)
    ("pentose" . SPARSER::MOLECULE)
    ("NF-κB, AP-1, and NRF2" . SPARSER::COLLECTION) ("FGF2" . SPARSER::PROTEIN)
    ("EBNA1" . SPARSER::PROTEIN)
    ("phosphogluconate dehydrogenase" . SPARSER::PROTEIN)
    ("ATP synthase" . SPARSER::PROTEIN) ("DCF-DA" . SPARSER::DRUG)
    ("GLUT1" . SPARSER::PROTEIN)
    ("glutamate-cysteine ligase" . SPARSER::PROTEIN)
    ("heme oxygenase 1" . SPARSER::PROTEIN) ("SRXN1" . SPARSER::PROTEIN)
    ("sulfiredoxin 1" . SPARSER::PROTEIN) ("TRX1" . SPARSER::PROTEIN)
    ("thioredoxin 1" . SPARSER::PROTEIN) ("per 1 " . SPARSER::PROTEIN)
    ("ICAM1" . SPARSER::PROTEIN) ("c-Fos" . SPARSER::PROTEIN)
    ("Transcription Factor" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("SQSTM1" . SPARSER::PROTEIN) ("p62" . SPARSER::PROTEIN)
    ("β-TrCP" . SPARSER::PROTEIN) ("activator protein 1" . SPARSER::PROTEIN)
    ("EGFR-/Keap1" . SPARSER::COLLECTION)
    ("K-RAS and ERK" . SPARSER::COLLECTION)
    ("hypoxia- and TGF- β" . SPARSER::COLLECTION)
    ("Nrf2-EGFR" . SPARSER::COLLECTION) ("K-RAS-ERK" . SPARSER::COLLECTION)
    ("NOX1 and NOX4" . SPARSER::COLLECTION) ("Trx1" . SPARSER::PROTEIN)
    ("Trx" . SPARSER::PROTEIN) ("MAPK and Smad" . SPARSER::COLLECTION)
    ("TGF- β or intermittent hypoxia" . SPARSER::COLLECTION)
    ("intermittent hypoxia" . SPARSER::PROTEIN)
    ("EGFR-Keap1" . SPARSER::COLLECTION)
    ("EGFR and Keap1" . SPARSER::COLLECTION)
    ("dysfunctional Keap1" . SPARSER::PROTEIN) ("Ub-" . SPARSER::PROTEIN)
    ("ubiquitin-" . SPARSER::PROTEIN) ("UPP" . SPARSER::PROTEIN)
    ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("abnormal vasculature" . SPARSER::PROTEIN)
    ("NOX1, NOX2, or NOX4" . SPARSER::COLLECTION)
    ("Cav-1, NOX1, NOX2, and NOX4" . SPARSER::COLLECTION)
    ("EGFR, and HO-1" . SPARSER::COLLECTION)
    ("Nrf2/EGFR" . SPARSER::COLLECTION)
    ("the fluorescent indicator H 2 DCFH-DA" . SPARSER::DRUG)
    ("Nrf2 or EGFR" . SPARSER::COLLECTION) ("MAPKs" . SPARSER::PROTEIN)
    ("EGFR and Nrf2" . SPARSER::COLLECTION)
    ("kinase, and JNK" . SPARSER::COLLECTION)
    ("PI3K-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("neither EGFR nor Nrf2" . SPARSER::COLLECTION)
    ("HO-1-siRNA" . SPARSER::COLLECTION) ("Nrf2-siRNA" . SPARSER::COLLECTION)
    ("inhibitor (TKI)" . SPARSER::INHIBITOR)
    ("EGFR-tyrosine kinase" . SPARSER::COLLECTION)
    ("TGF- β or hypoxia/reoxygenation" . SPARSER::COLLECTION)
    ("Smad3 or vimentin" . SPARSER::COLLECTION)
    ("HO-1 and Srx mRNAs" . SPARSER::COLLECTION)
    ("Nrf2 and its downstream targets" . SPARSER::COLLECTION)
    ("HO-1 and Srx-1" . SPARSER::COLLECTION) ("HIF-" . SPARSER::PROTEIN-FAMILY)
    ("Cul3-Rbx" . SPARSER::COLLECTION) ("Rbx" . SPARSER::PROTEIN)
    ("Nrf2 and its target genes" . SPARSER::COLLECTION)
    ("ARE-" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("TGF- β and hypoxia/reoxygenation" . SPARSER::COLLECTION)
    ("-cysteine" . SPARSER::COLLECTION)
    ("hypoxia and TGF- β" . SPARSER::COLLECTION)
    ("Nrf2 and EGFR" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR) and nuclear factor (erythroid-derived 2)-like"
     . SPARSER::COLLECTION)
    ("TGF- β and hypoxia" . SPARSER::COLLECTION)
    ("hypoxia and transforming growth factor-" . SPARSER::COLLECTION)
    ("transforming growth factor-" . SPARSER::PROTEIN)
    ("PD98059" . SPARSER::MOLECULE) ("IR 5 " . SPARSER::PROTEIN)
    ("Cav-1" . SPARSER::PROTEIN) ("TGF β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DCFH-DA" . SPARSER::DRUG) ("lamin B1" . SPARSER::PROTEIN)
    ("NOX2" . SPARSER::PROTEIN) ("phospho-JNK" . SPARSER::PROTEIN)
    ("TGF- β  1" . SPARSER::PROTEIN) ("c-Cbl" . SPARSER::PROTEIN)
    ("Cul3" . SPARSER::PROTEIN)
    ("Kelch-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("Srx1" . SPARSER::PROTEIN) ("sulfiredoxin-1" . SPARSER::PROTEIN)
    ("Nuclear factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("nuclear factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("TGF- β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("A large prospective cohort" . SPARSER::MOLECULE)
    ("confirmed vascular malformations" . SPARSER::PROTEIN)
    ("malformations" . SPARSER::PROTEIN)
    ("VEGF and other genes" . SPARSER::COLLECTION)
    ("fetal-placental vasculature" . SPARSER::PROTEIN)
    ("retina" . SPARSER::DRUG) ("endothelial integrins" . SPARSER::PROTEIN)
    ("vitronectin" . SPARSER::PROTEIN) ("plasmin" . SPARSER::PROTEIN)
    ("regulatory cytokines" . SPARSER::PROTEIN)
    ("placental growth factor" . SPARSER::GROWTH-FACTOR)
    ("PlGF" . SPARSER::PROTEIN) ("angiogenic cytokines" . SPARSER::PROTEIN)
    ("placental oxygen" . SPARSER::MOLECULE)
    ("its molecular angiogenic regulators VEGF and FGF-2"
     . SPARSER::COLLECTION)
    ("umbilical cord plasma PAI-1" . SPARSER::PROTEIN)
    ("a basal media" . SPARSER::PROTEIN)
    ("venous cord blood oxygen" . SPARSER::MOLECULE)
    ("VEGF or FGF-2" . SPARSER::COLLECTION)
    ("PAI-1 and VEGF" . SPARSER::COLLECTION)
    ("PAI-1, VEGF, and FGF-2" . SPARSER::COLLECTION)
    ("umbilical oxygen" . SPARSER::MOLECULE)
    ("VEGF and FGF-2" . SPARSER::COLLECTION) ("BP" . SPARSER::PROTEIN)
    ("fetal hypoxia" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor A (VEGF) and fibroblast growth factor 2 (FGF-2)"
     . SPARSER::COLLECTION)
    ("the placental vasculature" . SPARSER::PROTEIN)
    ("a prognostic biomarker" . SPARSER::MOLECULE)
    ("plasminogen" . SPARSER::PROTEIN)
    ("a compromised placental vasculature" . SPARSER::PROTEIN)
    ("Biomarkers" . SPARSER::MOLECULE)
    ("pathological hypoxia" . SPARSER::PROTEIN)
    ("Venous umbilical PAI-1" . SPARSER::PROTEIN) ("s 10" . SPARSER::PROTEIN)
    ("FLT-1" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor receptor 1" . SPARSER::PROTEIN)
    ("CDV1" . SPARSER::PROTEIN) ("FGF-2" . SPARSER::PROTEIN)
    ("miR-29b or miR-29c" . SPARSER::COLLECTION)
    ("promoters or suppressors" . SPARSER::COLLECTION)
    ("hTERT and miR-29a" . SPARSER::COLLECTION)
    ("miR-29 and ITGB1" . SPARSER::COLLECTION)
    ("Luc-ITGB1" . SPARSER::COLLECTION)
    ("miR-29b and miR-29c" . SPARSER::COLLECTION)
    ("used western blot" . SPARSER::PROTEIN)
    ("exogenous hTERT" . SPARSER::PROTEIN)
    ("dual-luciferase" . SPARSER::PROTEIN) ("Gene 2" . SPARSER::PROTEIN)
    ("MiR-29" . SPARSER::PROTEIN) ("miR-29 " . SPARSER::PROTEIN)
    ("miR-29c" . SPARSER::PROTEIN) ("miR-29b" . SPARSER::MOLECULE)
    ("FOXO3a" . SPARSER::PROTEIN) ("MMP14" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("the catalytically-competent conformations" . SPARSER::BIO-CONFORMATION)
    ("K-Ras4B-GTP–GAP" . SPARSER::PROTEIN-PAIR)
    ("the intrinsically mobile K-Ras4B" . SPARSER::PROTEIN)
    ("state " . SPARSER::BIO-STATE)
    ("K-Ras4B and the two inactive substates" . SPARSER::COLLECTION)
    ("‘inactive’ state and ‘active’ state" . SPARSER::COLLECTION)
    ("Raf, PI3K and RalGDS" . SPARSER::COLLECTION)
    ("oncoproteins" . SPARSER::PROTEIN) ("-GTP-GAP" . SPARSER::COLLECTION)
    ("catalytically competent state" . SPARSER::BIO-STATE)
    ("the free K-Ras4B ( xref ) and the K-Ras4B–GAP complex ( xref )"
     . SPARSER::COLLECTION)
    ("GTP, and GAP" . SPARSER::COLLECTION)
    ("Catalytically Competent Conformation" . SPARSER::BIO-CONFORMATION)
    ("Conformation" . SPARSER::BIO-CONFORMATION) ("–GTP" . SPARSER::PROTEIN)
    ("Nucleotide" . SPARSER::NUCLEOTIDE) ("Mutants" . SPARSER::MUTANT)
    ("Mut" . SPARSER::PROTEIN) ("State" . SPARSER::BIO-STATE)
    ("the two conformational states" . SPARSER::BIO-STATE)
    ("‘inactive’ and ‘active’" . SPARSER::COLLECTION)
    ("‘active’" . SPARSER::ACTIVE) ("‘inactive’" . SPARSER::INACTIVE)
    ("Active and Inactive" . SPARSER::COLLECTION)
    ("Inactive" . SPARSER::INACTIVE)
    ("K-Ras4B WT -GTP and its oncogenic mutants" . SPARSER::COLLECTION)
    ("runs" . SPARSER::PROTEIN-FAMILY)
    ("Raf, PI3K, RalGDS and GAP" . SPARSER::COLLECTION)
    ("K-Ras4B and GAP’s" . SPARSER::COLLECTION)
    ("K-Ras4B and GAP" . SPARSER::COLLECTION)
    ("catalytically competent conformation" . SPARSER::BIO-CONFORMATION)
    ("-GTP–GAP" . SPARSER::COLLECTION) ("K-Ras4B–GAP" . SPARSER::COLLECTION)
    ("GDP-" . SPARSER::NUCLEOTIDE)
    ("cancer-associated Ras isoforms" . SPARSER::ISOFORM)
    ("K-Ras4A and K-Ras4B" . SPARSER::COLLECTION)
    ("phosphatidylinositol 3-kinase (PI3K) and Ral guanine nucleotide dissociation stimulator (RalGDS)"
     . SPARSER::COLLECTION)
    ("Raf kinase, phosphatidylinositol 3-kinase (PI3K) and Ral guanine nucleotide dissociation stimulator (RalGDS)"
     . SPARSER::COLLECTION)
    ("RalGDS" . SPARSER::PROTEIN)
    ("the catalytically-competent conformation and pre-organizes catalytic residue Q61"
     . SPARSER::COLLECTION)
    ("the catalytically-competent conformation" . SPARSER::BIO-CONFORMATION)
    ("-GDP" . SPARSER::NUCLEOTIDE)
    ("active and inactive" . SPARSER::COLLECTION)
    ("the mutants (K-Ras4B G12C/G12D/G12V -GTP/GDP, K-Ras4B G13D -GTP/GDP, K-Ras4B Q61H -GTP/GDP) and their complexes with GAP"
     . SPARSER::COLLECTION)
    ("GTP " . SPARSER::NUCLEOTIDE) ("ND 1" . SPARSER::PROTEIN)
    ("OE 1" . SPARSER::PROTEIN) ("NH 2" . SPARSER::MOLECULE)
    ("oxygen atom" . SPARSER::MOLECULE) ("P34" . SPARSER::PROTEIN)
    ("TIP3" . SPARSER::PROTEIN) ("GTPase-activating" . SPARSER::PROTEIN)
    ("Ral guanine nucleotide dissociation stimulator" . SPARSER::PROTEIN)
    ("nicotine" . SPARSER::DRUG)
    ("increased inflammatory cytokines" . SPARSER::PROTEIN)
    ("only one tumor type" . TYPE)
    ("the highly transforming c" . SPARSER::PROTEIN) ("akt" . SPARSER::PROTEIN)
    ("ral" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("our local cohort" . SPARSER::MOLECULE)
    ("our local cohorts" . SPARSER::MOLECULE) ("gGc" . SPARSER::PROTEIN)
    ("the local cohort" . SPARSER::MOLECULE)
    ("Ral" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K and MEK" . SPARSER::COLLECTION) ("codons" . SPARSER::PROTEIN)
    ("genes or genomes" . SPARSER::COLLECTION)
    ("ras family" . SPARSER::PROTEIN) ("SIRT1/mTOR/AR" . SPARSER::COLLECTION)
    ("a robust upstream regulator" . SPARSER::REGULATOR)
    ("androgen and the AR" . SPARSER::COLLECTION)
    ("Skp2 and its isoform Skp2B" . SPARSER::COLLECTION)
    ("Skp2B" . SPARSER::PROTEIN) ("BRCA1 and Rad51" . SPARSER::COLLECTION)
    ("HR and non-homologous" . SPARSER::COLLECTION)
    ("recombinogenic AR- and TOP2B-mediated DSBs" . SPARSER::COLLECTION)
    ("recombinogenic AR-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AR and topoisomerase" . SPARSER::COLLECTION)
    ("AR-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mre11/Rad50/Nbs1" . SPARSER::COLLECTION)
    ("BRCA1 and SIRT1" . SPARSER::COLLECTION)
    ("further suggesting SIRT1" . SPARSER::PROTEIN)
    ("mTOR, AR and Skp2" . SPARSER::COLLECTION)
    ("mTOR/AR/Skp2" . SPARSER::COLLECTION) ("Skp2" . SPARSER::PROTEIN)
    ("Skp" . SPARSER::PROTEIN) ("histone and protein" . SPARSER::COLLECTION)
    ("/PR" . SPARSER::COLLECTION) ("/HER2" . SPARSER::COLLECTION)
    ("/AR" . SPARSER::COLLECTION) ("bicalutamide" . SPARSER::DRUG)
    ("Androgens and AR" . SPARSER::COLLECTION)
    ("Wnt and HER2" . SPARSER::COLLECTION)
    ("AR and growth factor" . SPARSER::COLLECTION)
    ("BRCA1 and AR" . SPARSER::COLLECTION)
    ("dihydrotestosterone (DHT)" . SPARSER::DRUG)
    ("ER and AR" . SPARSER::COLLECTION) ("receptor (ER)" . SPARSER::RECEPTOR)
    ("Brca1" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor" . SPARSER::PROTEIN)
    ("TOP2B" . SPARSER::PROTEIN) ("Nbs1" . SPARSER::PROTEIN)
    ("Rad50" . SPARSER::PROTEIN) ("Mre11" . SPARSER::PROTEIN)
    ("anti-androgen" . SPARSER::DRUG) ("ROCKs" . SPARSER::PROTEIN-FAMILY)
    ("gastric smooth muscle" . SPARSER::PROTEIN)
    ("phagocytic NADPH oxidase catalytic subunit gp91 phox (NOX1, NOX3-NOX5, DUOX1, DUOX2) and homologues"
     . SPARSER::COLLECTION)
    ("phagocytic NADPH oxidase catalytic subunit gp91 phox" . SPARSER::PROTEIN)
    ("phox or NOXO1" . SPARSER::COLLECTION)
    ("phox or NOXA1" . SPARSER::COLLECTION) ("NOX3-NOX5" . SPARSER::COLLECTION)
    ("phox" . SPARSER::PROTEIN)
    ("glutathione and vitamin C" . SPARSER::COLLECTION)
    ("lipids, and proteins" . SPARSER::COLLECTION)
    ("enzymes and proteins" . SPARSER::COLLECTION) ("ions" . SPARSER::MOLECULE)
    ("antibiotic" . SPARSER::DRUG)
    ("1 mM EGTA and 1 μM thapsigargin [ xref ]" . SPARSER::COLLECTION)
    ("thapsigargin" . SPARSER::MOLECULE) ("EGTA" . SPARSER::MOLECULE)
    ("ROCK1 or ROCK2" . SPARSER::COLLECTION)
    ("siRNA and ROCK2" . SPARSER::COLLECTION)
    ("ROCK1 and ROCK2" . SPARSER::COLLECTION)
    ("hydrogen peroxide and increase in cell proliferation in esophageal adenocarcinoma cells [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("Rho and Rho kinase" . SPARSER::COLLECTION) ("NOX" . SPARSER::PROTEIN)
    ("salt" . SPARSER::MOLECULE) ("ionophore" . SPARSER::MOLECULE)
    ("ROCK" . SPARSER::PROTEIN-FAMILY) ("FLO-1" . SPARSER::PROTEIN)
    ("MYPT1" . SPARSER::PROTEIN)
    ("myosin phosphatase regulatory subunit" . SPARSER::PROTEIN)
    ("EF-hand" . SPARSER::PROTEIN-FAMILY) ("NOXA1" . SPARSER::PROTEIN)
    ("p51" . SPARSER::PROTEIN) ("NOXO1" . SPARSER::PROTEIN)
    ("p41" . SPARSER::PROTEIN) ("DUOX2" . SPARSER::PROTEIN)
    ("DUOX1" . SPARSER::PROTEIN) ("NOX3" . SPARSER::PROTEIN)
    ("NOX1" . SPARSER::PROTEIN) ("gp91 phox" . SPARSER::PROTEIN)
    ("vitamin C" . SPARSER::MOLECULE)
    ("myosin-binding subunit" . SPARSER::PROTEIN) ("NH2" . SPARSER::MOLECULE)
    ("β-Actin" . SPARSER::PROTEIN) ("p160ROCK" . SPARSER::PROTEIN)
    ("myosin phosphatase" . SPARSER::PROTEIN)
    ("proton pump" . SPARSER::PROTEIN) ("BAR-T" . SPARSER::PROTEIN)
    ("ROCK2" . SPARSER::PROTEIN) ("NOX5" . SPARSER::PROTEIN)
    ("which targets PTTG1" . SPARSER::PROTEIN) ("curcumin" . SPARSER::DRUG)
    ("cyclin D1 and cyclin-dependent kinases" . SPARSER::COLLECTION)
    ("ITGA4, ITGB7, ITGA5, ITGB1, and Rho family" . SPARSER::COLLECTION)
    ("integrins and Rho GTPase" . SPARSER::COLLECTION)
    ("proteins, growth factors, and cytokines" . SPARSER::COLLECTION)
    ("Integrins" . SPARSER::PROTEIN) ("PTTG1 and MMPs" . SPARSER::COLLECTION)
    ("integrins and Rho family" . SPARSER::COLLECTION)
    ("PTTG1 and ITGA4" . SPARSER::COLLECTION)
    ("ITGA4 or RhoA/B/C" . SPARSER::COLLECTION)
    ("vimentin and cytokeratin" . SPARSER::COLLECTION)
    ("αVβ3-FAK" . SPARSER::COLLECTION)
    ("fibroblast growth factor 2 and vascular endothelial"
     . SPARSER::COLLECTION)
    ("miRNA and the mRNA" . SPARSER::COLLECTION) ("mer" . SPARSER::PROTEIN)
    ("ITGA4 and Rho family" . SPARSER::COLLECTION)
    ("kinase and mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("integrins and Rho-family" . SPARSER::COLLECTION)
    ("ITGA4, ITGA5, and integrin" . SPARSER::COLLECTION)
    ("integrins and PTTG1" . SPARSER::COLLECTION)
    ("ITGA4, RhoA, and RhoC" . SPARSER::COLLECTION) ("RhoC" . SPARSER::PROTEIN)
    ("PTB" . SPARSER::PROTEIN) ("MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("Akt and Erk" . SPARSER::COLLECTION)
    ("PTTG1 and cytokeratin 7" . SPARSER::COLLECTION)
    ("parental HTR-8" . SPARSER::PROTEIN)
    ("simian virus 40 (SV40) large T antigen" . SPARSER::MOLECULE)
    ("HTR-8" . SPARSER::PROTEIN) ("securin" . SPARSER::PROTEIN)
    ("integrin and matrix metalloproteinase" . SPARSER::COLLECTION)
    ("CTBs" . SPARSER::PROTEIN) ("PTTG1 and MMP" . SPARSER::COLLECTION)
    ("ITGA5, and integrin" . SPARSER::COLLECTION)
    ("-2 and MMP-9" . SPARSER::COLLECTION)
    ("western blot, and zymography" . SPARSER::COLLECTION)
    ("blot, and zymography" . SPARSER::COLLECTION)
    ("CK2 alpha" . SPARSER::PROTEIN) ("Rho GTPase" . SPARSER::PROTEIN)
    ("ECT2" . SPARSER::PROTEIN) ("Rho-GEF" . SPARSER::PROTEIN)
    ("fibroblast growth factor 2" . SPARSER::PROTEIN)
    ("ROCK1" . SPARSER::PROTEIN) ("Rho kinase" . SPARSER::PROTEIN)
    ("ITGB7" . SPARSER::PROTEIN) ("cytokeratin7" . SPARSER::PROTEIN)
    ("R-250" . SPARSER::PROTEIN) ("alpha4" . SPARSER::PROTEIN)
    ("a 37" . SPARSER::PROTEIN) ("MMP-2" . SPARSER::PROTEIN)
    ("FGF4" . SPARSER::PROTEIN)
    ("fibroblast growth factor 4" . SPARSER::PROTEIN)
    ("T antigen" . SPARSER::MOLECULE)
    ("phosphatase of regenerating liver-3" . SPARSER::PROTEIN)
    ("ITGB1" . SPARSER::PROTEIN) ("ITGA5" . SPARSER::PROTEIN)
    ("ITGA4" . SPARSER::PROTEIN) ("alpha 4" . SPARSER::PROTEIN)
    ("PTTG1" . SPARSER::PROTEIN) ("MRI" . SPARSER::PROTEIN)
    ("fluorescein" . SPARSER::MOLECULE) ("BODIPY" . SPARSER::DRUG)
    ("near-infrared light" . SPARSER::PROTEIN)
    ("PARP1 and PARPi-FL" . SPARSER::COLLECTION) ("PEG" . SPARSER::PROTEIN)
    ("PPV" . SPARSER::MOLECULE)
    ("a fluorescent PARP1-targeted small molecule" . SPARSER::MOLECULE)
    ("Olaparib" . SPARSER::DRUG)
    ("a valuable therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("a robust biomarker" . SPARSER::MOLECULE)
    ("lip" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Polymerase" . SPARSER::PROTEIN)
    ("LSM 5" . SPARSER::PROTEIN) ("CC1" . SPARSER::PROTEIN)
    ("Foxn1" . SPARSER::PROTEIN)
    ("Cdx2 and placental lactogen" . SPARSER::COLLECTION)
    ("MLL" . SPARSER::PROTEIN)
    ("STAT4, IL-18Rα, and IL-12Rβ2" . SPARSER::COLLECTION)
    ("INF" . SPARSER::PROTEIN) ("TAD2" . SPARSER::PROTEIN)
    ("GCM" . SPARSER::PROTEIN-FAMILY) ("polypeptide" . SPARSER::PROTEIN)
    ("chimeric GCM1 and GCM2" . SPARSER::COLLECTION)
    ("GCM1 and GCM2" . SPARSER::COLLECTION)
    ("Gata3 and Gcm2" . SPARSER::COLLECTION)
    ("Gata3, Gcm2, and MafB" . SPARSER::COLLECTION) ("PHT" . SPARSER::MOLECULE)
    ("SP1, Gcm2, and MafB" . SPARSER::COLLECTION) ("PTH" . SPARSER::PROTEIN)
    ("MafB" . SPARSER::PROTEIN) ("GATA3 and HtrA4" . SPARSER::COLLECTION)
    ("the placenta-specific GCM1 transcription factor" . SPARSER::PROTEIN)
    ("Gata2" . SPARSER::PROTEIN) ("Gata" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GATA1 and GATA2" . SPARSER::COLLECTION)
    ("pGal4-GCM1" . SPARSER::COLLECTION)
    ("pGATA3-FLAG" . SPARSER::PROTEIN-PAIR) ("pG5-Luc" . SPARSER::COLLECTION)
    ("pGal4" . SPARSER::PROTEIN) ("Gal4-GCM1" . SPARSER::COLLECTION)
    ("GCM1-FLAG" . SPARSER::COLLECTION) ("Gal4" . SPARSER::PROTEIN)
    ("ΔZF1-FLAG" . SPARSER::COLLECTION) ("pGal4-GATA3" . SPARSER::PROTEIN-PAIR)
    ("Gal" . SPARSER::PROTEIN) ("GATA3 and GATA3" . SPARSER::COLLECTION)
    ("HA-GATA3" . SPARSER::COLLECTION) ("pHA-GATA3" . SPARSER::COLLECTION)
    ("GST-GCM1" . SPARSER::COLLECTION) ("GATA3 and GCM2" . SPARSER::COLLECTION)
    ("pHA-GCM1" . SPARSER::COLLECTION) ("HA-GCM1" . SPARSER::COLLECTION)
    ("GATA3-FLAG" . SPARSER::COLLECTION) ("i–k" . SPARSER::PROTEIN)
    ("c" . SPARSER::PROTEIN) ("GCM1 and GATA3" . SPARSER::COLLECTION)
    ("GATA" . SPARSER::PROTEIN) ("parathyroid" . SPARSER::PROTEIN-FAMILY)
    ("syncytin-1 and syncytin-2 fusogenic proteins and HtrA4 serine protease"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("syncytin-1 and syncytin-2" . SPARSER::COLLECTION)
    ("proteins and HtrA4" . SPARSER::COLLECTION)
    ("a placenta-specific transcription factor" . SPARSER::PROTEIN)
    ("Glial" . SPARSER::PROTEIN) ("TG" . SPARSER::PROTEIN)
    ("tip" . SPARSER::PROTEIN) ("STB" . SPARSER::PROTEIN)
    ("GATA3 and GCM1" . SPARSER::COLLECTION)
    ("Placental transcription factor GCM1" . SPARSER::PROTEIN)
    ("F-12 " . SPARSER::PROTEIN) ("Cdx2" . SPARSER::PROTEIN)
    ("ASH2L" . SPARSER::PROTEIN) ("RUNX3" . SPARSER::PROTEIN)
    ("IL-12Rβ2" . SPARSER::PROTEIN) ("IL-18" . SPARSER::PROTEIN)
    ("STAT4" . SPARSER::PROTEIN) ("parathyroid hormone" . SPARSER::PROTEIN)
    ("Gcm2" . SPARSER::PROTEIN) ("Gata3" . SPARSER::PROTEIN)
    ("GATA2" . SPARSER::PROTEIN) ("GATA1" . SPARSER::PROTEIN)
    ("VP16" . SPARSER::DRUG) ("ZF1" . SPARSER::PROTEIN)
    ("E1" . SPARSER::MOLECULE) ("4-1 " . SPARSER::PROTEIN)
    ("CK7" . SPARSER::PROTEIN) ("placental lactogen" . SPARSER::PROTEIN)
    ("GATA1-6" . SPARSER::PROTEIN) ("syncytin-2" . SPARSER::PROTEIN)
    ("syncytin-1" . SPARSER::PROTEIN) ("zinc finger" . SPARSER::PROTEIN)
    ("GCM2" . SPARSER::PROTEIN) ("GATA3" . SPARSER::PROTEIN)
    ("HtrA4" . SPARSER::PROTEIN) ("GCM1" . SPARSER::PROTEIN)
    ("-deoxycytidine" . SPARSER::COLLECTION)
    ("salivary gland ACC" . SPARSER::PROTEIN)
    ("glycine and histidine" . SPARSER::COLLECTION)
    ("histidine" . SPARSER::AMINO-ACID) ("MVD" . SPARSER::PROTEIN)
    ("a valuable diagnostic and prognostic biomarker" . SPARSER::MOLECULE)
    ("demethylase" . SPARSER::PROTEIN)
    ("a diagnostic biomarker and predictor" . SPARSER::COLLECTION)
    ("a diagnostic biomarker" . SPARSER::MOLECULE)
    ("AXIN2 , CTLA4 , CCND1 , FGFs , FRA1 , ITF2 , MMP7 , JUN , LEF1 , MYC and TCF1"
     . SPARSER::COLLECTION)
    ("FGFs" . SPARSER::PROTEIN) ("IIb" . SPARSER::DRUG)
    ("ANT" . SPARSER::PROTEIN) ("TEC" . SPARSER::PROTEIN)
    ("Cyclin D1 and c-Myc" . SPARSER::COLLECTION)
    ("suprabasin" . SPARSER::PROTEIN) ("Suprabasin" . SPARSER::PROTEIN)
    ("p84" . SPARSER::PROTEIN)
    ("Glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("IWR-1" . SPARSER::PROTEIN)
    ("12-O-tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("Ca (2+)" . SPARSER::CALCIUM-ION) ("GASC1" . SPARSER::PROTEIN)
    ("S33 " . SPARSER::PROTEIN) ("ITF2" . SPARSER::PROTEIN)
    ("FRA1" . SPARSER::PROTEIN) ("AXIN2" . SPARSER::PROTEIN)
    ("M1" . SPARSER::MOLECULE) ("ERBB2-ER" . SPARSER::COLLECTION)
    ("TOM1L1 and ERBB2" . SPARSER::COLLECTION)
    ("RELB and its target BCL2" . SPARSER::COLLECTION)
    ("RELB" . SPARSER::PROTEIN)
    ("the alternate ESCRT 0 complex" . SPARSER::BIO-COMPLEX)
    ("TOM1L1 and TOLLIP" . SPARSER::COLLECTION)
    ("proteins and TOM1L1" . SPARSER::COLLECTION)
    ("the kinesins KIF5B and KIF3A/KIF3B" . SPARSER::COLLECTION)
    ("KIF3A/KIF3B" . SPARSER::COLLECTION)
    ("kinesins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("optineurin, NDP52 or T6BP" . SPARSER::COLLECTION)
    ("optineurin" . SPARSER::PROTEIN) ("Myosin" . SPARSER::PROTEIN-FAMILY)
    ("p21-activated protein kinase" . SPARSER::COLLECTION)
    ("This phosphomimetic mutant" . SPARSER::MUTANT)
    ("TOLLIP and MT1-MMP" . SPARSER::COLLECTION)
    ("MT1-MMP and TOM1L1" . SPARSER::COLLECTION) ("RAB11-" . SPARSER::PROTEIN)
    ("RAB-7-" . SPARSER::PROTEIN) ("mCherry–MT1-MMP" . SPARSER::COLLECTION)
    ("RAB-7/MT1-MMP" . SPARSER::COLLECTION) ("ERBB2-" . SPARSER::PROTEIN)
    ("the fluorescent gelatin matrix" . SPARSER::PROTEIN-FAMILY)
    ("F-actin-" . SPARSER::BIO-COMPLEX)
    ("The vesicular trafficking protein TOLLIP" . SPARSER::PROTEIN)
    ("TOM1L1-GAT" . SPARSER::COLLECTION) ("GAT-" . SPARSER::PROTEIN)
    ("TOM1L1−" . SPARSER::PROTEIN) ("SRC and CHC" . SPARSER::COLLECTION)
    ("SRC- and CHC-binding-independent" . SPARSER::COLLECTION)
    ("SRC-" . SPARSER::PROTEIN) ("linker" . SPARSER::LINKER)
    ("a dual EGFR/ERBB2 inhibitor" . SPARSER::INHIBITOR)
    ("EGFR/ERBB2" . SPARSER::COLLECTION) ("Lapatinib" . SPARSER::DRUG)
    ("ERBB2 and TOM1L1" . SPARSER::COLLECTION)
    ("the most frequently co-amplified gene" . SPARSER::GENE)
    ("TOM1L1-ERBB2" . SPARSER::COLLECTION) ("CHC" . SPARSER::PROTEIN)
    ("TOLLIP (Toll-interacting protein) or ubiquitin" . SPARSER::COLLECTION)
    ("VHS and GAT" . SPARSER::COLLECTION) ("GGAs" . SPARSER::MOLECULE)
    ("GGA and TOM1" . SPARSER::COLLECTION) ("GGA" . SPARSER::MOLECULE)
    ("TOM1, TOM1L1 and TOM1L2" . SPARSER::COLLECTION)
    ("Hrs, Stam1, Stam2, GGA1, GGA2 and GGA3" . SPARSER::COLLECTION)
    ("Stam2" . SPARSER::PROTEIN) ("Stam1" . SPARSER::PROTEIN)
    ("Stam" . SPARSER::PROTEIN) ("Hrs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VHS" . SPARSER::PROTEIN) ("Srcasm" . SPARSER::PROTEIN)
    ("MYB" . SPARSER::PROTEIN) ("a crucial inducer" . SPARSER::PROTEIN)
    ("endopeptidases or matrix" . SPARSER::COLLECTION)
    ("metalloproteases" . SPARSER::PROTEIN)
    ("endopeptidases" . SPARSER::PROTEIN) ("cathepsins" . SPARSER::PROTEIN)
    ("HUNK" . SPARSER::PROTEIN) ("ACF" . SPARSER::PROTEIN)
    ("HER2 or neu" . SPARSER::COLLECTION) ("TOLLIP" . SPARSER::PROTEIN)
    ("1L" . SPARSER::PROTEIN) ("Mg2+" . SPARSER::MOLECULE)
    ("Sulforhodamine B" . SPARSER::MOLECULE) ("a 20 " . SPARSER::PROTEIN)
    ("AG879" . SPARSER::DRUG) ("SU6656" . SPARSER::PROTEIN)
    ("P42 MAPK" . SPARSER::PROTEIN) ("P44" . SPARSER::PROTEIN)
    ("KIF3B" . SPARSER::PROTEIN) ("KIF3A" . SPARSER::PROTEIN)
    ("KIF5B" . SPARSER::PROTEIN) ("kinesin family" . SPARSER::PROTEIN)
    ("T6BP" . SPARSER::PROTEIN) ("NDP52" . SPARSER::PROTEIN)
    ("VAMP7" . SPARSER::PROTEIN) ("PKCι" . SPARSER::PROTEIN)
    ("atypical protein kinase" . SPARSER::PROTEIN)
    ("activated protein kinase" . SPARSER::PROTEIN) ("RAB4" . SPARSER::PROTEIN)
    ("ERRB2" . SPARSER::PROTEIN) ("TSG101" . SPARSER::PROTEIN)
    ("Glutamic acid" . SPARSER::AMINO-ACID) ("RAB5" . SPARSER::PROTEIN)
    ("RAB11" . SPARSER::PROTEIN) ("RAB-7" . SPARSER::PROTEIN)
    ("SRC-like" . SPARSER::PROTEIN) ("p85" . SPARSER::PROTEIN)
    ("GRB2" . SPARSER::PROTEIN) ("clathrin heavy chain" . SPARSER::PROTEIN)
    ("Toll-interacting protein" . SPARSER::PROTEIN) ("GGA3" . SPARSER::PROTEIN)
    ("GGA2" . SPARSER::PROTEIN) ("GGA1" . SPARSER::PROTEIN)
    ("Vps27" . SPARSER::PROTEIN) ("TOM1L2" . SPARSER::PROTEIN)
    ("TOM1" . SPARSER::PROTEIN) ("PlexinB1" . SPARSER::PROTEIN)
    ("beta 4" . SPARSER::PROTEIN) ("anti-ERBB2" . SPARSER::DRUG)
    ("MT1-MMP" . SPARSER::PROTEIN) ("TOM1L1" . SPARSER::PROTEIN)
    ("ERBB2" . SPARSER::PROTEIN)
    ("probable aptamers and their aptamer-likeness" . SPARSER::COLLECTION)
    ("probable aptamers" . SPARSER::PROTEIN)
    ("ER detection mostly uses antibodies" . SPARSER::ANTIBODY)
    ("ER-antibody" . SPARSER::COLLECTION) ("ERα-ERaptR4" . SPARSER::COLLECTION)
    ("the most prominent aptamer" . SPARSER::PROTEIN)
    ("ERα and a random RNA (hairpin)" . SPARSER::COLLECTION)
    ("selected probable aptamers" . SPARSER::PROTEIN)
    ("probable ERα-aptamers" . SPARSER::PROTEIN-PAIR)
    ("ERα-aptamers" . SPARSER::PROTEIN-PAIR)
    ("minimal energy conformations" . SPARSER::BIO-CONFORMATION)
    ("full length palindromic EREs" . SPARSER::PROTEIN)
    ("a monomeric ER" . SPARSER::PROTEIN)
    ("dimerized estrogen receptors" . SPARSER::RECEPTOR)
    ("Ligands" . SPARSER::LIGAND) ("mask" . SPARSER::PROTEIN)
    ("RNase" . SPARSER::PROTEIN) ("considerable homology" . SPARSER::PROTEIN)
    ("66 kDa (full length ERα) and 46 kDa (transcript variant)"
     . SPARSER::COLLECTION)
    ("-ERα" . SPARSER::COLLECTION) ("SDS" . SPARSER::PROTEIN)
    ("MDA" . SPARSER::DRUG) ("Aptamer and antibody-" . SPARSER::COLLECTION)
    ("Aptamer" . SPARSER::PROTEIN) ("ERaptR4" . SPARSER::PROTEIN)
    ("ER-ERaptR4" . SPARSER::PROTEIN-PAIR)
    ("ERα-antibody" . SPARSER::COLLECTION)
    ("the selected probable aptamers form" . SPARSER::FORM)
    ("the near-native complexes" . SPARSER::BIO-COMPLEX)
    ("SD- " . SPARSER::PROTEIN)
    ("ERα -RNAs (ERaptR1-ERaptR18) and ERα-random RNAs" . SPARSER::COLLECTION)
    ("-RNAs" . SPARSER::RNA) ("resulting complexes" . SPARSER::BIO-COMPLEX)
    ("the most probable aptamer" . SPARSER::PROTEIN) ("SD " . SPARSER::PROTEIN)
    ("thrombin-RNA aptamer complex and VEGF 165 -RNA aptamer complex"
     . SPARSER::COLLECTION)
    ("AV" . SPARSER::MOLECULE) ("RNA-" . SPARSER::RNA)
    ("thrombin (1PPB) and VEGF" . SPARSER::COLLECTION)
    ("-ccgguagucgcauggcccaucgcgcccgg-3" . SPARSER::COLLECTION)
    ("-gggaacaaagcugaaguacuuaccc-3" . SPARSER::COLLECTION)
    ("VGH" . SPARSER::PROTEIN) ("PDB" . SPARSER::MOLECULE)
    ("aptamer-protein" . SPARSER::COLLECTION)
    ("form strong hairpins" . SPARSER::PROTEIN-FAMILY)
    ("their RNA analogs using MC-Fold and MC-Sym algorithms xref"
     . SPARSER::COLLECTION)
    ("the natural EREs" . SPARSER::PROTEIN) ("EREs" . SPARSER::PROTEIN)
    ("ERE-ER" . SPARSER::PROTEIN-PAIR) ("ERs" . SPARSER::PROTEIN)
    ("ER-aptamer" . SPARSER::COLLECTION)
    ("protein-aptamer" . SPARSER::COLLECTION) ("aptamers" . SPARSER::PROTEIN)
    ("antibody-" . SPARSER::PROTEIN)
    ("a crucial biomarker" . SPARSER::MOLECULE) ("aptamer" . SPARSER::PROTEIN)
    ("ERα-aptamer" . SPARSER::COLLECTION)
    ("-GGGGUCAAGGUGACCCC-3" . SPARSER::COLLECTION) ("-RNA" . SPARSER::RNA)
    ("Near-native RNA analogs" . SPARSER::ANALOG)
    ("ERE" . SPARSER::DNA-RESPONSE-ELEMENT) ("analogs" . SPARSER::ANALOG)
    ("chemical-antibody" . SPARSER::PROTEIN) ("−3" . SPARSER::PROTEIN)
    ("M −1" . SPARSER::PROTEIN)
    ("proteins and non-coding" . SPARSER::COLLECTION)
    ("FOXD3, STAT3, and OLA1P2" . SPARSER::COLLECTION)
    ("Cao" . SPARSER::MOLECULE) ("aspirin-induced OLA1P2" . SPARSER::PROTEIN)
    ("even protein-coding RNA" . SPARSER::RNA)
    ("A muscle-specific lncRNA" . SPARSER::RNA)
    ("MAML1 and MEF2C" . SPARSER::COLLECTION)
    ("linc-MD1" . SPARSER::COLLECTION) ("forkhead" . SPARSER::PROTEIN)
    ("polyacrylamide" . SPARSER::DRUG)
    ("STAT3 and OLA1P2" . SPARSER::COLLECTION) ("RIP" . SPARSER::PROTEIN)
    ("OLA1P2" . SPARSER::PROTEIN) ("shRNA-OLA1P2" . SPARSER::COLLECTION)
    ("LncRNA" . SPARSER::RNA) ("mRNA and FOXD3" . SPARSER::COLLECTION)
    ("NCOA1, and MEF-2" . SPARSER::COLLECTION) ("biotin" . SPARSER::PROTEIN)
    ("SFPQ/PTBP2" . SPARSER::COLLECTION) ("SFPQ" . SPARSER::PROTEIN)
    ("S6K1 and 4E-BP1" . SPARSER::COLLECTION) ("c-Raf" . SPARSER::PROTEIN-PAIR)
    ("new CRC" . SPARSER::PROTEIN)
    ("the same conservative STAT3 transcription response element"
     . SPARSER::DNA-RESPONSE-ELEMENT)
    ("an aspirin-induced upregulated lncRNA" . SPARSER::RNA)
    ("streptavidin-agarose" . SPARSER::DRUG) ("PANC-1" . SPARSER::PROTEIN)
    ("SHP1" . SPARSER::PROTEIN) ("MEF2C" . SPARSER::PROTEIN)
    ("MAML1" . SPARSER::PROTEIN) ("MD1" . SPARSER::PROTEIN)
    ("8B" . SPARSER::PROTEIN) ("S6D" . SPARSER::PROTEIN)
    ("A-C" . SPARSER::PROTEIN) ("A-D" . SPARSER::PROTEIN)
    ("JAK2" . SPARSER::PROTEIN) ("P2-P" . SPARSER::PROTEIN)
    ("MEF-2" . SPARSER::PROTEIN) ("forkhead box D3" . SPARSER::PROTEIN)
    ("TCF7 L2" . SPARSER::PROTEIN) ("PTBP2" . SPARSER::PROTEIN)
    ("PRC2" . SPARSER::PROTEIN) ("NF-kappaB" . SPARSER::PROTEIN)
    ("COX-1" . SPARSER::PROTEIN) ("FOXD3" . SPARSER::PROTEIN)
    ("OLA1" . SPARSER::PROTEIN) ("Per2 or HDAC1" . SPARSER::COLLECTION)
    ("butyrate" . SPARSER::PROTEIN)
    ("a novel prognostic biomarker" . SPARSER::MOLECULE)
    ("iris" . SPARSER::PROTEIN) ("circadian protein" . SPARSER::PROTEIN)
    ("BS" . SPARSER::PROTEIN)
    ("circadian clock molecule mRNA" . SPARSER::PROTEIN)
    ("NFIL3, Per1, Per2, Bmal1, Cry1, Cry2, Clock and Npas2"
     . SPARSER::COLLECTION)
    ("Npas2" . SPARSER::PROTEIN) ("Cry2" . SPARSER::PROTEIN)
    ("Cry1" . SPARSER::PROTEIN) ("Bmal1" . SPARSER::PROTEIN)
    ("Clock" . SPARSER::PROTEIN) ("Per2 and E-cadherin" . SPARSER::COLLECTION)
    ("clock" . SPARSER::PROTEIN) ("Cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("circadian protein Per2" . SPARSER::PROTEIN)
    ("the circadian proteins" . SPARSER::PROTEIN) ("CD69" . SPARSER::PROTEIN)
    ("NK1.1" . SPARSER::PROTEIN) ("CD14" . SPARSER::PROTEIN)
    ("CD11c" . SPARSER::PROTEIN) ("RU486" . SPARSER::DRUG)
    ("SIP-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ZEB-1" . SPARSER::PROTEIN)
    ("Per1" . SPARSER::PROTEIN) ("NFIL3" . SPARSER::PROTEIN)
    ("HIF1α" . SPARSER::PROTEIN) ("Period 2" . SPARSER::PROTEIN)
    ("Per2" . SPARSER::PROTEIN) ("Safran" . SPARSER::DRUG)
    ("CASP" . SPARSER::PROTEIN) ("herceptin" . SPARSER::DRUG)
    ("HER-2" . SPARSER::PROTEIN) ("HR 1" . SPARSER::PROTEIN-FAMILY)
    ("c-erb" . SPARSER::PROTEIN) ("gene-trap" . SPARSER::PROTEIN)
    ("the first 1198 amino acids of the wild-type protein" . SPARSER::PROTEIN)
    ("neomycin" . SPARSER::DRUG) ("PARP1 and PARP3" . SPARSER::COLLECTION)
    ("the latter substrate" . SPARSER::SUBSTRATE)
    ("PARP1 or CHD2" . SPARSER::COLLECTION) ("EJ5" . SPARSER::PROTEIN)
    ("PARP1 and core NHEJ proteins ( xref H)" . SPARSER::COLLECTION)
    ("SNAP" . SPARSER::PROTEIN) ("CHD2 and H3.3" . SPARSER::COLLECTION)
    ("UV-C-induced DNA" . SPARSER::DNA) ("CHD4 or SNF2H" . SPARSER::COLLECTION)
    ("laser-induced chromatin" . SPARSER::PROTEIN)
    ("nuclease" . SPARSER::PROTEIN) ("functional KU80" . SPARSER::PROTEIN)
    ("GFP-XRCC1" . SPARSER::COLLECTION) ("GFP-KU70" . SPARSER::COLLECTION)
    ("GFP-tagged KU70 ( xref ) or GFP-tagged XRCC4" . SPARSER::COLLECTION)
    ("CHD2 and NHEJ proteins" . SPARSER::COLLECTION)
    ("endogenous CHD2 and endogenous KU70 ( xref A) or GFP-tagged KU70 ( xref G)"
     . SPARSER::COLLECTION)
    ("endogenous KU70 ( xref A) or GFP-tagged KU70 ( xref G)"
     . SPARSER::COLLECTION)
    ("XRCC4-LigIV" . SPARSER::PROTEIN-PAIR)
    ("a temperature-sensitive allele" . SPARSER::ALLELE)
    ("shelterin" . SPARSER::PROTEIN)
    ("proteins or PARP1" . SPARSER::COLLECTION)
    ("CHD2 or PARP1" . SPARSER::COLLECTION)
    ("KU80 or DNA-PKcs" . SPARSER::COLLECTION)
    ("EJ5-GFP" . SPARSER::COLLECTION) ("endonuclease" . SPARSER::PROTEIN)
    ("CHD2 and one shRNA" . SPARSER::COLLECTION)
    ("the larger CHD2 protein" . SPARSER::PROTEIN)
    ("almost 3-fold weaker" . SPARSER::PROTEIN)
    ("both CHD2 WT and CHD2" . SPARSER::COLLECTION)
    ("the last C-terminal ∼200 amino acids" . SPARSER::AMINO-ACID)
    ("NBS1-mCherry" . SPARSER::COLLECTION) ("PARG" . SPARSER::PROTEIN)
    ("laser-induced DNA" . SPARSER::DNA) ("multi" . SPARSER::PROTEIN)
    ("GFP or CHD2-GFP from cells under denaturing conditions"
     . SPARSER::COLLECTION)
    ("all core histones and the related chromatin remodeler CHD1"
     . SPARSER::COLLECTION)
    ("a robust CHD2-interacting protein" . SPARSER::PROTEIN)
    ("CHD2-GFP" . SPARSER::COLLECTION) ("CHD2 and PARP1" . SPARSER::COLLECTION)
    ("PARP1 and CHD2" . SPARSER::COLLECTION)
    ("ISWI, INO80, and CHD" . SPARSER::COLLECTION)
    ("SWI2/SNF2" . SPARSER::COLLECTION) ("CHD" . SPARSER::PROTEIN)
    ("ISWI" . SPARSER::PROTEIN) ("LacR" . SPARSER::PROTEIN)
    ("PARP1-associated chromatin-modifying proteins" . SPARSER::PROTEIN)
    ("GFP-XRCC4" . SPARSER::COLLECTION)
    ("monitor possible chromatin" . SPARSER::PROTEIN)
    ("PAGFP-H2A" . SPARSER::COLLECTION) ("PA-GFP" . SPARSER::COLLECTION)
    ("SMARCAD1, INO80, p400, and CHD4" . SPARSER::COLLECTION)
    ("photo-activatable GFP fused" . SPARSER::PROTEIN)
    ("the DNA-dependent protein kinase (DNA-PK) and the XRCC4-LigIV complex ( xref )"
     . SPARSER::COLLECTION)
    ("broken DNA" . SPARSER::DNA) ("KU70-KU80" . SPARSER::COLLECTION)
    ("DNA-end" . SPARSER::DNA) ("PARP1, CHD2, and H3.3" . SPARSER::COLLECTION)
    ("DNA damage-associated poly(ADP-ribose) polymerase" . SPARSER::PROTEIN)
    ("ATPase activity" . SPARSER::PROTEIN) ("PARP3" . SPARSER::COLLECTION)
    ("Histone H3.3" . SPARSER::PROTEIN) ("SNF2H" . SPARSER::PROTEIN)
    ("S6E" . SPARSER::PROTEIN-FAMILY) ("XRCC1" . SPARSER::PROTEIN)
    ("G–4" . SPARSER::PROTEIN) ("TRF2" . SPARSER::PROTEIN)
    ("D–2" . SPARSER::PROTEIN) ("PARP2" . SPARSER::PROTEIN)
    ("ADP-ribosyl" . SPARSER::MOLECULE) ("CHD1" . SPARSER::PROTEIN)
    ("DNA-binding protein" . SPARSER::PROTEIN) ("SNF2" . SPARSER::PROTEIN)
    ("SWI2" . SPARSER::PROTEIN) ("CHD4" . SPARSER::PROTEIN)
    ("p400" . SPARSER::PROTEIN) ("INO80" . SPARSER::PROTEIN)
    ("SMARCAD1" . SPARSER::PROTEIN) ("PRDM2" . SPARSER::PROTEIN)
    ("RNF168" . SPARSER::PROTEIN) ("XRCC4" . SPARSER::PROTEIN)
    ("DNA-PK" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase" . SPARSER::PROTEIN)
    ("KU80" . SPARSER::PROTEIN) ("KU70" . SPARSER::PROTEIN)
    ("single-stranded DNA-binding protein" . SPARSER::PROTEIN)
    ("CHD2" . SPARSER::PROTEIN) ("MMF" . SPARSER::DRUG) ("DMF" . SPARSER::DRUG)
    ("a 3-AP-derived aldehyde" . SPARSER::MOLECULE)
    ("spermidine and spermine" . SPARSER::COLLECTION)
    ("acrolein" . SPARSER::MOLECULE) ("hydroxylamines" . SPARSER::MOLECULE)
    ("toxic metabolites" . SPARSER::PROTEIN)
    ("spermidine and reactive aldehydes" . SPARSER::COLLECTION)
    ("Nrf2 and HO-1" . SPARSER::COLLECTION) ("Nrf2/HO-1" . SPARSER::COLLECTION)
    ("NMDAR/SMO/ROS" . SPARSER::COLLECTION)
    ("pro-oxidative and pro-inflammatory molecules" . SPARSER::MOLECULE)
    ("a strong competitive inhibitor" . SPARSER::INHIBITOR)
    ("systemic glutathione" . SPARSER::DRUG)
    ("HO-1 and NQO1" . SPARSER::COLLECTION) ("astrocytes" . SPARSER::PROTEIN)
    ("the viral proteins" . SPARSER::PROTEIN)
    ("NQO1 and HO-1" . SPARSER::COLLECTION)
    ("SOD1, SOD2 and HO-1" . SPARSER::COLLECTION)
    ("genes and antioxidant genes" . SPARSER::COLLECTION)
    ("HIV-1 viral proteins" . SPARSER::PROTEIN)
    ("NMDAR and SMO" . SPARSER::COLLECTION)
    ("also known as electrophilic response elements"
     . SPARSER::DNA-RESPONSE-ELEMENT)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("Maf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glutathione peroxidase, thioredoxin, and peroxiredoxins"
     . SPARSER::COLLECTION)
    ("peroxiredoxins" . SPARSER::PROTEIN) ("thioredoxin" . SPARSER::PROTEIN)
    ("superoxide" . SPARSER::MOLECULE) ("catalase" . SPARSER::PROTEIN)
    ("receptor (NMDAR)" . SPARSER::RECEPTOR)
    ("reactive aldehydes" . SPARSER::MOLECULE)
    ("aldehydes" . SPARSER::MOLECULE)
    ("spermine oxidase (SMO)" . SPARSER::PROTEIN)
    ("aldehyde" . SPARSER::MOLECULE) ("spermidine" . SPARSER::MOLECULE)
    ("flavoprotein" . SPARSER::PROTEIN-FAMILY)
    ("a ubiquitous cell component" . SPARSER::COMPONENT)
    ("Spm" . SPARSER::PROTEIN) ("spermine" . SPARSER::PROTEIN)
    ("polyamine" . SPARSER::MOLECULE)
    ("a viral transcription factor" . SPARSER::PROTEIN)
    ("NMDAR/SMO/Nrf2" . SPARSER::COLLECTION)
    ("oxidative stress-responsive genes" . SPARSER::GENE)
    ("NMDAR" . SPARSER::PROTEIN) ("NMDA" . SPARSER::MOLECULE)
    ("SH-SY5Y" . SPARSER::PROTEIN) ("dimethyl fumarate" . SPARSER::DRUG)
    ("gp120" . SPARSER::DRUG) ("Lamin B1" . SPARSER::PROTEIN)
    ("laminB1" . SPARSER::PROTEIN) ("delta–" . SPARSER::PROTEIN)
    ("SOD2" . SPARSER::PROTEIN) ("A-3" . SPARSER::PROTEIN)
    ("G-3" . SPARSER::PROTEIN) ("SOD1" . SPARSER::PROTEIN)
    ("C -3" . SPARSER::PROTEIN) ("amine oxidase" . SPARSER::PROTEIN)
    ("N-acetylcysteine" . SPARSER::DRUG) ("MK-801" . SPARSER::MOLECULE)
    ("anti-oxidant" . SPARSER::DRUG)
    ("nuclear factor-erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("glutathione peroxidase" . SPARSER::PROTEIN)
    ("heme-oxygenase" . SPARSER::PROTEIN) ("NQO1" . SPARSER::PROTEIN)
    ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("nuclear factor erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("spermine oxidase" . SPARSER::PROTEIN)
    ("Notch3, PTEN, OCT4 and TRIF" . SPARSER::COLLECTION)
    ("TRIF" . SPARSER::PROTEIN)
    ("a known HECT-domain-containing E3 ubiquitin ligase" . SPARSER::PROTEIN)
    ("kinase and GSK3β" . SPARSER::COLLECTION)
    ("major c-Myc" . SPARSER::PROTEIN) ("Oncogene" . SPARSER::ONCOGENE)
    ("N-Myc and L-Myc" . SPARSER::COLLECTION)
    ("c-Myc, N-Myc and L-Myc" . SPARSER::COLLECTION)
    ("Oncogenes" . SPARSER::ONCOGENE) ("cinobufagin (CB)" . SPARSER::DRUG)
    ("BF" . SPARSER::MOLECULE)
    ("c-Myc and its target genes" . SPARSER::COLLECTION)
    ("AKT1 and ERK1" . SPARSER::COLLECTION)
    ("AKT and ERK" . SPARSER::COLLECTION)
    ("MAPK and AKT" . SPARSER::COLLECTION) ("flag" . SPARSER::PROTEIN-FAMILY)
    ("c-Myc-WWP2" . SPARSER::COLLECTION)
    ("a physiologically relevant E3 ligase" . SPARSER::LIGASE)
    ("a known HECT-domain-containing E3 ligase" . SPARSER::LIGASE)
    ("UBE2J2 , UBE2L6 , UBE2A , and WWP2" . SPARSER::COLLECTION)
    ("RPMI8226" . SPARSER::PROTEIN)
    ("CCNA1 , CCND1 , CCNE1 , CDC2 , CDC25A , EIF2A , EIF4E , DHFR , and TERT"
     . SPARSER::COLLECTION)
    ("DHFR" . SPARSER::PROTEIN) ("SRE" . SPARSER::PROTEIN)
    ("HSE" . SPARSER::PROTEIN) ("E2F, GRE, MYC, and Rb" . SPARSER::COLLECTION)
    ("cyclin D1 and cyclin E1" . SPARSER::COLLECTION)
    ("RPMI 8226" . SPARSER::PROTEIN) ("the bioactive GBT" . SPARSER::MOLECULE)
    ("proapoptotic Bax and Fas" . SPARSER::COLLECTION)
    ("Tiam1 and p21" . SPARSER::COLLECTION)
    ("Bax and Fas" . SPARSER::COLLECTION) ("Topo" . SPARSER::PROTEIN)
    ("gamabufotalin (GBT) and resibufogenin" . SPARSER::COLLECTION)
    ("resibufogenin" . SPARSER::DRUG) ("bufalin" . SPARSER::DRUG)
    ("cinobufagin" . SPARSER::DRUG) ("bufadienolides" . SPARSER::MOLECULE)
    ("shRNA or small molecule inhibitors" . SPARSER::COLLECTION)
    ("cyclin D1, c-Myc, mTOR, CD40 and Hsp90" . SPARSER::COLLECTION)
    ("IL-6 or other autocrine cytokines and growth factors"
     . SPARSER::COLLECTION)
    ("other autocrine cytokines and growth factors" . SPARSER::COLLECTION)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("osteoclasts" . SPARSER::PROTEIN) ("GBT" . SPARSER::MOLECULE)
    ("gamabufotalin" . SPARSER::MOLECULE) ("CDC-2" . SPARSER::PROTEIN)
    ("C/EBPα" . SPARSER::PROTEIN) ("c -Myc" . SPARSER::PROTEIN)
    ("N-Myc" . SPARSER::PROTEIN) ("CD19" . SPARSER::PROTEIN)
    ("M-protein" . SPARSER::PROTEIN) ("SP600125" . SPARSER::PROTEIN)
    ("ERK1" . SPARSER::PROTEIN) ("UBE2A" . SPARSER::PROTEIN)
    ("UBE2L6" . SPARSER::PROTEIN) ("UBE2J2" . SPARSER::PROTEIN)
    ("EIF2A" . SPARSER::PROTEIN) ("CDC25A" . SPARSER::PROTEIN)
    ("CCNA1" . SPARSER::PROTEIN) ("c-MYC" . SPARSER::PROTEIN)
    ("JC-1" . SPARSER::MOLECULE) ("CD138" . SPARSER::PROTEIN)
    ("Tiam1" . SPARSER::PROTEIN) ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD40" . SPARSER::PROTEIN) ("WWP2" . SPARSER::PROTEIN)
    ("ubiquitin-protein ligase" . SPARSER::PROTEIN)
    ("the major mitochondrial chaperone" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase 1 (CDK1) and cyclin-dependent kinase 4 (CDK4)"
     . SPARSER::COLLECTION)
    ("citrate" . SPARSER::PROTEIN) ("Excessive ROS" . SPARSER::PROTEIN)
    ("Nrf2/Keap1" . SPARSER::COLLECTION)
    ("respiratory complexes" . SPARSER::BIO-COMPLEX)
    ("CDK1 and CDK4" . SPARSER::COLLECTION)
    ("EEF1A2, CDK1, and CDK4" . SPARSER::COLLECTION)
    ("vimentin and angiomotin" . SPARSER::COLLECTION)
    ("angiomotin" . SPARSER::PROTEIN)
    ("SDHB, COA7, CDK1, and CDK4" . SPARSER::COLLECTION)
    ("SDHB" . SPARSER::PROTEIN)
    ("these nine mitochondrial ribosomal genes" . SPARSER::GENE)
    ("ribosomes" . SPARSER::BIO-COMPLEX)
    ("very long-chain specific acyl-CoA dehydrogenase and hydroxyacyl-coenzyme"
     . SPARSER::COLLECTION)
    ("dehydrogenase and hydroxyacyl-coenzyme" . SPARSER::COLLECTION)
    ("coenzyme" . SPARSER::MOLECULE) ("hydroxyacyl" . SPARSER::PROTEIN)
    ("enoyl" . SPARSER::PROTEIN)
    ("COX7C, COX6A1, COX7A2, COA7, and COA5" . SPARSER::COLLECTION)
    ("COA" . SPARSER::MOLECULE) ("COX" . SPARSER::PROTEIN)
    ("differentially expressed proteins" . SPARSER::PROTEIN)
    ("The generated tryptic peptides" . SPARSER::PEPTIDE)
    ("solution" . SPARSER::MOLECULE)
    ("the representative Western blot" . SPARSER::PROTEIN)
    ("a tumor suppressor or a promoter" . SPARSER::COLLECTION)
    ("MnSOD" . SPARSER::PROTEIN)
    ("the respiratory complexes" . SPARSER::BIO-COMPLEX)
    ("Substrates" . SPARSER::SUBSTRATE) ("HSP60" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase 1" . SPARSER::PROTEIN)
    ("EEF1A2" . SPARSER::PROTEIN) ("COX6A1" . SPARSER::PROTEIN)
    ("COX7C" . SPARSER::PROTEIN) ("SIRT3" . SPARSER::PROTEIN)
    ("ErbB2 peptides and NY-ESO peptide ( xref , xref )" . SPARSER::COLLECTION)
    ("proteins and iv" . SPARSER::COLLECTION)
    ("MUC1 ( xref , xref ) and survivin 2B ( xref )" . SPARSER::COLLECTION)
    ("ErbB2 ( xref ), MUC1 ( xref , xref ) and survivin 2B ( xref )"
     . SPARSER::COLLECTION)
    ("CTLs" . SPARSER::PROTEIN)
    ("usually 8–10 amino acids" . SPARSER::AMINO-ACID)
    ("MHC" . SPARSER::PROTEIN) ("peptide-" . SPARSER::PEPTIDE)
    ("itch, erythema and tumescence" . SPARSER::COLLECTION)
    ("itch" . SPARSER::PROTEIN)
    ("CEA- and ErbB2-specific" . SPARSER::COLLECTION)
    ("CEA-" . SPARSER::PROTEIN) ("ErbB2 and CEA" . SPARSER::COLLECTION)
    ("para" . SPARSER::PROTEIN-FAMILY)
    ("at least one peptide" . SPARSER::PEPTIDE) ("DCs" . SPARSER::MOLECULE)
    ("the antigenic peptides" . SPARSER::PEPTIDE)
    ("MUC1, ErbB2 and CEA" . SPARSER::COLLECTION)
    ("Peptide" . SPARSER::PEPTIDE)
    ("taxane, trastuzumab, lapatinib and capecitabine" . SPARSER::COLLECTION)
    ("capecitabine" . SPARSER::DRUG) ("taxane" . SPARSER::DRUG)
    ("OV" . SPARSER::MOLECULE) ("CEA, ErbB2 and MUC1" . SPARSER::COLLECTION)
    ("CEA and MUC1" . SPARSER::COLLECTION)
    ("anti-CTLA4 and anti-PD1" . SPARSER::COLLECTION)
    ("ErbB2 (KIFGSLAFL) and MUC1 (SAPDNRPAL) peptides" . SPARSER::COLLECTION)
    ("CEA (YLSGADLNL), ErbB2 (KIFGSLAFL) and MUC1 (SAPDNRPAL) peptides"
     . SPARSER::COLLECTION)
    ("a highly glycosylated type I transmembrane glycoprotein"
     . SPARSER::PROTEIN)
    ("mucin" . SPARSER::PROTEIN) ("TAAs" . SPARSER::DRUG)
    ("monoclonal antibodies ( xref ) and hormonetherapy ( xref )"
     . SPARSER::COLLECTION)
    ("MUC1, ErbB2 and carcinoembryonic" . SPARSER::COLLECTION)
    ("CEA" . SPARSER::PROTEIN) ("carcinoembryonic" . SPARSER::PROTEIN)
    ("CAP-1" . SPARSER::PROTEIN) ("CA-125" . SPARSER::PROTEIN)
    ("FoxP3" . SPARSER::PROTEIN) ("FOXP3" . SPARSER::PROTEIN)
    ("M-A" . SPARSER::PROTEIN) ("CD25" . SPARSER::PROTEIN)
    ("CD45RA" . SPARSER::PROTEIN) ("CD4" . SPARSER::PROTEIN)
    ("Alkaline Phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("IFNγ" . SPARSER::PROTEIN) ("IL-2" . SPARSER::PROTEIN)
    ("GM-CSF" . SPARSER::PROTEIN) ("PD1" . SPARSER::PROTEIN)
    ("CTLA4" . SPARSER::PROTEIN) ("anti-ErbB2" . SPARSER::DRUG)
    ("CD8" . SPARSER::PROTEIN) ("HLA-A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MUC1" . SPARSER::PROTEIN)
    ("BIK, PUMA, BMF, BAX, and MCL-1S" . SPARSER::COLLECTION)
    ("cytarabine" . SPARSER::MOLECULE) ("p70S6K" . SPARSER::PROTEIN)
    ("imatinib" . SPARSER::DRUG) ("carboplatin" . SPARSER::DRUG)
    ("p53 up-regulated modulator of apoptosis (PUMA), BCL-2-modifying factor (BMF), and BCL-2-associated X protein (BAX) ( p  < 0.05)"
     . SPARSER::COLLECTION)
    ("BCL-2-associated X protein (BAX)" . SPARSER::PROTEIN)
    ("protein (BAX)" . SPARSER::PROTEIN) ("BCL-2/BAX" . SPARSER::COLLECTION)
    ("BMF" . SPARSER::PROTEIN) ("BIK" . SPARSER::PROTEIN)
    ("REH-FAK" . SPARSER::COLLECTION)
    ("AKT and phospho-AKT" . SPARSER::COLLECTION)
    ("AKT and FAK" . SPARSER::COLLECTION)
    ("rapamycin and FAK" . SPARSER::COLLECTION)
    ("BCR/ABL" . SPARSER::COLLECTION) ("ABL" . SPARSER::PROTEIN)
    ("BCR" . SPARSER::PROTEIN) ("a bacterial macrolide" . SPARSER::MOLECULE)
    ("macrolide" . SPARSER::MOLECULE) ("Rapamycin" . SPARSER::DRUG)
    ("high-risk acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("the human precursor B acute lymphoblastic leukemia cells REH"
     . SPARSER::PROTEIN)
    ("REH" . SPARSER::PROTEIN) ("Multi" . SPARSER::PROTEIN)
    ("Acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("p70S6" . SPARSER::PROTEIN)
    ("p53 up-regulated modulator of apoptosis" . SPARSER::PROTEIN)
    ("pro-B" . SPARSER::DRUG) ("phosphatidylinositol" . SPARSER::PROTEIN)
    ("MET and paxillin" . SPARSER::COLLECTION)
    ("MET and EGFR" . SPARSER::COLLECTION)
    ("MET and HGF" . SPARSER::COLLECTION) ("Serious AEs" . SPARSER::PROTEIN)
    ("nail" . SPARSER::PROTEIN) ("Biomarker" . SPARSER::MOLECULE)
    ("MET and PTEN" . SPARSER::COLLECTION)
    ("irinotecan and cetuximab" . SPARSER::COLLECTION)
    ("62 received tivantinib and 59 received placebo (one patient randomized to placebo did not receive study medication)"
     . SPARSER::COLLECTION)
    ("MAPK and PI3K" . SPARSER::COLLECTION) ("HOS" . SPARSER::PROTEIN)
    ("oxaliplatin or irinotecan" . SPARSER::COLLECTION)
    ("leucovorin" . SPARSER::DRUG)
    ("cetuximab and irinotecan" . SPARSER::COLLECTION)
    ("Tivantinib" . SPARSER::DRUG)
    ("previously treated KRAS  WT mCRC" . SPARSER::PROTEIN)
    ("cetuximab (500 mg/m 2 ) and irinotecan (180 mg/m 2 )"
     . SPARSER::COLLECTION)
    ("CETIRI" . SPARSER::DRUG) ("irinotecan (CETIRI)" . SPARSER::DRUG)
    ("cetuximab " . SPARSER::DRUG) ("tivantinib" . SPARSER::DRUG)
    ("mCRC" . SPARSER::PROTEIN) ("irinotecan" . SPARSER::DRUG)
    ("Cetuximab" . SPARSER::DRUG) ("multi-protein" . SPARSER::COLLECTION)
    ("DAXX and DAXX" . SPARSER::COLLECTION)
    ("ATPase/helicase" . SPARSER::COLLECTION)
    ("The most frequently mutated genes included TP53 , ATRX , MED12 , FSIP2 , ABCA13 , and ANKRD26"
     . SPARSER::COLLECTION)
    ("TP53 , ATRX , MED12 , FSIP2 , ABCA13 , and ANKRD26"
     . SPARSER::COLLECTION)
    ("altogether 43 such genes" . SPARSER::GENE)
    ("TP53 or ATRX" . SPARSER::COLLECTION)
    ("ATRX or DAXX" . SPARSER::COLLECTION)
    ("ATRX and DAXX" . SPARSER::COLLECTION)
    ("TP53 and ATRX" . SPARSER::COLLECTION)
    ("TP53, ATRX, and DAXX" . SPARSER::COLLECTION)
    ("Ile" . SPARSER::AMINO-ACID) ("Stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Glu" . SPARSER::AMINO-ACID)
    ("a premature stop-codon" . SPARSER::PROTEIN-PAIR)
    ("stop-codon" . SPARSER::PROTEIN-PAIR)
    ("X-linked ( ATRX )" . SPARSER::PROTEIN)
    ("genes and mechanisms" . SPARSER::COLLECTION)
    ("RB1 , MDM2 , CDKN2A , and KIT" . SPARSER::COLLECTION)
    ("possible new drugs" . SPARSER::DRUG)
    ("TP53 , ATRX , and MED12" . SPARSER::COLLECTION)
    ("DAXX" . SPARSER::PROTEIN) ("TP53 and MED12" . SPARSER::COLLECTION)
    ("Most frequently mutated genes included tumor protein P53"
     . SPARSER::PROTEIN)
    ("ATRX" . SPARSER::PROTEIN)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("ankyrin repeat" . SPARSER::PROTEIN) ("member 13" . SPARSER::PROTEIN)
    ("death-domain associated protein" . SPARSER::PROTEIN)
    ("MED12" . SPARSER::PROTEIN)
    ("mediator complex subunit 12" . SPARSER::PROTEIN)
    ("mental retardation" . SPARSER::PROTEIN)
    ("tumor protein P53" . SPARSER::PROTEIN)
    ("external environmental cues" . SPARSER::PROTEIN-FAMILY)
    ("what controls SIRT1" . SPARSER::PROTEIN)
    ("ATP-binding cassette, sub-family A (ABC1), member 1 or Srebp-1c"
     . SPARSER::COLLECTION)
    ("Srebp" . SPARSER::PROTEIN-FAMILY) ("Receptor (LXR)" . SPARSER::RECEPTOR)
    ("LXR" . SPARSER::PROTEIN) ("run" . SPARSER::PROTEIN-FAMILY)
    ("fructose" . SPARSER::PROTEIN)
    ("lipid and carbohydrate concentrations" . SPARSER::COLLECTION)
    ("two main gluconeogenetic enzymes" . SPARSER::ENZYME)
    ("G6Pc" . SPARSER::PROTEIN) ("PEPCK" . SPARSER::PROTEIN)
    ("phosphoenolpyruvate" . SPARSER::MOLECULE)
    ("long chain fatty acids family 6" . SPARSER::PROTEIN)
    ("—fatty acid synthase (FAS)" . SPARSER::COLLECTION)
    ("—fatty acid synthase" . SPARSER::COLLECTION) ("SCD" . SPARSER::PROTEIN)
    ("ACC" . SPARSER::PROTEIN)
    ("acyl-CoA dehydrogenase (ACADM) and acyl-CoA oxidase"
     . SPARSER::COLLECTION)
    ("dehydrogenase (ACADM)" . SPARSER::PROTEIN) ("oxidase" . SPARSER::PROTEIN)
    ("ACADM" . SPARSER::PROTEIN)
    ("lipid and glucose levels" . SPARSER::COLLECTION)
    ("triglycerides" . SPARSER::MOLECULE)
    ("almost no intracellular lipid" . SPARSER::LIPID)
    ("normal human fetal hepatocytes" . SPARSER::PROTEIN)
    ("Human fetal hepatocytes" . SPARSER::PROTEIN) ("Sirtinol" . SPARSER::DRUG)
    ("adult and fetal hepatocytes" . SPARSER::PROTEIN)
    ("lipids and carbohydrates" . SPARSER::COLLECTION)
    ("hyaline" . SPARSER::PROTEIN) ("NAD" . SPARSER::MOLECULE)
    ("lipid and carbohydrate metabolisms" . SPARSER::COLLECTION)
    ("the human fetal hepatocytes" . SPARSER::PROTEIN)
    ("AKT/FOXO1" . SPARSER::COLLECTION)
    ("human fetal hepatocytes" . SPARSER::PROTEIN)
    ("member 1" . SPARSER::PROTEIN) ("sub-family A (ABC1)" . SPARSER::PROTEIN)
    ("Forkhead box O1" . SPARSER::PROTEIN)
    ("glucose-6-phosphatase" . SPARSER::PROTEIN) ("ELOVL6" . SPARSER::PROTEIN)
    ("family 6" . SPARSER::PROTEIN) ("long chain" . SPARSER::PROTEIN)
    ("stearoyl-CoA" . SPARSER::MOLECULE)
    ("fatty acid synthase" . SPARSER::PROTEIN) ("CPT1" . SPARSER::PROTEIN)
    ("ACOX1" . SPARSER::PROTEIN) ("acyl-CoA" . SPARSER::MOLECULE)
    ("TORC2" . SPARSER::PROTEIN)
    ("Hypoxanthine-guanine phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("Type XI" . SPARSER::PROTEIN) ("of pregnancy" . SPARSER::PROTEIN)
    ("NAD+" . SPARSER::MOLECULE) ("homolog)" . SPARSER::PROTEIN)
    ("STAT3, NF κ B and nitric oxide" . SPARSER::COLLECTION)
    ("phospho-p65 as well as its downstream targets (MMP-9, VEGF, IL-6 and IL-8)"
     . SPARSER::COLLECTION)
    ("MMP-9, VEGF, IL-6 and IL-8" . SPARSER::COLLECTION)
    ("NFκB and STAT3" . SPARSER::COLLECTION)
    ("TNF-α and IL-6" . SPARSER::COLLECTION)
    ("IL-6, IL-8 and TNF- α" . SPARSER::COLLECTION)
    ("docetaxel" . SPARSER::DRUG)
    ("IL-6, IL-8 and TNF-α" . SPARSER::COLLECTION)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-6, IL-8, and TNF-α" . SPARSER::COLLECTION)
    ("prostanoids" . SPARSER::MOLECULE)
    ("fibronectin-integrin" . SPARSER::COLLECTION)
    ("NFκB, STAT3 and Nitric Oxide" . SPARSER::COLLECTION)
    ("MMP-9, PgE2, TNF-α, IL-6 and IL-8" . SPARSER::COLLECTION)
    ("colchicine- and RCE-treated embryos" . SPARSER::COLLECTION)
    ("colchicine- and RCE-treated tumors" . SPARSER::COLLECTION)
    ("colchicine-" . SPARSER::DRUG) ("the upper CAM" . SPARSER::PROTEIN)
    ("CAM" . SPARSER::PROTEIN) ("iNOS" . SPARSER::PROTEIN)
    ("STAT3 and NFκB" . SPARSER::COLLECTION)
    ("IL-6 and IL-8" . SPARSER::COLLECTION)
    ("IL-6, and IL-8" . SPARSER::COLLECTION) ("pg" . SPARSER::MOLECULE)
    ("a pro-angiogenic growth factor" . SPARSER::GROWTH-FACTOR)
    ("MMP-9 and PgE2" . SPARSER::COLLECTION)
    ("MMP-9 and prostaglandin E2" . SPARSER::COLLECTION)
    ("ethanol" . SPARSER::PROTEIN)
    ("STAT3, NFκB and nitric oxide" . SPARSER::COLLECTION)
    ("alkaloids and steroids" . SPARSER::COLLECTION)
    ("alkaloids" . SPARSER::MOLECULE) ("herbal medicine" . SPARSER::DRUG)
    ("Common chemotherapeutic agents target three receptors"
     . SPARSER::RECEPTOR)
    ("NFκB, STAT3 and nitric oxide" . SPARSER::COLLECTION)
    ("TNF-α, IL-6 and IL-8" . SPARSER::COLLECTION)
    ("MMP-9 and prostaglandin E 2" . SPARSER::COLLECTION)
    ("NF κ B" . SPARSER::PROTEIN) ("Estrogen Receptor" . SPARSER::PROTEIN)
    ("TNF- α" . SPARSER::PROTEIN) ("protein expressed in" . SPARSER::PROTEIN)
    ("E 19" . SPARSER::PROTEIN) ("nitric oxide synthase" . SPARSER::PROTEIN)
    ("Nitric Oxide" . SPARSER::MOLECULE) ("anti-angiogenic" . SPARSER::DRUG)
    ("Prostaglandin E 2" . SPARSER::MOLECULE)
    ("Matrix metalloproteinase-9" . SPARSER::PROTEIN)
    ("prostaglandin E2" . SPARSER::MOLECULE) ("E19" . SPARSER::PROTEIN)
    ("Growth Factor" . SPARSER::GROWTH-FACTOR)
    ("Vascular Endothelial" . SPARSER::PROTEIN)
    ("heparan sulfate" . SPARSER::MOLECULE)
    ("Serum Albumin" . SPARSER::PROTEIN)
    ("chemo-attractant" . SPARSER::PROTEIN) ("NFκB" . SPARSER::PROTEIN)
    ("IL-8" . SPARSER::PROTEIN) ("PgE2" . SPARSER::DRUG)
    ("prostaglandin E 2" . SPARSER::MOLECULE) ("SMC" . SPARSER::PROTEIN)
    ("Tie" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("this homogenous cohort" . SPARSER::MOLECULE)
    ("colon cancer or CRC" . SPARSER::COLLECTION) ("GGC " . SPARSER::PROTEIN)
    ("AGT" . SPARSER::PROTEIN) ("pG" . SPARSER::MOLECULE)
    ("GAT" . SPARSER::PROTEIN) ("GGT " . SPARSER::PROTEIN)
    ("synchronous metastatic CRC" . SPARSER::PROTEIN)
    ("anti-epidermal growth factor receptor ( EGFR ) monoclonal antibodies"
     . SPARSER::ANTIBODY)
    ("PTEN/PI3K/Akt" . SPARSER::COLLECTION)
    ("Ras/Raf/MAP/MEK/ERK" . SPARSER::COLLECTION)
    ("metastatic CRC" . SPARSER::PROTEIN) ("TTR" . SPARSER::PROTEIN)
    ("p53-regulated miRNAs and target genes" . SPARSER::COLLECTION)
    ("c-myc (direct target of miR-590, miR-148a, miR-27a and miR-34c) and MDM2 (direct target of miR-590, miR-148a, miR-27a and miR-9-2)"
     . SPARSER::COLLECTION)
    ("E2F3, c-myc (direct target of miR-590, miR-148a, miR-27a and miR-34c) and MDM2 (direct target of miR-590, miR-148a, miR-27a and miR-9-2)"
     . SPARSER::COLLECTION)
    ("hsa-miR-19a" . SPARSER::PROTEIN-PAIR)
    ("hsa-miR-7-3p" . SPARSER::COLLECTION) ("hsa-miR-20a" . SPARSER::PROTEIN)
    ("hsa-miR-27a" . SPARSER::PROTEIN) ("hsa-miR-27a-5p" . SPARSER::COLLECTION)
    ("hsa-miR-20a-5p" . SPARSER::COLLECTION) ("5p" . SPARSER::PROTEIN)
    ("acute leukemia" . SPARSER::PROTEIN)
    ("miR-18a-5p" . SPARSER::PROTEIN-PAIR) ("malignant HCC" . SPARSER::PROTEIN)
    ("miR-18a, miR-19a and miR-20a" . SPARSER::COLLECTION)
    ("hsa-miR-125a" . SPARSER::COLLECTION) ("miR-18a" . SPARSER::PROTEIN)
    ("etc" . SPARSER::PROTEIN)
    ("human disease-associated miRNAs" . SPARSER::PROTEIN)
    ("hsa-miR-18a" . SPARSER::COLLECTION) ("hsa" . SPARSER::PROTEIN)
    ("the most robustly-induced miRNAs" . SPARSER::PROTEIN)
    ("mature miRNAs" . SPARSER::PROTEIN) ("Guanine" . SPARSER::PROTEIN)
    ("mature miRNA" . SPARSER::PROTEIN) ("uridine" . SPARSER::PROTEIN)
    ("further small RNA" . SPARSER::RNA)
    ("ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("the cell cycle-associated proteins" . SPARSER::PROTEIN)
    ("Wnt-1, DNMT1, ERK1/2, AKT and TNFRS6B" . SPARSER::COLLECTION)
    ("p53-miRNA" . SPARSER::COLLECTION)
    ("small RNA sequencing and systematic bioinformatic analysis"
     . SPARSER::COLLECTION)
    ("MAPK1" . SPARSER::PROTEIN) ("E2F3" . SPARSER::PROTEIN)
    ("JAK-STAT" . SPARSER::PROTEIN) ("SOCS3" . SPARSER::PROTEIN)
    ("miR-29" . SPARSER::PROTEIN) ("miR-125a" . SPARSER::PROTEIN)
    ("miR-27a-5p" . SPARSER::MOLECULE) ("miR-92a" . SPARSER::MOLECULE)
    ("c-5" . SPARSER::PROTEIN) ("pre-miRNA" . SPARSER::RNA)
    ("Wnt-1" . SPARSER::PROTEIN)
    ("the EGF receptor [ xref , xref , xref ] as well as molecules"
     . SPARSER::COLLECTION)
    ("Akt, Ras and MKNK1" . SPARSER::COLLECTION)
    ("soluble protein" . SPARSER::PROTEIN)
    ("metalloprotease" . SPARSER::PROTEIN) ("Erb" . SPARSER::PROTEIN)
    ("GC- and GT-box" . SPARSER::COLLECTION) ("GC-" . SPARSER::PROTEIN)
    ("GT" . SPARSER::PROTEIN) ("viral RNA" . SPARSER::RNA)
    ("antibodies and / or pre-treatment" . SPARSER::COLLECTION)
    ("ErB" . SPARSER::PROTEIN) ("Mithramycin" . SPARSER::DRUG)
    ("HRG-" . SPARSER::PROTEIN) ("HRG" . SPARSER::PROTEIN)
    ("Heregulin" . SPARSER::PROTEIN) ("Triciribine" . SPARSER::MOLECULE)
    ("soluble NRG1" . SPARSER::PROTEIN)
    ("NRG1 and Epiregulin" . SPARSER::COLLECTION)
    ("Epiregulin" . SPARSER::PROTEIN)
    ("MRP2 and the Na + /K + ATPase" . SPARSER::COLLECTION)
    ("ATPase" . SPARSER::PROTEIN) ("-Methylcytidine" . SPARSER::MOLECULE)
    ("Methylcytidine" . SPARSER::MOLECULE)
    ("EGFR and ErbB3" . SPARSER::COLLECTION)
    ("EGFR (Entrez Gene: 1956) and ErbB3 (Entrez Gene: 2065)"
     . SPARSER::COLLECTION)
    ("PHH" . SPARSER::PROTEIN)
    ("EGFR, ErbB2, ErbB3 and ErbB4" . SPARSER::COLLECTION)
    ("the sub-genomic HCV replicon genotype 1b" . SPARSER::PROTEIN)
    ("EGFR or ErbB2" . SPARSER::COLLECTION)
    ("Neuregulin (NRG)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ErbB2 and ErbB3" . SPARSER::COLLECTION) ("ErbBs" . SPARSER::PROTEIN)
    ("/protein kinase B" . SPARSER::COLLECTION)
    ("the respective receptor molecule" . SPARSER::MOLECULE)
    ("known ligand" . SPARSER::LIGAND)
    ("ErbB3 (HER3) and ErbB4 (HER4)" . SPARSER::COLLECTION)
    ("ErbB1, or HER1" . SPARSER::COLLECTION) ("Neuregulins" . SPARSER::PROTEIN)
    ("Heregulins" . SPARSER::DRUG)
    ("four type 1 tyrosine kinase transmembrane glycoproteins"
     . SPARSER::PROTEIN)
    ("EGFR and EGFR" . SPARSER::COLLECTION)
    ("CD81-Claudin-1" . SPARSER::COLLECTION) ("cofactor" . SPARSER::MOLECULE)
    ("ligand-" . SPARSER::LIGAND)
    ("Akt and Phospholipase C" . SPARSER::COLLECTION)
    ("PLC" . SPARSER::PROTEIN) ("Receptor (EGFR)" . SPARSER::RECEPTOR)
    ("Receptor" . SPARSER::RECEPTOR)
    ("ErbB3 and the two other family members ErbB2 and EGFR"
     . SPARSER::COLLECTION)
    ("ErbB2 and EGFR" . SPARSER::COLLECTION)
    ("NRG1 or Sp1" . SPARSER::COLLECTION) ("Neuregulin" . SPARSER::PROTEIN)
    ("EGFR and ErbB2" . SPARSER::COLLECTION)
    ("ErbB3 and ErbB4" . SPARSER::COLLECTION) ("1b" . SPARSER::PROTEIN)
    ("receptor (EGFR)" . SPARSER::RECEPTOR) ("MKNK1" . SPARSER::PROTEIN)
    ("ADAM17" . SPARSER::PROTEIN) ("co-factor" . SPARSER::MOLECULE)
    ("Nrdp1" . SPARSER::PROTEIN) ("NRG2" . SPARSER::PROTEIN)
    ("NS5B" . SPARSER::PROTEIN) ("β- actin" . SPARSER::PROTEIN)
    ("Mg 2+" . SPARSER::MOLECULE) ("Ca 2+" . SPARSER::CALCIUM-ION)
    ("beta 1" . SPARSER::PROTEIN) ("JC1" . SPARSER::MOLECULE)
    ("reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HRG1" . SPARSER::PROTEIN) ("K +" . SPARSER::MOLECULE)
    ("Na +" . SPARSER::MOLECULE) ("MRP2" . SPARSER::PROTEIN)
    ("IgG2a" . SPARSER::PROTEIN) ("IgG2A" . SPARSER::PROTEIN)
    ("NS5A" . SPARSER::PROTEIN) ("co-receptors" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("extracellular signal-regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("co-receptor" . SPARSER::PROTEIN) ("orphan receptor" . SPARSER::PROTEIN)
    ("Claudin-1" . SPARSER::PROTEIN) ("CD81" . SPARSER::PROTEIN)
    ("Phospholipase C" . SPARSER::PROTEIN) ("Th2" . SPARSER::PROTEIN)
    ("TC-PTP" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("NS3" . SPARSER::PROTEIN) ("NRG1" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase (PI3K) and Akt [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("substrate (IRS)" . SPARSER::SUBSTRATE) ("IRS" . SPARSER::PROTEIN)
    ("Akt or mTOR" . SPARSER::COLLECTION)
    ("anabolic proteins" . SPARSER::PROTEIN)
    ("mTOR and raptor" . SPARSER::COLLECTION) ("raptor" . SPARSER::PROTEIN)
    ("mRNA and total protein" . SPARSER::COLLECTION)
    ("type I, IIA and IIX" . SPARSER::COLLECTION) ("max" . SPARSER::PROTEIN)
    ("VO" . SPARSER::MOLECULE) ("pre-" . SPARSER::PROTEIN)
    ("RM" . SPARSER::MOLECULE) ("MAFbx and MuRF-1" . SPARSER::COLLECTION)
    ("MAFbx" . SPARSER::PROTEIN) ("Akt and mTOR" . SPARSER::COLLECTION)
    ("type I and type II" . SPARSER::COLLECTION) ("REDD1" . SPARSER::PROTEIN)
    ("MuRF1" . SPARSER::PROTEIN) ("citrate synthase" . SPARSER::PROTEIN)
    ("muscle)" . SPARSER::PROTEIN) ("fast-type" . SPARSER::PROTEIN)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("Akt-mTOR" . SPARSER::PROTEIN) ("MuRF-1" . SPARSER::PROTEIN)
    ("a catalytic mutant or a mutant" . SPARSER::COLLECTION)
    ("art" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the editorial decision letter" . SPARSER::MOLECULE)
    ("letter" . SPARSER::MOLECULE)
    ("Mps1 and either Plk1" . SPARSER::COLLECTION)
    ("centromere/KT-associated CPC" . SPARSER::PROTEIN)
    ("Sororin-Wapl" . SPARSER::COLLECTION) ("Wapl" . SPARSER::PROTEIN)
    ("Sororin" . SPARSER::PROTEIN) ("Shugoshin and CPC" . SPARSER::COLLECTION)
    ("The only previously described inhibitor" . SPARSER::INHIBITOR)
    ("Bub1, BAY-320 and BAY-524" . SPARSER::COLLECTION)
    ("Bub1/Mps1" . SPARSER::COLLECTION) ("GFP-H2B" . SPARSER::COLLECTION)
    ("Mps1 or Bub1" . SPARSER::COLLECTION)
    ("Mps1 or BubR1" . SPARSER::COLLECTION) ("Eg5" . SPARSER::PROTEIN)
    ("Monastrol" . SPARSER::DRUG) ("Reversine" . SPARSER::DRUG)
    ("EGFP-Bub1" . SPARSER::COLLECTION)
    ("an immobile fraction" . SPARSER::COMPONENT)
    ("Mad1, Mad2 and BubR1" . SPARSER::COLLECTION)
    ("mitotic kinases" . SPARSER::KINASE)
    ("Bub1 and Haspin" . SPARSER::COLLECTION) ("MCAK" . SPARSER::PROTEIN)
    ("CENP-A and histone" . SPARSER::COLLECTION) ("INCENP" . SPARSER::PROTEIN)
    ("centromeres" . SPARSER::PROTEIN) ("Sgo" . SPARSER::PROTEIN)
    ("phospho-histone" . SPARSER::PROTEIN) ("amine" . SPARSER::MOLECULE)
    ("cyclopropyl" . SPARSER::MOLECULE)
    ("kinase-proficient Bub1" . SPARSER::PROTEIN)
    ("Saccharomyces" . SPARSER::PROTEIN) ("Survivin" . SPARSER::PROTEIN)
    ("Haspin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Borealin" . SPARSER::PROTEIN)
    ("only few substrates" . SPARSER::SUBSTRATE)
    ("Sgo1 and Sgo2" . SPARSER::COLLECTION)
    ("kinase, CENP-E, CENP-F, BubR1, Mad1 and Mad2" . SPARSER::COLLECTION)
    ("Mad2" . SPARSER::PROTEIN) ("Mad1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mad" . SPARSER::PROTEIN) ("MELT" . SPARSER::DRUG)
    ("termed mitotic checkpoint complex (MCC)" . SPARSER::BIO-COMPLEX)
    ("complex (MCC)" . SPARSER::BIO-COMPLEX)
    ("a diffusible inhibitor" . SPARSER::INHIBITOR)
    ("anaphase-promoting complex/cyclosome" . SPARSER::COLLECTION)
    ("cyclosome" . SPARSER::PROTEIN)
    ("several KT-associated protein kinases" . SPARSER::PROTEIN)
    ("benzimidazoles" . SPARSER::DRUG)
    ("two new molecules that inhibit Bub1’s" . SPARSER::MOLECULE)
    ("von" . SPARSER::PROTEIN) ("Baron" . SPARSER::PROTEIN)
    ("Shugoshin and the chromosomal passenger complex (CPC)"
     . SPARSER::COLLECTION)
    ("complex (CPC)" . SPARSER::BIO-COMPLEX) ("CPC" . SPARSER::PROTEIN)
    ("Shugoshin" . SPARSER::PROTEIN) ("SAC" . SPARSER::PROTEIN)
    ("1 A" . SPARSER::PROTEIN) ("BUB1" . SPARSER::PROTEIN)
    ("301A" . SPARSER::PROTEIN) ("AIM-1" . SPARSER::PROTEIN)
    ("LT1" . SPARSER::PROTEIN) ("RO-3306" . SPARSER::DRUG)
    ("Na3VO4" . SPARSER::MOLECULE) ("a 2 " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PP2A" . SPARSER::PROTEIN) ("phosphatase 2" . SPARSER::PROTEIN)
    ("Plk1" . SPARSER::PROTEIN) ("CENP-B" . SPARSER::PROTEIN)
    ("CENP-A" . SPARSER::PROTEIN) ("Cdc20" . SPARSER::PROTEIN)
    ("CENP-F" . SPARSER::PROTEIN) ("CENP-E" . SPARSER::PROTEIN)
    ("Sgo2" . SPARSER::PROTEIN) ("Sgo1" . SPARSER::PROTEIN)
    ("KNL-1" . SPARSER::PROTEIN)
    ("anaphase-promoting complex" . SPARSER::PROTEIN)
    ("Mps1" . SPARSER::PROTEIN) ("BRCA1-DBR" . SPARSER::COLLECTION)
    ("BRCA1-DBR/CHK1" . SPARSER::COLLECTION)
    ("TOPBP1, CLASPIN and CHK1" . SPARSER::COLLECTION)
    ("ATR, TOPBP1, CHK1, and BRCA1" . SPARSER::COLLECTION)
    ("TOPBP1/CLASPIN/CHK1" . SPARSER::COLLECTION)
    ("CLASPIN" . SPARSER::PROTEIN) ("ATM-" . SPARSER::PROTEIN)
    ("421-701aa" . SPARSER::PROTEIN) ("significantly more EdU" . SPARSER::DRUG)
    ("ΔDBR" . SPARSER::PROTEIN) ("Δ11" . SPARSER::PROTEIN)
    ("BRCA1-ΔDBR" . SPARSER::COLLECTION) ("DS" . SPARSER::PROTEIN)
    ("SS" . SPARSER::PROTEIN) ("MBP-421-701aa" . SPARSER::PROTEIN-PAIR)
    ("AFM" . SPARSER::PROTEIN)
    ("Further analysis using 3 MBP-tagged BRCA1" . SPARSER::PROTEIN)
    ("the precise DBR" . SPARSER::PROTEIN) ("BRCA1-Δ11" . SPARSER::COLLECTION)
    ("a large multifunctional protein" . SPARSER::PROTEIN)
    ("DBR" . SPARSER::PROTEIN) ("Cdc25" . SPARSER::PROTEIN)
    ("TOPBP1" . SPARSER::PROTEIN) ("PARP1" . SPARSER::PROTEIN)
    ("I-SceI" . SPARSER::PROTEIN) ("x 104" . SPARSER::PROTEIN)
    ("reducing agent" . SPARSER::MOLECULE)
    ("ammonium chloride" . SPARSER::MOLECULE)
    ("aspartic acid" . SPARSER::AMINO-ACID) ("two domains" . SPARSER::PROTEIN)
    ("three domains" . SPARSER::PROTEIN)
    ("breast cancer associated gene 1" . SPARSER::PROTEIN)
    ("mapping" . SPARSER::PROTEIN) ("ER– and ER+" . SPARSER::COLLECTION)
    ("UK" . SPARSER::PROTEIN) ("ILC" . SPARSER::PROTEIN)
    ("FHIT" . SPARSER::PROTEIN) ("-Het " . SPARSER::COLLECTION)
    ("Het " . SPARSER::HUMAN-PROTEIN-FAMILY) ("ER–" . SPARSER::PROTEIN)
    ("-Het" . SPARSER::COLLECTION) ("Het" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FGFR2 (rs2981579: OR 1.29, 95 % CI 1.24, 1.35; P  = 9.0 × 10 -30 ) and TOX3 (rs3803662: OR 1.15, 95 % CI 1.1, 1.21; P  = 1.7 × 10 -8 )"
     . SPARSER::COLLECTION)
    ("aims" . SPARSER::PROTEIN)
    ("different pathological subtypes" . SPARSER::PROTEIN)
    ("co-existing invasive components" . SPARSER::COMPONENT)
    ("the invasive component" . SPARSER::COMPONENT) ("LGR6" . SPARSER::PROTEIN)
    ("ZNF365" . SPARSER::PROTEIN) ("ATXN7" . SPARSER::PROTEIN)
    ("SLC4A7" . SPARSER::PROTEIN) ("CDKN2" . SPARSER::PROTEIN)
    ("TGFBR2" . SPARSER::PROTEIN) ("MAP3K1" . SPARSER::PROTEIN)
    ("chr3" . SPARSER::PROTEIN) ("TOX3" . SPARSER::PROTEIN)
    ("FGFR2" . SPARSER::PROTEIN) ("aPKC" . SPARSER::PROTEIN)
    ("EGFR and TGFβR" . SPARSER::COLLECTION)
    ("particular HDAC3" . SPARSER::PROTEIN)
    ("ERK and PI3K" . SPARSER::COLLECTION)
    ("TGF-β1/SMAD3" . SPARSER::COLLECTION)
    ("EGFR and HER2" . SPARSER::COLLECTION)
    ("c-Src and MMPs" . SPARSER::COLLECTION)
    ("DNMT1 and p53" . SPARSER::COLLECTION)
    ("nanoparticle" . SPARSER::MOLECULE)
    ("Celastrol and taxol" . SPARSER::COLLECTION)
    ("Celastrol" . SPARSER::MOLECULE)
    ("HDAC3 and pEGFGR" . SPARSER::COLLECTION) ("Gefitinib" . SPARSER::DRUG)
    ("EGFR inhibitor and the invasion potential" . SPARSER::COLLECTION)
    ("CTX and gefitinib" . SPARSER::COLLECTION)
    ("EGFR inhibitors and the invasion potential" . SPARSER::COLLECTION)
    ("cetuximab (CTX) and gefitinib" . SPARSER::COLLECTION)
    ("CTX" . SPARSER::PROTEIN) ("miR-126-DNMT1" . SPARSER::COLLECTION)
    ("EGFR-Akt" . SPARSER::COLLECTION)
    ("ABCB1 and ABCG2" . SPARSER::COLLECTION)
    ("ABCB1, ABCC1 and ABCG2" . SPARSER::COLLECTION)
    ("HDAC3 and DNMT1" . SPARSER::COLLECTION)
    ("DNMT1, GATA-1 and SP1" . SPARSER::COLLECTION) ("SP1" . SPARSER::PROTEIN)
    ("taxol and celastrol" . SPARSER::COLLECTION)
    ("celastrol" . SPARSER::MOLECULE)
    ("AP1 and E2F-depenedent" . SPARSER::COLLECTION) ("Cho" . SPARSER::PROTEIN)
    ("c-Met and EGFR" . SPARSER::COLLECTION)
    ("Ras/Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("HDAC4 and HDAC-6" . SPARSER::COLLECTION) ("vorinostat" . SPARSER::DRUG)
    ("SAHA" . SPARSER::DRUG) ("tubulin" . SPARSER::PROTEIN)
    ("Atypical protein kinase" . SPARSER::PROTEIN) ("PKCα" . SPARSER::PROTEIN)
    ("SMAD3" . SPARSER::PROTEIN) ("C-Src-" . SPARSER::PROTEIN)
    ("Site 1" . SPARSER::PROTEIN) ("site 2" . SPARSER::PROTEIN)
    ("site 1" . SPARSER::PROTEIN) ("Sp1" . SPARSER::PROTEIN)
    ("GATA-1" . SPARSER::PROTEIN) ("DNMT1" . SPARSER::PROTEIN)
    ("3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("HDAC2" . SPARSER::PROTEIN) ("HDAC-6" . SPARSER::PROTEIN)
    ("HDAC4" . SPARSER::PROTEIN) ("Runx2" . SPARSER::PROTEIN)
    ("HIF1β" . SPARSER::PROTEIN) ("SIAH2" . SPARSER::PROTEIN)
    ("PKCδ" . SPARSER::PROTEIN) ("HDAC3" . SPARSER::PROTEIN)
    ("Ubiquitin" . SPARSER::PROTEIN) ("USP/β-catenin" . SPARSER::COLLECTION)
    ("pyruvate" . SPARSER::PROTEIN)
    ("ovarian tumor related proteases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteases (USP)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Approximately 95 putative DUBs" . SPARSER::PROTEIN)
    ("Mov34" . SPARSER::PROTEIN) ("metalloenzyme" . SPARSER::PROTEIN-FAMILY)
    ("hydrolases" . SPARSER::PROTEIN) ("USP" . SPARSER::PROTEIN)
    ("polyubiquitin" . SPARSER::PROTEIN) ("monoubiquitin" . SPARSER::PROTEIN)
    ("transducin" . SPARSER::PROTEIN)
    ("serine-threonine" . SPARSER::COLLECTION)
    ("CK1 and GSK3" . SPARSER::COLLECTION)
    ("β-catenin and APS" . SPARSER::COLLECTION) ("APS" . SPARSER::PROTEIN)
    ("DCN" . SPARSER::PROTEIN)
    ("CDH2 , KIFC1 , and FALZ" . SPARSER::COLLECTION)
    ("β-catenin and ZEB1" . SPARSER::COLLECTION)
    ("CTRL or ZEB1-specific siRNA" . SPARSER::COLLECTION)
    ("CTRL, USP4, or β-catenin" . SPARSER::COLLECTION)
    ("ZEB1 and E-cadherin" . SPARSER::COLLECTION)
    ("CTRL or siRNAs" . SPARSER::COLLECTION) ("axin" . SPARSER::PROTEIN)
    ("tankyrase" . SPARSER::PROTEIN) ("b" . SPARSER::PROTEIN)
    ("FLAG-USP4" . SPARSER::COLLECTION)
    ("USP4/β-catenin" . SPARSER::COLLECTION)
    ("CTRL and USP4" . SPARSER::COLLECTION)
    ("IgG or β-catenin" . SPARSER::COLLECTION)
    ("an appropriate control IgG or an antibody" . SPARSER::COLLECTION)
    ("USP4 or β-catenin" . SPARSER::COLLECTION)
    ("CTRL or USP4-specific siRNA" . SPARSER::COLLECTION)
    ("CTRL" . SPARSER::PROTEIN) ("b-catenin" . SPARSER::COLLECTION)
    ("APC and GSK3β" . SPARSER::COLLECTION)
    ("vascular endothelial growth factor A ( VEGFA )" . SPARSER::PROTEIN)
    ("c-Jun ( JUN )" . SPARSER::PROTEIN) ("VEGFA" . SPARSER::PROTEIN)
    ("JUN" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-catenin and USP4" . SPARSER::COLLECTION) ("DUB" . SPARSER::PROTEIN)
    ("LV" . SPARSER::MOLECULE) ("USP8/UBPY" . SPARSER::COLLECTION)
    ("UBPY" . SPARSER::PROTEIN) ("DUBs" . SPARSER::PROTEIN)
    ("β-catenin or its regulator" . SPARSER::COLLECTION)
    ("c-Myc, cyclin D1, VEGF-A, MMP-7, and survivin" . SPARSER::COLLECTION)
    ("USP4 and β-catenin" . SPARSER::COLLECTION) ("SNAI1" . SPARSER::PROTEIN)
    ("ARF-binding protein 1" . SPARSER::PROTEIN) ("Ro52" . SPARSER::PROTEIN)
    ("JAB1" . SPARSER::PROTEIN) ("homolog 1" . SPARSER::PROTEIN)
    ("CK1" . SPARSER::PROTEIN) ("HOXB9" . SPARSER::PROTEIN)
    ("LEF1" . SPARSER::PROTEIN) ("ST6GALNAC5" . SPARSER::PROTEIN)
    ("DCUN1" . SPARSER::PROTEIN) ("KIFC1" . SPARSER::PROTEIN)
    ("XAV939" . SPARSER::DRUG) ("β-Catenin" . SPARSER::PROTEIN)
    ("EDN1" . SPARSER::PROTEIN) ("endothelin 1" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor A" . SPARSER::PROTEIN)
    ("SOX9" . SPARSER::PROTEIN) ("sex determining region Y" . SPARSER::PROTEIN)
    ("zinc finger E-box-binding homeobox 1" . SPARSER::PROTEIN)
    ("phospho-kinases" . SPARSER::PROTEIN) ("USP34" . SPARSER::PROTEIN)
    ("G-protein coupled" . SPARSER::PROTEIN) ("USP8" . SPARSER::PROTEIN)
    ("S33" . SPARSER::PROTEIN) ("VEGF-A" . SPARSER::PROTEIN)
    ("USP4" . SPARSER::PROTEIN) ("being homozygous CC" . SPARSER::MOLECULE)
    ("Australian cohorts" . SPARSER::MOLECULE)
    ("bisulfite-treated DNA molecules" . SPARSER::MOLECULE)
    ("Representative examples" . SPARSER::EXAMPLE)
    ("Examples" . SPARSER::EXAMPLE)
    ("genotypes, and MGMT" . SPARSER::COLLECTION)
    ("a heterozygous SNP" . SPARSER::NUCLEOTIDE)
    ("Bisulfite" . SPARSER::MOLECULE) ("melting" . SPARSER::DRUG)
    ("CDKN2B" . SPARSER::PROTEIN) ("O 6" . SPARSER::PROTEIN)
    ("O 6 -methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("miR-126 and other proto-oncogenes" . SPARSER::COLLECTION)
    ("/Akt" . SPARSER::COLLECTION)
    ("H-ras, K-ras and N-ras" . SPARSER::COLLECTION)
    ("angiogenic growth factors" . SPARSER::GROWTH-FACTOR)
    ("miRNA and its target genes" . SPARSER::COLLECTION)
    ("mRNA and proteins" . SPARSER::COLLECTION)
    ("miR-126 and KRAS" . SPARSER::COLLECTION)
    ("miR-221, let-7a, miR-21 and miR-126" . SPARSER::COLLECTION)
    ("miR-221, let-7a, miR-21, and miR-126" . SPARSER::COLLECTION)
    ("miR-181a" . SPARSER::MOLECULE) ("Ras family" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N-ras" . SPARSER::PROTEIN) ("H-ras" . SPARSER::PROTEIN)
    ("EGFL7" . SPARSER::PROTEIN) ("mIR-126" . SPARSER::PROTEIN)
    ("annexin-V" . SPARSER::PROTEIN) ("miR-221" . SPARSER::PROTEIN)
    ("YK" . SPARSER::MOLECULE) ("dystrophic" . SPARSER::PROTEIN)
    ("NAT10 and other nucleolar proteins" . SPARSER::COLLECTION)
    ("other nucleolar proteins" . SPARSER::PROTEIN)
    ("nucleolar protein ARF" . SPARSER::PROTEIN)
    ("polyubiquitination" . SPARSER::PROTEIN) ("ubiquitins" . SPARSER::PROTEIN)
    ("thioester" . SPARSER::MOLECULE) ("Ub" . SPARSER::PROTEIN)
    ("casein" . SPARSER::PROTEIN-FAMILY) ("TrCP" . SPARSER::PROTEIN)
    ("nucleolar protein NAT10" . SPARSER::PROTEIN)
    ("far more complex" . SPARSER::BIO-COMPLEX)
    ("ARF/RPs" . SPARSER::COLLECTION)
    ("Several ribosomal and nucleolar proteins" . SPARSER::PROTEIN)
    ("RPL5, RPL11, RPL23, NPM/B23, and nucleostemin" . SPARSER::COLLECTION)
    ("nucleostemin" . SPARSER::PROTEIN) ("NPM" . SPARSER::PROTEIN)
    ("CRCs" . SPARSER::PROTEIN) ("p21, Puma, and Bax" . SPARSER::COLLECTION)
    ("the nucleoplasmic NAT10" . SPARSER::PROTEIN)
    ("actinomycin D and doxorubicin" . SPARSER::COLLECTION)
    ("NAT10 and p53" . SPARSER::COLLECTION)
    ("doxorubicin and UV" . SPARSER::COLLECTION)
    ("p21, Puma, and Mdm2" . SPARSER::COLLECTION)
    ("actinomycin D, etoposide, and doxorubicin" . SPARSER::COLLECTION)
    ("either wild‐type NAT10 or the NAT10 GE mutant" . SPARSER::COLLECTION)
    ("NAT10 mRNA and ectopically expressed Flag‐NAT10" . SPARSER::COLLECTION)
    ("HECT" . SPARSER::PROTEIN) ("NAT10 and NAT10" . SPARSER::COLLECTION)
    ("NAT10 and GST‐Mdm2" . SPARSER::COLLECTION)
    ("se" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53, p21, and Puma" . SPARSER::COLLECTION)
    ("NAT10 and wild‐type" . SPARSER::COLLECTION)
    ("glycine" . SPARSER::AMINO-ACID) ("HAT" . SPARSER::PROTEIN)
    ("‐Gly/Ala" . SPARSER::COLLECTION) ("Arg/Gln" . SPARSER::COLLECTION)
    ("Gly" . SPARSER::AMINO-ACID) ("Gln" . SPARSER::AMINO-ACID)
    ("Arg" . SPARSER::AMINO-ACID) ("CoA" . SPARSER::MOLECULE)
    ("Mapping" . SPARSER::PROTEIN) ("NAT10 and Mdm2" . SPARSER::COLLECTION)
    ("p53 and Mdm2" . SPARSER::COLLECTION) ("Remodelin" . SPARSER::DRUG)
    ("a nucleolar protein" . SPARSER::PROTEIN) ("GNAT" . SPARSER::PROTEIN)
    ("hALP" . SPARSER::PROTEIN) ("Tip60, hMOF, and MOZ" . SPARSER::COLLECTION)
    ("MOZ" . SPARSER::PROTEIN) ("hMOF" . SPARSER::PROTEIN)
    ("MYST" . SPARSER::PROTEIN-FAMILY) ("KR" . SPARSER::PROTEIN-FAMILY)
    ("HDAC1 and SIRT1" . SPARSER::COLLECTION)
    ("CBP/p300" . SPARSER::COLLECTION) ("HATs" . SPARSER::PROTEIN)
    ("acetyltransferases" . SPARSER::PROTEIN) ("ARF/RP" . SPARSER::COLLECTION)
    ("RP" . SPARSER::PROTEIN) ("Ribosomal proteins" . SPARSER::PROTEIN)
    ("RPs" . SPARSER::PROTEIN) ("Nucleolar protein ARF" . SPARSER::PROTEIN)
    ("an essential inhibitor" . SPARSER::INHIBITOR)
    ("nucleolar protein" . SPARSER::PROTEIN)
    ("nucleolar proteins" . SPARSER::PROTEIN)
    ("Several nucleolar proteins" . SPARSER::PROTEIN)
    ("Mdm2–p53" . SPARSER::COLLECTION) ("UBCH5" . SPARSER::PROTEIN)
    ("UBE1" . SPARSER::PROTEIN) ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NEDD4" . SPARSER::PROTEIN) ("RPL23" . SPARSER::PROTEIN)
    ("RPL11" . SPARSER::PROTEIN) ("RPL5" . SPARSER::PROTEIN)
    ("E3s" . SPARSER::MOLECULE) ("Tip60" . SPARSER::PROTEIN)
    ("L11" . SPARSER::PROTEIN) ("ligase activity" . SPARSER::PROTEIN)
    ("NAT10" . SPARSER::PROTEIN) ("acute cannabis" . SPARSER::DRUG)
    ("metabolite" . SPARSER::MOLECULE) ("acute THC" . SPARSER::DRUG)
    ("Dopamine" . SPARSER::DRUG) ("Cannabis" . SPARSER::DRUG)
    ("COMT and AKT1" . SPARSER::COLLECTION) ("AKTI" . SPARSER::PROTEIN)
    ("THC and cannabidiol" . SPARSER::COLLECTION)
    ("AKT1 or COMT" . SPARSER::COLLECTION) ("Met/Met" . SPARSER::COLLECTION)
    ("Val/Met" . SPARSER::COLLECTION) ("Val/Val" . SPARSER::COLLECTION)
    ("Val" . SPARSER::AMINO-ACID) ("Methionine" . SPARSER::AMINO-ACID)
    ("Valine" . SPARSER::AMINO-ACID) ("dopamine" . SPARSER::PROTEIN)
    ("striatum" . SPARSER::PROTEIN) ("cannabidiol" . SPARSER::DRUG)
    ("THC" . SPARSER::DRUG)
    ("AKT1 and catechol-O-methyltransferase" . SPARSER::COLLECTION)
    ("COMT" . SPARSER::PROTEIN) ("cannabis" . SPARSER::DRUG)
    ("DRD2" . SPARSER::PROTEIN)
    ("catechol-O-methyltransferase" . SPARSER::PROTEIN)
    ("IL1A, NFKB1 and PAR1" . SPARSER::COLLECTION)
    ("PAR1 (30 %) and NFKB1 (17 %)" . SPARSER::COLLECTION)
    ("IL4 (34 %), PAR1 (30 %) and NFKB1 (17 %)" . SPARSER::COLLECTION)
    ("allele and genotype" . SPARSER::COLLECTION)
    ("pro-inflammatory mediators" . SPARSER::PROTEIN)
    ("TNF, IL1β, IL2, IL6, CXCL8 and CCL2" . SPARSER::COLLECTION)
    ("TNF" . SPARSER::PROTEIN) ("A2/A2" . SPARSER::COLLECTION)
    ("Ins/Ins" . SPARSER::COLLECTION) ("Ins" . SPARSER::PROTEIN)
    ("the pro-inflammatory cytokine IL1A" . SPARSER::PROTEIN)
    ("IL1A , IL4 , NFKB1 and PAR1" . SPARSER::COLLECTION)
    ("NFKB1 (rs28362491) and PAR1 (rs11267092) gene polymorphisms"
     . SPARSER::COLLECTION)
    ("four IL1A (rs3783553), IL4 (rs79071878), NFKB1 (rs28362491) and PAR1 (rs11267092) gene polymorphisms"
     . SPARSER::COLLECTION)
    ("POP7" . SPARSER::PROTEIN) ("IL - 1A" . SPARSER::PROTEIN)
    ("CCL2" . SPARSER::PROTEIN) ("CXCL8" . SPARSER::PROTEIN)
    ("IL2" . SPARSER::PROTEIN) ("IL1β" . SPARSER::PROTEIN)
    ("G protein-coupled" . SPARSER::PROTEIN)
    ("Transcription factor" . SPARSER::PROTEIN)
    ("A3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Interleukin-4" . SPARSER::PROTEIN)
    ("PAR1" . SPARSER::PROTEIN) ("receptor 1" . SPARSER::PROTEIN)
    ("NFKB1" . SPARSER::PROTEIN) ("IL4" . SPARSER::PROTEIN)
    ("interleukin 4" . SPARSER::PROTEIN) ("IL1A" . SPARSER::PROTEIN)
    ("interleukin 1" . SPARSER::PROTEIN)
    ("a morphologically heterogeneous type" . TYPE)
    ("c-Met-shRNA" . SPARSER::COLLECTION)
    ("c-Met-RNA2" . SPARSER::PROTEIN-PAIR) ("TMZ-treatment" . SPARSER::DRUG)
    ("log-rank" . SPARSER::PROTEIN) ("anti-MET/HGF" . SPARSER::COLLECTION)
    ("Erk, Akt, and Stat3" . SPARSER::COLLECTION)
    ("genes, proto-oncogenes and markers" . SPARSER::COLLECTION)
    ("the most common and malignant histological tumor type" . TYPE)
    ("TMZ" . SPARSER::DRUG) ("temozolomide" . SPARSER::DRUG)
    ("Aberrant c-Met" . SPARSER::PROTEIN) ("P13" . SPARSER::PROTEIN)
    ("RNA1" . SPARSER::PROTEIN-FAMILY)
    ("O-6-methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("IDH1" . SPARSER::PROTEIN) ("Hepatocyte growth factor" . SPARSER::PROTEIN)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("hepatocyte growth factor receptor" . SPARSER::PROTEIN)
    ("O6-methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("C-Met" . SPARSER::PROTEIN) ("Protein and Gene" . SPARSER::COLLECTION)
    ("the 2 Western cohorts" . SPARSER::MOLECULE)
    ("larger validation cohorts" . SPARSER::MOLECULE)
    ("its relatively large cohort and long duration" . SPARSER::COLLECTION)
    ("trastuzumab and vinorelbine" . SPARSER::COLLECTION)
    ("vinorelbine" . SPARSER::DRUG) ("hyperactive mTOR" . SPARSER::PROTEIN)
    ("HER2 and LKB1" . SPARSER::COLLECTION)
    ("LKB1 and pACC" . SPARSER::COLLECTION)
    ("functional LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a pivotal kinase" . SPARSER::KINASE) ("estradiol" . SPARSER::PROTEIN)
    ("LKB1 and ER" . SPARSER::COLLECTION)
    ("LKB1 and ERα" . SPARSER::COLLECTION) ("pACC" . SPARSER::PROTEIN)
    ("the high LKB1 and low LKB1" . SPARSER::COLLECTION)
    ("The major histological subtypes" . SPARSER::PROTEIN)
    ("MMH" . SPARSER::PROTEIN) ("protein and gene" . SPARSER::COLLECTION)
    ("gene and protein" . SPARSER::COLLECTION)
    ("Liver Kinase B1" . SPARSER::PROTEIN) ("D11" . SPARSER::PROTEIN)
    ("calmodulin-dependent protein kinase" . SPARSER::PROTEIN)
    ("AMPK subfamily" . SPARSER::PROTEIN) ("AMP- activated" . SPARSER::PROTEIN)
    ("AMP-activated" . SPARSER::PROTEIN)
    ("transcriptional repressor and EMT-activator" . SPARSER::COLLECTION)
    ("YAP/TAZ" . SPARSER::PROTEIN) ("AP-1" . SPARSER::PROTEIN)
    ("MCAT" . SPARSER::PROTEIN)
    ("the CTGF promoter and co-stimulates activation of a subset of target genes (termed ‘common ZEB1/YAP set')"
     . SPARSER::COLLECTION)
    ("YAP/TAZ-TEAD" . SPARSER::PROTEIN-PAIR)
    ("ZEB1-Smad3-p300-P/CAF" . SPARSER::COLLECTION)
    ("PC2-CtBP-LSD1-LCoR" . SPARSER::COLLECTION) ("LCoR" . SPARSER::PROTEIN)
    ("CtBP" . SPARSER::PROTEIN)
    ("ZEB1 and other EMT-activators" . SPARSER::COLLECTION)
    ("an oncogenic transmembrane receptor tyrosine kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a secreted extracellular matrix-associated protein" . SPARSER::PROTEIN)
    ("PATJ or the miR-200 family" . SPARSER::COLLECTION)
    ("Vimentin , N-Cadherin or matrix" . SPARSER::COLLECTION)
    ("PATJ" . SPARSER::PROTEIN) ("aggressive breast cancer types" . TYPE)
    ("ZEB1 and common ZEB1/YAP target genes" . SPARSER::COLLECTION)
    ("ZEB1 and TAZ" . SPARSER::COLLECTION) ("carboxy" . SPARSER::MOLECULE)
    ("HA- and His-pull-downs" . SPARSER::COLLECTION)
    ("His" . SPARSER::AMINO-ACID) ("ZEB1 or V5-tagged" . SPARSER::COLLECTION)
    ("a minimal promoter" . SPARSER::PROMOTER)
    ("CTGF and CYR61" . SPARSER::COLLECTION) ("synergizes" . SPARSER::PROTEIN)
    ("CDH1 and MIR200C" . SPARSER::COLLECTION)
    ("ZEB1 and re-ChIP" . SPARSER::COLLECTION)
    ("CTGF, CYR61, SDPR and AXL" . SPARSER::COLLECTION)
    ("SDPR" . SPARSER::PROTEIN) ("TEAD" . SPARSER::PROTEIN)
    ("LATS" . SPARSER::PROTEIN) ("Scribble" . SPARSER::PROTEIN)
    ("even slightly upregulated TAZ" . SPARSER::PROTEIN)
    ("ZEB1, the Hippo effectors YAP/TAZ and the EMT-activator SNAI2 (Slug)"
     . SPARSER::COLLECTION)
    ("CTGF and AXL" . SPARSER::COLLECTION) ("claudin" . SPARSER::PROTEIN)
    ("Snail-" . SPARSER::PROTEIN) ("ZEB" . SPARSER::PROTEIN)
    ("aggressive cancer types" . TYPE) ("HPRT1" . SPARSER::PROTEIN)
    ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("per 1 " . SPARSER::PROTEIN)
    ("WWTR1" . SPARSER::PROTEIN) ("YAP1" . SPARSER::PROTEIN)
    ("Smad1" . SPARSER::PROTEIN) ("Runx1" . SPARSER::PROTEIN)
    ("P/CAF" . SPARSER::PROTEIN) ("BRG1" . SPARSER::PROTEIN)
    ("LSD1" . SPARSER::PROTEIN) ("PC2" . SPARSER::PROTEIN)
    ("N-Cadherin" . SPARSER::PROTEIN) ("Crumbs3" . SPARSER::PROTEIN)
    ("E-Cadherin" . SPARSER::PROTEIN) ("YAP/TEAD" . SPARSER::PROTEIN)
    ("SNAI2" . SPARSER::PROTEIN) ("CYR61" . SPARSER::PROTEIN)
    ("p and p" . SPARSER::COLLECTION)
    ("cyclin E and CDK2" . SPARSER::COLLECTION)
    ("CDK2/cyclin A2" . SPARSER::COLLECTION) ("streptozotocin" . SPARSER::DRUG)
    ("PA-" . SPARSER::PROTEIN) ("lentiviral shRNAs" . SPARSER::RNA)
    ("CDK2 or PDK1" . SPARSER::COLLECTION)
    ("the pro-survival protein BCL-2 and the pro-apoptotic protein BAX"
     . SPARSER::COLLECTION)
    ("the pro-apoptotic protein BAX" . SPARSER::PROTEIN)
    ("BCL-2 and BAX" . SPARSER::COLLECTION)
    ("apoptosis-associated kinases Akt and p38MAPK" . SPARSER::COLLECTION)
    ("Akt and p38MAPK" . SPARSER::COLLECTION)
    ("annexin V and 7-AAD" . SPARSER::COLLECTION)
    ("two different lentiviral small hairpin RNAs" . SPARSER::RNA)
    ("Electron" . SPARSER::MOLECULE)
    ("differentially phosphorylated forms" . SPARSER::FORM)
    ("either GIT27 or its vehicle 24 h prior and 2 " . SPARSER::COLLECTION)
    ("normal glucose" . SPARSER::PROTEIN) ("Sera" . SPARSER::PROTEIN)
    ("LPS- or PA-treatment" . SPARSER::COLLECTION) ("LPS-" . SPARSER::PROTEIN)
    ("annexin V and 7-Aminoactinomycin-D" . SPARSER::COLLECTION)
    ("endotoxin" . SPARSER::MOLECULE) ("toxin" . SPARSER::MOLECULE)
    ("inducers" . SPARSER::MOLECULE) ("PA" . SPARSER::PROTEIN)
    ("Puromycin" . SPARSER::DRUG)
    ("had developed proteinuria" . SPARSER::PROTEIN)
    ("albumin/creatine" . SPARSER::COLLECTION) ("creatine" . SPARSER::PROTEIN)
    ("albumin" . SPARSER::PROTEIN)
    ("CDK2 and Wilms tumor 1" . SPARSER::COLLECTION)
    ("CDK2 and nephrin" . SPARSER::COLLECTION) ("nephrin" . SPARSER::PROTEIN)
    ("isolated rat glomerular and tubular fractions" . SPARSER::COMPONENT)
    ("Akt/CDK2" . SPARSER::COLLECTION)
    ("lipid-soluble membrane components" . SPARSER::COMPONENT)
    ("angiotensin II, and lipopolysaccharides" . SPARSER::COLLECTION)
    ("endotoxins" . SPARSER::MOLECULE) ("Pima" . SPARSER::DRUG)
    ("CDK2 and PDK1" . SPARSER::COLLECTION) ("roscovitine" . SPARSER::DRUG)
    ("proteinuria" . SPARSER::PROTEIN)
    ("immunomodulatory agent GIT27" . SPARSER::DRUG)
    ("TLR" . SPARSER::PROTEIN-FAMILY) ("lipopolysaccharide" . SPARSER::PROTEIN)
    ("sera" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("3-phosphoinositide dependent protein kinase-1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 4" . SPARSER::PROTEIN)
    ("TLR4" . SPARSER::PROTEIN) ("Toll-like receptor 4" . SPARSER::PROTEIN)
    ("WT1" . SPARSER::PROTEIN) ("Wilms tumor 1" . SPARSER::PROTEIN)
    ("angiotensin II" . SPARSER::PROTEIN) ("GIT27" . SPARSER::DRUG)
    ("chronic hypoxia" . SPARSER::PROTEIN)
    ("multiple p53 or HIF-dependent miRs" . SPARSER::COLLECTION)
    ("miRs" . SPARSER::PROTEIN) ("hypoxia-" . SPARSER::PROTEIN)
    ("DYNLL1 and tumor hypoxia" . SPARSER::COLLECTION)
    ("normoxia and hypoxia" . SPARSER::COLLECTION)
    ("either p53 (HCT116 p53 −/− ) or HIF-1α (RKO HIF-1α −/− )"
     . SPARSER::COLLECTION)
    ("neither p53 nor HIF-1" . SPARSER::COLLECTION)
    ("p53 and HIF-1" . SPARSER::COLLECTION)
    ("p53 or HIF-1α" . SPARSER::COLLECTION)
    ("RKO HIF-1α +/+ and RKO HIF-1α −/−" . SPARSER::COLLECTION)
    ("severe hypoxia" . SPARSER::PROTEIN) ("mild hypoxia" . SPARSER::PROTEIN)
    ("hTERT" . SPARSER::PROTEIN) ("SER" . SPARSER::AMINO-ACID)
    ("phosphorylated ATM (ATM-S1981) and the ATM target Kap-1 (Kap1-S824)"
     . SPARSER::COLLECTION)
    ("Kap-1" . SPARSER::PROTEIN) ("Kap" . SPARSER::PROTEIN)
    ("HIF-1 and p53" . SPARSER::COLLECTION)
    ("NaCl and chloroquine" . SPARSER::COLLECTION) ("APH" . SPARSER::PROTEIN)
    ("chloroquine" . SPARSER::PROTEIN) ("ATM/ATR" . SPARSER::COLLECTION)
    ("MMR" . SPARSER::PROTEIN) ("mismatch" . SPARSER::PROTEIN)
    ("aberrant and inefficient vasculature" . SPARSER::PROTEIN)
    ("vasculature" . SPARSER::PROTEIN) ("p53 and HIF-1α" . SPARSER::COLLECTION)
    ("ATM interactor (ATMIN)" . SPARSER::PROTEIN)
    ("aphidicolin and hydroxyurea" . SPARSER::COLLECTION)
    ("aphidicolin" . SPARSER::PROTEIN) ("ATMIN" . SPARSER::PROTEIN)
    ("SULF2" . SPARSER::PROTEIN) ("PHLDA3" . SPARSER::PROTEIN)
    ("KANK3" . SPARSER::PROTEIN) ("INPP5D" . SPARSER::PROTEIN)
    ("CYFIP2" . SPARSER::PROTEIN) ("BTG2" . SPARSER::PROTEIN)
    ("γH2AX" . SPARSER::PROTEIN) ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("micro-RNAs" . SPARSER::MICRO-RNA) ("18 h" . SPARSER::PROTEIN)
    ("KU-55933" . SPARSER::DRUG) ("Kap1" . SPARSER::PROTEIN)
    ("Zn 2+" . SPARSER::MOLECULE) ("53BP1" . SPARSER::PROTEIN)
    ("Rad51" . SPARSER::PROTEIN) ("DYNLL1" . SPARSER::PROTEIN)
    ("ATM interactor" . SPARSER::PROTEIN) ("anti-apoptotic" . SPARSER::PROTEIN)
    ("Bim:anti-apoptotic" . SPARSER::PROTEIN-PAIR)
    ("recurrent NB" . SPARSER::PROTEIN) ("Given ABT-199" . SPARSER::DRUG)
    ("Bim or other activator BH3 proteins" . SPARSER::COLLECTION)
    ("CPM " . SPARSER::PROTEIN) ("ABT-199 and CPM" . SPARSER::COLLECTION)
    ("CPM" . SPARSER::PROTEIN) ("previously tested ABT-737" . SPARSER::DRUG)
    ("alkylator" . SPARSER::MOLECULE)
    ("ABT-199 and cyclophosphamide" . SPARSER::COLLECTION)
    ("melphalan" . SPARSER::DRUG) ("Mcl-1 given ABT-199" . SPARSER::DRUG)
    ("Bcl-2 and Mcl-1" . SPARSER::COLLECTION)
    ("proteins, Bcl-2 and Mcl-1" . SPARSER::COLLECTION)
    ("etoposide" . SPARSER::PROTEIN) ("phosphatidylserine" . SPARSER::PROTEIN)
    ("Caspases" . SPARSER::PROTEIN) ("Bax and/or Bak" . SPARSER::COLLECTION)
    ("caspases" . SPARSER::PROTEIN) ("MOMP" . SPARSER::PROTEIN)
    ("SMS-SAN" . SPARSER::COLLECTION) ("Bim:Bcl-2" . SPARSER::BIO-COMPLEX)
    ("SAN" . SPARSER::PROTEIN) ("SMS" . SPARSER::PROTEIN)
    ("ABT-199 or ABT-737" . SPARSER::COLLECTION)
    ("pro-apoptotic small molecules" . SPARSER::MOLECULE)
    ("the unique primed state" . SPARSER::BIO-STATE)
    ("protein:protein" . SPARSER::BIO-COMPLEX)
    ("stress-activated BH3 proteins" . SPARSER::PROTEIN)
    ("fits" . SPARSER::PROTEIN-FAMILY) ("Bik" . SPARSER::PROTEIN)
    ("Bad" . SPARSER::PROTEIN) ("Bid" . SPARSER::PROTEIN)
    ("Bak" . SPARSER::PROTEIN)
    ("mitochondrial resident Bcl-2 family proteins" . SPARSER::PROTEIN)
    ("Mcl-1 and Bcl-2" . SPARSER::COLLECTION)
    ("NBs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Venetoclax" . SPARSER::DRUG)
    ("mature platelets" . SPARSER::PROTEIN) ("Navitoclax" . SPARSER::DRUG)
    ("cyclophosphamide and ABT-737" . SPARSER::COLLECTION)
    ("/Bcl-w" . SPARSER::COLLECTION) ("Bcl-2/Bcl-X" . SPARSER::COLLECTION)
    ("cyclophosphamide" . SPARSER::DRUG)
    ("the pro-apoptotic protein" . SPARSER::PROTEIN) ("Bim" . SPARSER::PROTEIN)
    ("NB" . SPARSER::PROTEIN) ("ABT-199 " . SPARSER::DRUG)
    ("alkylating agent" . SPARSER::MOLECULE) ("caspases 3" . SPARSER::PROTEIN)
    ("L-Glutamine" . SPARSER::MOLECULE) ("AT-101" . SPARSER::DRUG)
    ("HA14-1" . SPARSER::DRUG) ("Bfl-1" . SPARSER::PROTEIN)
    ("Mcl-1" . SPARSER::PROTEIN) ("Bcl-x" . SPARSER::PROTEIN)
    ("Bcl-w" . SPARSER::PROTEIN) ("Bcl-X" . SPARSER::PROTEIN)
    ("ABT-737" . SPARSER::DRUG) ("ETS2, COP1 and mtp53" . SPARSER::COLLECTION)
    ("dCK" . SPARSER::PROTEIN)
    ("COP1, DET1, ETS2 and mtp53" . SPARSER::COLLECTION)
    ("HA-ubiquitin" . SPARSER::COLLECTION)
    ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("serine triple mutant (S220, S225, S248) and DET1" . SPARSER::COLLECTION)
    ("serine triple mutant" . SPARSER::MUTANT)
    ("ETS2/DET1" . SPARSER::COLLECTION) ("serines" . SPARSER::AMINO-ACID)
    ("CDK10 and ETS2" . SPARSER::COLLECTION)
    ("opted" . SPARSER::HUMAN-PROTEIN-FAMILY) ("VP" . SPARSER::PROTEIN)
    ("Δ8–l04" . SPARSER::PROTEIN) ("ETS2 and DET1" . SPARSER::COLLECTION)
    ("ETS2 and COP1" . SPARSER::COLLECTION)
    ("ETS2, COP1 and DET1" . SPARSER::COLLECTION)
    ("COP1, DET1 and ETS2" . SPARSER::COLLECTION)
    ("the DDBl protein's" . SPARSER::PROTEIN)
    ("propellers" . SPARSER::PROTEIN-FAMILY)
    ("ETS2/COP1" . SPARSER::COLLECTION) ("Myc-ETS2" . SPARSER::COLLECTION)
    ("Myc-DET1DET1" . SPARSER::COLLECTION) ("Myc-COP1" . SPARSER::COLLECTION)
    ("unt" . SPARSER::MOLECULE) ("COP1 and DET1" . SPARSER::COLLECTION)
    ("Proteasomal" . SPARSER::PROTEIN)
    ("commercially available antibodies" . SPARSER::ANTIBODY)
    ("either COP1 or its binding partner DET1" . SPARSER::COLLECTION)
    ("SCF" . SPARSER::PROTEIN)
    ("possible therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("possible target genes" . SPARSER::GENE)
    ("c-Jun and the ETS proteins ETS variant 1 (ETV1)" . SPARSER::COLLECTION)
    ("ETS variant 4 (ETV4) and ETS variant 5 (ETV5)" . SPARSER::COLLECTION)
    ("the Damage-Specific DNA Binding Protein 1 (DDB1)–Cullin 4a (Cul4a) E3 ligase complex"
     . SPARSER::BIO-COMPLEX)
    ("Cul4a" . SPARSER::PROTEIN)
    ("the constitutive photomorphogenesis protein 1 (COP1) and the adaptor protein De-etiolated"
     . SPARSER::COLLECTION)
    ("most probable candidate ubiquitin ligases" . SPARSER::LIGASE)
    ("an evolutionary conserved proto-oncogene and a downstream effector"
     . SPARSER::COLLECTION)
    ("ETS2, an evolutionary conserved proto-oncogene and a downstream effector"
     . SPARSER::COLLECTION)
    ("an evolutionary conserved proto-oncogene" . SPARSER::PROTEIN)
    ("proteases and anti-apoptotic" . SPARSER::COLLECTION)
    ("Ras/Raf/MAPK" . SPARSER::COLLECTION)
    ("proteases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ETS erythroblastosis virus E26 oncogene homologue (ETS1) and ETS erythroblastosis virus E26 oncogene homologue"
     . SPARSER::COLLECTION)
    ("DET1/ETS2" . SPARSER::COLLECTION) ("COP1/DET1" . SPARSER::COLLECTION)
    ("DET1 and ETS2" . SPARSER::COLLECTION) ("ligases" . SPARSER::PROTEIN)
    ("pGL4" . SPARSER::PROTEIN) ("sc-35" . SPARSER::PROTEIN)
    ("Ets-2" . SPARSER::PROTEIN) ("l26" . SPARSER::PROTEIN)
    ("C-20" . SPARSER::PROTEIN) ("E-5" . SPARSER::PROTEIN)
    ("beta-Galactosidase" . SPARSER::PROTEIN) ("RFWD2" . SPARSER::PROTEIN)
    ("cyclin dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDK10" . SPARSER::PROTEIN) ("D-X" . SPARSER::PROTEIN)
    ("P-E" . SPARSER::PROTEIN) ("MG-132" . SPARSER::DRUG)
    ("Cul4" . SPARSER::PROTEIN) ("Cullin 4" . SPARSER::PROTEIN)
    ("DDB1" . SPARSER::PROTEIN)
    ("Damage-Specific DNA Binding Protein 1" . SPARSER::PROTEIN)
    ("ETV5" . SPARSER::PROTEIN) ("ETS variant 5" . SPARSER::PROTEIN)
    ("ETV4" . SPARSER::PROTEIN) ("ETS variant 4" . SPARSER::PROTEIN)
    ("ETV1" . SPARSER::PROTEIN) ("ETS variant 1" . SPARSER::PROTEIN)
    ("c-Jun" . SPARSER::PROTEIN) ("ETS2 protein" . SPARSER::PROTEIN)
    ("proto-oncogene" . SPARSER::PROTEIN) ("ETS1" . SPARSER::PROTEIN)
    ("ETS family" . SPARSER::PROTEIN) ("DET1" . SPARSER::PROTEIN)
    ("De-" . SPARSER::MOLECULE) ("COP1" . SPARSER::PROTEIN)
    ("ETS2" . SPARSER::PROTEIN) ("which targets OLFM4" . SPARSER::PROTEIN)
    ("/AKT" . SPARSER::COLLECTION)
    ("estrogen and progesterone" . SPARSER::COLLECTION)
    ("CLDN10 and CITRON" . SPARSER::COLLECTION) ("CITRON" . SPARSER::PROTEIN)
    ("Western blot and miR-486-5" . SPARSER::COLLECTION)
    ("blot and miR-486-5" . SPARSER::COLLECTION)
    ("OLFM4 and ERα" . SPARSER::COLLECTION)
    ("ERα and PR" . SPARSER::COLLECTION)
    ("OLFM4, ERα, and PR" . SPARSER::COLLECTION)
    ("hGC-1" . SPARSER::COLLECTION)
    ("estrogen and progesterone, and estrogens" . SPARSER::COLLECTION)
    ("progesterone, and estrogens" . SPARSER::COLLECTION)
    ("estrogens" . SPARSER::MOLECULE) ("CLDN10" . SPARSER::PROTEIN)
    ("Pim-1" . SPARSER::PROTEIN) ("17β-estradiol" . SPARSER::PROTEIN)
    ("granulocyte colony-stimulating factor" . SPARSER::PROTEIN)
    ("GW112" . SPARSER::PROTEIN) ("Olfactomedin 4" . SPARSER::PROTEIN)
    ("Estrogen receptor" . SPARSER::PROTEIN) ("OLFM4" . SPARSER::PROTEIN)
    ("olfactomedin 4" . SPARSER::PROTEIN)
    ("protein and KRAS and BRAF" . SPARSER::COLLECTION)
    ("both KRAS (17-41%) and BRAF (30-71%)" . SPARSER::COLLECTION)
    ("serous BOT" . SPARSER::PROTEIN)
    ("a significantly greater fraction" . SPARSER::COMPONENT)
    ("van" . SPARSER::PROTEIN) ("CISH" . SPARSER::PROTEIN)
    ("a serous BOT and the COSM26129" . SPARSER::COLLECTION)
    ("a serous BOT" . SPARSER::PROTEIN) ("BOT" . SPARSER::PROTEIN)
    ("SNP" . SPARSER::NUCLEOTIDE)
    ("EGFR , BRAF and KRAS" . SPARSER::COLLECTION)
    ("monoclonal antibodies and small-molecule tyrosine kinase inhibitors"
     . SPARSER::COLLECTION)
    ("monoclonal antibodies" . SPARSER::ANTIBODY)
    ("RAS and RAF" . SPARSER::COLLECTION)
    ("Serous and mucinous varieties" . SPARSER::VARIETY)
    ("varieties" . SPARSER::VARIETY) ("cyclin-D1" . SPARSER::PROTEIN)
    ("GDI, GDF and GEF" . SPARSER::COLLECTION)
    ("Mon1a–CcZ1" . SPARSER::PROTEIN-PAIR)
    ("the phosphomimetic mutant" . SPARSER::MUTANT)
    ("GDP and GTP" . SPARSER::COLLECTION) ("PM" . SPARSER::PROTEIN)
    ("A phosphomimetic Y183D mutant" . SPARSER::MUTANT)
    ("Rab-interacting lysosomal protein (RILP)" . SPARSER::PROTEIN)
    ("RILP" . SPARSER::PROTEIN)
    ("cytoplasmic GDP-associated inactive Rab7" . SPARSER::PROTEIN)
    ("GDP/GTP" . SPARSER::PROTEIN-PAIR) ("GDF" . SPARSER::PROTEIN)
    ("Rabs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a phosphomimetic Rab7 mutant" . SPARSER::MUTANT)
    ("phosphomimetic mutant" . SPARSER::MUTANT)
    ("phospho-mimetic mutants" . SPARSER::MUTANT)
    ("late endo-lysosomal marker LAMP2" . SPARSER::PROTEIN)
    ("endo-lysosomal" . SPARSER::COLLECTION) ("endo" . SPARSER::PROTEIN)
    ("Wild-type Rab7 and a phospho-dead mutant (S72A/Y183F)"
     . SPARSER::COLLECTION)
    ("a constitutively phospho-mimetic mutant" . SPARSER::MUTANT)
    ("punctate" . SPARSER::PROTEIN)
    ("serine and tyrosine" . SPARSER::COLLECTION)
    ("catalytically protein phosphatase dead C124S and Y138F mutants"
     . SPARSER::MUTANT)
    ("PTEN and Rab7" . SPARSER::COLLECTION) ("MBP-PTEN" . SPARSER::COLLECTION)
    ("GST-Rab7" . SPARSER::COLLECTION) ("MBP" . SPARSER::PROTEIN)
    ("non-hydrolyzable GTP (GTP-γ-S) or GDP (GDP-β-S)" . SPARSER::COLLECTION)
    ("protein and weaker" . SPARSER::COLLECTION)
    ("particular guanine nucleotide-associated Rab7" . SPARSER::PROTEIN)
    ("membrane-associated GTP-bound active conformations"
     . SPARSER::BIO-CONFORMATION)
    ("conformations" . SPARSER::BIO-CONFORMATION)
    ("exogenously expressed SFB-tagged Rab7 ( xref ) and conversely endogenous Rab7"
     . SPARSER::COLLECTION)
    ("PTEN-Rab7" . SPARSER::COLLECTION) ("SFB" . SPARSER::PROTEIN)
    ("SBP" . SPARSER::PROTEIN) ("streptavidin" . SPARSER::PROTEIN)
    ("a PTEN-associated protein" . SPARSER::PROTEIN)
    ("MDA-MB 468" . SPARSER::PROTEIN)
    ("alexa Flour 647-conjugated EGF" . SPARSER::PROTEIN)
    ("an essential lipid" . SPARSER::LIPID) ("EGF/EGFR" . SPARSER::COLLECTION)
    ("clathrin" . SPARSER::PROTEIN)
    ("a transmembrane receptor tyrosine kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a dual-specific phosphatase" . SPARSER::PHOSPHATASE)
    ("lipid and protein" . SPARSER::COLLECTION)
    ("Phosphatase and tensin" . SPARSER::COLLECTION)
    ("Phosphatase" . SPARSER::PHOSPHATASE) ("Rab7" . SPARSER::PROTEIN)
    ("GDI" . SPARSER::PROTEIN) ("a functional PTEN" . SPARSER::PROTEIN)
    ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatase and tensin" . SPARSER::COLLECTION)
    ("tensin" . SPARSER::PROTEIN) ("pH 3" . SPARSER::MOLECULE)
    ("FGF1" . SPARSER::PROTEIN) ("CD 63" . SPARSER::PROTEIN)
    ("triton X-100" . SPARSER::MOLECULE) ("GTPγS" . SPARSER::PROTEIN)
    ("GDPβS" . SPARSER::MOLECULE) ("myelin basic protein" . SPARSER::PROTEIN)
    ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N -methyl- D -aspartate" . SPARSER::MOLECULE)
    ("Mon1a" . SPARSER::PROTEIN)
    ("Rab-interacting lysosomal protein" . SPARSER::PROTEIN)
    ("Mon1" . SPARSER::PROTEIN-FAMILY) ("Phos-tag" . SPARSER::DRUG)
    ("S-protein" . SPARSER::PROTEIN) ("CD63" . SPARSER::PROTEIN)
    ("EEA1" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-phosphate" . SPARSER::MOLECULE)
    ("PI3K-AKT" . SPARSER::PROTEIN) ("PIP2" . SPARSER::PIP2)
    ("phosphatidylinositol-4,5-bisphosphate" . SPARSER::PIP2)
    ("PIP3" . SPARSER::PIP3)
    ("phosphatidylinositol-3,4,5-trisphosphate" . SPARSER::PIP3)
    ("autosomal dominant" . SPARSER::PROTEIN)
    ("protein phosphatase" . SPARSER::PROTEIN)
    ("genes and microRNAs" . SPARSER::COLLECTION)
    ("the mouse Kcnq1ot1" . SPARSER::PROTEIN)
    ("Jarid1c or Utx" . SPARSER::COLLECTION) ("Jarid1c" . SPARSER::PROTEIN)
    ("histone methyltransferases and the polycomb group proteins Eed"
     . SPARSER::COLLECTION)
    ("Ezh2" . SPARSER::PROTEIN) ("Eed" . SPARSER::PROTEIN)
    ("polycomb" . SPARSER::PROTEIN) ("Xist" . SPARSER::PROTEIN)
    ("Kcnq1ot1" . SPARSER::PROTEIN) ("Kcnq1" . SPARSER::PROTEIN)
    ("Differentially" . SPARSER::PROTEIN)
    ("PHLDA2 and SLC22A18" . SPARSER::COLLECTION)
    ("SLC22A18, PHLDA2 and CDKN1C" . SPARSER::COLLECTION)
    ("PHLDA2 and cyclin-dependent kinase inhibitor 1C" . SPARSER::COLLECTION)
    ("RNA-fluorescence" . SPARSER::RNA) ("only G allele" . SPARSER::ALLELE)
    ("inhibitor ( AXIN )" . SPARSER::INHIBITOR) ("AXIN" . SPARSER::PROTEIN)
    ("XIST" . SPARSER::PROTEIN)
    ("the HOX transcript antisense RNA ( HOTAIR ) and the KCNQ1 opposite strand/antisense transcript 1 ( KCNQ1OT1 , also known as LIT1 )"
     . SPARSER::COLLECTION)
    ("RNA ( HOTAIR )" . SPARSER::RNA) ("HOTAIR" . SPARSER::PROTEIN)
    ("HOX" . SPARSER::PROTEIN) ("SLC22A18 and PHLDA2" . SPARSER::COLLECTION)
    ("lncRNA" . SPARSER::RNA) ("lncRNAs" . SPARSER::RNA)
    ("β-tubulin" . SPARSER::PROTEIN) ("L-15" . SPARSER::PROTEIN)
    ("MALAT1" . SPARSER::PROTEIN) ("1-L" . SPARSER::PROTEIN)
    ("Suz12" . SPARSER::PROTEIN) ("NF-Y" . SPARSER::PROTEIN)
    ("TCF-1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 1C" . SPARSER::PROTEIN)
    ("member 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("family A" . SPARSER::PROTEIN)
    ("pleckstrin homology-like domain" . SPARSER::PROTEIN)
    ("solute carrier family 22 member 18" . SPARSER::PROTEIN)
    ("DLD-1" . SPARSER::PROTEIN) ("E2F4" . SPARSER::PROTEIN)
    ("casein kinase 1" . SPARSER::PROTEIN) ("LIT1" . SPARSER::PROTEIN)
    ("INK4A" . SPARSER::PROTEIN) ("PHLDA2" . SPARSER::PROTEIN)
    ("SLC22A18" . SPARSER::PROTEIN) ("KCNQ1" . SPARSER::PROTEIN)
    ("KCNQ1OT1" . SPARSER::PROTEIN) ("Rheb and mTOR" . SPARSER::COLLECTION)
    ("TSC2-Rag" . SPARSER::COLLECTION)
    ("Each stress alone causes TSC2" . SPARSER::PROTEIN)
    ("met—amino acids" . SPARSER::COLLECTION)
    ("COS and HepG2" . SPARSER::COLLECTION) ("COS" . SPARSER::MOLECULE)
    ("constitutively lysosomal TSC2" . SPARSER::PROTEIN) ("Type" . TYPE)
    ("growth factors and amino acids" . SPARSER::COLLECTION)
    ("TSC2/LAMP2" . SPARSER::COLLECTION)
    ("TSC2, TSC1 and TBC1D7" . SPARSER::COLLECTION)
    ("the peroxisomal marker PMP70" . SPARSER::PROTEIN)
    ("TSC1 -null MEFs" . SPARSER::PROTEIN)
    ("TSC2 and TSC1" . SPARSER::COLLECTION) ("low-glucose" . SPARSER::PROTEIN)
    ("NaCl" . SPARSER::PROTEIN) ("cobalt" . SPARSER::MOLECULE)
    ("TSC2 -null MEFs" . SPARSER::PROTEIN)
    ("FBS and amino acids" . SPARSER::COLLECTION)
    ("amino-acid removal inactivated mTORC1" . SPARSER::PROTEIN)
    ("conformation" . SPARSER::BIO-CONFORMATION)
    ("complex (TSC)" . SPARSER::BIO-COMPLEX)
    ("TSC1, TSC2 and TBC1D7" . SPARSER::COLLECTION) ("TSC" . SPARSER::PROTEIN)
    ("Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("amino acid and growth factor" . SPARSER::COLLECTION)
    ("amino acids and growth factors" . SPARSER::COLLECTION)
    ("–3 " . SPARSER::PROTEIN) ("beta-glycerophosphate" . SPARSER::DRUG)
    ("p-p38" . SPARSER::PROTEIN) ("NaHCO 3" . SPARSER::DRUG)
    ("CCL-2" . SPARSER::PROTEIN) ("PMP70" . SPARSER::PROTEIN)
    ("CoCl 2" . SPARSER::MOLECULE) ("D -glucose" . SPARSER::MOLECULE)
    ("sodium chloride" . SPARSER::DRUG) ("LAMP2" . SPARSER::PROTEIN)
    ("TBC1D7" . SPARSER::PROTEIN) ("TSC1" . SPARSER::PROTEIN)
    ("PDCD4 and TIMP3" . SPARSER::COLLECTION)
    ("PR and PDX" . SPARSER::COLLECTION)
    ("colorectal cancer PDX" . SPARSER::PROTEIN)
    ("Estrogen and HER2" . SPARSER::COLLECTION)
    ("Estrogen" . SPARSER::MOLECULE) ("an Italian ICC PDX" . SPARSER::PROTEIN)
    ("PR and its PDX" . SPARSER::COLLECTION)
    ("differentially expressed genes" . SPARSER::GENE)
    ("nucleosome" . SPARSER::PROTEIN) ("GO" . SPARSER::PROTEIN)
    ("CGH" . SPARSER::PROTEIN)
    ("EMA as well as the Hematoxillin" . SPARSER::COLLECTION)
    ("EMA" . SPARSER::PROTEIN) ("BTC" . SPARSER::PROTEIN)
    ("asbestos" . SPARSER::MOLECULE) ("toxins" . SPARSER::MOLECULE)
    ("ECC" . SPARSER::MOLECULE) ("gene and microRNA" . SPARSER::COLLECTION)
    ("Shi" . SPARSER::PROTEIN) ("TIMP3" . SPARSER::PROTEIN)
    ("miR-21" . SPARSER::PROTEIN) ("anti- EGFR" . SPARSER::PROTEIN)
    ("b-5" . SPARSER::PROTEIN) ("miR-15b" . SPARSER::MOLECULE)
    ("let-7" . SPARSER::RNA) ("Cytokeratin 7" . SPARSER::PROTEIN)
    ("RPL21" . SPARSER::PROTEIN) ("B-RAF" . SPARSER::PROTEIN)
    ("PI3" . SPARSER::PROTEIN) ("N-RAS" . SPARSER::PROTEIN)
    ("K-RAS" . SPARSER::PROTEIN) ("cytokeratin 7" . SPARSER::PROTEIN)
    ("TS" . SPARSER::PROTEIN) ("ctDNA" . SPARSER::PROTEIN)
    ("Kappa " . SPARSER::PROTEIN-FAMILY) ("TKI-naïve" . SPARSER::PROTEIN-PAIR)
    ("mixtures" . SPARSER::MOLECULE) ("– 2" . SPARSER::PROTEIN)
    ("EGFR-TKI" . SPARSER::PROTEIN) ("p53 and RB1" . SPARSER::COLLECTION)
    ("paclitaxel and cisplatin" . SPARSER::COLLECTION)
    ("p53 or miRNAs" . SPARSER::COLLECTION) ("pRB-E2F1" . SPARSER::COLLECTION)
    ("pRB" . SPARSER::PROTEIN) ("E2F1-RB" . SPARSER::COLLECTION)
    ("Chk1 and Wee1" . SPARSER::COLLECTION) ("E2F-RB1" . SPARSER::COLLECTION)
    ("RB1-E2F1" . SPARSER::COLLECTION) ("BLM and IR" . SPARSER::COLLECTION)
    ("a larger cohort" . SPARSER::MOLECULE)
    ("radiosensitizers" . SPARSER::DRUG) ("RB1 and E2F1" . SPARSER::COLLECTION)
    ("these TFs control Chk1’s" . SPARSER::PROTEIN)
    ("the Dominant Negative (DN) form" . SPARSER::FORM)
    ("E2F1 and pGL3-F0" . SPARSER::COLLECTION) ("–1 " . SPARSER::PROTEIN)
    ("E2F1 and p53" . SPARSER::COLLECTION)
    ("p53 and E2F1" . SPARSER::COLLECTION) ("DNA-" . SPARSER::DNA)
    ("transcription factor (TF)" . SPARSER::PROTEIN)
    ("IR or BLM" . SPARSER::COLLECTION)
    ("both full-length and short forms" . SPARSER::COLLECTION)
    ("the classic Chk1" . SPARSER::PROTEIN) ("WB" . SPARSER::PROTEIN)
    ("western blot (WB)" . SPARSER::PROTEIN)
    ("BLM or IR" . SPARSER::COLLECTION)
    ("cisplatin (CDDP)" . SPARSER::MOLECULE)
    ("the radiomimetic agent Bleomycin (BLM) and IR" . SPARSER::COLLECTION)
    ("the radiomimetic agent Bleomycin (BLM)" . SPARSER::DRUG)
    ("Bleomycin (BLM)" . SPARSER::DRUG) ("BLM" . SPARSER::PROTEIN)
    ("CDDP" . SPARSER::DRUG) ("RB1/E2F1" . SPARSER::COLLECTION)
    ("a predictive biomarker" . SPARSER::MOLECULE)
    ("ATR and ATM" . SPARSER::COLLECTION)
    ("a multifunctional Ser/Thr kinase protein" . SPARSER::PROTEIN)
    ("IB" . SPARSER::DRUG) ("p53 and RB/E2F1" . SPARSER::COLLECTION)
    ("that Chk1’s" . SPARSER::PROTEIN) ("RB/E2F1" . SPARSER::COLLECTION)
    ("GC" . SPARSER::PROTEIN) ("Monoclonal Antibody" . SPARSER::DRUG)
    ("6B" . SPARSER::PROTEIN) ("Rb- 1" . SPARSER::PROTEIN)
    ("pEF1" . SPARSER::PROTEIN) ("p53 " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PEF1" . SPARSER::PROTEIN) ("HEY1" . SPARSER::PROTEIN)
    ("pSG5" . SPARSER::PROTEIN) ("delta-" . SPARSER::PROTEIN)
    ("Wee1" . SPARSER::PROTEIN) ("miR-16" . SPARSER::PROTEIN)
    ("BCl-2" . SPARSER::PROTEIN) ("AZD7762" . SPARSER::DRUG)
    ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Hey1" . SPARSER::PROTEIN)
    ("Caspase 3" . SPARSER::PROTEIN) ("Checkpoint Kinase 1" . SPARSER::PROTEIN)
    ("PAF53 and U3-55k" . SPARSER::COLLECTION)
    ("U3-55k or other U3 snoRNA-specific proteins" . SPARSER::COLLECTION)
    ("NOP56, NOP58 or fibrillarin" . SPARSER::COLLECTION)
    ("SIRT7 and U3-55k" . SPARSER::COLLECTION)
    ("a U3 snoRNA-associated protein" . SPARSER::PROTEIN)
    ("the nucleolar protein U3-55k" . SPARSER::PROTEIN)
    ("GABP" . SPARSER::PROTEIN)
    ("a weak or substrate-specific deacetylase activity" . SPARSER::PROTEIN)
    ("SIRT7 and U3" . SPARSER::COLLECTION)
    ("U3-55k-associated U3 snoRNA" . SPARSER::RNA)
    ("nucleolar U3-55k" . SPARSER::PROTEIN) ("K12/25R" . SPARSER::PROTEIN)
    ("ribonucleotide (AICAR)" . SPARSER::MOLECULE)
    ("ribonucleotide" . SPARSER::MOLECULE) ("mutB" . SPARSER::PROTEIN)
    ("GST-15.5k" . SPARSER::COLLECTION)
    ("bead-bound GFP-U3-55k" . SPARSER::COLLECTION)
    ("GFP-U3-55k" . SPARSER::COLLECTION) ("2KQ" . SPARSER::PROTEIN)
    ("U3-55k/2KR" . SPARSER::COLLECTION) ("U3-55k/2KQ" . SPARSER::PROTEIN)
    ("18S rRNA processing intermediates 21S and 18SE RNA ( xref and xref )"
     . SPARSER::COLLECTION)
    ("SE" . SPARSER::PROTEIN) ("U3-55k or SIRT7" . SPARSER::COLLECTION)
    ("wild-type U3-55k and the mutants" . SPARSER::COLLECTION)
    ("arginine or glutamine" . SPARSER::COLLECTION)
    ("U3-55k and U3" . SPARSER::COLLECTION) ("GFP-SIRT7" . SPARSER::COLLECTION)
    ("SIRT1 or SIRT6" . SPARSER::COLLECTION)
    ("Flag-U3-55k" . SPARSER::COLLECTION)
    ("SIRT7 or another nuclear sirtuin" . SPARSER::COLLECTION)
    ("SIRT1, SIRT6 and SIRT7" . SPARSER::COLLECTION)
    ("acetyltransferase" . SPARSER::PROTEIN)
    ("trichostatin" . SPARSER::MOLECULE)
    ("U3-55k, NOP56, NOP58, fibrillarin and 15.5k" . SPARSER::COLLECTION)
    ("PCAF" . SPARSER::PROTEIN) ("SIRT7/H187Y" . SPARSER::PROTEIN)
    ("exogenous SIRT7" . SPARSER::PROTEIN)
    ("a competitive inhibitor" . SPARSER::INHIBITOR)
    ("NAM" . SPARSER::PROTEIN-FAMILY) ("shorter RNAs" . SPARSER::RNA)
    ("HA-" . SPARSER::PROTEIN) ("auxiliary proteins" . SPARSER::PROTEIN)
    ("mature U3 snoRNA" . SPARSER::RNA) ("pre-U3" . SPARSER::COLLECTION)
    ("mature snoRNAs" . SPARSER::RNA) ("U3 and U13" . SPARSER::COLLECTION)
    ("small Cajal body-specific (sca) RNAs" . SPARSER::RNA)
    ("Cajal" . SPARSER::PROTEIN) ("ACA" . SPARSER::PROTEIN)
    ("ribosomal proteins and snoRNAs" . SPARSER::COLLECTION)
    ("proteins and snoRNAs" . SPARSER::COLLECTION)
    ("SIRT7-associated RNA" . SPARSER::RNA)
    ("numerous messenger RNAs (mRNAs) and non-coding RNAs ( xref )"
     . SPARSER::COLLECTION)
    ("SIRT7-associated RNAs" . SPARSER::RNA) ("snoRNAs" . SPARSER::RNA)
    ("Rrp9" . SPARSER::PROTEIN) ("UBF" . SPARSER::PROTEIN)
    ("mature 18S rRNA" . SPARSER::PROTEIN)
    ("chemical cross-linking and mutational studies" . SPARSER::COLLECTION)
    ("-ETS" . SPARSER::COLLECTION) ("ATPases" . SPARSER::PROTEIN)
    ("helicases" . SPARSER::PROTEIN) ("endonucleases" . SPARSER::PROTEIN)
    ("MDa" . SPARSER::DRUG)
    ("15.5k, Nop56, Nop58, and fibrillarin" . SPARSER::COLLECTION)
    ("Nop58" . SPARSER::PROTEIN) ("Nop56" . SPARSER::PROTEIN)
    ("15.5k" . SPARSER::PROTEIN) ("fibrillarin" . SPARSER::PROTEIN)
    ("the mature 28S, 18S and 5.8S rRNAs" . SPARSER::RNA)
    ("The initial 47S ribosomal precursor RNA" . SPARSER::RNA)
    ("rRNAs" . SPARSER::RNA)
    ("ribosomal proteins, and proteins" . SPARSER::COLLECTION)
    ("small nucleolar RNPs" . SPARSER::PROTEIN)
    ("proteins, and proteins" . SPARSER::COLLECTION)
    ("RNPs" . SPARSER::PROTEIN) ("polymerases" . SPARSER::PROTEIN)
    ("Ribosome" . SPARSER::BIO-COMPLEX) ("pre" . SPARSER::PROTEIN)
    ("U3-55k" . SPARSER::PROTEIN) ("snoRNP" . SPARSER::BIO-COMPLEX)
    ("snoRNA" . SPARSER::RNA) ("small nucleolar RNP" . SPARSER::PROTEIN)
    ("pre-rRNA" . SPARSER::COLLECTION) ("snoRNPs" . SPARSER::BIO-COMPLEX)
    ("RNP" . SPARSER::PROTEIN) ("pre-ribosomal RNA" . SPARSER::RNA)
    ("BR 3" . SPARSER::PROTEIN) ("guide RNAs" . SPARSER::RNA)
    ("DNase I" . SPARSER::PROTEIN) ("−2" . SPARSER::PROTEIN)
    ("B-5" . SPARSER::PROTEIN) ("Pax-2" . SPARSER::PROTEIN)
    ("K18" . SPARSER::PROTEIN)
    ("5-aminoimidazole-4-carboxamide" . SPARSER::MOLECULE)
    ("TIF-IA" . SPARSER::PROTEIN) ("2KR" . SPARSER::PROTEIN)
    ("K25" . SPARSER::PROTEIN) ("sirtuin 7" . SPARSER::PROTEIN)
    ("NOP58" . SPARSER::PROTEIN) ("NOP56" . SPARSER::PROTEIN)
    ("SNORA74A" . SPARSER::PROTEIN) ("U13" . SPARSER::PROTEIN)
    ("messenger RNAs" . SPARSER::RNA) ("PAF53" . SPARSER::PROTEIN)
    ("upstream binding factor" . SPARSER::PROTEIN)
    ("ribonucleoprotein complex" . SPARSER::BIO-COMPLEX)
    ("RNA polymerase I" . SPARSER::PROTEIN) ("SIRT7" . SPARSER::PROTEIN)
    ("/CD117" . SPARSER::COLLECTION)
    ("different monoclonal antibodies" . SPARSER::ANTIBODY)
    ("IGF1 and IGF2" . SPARSER::COLLECTION) ("MEK/ERK" . SPARSER::COLLECTION)
    ("hot" . SPARSER::PROTEIN)
    ("KIT ( n  = 35; 66.1 %) and PDGFRA ( n  = 4; 7.5 %)"
     . SPARSER::COLLECTION)
    ("The histological subtypes" . SPARSER::PROTEIN)
    ("RAS/RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("gastrointestinal smooth muscle" . SPARSER::PROTEIN)
    ("ANO1/TMEM16A" . SPARSER::COLLECTION) ("KIT/PDGFRA" . SPARSER::COLLECTION)
    ("SDH" . SPARSER::PROTEIN) ("KIT or PDGFRA" . SPARSER::COLLECTION)
    ("chemotaxis" . SPARSER::PROTEIN) ("tyrosines" . SPARSER::AMINO-ACID)
    ("transmembrane glycoproteins" . SPARSER::PROTEIN)
    ("KIT and PDGFRA" . SPARSER::COLLECTION)
    ("KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) and PDGFRA (platelet-derived growth factor receptor-α)"
     . SPARSER::COLLECTION)
    ("RFS" . SPARSER::PROTEIN)
    ("KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) or PDGFRA (platelet-derived growth factor receptor α)"
     . SPARSER::COLLECTION)
    ("inhibitors (TKI)" . SPARSER::INHIBITOR) ("PDGFRA" . SPARSER::PROTEIN)
    ("KIT" . SPARSER::PROTEIN) ("IGF2" . SPARSER::PROTEIN)
    ("Group B" . SPARSER::PROTEIN) ("Group A" . SPARSER::PROTEIN)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("TMEM16A" . SPARSER::PROTEIN) ("ANO1" . SPARSER::PROTEIN)
    ("chloride channel" . SPARSER::PROTEIN)
    ("stem cell factor" . SPARSER::PROTEIN)
    ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD117" . SPARSER::PROTEIN)
    ("DOG1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog"
     . SPARSER::PROTEIN)
    ("extracellular HSP27" . SPARSER::PROTEIN)
    ("exposed subendothelial collagen" . SPARSER::PROTEIN)
    ("global ischemia" . SPARSER::PROTEIN) ("ischemia" . SPARSER::PROTEIN)
    ("IL" . SPARSER::PROTEIN) ("interleukin" . SPARSER::PROTEIN)
    ("form, dimer or monomer" . SPARSER::COLLECTION)
    ("inhibitor and granule" . SPARSER::COLLECTION)
    ("HSP27 and p44/p42 MAP kinase" . SPARSER::COLLECTION)
    ("collagen, ADP, ristocetin or TX" . SPARSER::COLLECTION)
    ("TX" . SPARSER::PROTEIN) ("ADP" . SPARSER::PROTEIN)
    ("rivaroxaban and edoxaban" . SPARSER::COLLECTION)
    ("ser" . SPARSER::AMINO-ACID)
    ("edoxaban as well as rivaroxaban" . SPARSER::COLLECTION)
    ("MAP kinase and HSP27" . SPARSER::COLLECTION)
    ("rivaroxaban or edoxaban" . SPARSER::COLLECTION)
    ("dimer or monomer" . SPARSER::COLLECTION)
    ("HSPC (HSP90) and HSPB (low-molecular weight HSPs)" . SPARSER::COLLECTION)
    ("HSPA (HSP70), HSPC (HSP90) and HSPB (low-molecular weight HSPs)"
     . SPARSER::COLLECTION)
    ("HSPC" . SPARSER::PROTEIN) ("HSPA" . SPARSER::PROTEIN-FAMILY)
    ("chaperones" . SPARSER::PROTEIN) ("anticoagulant" . SPARSER::DRUG)
    ("anticoagulants" . SPARSER::DRUG) ("-1 and PAR-4" . SPARSER::COLLECTION)
    ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY) ("fibrin" . SPARSER::PROTEIN)
    ("fibrinogen" . SPARSER::PROTEIN)
    ("GPVI and integrin" . SPARSER::COLLECTION) ("GPVI" . SPARSER::PROTEIN)
    ("Collagen" . SPARSER::PROTEIN) ("Ib" . SPARSER::DRUG)
    ("rivaroxaban" . SPARSER::DRUG)
    ("Rivaroxaban as well as edoxaban" . SPARSER::COLLECTION)
    ("both HSP27 and p44/p42 MAP kinase" . SPARSER::COLLECTION)
    ("edoxaban" . SPARSER::DRUG) ("Rivaroxaban" . SPARSER::DRUG)
    ("p44/p42" . SPARSER::COLLECTION) ("thrombin" . SPARSER::PROTEIN)
    ("Thrombin" . SPARSER::PROTEIN) ("FXa" . SPARSER::PROTEIN)
    ("GTP-binding protein" . SPARSER::PROTEIN) ("PDGF-AB" . SPARSER::PROTEIN)
    ("HSP70" . SPARSER::PROTEIN) ("AT-III" . SPARSER::PROTEIN)
    ("antithrombin-III" . SPARSER::PROTEIN)
    ("tissue factor" . SPARSER::PROTEIN)
    ("von Willebrand factor" . SPARSER::PROTEIN) ("p42" . SPARSER::PROTEIN)
    ("Src and an unphosphorylated Pyk2 molecule" . SPARSER::COLLECTION)
    ("proline" . SPARSER::AMINO-ACID) ("BAPTA" . SPARSER::MOLECULE)
    ("the associated Src" . SPARSER::PROTEIN)
    ("Src and FAK" . SPARSER::COLLECTION)
    ("kinases, FAK and Pyk2" . SPARSER::COLLECTION)
    ("Myc-Pyk2-WT phosphorylated co-expressed GFP-Pyk2-KD"
     . SPARSER::COLLECTION)
    ("GFP-Pyk2-KD" . SPARSER::COLLECTION) ("versa" . SPARSER::PROTEIN)
    ("Pyk2-KD" . SPARSER::COLLECTION) ("ΔSH2" . SPARSER::PROTEIN)
    ("ΔSH3" . SPARSER::PROTEIN) ("Src-ΔSH2" . SPARSER::COLLECTION)
    ("Src-ΔSH3" . SPARSER::COLLECTION) ("Src- R175L/W118K" . SPARSER::PROTEIN)
    ("Src-" . SPARSER::PROTEIN) ("Fyn" . SPARSER::PROTEIN)
    ("Src-KD" . SPARSER::COLLECTION) ("Pyk2 and FAK" . SPARSER::COLLECTION)
    ("Src-Pyk2" . SPARSER::COLLECTION) ("FAK and Pyk2" . SPARSER::COLLECTION)
    ("FAT" . SPARSER::PROTEIN) ("RAFTK and CAK-β" . SPARSER::COLLECTION)
    ("RAFTK" . SPARSER::PROTEIN) ("plausible drug" . SPARSER::DRUG)
    ("Ca2+" . SPARSER::CALCIUM-ION) ("T-1" . SPARSER::PROTEIN)
    ("Myc-tagged" . SPARSER::PROTEIN)
    ("Ca2+/calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("Proline-rich tyrosine kinase 2" . SPARSER::PROTEIN)
    ("total and activated RhoB" . SPARSER::PROTEIN) ("EMTB" . SPARSER::PROTEIN)
    ("dominant-negative RhoB" . SPARSER::PROTEIN)
    ("c-Src and RhoB" . SPARSER::COLLECTION)
    ("mCherry-Src" . SPARSER::COLLECTION) ("GFP-RhoB" . SPARSER::COLLECTION)
    ("mCherry" . SPARSER::PROTEIN)
    ("further implicating GEF-H1" . SPARSER::PROTEIN)
    ("GFP-GEF-H1" . SPARSER::COLLECTION)
    ("RFP-cortactin" . SPARSER::COLLECTION) ("RFP" . SPARSER::PROTEIN)
    ("CK" . SPARSER::PROTEIN) ("puncta" . SPARSER::PROTEIN)
    ("nocodazole" . SPARSER::DRUG) ("GFP-Src" . SPARSER::COLLECTION)
    ("RPE" . SPARSER::PROTEIN) ("RhoB and actin" . SPARSER::COLLECTION)
    ("microtubules and actin" . SPARSER::COLLECTION) ("MTs" . SPARSER::PROTEIN)
    ("RhoB" . SPARSER::PROTEIN) ("Arp2/3" . SPARSER::PROTEIN)
    ("Wave1" . SPARSER::PROTEIN) ("SP5" . SPARSER::PROTEIN)
    ("c-Src-" . SPARSER::PROTEIN) ("mDia2" . SPARSER::PROTEIN)
    ("WAVE1" . SPARSER::PROTEIN) ("perinuclear region" . SPARSER::PROTEIN)
    ("GEF-H1" . SPARSER::PROTEIN)
    ("exchange factor" . SPARSER::EXCHANGE-FACTOR) ("c-Src" . SPARSER::PROTEIN)
    ("proto-oncogene c-Src" . SPARSER::PROTEIN)
    ("MSCs, and RNA" . SPARSER::COLLECTION) ("SFN" . SPARSER::PROTEIN)
    ("sulforaphane" . SPARSER::PROTEIN) ("ST2" . SPARSER::PROTEIN)
    ("NRF2/hypoxia-inducible factor-1" . SPARSER::COLLECTION)
    ("NRF2–SIRT1" . SPARSER::COLLECTION)
    ("t-BHQ-treated LP MSCs" . SPARSER::PROTEIN) ("alizarin" . SPARSER::DRUG)
    ("these OTA-treated EP MSCs" . SPARSER::PROTEIN)
    ("shNRF2-infected EP MSCs" . SPARSER::PROTEIN)
    ("The western blot" . SPARSER::PROTEIN)
    ("HO-1 , NQO-1 , and SIRT1" . SPARSER::COLLECTION)
    ("tumor-suppressor genes and NRF2 downstream target genes"
     . SPARSER::COLLECTION)
    ("p53 or HIC1" . SPARSER::COLLECTION) ("HIC1 or p53" . SPARSER::COLLECTION)
    ("SIRT1, and RUNX2" . SPARSER::COLLECTION) ("p-NRF2" . SPARSER::COLLECTION)
    ("MSCs, and SIRT1" . SPARSER::COLLECTION)
    ("OTA or t-BHQ treatment ( xref )" . SPARSER::COLLECTION)
    ("OTA or t" . SPARSER::COLLECTION)
    ("SOX2 , OCT4 , or NANOG" . SPARSER::COLLECTION)
    ("GROUP" . SPARSER::MOLECULE)
    ("SOX2 , NANOG , and OCT3/4" . SPARSER::COLLECTION)
    ("NANOG" . SPARSER::PROTEIN)
    ("t-BHQ-treated EP-MSCs" . SPARSER::COLLECTION)
    ("EP-MSCs" . SPARSER::COLLECTION)
    ("t-BHQ-treated EP MSCs" . SPARSER::PROTEIN)
    ("nucleic NRF2" . SPARSER::PROTEIN)
    ("MSCs and t-BHQ-treated" . SPARSER::COLLECTION)
    ("control EP MSCs and OTA-treated EP MSCs" . SPARSER::COLLECTION)
    ("OTA-treated EP MSCs" . SPARSER::PROTEIN)
    ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HO-1 and NQO-1" . SPARSER::COLLECTION)
    ("NRF2 and its phosphorylated form ( xref )" . SPARSER::COLLECTION)
    ("NRF2 and its phosphorylated form" . SPARSER::COLLECTION)
    ("HO-1 ( heme oxygenase-1 ) and NQO-1" . SPARSER::COLLECTION)
    ("quinone" . SPARSER::MOLECULE) ("dehydrogenase" . SPARSER::PROTEIN)
    ("oxygenase" . SPARSER::PROTEIN) ("heme" . SPARSER::MOLECULE)
    ("p53–SIRT1" . SPARSER::COLLECTION) ("EP or LP MSCs" . SPARSER::COLLECTION)
    ("NRF2 and MSC" . SPARSER::COLLECTION)
    ("NRF2 and stemness" . SPARSER::COLLECTION)
    ("NRF2 and SIRT1" . SPARSER::COLLECTION)
    ("p53 and SIRT1" . SPARSER::COLLECTION) ("MSC" . SPARSER::PROTEIN)
    ("BHQ" . SPARSER::PROTEIN) ("t-BHQ" . SPARSER::COLLECTION)
    ("EP" . SPARSER::PROTEIN) ("OTA" . SPARSER::MOLECULE)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("β - ACTIN" . SPARSER::PROTEIN) ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HDAC1" . SPARSER::PROTEIN) ("CXCR4" . SPARSER::PROTEIN)
    ("Mdm2" . SPARSER::PROTEIN) ("β -catenin" . SPARSER::PROTEIN)
    ("HIF-1 α" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor-1" . SPARSER::PROTEIN)
    ("HIC1" . SPARSER::PROTEIN)
    ("Runt-related transcription factor 2" . SPARSER::PROTEIN)
    ("OCT4" . SPARSER::PROTEIN) ("GROUP III" . SPARSER::PROTEIN)
    ("GROUP I" . SPARSER::PROTEIN) ("OCT3" . SPARSER::PROTEIN)
    ("SOX2" . SPARSER::PROTEIN) ("tert -Butylhydroquinone" . SPARSER::DRUG)
    ("NAD(P)H" . SPARSER::MOLECULE) ("NQO-1" . SPARSER::PROTEIN)
    ("HO-1" . SPARSER::PROTEIN) ("KEAP1" . SPARSER::PROTEIN)
    ("sirtuin 1" . SPARSER::PROTEIN)
    ("tert -butylhydroquinone" . SPARSER::DRUG)
    ("ochratoxin A" . SPARSER::MOLECULE) ("NRF2" . SPARSER::PROTEIN)
    ("suppressors" . SPARSER::SUPPRESSOR)
    ("a eukaryotic initiation complex eIF4F" . SPARSER::PROTEIN)
    ("eIF4E, eIF4G and eIF4A" . SPARSER::COLLECTION)
    ("PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("PDCD4 and PTEN" . SPARSER::COLLECTION) ("MicroRNA" . SPARSER::RNA)
    ("PTEN and PDCD4" . SPARSER::COLLECTION)
    ("taxol, trastuzumab, and doxorubicin" . SPARSER::COLLECTION)
    ("taxol" . SPARSER::DRUG) ("Gemcitabine" . SPARSER::DRUG)
    ("PDAC" . SPARSER::MOLECULE) ("FU" . SPARSER::PROTEIN)
    ("Messenger RNA" . SPARSER::RNA) ("PDCD4" . SPARSER::PROTEIN)
    ("hyperactive FAK" . SPARSER::PROTEIN)
    ("Lkb1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("lysyl oxidase (LOX)" . SPARSER::PROTEIN) ("LOX" . SPARSER::PROTEIN)
    ("anchors" . SPARSER::ANCHOR) ("LKB1-MARK1-FAK" . SPARSER::COLLECTION)
    ("the K78I kinase-dead LKB1 or the K78I-C430S double mutant LKB1"
     . SPARSER::COLLECTION)
    ("­MARK1" . SPARSER::COLLECTION) ("LKB1-MARK1" . SPARSER::COLLECTION)
    ("wild-type LKB1 and either constitutively active RhoA or cdc42"
     . SPARSER::COLLECTION)
    ("either empty GFP or GFP-LKB1" . SPARSER::COLLECTION)
    ("a C430S farnesylation mutant and the constitutively active form of either RhoA (Q63L) or cdc42 (Q61L)"
     . SPARSER::COLLECTION)
    ("GFP-LKB1" . SPARSER::COLLECTION) ("cdc42 and RhoA" . SPARSER::COLLECTION)
    ("a C430S farnesylation mutant or a K78I and C430S double mutant"
     . SPARSER::COLLECTION)
    ("GFP-tagged LKB1 mutants and domain" . SPARSER::COLLECTION)
    ("p114RhoGEF" . SPARSER::PROTEIN) ("RhoGEF" . SPARSER::PROTEIN)
    ("myosin" . SPARSER::PROTEIN-FAMILY)
    ("-AMP–activated" . SPARSER::COLLECTION)
    ("KRAS and P53" . SPARSER::COLLECTION)
    ("subsequent collagen" . SPARSER::PROTEIN)
    ("a serine/threonine kinase and a commonly mutated gene"
     . SPARSER::COLLECTION)
    ("For 3" . SPARSER::PROTEIN) ("SP8" . SPARSER::PROTEIN)
    ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("myosin light chain" . SPARSER::PROTEIN) ("HIF-1" . SPARSER::PROTEIN)
    ("lysyl oxidase" . SPARSER::PROTEIN) ("a 3D" . SPARSER::PROTEIN)
    ("GM6001" . SPARSER::DRUG) ("dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("PF-573228" . SPARSER::DRUG) ("I-C" . SPARSER::PROTEIN)
    ("cdc42" . SPARSER::PROTEIN) ("PAR-4" . SPARSER::PROTEIN)
    ("brain-specific" . SPARSER::PROTEIN) ("SIK1" . SPARSER::PROTEIN)
    ("NUAK1" . SPARSER::PROTEIN) ("AMP–activated" . SPARSER::PROTEIN)
    ("loss of heterozygosity" . SPARSER::PROTEIN)
    ("Liver kinase B1" . SPARSER::PROTEIN) ("MARK1" . SPARSER::PROTEIN)
    ("regenerative medicine" . SPARSER::DRUG)
    ("ERK1/2 and RUNX2" . SPARSER::COLLECTION)
    ("downstream factors around FAK" . SPARSER::PROTEIN)
    ("Oct4, Sox2, and Klf4" . SPARSER::COLLECTION) ("iPS" . SPARSER::PROTEIN)
    ("tyr" . SPARSER::AMINO-ACID) ("osterix" . SPARSER::PROTEIN)
    ("FAK, ERK1/2 and RUNX2" . SPARSER::COLLECTION)
    ("RUNX2 (p-RUNX2) and total RUNX2" . SPARSER::COLLECTION)
    ("p-RUNX2" . SPARSER::COLLECTION) ("p-ERK1/2" . SPARSER::PROTEIN)
    ("p-FAK" . SPARSER::COLLECTION) ("ALP" . SPARSER::PROTEIN)
    ("Alizarin" . SPARSER::DRUG)
    ("osteocalcin and RUNX2" . SPARSER::COLLECTION)
    ("osteocalcin" . SPARSER::PROTEIN)
    ("extra osteogenic reagents" . SPARSER::MOLECULE)
    ("reagents" . SPARSER::MOLECULE) ("APL" . SPARSER::PROTEIN)
    ("calcium" . SPARSER::CALCIUM)
    ("CD34, CD45, CD73, CD90 and CD105" . SPARSER::COLLECTION)
    ("FAK and ESW" . SPARSER::COLLECTION)
    ("The trabecular bone volume fraction and trabecular thickness"
     . SPARSER::COLLECTION)
    ("The trabecular bone volume fraction" . SPARSER::COMPONENT)
    ("goat" . SPARSER::PROTEIN) ("ERKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("siRNA, and U0126" . SPARSER::COLLECTION)
    ("FAK, ERK1/2, and RUNX2" . SPARSER::COLLECTION)
    ("MSCs" . SPARSER::PROTEIN) ("alpha-" . SPARSER::PROTEIN)
    ("phospho-ERK" . SPARSER::PROTEIN) ("Klf4" . SPARSER::PROTEIN)
    ("RUNX-2" . SPARSER::PROTEIN) ("CD105" . SPARSER::PROTEIN)
    ("CD73" . SPARSER::PROTEIN) ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD34" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RUNX2" . SPARSER::PROTEIN) ("prostatic" . SPARSER::PROTEIN)
    ("Wnt/β-catenin" . SPARSER::COLLECTION) ("water" . SPARSER::MOLECULE)
    ("LSL" . SPARSER::PROTEIN) ("UPII-Cre" . SPARSER::PROTEIN-PAIR)
    ("Transgene" . SPARSER::PROTEIN) ("Ck5" . SPARSER::PROTEIN)
    ("Ck5, Ck8, and p63" . SPARSER::COLLECTION)
    ("Ck" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CK5 and p63" . SPARSER::COLLECTION) ("p63 or CK5" . SPARSER::COLLECTION)
    ("TM" . SPARSER::PROTEIN)
    ("a tamoxifen-inducible Cre recombinase (CreERT2) and eGFP fusion gene"
     . SPARSER::COLLECTION)
    ("eGFP" . SPARSER::PROTEIN)
    ("both cytokeratin 5 (CK5) and p63" . SPARSER::COLLECTION)
    ("Cre-ERT2" . SPARSER::COLLECTION) ("cre" . SPARSER::PROTEIN)
    ("Ar" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BBN" . SPARSER::MOLECULE)
    ("GCE" . SPARSER::PROTEIN) ("CK-5" . SPARSER::PROTEIN)
    ("ki67" . SPARSER::PROTEIN) ("N-20" . SPARSER::PROTEIN)
    ("cytokeratin 5" . SPARSER::PROTEIN)
    ("recombinase activity" . SPARSER::PROTEIN)
    ("Enhanced Green Fluorescent Protein" . SPARSER::PROTEIN)
    ("ERT2" . SPARSER::PROTEIN) ("UPK3a" . SPARSER::PROTEIN)
    ("p63" . SPARSER::PROTEIN) ("CK5" . SPARSER::PROTEIN)
    ("N-butyl-N-(4-hydroxybutyl) nitrosamine" . SPARSER::MOLECULE)
    ("Upk3a" . SPARSER::PROTEIN) ("Dual function proteins" . SPARSER::PROTEIN)
    ("EGFR [ xref ] and GRK6A [ xref ]" . SPARSER::COLLECTION)
    ("the classical NES" . SPARSER::PROTEIN)
    ("importin β-related nuclear transport receptor" . SPARSER::RECEPTOR)
    ("importin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NES" . SPARSER::PROTEIN)
    ("receptors and effectors" . SPARSER::COLLECTION)
    ("Ras-ERK-RSK" . SPARSER::COLLECTION)
    ("Wnt-β-catenin" . SPARSER::COLLECTION)
    ("β-catenin and TCF1" . SPARSER::COLLECTION)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("a phospho-mimetic mutant" . SPARSER::MUTANT)
    ("peptidyl-prolyl" . SPARSER::COLLECTION)
    ("isomerase" . SPARSER::ISOMERASE) ("prolyl" . SPARSER::PROTEIN)
    ("its oligomeric state" . SPARSER::BIO-STATE)
    ("EBP50 and the PDZ ligands" . SPARSER::COLLECTION)
    ("rpS" . SPARSER::PROTEIN) ("LMB" . SPARSER::MOLECULE)
    ("optimal media" . SPARSER::PROTEIN)
    ("a candidate substrate of AGC kinases such as RSK1 and its implication in certain essential biological function"
     . SPARSER::COLLECTION)
    ("RSK2 and RSK3" . SPARSER::COLLECTION)
    ("RSK1 and EBP50" . SPARSER::COLLECTION)
    ("GST-fused full-length EBP50 and its truncated mutants"
     . SPARSER::COLLECTION)
    ("EBP50 and RSK1" . SPARSER::COLLECTION)
    ("GST-fused" . SPARSER::COLLECTION) ("GST" . SPARSER::PROTEIN)
    ("RSKs" . SPARSER::PROTEIN) ("modulators" . SPARSER::PROTEIN)
    ("Totally 1356 genes" . SPARSER::GENE) ("Ras-RSK1" . SPARSER::COLLECTION)
    ("extracellular signal-regulated kinase (ERK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The p90 ribosomal S6 kinase (RSK)" . SPARSER::PROTEIN-FAMILY)
    ("RSK" . SPARSER::PROTEIN)
    ("pleckstrin-homology domain leucine-rich repeat protein phosphatases (PHLPP) and scaffolds"
     . SPARSER::COLLECTION)
    ("phosphatases (PHLPP)" . SPARSER::PHOSPHATASE)
    ("-Akt" . SPARSER::COLLECTION) ("scaffolds" . SPARSER::SCAFFOLD)
    ("PHLPP" . SPARSER::PROTEIN) ("ion" . SPARSER::MOLECULE)
    ("Ezrin-radixin-moesin (ERM)" . SPARSER::COLLECTION)
    ("Ezrin-radixin-moesin" . SPARSER::COLLECTION) ("ezrin" . SPARSER::PROTEIN)
    ("phosphoprotein" . SPARSER::PROTEIN) ("ERM" . SPARSER::PROTEIN)
    ("moesin" . SPARSER::PROTEIN) ("radixin" . SPARSER::PROTEIN)
    ("Ezrin" . SPARSER::PROTEIN) ("Ras-ERK" . SPARSER::COLLECTION)
    ("18 h" . SPARSER::PROTEIN) ("PDZ1" . SPARSER::PROTEIN)
    ("N-C" . SPARSER::PROTEIN) ("Leptomycin B" . SPARSER::MOLECULE)
    ("CRM1" . SPARSER::PROTEIN) ("Pin1" . SPARSER::PROTEIN)
    ("GRK6" . SPARSER::PROTEIN) ("S10" . SPARSER::PROTEIN)
    ("leptomycin B" . SPARSER::MOLECULE)
    ("enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("TCF1" . SPARSER::PROTEIN)
    ("G protein-coupled receptor kinase 6" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3" . SPARSER::PROTEIN)
    ("leucine-rich repeat" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("EBP50" . SPARSER::PROTEIN) ("other bacterial lectins" . SPARSER::PROTEIN)
    ("ExoT" . SPARSER::PROTEIN) ("ExoU" . SPARSER::PROTEIN)
    ("cytotoxins" . SPARSER::PROTEIN) ("a central inducer" . SPARSER::PROTEIN)
    ("cyclin E2 and Rb" . SPARSER::COLLECTION)
    ("cadherin-catenin" . SPARSER::COLLECTION)
    ("tetraspanin" . SPARSER::PROTEIN-FAMILY)
    ("keratinocytes" . SPARSER::PROTEIN)
    ("TNF-α, IL-6 and IL-1β" . SPARSER::COLLECTION)
    ("cyclin E2 and the phosphorylation state" . SPARSER::COLLECTION)
    ("cyclin D1, cyclin E2 and Rb" . SPARSER::COLLECTION)
    ("Cdks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin D1 and c-myc" . SPARSER::COLLECTION)
    ("Wnt3a and LecB" . SPARSER::COLLECTION)
    ("a prototypical inducer" . SPARSER::PROTEIN)
    ("β-catenin around centrosomes" . SPARSER::PROTEIN)
    ("centrosomes" . SPARSER::PROTEIN) ("proteasomes" . SPARSER::PROTEIN)
    ("Baf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Lysosomal" . SPARSER::PROTEIN)
    ("proteasomal and lysosomal" . SPARSER::COLLECTION)
    ("lysosomal" . SPARSER::PROTEIN) ("LiCl" . SPARSER::DRUG)
    ("Akti" . SPARSER::PROTEIN) ("TCN" . SPARSER::DRUG)
    ("triciribine" . SPARSER::MOLECULE)
    ("Akt (and its upstream kinase PI3K) and GSK-3β" . SPARSER::COLLECTION)
    ("THP-1" . SPARSER::PROTEIN) ("iodide (PI)" . SPARSER::PROTEIN)
    ("thymidine" . SPARSER::PROTEIN) ("1A and 1B" . SPARSER::COLLECTION)
    ("the lectin and host cell receptors" . SPARSER::COLLECTION)
    ("a strong inducer" . SPARSER::PROTEIN)
    ("GSK-3β and Axin" . SPARSER::COLLECTION) ("Axin" . SPARSER::PROTEIN)
    ("These junctional complexes" . SPARSER::BIO-COMPLEX)
    ("CD151-tetraspanins" . SPARSER::COLLECTION)
    ("tetraspanins" . SPARSER::PROTEIN)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("carbohydrate" . SPARSER::MOLECULE) ("tetramer" . SPARSER::TETRAMER)
    ("ALI" . SPARSER::PROTEIN) ("-fucose" . SPARSER::MOLECULE)
    ("fucose" . SPARSER::MOLECULE)
    ("c-myc and cyclin D1" . SPARSER::COLLECTION)
    ("lactacystin" . SPARSER::DRUG)
    ("the involved bacterial virulence factors" . SPARSER::PROTEIN-FAMILY)
    ("a 20 " . SPARSER::PROTEIN) ("NH 4 Cl" . SPARSER::MOLECULE)
    ("Acetyl-CoA" . SPARSER::MOLECULE) ("MgSO 4" . SPARSER::DRUG)
    ("IL-1β" . SPARSER::PROTEIN) ("cyclin B1" . SPARSER::PROTEIN)
    ("cyclin E2" . SPARSER::PROTEIN) ("Wnt3a" . SPARSER::PROTEIN)
    ("γ-tubulin" . SPARSER::PROTEIN) ("β1-integrin" . SPARSER::PROTEIN)
    ("TWS119" . SPARSER::DRUG) ("lithium chloride" . SPARSER::DRUG)
    ("Akt1" . SPARSER::PROTEIN) ("C–E" . SPARSER::PROTEIN)
    ("CD151" . SPARSER::PROTEIN) ("Beta-catenin" . SPARSER::PROTEIN)
    ("virulence factor" . SPARSER::PROTEIN-FAMILY)
    ("virulence factors" . SPARSER::PROTEIN-FAMILY)
    ("several fibrotic genes" . SPARSER::GENE)
    ("subunit, and TGFβRII" . SPARSER::COLLECTION)
    ("hyaluronan" . SPARSER::PROTEIN) ("elastin" . SPARSER::PROTEIN)
    ("promoter, gene, and protein" . SPARSER::COLLECTION)
    ("protein or mRNA" . SPARSER::COLLECTION)
    ("α1β1 and αvβ3" . SPARSER::COLLECTION)
    ("progesterone receptor and GR" . SPARSER::COLLECTION)
    ("mRNA and collagen" . SPARSER::COLLECTION)
    ("an exogenous ITGB6 promoter" . SPARSER::PROMOTER)
    ("αvβ6 and Elk1" . SPARSER::COLLECTION) ("wax" . SPARSER::MOLECULE)
    ("significantly less Elk1 protein" . SPARSER::PROTEIN)
    ("mRNA and αvβ6" . SPARSER::COLLECTION) ("lobes" . SPARSER::PROTEIN)
    ("bleomycin-treated Elk1" . SPARSER::PROTEIN)
    ("Elk1 or GR siRNAs or both siRNAs" . SPARSER::COLLECTION)
    ("Elk1 or GR" . SPARSER::COLLECTION) ("GR and Elk1" . SPARSER::COLLECTION)
    ("Dexamethasone" . SPARSER::PROTEIN)
    ("glucocorticoids and progesterone" . SPARSER::COLLECTION)
    ("glucocorticoids" . SPARSER::PROTEIN) ("pGL3-" . SPARSER::PROTEIN)
    ("ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ITGB6 and αvβ6" . SPARSER::COLLECTION) ("Repressor" . SPARSER::REPRESSOR)
    ("a key cytokine" . SPARSER::PROTEIN) ("Itgb6" . SPARSER::PROTEIN)
    ("dexamethasone" . SPARSER::PROTEIN) ("Elk1 or Elk1" . SPARSER::COLLECTION)
    ("Elk1 and GR" . SPARSER::COLLECTION)
    ("both the Ets domain-containing protein Elk1 (Elk1) and the glucocorticoid receptor (GR)"
     . SPARSER::COLLECTION)
    ("glucocorticoid receptor (GR)" . SPARSER::PROTEIN)
    ("Elk1" . SPARSER::PROTEIN) ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("X-linked" . SPARSER::PROTEIN) ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PAI1" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor 1" . SPARSER::PROTEIN)
    ("Smad3" . SPARSER::PROTEIN) ("αvβ3" . SPARSER::PROTEIN)
    ("α1β1" . SPARSER::PROTEIN) ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ITGB 6" . SPARSER::PROTEIN) ("Progesterone Receptor" . SPARSER::PROTEIN)
    ("Glucocorticoid Receptor" . SPARSER::PROTEIN) ("ch2" . SPARSER::MOLECULE)
    ("Smad2" . SPARSER::PROTEIN) ("ELK1" . SPARSER::PROTEIN)
    ("B2M" . SPARSER::PROTEIN) ("β2-microglobulin" . SPARSER::PROTEIN)
    ("ets-1" . SPARSER::PROTEIN) ("glucocorticoid receptor" . SPARSER::PROTEIN)
    ("ITGB6" . SPARSER::PROTEIN) ("αvβ6" . SPARSER::PROTEIN)
    ("TGFβ1" . SPARSER::PROTEIN) ("target, and NAC" . SPARSER::COLLECTION)
    ("pulmonary emphysema" . SPARSER::PROTEIN)
    ("oxidants and antioxidants" . SPARSER::COLLECTION)
    ("oxidants" . SPARSER::MOLECULE)
    ("GCLC, GCLM, and glutathione reductase" . SPARSER::COLLECTION)
    ("GR" . SPARSER::PROTEIN) ("GSH and NAC" . SPARSER::COLLECTION)
    ("Caspase" . SPARSER::PROTEIN) ("COPD and non-COPD" . SPARSER::COLLECTION)
    ("proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GCLC and GCLM" . SPARSER::COLLECTION) ("GSH" . SPARSER::DRUG)
    ("the glutathione cysteine ligase catalytic subunit (GCLC) and glutathione cysteine ligase modifier subunit (GCLM)"
     . SPARSER::COLLECTION)
    ("subunit (GCLM)" . SPARSER::FRAGMENT)
    ("catalytic subunit (GCLC)" . SPARSER::PROTEIN) ("GCLM" . SPARSER::PROTEIN)
    ("glutathione" . SPARSER::DRUG) ("a substantial ROS" . SPARSER::PROTEIN)
    ("NAC" . SPARSER::PROTEIN) ("H 2 O 2 and CSE" . SPARSER::COLLECTION)
    ("COPD and CTL" . SPARSER::COLLECTION) ("CTL" . SPARSER::PROTEIN)
    ("FEV" . SPARSER::PROTEIN) ("antioxidants and Nrf2" . SPARSER::COLLECTION)
    ("these genes and expression of these proteins [ xref ]"
     . SPARSER::COLLECTION)
    ("response element (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("approximately 1x10 17 oxidant molecules" . SPARSER::MOLECULE)
    ("oxidant" . SPARSER::PROTEIN)
    ("a gas component and a small particulate matter component"
     . SPARSER::COLLECTION)
    ("COPD, and cigarette" . SPARSER::COLLECTION)
    ("emphysema" . SPARSER::PROTEIN) ("antioxidants" . SPARSER::DRUG)
    ("nick" . SPARSER::PROTEIN) ("dUTP" . SPARSER::MOLECULE)
    ("reagent" . SPARSER::MOLECULE) ("CSE" . SPARSER::PROTEIN)
    ("a central transcription factor" . SPARSER::PROTEIN)
    ("antioxidant" . SPARSER::PROTEIN) ("COPD" . SPARSER::PROTEIN)
    ("glutathione reductase" . SPARSER::PROTEIN)
    ("α1-antitrypsin" . SPARSER::PROTEIN)
    ("Green fluorescent" . SPARSER::PROTEIN)
    ("green fluorescent" . SPARSER::PROTEIN) ("IgG 1" . SPARSER::BIO-COMPLEX)
    ("NFE2L2" . SPARSER::PROTEIN)
    ("other endogenous circular RNAs" . SPARSER::RNA) ("NR" . SPARSER::PROTEIN)
    ("other cell cycle-associated proteins" . SPARSER::PROTEIN)
    ("CDK6, p16 and p27" . SPARSER::COLLECTION)
    ("neither anti-p21 antibody nor anti-CDK2 antibody" . SPARSER::COLLECTION)
    ("the subsequent western blot" . SPARSER::PROTEIN)
    ("the circ-Foxo3–p21–CDK2 ternary complexes" . SPARSER::BIO-COMPLEX)
    ("CDK2–cyclin E" . SPARSER::COLLECTION)
    ("circ-Foxo3–p21–CDK2 ternary complex" . SPARSER::BIO-COMPLEX)
    ("an essential regulator" . SPARSER::REGULATOR)
    ("the circ-Foxo3–p21–CDK2 ternary complex" . SPARSER::BIO-COMPLEX)
    ("CDK2 monomer and the heterodimer" . SPARSER::COLLECTION)
    ("one monomer and one" . SPARSER::COLLECTION)
    ("circ-Foxo3–p21" . SPARSER::COLLECTION)
    ("circ-Foxo3–CDK2" . SPARSER::COLLECTION)
    ("significantly pulled-down more circ-Foxo3" . SPARSER::COLLECTION)
    ("Northern blot" . SPARSER::PROTEIN) ("siRNA-" . SPARSER::PROTEIN)
    ("the ternary complexes" . SPARSER::BIO-COMPLEX)
    ("the ternary complex" . SPARSER::BIO-COMPLEX) ("dimer" . SPARSER::DIMER)
    ("anti-CDK2 antibody only pulled-down p21" . SPARSER::PROTEIN)
    ("Foxo3, circ-Amotl1 and circFoxo3" . SPARSER::COLLECTION)
    ("in fact pull-down cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("other circular RNAs" . SPARSER::RNA) ("circ-PRL5" . SPARSER::COLLECTION)
    ("circ-RPS5" . SPARSER::COLLECTION) ("circ-MRPL47" . SPARSER::COLLECTION)
    ("PRL" . SPARSER::PROTEIN) ("CDK2 and p21" . SPARSER::COLLECTION)
    ("CDK2, CDK6, p16, p21and p27" . SPARSER::COLLECTION)
    ("ternary complexes" . SPARSER::BIO-COMPLEX)
    ("CDK2 and P21" . SPARSER::COLLECTION) ("Circ-Foxo3" . SPARSER::COLLECTION)
    ("Circ" . SPARSER::PROTEIN) ("RNAse" . SPARSER::PROTEIN)
    ("S3b" . SPARSER::PROTEIN) ("S3a" . SPARSER::PROTEIN)
    ("Epidermal growth factor (EGF)" . SPARSER::PROTEIN)
    ("p21 and CDK2" . SPARSER::COLLECTION)
    ("cyclin E/CDK2" . SPARSER::COLLECTION) ("Ser/Thr" . SPARSER::COLLECTION)
    ("Cyclins and cyclin-dependent kinases" . SPARSER::COLLECTION)
    ("Cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Both circular Foxo3 (circ-Foxo3) and linear Foxo3 (Foxo3 mRNA)"
     . SPARSER::COLLECTION)
    ("Both circular Foxo3" . SPARSER::PROTEIN)
    ("a circular RNA circular Foxo3" . SPARSER::PROTEIN)
    ("Another circular RNA" . SPARSER::RNA) ("SRY" . SPARSER::PROTEIN)
    ("these circular RNAs" . SPARSER::RNA) ("the circular RNAs" . SPARSER::RNA)
    ("Circular RNAs" . SPARSER::RNA)
    ("this circ-Foxo3-p21-CDK2 ternary complex" . SPARSER::BIO-COMPLEX)
    ("circ-Foxo3-p21-CDK2" . SPARSER::COLLECTION)
    ("the cell cycle proteins cyclin-dependent kinase 2 (also known as cell division protein kinase 2 or CDK2) and cyclin-dependent kinase inhibitor 1 (or p21)"
     . SPARSER::COLLECTION)
    ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("cell division protein kinase 2 or CDK2" . SPARSER::COLLECTION)
    ("the circular RNA circ-Foxo3" . SPARSER::COLLECTION)
    ("circ-Foxo3" . SPARSER::COLLECTION) ("circ" . SPARSER::PROTEIN)
    ("microRNA" . SPARSER::RNA) ("intronic RNAs" . SPARSER::RNA)
    ("exonic circular RNAs" . SPARSER::RNA) ("circular RNAs" . SPARSER::RNA)
    ("RNAse A" . SPARSER::PROTEIN) ("Cdk2" . SPARSER::PROTEIN)
    ("RPS5" . SPARSER::PROTEIN) ("MRPL47" . SPARSER::PROTEIN)
    ("3d" . SPARSER::PROTEIN-FAMILY)
    ("Epidermal growth factor" . SPARSER::PROTEIN)
    ("RNA binding protein" . SPARSER::PROTEIN) ("S1b" . SPARSER::PROTEIN)
    ("N1" . SPARSER::PROTEIN) ("cyclin C" . SPARSER::PROTEIN)
    ("regulator of cell cycle" . SPARSER::PROTEIN)
    ("Phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("miR-7" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 1" . SPARSER::PROTEIN)
    ("cell division protein kinase 2" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("Foxo3" . SPARSER::PROTEIN)
    ("neurofibromin and Rsk2" . SPARSER::COLLECTION)
    ("NF1 or Coffin-Lowry" . SPARSER::COLLECTION)
    ("Rsk2 and neurofibromin" . SPARSER::COLLECTION)
    ("other GEFs and/or GAPs" . SPARSER::COLLECTION)
    ("RasGEF and RasGAP" . SPARSER::COLLECTION) ("RasGEF" . SPARSER::PROTEIN)
    ("DAB2IP (Fig.  xref ) or neurofibromin (Fig.  xref )"
     . SPARSER::COLLECTION)
    ("RASA1 (Fig.  xref ), DAB2IP (Fig.  xref ) or neurofibromin (Fig.  xref )"
     . SPARSER::COLLECTION)
    ("Neurofibromin" . SPARSER::PROTEIN)
    ("MEK (Fig.  xref ) or Rsk (Fig.  xref )" . SPARSER::COLLECTION)
    ("Rsk1 or Rsk2" . SPARSER::COLLECTION)
    ("ribosomal S6 protein" . SPARSER::PROTEIN) ("BI" . SPARSER::PROTEIN)
    ("Rsk and both kinases" . SPARSER::COLLECTION)
    ("Erk (Fig.  xref ) or Rsk (Fig.  xref )" . SPARSER::COLLECTION)
    ("Erk and Rsk" . SPARSER::COLLECTION)
    ("Erk and Rsk1/2" . SPARSER::COLLECTION)
    ("K-Ras, N-Ras and H-Ras" . SPARSER::COLLECTION)
    ("MEK1/MEK2" . SPARSER::COLLECTION)
    ("Ras/Raf/MEK/Erk" . SPARSER::COLLECTION)
    ("GTP or GppNHp" . SPARSER::COLLECTION) ("GppNHp" . SPARSER::MOLECULE)
    ("Ras-IPs" . SPARSER::COLLECTION) ("SLO" . SPARSER::PROTEIN)
    ("IPs" . SPARSER::PROTEIN) ("GEF/GAP" . SPARSER::COLLECTION)
    ("net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GAPs and GEFs" . SPARSER::COLLECTION)
    ("RASA1, neurofibromin and DAB2IP" . SPARSER::COLLECTION)
    ("RASA1 and neurofibromin" . SPARSER::COLLECTION)
    ("RASA2, RASA3, RASA4, RASAL1 or RASAL2" . SPARSER::COLLECTION)
    ("p120GAP, and neurofibromin" . SPARSER::COLLECTION)
    ("Ras-GAPs" . SPARSER::COLLECTION)
    ("RasGRP and RasGRF" . SPARSER::COLLECTION)
    ("RasGRF" . SPARSER::PROTEIN-FAMILY)
    ("RasGRP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the Rsk inhibitor BI-D1870 [ xref ] or PI3K inhibition (Fig.  xref , Additional file xref : Figure S1)"
     . SPARSER::COLLECTION)
    ("MEK or ERK" . SPARSER::COLLECTION) ("Ras/Erk" . SPARSER::COLLECTION)
    ("GEFs and GAPs" . SPARSER::COLLECTION) ("GEFs" . SPARSER::PROTEIN)
    ("Erk or Rsk1/2" . SPARSER::COLLECTION)
    ("Erk and/or Rsk1/2" . SPARSER::COLLECTION)
    ("Rsk1 and Rsk 2" . SPARSER::COLLECTION)
    ("the two p90 ribosomal S6 kinase (Rsk) family members Rsk1 and Rsk2"
     . SPARSER::COLLECTION)
    ("Rsk" . SPARSER::PROTEIN)
    ("the Ras effector kinases MEK [ xref ] and/or Erk [ xref , xref – xref ]"
     . SPARSER::COLLECTION)
    ("Ras and its downstream effector kinase Erk" . SPARSER::COLLECTION)
    ("GEF" . SPARSER::GEF) ("RasGAP" . SPARSER::PROTEIN)
    ("Rsk1 and Rsk2" . SPARSER::COLLECTION)
    ("neurofibromin" . SPARSER::PROTEIN)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("hydrolase" . SPARSER::PROTEIN)
    ("Mitogen" . SPARSER::MITOGEN) ("Raf-1" . SPARSER::PROTEIN)
    ("P40)" . SPARSER::PROTEIN) ("pMD2" . SPARSER::MOLECULE)
    ("p70 S6" . SPARSER::PROTEIN) ("RSK3" . SPARSER::PROTEIN)
    ("RSK2" . SPARSER::PROTEIN) ("RSK1" . SPARSER::PROTEIN)
    ("p44" . SPARSER::PROTEIN) ("p-ERK1" . SPARSER::PROTEIN)
    ("C-4" . SPARSER::PROTEIN) ("p120RasGAP" . SPARSER::PROTEIN)
    ("SOS1" . SPARSER::PROTEIN) ("Map2k" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RPS6KA1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RPS6KA3" . SPARSER::PROTEIN)
    ("Erk2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Erk1" . SPARSER::PROTEIN)
    ("32P" . SPARSER::|32P|) ("U0126" . SPARSER::DRUG)
    ("p70-S6K" . SPARSER::PROTEIN) ("ribosomal protein S6" . SPARSER::PROTEIN)
    ("Gsk3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("N-Ras" . SPARSER::PROTEIN)
    ("MEK2" . SPARSER::PROTEIN) ("MEK1" . SPARSER::PROTEIN)
    ("Growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DAB2IP" . SPARSER::PROTEIN) ("RASAL2" . SPARSER::PROTEIN)
    ("RASAL1" . SPARSER::PROTEIN) ("RASA4" . SPARSER::PROTEIN)
    ("RASA3" . SPARSER::PROTEIN) ("RASA2" . SPARSER::PROTEIN)
    ("p120GAP" . SPARSER::PROTEIN) ("RASA1" . SPARSER::PROTEIN)
    ("Ras-GEF" . SPARSER::PROTEIN) ("Ras-GEFs" . SPARSER::PROTEIN)
    ("BI-D1870" . SPARSER::MOLECULE) ("Rsk 2" . SPARSER::PROTEIN)
    ("S6 kinase" . SPARSER::PROTEIN-FAMILY) ("p90" . SPARSER::PROTEIN)
    ("Grb-2" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("Ras-GDP" . SPARSER::PROTEIN) ("NF1" . SPARSER::PROTEIN)
    ("growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rsk2" . SPARSER::PROTEIN) ("Rsk1" . SPARSER::PROTEIN)
    ("Ras-GAP" . SPARSER::PROTEIN)
    ("nucleotide exchange factor" . SPARSER::NUCLEOTIDE-EXCHANGE-FACTOR)
    ("Ras-GTP" . SPARSER::PROTEIN) ("Growth factors" . SPARSER::GROWTH-FACTOR)
    ("TGF-β1 and HSP27" . SPARSER::COLLECTION)
    ("a matricellular protein and a proinflammatory cytokine"
     . SPARSER::COLLECTION)
    ("a proinflammatory cytokine" . SPARSER::PROTEIN)
    ("a matricellular protein" . SPARSER::PROTEIN)
    ("several myofibroblast-associated proteins" . SPARSER::PROTEIN)
    ("collagen and OPN" . SPARSER::COLLECTION)
    ("the major inducer" . SPARSER::PROTEIN)
    ("HSP27, α-SMA and OPN" . SPARSER::COLLECTION)
    ("hydroxyproline" . SPARSER::MOLECULE) ("BAL" . SPARSER::PROTEIN)
    ("fibroblastic foci (FF)" . SPARSER::PROTEIN)
    ("strong HSP27" . SPARSER::PROTEIN) ("scarce HSP27" . SPARSER::PROTEIN)
    ("α-SMA, OPN, and type I" . SPARSER::COLLECTION)
    ("HSP27 and GFP" . SPARSER::COLLECTION)
    ("OPN and HSP27" . SPARSER::COLLECTION)
    ("α-SMA and HSP27" . SPARSER::COLLECTION)
    ("PBS or bleomycin" . SPARSER::COLLECTION) ("Bleomycin" . SPARSER::DRUG)
    ("FBS and TGF-β1" . SPARSER::COLLECTION) ("AAD" . SPARSER::MOLECULE)
    ("sharp" . SPARSER::PROTEIN) ("p-HSP27" . SPARSER::COLLECTION)
    ("NHLF" . SPARSER::PROTEIN)
    ("HSP27 as well as α-SMA" . SPARSER::COLLECTION)
    ("fibronectin (FN) and type I collagen" . SPARSER::COLLECTION)
    ("collagen and osteopontin (OPN)" . SPARSER::COLLECTION)
    ("collagen and osteopontin" . SPARSER::COLLECTION) ("TGF-" . SPARSER::DRUG)
    ("TGF" . SPARSER::DRUG) ("monomer" . SPARSER::MONOMER)
    ("crystallin" . SPARSER::PROTEIN) ("inducer" . SPARSER::MOLECULE)
    ("HSP27 and α-SMA" . SPARSER::COLLECTION)
    ("α-SMA, OPN and type I" . SPARSER::COLLECTION)
    ("bleomycin" . SPARSER::DRUG)
    ("osteopontin (OPN) and type 1 collagen" . SPARSER::COLLECTION)
    ("OPN" . SPARSER::PROTEIN) ("osteopontin" . SPARSER::PROTEIN)
    ("smooth muscle" . SPARSER::PROTEIN) ("OGX-427" . SPARSER::DRUG)
    ("HSP47" . SPARSER::PROTEIN) ("NOX4" . SPARSER::PROTEIN)
    ("NADPH oxidase" . SPARSER::PROTEIN) ("IL-13 receptor" . SPARSER::PROTEIN)
    ("Spp1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("COL1A1" . SPARSER::PROTEIN)
    ("FN1" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("a2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("HFL-1" . SPARSER::PROTEIN) ("capping protein" . SPARSER::PROTEIN)
    ("HSPB1" . SPARSER::PROTEIN)
    ("Transforming growth factor" . SPARSER::PROTEIN)
    ("α-SMA" . SPARSER::PROTEIN) ("TGF-β1" . SPARSER::PROTEIN)
    ("HSP27" . SPARSER::PROTEIN)
    ("EGFR , Kras or PIK3CA" . SPARSER::COLLECTION)
    ("AKT1 and urethane" . SPARSER::COLLECTION)
    ("mutant Pik3ca and/or Pten" . SPARSER::COLLECTION)
    ("a weak oncogene" . SPARSER::ONCOGENE)
    ("SP-C-driven Cre" . SPARSER::PROTEIN)
    ("CCSP-driven Cre" . SPARSER::PROTEIN) ("CCSP" . SPARSER::PROTEIN)
    ("Pten" . SPARSER::PROTEIN) ("Pik3ca" . SPARSER::PROTEIN)
    ("Pik" . SPARSER::BIO-COMPLEX) ("Egfr" . SPARSER::PROTEIN)
    ("the upstream regulators EGFR (3–4 weeks) or KRAS G12D (3 weeks)"
     . SPARSER::COLLECTION)
    ("CC10 and SP-C" . SPARSER::COLLECTION)
    ("SP-C and CC10" . SPARSER::COLLECTION)
    ("surfactant protein C (SPC)" . SPARSER::PROTEIN)
    ("Clara cell-associated protein" . SPARSER::PROTEIN)
    ("CRE" . SPARSER::PROTEIN) ("formalin" . SPARSER::MOLECULE)
    ("carbamate" . SPARSER::MOLECULE) ("SV" . SPARSER::MOLECULE)
    ("pAKT" . SPARSER::PROTEIN-FAMILY) ("Ki67 and p21" . SPARSER::COLLECTION)
    ("solvent" . SPARSER::MOLECULE) ("pS" . SPARSER::PROTEIN)
    ("Ttf1-Cre" . SPARSER::COLLECTION) ("Ttf1" . SPARSER::PROTEIN)
    ("patched" . SPARSER::PROTEIN) ("recombinase" . SPARSER::PROTEIN)
    ("Southern blot" . SPARSER::PROTEIN)
    ("loxP-flanked transcriptional stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT1 and AKT2" . SPARSER::COLLECTION)
    ("EGFR or HER2" . SPARSER::COLLECTION)
    ("p110 α-catalytic subunit of PI3K" . SPARSER::COLLECTION)
    ("ADC" . SPARSER::PROTEIN) ("urethane" . SPARSER::MOLECULE)
    ("5–2" . SPARSER::PROTEIN) ("A-G" . SPARSER::PROTEIN)
    ("etc." . SPARSER::PROTEIN) ("surfactant protein C" . SPARSER::PROTEIN)
    ("AT2" . SPARSER::PROTEIN) ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CC10" . SPARSER::PROTEIN) ("GSK3α" . SPARSER::PROTEIN)
    ("CC-10" . SPARSER::PROTEIN) ("SP-C" . SPARSER::PROTEIN)
    ("Tween20" . SPARSER::MOLECULE) ("1–2" . SPARSER::PROTEIN)
    ("GSK3-β" . SPARSER::PROTEIN) ("GSK3-α" . SPARSER::PROTEIN)
    ("FoxO1" . SPARSER::PROTEIN) ("a 11" . SPARSER::PROTEIN)
    ("glutamic acid" . SPARSER::AMINO-ACID) ("AKT3" . SPARSER::PROTEIN)
    ("AKT2" . SPARSER::PROTEIN)
    ("catalytic subunit of PI3K" . SPARSER::PROTEIN)
    ("p110 α" . SPARSER::PROTEIN) ("Ki-ras" . SPARSER::PROTEIN)
    ("AKT1" . SPARSER::PROTEIN) ("eIF4" . SPARSER::PROTEIN)
    ("a promiscuous transcription factor" . SPARSER::PROTEIN)
    ("antisense" . SPARSER::PROTEIN) ("PDX" . SPARSER::PROTEIN)
    ("CB" . SPARSER::PROTEIN) ("PDXs" . SPARSER::PROTEIN)
    ("Group" . SPARSER::MOLECULE) ("MCL-1 and p4E-BP1" . SPARSER::COLLECTION)
    ("Neither MLN8237 nor ABT-199" . SPARSER::COLLECTION)
    ("ABT-199 and MLN8237" . SPARSER::COLLECTION)
    ("BIM:MCL-1" . SPARSER::BIO-COMPLEX)
    ("MCL-1 and BIM" . SPARSER::COLLECTION) ("BIM/MCL-1" . SPARSER::COLLECTION)
    ("exogenous MCL-1" . SPARSER::PROTEIN)
    ("4EBP1:eIF4E" . SPARSER::BIO-COMPLEX)
    ("cap-bound proteins" . SPARSER::PROTEIN) ("-GTP" . SPARSER::PROTEIN)
    ("Sepharose" . SPARSER::MOLECULE)
    ("MLN8237 and VX680" . SPARSER::COLLECTION)
    ("p-4E-BP1" . SPARSER::COLLECTION)
    ("the eIF4G:eIF4E complex and downregulation of cap-dependent MCL-1 protein translation ( xref , xref , xref )"
     . SPARSER::COLLECTION)
    ("eIF4G:eIF4E" . SPARSER::BIO-COMPLEX)
    ("BCL-xL and MCL-1" . SPARSER::COLLECTION)
    ("the two drugs as well as the apoptosis-inducing potency"
     . SPARSER::COLLECTION)
    ("p " . SPARSER::PROTEIN)
    ("the dual Aurora inhibitor VX680" . SPARSER::DRUG)
    ("anchor" . SPARSER::ANCHOR) ("BCL-2:BCL-xL" . SPARSER::BIO-COMPLEX)
    ("BCL-2 and BCL-xL" . SPARSER::COLLECTION) ("venetoclax" . SPARSER::DRUG)
    ("MDM2 and MIR17HG" . SPARSER::COLLECTION)
    ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein and RNA" . SPARSER::COLLECTION)
    ("MYCN and PMAIP1" . SPARSER::COLLECTION) ("sh" . SPARSER::PROTEIN-FAMILY)
    ("BCL-2/BCL-xL" . SPARSER::COLLECTION)
    ("pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("the in-clinic BCL-2/BCL-2/xL inhibitor ABT-263" . SPARSER::DRUG)
    ("navitoclax" . SPARSER::DRUG) ("the BH3 mimetic ABT-263" . SPARSER::DRUG)
    ("KRAS and BRAF" . SPARSER::COLLECTION)
    ("MCL-1/BCL-xL/BCL-2" . SPARSER::COLLECTION)
    ("EWS-FLI1" . SPARSER::COLLECTION)
    ("a classical oncogene" . SPARSER::ONCOGENE)
    ("bHLH-LZ" . SPARSER::COLLECTION) ("LZ" . SPARSER::PROTEIN)
    ("well-defined driver oncogenes" . SPARSER::ONCOGENE)
    ("MLN8237 and ABT-199" . SPARSER::COLLECTION) ("MYCN" . SPARSER::PROTEIN)
    ("–3 " . SPARSER::PROTEIN) ("β-cyclodextrin" . SPARSER::MOLECULE)
    ("Glo 3" . SPARSER::PROTEIN) ("Bcl-xL" . SPARSER::PROTEIN)
    ("4EBP1" . SPARSER::PROTEIN) ("MLN0128" . SPARSER::DRUG)
    ("p4" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GSK3" . SPARSER::PROTEIN)
    ("VX680" . SPARSER::DRUG) ("BS2" . SPARSER::PROTEIN)
    ("BS1" . SPARSER::PROTEIN) ("MIR17HG" . SPARSER::PROTEIN)
    ("RPE-1" . SPARSER::PROTEIN) ("NOXA protein" . SPARSER::PROTEIN)
    ("C–1" . SPARSER::PROTEIN) ("A–S1" . SPARSER::PROTEIN)
    ("PMAIP1" . SPARSER::PROTEIN) ("TORC1" . SPARSER::PROTEIN)
    ("ABT-263" . SPARSER::DRUG) ("FLI1" . SPARSER::PROTEIN)
    ("MLN8237" . SPARSER::DRUG) ("Aurora Kinase A" . SPARSER::PROTEIN)
    ("BCL-xL" . SPARSER::PROTEIN) ("ABT-199" . SPARSER::DRUG)
    ("HT-therapy-induced dormant CD133" . SPARSER::PROTEIN)
    ("Notch3 and Mitotracker" . SPARSER::COLLECTION)
    ("Notch3 and enzymes" . SPARSER::COLLECTION)
    ("HK-2, PMK-2 and PDH-A" . SPARSER::COLLECTION)
    ("IL6/Notch3" . SPARSER::COLLECTION)
    ("rotenone and oligomycin" . SPARSER::COLLECTION)
    ("TamR-FACS-isolated CD133" . SPARSER::PROTEIN)
    ("self-renewal-deficient CD133" . SPARSER::PROTEIN)
    ("a 20-" . SPARSER::PROTEIN) ("MitoS" . SPARSER::DRUG)
    ("ethidium" . SPARSER::MOLECULE) ("media" . SPARSER::PROTEIN)
    ("PMK-2, LDHA, ACACA, FASN, ACLY, ALDOC and ENO2" . SPARSER::COLLECTION)
    ("ALDOC" . SPARSER::PROTEIN) ("ACLY" . SPARSER::PROTEIN)
    ("FASN" . SPARSER::PROTEIN) ("ACACA" . SPARSER::PROTEIN)
    ("LDHA" . SPARSER::PROTEIN) ("MAg" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DAPI" . SPARSER::DRUG) ("a dormant CD133" . SPARSER::PROTEIN)
    ("Mito" . SPARSER::DRUG) ("autocrine IL6" . SPARSER::PROTEIN)
    ("Tam or Fulv" . SPARSER::COLLECTION) ("Tam" . SPARSER::PROTEIN)
    ("Stat3 and re-expressed" . SPARSER::COLLECTION)
    ("Stat3 and Notch3" . SPARSER::COLLECTION)
    ("fulvestrant and tamoxifen" . SPARSER::COLLECTION)
    ("IL6, Stat3 and CD133" . SPARSER::COLLECTION)
    ("HTR-Mets" . SPARSER::COLLECTION) ("HTS" . SPARSER::PROTEIN)
    ("Stat3/Notch3/CD133" . SPARSER::COLLECTION) ("Mets" . SPARSER::PROTEIN)
    ("new cohorts" . SPARSER::MOLECULE)
    ("first isolated tamoxifen- and fulvestrant-resistant (TamR/FulvR) metastatic lesions"
     . SPARSER::COLLECTION)
    ("tamoxifen-" . SPARSER::MOLECULE) ("ER-IL6" . SPARSER::COLLECTION)
    ("ER/CD133/IL6" . SPARSER::COLLECTION)
    ("luciferase and oestrogen" . SPARSER::COLLECTION)
    ("Tamoxifen" . SPARSER::MOLECULE)
    ("tamoxifen or tocilizumab" . SPARSER::COLLECTION)
    ("tocilizumab" . SPARSER::DRUG) ("ER/IL6" . SPARSER::COLLECTION)
    ("exogenous IL6" . SPARSER::PROTEIN) ("IL6 and IL6" . SPARSER::COLLECTION)
    ("tamoxifen or fulvestrant" . SPARSER::COLLECTION)
    ("MFP" . SPARSER::PROTEIN) ("fat" . SPARSER::PROTEIN)
    ("CD24, ALDH1 and CD44" . SPARSER::COLLECTION)
    ("/CD133" . SPARSER::COLLECTION) ("/CD44" . SPARSER::COLLECTION)
    ("oestradiol" . SPARSER::MOLECULE) ("MCF7" . SPARSER::PROTEIN)
    ("HTR" . SPARSER::PROTEIN) ("Luminal" . SPARSER::DRUG)
    ("CD133 and IL6" . SPARSER::COLLECTION) ("/CD24" . SPARSER::COLLECTION)
    ("IL6-Notch3" . SPARSER::COLLECTION) ("dormant CD133" . SPARSER::PROTEIN)
    ("an IL6-driven feed-forward ER lo -IL6" . SPARSER::COLLECTION)
    ("-IL6" . SPARSER::COLLECTION) ("/IL6" . SPARSER::COLLECTION)
    ("/ER" . SPARSER::COLLECTION) ("l −1" . SPARSER::PROTEIN)
    ("MTND1" . SPARSER::PROTEIN) ("min −1" . SPARSER::PROTEIN)
    ("- 3" . SPARSER::PROTEIN) ("D-Glucose" . SPARSER::MOLECULE)
    ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("beta-galactosidase" . SPARSER::PROTEIN) ("g −1" . SPARSER::PROTEIN)
    ("D-glucose" . SPARSER::MOLECULE)
    ("green fluorescent protein" . SPARSER::PROTEIN)
    ("severe combined immunodeficiency" . SPARSER::PROTEIN)
    ("ERα" . SPARSER::PROTEIN) ("HK-2" . SPARSER::PROTEIN)
    ("ENO2" . SPARSER::PROTEIN) ("PMK-2" . SPARSER::PROTEIN)
    ("(beta" . SPARSER::PROTEIN) ("shN3" . SPARSER::PROTEIN)
    ("ESR1" . SPARSER::PROTEIN) ("Notch3" . SPARSER::PROTEIN)
    ("IL6R" . SPARSER::PROTEIN)
    ("biologic and molecular mechanisms underlying the pathologic differences between MBC and FBC"
     . SPARSER::COLLECTION)
    ("ER− and ER+" . SPARSER::COLLECTION) ("ER− and PR−" . SPARSER::COLLECTION)
    ("ER and PR" . SPARSER::COLLECTION)
    ("nodal, ER and PR" . SPARSER::COLLECTION) ("nodal" . SPARSER::PROTEIN)
    ("ER− (9.7 % vs. 3.3 %, P  = 0.17) and PR− (21.4 % vs. 13.2 %, P  = 0.27)"
     . SPARSER::COLLECTION)
    ("ER or PR" . SPARSER::COLLECTION)
    ("ER, PR and HER2" . SPARSER::COLLECTION) ("Modifiers" . SPARSER::MOLECULE)
    ("HER2−" . SPARSER::PROTEIN) ("PR−" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ER−" . SPARSER::PROTEIN) ("receptor–" . SPARSER::RECEPTOR)
    ("BRCA" . SPARSER::PROTEIN-FAMILY) ("Male" . SPARSER::MOLECULE)
    ("BRCA2-" . SPARSER::PROTEIN) ("OR 2" . SPARSER::MOLECULE)
    ("OR 1" . SPARSER::PROTEIN) ("BRCA 2" . SPARSER::PROTEIN)
    ("cancer 2" . SPARSER::PROTEIN)
    ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("progesterone receptor" . SPARSER::PROTEIN)
    ("MSP and Q-MSP" . SPARSER::COLLECTION)
    ("the MGMT gene and GSTP1 gene" . SPARSER::COLLECTION)
    ("gene and environment" . SPARSER::COLLECTION) ("MGMT" . SPARSER::PROTEIN)
    ("rank" . SPARSER::PROTEIN) ("MSP, Q-MSP and BSP" . SPARSER::COLLECTION)
    ("MSRA" . SPARSER::PROTEIN) ("genes and HNSCC" . SPARSER::COLLECTION)
    ("protein 1A" . SPARSER::PROTEIN) ("GSTP1" . SPARSER::PROTEIN)
    ("RASSF1" . SPARSER::PROTEIN) ("cyclin:CDK:RB" . SPARSER::BIO-COMPLEX)
    ("the most relevant biologic" . SPARSER::DRUG)
    ("exemestane" . SPARSER::DRUG) ("pRb " . SPARSER::PROTEIN)
    ("palbociclib and abemaciclib" . SPARSER::COLLECTION)
    ("the latter cohort" . SPARSER::MOLECULE)
    ("abemaciclib and fulvestrant" . SPARSER::COLLECTION)
    ("abemaciclib" . SPARSER::DRUG)
    ("The molecules and ongoing trials in breast cancer" . SPARSER::COLLECTION)
    ("a heavily pre-treated cohort" . SPARSER::MOLECULE)
    ("goserelin" . SPARSER::DRUG)
    ("fulvestrant and placebo" . SPARSER::COLLECTION)
    ("palbociclib and fulvestrant" . SPARSER::COLLECTION)
    ("fulvestrant" . SPARSER::DRUG) ("TRIO" . SPARSER::PROTEIN)
    ("San" . SPARSER::PROTEIN)
    ("biomarkers absent (n = 25) HR " . SPARSER::PROTEIN)
    ("HR " . SPARSER::PROTEIN)
    ("letrozole and palbociclib" . SPARSER::COLLECTION)
    ("palbociclib and letrozole" . SPARSER::COLLECTION)
    ("palbociclib and tamoxifen or trastuzumab" . SPARSER::COLLECTION)
    ("tamoxifen or trastuzumab" . SPARSER::COLLECTION)
    ("Food and Drug Administration (FDA)" . SPARSER::COLLECTION)
    ("Drug" . SPARSER::DRUG) ("Food" . SPARSER::MOLECULE)
    ("Palbociclib" . SPARSER::DRUG) ("ray" . SPARSER::PROTEIN)
    ("CDKs, AKT, Chk1, and protein" . SPARSER::COLLECTION)
    ("analog" . SPARSER::ANALOG) ("staurosporine" . SPARSER::MOLECULE)
    ("UCN-01 and R-Rescovitine (seliciclib; Cyclacel)" . SPARSER::COLLECTION)
    ("seliciclib" . SPARSER::DRUG)
    ("a classic pan-CDK inhibitor" . SPARSER::INHIBITOR)
    ("Flavopiridol" . SPARSER::DRUG)
    ("flavopiridol, R-roscovitine, and UCN-01" . SPARSER::COLLECTION)
    ("flavopiridol" . SPARSER::DRUG)
    ("these respective receptors" . SPARSER::PROTEIN)
    ("ER and HER2" . SPARSER::COLLECTION)
    ("growth factor and steroid hormone" . SPARSER::COLLECTION)
    ("CDK4/6 and endocrine" . SPARSER::COLLECTION)
    ("cyclin D1 and CDK4" . SPARSER::COLLECTION)
    ("wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Notch1-driven T cell acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("functional cyclin D1" . SPARSER::PROTEIN)
    ("neu and ras" . SPARSER::COLLECTION)
    ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY) ("neu" . SPARSER::PROTEIN)
    ("CDK2, CDK3, CDK4, and CDK6" . SPARSER::COLLECTION)
    ("CDK–cyclin" . SPARSER::COLLECTION) ("p21 and p27" . SPARSER::COLLECTION)
    ("peroxisome" . SPARSER::PROTEIN)
    ("p21 as well as p27" . SPARSER::COLLECTION)
    ("the INK4 (p16, p15, p18, p19) and CIP/KIP (p21, p27, p57) protein families [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("CKIs" . SPARSER::PROTEIN) ("late S phase CDK2" . SPARSER::PROTEIN)
    ("PRMT5–MEP50" . SPARSER::COLLECTION)
    ("cyclin D:CDK4" . SPARSER::BIO-COMPLEX) ("MARCKS" . SPARSER::PROTEIN)
    ("mitogen" . SPARSER::MITOGEN)
    ("the cyclin D1:CDK4/6 complex lifts pRb’s" . SPARSER::PROTEIN)
    ("CDK4/CDK6" . SPARSER::COLLECTION) ("p107 and p130" . SPARSER::COLLECTION)
    ("CDKs and cyclins" . SPARSER::COLLECTION)
    ("CDK-cyclin" . SPARSER::COLLECTION) ("holoenzyme" . SPARSER::PROTEIN)
    ("transcriptional CDKs" . SPARSER::PROTEIN)
    ("regulatory CDKs" . SPARSER::PROTEIN)
    ("one mitotic CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("various cyclins and their associated CDKs [ xref ]"
     . SPARSER::COLLECTION)
    ("their associated CDKs" . SPARSER::PROTEIN)
    ("cyclin D:CDK4/6" . SPARSER::BIO-COMPLEX)
    ("cyclin:CDK" . SPARSER::BIO-COMPLEX)
    ("CDK4 and cyclin D1" . SPARSER::COLLECTION)
    ("cyclin D1:CDK4/6" . SPARSER::BIO-COMPLEX) ("pRb" . SPARSER::PROTEIN)
    ("cyclin/CDK" . SPARSER::COLLECTION)
    ("activators and kinases" . SPARSER::COLLECTION)
    ("Medicine" . SPARSER::DRUG) ("sea" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("his" . SPARSER::AMINO-ACID) ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tim" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Paul" . SPARSER::PROTEIN)
    ("temperature-sensitive yeast mutants" . SPARSER::MUTANT)
    ("ER" . SPARSER::PROTEIN) ("palbociclib" . SPARSER::DRUG)
    ("broadly acting CDK inhibitors" . SPARSER::INHIBITOR)
    ("BYL719" . SPARSER::DRUG) ("LEE011" . SPARSER::DRUG)
    ("LY2835219" . SPARSER::DRUG) ("PD 0332991" . SPARSER::DRUG)
    ("Chk1" . SPARSER::PROTEIN) ("UCN-01" . SPARSER::DRUG)
    ("R-roscovitine" . SPARSER::DRUG) ("steroid hormone" . SPARSER::MOLECULE)
    ("cyclin E1" . SPARSER::PROTEIN) ("cyclin D3" . SPARSER::PROTEIN)
    ("ErbB-2" . SPARSER::PROTEIN) ("CDK3" . SPARSER::PROTEIN)
    ("ER-alpha" . SPARSER::PROTEIN) ("Cyclin D1" . SPARSER::PROTEIN)
    ("transforming growth factor" . SPARSER::PROTEIN)
    ("p18" . SPARSER::PROTEIN) ("INK4" . SPARSER::PROTEIN)
    ("Negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("cyclin A2" . SPARSER::PROTEIN) ("MEP50" . SPARSER::PROTEIN)
    ("PRMT5" . SPARSER::PROTEIN) ("FOXM1" . SPARSER::PROTEIN)
    ("Cdt1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SMAD2" . SPARSER::PROTEIN)
    ("p130" . SPARSER::PROTEIN) ("p107" . SPARSER::PROTEIN)
    ("E2F" . SPARSER::PROTEIN-FAMILY) ("cyclin family" . SPARSER::PROTEIN)
    ("CDK8" . SPARSER::PROTEIN) ("CDK7" . SPARSER::PROTEIN)
    ("CDK1" . SPARSER::PROTEIN) ("CDK2" . SPARSER::PROTEIN)
    ("cyclin D" . SPARSER::PROTEIN) ("anti-estrogens" . SPARSER::DRUG)
    ("PD-0332991" . SPARSER::DRUG) ("CDK4/6" . SPARSER::PROTEIN)
    ("anti-estrogen" . SPARSER::DRUG)
    ("aggressive subtypes" . SPARSER::PROTEIN)
    ("transcription factor (TCF)" . SPARSER::PROTEIN)
    ("ETS" . SPARSER::PROTEIN) ("thyroglobulin" . SPARSER::PROTEIN)
    ("symporter" . SPARSER::PROTEIN) ("iodine" . SPARSER::MOLECULE)
    ("the follicular and diffuse sclerosing variants" . SPARSER::VARIANT)
    ("included follicular and diffuse sclerosing variants" . SPARSER::VARIANT)
    ("PTC and FTCs" . SPARSER::COLLECTION)
    ("classic PTC (8.8 %, 95 % CI 6.8–11.1) and follicular variant (6.6 %, 95 % CI 4.5–9.3)"
     . SPARSER::COLLECTION)
    ("follicular variant" . SPARSER::VARIANT)
    ("classic PTC and FTC" . SPARSER::COLLECTION)
    ("the follicular variant" . SPARSER::VARIANT)
    ("PTC and FTC" . SPARSER::COLLECTION) ("classic PTC" . SPARSER::PROTEIN)
    ("PR or SD" . SPARSER::COLLECTION)
    ("follicular and diffuse sclerosing variants" . SPARSER::VARIANT)
    ("aggressive histologic subtypes" . SPARSER::PROTEIN)
    ("FTCs" . SPARSER::DRUG) ("unselected consecutive PTC" . SPARSER::PROTEIN)
    ("PTCs" . SPARSER::PROTEIN)
    ("EML4 , STRN , TFG , and GTF2IRD1" . SPARSER::COLLECTION)
    ("TFG" . SPARSER::PROTEIN) ("STRN" . SPARSER::PROTEIN)
    ("FTC" . SPARSER::DRUG) ("ATG" . SPARSER::DRUG)
    ("thymine" . SPARSER::MOLECULE)
    ("additional prognostic biomarkers" . SPARSER::MOLECULE)
    ("PTC" . SPARSER::PROTEIN) ("endocrine" . SPARSER::PROTEIN)
    ("Thyroid" . SPARSER::PROTEIN) ("BRAF and TERT" . SPARSER::COLLECTION)
    ("p " . SPARSER::PROTEIN) ("TERT" . SPARSER::PROTEIN)
    ("telomerase activity" . SPARSER::PROTEIN)
    ("thyroid-stimulating hormone receptor" . SPARSER::PROTEIN)
    ("sodium iodide" . SPARSER::MOLECULE) ("p80" . SPARSER::PROTEIN)
    ("GTF2IRD1" . SPARSER::PROTEIN) ("EML4" . SPARSER::PROTEIN)
    ("RSR and ATRIP" . SPARSER::COLLECTION)
    ("HDACs and sirtuins" . SPARSER::COLLECTION)
    ("associated proteins" . SPARSER::PROTEIN)
    ("SIRT2 or control siRNA" . SPARSER::COLLECTION)
    ("bacterial purified recombinant trimeric RPA" . SPARSER::PROTEIN)
    ("ATR, TopBP1, or NBS1" . SPARSER::COLLECTION)
    ("RPA70 and RPA32" . SPARSER::COLLECTION)
    ("mouse mammary tumor Sirt2 knockout (MMT S2KO) cells ( xref ) complemented"
     . SPARSER::PROTEIN)
    ("GFP-ATRIP" . SPARSER::COLLECTION) ("IdU" . SPARSER::DRUG)
    ("glutamine" . SPARSER::AMINO-ACID)
    ("SIRT2 or a non-targeting (NT) siRNA" . SPARSER::COLLECTION)
    ("SIRT2 or non-targeting" . SPARSER::COLLECTION)
    ("HU and camptothecin" . SPARSER::COLLECTION) ("CPT" . SPARSER::PROTEIN)
    ("camptothecin" . SPARSER::DRUG) ("HU" . SPARSER::DRUG)
    ("nicotinamide or TSA" . SPARSER::COLLECTION)
    ("acetylated endogenous ATRIP and exogenous tagged wild-type HA-ATRIP"
     . SPARSER::COLLECTION)
    ("exogenous tagged wild-type HA-ATRIP" . SPARSER::COLLECTION)
    ("a rabbit monoclonal anti-acetyl ATRIP K32 antibody" . SPARSER::ANTIBODY)
    ("arginines" . SPARSER::AMINO-ACID) ("Lysines" . SPARSER::AMINO-ACID)
    ("a legitimate SIRT2 downstream deacetylation target"
     . SPARSER::TARGET-PROTEIN)
    ("FLAG-SIRT2" . SPARSER::COLLECTION) ("HDAC" . SPARSER::PROTEIN)
    ("hydroxyurea" . SPARSER::DRUG) ("ATRIP or ATR" . SPARSER::COLLECTION)
    ("FLAG-SIRT1" . SPARSER::COLLECTION) ("SIRT2-GFP" . SPARSER::COLLECTION)
    ("FLAG-ATR" . SPARSER::COLLECTION) ("HA" . SPARSER::PROTEIN)
    ("SIRT2 and ATRIP" . SPARSER::COLLECTION)
    ("SIRT2-FLAG" . SPARSER::COLLECTION) ("HA-ATRIP" . SPARSER::COLLECTION)
    ("FLAG" . SPARSER::PROTEIN-FAMILY) ("Complex" . SPARSER::BIO-COMPLEX)
    ("ATM and DNA" . SPARSER::COLLECTION)
    ("DDR and DNA repair proteins" . SPARSER::COLLECTION)
    ("SIRT1 and SIRT6" . SPARSER::COLLECTION)
    ("topoisomerase II beta binding protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("9-1-1 complex and MRN" . SPARSER::COLLECTION)
    ("topoisomerase" . SPARSER::PROTEIN)
    ("MRE11-RAD50-NBS1" . SPARSER::COLLECTION)
    ("RAD9-HUS1-RAD1" . SPARSER::COLLECTION)
    ("clamp" . SPARSER::PROTEIN-FAMILY) ("protein A (RPA)" . SPARSER::PROTEIN)
    ("ATR and ATRIP" . SPARSER::COLLECTION)
    ("ataxia telangiectasia mutated and Rad3" . SPARSER::COLLECTION)
    ("apex" . SPARSER::PROTEIN) ("DDR" . SPARSER::PROTEIN)
    ("RSR" . SPARSER::MOLECULE) ("ssDNA" . SPARSER::PROTEIN)
    ("RPA-ssDNA" . SPARSER::COLLECTION) ("ATR-ATRIP" . SPARSER::COLLECTION)
    ("RPA" . SPARSER::PROTEIN) ("ATRIP" . SPARSER::PROTEIN)
    ("ataxia telangiectasia-mutated and Rad3-related" . SPARSER::COLLECTION)
    ("ATR" . SPARSER::PROTEIN) ("aa 1" . SPARSER::PROTEIN)
    ("RPA32" . SPARSER::PROTEIN) ("RPA70" . SPARSER::PROTEIN)
    ("deacetylase activity" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase-related kinase" . SPARSER::PROTEIN)
    ("DNA-PKcs" . SPARSER::PROTEIN) ("SIRT6" . SPARSER::PROTEIN)
    ("CDK9" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 9" . SPARSER::PROTEIN)
    ("BubR1" . SPARSER::PROTEIN) ("Sirt2" . SPARSER::PROTEIN)
    ("Sirtuin 2" . SPARSER::PROTEIN) ("CHK1" . SPARSER::PROTEIN)
    ("TopBP1" . SPARSER::PROTEIN) ("9-1-1 complex" . SPARSER::|9-1-1|)
    ("MRE11" . SPARSER::PROTEIN) ("RAD1" . SPARSER::PROTEIN)
    ("HUS1" . SPARSER::PROTEIN) ("RAD9" . SPARSER::PROTEIN)
    ("RAD17" . SPARSER::PROTEIN) ("ATR interacting protein" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("ATR-interacting protein" . SPARSER::PROTEIN) ("SIRT2" . SPARSER::PROTEIN)
    ("sirtuin 2" . SPARSER::PROTEIN)
    ("ataxia telangiectasia-mutated" . SPARSER::PROTEIN)
    ("CRC and perhaps" . SPARSER::COLLECTION) ("SCs" . SPARSER::PROTEIN)
    ("RNF20 +/− inflammatory leukocytes and macrophages" . SPARSER::COLLECTION)
    ("leukocytes and macrophages" . SPARSER::COLLECTION)
    ("EGF and IFN-γ" . SPARSER::COLLECTION)
    ("human tumors often underexpress p50" . SPARSER::PROTEIN)
    ("transactivation-competent p65-containing dimers" . SPARSER::DIMER)
    ("p50-p65 heterodimers or p65 homodimers" . SPARSER::COLLECTION)
    ("p50-p65" . SPARSER::COLLECTION) ("CAC" . SPARSER::PROTEIN)
    ("IL6 and IL8" . SPARSER::COLLECTION)
    ("inflammation-associated CRC" . SPARSER::PROTEIN)
    ("DSS-AOM" . SPARSER::COLLECTION) ("epsilon" . SPARSER::PROTEIN)
    ("excessive ROS and nitric oxide" . SPARSER::COLLECTION)
    ("ROS and nitric oxide" . SPARSER::COLLECTION)
    ("Arginase" . SPARSER::PROTEIN)
    ("DSS-treated RNF20 +/−" . SPARSER::PROTEIN)
    ("cingulin" . SPARSER::PROTEIN) ("prone" . SPARSER::PROTEIN-FAMILY)
    ("heterozygotes" . SPARSER::PROTEIN)
    ("sodium sulfate (DSS)" . SPARSER::MOLECULE) ("Dextran" . SPARSER::DEXTRAN)
    ("Prone" . SPARSER::PROTEIN-FAMILY) ("monocytes" . SPARSER::PROTEIN)
    ("leukocytes" . SPARSER::PROTEIN) ("mRNA and H2Bub1" . SPARSER::COLLECTION)
    ("trap" . SPARSER::PROTEIN)
    ("chromatin-associated NF-κB subunits" . SPARSER::FRAGMENT)
    ("p65-p50" . SPARSER::COLLECTION) ("p21/CDKN1A" . SPARSER::COLLECTION)
    ("p65 and p50" . SPARSER::COLLECTION)
    ("IL8 and CXCL1" . SPARSER::COLLECTION)
    ("primarily p65/p50 dimers" . SPARSER::DIMER)
    ("p65/p50" . SPARSER::COLLECTION) ("wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RNF40 and hRAD6A" . SPARSER::COLLECTION)
    ("p53 and Bcl2" . SPARSER::COLLECTION)
    ("mature cytokine mRNA" . SPARSER::PROTEIN)
    ("heterogeneous nuclear RNA" . SPARSER::RNA)
    ("IL8 and IL6" . SPARSER::COLLECTION) ("hnRNA" . SPARSER::RNA)
    ("RNF20 mRNA ( xref C) or protein ( xref A)" . SPARSER::COLLECTION)
    ("promoters and bodies" . SPARSER::COLLECTION)
    ("RNF20 and RNF40" . SPARSER::COLLECTION)
    ("inflammation-associated genes" . SPARSER::GENE)
    ("SWI/SNF" . SPARSER::COLLECTION) ("SNF" . SPARSER::PROTEIN-FAMILY)
    ("SWI" . SPARSER::PROTEIN) ("TFIIS" . SPARSER::PROTEIN)
    ("polymerase-associated factor (PAF) complex" . SPARSER::BIO-COMPLEX)
    ("PAF" . SPARSER::PROTEIN-FAMILY) ("Pol" . SPARSER::PROTEIN)
    ("/RNF40" . SPARSER::COLLECTION) ("Eukaryotic DNA" . SPARSER::DNA)
    ("nucleosomes" . SPARSER::PROTEIN)
    ("p65, c-Rel, and RelB" . SPARSER::COLLECTION)
    ("c-Rel, and RelB" . SPARSER::COLLECTION) ("RelB" . SPARSER::PROTEIN)
    ("RelA" . SPARSER::PROTEIN)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("kappa" . SPARSER::PROTEIN-FAMILY)
    ("repressive p50 homodimers" . SPARSER::HOMODIMER)
    ("RNF20 and H2Bub1" . SPARSER::COLLECTION)
    ("heterochromatin" . SPARSER::PROTEIN) ("homodimers" . SPARSER::HOMODIMER)
    ("RNF20/RNF40" . SPARSER::COLLECTION) ("RNF43" . SPARSER::PROTEIN)
    ("D–7" . SPARSER::PROTEIN) ("elongation factor" . SPARSER::PROTEIN)
    ("EHMT1" . SPARSER::PROTEIN) ("γ-H2AX" . SPARSER::PROTEIN)
    ("nitric oxide" . SPARSER::MOLECULE) ("Gr1" . SPARSER::PROTEIN)
    ("CD3" . SPARSER::PROTEIN) ("CD206" . SPARSER::PROTEIN)
    ("S5" . SPARSER::MOLECULE) ("S5B" . SPARSER::PROTEIN)
    ("MIP2" . SPARSER::PROTEIN) ("IFN-γ" . SPARSER::PROTEIN)
    ("tight junction" . SPARSER::PROTEIN)
    ("sodium sulfate" . SPARSER::MOLECULE) ("IκB" . SPARSER::PROTEIN)
    ("CXCL1" . SPARSER::PROTEIN) ("IL6" . SPARSER::PROTEIN)
    ("IL8" . SPARSER::PROTEIN) ("TNF-α" . SPARSER::PROTEIN)
    ("tumor necrosis factor" . SPARSER::PROTEIN)
    ("interferon gamma" . SPARSER::PROTEIN)
    ("RNA polymerase II" . SPARSER::PROTEIN) ("hBRE1" . SPARSER::PROTEIN)
    ("H2B" . SPARSER::PROTEIN) ("c-Rel" . SPARSER::PROTEIN)
    ("p52" . SPARSER::PROTEIN) ("NF-kB" . SPARSER::PROTEIN)
    ("p50" . SPARSER::PROTEIN) ("p65" . SPARSER::PROTEIN)
    ("Bub1" . SPARSER::PROTEIN) ("histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RNF40" . SPARSER::PROTEIN) ("RNF20" . SPARSER::PROTEIN)
    ("eIF4E3" . SPARSER::PROTEIN) ("eIF4F, or eIF4F" . SPARSER::COLLECTION)
    ("eIF4F or eIF4F" . SPARSER::COLLECTION)
    ("Even hypoxia-inducible mRNAs" . SPARSER::PROTEIN)
    ("available mRNAs" . SPARSER::PROTEIN) ("HIF-1β (ARNT)" . SPARSER::PROTEIN)
    ("a mandatory subunit" . SPARSER::FRAGMENT) ("ARNT" . SPARSER::PROTEIN)
    ("eIF4E and eIF4E2" . SPARSER::COLLECTION) ("VHL" . SPARSER::PROTEIN)
    ("EGFR and IGF1R" . SPARSER::COLLECTION) ("Proteins" . SPARSER::PROTEIN)
    ("RBM5 and MDM4" . SPARSER::COLLECTION)
    ("RBM3 and RPL32" . SPARSER::COLLECTION)
    ("either normoxic eIF4F" . SPARSER::PROTEIN) ("Class" . CLASS)
    ("polysomes" . SPARSER::BIO-COMPLEX)
    ("eIF4A ( xref ) and eIF4G3" . SPARSER::COLLECTION)
    ("eIF4E2, eIF4A ( xref ) and eIF4G3" . SPARSER::COLLECTION)
    ("eIF4G3" . SPARSER::PROTEIN) ("eIF4E or eIF4G1" . SPARSER::COLLECTION)
    ("eIF4E and eIF4G1" . SPARSER::COLLECTION) ("eIF4G1" . SPARSER::PROTEIN)
    ("eIF4F and eIF4F" . SPARSER::COLLECTION) ("ell" . SPARSER::PROTEIN)
    ("Targets" . SPARSER::TARGET-PROTEIN)
    ("fractions (MO)" . SPARSER::COMPONENT) ("fractions" . SPARSER::COMPONENT)
    ("normoxia (21% O 2 ) or hypoxia (1% O 2 , 24h)" . SPARSER::COLLECTION)
    ("ribosome" . SPARSER::BIO-COMPLEX)
    ("the cap-binding eIF4E2 and the O 2 -regulated HIF-2α ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("eIF4E2" . SPARSER::PROTEIN)
    ("the RNA helicase eIF4A and the scaffold eIF4G" . SPARSER::COLLECTION)
    ("The cap-binding eIF4E, the RNA helicase eIF4A and the scaffold eIF4G"
     . SPARSER::COLLECTION)
    ("helicase" . SPARSER::PROTEIN) ("normoxia" . SPARSER::PROTEIN)
    ("key mRNAs" . SPARSER::PROTEIN) ("cellular mRNAs" . SPARSER::PROTEIN)
    ("the normoxic eIF4F" . SPARSER::PROTEIN)
    ("Actinomycin D" . SPARSER::MOLECULE) ("N 2" . SPARSER::PROTEIN)
    ("U87MG" . SPARSER::PROTEIN) ("cap-binding protein" . SPARSER::PROTEIN)
    ("RBM4" . SPARSER::PROTEIN)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("HIF-1β" . SPARSER::PROTEIN) ("MDM4" . SPARSER::PROTEIN)
    ("RBM5" . SPARSER::PROTEIN) ("RPL32" . SPARSER::PROTEIN)
    ("RBM3" . SPARSER::PROTEIN) ("homolog of" . SPARSER::PROTEIN)
    ("H/ R" . SPARSER::PROTEIN) ("H /R" . SPARSER::PROTEIN)
    ("E2" . SPARSER::MOLECULE)
    ("ovarian cancer syndrome families" . SPARSER::PROTEIN-FAMILY)
    ("BRCA1 or BRCA2" . SPARSER::COLLECTION)
    ("only two alleles" . SPARSER::ALLELE)
    ("the recurrent BRCA1" . SPARSER::PROTEIN) ("adenine" . SPARSER::MOLECULE)
    ("SD" . SPARSER::PROTEIN) ("intron" . SPARSER::PROTEIN)
    ("BRCA1 , BRCA2 , TP53 , BRIP1 , PALB2 , CHEK2 , RAD50 , NBS1 and RAD51C"
     . SPARSER::COLLECTION)
    ("BRCA1 , BRCA2 , ATM , TP53 , RAD51C and XRCC2" . SPARSER::COLLECTION)
    ("ATM" . SPARSER::PROTEIN) ("insA" . SPARSER::PROTEIN)
    ("delC" . SPARSER::PROTEIN) ("exon-intron" . SPARSER::COLLECTION)
    ("BRCA1 and BRCA2" . SPARSER::COLLECTION) ("NBS1" . SPARSER::PROTEIN)
    ("RAD50" . SPARSER::PROTEIN) ("CHEK2" . SPARSER::PROTEIN)
    ("XRCC2" . SPARSER::PROTEIN) ("RAD51C" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor/HER2" . SPARSER::COLLECTION)
    ("aromatase" . SPARSER::PROTEIN)
    ("linsitinib and BMS‐754807" . SPARSER::COLLECTION)
    ("the most frequent DLT and/or most common treatment‐related AE"
     . SPARSER::COLLECTION)
    ("the most frequent DLT" . SPARSER::PROTEIN)
    ("severe hyperglycemia" . SPARSER::PROTEIN)
    ("other IGF‐1R/IR dual kinases inhibitors" . SPARSER::INHIBITOR)
    ("paclitaxel and erlotinib" . SPARSER::COLLECTION)
    ("everolimus" . SPARSER::DRUG)
    ("the actual molecular target" . SPARSER::TARGET-PROTEIN)
    ("other IGF‐1R/IR dual kinase inhibitors" . SPARSER::INHIBITOR)
    ("linsitinib" . SPARSER::DRUG) ("MTD and RP2D" . SPARSER::COLLECTION)
    ("DLT" . SPARSER::PROTEIN) ("MTD" . SPARSER::PROTEIN)
    ("DLTs" . SPARSER::PROTEIN) ("AEs" . SPARSER::PROTEIN)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("anti" . SPARSER::PROTEIN)
    ("SK" . SPARSER::PROTEIN) ("TC" . SPARSER::PROTEIN)
    ("FLI" . SPARSER::PROTEIN) ("EWS" . SPARSER::PROTEIN)
    ("several dual IGF‐1R/IR TKIs" . SPARSER::PROTEIN)
    ("indazole" . SPARSER::MOLECULE)
    ("three ligands (IGF‐1, IGF‐2, and insulin), three corresponding cell membrane receptors (IGF‐1R, IGF‐2R, and IR), and seven IGF‐binding proteins (IGFBP1–7)"
     . SPARSER::COLLECTION)
    ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Sorafenib" . SPARSER::DRUG)
    ("sunitinib" . SPARSER::DRUG) ("sorafenib" . SPARSER::DRUG)
    ("letrozole" . SPARSER::DRUG) ("hyperglycemia" . SPARSER::PROTEIN)
    ("KW" . SPARSER::MOLECULE) ("NCT" . SPARSER::PROTEIN)
    ("IGF" . SPARSER::PROTEIN) ("G 2 /M" . SPARSER::PROTEIN)
    ("aurora kinase A" . SPARSER::PROTEIN)
    ("kinase insert domain receptor" . SPARSER::PROTEIN)
    ("Jak2" . SPARSER::PROTEIN) ("CYP3A4" . SPARSER::PROTEIN)
    ("RP2" . SPARSER::PROTEIN) ("Insulin receptor" . SPARSER::PROTEIN)
    ("IGFBP1" . SPARSER::PROTEIN) ("vascular endothelial" . SPARSER::PROTEIN)
    ("insulin receptor" . SPARSER::PROTEIN)
    ("Bacterial lectin PFL" . SPARSER::PROTEIN) ("dynein" . SPARSER::PROTEIN)
    ("functional RAB7" . SPARSER::PROTEIN) ("microtubules" . SPARSER::PROTEIN)
    ("RAB" . SPARSER::PROTEIN)
    ("vesicular trafficking proteins" . SPARSER::PROTEIN)
    ("ROS-p38-p53" . SPARSER::COLLECTION)
    ("high mannose N-glycans as well as monosaccharides" . SPARSER::COLLECTION)
    ("glycoproteins" . SPARSER::PROTEIN)
    ("monosaccharides" . SPARSER::MOLECULE) ("ConA" . SPARSER::DRUG)
    ("calpain" . SPARSER::PROTEIN)
    ("many autophagic proteins" . SPARSER::PROTEIN)
    ("proteins and organelles" . SPARSER::COLLECTION)
    ("substances" . SPARSER::SUBSTANCE) ("integrin/EGFR" . SPARSER::COLLECTION)
    ("integrins and EGFR" . SPARSER::COLLECTION)
    ("both EGFR and α2 integrin" . SPARSER::COLLECTION)
    ("the high mannose binding bacterial lectin PFL" . SPARSER::PROTEIN)
    ("ATG9A and HSPB8 siRNAs or control siRNA" . SPARSER::COLLECTION)
    ("ATG9A and HSPB8" . SPARSER::COLLECTION)
    ("RAB7 and LC3" . SPARSER::COLLECTION)
    ("caspase-7 nor caspase-3" . SPARSER::COLLECTION)
    ("caspase-9, caspase-7 nor caspase-3" . SPARSER::COLLECTION)
    ("PFL-EGFR" . SPARSER::COLLECTION) ("autophagic genes" . SPARSER::GENE)
    ("ATG7 and ATG3" . SPARSER::COLLECTION)
    ("Beclin-1 and ATG5" . SPARSER::COLLECTION)
    ("elongation" . SPARSER::PROTEIN)
    ("ATG5, ATG7, ATG9A, ATG12, and ATG13" . SPARSER::COLLECTION)
    ("FBS" . SPARSER::PROTEIN) ("RPMI" . SPARSER::PROTEIN)
    ("PFL and EGFR" . SPARSER::COLLECTION) ("glycoprotein" . SPARSER::PROTEIN)
    ("mannan" . SPARSER::MOLECULE)
    ("Alexa568-conjugated secondary antibody" . SPARSER::PROTEIN)
    ("Fluorescent-labeled PFL" . SPARSER::PROTEIN) ("p  " . SPARSER::PROTEIN)
    ("trypsin" . SPARSER::PROTEIN) ("biotin-PFL" . SPARSER::PROTEIN-PAIR)
    ("avidin" . SPARSER::PROTEIN) ("collagen" . SPARSER::PROTEIN)
    ("the bacterial lectin PFL" . SPARSER::PROTEIN)
    ("monosaccharide" . SPARSER::MOLECULE)
    ("several other homologous proteins" . SPARSER::PROTEIN)
    ("bacterial PFL" . SPARSER::PROTEIN)
    ("well-characterized cyanobacterial OAA" . SPARSER::MOLECULE)
    ("ESA" . SPARSER::PROTEIN) ("OAA" . SPARSER::MOLECULE)
    ("lectins" . SPARSER::PROTEIN) ("Lectins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an anti-cancer drug or an adjuvant" . SPARSER::COLLECTION)
    ("integrin and EGFR" . SPARSER::COLLECTION) ("EGFP" . SPARSER::PROTEIN)
    ("RAB7 siRNA as well as LC3 siRNA" . SPARSER::COLLECTION)
    ("autophagic proteins" . SPARSER::PROTEIN)
    ("Gene and protein" . SPARSER::COLLECTION) ("peptide" . SPARSER::PEPTIDE)
    ("lectin (PFL)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mannose" . SPARSER::MOLECULE) ("anoikis" . SPARSER::PROTEIN)
    ("PFL" . SPARSER::PROTEIN) ("lectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SP-D" . SPARSER::PROTEIN) ("surfactant protein D" . SPARSER::PROTEIN)
    ("transmembrane protein" . SPARSER::PROTEIN)
    ("Concanavalin A" . SPARSER::DRUG) ("RAB family" . SPARSER::PROTEIN)
    ("e1" . SPARSER::MOLECULE) ("ATG13" . SPARSER::PROTEIN)
    ("ATG12" . SPARSER::PROTEIN) ("ATG7" . SPARSER::PROTEIN)
    ("Beclin-1" . SPARSER::PROTEIN) ("P40" . SPARSER::PROTEIN)
    ("penicillin G" . SPARSER::MOLECULE) ("ATG5" . SPARSER::PROTEIN)
    ("ATG9A" . SPARSER::PROTEIN) ("caspase-9" . SPARSER::PROTEIN)
    ("HSPB8" . SPARSER::PROTEIN) ("ATG 13" . SPARSER::PROTEIN)
    ("ATG 12" . SPARSER::PROTEIN) ("ATG 9A" . SPARSER::PROTEIN)
    ("ATG 7" . SPARSER::PROTEIN) ("ATG 5" . SPARSER::PROTEIN)
    ("ATG3" . SPARSER::PROTEIN) ("Beclin1" . SPARSER::PROTEIN)
    ("envelope glycoproteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N-glycans" . SPARSER::MOLECULE)
    ("mannose-binding lectin" . SPARSER::PROTEIN)
    ("anti-viral" . SPARSER::DRUG) ("mannose-binding" . SPARSER::PROTEIN)
    ("ATG9" . SPARSER::PROTEIN-FAMILY) ("RAB7" . SPARSER::PROTEIN)
    ("promoter and tumor" . SPARSER::COLLECTION)
    ("Sec8 and Sec6" . SPARSER::COLLECTION)
    ("Waf1/Cip1 and p27 Kip1" . SPARSER::COLLECTION)
    ("Exo70 and HNF4α" . SPARSER::COLLECTION)
    ("HNF4α-Exo70" . SPARSER::COLLECTION)
    ("Cyclin B1 and Cdk7" . SPARSER::COLLECTION)
    ("Cdc2, Cyclin B1 and Cdk7" . SPARSER::COLLECTION)
    ("HNF4α or Exo70" . SPARSER::COLLECTION)
    ("a traditional Chinese medicine" . SPARSER::DRUG)
    ("medicine" . SPARSER::DRUG)
    ("the HNF4α and the Exo70 promoter" . SPARSER::COLLECTION)
    ("the S1-nuclear protein complex" . SPARSER::BIO-COMPLEX)
    ("mixture" . SPARSER::MOLECULE) ("cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("its dominant-negative mutant HNF4α" . SPARSER::PROTEIN)
    ("A dominant-negative mutant HNF4α" . SPARSER::PROTEIN)
    ("pyruvate carboxylase (PC)" . SPARSER::PROTEIN) ("PC" . SPARSER::PROTEIN)
    ("homodimer" . SPARSER::HOMODIMER)
    ("Exo70 dominant-negative mutant" . SPARSER::MUTANT)
    ("adipocytes" . SPARSER::PROTEIN) ("subunit" . SPARSER::FRAGMENT)
    ("a heterooctameric complex" . SPARSER::BIO-COMPLEX)
    ("Sec3, Sec5, Sec6, Sec8, Sec10, Sec15, Exo70 and Exo84"
     . SPARSER::COLLECTION)
    ("Sec10" . SPARSER::PROTEIN) ("Sec8" . SPARSER::PROTEIN)
    ("Sec6" . SPARSER::PROTEIN) ("Sec5" . SPARSER::PROTEIN)
    ("Sec3" . SPARSER::PROTEIN) ("Exocyst" . SPARSER::BIO-COMPLEX)
    ("Exo70 or HNF4α" . SPARSER::COLLECTION)
    ("HNF4α and Exo70" . SPARSER::COLLECTION) ("berberine" . SPARSER::MOLECULE)
    ("exocyst" . SPARSER::BIO-COMPLEX)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cdk7" . SPARSER::PROTEIN) ("Cyclin B1" . SPARSER::PROTEIN)
    ("exo70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pyruvate carboxylase" . SPARSER::PROTEIN) ("ABCA1" . SPARSER::PROTEIN)
    ("ApoA-I" . SPARSER::PROTEIN)
    ("Hepatocyte nuclear factor 4 alpha" . SPARSER::PROTEIN)
    ("GLUT4" . SPARSER::PROTEIN) ("Exo84" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Sec15" . SPARSER::PROTEIN-FAMILY) ("Cdc2" . SPARSER::PROTEIN)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("HNF4α" . SPARSER::PROTEIN) ("factor 4" . SPARSER::PROTEIN)
    ("Exo70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytokines/chemokines" . SPARSER::COLLECTION)
    ("chemokines" . SPARSER::PROTEIN) ("cytokines" . SPARSER::PROTEIN)
    ("transcriptional activator or repressor" . SPARSER::COLLECTION)
    ("GBP1 as well as three other proteins (S100A10, major vault protein, and carbonic anhydrase III)"
     . SPARSER::COLLECTION)
    ("S100A10, major vault protein, and carbonic anhydrase III"
     . SPARSER::COLLECTION)
    ("hematoxylin and eosin (H&E) staining" . SPARSER::COLLECTION)
    ("hematoxylin" . SPARSER::MOLECULE) ("U87-lacZ" . SPARSER::COLLECTION)
    ("lacZ" . SPARSER::PROTEIN) ("U87-LacZ" . SPARSER::COLLECTION)
    ("U87-GBP1" . SPARSER::COLLECTION) ("LacZ" . SPARSER::PROTEIN)
    ("U87-" . SPARSER::PROTEIN) ("the mutated promoter" . SPARSER::PROMOTER)
    ("EGFRvIII–p38" . SPARSER::COLLECTION)
    ("receptor, phospho-p38, and GBP1" . SPARSER::COLLECTION)
    ("EGFR or p38" . SPARSER::COLLECTION)
    ("EGFR and p38" . SPARSER::COLLECTION)
    ("the proximal promoter" . SPARSER::PROMOTER)
    ("the messenger RNA (mRNA) and protein expression levels of GBP1"
     . SPARSER::COLLECTION)
    ("EGFRvIII and kinase" . SPARSER::COLLECTION)
    ("U87-EGFRvIII" . SPARSER::COLLECTION)
    ("metallopeptidase" . SPARSER::PROTEIN) ("Stat1" . SPARSER::PROTEIN)
    ("MAPK/YY1" . SPARSER::COLLECTION) ("Stat" . SPARSER::PROTEIN)
    ("interferon" . SPARSER::PROTEIN)
    ("inhibitors or antibodies" . SPARSER::COLLECTION)
    ("MAPK/Yin" . SPARSER::COLLECTION) ("Yin" . SPARSER::PROTEIN)
    ("EGFRvIII" . SPARSER::PROTEIN) ("CD31" . SPARSER::PROTEIN)
    ("polynucleotide kinase" . SPARSER::PROTEIN) ("anti–β" . SPARSER::PROTEIN)
    ("c20" . SPARSER::PROTEIN) ("pCL10" . SPARSER::PROTEIN)
    ("co-factors" . SPARSER::MOLECULE)
    ("carbonic anhydrase III" . SPARSER::PROTEIN)
    ("major vault protein" . SPARSER::PROTEIN) ("S100A10" . SPARSER::PROTEIN)
    ("SB203580" . SPARSER::DRUG) ("AG1478" . SPARSER::DRUG)
    ("actinomycin D" . SPARSER::MOLECULE) ("U87" . SPARSER::PROTEIN)
    ("MMP1" . SPARSER::PROTEIN) ("interferon-induced" . SPARSER::PROTEIN)
    ("YY1" . SPARSER::PROTEIN) ("GBP1" . SPARSER::PROTEIN)
    ("protein-1" . SPARSER::PROTEIN) ("Allelic variants" . SPARSER::VARIANT)
    ("dihydrotestosterone" . SPARSER::DRUG) ("androgens" . SPARSER::DRUG)
    ("cryptic" . SPARSER::PROTEIN) ("the AR gene and no" . SPARSER::COLLECTION)
    ("any other allelic variant" . SPARSER::VARIANT)
    ("the mild NC genotype" . SPARSER::PROTEIN) ("dL" . SPARSER::MOLECULE)
    ("clitoromegaly carried shorter CAG alleles" . SPARSER::ALLELE)
    ("antiandrogen" . SPARSER::DRUG) ("shorter alleles" . SPARSER::ALLELE)
    ("shorter CAG alleles" . SPARSER::ALLELE)
    ("a noteworthy NC cohort" . SPARSER::MOLECULE)
    ("androgen receptor and 5α-reductase" . SPARSER::COLLECTION)
    ("Dihydrotestosterone (DHT)" . SPARSER::DRUG)
    ("androgen receptor ( AR )" . SPARSER::PROTEIN)
    ("testosterone" . SPARSER::MOLECULE) ("DHT" . SPARSER::PROTEIN)
    ("Dihydrotestosterone" . SPARSER::DRUG)
    ("androgen receptor (AR)" . SPARSER::PROTEIN) ("Androgens" . SPARSER::DRUG)
    ("androgen receptor and 5-α-reductase" . SPARSER::COLLECTION)
    ("the severe allele" . SPARSER::ALLELE)
    ("the mild allele" . SPARSER::ALLELE) ("Genotypes" . SPARSER::PROTEIN)
    ("the classical form" . SPARSER::FORM)
    ("classical and nonclassical (NC) forms" . SPARSER::FORM)
    ("ACTH" . SPARSER::PROTEIN) ("cortisol" . SPARSER::PROTEIN)
    ("the CYP21A2 genotype's" . SPARSER::PROTEIN)
    ("longer CAG alleles" . SPARSER::ALLELE) ("nCAG" . SPARSER::PROTEIN)
    ("nCAG-AR and SRD5A2" . SPARSER::COLLECTION)
    ("nCAG-AR" . SPARSER::PROTEIN-PAIR) ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Androgen" . SPARSER::PROTEIN) ("androgen" . SPARSER::PROTEIN)
    ("the nonclassical form (NC)" . SPARSER::FORM)
    ("genotypes and 17OH-progesterone" . SPARSER::COLLECTION)
    ("OHP" . SPARSER::PROTEIN) ("progesterone" . SPARSER::PROTEIN)
    ("P30" . SPARSER::DRUG) ("P50" . SPARSER::PROTEIN)
    ("Steroid 21-hydroxylase" . SPARSER::PROTEIN)
    ("CYP21A2" . SPARSER::PROTEIN) ("SRD5A2" . SPARSER::PROTEIN)
    ("type 2" . SPARSER::PROTEIN) ("androgen receptor" . SPARSER::PROTEIN)
    ("OH-" . SPARSER::MOLECULE) ("Ali" . SPARSER::PROTEIN)
    ("NPM1 MUT FLT3 WT and Other genotypes" . SPARSER::COLLECTION)
    ("genotypes" . SPARSER::PROTEIN) ("HR " . SPARSER::PROTEIN)
    ("CIR" . SPARSER::PROTEIN)
    ("isoform or frameshift or nonsense" . SPARSER::COLLECTION)
    ("leucine" . SPARSER::AMINO-ACID) ("isoform" . SPARSER::ISOFORM)
    ("EBP" . SPARSER::PROTEIN) ("SII" . SPARSER::PROTEIN)
    ("NPM1 , FLT3 and CEBPA" . SPARSER::COLLECTION) ("IR" . SPARSER::PROTEIN)
    ("fit" . SPARSER::PROTEIN-FAMILY) ("Thein" . SPARSER::MOLECULE)
    ("nucleophosmin" . SPARSER::PROTEIN) ("genotype" . SPARSER::PROTEIN)
    ("NPM1 and wild‐type FLT3 ( NPM1  MUT  FLT3  WT ) genotype"
     . SPARSER::PROTEIN)
    ("NPM1 and wild‐type" . SPARSER::COLLECTION)
    ("CEBPA , NPM1 and FLT3" . SPARSER::COLLECTION)
    ("CEBPA" . SPARSER::PROTEIN) ("myeloid" . SPARSER::PROTEIN)
    ("p30" . SPARSER::PROTEIN)
    ("CCAAT/enhancer binding protein" . SPARSER::PROTEIN)
    ("FLT3" . SPARSER::PROTEIN) ("NPM1" . SPARSER::PROTEIN)
    ("catabolism" . SPARSER::PROTEIN)
    ("a unique cysteine" . SPARSER::AMINO-ACID)
    ("cysteine" . SPARSER::AMINO-ACID) ("derivative" . SPARSER::DERIVATIVE)
    ("Derivatives" . SPARSER::DERIVATIVE)
    ("anti-HER2 and anti-PDGFR" . SPARSER::COLLECTION)
    ("PDGFR" . SPARSER::PROTEIN)
    ("radiolabelled small molecules" . SPARSER::MOLECULE)
    ("tracers" . SPARSER::MOLECULE)
    ("radiolabelled monoclonal antibodies" . SPARSER::ANTIBODY)
    ("Mxs" . SPARSER::PROTEIN) ("PBS" . SPARSER::PROTEIN)
    ("Da" . SPARSER::MOLECULE) ("scaffold" . SPARSER::SCAFFOLD)
    ("bulky (150 kDa) antibodies" . SPARSER::ANTIBODY)
    ("epidermal growth factor (EGF)" . SPARSER::PROTEIN)
    ("radiolabelled natural ligand" . SPARSER::LIGAND)
    ("the 111 In-labeled anti-EGFR antibody" . SPARSER::ANTIBODY)
    ("anthracyclines and taxanes" . SPARSER::COLLECTION)
    ("taxanes" . SPARSER::DRUG) ("anthracyclines" . SPARSER::MOLECULE)
    ("monoclonal antibodies cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tracer" . SPARSER::MOLECULE) ("chelator" . SPARSER::MOLECULE)
    ("DFO" . SPARSER::MOLECULE) ("deferoxamine" . SPARSER::MOLECULE)
    ("EGFR-targeting monoclonal antibodies and tyrosine-kinase inhibitors"
     . SPARSER::INHIBITOR)
    ("antibodies and tyrosine-kinase" . SPARSER::COLLECTION)
    ("a transmembrane tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("sodium hydroxide" . SPARSER::MOLECULE) ("CO 3" . SPARSER::PROTEIN)
    ("Anti-EGFR" . SPARSER::PROTEIN) ("protein A" . SPARSER::PROTEIN)
    ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("PI3K, VEGFR-2, β-catenin, and E-cadherin" . SPARSER::COLLECTION)
    ("mononuclear cell chemotactic factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Notch1, and CD44" . SPARSER::COLLECTION) ("CX-CR5" . SPARSER::COLLECTION)
    ("CX" . SPARSER::PROTEIN-FAMILY) ("uPA" . SPARSER::PROTEIN)
    ("hepatocytes" . SPARSER::PROTEIN) ("SIRT1-siRNA" . SPARSER::COLLECTION)
    ("siRNA-SIRT1" . SPARSER::COLLECTION) ("PI3K/Akt" . SPARSER::COLLECTION)
    ("Vimentin, N-cadherin, and E-cadherin" . SPARSER::COLLECTION)
    ("Vimentin and N-cadherin" . SPARSER::COLLECTION)
    ("GAPDH" . SPARSER::PROTEIN) ("agarose" . SPARSER::MOLECULE)
    ("oncogenes and epithelial-mesenchymal transition (EMT)"
     . SPARSER::COLLECTION)
    ("mesenchymal markers vimentin and N-cadherin" . SPARSER::COLLECTION)
    ("vimentin and N-cadherin" . SPARSER::COLLECTION)
    ("N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("vimentin, E-cadherin, and N-cadherin" . SPARSER::COLLECTION)
    ("SiRNA" . SPARSER::PROTEIN) ("PC-3" . SPARSER::PROTEIN)
    ("homologue" . SPARSER::PROTEIN) ("VEGFR-2" . SPARSER::PROTEIN)
    ("MCP-1" . SPARSER::PROTEIN) ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Notch1" . SPARSER::PROTEIN) ("plasminogen activator" . SPARSER::PROTEIN)
    ("group E" . SPARSER::PROTEIN) ("group D" . SPARSER::PROTEIN)
    ("group C" . SPARSER::PROTEIN) ("housekeeping gene" . SPARSER::PROTEIN)
    ("K16" . SPARSER::PROTEIN) ("1K" . SPARSER::PROTEIN)
    ("tumor suppressor protein" . SPARSER::PROTEIN) ("P73" . SPARSER::PROTEIN)
    ("P300" . SPARSER::PROTEIN) ("DNA repair protein" . SPARSER::PROTEIN)
    ("N-cadherin" . SPARSER::PROTEIN)
    ("genes and factors" . SPARSER::COLLECTION)
    ("E-cadherin, ICAM-1, VCAM-1 and CK8/18" . SPARSER::COLLECTION)
    ("IF" . SPARSER::PROTEIN) ("filament" . SPARSER::PROTEIN-FAMILY)
    ("cytokeratins" . SPARSER::PROTEIN-FAMILY)
    ("Cytokeratin" . SPARSER::PROTEIN-FAMILY)
    ("CD11b/CD18" . SPARSER::COLLECTION) ("CD11a/CD18" . SPARSER::COLLECTION)
    ("ICAM-1 and VCAM-1" . SPARSER::COLLECTION)
    ("E-cadherin and ICAM-1" . SPARSER::COLLECTION)
    ("E-cadherin, ICAM-1, VCAM-1, and CK8/18" . SPARSER::COLLECTION)
    ("VCAM-1 and CK8/18" . SPARSER::COLLECTION)
    ("ICAM-1, VCAM-1, and CK8/18" . SPARSER::COLLECTION)
    ("Genes" . SPARSER::GENE)
    ("vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1)"
     . SPARSER::COLLECTION)
    ("cytokeratin" . SPARSER::PROTEIN-FAMILY) ("CK 8" . SPARSER::PROTEIN)
    ("CD11b" . SPARSER::PROTEIN) ("MAC-1" . SPARSER::PROTEIN)
    ("CD18" . SPARSER::PROTEIN) ("CD11a" . SPARSER::PROTEIN)
    ("LFA-1" . SPARSER::PROTEIN) ("antigen-1" . SPARSER::PROTEIN)
    ("as 2" . SPARSER::PROTEIN) ("ICAM-1" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule-1" . SPARSER::PROTEIN)
    ("VCAM-1" . SPARSER::PROTEIN)
    ("vascular cell adhesion molecule-1" . SPARSER::PROTEIN)
    ("CK8" . SPARSER::PROTEIN)
    ("HER2-upregulation-induced EMT" . SPARSER::PROTEIN)
    ("cisplatin and fluorouracil" . SPARSER::COLLECTION)
    ("fluorouracil" . SPARSER::DRUG)
    ("specifically targets HER2 protein" . SPARSER::PROTEIN)
    ("a first-line chemotherapeutic drug" . SPARSER::DRUG)
    ("HER2 and Snail" . SPARSER::COLLECTION) ("FISH" . SPARSER::PROTEIN)
    ("HER2, Herceptin, or CP724714" . SPARSER::COLLECTION)
    ("FITC-phalloidin staining" . SPARSER::MOLECULE)
    ("FITC-phalloidin" . SPARSER::MOLECULE) ("phalloidin" . SPARSER::MOLECULE)
    ("RI" . SPARSER::MOLECULE)
    ("single positive or double negative group" . SPARSER::MOLECULE)
    ("monoclonal antibody Herceptin, small molecular targeted drug CP724714, or small interfering RNAs (siRNAs)"
     . SPARSER::COLLECTION)
    ("DDP" . SPARSER::PROTEIN) ("HER2 and EMT" . SPARSER::COLLECTION)
    ("HER1, HER3 and HER4" . SPARSER::COLLECTION) ("ErbB4" . SPARSER::PROTEIN)
    ("ErbB2" . SPARSER::PROTEIN) ("EGFRs" . SPARSER::PROTEIN)
    ("TK" . SPARSER::PROTEIN)
    ("gemcitabine and paclitaxel" . SPARSER::COLLECTION)
    ("gemcitabine" . SPARSER::DRUG) ("oxaliplatin" . SPARSER::DRUG)
    ("E-cadherin, Claudin1 and zonula" . SPARSER::COLLECTION)
    ("vimentin and fibronectin" . SPARSER::COLLECTION)
    ("zonula" . SPARSER::PROTEIN) ("HER2/Snail" . SPARSER::COLLECTION)
    ("Herceptin" . SPARSER::DRUG) ("chemotherapeutic drug" . SPARSER::DRUG)
    ("SP2" . SPARSER::PROTEIN) ("IGF1" . SPARSER::PROTEIN)
    ("ZO-1" . SPARSER::PROTEIN) ("Monoclonal antibody" . SPARSER::DRUG)
    ("chromosome 17" . SPARSER::PROTEIN) ("F-actin" . SPARSER::BIO-COMPLEX)
    ("6.3 " . SPARSER::PROTEIN) ("ErbB3" . SPARSER::PROTEIN)
    ("ErbB1" . SPARSER::PROTEIN) ("ZEB2" . SPARSER::PROTEIN)
    ("ZEB1" . SPARSER::PROTEIN) ("ZO1" . SPARSER::PROTEIN)
    ("Claudin1" . SPARSER::PROTEIN) ("CP724714" . SPARSER::DRUG)
    ("a new TKI" . SPARSER::PROTEIN) ("original TKI" . SPARSER::PROTEIN)
    ("MET or HER2" . SPARSER::COLLECTION) ("ERK and AKT" . SPARSER::COLLECTION)
    ("EGFR and fibroblast growth factor receptor" . SPARSER::COLLECTION)
    ("FGFR" . SPARSER::PROTEIN)
    ("HER2, AXL, IGF1R, BRAF and CRKL" . SPARSER::COLLECTION)
    ("PTEN and RAS" . SPARSER::COLLECTION) ("CRKL" . SPARSER::PROTEIN)
    ("S4 and MET‐TKI" . SPARSER::COLLECTION) ("crizotinib" . SPARSER::DRUG)
    ("ERBB3 and MET" . SPARSER::COLLECTION) ("RTK" . SPARSER::PROTEIN)
    ("afatinib (2G‐TKI) and AZD9291 (another 3G‐TKI; Table xref )"
     . SPARSER::COLLECTION)
    ("erlotinib (1G‐TKI), afatinib (2G‐TKI) and AZD9291 (another 3G‐TKI; Table xref )"
     . SPARSER::COLLECTION)
    ("afatinib" . SPARSER::DRUG) ("wild‐type EGFR" . SPARSER::PROTEIN)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("rociletinib and AZD9291" . SPARSER::COLLECTION)
    ("rociletinib" . SPARSER::DRUG) ("Mutant" . SPARSER::MUTANT)
    ("FGFR3" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("IGF1R" . SPARSER::PROTEIN)
    ("hepatocyte growth factor" . SPARSER::PROTEIN) ("F10" . SPARSER::PROTEIN)
    ("ERBB3" . SPARSER::PROTEIN)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Kit 2" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("2–4" . SPARSER::PROTEIN) ("L–1" . SPARSER::PROTEIN)
    ("adenosine triphosphate" . SPARSER::MOLECULE) ("AZD9291" . SPARSER::DRUG)
    ("CREB1/c-Met-Akt/GSK-3β/Snail" . SPARSER::COLLECTION)
    ("p-CREB" . SPARSER::COLLECTION) ("CREB-VEGF" . SPARSER::COLLECTION)
    ("VEGF" . SPARSER::PROTEIN)
    ("c-Met/AKT/GSK-3β/snail" . SPARSER::COLLECTION)
    ("snail" . SPARSER::PROTEIN) ("HGF" . SPARSER::PROTEIN)
    ("Guo" . SPARSER::MOLECULE) ("pc-Met" . SPARSER::COLLECTION)
    ("CREB1 and MITF" . SPARSER::COLLECTION)
    ("MITF and c-Met" . SPARSER::COLLECTION)
    ("c-Met and MITF" . SPARSER::COLLECTION)
    ("c-Met ( r =0.340, P =0.021) and MITF ( r =0.364, P =0.013)"
     . SPARSER::COLLECTION)
    ("CREB1 , c-Met , and MITF" . SPARSER::COLLECTION)
    ("AKT/GSK-3β/Snail" . SPARSER::COLLECTION)
    ("GSK-3β , fibronectin , and Snail" . SPARSER::COLLECTION)
    ("c-Met/AKT/GSK-3β/Snail" . SPARSER::COLLECTION)
    ("Target" . SPARSER::TARGET-PROTEIN)
    ("c-Met , CREB1 , GCLC , TGFβR1 , and ARMC1" . SPARSER::COLLECTION)
    ("c-Met, CREB1 , GCLC, TGFβR1 , and ARMC1" . SPARSER::COLLECTION)
    ("GCLC" . SPARSER::PROTEIN)
    ("potential direct targets" . SPARSER::TARGET-PROTEIN)
    ("CREB1 and c-Met" . SPARSER::COLLECTION)
    ("Slug and Snail" . SPARSER::COLLECTION) ("Vimentin" . SPARSER::PROTEIN)
    ("BSP" . SPARSER::PROTEIN) ("Akt/GSK-3β/Snail" . SPARSER::COLLECTION)
    ("DLK1-DIO3" . SPARSER::COLLECTION) ("nucleotides" . SPARSER::NUCLEOTIDE)
    ("c-MET/CREB1-Akt/GSK-3β/Snail" . SPARSER::COLLECTION)
    ("MITF" . SPARSER::PROTEIN) ("c-Met and CREB1" . SPARSER::COLLECTION)
    ("c-Met/Akt/GSK-3β/Snail" . SPARSER::COLLECTION) ("BCa" . SPARSER::PROTEIN)
    ("GSK-3 β" . SPARSER::PROTEIN) ("Dual-luciferase" . SPARSER::PROTEIN)
    ("small nuclear RNA" . SPARSER::RNA) ("TGFβR" . SPARSER::PROTEIN)
    ("DIO3" . SPARSER::PROTEIN) ("DLK1" . SPARSER::PROTEIN)
    ("c-MET" . SPARSER::PROTEIN) ("CREB1" . SPARSER::PROTEIN)
    ("GSK-3β" . SPARSER::PROTEIN) ("c-Met" . SPARSER::PROTEIN)
    ("consecutive cohort" . SPARSER::MOLECULE) ("cohorts" . SPARSER::MOLECULE)
    ("TMA" . SPARSER::MOLECULE) ("TMAs" . SPARSER::MOLECULE)
    ("gastric HER family" . SPARSER::PROTEIN-FAMILY)
    ("trastuzumab" . SPARSER::DRUG)
    ("EGFR[ xref , xref , xref ] or HER3 [ xref ]" . SPARSER::COLLECTION)
    ("particular HER3" . SPARSER::PROTEIN) ("adjuvant" . SPARSER::DRUG)
    ("a dual EGFR and HER3 inhibitor" . SPARSER::INHIBITOR)
    ("Tao" . SPARSER::DRUG) ("lapatinib" . SPARSER::DRUG)
    ("membranous HER3" . SPARSER::PROTEIN) ("MET" . SPARSER::PROTEIN)
    ("antibodies (mAbs) and tyrosine kinase inhibitors (TKIs)"
     . SPARSER::COLLECTION)
    ("mAbs" . SPARSER::DRUG) ("prognostic biomarkers" . SPARSER::MOLECULE)
    ("RAS-RAF-MAP" . SPARSER::COLLECTION) ("MAP" . SPARSER::PROTEIN)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K and Akt" . SPARSER::COLLECTION)
    ("EGFR, HER2 or HER3" . SPARSER::COLLECTION)
    ("the entire cohort" . SPARSER::MOLECULE)
    ("EGFR or HER3" . SPARSER::COLLECTION)
    ("HER2 and HER3" . SPARSER::COLLECTION) ("Antibody" . SPARSER::PROTEIN)
    ("HER" . SPARSER::PROTEIN) ("heterodimers" . SPARSER::HETERODIMER)
    ("HER2, HER3 and HER4" . SPARSER::COLLECTION)
    ("parts" . SPARSER::COMPONENT) ("complement" . SPARSER::PROTEIN)
    ("a consecutive cohort" . SPARSER::MOLECULE)
    ("EGFR and HER3" . SPARSER::COLLECTION) ("HER1/EGFR" . SPARSER::COLLECTION)
    ("EGFR antibody" . SPARSER::PROTEIN) ("type 3" . SPARSER::PROTEIN)
    ("type 1" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER4" . SPARSER::PROTEIN)
    ("epidermal growth factor receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HER3" . SPARSER::PROTEIN) ("HER1" . SPARSER::PROTEIN)
    ("biomarker" . SPARSER::MOLECULE) ("stat" . SPARSER::PROTEIN)
    ("extractable survival data group" . SPARSER::MOLECULE)
    ("HRs and 95% CI" . SPARSER::COLLECTION) ("p-STAT3" . SPARSER::COLLECTION)
    ("dimers" . SPARSER::DIMER) ("monomers" . SPARSER::MONOMER)
    ("Tyrosine" . SPARSER::AMINO-ACID)
    ("HER2, EGFR, COX-2, and K-ras" . SPARSER::COLLECTION)
    ("COX-2, and K-ras" . SPARSER::COLLECTION) ("HR " . SPARSER::PROTEIN)
    ("p-stat3" . SPARSER::COLLECTION) ("CD24" . SPARSER::PROTEIN)
    ("ERCC1" . SPARSER::PROTEIN) ("erbB-2" . SPARSER::PROTEIN)
    ("Stat3" . SPARSER::PROTEIN) ("S4" . SPARSER::PROTEIN-FAMILY)
    ("STAT3" . SPARSER::PROTEIN) ("K-ras" . SPARSER::PROTEIN)
    ("COX-2" . SPARSER::PROTEIN) ("HER2" . SPARSER::PROTEIN)
    ("stat3" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("CBP" . SPARSER::PROTEIN) ("Bcl9/9 l" . SPARSER::PROTEIN)
    ("a potential inhibitor" . SPARSER::INHIBITOR)
    ("Bcl9 and Bcl9l" . SPARSER::COLLECTION)
    ("first demonstrated using loxP-flanked alleles and tamoxifen inducible CreERT2"
     . SPARSER::COLLECTION)
    ("an attractive potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("conditional Bcl9 / 9l knockout alleles" . SPARSER::ALLELE)
    ("Apc and Kras" . SPARSER::COLLECTION)
    ("traits and poorest" . SPARSER::COLLECTION)
    ("these public gene" . SPARSER::GENE)
    ("mesenchymal (EMT) traits" . SPARSER::PROTEIN)
    ("BCl9/9L-β-catenin" . SPARSER::COLLECTION) ("arm" . SPARSER::PROTEIN)
    ("BCl9/9L" . SPARSER::PROTEIN) ("Ascl2" . SPARSER::PROTEIN)
    ("ISCs" . SPARSER::PROTEIN) ("Bcl9/9l-β-catenin" . SPARSER::COLLECTION)
    ("conditional Bcl9 / 9l -null alleles" . SPARSER::ALLELE)
    ("residual Bcl9 protein" . SPARSER::PROTEIN)
    ("tamoxifen" . SPARSER::MOLECULE) ("Organoids" . SPARSER::PROTEIN)
    ("NOD" . SPARSER::PROTEIN) ("organoids" . SPARSER::PROTEIN)
    ("adenoma-derived organoids" . SPARSER::PROTEIN)
    ("R-spondin and EGF" . SPARSER::COLLECTION) ("EGF" . SPARSER::PROTEIN)
    ("traits and BCL9L" . SPARSER::COLLECTION) ("Subtypes" . SPARSER::PROTEIN)
    ("EMT-" . SPARSER::PROTEIN) ("DMH/DSS" . SPARSER::COLLECTION)
    ("DMH" . SPARSER::PROTEIN) ("WNT-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("intestinal WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GSEA" . SPARSER::PROTEIN) ("biologic" . SPARSER::DRUG)
    ("BRAF , KRAS or P53" . SPARSER::COLLECTION) ("BRAF" . SPARSER::PROTEIN)
    ("BCL9/9L" . SPARSER::PROTEIN) ("BCL9 / 9L" . SPARSER::PROTEIN)
    ("vimentin" . SPARSER::PROTEIN) ("transgene" . SPARSER::PROTEIN)
    ("Apc  1638N and villin-driven Kras  G12V alleles (hereafter Apc / Kras )"
     . SPARSER::COLLECTION)
    ("villin-driven Kras  G12V alleles" . SPARSER::ALLELE)
    ("Apc and oncogenic Kras" . SPARSER::COLLECTION) ("Apc" . SPARSER::PROTEIN)
    ("AOM/DSS" . SPARSER::COLLECTION) ("Bcl9 / 9l" . SPARSER::PROTEIN)
    ("Gene" . SPARSER::GENE) ("EMT and a group" . SPARSER::COLLECTION)
    ("driven human CRC" . SPARSER::PROTEIN) ("DSS" . SPARSER::PROTEIN)
    ("sulphate" . SPARSER::MOLECULE) ("dextran" . SPARSER::DEXTRAN)
    ("AOM" . SPARSER::PROTEIN) ("mutagen" . SPARSER::MOLECULE)
    ("Bcl9/9l" . SPARSER::PROTEIN)
    ("ablating WNTless" . SPARSER::PROTEIN-FAMILY)
    ("WNTless" . SPARSER::PROTEIN-FAMILY)
    ("two likely redundant paralogs" . SPARSER::PROTEIN)
    ("Bcl9 or Bcl9l" . SPARSER::COLLECTION) ("Bcl9l" . SPARSER::PROTEIN)
    ("paralogs" . SPARSER::PROTEIN) ("TCF or β-catenin" . SPARSER::COLLECTION)
    ("TCF/LEF" . SPARSER::PROTEIN) ("LEF" . SPARSER::PROTEIN)
    ("ligands" . SPARSER::LIGAND) ("WNT-β-catenin" . SPARSER::COLLECTION)
    ("BCL9/9L-β-catenin" . SPARSER::COLLECTION) ("Bcl9" . SPARSER::PROTEIN)
    ("CRC" . SPARSER::PROTEIN) ("β-catenin/TCF" . SPARSER::COLLECTION)
    ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TCF" . SPARSER::PROTEIN)
    ("SW480" . SPARSER::PROTEIN) ("HD2" . SPARSER::PROTEIN)
    ("4-OHT" . SPARSER::DRUG) ("keratin 20" . SPARSER::PROTEIN)
    ("B–D" . SPARSER::PROTEIN) ("BCL9L" . SPARSER::PROTEIN)
    ("P53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("1B" . SPARSER::PROTEIN)
    ("1A" . SPARSER::PROTEIN) ("4-hydroxytamoxifen" . SPARSER::DRUG)
    ("R-spondin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("growth factor" . SPARSER::GROWTH-FACTOR) ("E7" . SPARSER::PROTEIN-FAMILY)
    ("BCL9" . SPARSER::PROTEIN) ("only human Gli1" . SPARSER::PROTEIN)
    ("AICAR and Metformin" . SPARSER::COLLECTION) ("ligase" . SPARSER::LIGASE)
    ("Itch" . SPARSER::PROTEIN) ("TXNIP" . SPARSER::PROTEIN)
    ("the mTORC regulator Rag GTPase or the mitochondrial respiratory-chain complex"
     . SPARSER::COLLECTION)
    ("GTPase" . SPARSER::GTPASE) ("Rag" . SPARSER::PROTEIN)
    ("mTORC" . SPARSER::PROTEIN) ("biguanides" . SPARSER::MOLECULE)
    ("the phosphomimetic Ser408E mutants" . SPARSER::MUTANT)
    ("CC" . SPARSER::MOLECULE) ("A-769662 or vehicle" . SPARSER::COLLECTION)
    ("Gli1 and 14-3-3" . SPARSER::COLLECTION)
    ("Gli1 and 14-3-3 epsilon" . SPARSER::COLLECTION)
    ("Compound C (CC)" . SPARSER::MOLECULE) ("antisera" . SPARSER::PROTEIN)
    ("a phosphomimetic S408E mutant" . SPARSER::MUTANT)
    ("Alanine" . SPARSER::AMINO-ACID) ("Serine" . SPARSER::AMINO-ACID)
    ("aa" . SPARSER::MOLECULE) ("fragments" . SPARSER::FRAGMENT)
    ("map" . SPARSER::PROTEIN) ("Gli-Luc" . SPARSER::COLLECTION)
    ("Gli2 or Gli3" . SPARSER::COLLECTION)
    ("CAMKK2/AMPK" . SPARSER::COLLECTION)
    ("Gli2 and Gli3" . SPARSER::COLLECTION)
    ("AMPK and 32 P" . SPARSER::COLLECTION) ("MEF" . SPARSER::PROTEIN)
    ("Metformin" . SPARSER::DRUG) ("deoxyglucose" . SPARSER::MOLECULE)
    ("Sag" . SPARSER::PROTEIN) ("agonist" . SPARSER::AGONIST)
    ("AMP/ATP" . SPARSER::PROTEIN-PAIR)
    ("glucose and lipids" . SPARSER::COLLECTION)
    ("Ptch or Smo" . SPARSER::COLLECTION) ("antagonists" . SPARSER::MOLECULE)
    ("Sufu or Gli" . SPARSER::COLLECTION) ("Sufu" . SPARSER::PROTEIN)
    ("Gli1, Gli2 and Gli3" . SPARSER::COLLECTION) ("Gli2" . SPARSER::PROTEIN)
    ("Gli" . SPARSER::PROTEIN) ("Smo" . SPARSER::PROTEIN)
    ("Ptch" . SPARSER::PROTEIN) ("Patched" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Shh" . SPARSER::PROTEIN) ("agonists" . SPARSER::AGONIST)
    ("AMPKα" . SPARSER::PROTEIN-FAMILY) ("CRTC2" . SPARSER::PROTEIN)
    ("Ampkα" . SPARSER::PROTEIN-FAMILY) ("p24" . SPARSER::PROTEIN)
    ("MnCl 2" . SPARSER::DRUG)
    ("phospho-Serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Glut1" . SPARSER::PROTEIN) ("14-3-3" . SPARSER::PROTEIN)
    ("14-3-3 epsilon" . SPARSER::PROTEIN) ("Compound C" . SPARSER::MOLECULE)
    ("STO609" . SPARSER::DRUG) ("CAMKK2" . SPARSER::PROTEIN)
    ("32 P" . SPARSER::|32P|) ("beta subunit" . SPARSER::PROTEIN)
    ("A-769662" . SPARSER::DRUG) ("alpha subunit" . SPARSER::PROTEIN)
    ("catalytic subunit" . SPARSER::PROTEIN)
    ("gamma subunit" . SPARSER::PROTEIN) ("Gli3" . SPARSER::PROTEIN)
    ("Sonic Hedgehog" . SPARSER::PROTEIN) ("Gli1" . SPARSER::PROTEIN)
    ("radio-labelled tigatuzumab" . SPARSER::DRUG)
    ("TRAIL-R-targeting" . SPARSER::PROTEIN-PAIR)
    ("newly developed TRAIL-R-agonistic antibodies" . SPARSER::ANTIBODY)
    ("DNA-repair" . SPARSER::DNA) ("PKC" . SPARSER::PROTEIN)
    ("FLIP" . SPARSER::PROTEIN) ("antagonist" . SPARSER::MOLECULE)
    ("exactly BRCA2" . SPARSER::PROTEIN)
    ("individual proximal FA genes" . SPARSER::GENE)
    ("several pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("BCL2, MCL-1 and BCL-XL" . SPARSER::COLLECTION)
    ("BAX and BIM" . SPARSER::COLLECTION)
    ("principal regulators" . SPARSER::REGULATOR) ("BID" . SPARSER::PROTEIN)
    ("BIM" . SPARSER::PROTEIN) ("pro-apoptotic molecules" . SPARSER::MOLECULE)
    ("BAX, PUMA or NOXA" . SPARSER::COLLECTION)
    ("BCL-2 and BCL-XL" . SPARSER::COLLECTION) ("NOXA" . SPARSER::PROTEIN)
    ("BAX" . SPARSER::PROTEIN) ("FAS and TRAIL-R" . SPARSER::COLLECTION)
    ("MMC or TRAIL-R" . SPARSER::COLLECTION) ("DNA-damage" . SPARSER::DNA)
    ("TRAIL-R-agonistic antibodies" . SPARSER::ANTIBODY)
    ("the classical ICL-agent MMC" . SPARSER::PROTEIN) ("p" . SPARSER::PROTEIN)
    ("TRAIL-R1 and -R2" . SPARSER::COLLECTION)
    ("the pro-apoptotic molecule PUMA" . SPARSER::PROTEIN)
    ("PUMA" . SPARSER::PROTEIN) ("principal mediators" . SPARSER::PROTEIN)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("pro-" . SPARSER::AMINO-ACID) ("pro" . SPARSER::AMINO-ACID)
    ("complex (DISC)" . SPARSER::BIO-COMPLEX) ("DISC" . SPARSER::BIO-COMPLEX)
    ("MMC or LBY135" . SPARSER::COLLECTION)
    ("BRCA2-siRNA" . SPARSER::COLLECTION) ("-siRNA" . SPARSER::COLLECTION)
    ("TRAIL-R agonistic antibodies" . SPARSER::ANTIBODY)
    ("complemented" . SPARSER::PROTEIN) ("NEO" . SPARSER::PROTEIN)
    ("the FAS-agonistic antibody anti-Apo-1" . SPARSER::ANTIBODY)
    ("FAS" . SPARSER::PROTEIN) ("MMC" . SPARSER::PROTEIN)
    ("DLD" . SPARSER::PROTEIN) ("CS" . SPARSER::PROTEIN)
    ("tigatuzumab" . SPARSER::DRUG)
    ("recombinant TRAIL or agonistic antibodies" . SPARSER::COLLECTION)
    ("agonistic antibodies" . SPARSER::ANTIBODY)
    ("TRAIL-receptor-2" . SPARSER::COLLECTION) ("PARP" . SPARSER::PROTEIN)
    ("FANCC or FANCG" . SPARSER::COLLECTION) ("FANCG" . SPARSER::PROTEIN)
    ("at least 15 FA genes" . SPARSER::GENE)
    ("exogenous and endogenous DNA" . SPARSER::DNA)
    ("TRAIL-receptors" . SPARSER::COLLECTION) ("TRAIL" . SPARSER::PROTEIN)
    ("ICL" . SPARSER::PROTEIN) ("4 −1" . SPARSER::PROTEIN)
    ("IgG1" . SPARSER::BIO-COMPLEX) ("Bcl-2" . SPARSER::PROTEIN)
    ("β-ACTIN" . SPARSER::PROTEIN) ("CASPASE 9" . SPARSER::PROTEIN)
    ("L-glutamine" . SPARSER::MOLECULE) ("RAD51" . SPARSER::PROTEIN)
    ("Apo 1" . SPARSER::PROTEIN) ("TNFSF10" . SPARSER::PROTEIN)
    ("MCL-1" . SPARSER::PROTEIN) ("BCL2" . SPARSER::PROTEIN)
    ("cytochrome c" . SPARSER::PROTEIN) ("BCL-XL" . SPARSER::PROTEIN)
    ("BCL-2" . SPARSER::PROTEIN) ("mitochondrial)" . SPARSER::PROTEIN)
    ("caspase 8" . SPARSER::PROTEIN) ("CASPASE8" . SPARSER::PROTEIN)
    ("CASPASE3" . SPARSER::PROTEIN) ("siRNA-mediated" . SPARSER::PROTEIN)
    ("Apo-1" . SPARSER::PROTEIN) ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("apoptosis-inducing" . SPARSER::PROTEIN) ("TRAIL-R1" . SPARSER::PROTEIN)
    ("TRAIL-receptor-1" . SPARSER::PROTEIN)
    ("Fanconi Anemia" . SPARSER::PROTEIN) ("TRAIL-R2" . SPARSER::PROTEIN)
    ("Rep" . SPARSER::PROTEIN)
    ("P-glycoprotein and drug" . SPARSER::COLLECTION)
    ("Tyr" . SPARSER::AMINO-ACID)
    ("macrophages, and Caco-V100" . SPARSER::COLLECTION)
    ("Taxol" . SPARSER::DRUG) ("caveolins" . SPARSER::PROTEIN-FAMILY)
    ("CAV1/P-glycoprotein" . SPARSER::COLLECTION)
    ("P-glycoprotein and CAV1" . SPARSER::COLLECTION)
    ("The essential protein CAV1" . SPARSER::PROTEIN)
    ("wild-type CAV1 and the K176R mutant" . SPARSER::COLLECTION)
    ("the light buoyant density membrane fraction" . SPARSER::COMPONENT)
    ("either wild-type CAV1 or the K176R mutant" . SPARSER::COLLECTION)
    ("Sigma" . SPARSER::PROTEIN-FAMILY) ("iodixanol" . SPARSER::DRUG)
    ("V5-tagged CAV1" . SPARSER::PROTEIN)
    ("doxorubicin and cisplatin" . SPARSER::COLLECTION)
    ("cisplatin and cells" . SPARSER::COLLECTION)
    ("doxorubicin or cisplatin" . SPARSER::COLLECTION)
    ("CAV1 or CAV1" . SPARSER::COLLECTION) ("paclitaxel" . SPARSER::DRUG)
    ("Paclitaxel" . SPARSER::DRUG) ("cisplatin" . SPARSER::DRUG)
    ("Cisplatin" . SPARSER::DRUG) ("CAV1-" . SPARSER::PROTEIN)
    ("wild-type CAV1 or the K176R mutant" . SPARSER::COLLECTION)
    ("verapamil" . SPARSER::DRUG) ("novobiocin" . SPARSER::DRUG)
    ("MK" . SPARSER::PROTEIN) ("eFluxx-ID" . SPARSER::COLLECTION)
    ("Gold" . SPARSER::MOLECULE) ("ID" . SPARSER::PROTEIN)
    ("macrophages" . SPARSER::PROTEIN) ("LPS" . SPARSER::PROTEIN)
    ("macrophage" . SPARSER::PROTEIN)
    ("a V5-tagged lysine 176-to-arginine (K176R) mutant" . SPARSER::MUTANT)
    ("acceptor" . SPARSER::MOLECULE)
    ("a 178-amino-acid protein" . SPARSER::PROTEIN)
    ("lysines" . SPARSER::AMINO-ACID)
    ("CAV1 and P-glycoprotein" . SPARSER::COLLECTION)
    ("MDR-associated protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BCRP/ABCG2" . SPARSER::COLLECTION) ("MRP1/ABCC1" . SPARSER::COLLECTION)
    ("BCRP" . SPARSER::PROTEIN) ("colchicine" . SPARSER::DRUG)
    ("adriamycin" . SPARSER::DRUG) ("homo-oligomers" . SPARSER::PROTEIN)
    ("oligomer" . SPARSER::MOLECULE)
    ("a 178-amino-acid (24 kDa) protein" . SPARSER::PROTEIN)
    ("oligomers" . SPARSER::MOLECULE) ("kDa" . SPARSER::PROTEIN)
    ("lipids and proteins" . SPARSER::COLLECTION)
    ("sphingolipid-" . SPARSER::MOLECULE) ("lipid" . SPARSER::LIPID)
    ("sphingolipid" . SPARSER::MOLECULE) ("lipids" . SPARSER::LIPID)
    ("phospholipid" . SPARSER::PHOSPHOLIPID) ("arginine" . SPARSER::AMINO-ACID)
    ("the principal structural protein" . SPARSER::PROTEIN)
    ("receptors and signaling proteins" . SPARSER::COLLECTION)
    ("sodium bicarbonate" . SPARSER::DRUG) ("phenol red" . SPARSER::DRUG)
    ("AS2" . SPARSER::PROTEIN) ("Rab5" . SPARSER::PROTEIN)
    ("cis -diamminedichloroplatinum" . SPARSER::DRUG)
    ("p-glycoprotein" . SPARSER::PROTEIN) ("3-1" . SPARSER::PROTEIN)
    ("1-1" . SPARSER::PROTEIN) ("integral membrane protein" . SPARSER::PROTEIN)
    ("caveolin 1" . SPARSER::PROTEIN)
    ("cancer resistance protein" . SPARSER::PROTEIN)
    ("ABCC1" . SPARSER::PROTEIN) ("MRP1" . SPARSER::PROTEIN)
    ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("scaffolding protein" . SPARSER::PROTEIN) ("CAV1" . SPARSER::PROTEIN)
    ("Caveolin-1" . SPARSER::PROTEIN) ("Matrix" . SPARSER::PROTEIN-FAMILY)
    ("CDC2 and cyclinB1" . SPARSER::COLLECTION)
    ("CDC2/cyclinB1" . SPARSER::COLLECTION) ("FZD" . SPARSER::PROTEIN-FAMILY)
    ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMP2, MMP3 and MMP9" . SPARSER::COLLECTION) ("Myc" . SPARSER::PROTEIN)
    ("a potential tumour suppressor" . SPARSER::SUPPRESSOR)
    ("histological type" . TYPE) ("inhibitor (TSA)" . SPARSER::INHIBITOR)
    ("TSA" . SPARSER::PROTEIN) ("deoxycytidine" . SPARSER::PROTEIN)
    ("MSP" . SPARSER::PROTEIN) ("TSGs" . SPARSER::PROTEIN)
    ("lymphoid" . SPARSER::PROTEIN) ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("lung tumour histological types" . TYPE) ("cyclinB1" . SPARSER::PROTEIN)
    ("CDC2" . SPARSER::PROTEIN) ("messenger RNA" . SPARSER::RNA)
    ("hydrogen peroxide" . SPARSER::DRUG) ("TIMP2" . SPARSER::PROTEIN)
    ("MMP7" . SPARSER::PROTEIN) ("MMP3" . SPARSER::PROTEIN)
    ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("serum albumin" . SPARSER::PROTEIN)
    ("polyvinylidene fluoride" . SPARSER::DRUG) ("G418" . SPARSER::MOLECULE)
    ("DNA polymerase" . SPARSER::PROTEIN)
    ("activator protein" . SPARSER::PROTEIN) ("p13" . SPARSER::PROTEIN)
    ("Paired box 5" . SPARSER::PROTEIN) ("GADD45G" . SPARSER::PROTEIN)
    ("PAX5" . SPARSER::PROTEIN) ("paired box 5" . SPARSER::PROTEIN)
    ("alisertib and danusertib" . SPARSER::COLLECTION)
    ("danusertib" . SPARSER::DRUG) ("alisertib" . SPARSER::DRUG)
    ("hypoxia and low glucose" . SPARSER::COLLECTION)
    ("glucose" . SPARSER::MOLECULE) ("oncoprotein" . SPARSER::PROTEIN)
    ("a dual pharmacological inhibitor" . SPARSER::INHIBITOR)
    ("FADD" . SPARSER::PROTEIN) ("Effective indirect KRAS" . SPARSER::PROTEIN)
    ("Annexin V/PI" . SPARSER::COLLECTION) ("RexB" . SPARSER::PROTEIN-FAMILY)
    ("Doxycycline" . SPARSER::DRUG)
    ("potential therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("MTT" . SPARSER::MOLECULE)
    ("a dual Aurora kinase pharmacological inhibitor" . SPARSER::INHIBITOR)
    ("AI" . SPARSER::PROTEIN) ("Inhibitor" . SPARSER::INHIBITOR)
    ("KRAS, AURKA and AURKB" . SPARSER::COLLECTION)
    ("the red fluorescent reporter protein" . SPARSER::PROTEIN)
    ("RalA" . SPARSER::PROTEIN) ("potential KRAS" . SPARSER::PROTEIN)
    ("traditional KRAS effectors" . SPARSER::EFFECTOR)
    ("successful KRAS" . SPARSER::PROTEIN)
    ("a dual AURKA/AURKB inhibitor" . SPARSER::INHIBITOR)
    ("AURKA/AURKB" . SPARSER::COLLECTION)
    ("AURKA and/or AURKB" . SPARSER::COLLECTION)
    ("a dual Aurora kinase inhibitor" . SPARSER::INHIBITOR)
    ("therapeutically relevant KRAS" . SPARSER::PROTEIN)
    ("AURKA or AURKB" . SPARSER::COLLECTION)
    ("AURKA and AURKB" . SPARSER::COLLECTION) ("AURKB" . SPARSER::PROTEIN)
    ("AURKA" . SPARSER::PROTEIN) ("RNase A" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("α-tubulin" . SPARSER::PROTEIN) ("CDCA8" . SPARSER::PROTEIN)
    ("LIMK2" . SPARSER::PROTEIN) ("CK1α" . SPARSER::PROTEIN)
    ("1D" . SPARSER::PROTEIN) ("Twist2/E-cadherin" . SPARSER::COLLECTION)
    ("HIF-2α, Twist1/2 and E-cadherin" . SPARSER::COLLECTION)
    ("bipartite" . SPARSER::PROTEIN)
    ("homology, and gene" . SPARSER::COLLECTION)
    ("Several pivotal proteins" . SPARSER::PROTEIN)
    ("Hypoxia" . SPARSER::PROTEIN)
    ("Twist1, Twist2 and E-cadherin" . SPARSER::COLLECTION)
    ("Twist1 and Twist2" . SPARSER::COLLECTION)
    ("MMP2 and MMP9" . SPARSER::COLLECTION) ("si" . SPARSER::PROTEIN)
    ("Matrigel" . SPARSER::PROTEIN) ("si-HIF-2α" . SPARSER::COLLECTION)
    ("Western Blot" . SPARSER::PROTEIN) ("Blot" . SPARSER::PROTEIN)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HIF-1α and HIF-2α" . SPARSER::COLLECTION)
    ("hypoxia-inducible factor (HIF)" . SPARSER::PROTEIN)
    ("HIF" . SPARSER::PROTEIN-FAMILY) ("radical" . SPARSER::MOLECULE)
    ("Twist1 and E-cadherin" . SPARSER::COLLECTION)
    ("Twist2 and E-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin and MMPs" . SPARSER::COLLECTION)
    ("Western blot" . SPARSER::PROTEIN)
    ("HIF-2α and EMT" . SPARSER::COLLECTION) ("Chromatin" . SPARSER::PROTEIN)
    ("HIF-2α and E-cadherin" . SPARSER::COLLECTION) ("H 2 O 2" . SPARSER::DRUG)
    ("− 3" . SPARSER::PROTEIN) ("MMP9" . SPARSER::PROTEIN)
    ("MMP2" . SPARSER::PROTEIN) ("VE-cadherin" . SPARSER::PROTEIN)
    ("HIF2α" . SPARSER::PROTEIN) ("Full-length" . SPARSER::PROTEIN)
    ("basic helix-loop-helix" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("Twist1" . SPARSER::PROTEIN) ("Twist2" . SPARSER::PROTEIN)
    ("HIF-2α" . SPARSER::PROTEIN) ("estrogen" . SPARSER::MOLECULE)
    ("/p53" . SPARSER::COLLECTION) ("Fancd2" . SPARSER::PROTEIN)
    ("mutated alleles" . SPARSER::ALLELE) ("mutated forms" . SPARSER::FORM)
    ("these polymorphic alleles" . SPARSER::ALLELE)
    ("gene and promoter" . SPARSER::COLLECTION) ("States" . SPARSER::BIO-STATE)
    ("FANCJ or FANCF" . SPARSER::COLLECTION)
    ("FANCM and other component genes" . SPARSER::COLLECTION)
    ("FANCD1 and FANCN" . SPARSER::COLLECTION)
    ("FANCJ, FANCF, and FANCM" . SPARSER::COLLECTION)
    ("FANCM" . SPARSER::PROTEIN) ("FANCF" . SPARSER::PROTEIN)
    ("FANCD2 or FANCI" . SPARSER::COLLECTION)
    ("functionally-related low-penetrance alleles" . SPARSER::ALLELE)
    ("trigger" . SPARSER::PROTEIN) ("FANCD2 and FANCI" . SPARSER::COLLECTION)
    ("FANCI" . SPARSER::PROTEIN) ("FANCL or FANCJ" . SPARSER::COLLECTION)
    ("FANCA, FANCC, and FANCD1" . SPARSER::COLLECTION)
    ("FANCL" . SPARSER::PROTEIN) ("FANCA" . SPARSER::PROTEIN)
    ("FANCJ" . SPARSER::PROTEIN) ("FANCN" . SPARSER::PROTEIN)
    ("complex, and repair" . SPARSER::COLLECTION)
    ("nucleobases" . SPARSER::NUCLEOBASE) ("diepoxybutane" . SPARSER::MOLECULE)
    ("chemicals" . SPARSER::MOLECULE)
    ("low-penetrance polymorphic alleles" . SPARSER::ALLELE)
    ("metabolites" . SPARSER::MOLECULE) ("tobacco" . SPARSER::DRUG)
    ("FANCC and FANCD1" . SPARSER::COLLECTION) ("FANCC" . SPARSER::PROTEIN)
    ("FA" . SPARSER::PROTEIN) ("smoke" . SPARSER::MOLECULE)
    ("cigarette" . SPARSER::DRUG) ("ATP-dependent" . SPARSER::PROTEIN)
    ("adaptor protein" . SPARSER::PROTEIN) ("FANCD2" . SPARSER::PROTEIN)
    ("X chromosome" . SPARSER::PROTEIN) ("BRCA1" . SPARSER::PROTEIN)
    ("BRIP1" . SPARSER::PROTEIN) ("PALB2" . SPARSER::PROTEIN)
    ("BRCA2" . SPARSER::PROTEIN) ("Cytochrome P450" . SPARSER::PROTEIN-FAMILY)
    ("FANCD1" . SPARSER::PROTEIN) ("Fanconi anemia" . SPARSER::PROTEIN)
    ("Sox7 and Sox4" . SPARSER::COLLECTION)
    ("heterologous sarcomatous components" . SPARSER::COMPONENT)
    ("β-catenin, Sox4, and p300" . SPARSER::COLLECTION)
    ("Sox9 and/or Sox7" . SPARSER::COLLECTION)
    ("Sox4-BEs" . SPARSER::PROTEIN-PAIR)
    ("Slug and Sox4" . SPARSER::COLLECTION)
    ("both Slug and nuclear β-catenin" . SPARSER::COLLECTION)
    ("sarcomatous and carcinomatous components" . SPARSER::COMPONENT)
    ("Sox7/Sox4" . SPARSER::COLLECTION)
    ("Sox4, Sox7, or Sox9" . SPARSER::COLLECTION)
    ("a significantly higher Slug" . SPARSER::PROTEIN)
    ("Sox4/Sox7/Sox9" . SPARSER::COLLECTION)
    ("Sox7/Sox9" . SPARSER::COLLECTION) ("Sox4/Sox9" . SPARSER::COLLECTION)
    ("the carcinomatous components" . SPARSER::COMPONENT)
    ("both the carcinomatous and sarcomatous components" . SPARSER::COMPONENT)
    ("Slug, Sox4, Sox7, and Sox9" . SPARSER::COLLECTION)
    ("Slug, β-catenin, and Sox" . SPARSER::COLLECTION)
    ("either DNA-BD-fused full-length β-catenin or Sox4 fragment (pM-β-cat or pM-Sox4) and p300"
     . SPARSER::COLLECTION)
    ("β-catenin or Sox4" . SPARSER::COLLECTION)
    ("Sox4, Sox7 or Sox9" . SPARSER::COLLECTION)
    ("pM-β-catenin" . SPARSER::COLLECTION) ("pM-Sox4" . SPARSER::COLLECTION)
    ("luc" . SPARSER::PROTEIN) ("Flag-p300" . SPARSER::COLLECTION)
    ("HA-β-catenin" . SPARSER::COLLECTION) ("GFP-Sox4" . SPARSER::COLLECTION)
    ("Flag" . SPARSER::PROTEIN-FAMILY) ("GFP" . SPARSER::PROTEIN)
    ("dominant-negative TCF4" . SPARSER::PROTEIN)
    ("the multifunctional coactivator p300" . SPARSER::PROTEIN)
    ("Sox4 and β-catenin" . SPARSER::COLLECTION)
    ("β-catenin and Sox4" . SPARSER::COLLECTION)
    ("Sox4-3" . SPARSER::COLLECTION) ("Sox4-2" . SPARSER::COLLECTION)
    ("Sox4-1" . SPARSER::COLLECTION) ("AF" . SPARSER::PROTEIN)
    ("Sox7 and/or Sox9" . SPARSER::COLLECTION) ("SL" . SPARSER::PROTEIN)
    ("Sox6 and Sox11" . SPARSER::COLLECTION)
    ("protein and mRNA" . SPARSER::COLLECTION) ("Sox6" . SPARSER::PROTEIN)
    ("β-catenin, and Slug" . SPARSER::COLLECTION) ("EmCa" . SPARSER::DRUG)
    ("the sarcomatous component" . SPARSER::COMPONENT)
    ("repressors" . SPARSER::REPRESSOR) ("Snail" . SPARSER::PROTEIN)
    ("the sarcomatous components" . SPARSER::COMPONENT) ("type" . TYPE)
    ("sarcomatous components" . SPARSER::COMPONENT)
    ("Sox7 and Sox9" . SPARSER::COLLECTION)
    ("β-catenin/p300" . SPARSER::COLLECTION)
    ("carcinomatous components" . SPARSER::COMPONENT)
    ("β-catenin and Slug" . SPARSER::COLLECTION)
    ("β-catenin and p300" . SPARSER::COLLECTION)
    ("Sox7 or Sox9" . SPARSER::COLLECTION)
    ("Sox4, Sox7, and Sox9" . SPARSER::COLLECTION) ("ALDH" . SPARSER::PROTEIN)
    ("Slug" . SPARSER::PROTEIN) ("traits" . SPARSER::PROTEIN)
    ("example" . SPARSER::EXAMPLE) ("S3B" . SPARSER::PROTEIN)
    ("S3A" . SPARSER::PROTEIN) ("G2/M" . SPARSER::PROTEIN)
    ("S1B" . SPARSER::PROTEIN) ("ALDH1" . SPARSER::PROTEIN)
    ("B14" . SPARSER::PROTEIN) ("ALDH 1" . SPARSER::PROTEIN)
    ("anti-β" . SPARSER::PROTEIN) ("Nonidet P-40" . SPARSER::DRUG)
    ("CD133" . SPARSER::PROTEIN) ("Sox2" . SPARSER::PROTEIN)
    ("CD44" . SPARSER::PROTEIN) ("waf1" . SPARSER::PROTEIN)
    ("Sox11" . SPARSER::PROTEIN) ("Anti-" . SPARSER::ANTIBODY)
    ("p27 kip1" . SPARSER::PROTEIN) ("Anti-β" . SPARSER::PROTEIN)
    ("pG5" . SPARSER::PROTEIN) ("pGL3B" . SPARSER::MOLECULE)
    ("TCF4" . SPARSER::PROTEIN) ("p300" . SPARSER::PROTEIN)
    ("Sox9" . SPARSER::PROTEIN) ("Sox7" . SPARSER::PROTEIN)
    ("Sox4" . SPARSER::PROTEIN) ("aldehyde dehydrogenase" . SPARSER::PROTEIN)
    ("STK2" . SPARSER::PROTEIN) ("β-catenin" . SPARSER::PROTEIN)
    ("T-cell-APC" . SPARSER::COLLECTION) ("APC" . SPARSER::PROTEIN)
    ("IBD" . SPARSER::PROTEIN) ("thiopurine" . SPARSER::MOLECULE)
    ("mineralocorticoid" . SPARSER::MOLECULE) ("Cigarette" . SPARSER::DRUG)
    ("alleles" . SPARSER::ALLELE) ("alcohol" . SPARSER::DRUG)
    ("interleukin 6, metalloproteinase-9, and plasminogen activator inhibitor-1"
     . SPARSER::COLLECTION)
    ("metalloproteinase" . SPARSER::PROTEIN) ("biomarkers" . SPARSER::MOLECULE)
    ("Rac1 and mineralocorticoid receptor" . SPARSER::COLLECTION)
    ("aldosterone" . SPARSER::PROTEIN) ("cytokine" . SPARSER::PROTEIN)
    ("neutrophil" . SPARSER::PROTEIN) ("p22" . SPARSER::PROTEIN)
    ("an inactive GDP-bound state and an active GTP-bound state [ xref ]"
     . SPARSER::COLLECTION)
    ("GDP" . SPARSER::NUCLEOTIDE) ("triphosphatases" . SPARSER::PROTEIN)
    ("guanosine" . SPARSER::MOLECULE)
    ("MECOM , UNCX , WDR72 , UMOD , and GNAS" . SPARSER::COLLECTION)
    ("GNAS" . SPARSER::PROTEIN) ("MECOM" . SPARSER::PROTEIN)
    ("variants" . SPARSER::VARIANT) ("Han" . SPARSER::PROTEIN)
    ("\"T-A-G-A-G-G" . SPARSER::COLLECTION)
    ("\"C-T-G-G-G-G" . SPARSER::COLLECTION) ("–1" . SPARSER::PROTEIN)
    ("allele" . SPARSER::ALLELE)
    ("Allele, genotype, and haplotype" . SPARSER::COLLECTION)
    ("Allele" . SPARSER::ALLELE) ("T-cell" . SPARSER::PROTEIN)
    ("PAI-1" . SPARSER::PROTEIN) ("IL-6" . SPARSER::PROTEIN)
    ("G-A-A" . SPARSER::PROTEIN) ("A-A-G" . SPARSER::PROTEIN)
    ("–2" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("interleukin 6" . SPARSER::PROTEIN)
    ("mineralocorticoid receptor" . SPARSER::PROTEIN)
    ("WDR72" . SPARSER::PROTEIN) ("G-A" . SPARSER::PROTEIN)
    ("T-A" . SPARSER::PROTEIN) ("G-G" . SPARSER::PROTEIN)
    ("C-T" . SPARSER::PROTEIN) ("Rho family" . SPARSER::PROTEIN)
    ("RAC1" . SPARSER::PROTEIN) ("MDM2, and phos-MDM2" . SPARSER::COLLECTION)
    ("5-FU, vincristine, and doxorubicin" . SPARSER::COLLECTION)
    ("vincristine" . SPARSER::DRUG) ("p21 Cip1/WAF1" . SPARSER::COLLECTION)
    ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("various anticancer drugs and irradiation" . SPARSER::COLLECTION)
    ("p53 and/or Rb" . SPARSER::COLLECTION) ("Mutated forms" . SPARSER::FORM)
    ("nucleoside" . SPARSER::MOLECULE) ("TNM" . SPARSER::MOLECULE)
    ("cirrhosis" . SPARSER::PROTEIN) ("group, and 5-FU" . SPARSER::COLLECTION)
    ("p-Akt and p-MDM2" . SPARSER::COLLECTION)
    ("p-MDM2" . SPARSER::PROTEIN-PAIR) ("p-Akt" . SPARSER::COLLECTION)
    ("phos-Akt and phos-MDM2" . SPARSER::COLLECTION)
    ("Akt and MDM2" . SPARSER::COLLECTION) ("CHX" . SPARSER::PROTEIN)
    ("Cycloheximide" . SPARSER::PROTEIN)
    ("DNA and siNgBR" . SPARSER::COLLECTION)
    ("CDK6 and CyclinD1" . SPARSER::COLLECTION)
    ("p53 and p21 protein" . SPARSER::COLLECTION)
    ("CDK6/CyclinD1" . SPARSER::COLLECTION)
    ("p53 protein and downstream p21 protein" . SPARSER::COLLECTION)
    ("pIRES-NgBR" . SPARSER::COLLECTION) ("AO/EB" . SPARSER::COLLECTION)
    ("EB" . SPARSER::PROTEIN-FAMILY) ("AO" . SPARSER::PROTEIN)
    ("iodide" . SPARSER::PROTEIN) ("propidium" . SPARSER::MOLECULE)
    ("siRNAs" . SPARSER::PROTEIN) ("western blot" . SPARSER::PROTEIN)
    ("a potential novel drug target" . SPARSER::TARGET-PROTEIN)
    ("estrogen receptor and survivin" . SPARSER::COLLECTION)
    ("survivin" . SPARSER::PROTEIN) ("EC" . SPARSER::PROTEIN)
    ("reticulon" . SPARSER::PROTEIN) ("Nogo" . SPARSER::PROTEIN)
    ("cytotoxic" . SPARSER::PROTEIN) ("Oct4-AKT-ABCG2" . SPARSER::COLLECTION)
    ("doxorubicin" . SPARSER::PROTEIN) ("multidrug" . SPARSER::PROTEIN)
    ("transporters" . SPARSER::PROTEIN) ("transporter" . SPARSER::PROTEIN)
    ("complex and numerous [ xref – xref ]" . SPARSER::COLLECTION)
    ("hypoxia" . SPARSER::PROTEIN) ("chemotherapeutic drugs" . SPARSER::DRUG)
    ("drugs" . SPARSER::DRUG) ("HCC" . SPARSER::PROTEIN)
    ("PI3K/Akt/MDM2" . SPARSER::COLLECTION) ("ubiquitin" . SPARSER::PROTEIN)
    ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NgBR" . SPARSER::PROTEIN)
    ("acridine orange" . SPARSER::MOLECULE) ("cyclinD1" . SPARSER::PROTEIN)
    ("p27 Kip1" . SPARSER::PROTEIN)
    ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cell membrane" . SPARSER::PROTEIN) ("LY294002" . SPARSER::MOLECULE)
    ("CyclinD1" . SPARSER::PROTEIN) ("CCK-8" . SPARSER::PROTEIN)
    ("estrogen receptor" . SPARSER::PROTEIN) ("caveolin-1" . SPARSER::PROTEIN)
    ("ABCG2" . SPARSER::PROTEIN) ("Oct4" . SPARSER::PROTEIN)
    ("P-glycoprotein" . SPARSER::PROTEIN)
    ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MDR1" . SPARSER::PROTEIN)
    ("ABCB1" . SPARSER::PROTEIN) ("ATP-binding cassette" . SPARSER::PROTEIN)
    ("5FU" . SPARSER::DRUG) ("Nogo-B" . SPARSER::PROTEIN)
    ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Nogo-B receptor" . SPARSER::PROTEIN)
    ("miRNAs and mRNAs" . SPARSER::COLLECTION)
    ("key cell cycle regulatory proteins (Cdk4 and Cdk6) and oncogenes"
     . SPARSER::COLLECTION)
    ("mRNA or protein" . SPARSER::COLLECTION)
    ("c-Myc and K-Ras" . SPARSER::COLLECTION)
    ("other miRNAs and/or RNA binding proteins" . SPARSER::COLLECTION)
    ("even highly expressed miRNAs" . SPARSER::PROTEIN)
    ("double stranded mature mRNA/miRNA" . SPARSER::COLLECTION)
    ("mRNA/miRNA" . SPARSER::COLLECTION) ("a given miRNA" . SPARSER::PROTEIN)
    ("mRNA and protein" . SPARSER::COLLECTION)
    ("CDK4, CDK6, MYC or KRAS" . SPARSER::COLLECTION)
    ("HG" . SPARSER::MOLECULE) ("hairpins" . SPARSER::PROTEIN-FAMILY)
    ("WAF1 and MDM2" . SPARSER::COLLECTION)
    ("HT29-neo and HT29-tsp53" . SPARSER::COLLECTION)
    ("neo" . SPARSER::PROTEIN) ("TNIK, GDA and LGR5" . SPARSER::COLLECTION)
    ("GDA" . SPARSER::PROTEIN) ("TNIK" . SPARSER::PROTEIN)
    ("miRNA-mediated gene silencing or even p53-dependent transcriptional repression"
     . SPARSER::COLLECTION)
    ("very few mRNAs" . SPARSER::PROTEIN)
    ("the entire mRNA" . SPARSER::PROTEIN)
    ("Cdk4 or Cdk6" . SPARSER::COLLECTION) ("WAF" . SPARSER::PROTEIN)
    ("CDK4, CDK6, KRAS or MYC" . SPARSER::COLLECTION)
    ("MDM2 and CDKN1A" . SPARSER::COLLECTION) ("ST" . SPARSER::PROTEIN)
    ("the p53-responsive CDKN1A (encoding the cyclin-dependent kinase inhibitor p21, also known as WAF1 and CIP1) and MDM2 ( xref )"
     . SPARSER::COLLECTION)
    ("WAF1 and CIP1" . SPARSER::COLLECTION)
    ("MYC and KRAS" . SPARSER::COLLECTION)
    ("at least 2 p53-responsive miRNAs" . SPARSER::PROTEIN)
    ("MYC and CDK4" . SPARSER::COLLECTION)
    ("KRAS and CDK6" . SPARSER::COLLECTION)
    ("CDK4 and MYC" . SPARSER::COLLECTION)
    ("The miR-34a-5p miRNA reportedly targets MYC, CDK4 and CDK6 mRNAs"
     . SPARSER::PROTEIN)
    ("MYC, CDK4 and CDK6" . SPARSER::COLLECTION) ("MYC" . SPARSER::PROTEIN)
    ("the mature miRNAs" . SPARSER::PROTEIN)
    ("the bi-cistronic pri-miRNA" . SPARSER::RNA)
    ("known functional miRNAs" . SPARSER::PROTEIN)
    ("gauge" . SPARSER::PROTEIN-FAMILY)
    ("bicistronic miRNA genes" . SPARSER::GENE)
    ("only 13 pri-miRNAs" . SPARSER::RNA)
    ("differentially expressed miRNAs" . SPARSER::PROTEIN)
    ("differentially" . SPARSER::PROTEIN)
    ("Cdk4 and Cdk6" . SPARSER::COLLECTION)
    ("a sequence-specific transcription factor" . SPARSER::PROTEIN)
    ("primary miRNAs" . SPARSER::PROTEIN) ("Dicer-" . SPARSER::PROTEIN)
    ("Drosha-" . SPARSER::PROTEIN) ("Dicer" . SPARSER::PROTEIN)
    ("Drosha" . SPARSER::PROTEIN)
    ("short evolutionarily conserved RNAs" . SPARSER::RNA)
    ("a DNA damage-inducible sequence-specific transcription factor"
     . SPARSER::PROTEIN)
    ("mRNA and p21" . SPARSER::COLLECTION)
    ("CDK4 or CDK6" . SPARSER::COLLECTION)
    ("the Cdk4 and/or Cdk6 G 1 cyclin-dependent kinases (cdks)"
     . SPARSER::COLLECTION)
    ("cdks" . SPARSER::PROTEIN) ("oligonucleotide" . SPARSER::MOLECULE)
    ("CDK4 and CDK6" . SPARSER::COLLECTION) ("exogenous DNA" . SPARSER::DNA)
    ("variant" . SPARSER::VARIANT)
    ("proteins and microRNAs" . SPARSER::COLLECTION)
    ("RNA binding" . SPARSER::PROTEIN) ("LGR5" . SPARSER::PROTEIN)
    ("CIP1" . SPARSER::PROTEIN) ("PDE2A" . SPARSER::PROTEIN)
    ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("miR-200c" . SPARSER::MOLECULE)
    ("c-Myc" . SPARSER::PROTEIN) ("Lgr5" . SPARSER::PROTEIN)
    ("K-Ras" . SPARSER::PROTEIN) ("m1" . SPARSER::MOLECULE)
    ("reverse transcriptase" . SPARSER::PROTEIN)
    ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CO2" . SPARSER::PROTEIN)
    ("pri-miRNA" . SPARSER::RNA)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("pri-miRNAs" . SPARSER::RNA) ("protein can" . SPARSER::PROTEIN)
    ("Cdk6" . SPARSER::PROTEIN) ("Cdk4" . SPARSER::PROTEIN)
    ("miR-34a" . SPARSER::MOLECULE) ("CDK6" . SPARSER::PROTEIN)
    ("light" . SPARSER::PROTEIN)
    ("L-MYC and other unidentified targets" . SPARSER::COLLECTION)
    ("directly targets MDM2" . SPARSER::PROTEIN)
    ("Chemotherapeutic agent Doxorubicin" . SPARSER::PROTEIN)
    ("Doxorubicin" . SPARSER::PROTEIN) ("Iodide (PI)" . SPARSER::PROTEIN)
    ("5-FU, p53+/+ and p53−/−" . SPARSER::COLLECTION)
    ("cytometry" . SPARSER::PROTEIN) ("PI" . SPARSER::PROTEIN)
    ("Iodide" . SPARSER::PROTEIN) ("Propidium" . SPARSER::MOLECULE)
    ("FITC" . SPARSER::MOLECULE) ("MDM2 and p53" . SPARSER::COLLECTION)
    ("Fluorouracil" . SPARSER::DRUG)
    ("p21 , Puma and Bax" . SPARSER::COLLECTION)
    ("p21 , Puma , Bax , Fas , GADD45 , GLS2 and LIF" . SPARSER::COLLECTION)
    ("LIF" . SPARSER::PROTEIN) ("Fas" . SPARSER::PROTEIN)
    ("Bax" . SPARSER::PROTEIN) ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-Luc" . SPARSER::COLLECTION) ("MDM2 and Actin" . SPARSER::COLLECTION)
    ("Actin" . SPARSER::PROTEIN) ("its associated mRNAs" . SPARSER::PROTEIN)
    ("Streptavidin" . SPARSER::PROTEIN)
    ("a bona fide miRNA" . SPARSER::PROTEIN)
    ("oligonucleotides" . SPARSER::MOLECULE) ("weaker" . SPARSER::PROTEIN)
    ("a potential miRNA" . SPARSER::PROTEIN)
    ("the potential miRNAs" . SPARSER::PROTEIN)
    ("MDM2-p53" . SPARSER::COLLECTION) ("microRNAs" . SPARSER::RNA)
    ("forms" . SPARSER::FORM) ("–3" . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("MgCl2" . SPARSER::MOLECULE) ("pGL2" . SPARSER::PROTEIN)
    ("AC-3" . SPARSER::PROTEIN) ("C-3" . SPARSER::PROTEIN)
    ("β-gal" . SPARSER::PROTEIN) ("annexin V" . SPARSER::PROTEIN)
    ("5-FU" . SPARSER::PROTEIN) ("GLS2" . SPARSER::PROTEIN)
    ("GADD45" . SPARSER::PROTEIN) ("single-stranded RNA" . SPARSER::RNA)
    ("L-MYC" . SPARSER::PROTEIN) ("miR-339–5p" . SPARSER::MOLECULE)
    ("miR-125b" . SPARSER::MOLECULE) ("SNP309" . SPARSER::PROTEIN)
    ("MDM2 protein" . SPARSER::PROTEIN)
    ("Tumor suppressor p53" . SPARSER::PROTEIN)
    ("tumor suppressor p53" . SPARSER::PROTEIN) ("ALK" . SPARSER::PROTEIN)
    ("EGFR and KRAS" . SPARSER::COLLECTION) ("NCCN" . SPARSER::MOLECULE)
    ("subtypes" . SPARSER::PROTEIN) ("Chen" . SPARSER::PROTEIN)
    ("gold" . SPARSER::MOLECULE) ("trim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TKI" . SPARSER::PROTEIN)
    ("cetuximab or panitumumab" . SPARSER::COLLECTION)
    ("FDA" . SPARSER::PROTEIN) ("panitumumab" . SPARSER::DRUG)
    ("cetuximab" . SPARSER::DRUG) ("mAb" . SPARSER::DRUG)
    ("-mutant" . SPARSER::MUTANT) ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HRAS and NRAS" . SPARSER::COLLECTION) ("STAT" . SPARSER::PROTEIN)
    ("GTPs" . SPARSER::NUCLEOTIDE) ("NRAS" . SPARSER::PROTEIN)
    ("HRAS" . SPARSER::PROTEIN) ("Platinum" . SPARSER::MOLECULE)
    ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("foci" . SPARSER::PROTEIN)
    ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("male" . SPARSER::MOLECULE)
    ("NOS" . SPARSER::PROTEIN) ("IIIb" . SPARSER::DRUG)
    ("KRAS and EGFR" . SPARSER::COLLECTION)
    ("gefitinib or erlotinib" . SPARSER::COLLECTION)
    ("erlotinib" . SPARSER::DRUG) ("gefitinib" . SPARSER::DRUG)
    ("met" . SPARSER::AMINO-ACID) ("EGFR-TKIs" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor-tyrosine kinase" . SPARSER::COLLECTION)
    ("RR" . SPARSER::MOLECULE) ("TKIs" . SPARSER::PROTEIN)
    ("EGFR" . SPARSER::PROTEIN) ("HR" . SPARSER::PROTEIN)
    ("KRAS" . SPARSER::PROTEIN) ("miR-126" . SPARSER::PROTEIN)
    ("PIK3CA" . SPARSER::PROTEIN) ("anti-EGFR" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("guanosine triphosphate" . SPARSER::MOLECULE)
    ("membrane-bound" . SPARSER::PROTEIN)
    ("tyrosine kinase" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Luc-" . SPARSER::PROTEIN) ("Cai" . SPARSER::DRUG)
    ("SMO" . SPARSER::PROTEIN)
    ("the possible gene effectors" . SPARSER::EFFECTOR)
    ("extracellular proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("morpho-genesis" . SPARSER::COLLECTION) ("genesis" . SPARSER::PROTEIN)
    ("proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MMPs" . SPARSER::PROTEIN)
    ("vital anti-apoptosis protein Bcl2" . SPARSER::PROTEIN)
    ("caspase" . SPARSER::PROTEIN) ("p57 and p21" . SPARSER::COLLECTION)
    ("miR-326 inhibitor or miR-326 inhibitor NC" . SPARSER::COLLECTION)
    ("caspase-3 and caspase-7" . SPARSER::COLLECTION)
    ("MMP-7 and MMP-9" . SPARSER::COLLECTION)
    ("trans" . SPARSER::PROTEIN-FAMILY) ("western-blot" . SPARSER::PROTEIN)
    ("mut" . SPARSER::PROTEIN) ("CCND 1-3" . SPARSER::COLLECTION)
    ("NC" . SPARSER::PROTEIN) ("RB" . SPARSER::PROTEIN)
    ("oncogenes" . SPARSER::ONCOGENE) ("our western blot" . SPARSER::PROTEIN)
    ("SPC-A-1" . SPARSER::COLLECTION) ("SPC" . SPARSER::PROTEIN)
    ("Wang" . SPARSER::PROTEIN) ("EMT" . SPARSER::PROTEIN)
    ("MiR" . SPARSER::PROTEIN) ("platinum" . SPARSER::MOLECULE)
    ("RNAs" . SPARSER::RNA) ("miRNAs" . SPARSER::PROTEIN)
    ("MicroRNAs" . SPARSER::RNA) ("oncogene" . SPARSER::ONCOGENE)
    ("metalloproteinases (MMP)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMP" . SPARSER::PROTEIN)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p57(Kip2) and p21(Waf1/Cip1)" . SPARSER::COLLECTION)
    ("BrdU" . SPARSER::DRUG) ("miR" . SPARSER::PROTEIN)
    ("miRNA" . SPARSER::PROTEIN) ("Hsa" . SPARSER::PROTEIN)
    ("Ac-DEVD-pNA" . SPARSER::DRUG) ("NP-40" . SPARSER::DRUG)
    ("Caspase-3" . SPARSER::PROTEIN) ("Annexin V" . SPARSER::PROTEIN)
    ("caspase 3" . SPARSER::PROTEIN) ("Tween 20" . SPARSER::MOLECULE)
    ("Adam17" . SPARSER::PROTEIN)
    ("nin one binding protein" . SPARSER::PROTEIN)
    ("caspase-7" . SPARSER::PROTEIN) ("MMP-7" . SPARSER::PROTEIN)
    ("tumor suppressor gene" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CCK8" . SPARSER::PROTEIN) ("CCND 1" . SPARSER::PROTEIN)
    ("A-1" . SPARSER::PROTEIN) ("U6" . SPARSER::PROTEIN)
    ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE) ("MMP-9" . SPARSER::PROTEIN)
    ("Bcl2" . SPARSER::PROTEIN) ("caspase-3" . SPARSER::PROTEIN)
    ("Waf1/Cip1" . SPARSER::PROTEIN) ("Kip2" . SPARSER::PROTEIN)
    ("CDK4" . SPARSER::PROTEIN) ("cyclin D2" . SPARSER::PROTEIN)
    ("integrins and actin" . SPARSER::COLLECTION)
    ("tyrosine-phosphorylated proteins and SH2 domain-containing proteins"
     . SPARSER::COLLECTION)
    ("particularly concerning transiently associating IAC proteins"
     . SPARSER::PROTEIN)
    ("Pyk2 and Src" . SPARSER::COLLECTION)
    ("platelet-derived growth factor and epidermal growth factor"
     . SPARSER::COLLECTION)
    ("Src or catalytically inactive FAK" . SPARSER::COLLECTION)
    ("inactive" . SPARSER::INACTIVE) ("FRNK" . SPARSER::PROTEIN)
    ("only two IAC kinases" . SPARSER::PROTEIN)
    ("FAK [i], which suggests that FAK [i] and Src [i] specifically inhibit FAK and Src"
     . SPARSER::PROTEIN)
    ("associated signaling components" . SPARSER::COMPONENT)
    ("fraction (MF)" . SPARSER::COMPONENT)
    ("vinculin or FAK" . SPARSER::COLLECTION) ("t" . SPARSER::PROTEIN)
    ("FAK [i] or PF228" . SPARSER::COLLECTION)
    ("vinculin, paxillin, and FAK" . SPARSER::COLLECTION)
    ("FRAP" . SPARSER::PROTEIN)
    ("integrin, vinculin, and paxillin" . SPARSER::COLLECTION)
    ("selected IAC components and adhesion-dependent phosphorylation events"
     . SPARSER::COLLECTION)
    ("pY and α5" . SPARSER::COLLECTION) ("FAK-" . SPARSER::PROTEIN)
    ("FAK and paxillin" . SPARSER::COLLECTION)
    ("FAK, Src, or FAK and Src" . SPARSER::COLLECTION)
    ("Kinase" . SPARSER::KINASE) ("receptor and BAK" . SPARSER::COLLECTION)
    ("FAK [i] or Src [i]" . SPARSER::COLLECTION) ("EdU" . SPARSER::DRUG)
    ("DMSO or inhibitors" . SPARSER::COLLECTION)
    ("FAK [i] and Src [i]" . SPARSER::COLLECTION)
    ("monolayers" . SPARSER::PROTEIN) ("saracatinib" . SPARSER::DRUG)
    ("the SH2 domain–containing kinase YES1 (1.76-fold increase) and the phosphatase PTPN11 (1.65-fold decrease)"
     . SPARSER::COLLECTION)
    ("FAK and integrins" . SPARSER::COLLECTION)
    ("FAK or β1" . SPARSER::COLLECTION)
    ("protein–protein" . SPARSER::COLLECTION)
    ("only two proteins" . SPARSER::PROTEIN)
    ("Only 35 proteins" . SPARSER::PROTEIN) ("blebbistatin" . SPARSER::DRUG)
    ("DMSO and FAK" . SPARSER::COLLECTION)
    ("two unique peptides" . SPARSER::PEPTIDE)
    ("α5β1 and αVβ3" . SPARSER::COLLECTION) ("peptides" . SPARSER::PEPTIDE)
    ("canonical IAC proteins (vinculin, integrin-linked kinase [ILK], paxillin, and filamin A) and non-IAC components (Tf receptor and the mitochondrial protein BAK)"
     . SPARSER::COLLECTION)
    ("DMSO or FAK" . SPARSER::COLLECTION)
    ("paxillin, and filamin" . SPARSER::COLLECTION) ("BAK" . SPARSER::PROTEIN)
    ("filamin" . SPARSER::PROTEIN-FAMILY) ("ILK" . SPARSER::PROTEIN)
    ("DMSO" . SPARSER::MOLECULE) ("transferrin" . SPARSER::PROTEIN)
    ("ligand" . SPARSER::LIGAND) ("vinculin-" . SPARSER::PROTEIN)
    ("FAK [i] or PF228 ( xref )" . SPARSER::COLLECTION)
    ("FAK [i] or the established FAK inhibitor PF-573,228 (PF228; xref ; xref )"
     . SPARSER::COLLECTION)
    ("vinculin" . SPARSER::PROTEIN)
    ("both FAK [i] and PF271" . SPARSER::COLLECTION)
    ("FAK [i] and PF271" . SPARSER::COLLECTION)
    ("FAK [i] and a commonly used FAK inhibitor" . SPARSER::COLLECTION)
    ("FN" . SPARSER::PROTEIN) ("fibronectin" . SPARSER::PROTEIN)
    ("molecule" . SPARSER::MOLECULE)
    ("FAK and Src kinase" . SPARSER::COLLECTION) ("MEC" . SPARSER::PROTEIN)
    ("a potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("FAK and Src" . SPARSER::COLLECTION)
    ("paxillin and p130Cas" . SPARSER::COLLECTION)
    ("FAK–Src" . SPARSER::COLLECTION) ("paxillin" . SPARSER::PROTEIN)
    ("talin" . SPARSER::PROTEIN) ("tyrosine" . SPARSER::AMINO-ACID)
    ("generic anti-phosphotyrosine (pY) antibodies or fluorescent proteins"
     . SPARSER::COLLECTION)
    ("fluorescent proteins" . SPARSER::PROTEIN)
    ("generic anti-phosphotyrosine (pY) antibodies" . SPARSER::ANTIBODY)
    ("molecules" . SPARSER::MOLECULE)
    ("multimolecular integrin adhesion complexes (IACs) that facilitate the linkage between integrins and the actin cytoskeleton ( xref )"
     . SPARSER::COLLECTION)
    ("multimolecular integrin adhesion complexes" . SPARSER::BIO-COMPLEX)
    ("integrin–ECM" . SPARSER::COLLECTION)
    ("integrins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptors" . SPARSER::RECEPTOR) ("ECM" . SPARSER::PROTEIN)
    ("dSH" . SPARSER::PROTEIN) ("pY" . SPARSER::PROTEIN)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("the key IAC signaling components focal adhesion kinase (FAK) and Src"
     . SPARSER::COLLECTION)
    ("kinase (FAK)" . SPARSER::KINASE) ("Integrin" . SPARSER::PROTEIN)
    ("Src" . SPARSER::PROTEIN) ("FAK" . SPARSER::PROTEIN)
    ("integrin" . SPARSER::PROTEIN) ("6.3" . SPARSER::PROTEIN)
    ("a 20" . SPARSER::PROTEIN) ("F12" . SPARSER::PROTEIN)
    ("HCO 3" . SPARSER::MOLECULE) ("Bis-Tris" . SPARSER::MOLECULE)
    ("β-mercaptoethanol" . SPARSER::MOLECULE)
    ("full-length" . SPARSER::PROTEIN) ("anti–" . SPARSER::ANTIBODY)
    ("MgCl 2" . SPARSER::MOLECULE) ("l -glutamine" . SPARSER::MOLECULE)
    ("cyclin-dependent kinase 1" . SPARSER::PROTEIN)
    ("Pyk2" . SPARSER::PROTEIN) ("epidermal growth factor" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("3D" . SPARSER::PROTEIN-FAMILY) ("PP2" . SPARSER::DRUG)
    ("m 2" . SPARSER::MOLECULE) ("G–I" . SPARSER::PROTEIN)
    ("D–F" . SPARSER::PROTEIN) ("A–C" . SPARSER::PROTEIN)
    ("1–4" . SPARSER::PROTEIN) ("1 D" . SPARSER::PROTEIN)
    ("PTPN11" . SPARSER::PROTEIN) ("YES1" . SPARSER::PROTEIN)
    ("CRYL1" . SPARSER::PROTEIN) ("RRBP1" . SPARSER::PROTEIN)
    ("1 C" . SPARSER::PROTEIN) ("1 B" . SPARSER::PROTEIN)
    ("αVβ3" . SPARSER::PROTEIN) ("α5β1" . SPARSER::PROTEIN)
    ("PF228" . SPARSER::DRUG) ("Src kinase" . SPARSER::PROTEIN)
    ("Isl1" . SPARSER::PROTEIN) ("myosin-II" . SPARSER::PROTEIN)
    ("p130Cas" . SPARSER::PROTEIN) ("AZD0530" . SPARSER::DRUG)
    ("this model CTCF and Poly(ADP-ribose) polymerase 1 form functional complexes [ xref ]"
     . SPARSER::COLLECTION)
    ("nucleolin" . SPARSER::PROTEIN) ("CTCFL/BORIS" . SPARSER::COLLECTION)
    ("distinct TET- or DNMT-associated chromatin complexes"
     . SPARSER::COLLECTION)
    ("DNMT-associated chromatin complexes" . SPARSER::BIO-COMPLEX)
    ("distinct TET-" . SPARSER::PROTEIN) ("TET-" . SPARSER::PROTEIN)
    ("DNMT" . SPARSER::PROTEIN) ("TET1 and TET2" . SPARSER::COLLECTION)
    ("human acute leukemia" . SPARSER::PROTEIN)
    ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the DUSP2 promoter (Fig.  xref ) and CTCF-dependent induction of the DUSP2 promoter activity (Fig.  xref )"
     . SPARSER::COLLECTION)
    ("aza" . SPARSER::DRUG) ("DUSP2 and murine Dusp2" . SPARSER::COLLECTION)
    ("Dusp2" . SPARSER::PROTEIN) ("Dusp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RASSF1A and RASSF10" . SPARSER::COLLECTION)
    ("Family" . SPARSER::PROTEIN-FAMILY)
    ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the unmethylated DUSP 2 promoter (1.7-fold) and ivm DUSP2 promoter (1.4-fold)"
     . SPARSER::COLLECTION)
    ("Histone" . SPARSER::PROTEIN) ("CTCF and histone" . SPARSER::COLLECTION)
    ("antibody" . SPARSER::PROTEIN) ("tetracycline" . SPARSER::DRUG)
    ("CTCF-" . SPARSER::PROTEIN) ("CTCFL or BORIS" . SPARSER::COLLECTION)
    ("BORIS" . SPARSER::PROTEIN) ("CTCFL" . SPARSER::PROTEIN)
    ("paralogue" . SPARSER::PROTEIN) ("RNA and protein" . SPARSER::COLLECTION)
    ("siRNA" . SPARSER::PROTEIN) ("CpGs" . SPARSER::PROTEIN)
    ("epigenetically inactivated TSG" . SPARSER::PROTEIN)
    ("methyltransferases" . SPARSER::PROTEIN) ("cytidine" . SPARSER::MOLECULE)
    ("a methylated promoter" . SPARSER::PROMOTER)
    ("fragment" . SPARSER::FRAGMENT) ("thyroid" . SPARSER::PROTEIN)
    ("HTB" . SPARSER::DRUG) ("HF" . SPARSER::PROTEIN)
    ("MCC" . SPARSER::PROTEIN) ("CDKN2A/p16" . SPARSER::COLLECTION)
    ("CCCTC binding factor (CTCF)" . SPARSER::PROTEIN)
    ("leukemia" . SPARSER::PROTEIN) ("TET" . SPARSER::PROTEIN)
    ("derivatives" . SPARSER::DERIVATIVE) ("CpG" . SPARSER::PROTEIN)
    ("guanine" . SPARSER::PROTEIN) ("cytosine" . SPARSER::NUCLEOBASE)
    ("Promoter" . SPARSER::PROMOTER) ("genes (TSG)" . SPARSER::GENE)
    ("TSG" . SPARSER::PROTEIN) ("ERK1/2 and p38" . SPARSER::COLLECTION)
    ("phosphatase" . SPARSER::PHOSPHATASE)
    ("mitogen-activated protein kinases (MAPK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAPK" . SPARSER::PROTEIN) ("DUSPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dC" . SPARSER::MOLECULE) ("Aza" . SPARSER::DRUG)
    ("methyltransferase" . SPARSER::PROTEIN) ("bisulfite" . SPARSER::MOLECULE)
    ("CTCF" . SPARSER::PROTEIN)
    ("tumor-associated proteins" . SPARSER::PROTEIN)
    ("Dual specificity phosphatases" . SPARSER::PHOSPHATASE)
    ("phosphatases" . SPARSER::PHOSPHATASE)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("c-myc" . SPARSER::PROTEIN) ("p19ARF" . SPARSER::PROTEIN)
    ("testis specific" . SPARSER::PROTEIN) ("TET2" . SPARSER::PROTEIN)
    ("TET1" . SPARSER::PROTEIN) ("RASSF10" . SPARSER::PROTEIN)
    ("DUSP 2" . SPARSER::PROTEIN) ("chr5" . SPARSER::PROTEIN)
    ("site 1 " . SPARSER::PROTEIN) ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("beta-actin" . SPARSER::PROTEIN) ("HB2" . SPARSER::PROTEIN)
    ("chr2" . SPARSER::PROTEIN) ("S2" . SPARSER::MOLECULE)
    ("U3" . SPARSER::PROTEIN) ("2-4 " . SPARSER::PROTEIN)
    ("Protein A" . SPARSER::PROTEIN) ("N2" . SPARSER::PROTEIN)
    ("Triton X-100" . SPARSER::MOLECULE) ("Dual-Luciferase" . SPARSER::PROTEIN)
    ("pGL3" . SPARSER::PROTEIN) ("BSU1" . SPARSER::PROTEIN)
    ("BSL2" . SPARSER::PROTEIN) ("RASSF1A" . SPARSER::PROTEIN)
    ("CDH1" . SPARSER::PROTEIN) ("E-cadherin" . SPARSER::PROTEIN)
    ("CCCTC binding factor" . SPARSER::PROTEIN) ("TET1-3" . SPARSER::PROTEIN)
    ("E2F1" . SPARSER::PROTEIN) ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("DUSP2" . SPARSER::PROTEIN)
    ("dual specificity phosphatase 2" . SPARSER::PROTEIN)
    ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Nat" . SPARSER::PROTEIN)
    ("cyclin D1 or CCNE1" . SPARSER::COLLECTION)
    ("a hyperactive mTORC1" . SPARSER::PROTEIN) ("barrier" . SPARSER::PROTEIN)
    ("/P-S6" . SPARSER::COLLECTION) ("p21 or P-S6" . SPARSER::COLLECTION)
    ("UT" . SPARSER::PROTEIN-FAMILY)
    ("functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 -null MEFs" . SPARSER::PROTEIN)
    ("endogenous p21 ( xref ) and ectopic human p21 ( xref )"
     . SPARSER::COLLECTION)
    ("p21 and P-S6" . SPARSER::COLLECTION) ("cohort" . SPARSER::MOLECULE)
    ("p21, p53 and P-S6" . SPARSER::COLLECTION)
    ("an eIF4E-binding-defective 4E-BP1 mutant" . SPARSER::MUTANT)
    ("doxycycline" . SPARSER::DRUG) ("AA" . SPARSER::MOLECULE)
    ("LM" . SPARSER::MOLECULE) ("Ala" . SPARSER::AMINO-ACID)
    ("Met" . SPARSER::AMINO-ACID) ("Leu" . SPARSER::AMINO-ACID)
    ("p21 and eIF4E form separate complexes" . SPARSER::BIO-COMPLEX)
    ("p21 and eIF4E" . SPARSER::COLLECTION)
    ("4E-BP1 and mutant" . SPARSER::COLLECTION)
    ("4E-BP1/p21" . SPARSER::COLLECTION)
    ("exogenous human p21" . SPARSER::PROTEIN)
    ("p21 and 4E-BP1" . SPARSER::COLLECTION)
    ("phosphorylation-defective mutant" . SPARSER::MUTANT)
    ("4E-BP1 and the translation factor eIF4E" . SPARSER::COLLECTION)
    ("a 4E-BP1 phosphorylation-defective mutant" . SPARSER::MUTANT)
    ("alanines" . SPARSER::AMINO-ACID) ("ATP-competitive" . SPARSER::ATP)
    ("ATP" . SPARSER::ATP)
    ("mTORC1 and its proximal downstream effectors" . SPARSER::COLLECTION)
    ("its proximal downstream effectors" . SPARSER::EFFECTOR)
    ("torin-1 and rapamycin" . SPARSER::COLLECTION)
    ("rapamycin" . SPARSER::DRUG) ("chemical" . SPARSER::MOLECULE)
    ("AKT and FOXO" . SPARSER::COLLECTION) ("PI3K/AKT" . SPARSER::COLLECTION)
    ("FOXO" . SPARSER::PROTEIN-FAMILY) ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cycloheximide" . SPARSER::PROTEIN) ("partial" . SPARSER::PROTEIN)
    ("mTORC1 and p21" . SPARSER::COLLECTION)
    ("p53 and p21" . SPARSER::COLLECTION)
    ("p21 -null (p21KO) MEFs" . SPARSER::PROTEIN)
    ("p53 -null (p53KO) MEFs" . SPARSER::PROTEIN) ("shRNAs" . SPARSER::RNA)
    ("alternative reading frame (ARF) (also encoded by CDKN2A ) or p53 ( xref )"
     . SPARSER::COLLECTION)
    ("alternative reading frame (ARF)" . SPARSER::PROTEIN)
    ("ARF" . SPARSER::PROTEIN) ("p21 and p16" . SPARSER::COLLECTION)
    ("primary MEFs" . SPARSER::PROTEIN) ("RNA" . SPARSER::RNA)
    ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MEFs" . SPARSER::PROTEIN)
    ("fraction" . SPARSER::COMPONENT) ("mRNAs" . SPARSER::PROTEIN)
    ("eIF" . SPARSER::PROTEIN) ("oxygen and amino acids" . SPARSER::COLLECTION)
    ("RHEB and RRAGs" . SPARSER::COLLECTION) ("RAGs" . SPARSER::PROTEIN)
    ("RHEB" . SPARSER::PROTEIN) ("GTPases" . SPARSER::GTPASE)
    ("mTORC1 and mTORC2" . SPARSER::COLLECTION) ("refs" . SPARSER::PROTEIN)
    ("serine/threonine" . SPARSER::COLLECTION)
    ("cues" . SPARSER::PROTEIN-FAMILY) ("MTOR" . SPARSER::PROTEIN)
    ("threonine" . SPARSER::AMINO-ACID) ("serine" . SPARSER::AMINO-ACID)
    ("CDKN1B (p27) and CDKN1C (p57)" . SPARSER::COLLECTION)
    ("CIP/KIP" . SPARSER::COLLECTION) ("KIP" . SPARSER::PROTEIN)
    ("CIP" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases (CDKs) and CDK inhibitors"
     . SPARSER::COLLECTION)
    ("inhibitors" . SPARSER::INHIBITOR) ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDKs" . SPARSER::PROTEIN) ("p21 and mTORC1" . SPARSER::COLLECTION)
    ("mTORC1/4E-BP1/p21" . SPARSER::COLLECTION)
    ("p21 and phospho-S6-double-positive" . SPARSER::COLLECTION)
    ("mTORC1/4E-BP1" . SPARSER::COLLECTION) ("de-" . SPARSER::MOLECULE)
    ("β-actin" . SPARSER::PROTEIN) ("protein-G" . SPARSER::PROTEIN)
    ("2–4 " . SPARSER::PROTEIN) ("Na 3 VO 4" . SPARSER::MOLECULE)
    ("NP40" . SPARSER::MOLECULE) ("PLP1" . SPARSER::PROTEIN)
    ("E-2" . SPARSER::PROTEIN) ("E-1" . SPARSER::PROTEIN)
    ("β-Galactosidase" . SPARSER::PROTEIN)
    ("β-galactosidase" . SPARSER::PROTEIN) ("MIB-1" . SPARSER::PROTEIN)
    ("WAF-1" . SPARSER::PROTEIN) ("WAF1" . SPARSER::PROTEIN)
    ("monoclonal antibody" . SPARSER::DRUG)
    ("Ribosomal Protein" . SPARSER::PROTEIN) ("B12)" . SPARSER::PROTEIN)
    ("M2" . SPARSER::MOLECULE) ("FOXO1" . SPARSER::PROTEIN)
    ("H12" . SPARSER::PROTEIN) ("G10" . SPARSER::PROTEIN)
    ("anti-S" . SPARSER::ANTIBODY) ("H11" . SPARSER::PROTEIN)
    ("H2A" . SPARSER::PROTEIN) ("C3-1" . SPARSER::PROTEIN)
    ("p19" . SPARSER::PROTEIN) ("1C" . SPARSER::PROTEIN)
    ("nutlin3" . SPARSER::DRUG) ("LY-294002" . SPARSER::PROTEIN)
    ("GDC-0941" . SPARSER::DRUG) ("p110γ" . SPARSER::PROTEIN)
    ("p110β" . SPARSER::PROTEIN) ("p110δ" . SPARSER::PROTEIN)
    ("p110α" . SPARSER::PROTEIN) ("PI3Ki" . SPARSER::PROTEIN)
    ("BP1" . SPARSER::PROTEIN) ("1-4" . SPARSER::PROTEIN)
    ("CO 2" . SPARSER::PROTEIN) ("ml −1" . SPARSER::PROTEIN)
    ("cyclin E" . SPARSER::PROTEIN) ("CCNE1" . SPARSER::PROTEIN)
    ("S6K1" . SPARSER::PROTEIN) ("Ki67" . SPARSER::PROTEIN)
    ("cyclin D1" . SPARSER::PROTEIN) ("CCND1" . SPARSER::PROTEIN)
    ("nutlin-3" . SPARSER::DRUG) ("MDM2" . SPARSER::PROTEIN)
    ("-2" . SPARSER::PROTEIN) ("RB1" . SPARSER::PROTEIN)
    ("retinoblastoma protein" . SPARSER::PROTEIN) ("P-S6" . SPARSER::PROTEIN)
    ("Torin-1" . SPARSER::DRUG) ("torin-1" . SPARSER::DRUG)
    ("PI3K" . SPARSER::PROTEIN-FAMILY) ("MG132" . SPARSER::PROTEIN)
    ("p21 protein" . SPARSER::PROTEIN) ("H2AX" . SPARSER::PROTEIN)
    ("H2AFX" . SPARSER::PROTEIN) ("RasV12" . SPARSER::DRUG)
    ("H-Ras" . SPARSER::PROTEIN)
    ("alternative reading frame" . SPARSER::PROTEIN)
    ("CDKN2A" . SPARSER::PROTEIN) ("p16" . SPARSER::PROTEIN)
    ("ribosomal protein" . SPARSER::PROTEIN) ("EIF4E" . SPARSER::PROTEIN)
    ("4E-BP" . SPARSER::PROTEIN) ("EIF4EBP" . SPARSER::PROTEIN-FAMILY)
    ("S6K" . SPARSER::PROTEIN) ("RPS6" . SPARSER::PROTEIN)
    ("amino acids" . SPARSER::AMINO-ACID)
    ("growth factors" . SPARSER::GROWTH-FACTOR) ("TSC2" . SPARSER::PROTEIN)
    ("GTPase-activating protein" . SPARSER::PROTEIN)
    ("kinase activity" . SPARSER::PROTEIN) ("mTORC2" . SPARSER::PROTEIN)
    ("P21" . SPARSER::PROTEIN) ("p57" . SPARSER::PROTEIN)
    ("CDKN1C" . SPARSER::PROTEIN) ("p27" . SPARSER::PROTEIN)
    ("CDKN1B" . SPARSER::PROTEIN) ("CDKN1A" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("4E-BP1" . SPARSER::PROTEIN) ("mTORC1" . SPARSER::PROTEIN)
    ("p21" . SPARSER::PROTEIN) ("matrix" . SPARSER::PROTEIN-FAMILY)
    ("the Dock family proteins and other genes" . SPARSER::COLLECTION)
    ("CDH2, MACF1, ABL2 and TNS3" . SPARSER::COLLECTION)
    ("CTGF, Cyr61, Birc5, AXL and AREG" . SPARSER::COLLECTION)
    ("AXL" . SPARSER::PROTEIN)
    ("the SRC1-3 transcriptional cofactors" . SPARSER::PROTEIN)
    ("cofactors" . SPARSER::PROTEIN) ("Kras" . SPARSER::PROTEIN)
    ("matrigel" . SPARSER::PROTEIN) ("YAP/Tead-AP1" . SPARSER::COLLECTION)
    ("ABL2, CDH2, CNN3, DAAM1, GRP126, ITBG5, MACF1, MKLN1, NRP1, PARD3, PHLDB2 and TNS3"
     . SPARSER::COLLECTION)
    ("GRP" . SPARSER::PROTEIN) ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rac1 and CDC42" . SPARSER::COLLECTION)
    ("Dock4, Dock5 and Dock9" . SPARSER::COLLECTION)
    ("AP1 and Tead" . SPARSER::COLLECTION) ("Dock5" . SPARSER::PROTEIN)
    ("Dock4" . SPARSER::PROTEIN) ("Rac and Cdc42" . SPARSER::COLLECTION)
    ("Tead/AP1" . SPARSER::COLLECTION)
    ("Tead4, JunD, and Fra1/2" . SPARSER::COLLECTION)
    ("YAP/Tead and AP1" . SPARSER::COLLECTION)
    ("the previously known YAP/Tead" . SPARSER::PROTEIN)
    ("CTGF, Cyr61, Axl, Birc5 and AREG" . SPARSER::COLLECTION)
    ("Birc5" . SPARSER::PROTEIN) ("AREG" . SPARSER::PROTEIN)
    ("Axl" . SPARSER::PROTEIN) ("YAP/Tead" . SPARSER::PROTEIN)
    ("YAP/Tead-JunD" . SPARSER::PROTEIN-PAIR)
    ("Tead-JunD" . SPARSER::COLLECTION) ("Tead-Luc" . SPARSER::COLLECTION)
    ("SRC1/2/3" . SPARSER::COLLECTION) ("Bufalin" . SPARSER::DRUG)
    ("bHLH" . SPARSER::PROTEIN) ("Tead4 and JunD" . SPARSER::COLLECTION)
    ("fused" . SPARSER::PROTEIN) ("SRC3, JunD and Tead4" . SPARSER::COLLECTION)
    ("SRC" . SPARSER::PROTEIN) ("SRCs" . SPARSER::PROTEIN)
    ("NCOA1-3" . SPARSER::COLLECTION) ("hormone" . SPARSER::MOLECULE)
    ("receptor" . SPARSER::RECEPTOR) ("Tead/JunD" . SPARSER::COLLECTION)
    ("MKK7-JNK" . SPARSER::COLLECTION)
    ("CTGF and ANKRD1" . SPARSER::COLLECTION)
    ("a recently developed highly-specific JNK inhibitor" . SPARSER::INHIBITOR)
    ("kinases" . SPARSER::KINASE) ("JunD and Tead4" . SPARSER::COLLECTION)
    ("protein-protein" . SPARSER::COLLECTION)
    ("JunD and Fra1" . SPARSER::COLLECTION) ("JunD/Fra1" . SPARSER::COLLECTION)
    ("heterodimer" . SPARSER::HETERODIMER) ("ANK-mT-Luc" . SPARSER::COLLECTION)
    ("Tead4 and various AP1 proteins" . SPARSER::COLLECTION)
    ("JunD, cJun, Fos and Fra1" . SPARSER::COLLECTION)
    ("Luc" . SPARSER::PROTEIN) ("promoter or enhancer" . SPARSER::COLLECTION)
    ("ANK-Luc, Dock9-Luc and Tead4-Luc" . SPARSER::COLLECTION)
    ("Tead4-Luc" . SPARSER::COLLECTION) ("Dock9-Luc" . SPARSER::COLLECTION)
    ("ANK-Luc" . SPARSER::COLLECTION) ("ANK" . SPARSER::PROTEIN)
    ("ANKRD1 and Dock9" . SPARSER::COLLECTION)
    ("the active promoter" . SPARSER::PROMOTER)
    ("Tead1 or JunD" . SPARSER::COLLECTION)
    ("ANKRD1 and Tead4" . SPARSER::COLLECTION)
    ("Tead or AP1" . SPARSER::COLLECTION) ("component" . SPARSER::COMPONENT)
    ("ANKRD1, Dock9, and Tead4" . SPARSER::COLLECTION)
    ("Dock9" . SPARSER::PROTEIN) ("Tead and AP1" . SPARSER::COLLECTION)
    ("Tead4-AP1" . SPARSER::COLLECTION) ("promoters" . SPARSER::PROMOTER)
    ("enhancers" . SPARSER::PROTEIN) ("Active" . SPARSER::ACTIVE)
    ("Lys" . SPARSER::AMINO-ACID) ("genome-wide H3K4" . SPARSER::PROTEIN)
    ("Tead4/AP1" . SPARSER::COLLECTION) ("Tead4 and AP1" . SPARSER::COLLECTION)
    ("JunD and Fra1/2" . SPARSER::COLLECTION)
    ("JunD or Fra1/2" . SPARSER::COLLECTION)
    ("JunD, Fra1 and Fra2" . SPARSER::COLLECTION)
    ("repressor" . SPARSER::REPRESSOR) ("JunD and cJun" . SPARSER::COLLECTION)
    ("luciferase" . SPARSER::PROTEIN)
    ("JunD, cJun, Fos, Fra1 and Fra2" . SPARSER::COLLECTION)
    ("cJun" . SPARSER::PROTEIN) ("blot" . SPARSER::PROTEIN)
    ("Fos and ATF/CREB families" . SPARSER::COLLECTION)
    ("dimeric complexes" . SPARSER::BIO-COMPLEX)
    ("ATF/CREB" . SPARSER::COLLECTION) ("families" . SPARSER::PROTEIN-FAMILY)
    ("CREB" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ATF" . SPARSER::PROTEIN)
    ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("complexes" . SPARSER::BIO-COMPLEX)
    ("AP1 and Tead4" . SPARSER::COLLECTION) ("cis" . SPARSER::PROTEIN)
    ("active" . SPARSER::ACTIVE)
    ("CTGF, Cyr61, and ANKRD1" . SPARSER::COLLECTION)
    ("components and regulators" . SPARSER::COLLECTION)
    ("AmotL2, Ajuba, Tead1 and Tead4" . SPARSER::COLLECTION)
    ("Ajuba" . SPARSER::PROTEIN) ("components" . SPARSER::COMPONENT)
    ("CTGF" . SPARSER::PROTEIN) ("form" . SPARSER::FORM)
    ("Tead2" . SPARSER::PROTEIN) ("shRNA" . SPARSER::PROTEIN)
    ("KD" . SPARSER::PROTEIN) ("Teads" . SPARSER::PROTEIN)
    ("Tead4 and overall Tead proteins" . SPARSER::COLLECTION)
    ("Tead4 and pan-Tead" . SPARSER::COLLECTION)
    ("antibodies" . SPARSER::ANTIBODY) ("types" . TYPE)
    ("variety" . SPARSER::VARIETY) ("effectors" . SPARSER::EFFECTOR)
    ("TAZ" . SPARSER::PROTEIN) ("Yki" . SPARSER::PROTEIN)
    ("the only Tead family proteins" . SPARSER::PROTEIN)
    ("evolutionary conserved proteins" . SPARSER::PROTEIN)
    ("Tead-" . SPARSER::PROTEIN) ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tead" . SPARSER::PROTEIN) ("Tead-AP1" . SPARSER::COLLECTION)
    ("JNK" . SPARSER::PROTEIN) ("Tead4, JunD and Fra1/2" . SPARSER::COLLECTION)
    ("JunD" . SPARSER::PROTEIN) ("AP1" . SPARSER::PROTEIN)
    ("mediators" . SPARSER::PROTEIN) ("L15" . SPARSER::PROTEIN)
    ("F-12" . SPARSER::PROTEIN) ("TNS3" . SPARSER::PROTEIN)
    ("PHLDB2" . SPARSER::PROTEIN) ("PARD3" . SPARSER::PROTEIN)
    ("NRP1" . SPARSER::PROTEIN) ("MKLN1" . SPARSER::PROTEIN)
    ("MACF1" . SPARSER::PROTEIN) ("DAAM1" . SPARSER::PROTEIN)
    ("CNN3" . SPARSER::PROTEIN) ("CDH2" . SPARSER::PROTEIN)
    ("ABL2" . SPARSER::PROTEIN) ("G protein" . SPARSER::PROTEIN)
    ("Rac1" . SPARSER::PROTEIN) ("Cdc42" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("2/3" . SPARSER::PROTEIN) ("SRC3" . SPARSER::PROTEIN)
    ("NCOA1" . SPARSER::PROTEIN) ("p160" . SPARSER::PROTEIN)
    ("MKK7" . SPARSER::PROTEIN) ("H3K27ac" . SPARSER::MOLECULE)
    ("k4" . SPARSER::PROTEIN) ("H3K4" . SPARSER::PROTEIN)
    ("Fra2" . SPARSER::PROTEIN) ("activating protein" . SPARSER::PROTEIN)
    ("AmotL2" . SPARSER::PROTEIN) ("ANKRD1" . SPARSER::PROTEIN)
    ("Cyr61" . SPARSER::PROTEIN) ("colon cancer" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("Tead1" . SPARSER::PROTEIN) ("CDC42" . SPARSER::PROTEIN)
    ("-3" . SPARSER::PROTEIN) ("SRC1" . SPARSER::PROTEIN)
    ("Fra1" . SPARSER::PROTEIN) ("Tead4" . SPARSER::PROTEIN)
    ("therapeutics" . SPARSER::THERAPEUTICS)
    ("the relevant Sirt1 substrates" . SPARSER::SUBSTRATE)
    ("complex and multi-effector" . SPARSER::COLLECTION)
    ("effector" . SPARSER::EFFECTOR) ("complex" . SPARSER::BIO-COMPLEX)
    ("examples" . SPARSER::EXAMPLE)
    ("Nrf2 and its inhibitor" . SPARSER::COLLECTION) ("ROS" . SPARSER::PROTEIN)
    ("mES" . SPARSER::MOLECULE) ("chaperone" . SPARSER::PROTEIN)
    ("erythroid" . SPARSER::PROTEIN) ("GTP" . SPARSER::NUCLEOTIDE)
    ("mitochondrial Sirt3" . SPARSER::PROTEIN)
    ("mitochondrial-encoded subunits" . SPARSER::PROTEIN)
    ("subunits" . SPARSER::PROTEIN) ("SUBSTRATES" . SPARSER::SUBSTRATE)
    ("amyloid and tau" . SPARSER::COLLECTION) ("tau" . SPARSER::PROTEIN)
    ("amyloid" . SPARSER::PROTEIN) ("target" . SPARSER::TARGET-PROTEIN)
    ("drug" . SPARSER::DRUG) ("Given PGC-1α’s" . SPARSER::PROTEIN)
    ("Given PGC-1α" . SPARSER::PROTEIN)
    ("PGC-1α and the neuroprotective brain-derived neurotrophic factor (BDNF)"
     . SPARSER::COLLECTION)
    ("the neuroprotective brain-derived neurotrophic factor (BDNF)"
     . SPARSER::PROTEIN)
    ("BDNF" . SPARSER::PROTEIN) ("huntingtin" . SPARSER::PROTEIN)
    ("polyglutamine" . SPARSER::MOLECULE) ("Huntingtin" . SPARSER::PROTEIN)
    ("HD" . SPARSER::PROTEIN) ("MPTP" . SPARSER::PROTEIN)
    ("neurotoxin" . SPARSER::PROTEIN) ("rotenone" . SPARSER::PROTEIN)
    ("inhibitor" . SPARSER::INHIBITOR)
    ("the disease-susceptible neuron group" . SPARSER::MOLECULE)
    ("PGC-1α and NRF-1" . SPARSER::COLLECTION)
    ("PARIS, or ZNF746" . SPARSER::COLLECTION) ("PARIS" . SPARSER::PROTEIN)
    ("parkin" . SPARSER::PROTEIN) ("mutants" . SPARSER::MUTANT)
    ("Drosophila" . SPARSER::PROTEIN)
    ("PINK1 and Parkin" . SPARSER::COLLECTION) ("part" . SPARSER::COMPONENT)
    ("luminal" . SPARSER::DRUG) ("Sirt1-Sirt3" . SPARSER::COLLECTION)
    ("Das" . SPARSER::DRUG) ("group A (XPA)" . SPARSER::PROTEIN)
    ("nucleotide" . SPARSER::NUCLEOTIDE) ("XPA" . SPARSER::PROTEIN)
    ("NADH" . SPARSER::MOLECULE) ("II" . SPARSER::PROTEIN)
    ("Nicotinamide" . SPARSER::PROTEIN)
    ("the PTEN-induced putative kinase 1 (PINK1) and the E3 ubiquitin ligase Parkin"
     . SPARSER::COLLECTION)
    ("Parkin" . SPARSER::PROTEIN) ("PTEN" . SPARSER::PROTEIN)
    ("Given Sirt1’s" . SPARSER::PROTEIN) ("Given Sirt1" . SPARSER::PROTEIN)
    ("Sirt1, AMPK and PGC-1α" . SPARSER::COLLECTION)
    ("Epac1" . SPARSER::PROTEIN) ("Epac" . SPARSER::PROTEIN)
    ("isoforms" . SPARSER::ISOFORM) ("mRNA" . SPARSER::PROTEIN)
    ("Ser" . SPARSER::AMINO-ACID) ("Thr" . SPARSER::AMINO-ACID)
    ("phosphodiesterases" . SPARSER::PROTEIN) ("cAMP" . SPARSER::PROTEIN)
    ("Resveratrol" . SPARSER::PROTEIN) ("the major AMPK" . SPARSER::PROTEIN)
    ("intact Sirt1" . SPARSER::PROTEIN)
    ("the key cellular nutrient" . SPARSER::MOLECULE)
    ("SIRT1, AMPK AND PGC-1α" . SPARSER::COLLECTION)
    ("mutant" . SPARSER::MUTANT) ("promoter" . SPARSER::PROMOTER)
    ("Cre" . SPARSER::PROTEIN) ("exon" . SPARSER::PROTEIN)
    ("PGC-1α and Sirt1" . SPARSER::COLLECTION)
    ("PGC-1α and mtTFA" . SPARSER::COLLECTION)
    ("PGC-1α and COX IV" . SPARSER::COLLECTION) ("AICAR" . SPARSER::PROTEIN)
    ("mtTFA" . SPARSER::PROTEIN) ("which targets PGC-1α" . SPARSER::PROTEIN)
    ("proteasomal" . SPARSER::PROTEIN) ("a major NAD +" . SPARSER::MOLECULE)
    ("polymerase-1" . SPARSER::COLLECTION) ("enzyme" . SPARSER::ENZYME)
    ("polymerase" . SPARSER::PROTEIN) ("oxygen" . SPARSER::MOLECULE)
    ("skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hepatic gluconeogenic genes" . SPARSER::GENE)
    ("nutrient" . SPARSER::MOLECULE) ("p53 and Foxo3a" . SPARSER::COLLECTION)
    ("group" . SPARSER::MOLECULE) ("PKB" . SPARSER::PROTEIN)
    ("which increases PGC-1α’s" . SPARSER::PROTEIN)
    ("which increases PGC-1α" . SPARSER::PROTEIN) ("NRF" . SPARSER::PROTEIN)
    ("PGC" . SPARSER::PROTEIN) ("coactivators" . SPARSER::PROTEIN)
    ("genes" . SPARSER::GENE) ("state" . SPARSER::BIO-STATE)
    ("Mitochondria" . SPARSER::PROTEIN)
    ("mitochondrial Sirt1 and PGC-1α’s" . SPARSER::COLLECTION)
    ("mitochondrial Sirt1 and PGC-1α" . SPARSER::COLLECTION)
    ("Sirt1 and PGC-1α" . SPARSER::COLLECTION)
    ("the mitochondrial transcription factor A (TFAM)" . SPARSER::PROTEIN)
    ("transcription factor and regulator" . SPARSER::COLLECTION)
    ("TFAM" . SPARSER::PROTEIN) ("DNA" . SPARSER::DNA)
    ("Both Sirt1 and the nuclear transcription factor PGC-1α"
     . SPARSER::COLLECTION)
    ("platelets" . SPARSER::PROTEIN)
    ("Sirt1 and its substrate" . SPARSER::COLLECTION)
    ("substrate" . SPARSER::SUBSTRATE)
    ("the cytoplasmic acetyl-CoA synthetase ( xref ) and the actin binding protein cortactin ( xref )"
     . SPARSER::COLLECTION)
    ("cortactin" . SPARSER::PROTEIN) ("actin" . SPARSER::PROTEIN)
    ("synthetase" . SPARSER::PROTEIN)
    ("IGF-1/PI3 kinase" . SPARSER::COLLECTION)
    ("insulin-like growth factor-1-phosphoinositide 3-kinase"
     . SPARSER::COLLECTION)
    ("Sirt1 and SUV39H1" . SPARSER::COLLECTION) ("rRNA" . SPARSER::PROTEIN)
    ("a bona fide histone deacetylase" . SPARSER::PROTEIN)
    ("Sirt3, Sirt4 and Sirt5" . SPARSER::COLLECTION)
    ("kinase (AMPK)" . SPARSER::KINASE) ("mTOR" . SPARSER::PROTEIN)
    ("AMPK" . SPARSER::PROTEIN) ("kinase" . SPARSER::KINASE)
    ("AMP" . SPARSER::AMP) ("regulator" . SPARSER::REGULATOR)
    ("skeletal muscle" . SPARSER::PROTEIN) ("regulators" . SPARSER::REGULATOR)
    ("FoxO" . SPARSER::PROTEIN-FAMILY) ("Forkhead" . SPARSER::PROTEIN)
    ("suppressor" . SPARSER::SUPPRESSOR) ("targets" . SPARSER::TARGET-PROTEIN)
    ("Sirt1 ( xref ) and the specific activator SRT1720 ( xref )"
     . SPARSER::COLLECTION)
    ("activator" . SPARSER::ACTIVATOR)
    ("resveratrol and SRT1720" . SPARSER::COLLECTION)
    ("activators" . SPARSER::ACTIVATOR) ("resveratrol" . SPARSER::PROTEIN)
    ("SIR2 and its metazoan orthologues" . SPARSER::COLLECTION)
    ("DR" . SPARSER::MOLECULE) ("CR" . SPARSER::PROTEIN)
    ("metazoan" . SPARSER::PROTEIN-FAMILY) ("rDNA" . SPARSER::PROTEIN)
    ("chromatin" . SPARSER::PROTEIN) ("seven" . SPARSER::PROTEIN)
    ("elegans" . SPARSER::PROTEIN) ("Homologues" . SPARSER::PROTEIN)
    ("cellular NAD +" . SPARSER::MOLECULE) ("states" . SPARSER::BIO-STATE)
    ("redox" . SPARSER::PROTEIN) ("-O-acetyl-ADP-ribose" . SPARSER::MOLECULE)
    ("nicotinamide" . SPARSER::PROTEIN) ("Lysine" . SPARSER::AMINO-ACID)
    ("gene" . SPARSER::GENE) ("Regulator" . SPARSER::REGULATOR)
    ("proteins" . SPARSER::PROTEIN) ("Sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("a separate class IV" . SPARSER::PROTEIN)
    ("RPD3 and HDA1" . SPARSER::COLLECTION)
    ("HDACs, or sirtuins" . SPARSER::COLLECTION)
    ("homology" . SPARSER::PROTEIN) ("homologues" . SPARSER::PROTEIN)
    ("IV" . SPARSER::PROTEIN) ("classes" . CLASS)
    ("substrates" . SPARSER::SUBSTRATE) ("histones" . SPARSER::PROTEIN)
    ("HDACs" . SPARSER::PROTEIN) ("enzymes" . SPARSER::ENZYME)
    ("lysine" . SPARSER::AMINO-ACID) ("acetyl" . SPARSER::MOLECULE)
    ("Protein" . SPARSER::PROTEIN)
    ("defective mitochondria" . SPARSER::PROTEIN)
    ("mitochondria" . SPARSER::PROTEIN) ("protein" . SPARSER::PROTEIN)
    ("-1" . SPARSER::PROTEIN) ("Sirt1" . SPARSER::PROTEIN)
    ("deacetylases" . SPARSER::PROTEIN) ("histone" . SPARSER::PROTEIN)
    ("class" . CLASS) ("family" . SPARSER::PROTEIN-FAMILY)
    ("sirtuins" . SPARSER::PROTEIN-FAMILY) ("anti-" . SPARSER::ANTIBODY)
    ("Keap1" . SPARSER::PROTEIN)
    ("Kelch-like ECH associated protein 1" . SPARSER::PROTEIN)
    ("Nrf2" . SPARSER::PROTEIN)
    ("Nuclear factor erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("PDK1" . SPARSER::PROTEIN)
    ("pyruvate dehydrogenase kinase 1" . SPARSER::PROTEIN)
    ("HIF-1α" . SPARSER::PROTEIN)
    ("hypoxia inducible factor 1-alpha" . SPARSER::PROTEIN)
    ("TRAP1" . SPARSER::PROTEIN) ("DAF-16" . SPARSER::PROTEIN)
    ("sir2" . SPARSER::PROTEIN) ("FoxO3a" . SPARSER::PROTEIN)
    ("brain-derived neurotrophic factor" . SPARSER::PROTEIN)
    ("Complex I" . SPARSER::PROTEIN) ("NRF-1" . SPARSER::PROTEIN)
    ("ZNF746" . SPARSER::PROTEIN) ("α-synuclein" . SPARSER::PROTEIN)
    ("group A" . SPARSER::PROTEIN) ("LC3" . SPARSER::PROTEIN)
    ("light chain 3" . SPARSER::PROTEIN)
    ("ubiquitin ligase" . SPARSER::PROTEIN) ("E3" . SPARSER::MOLECULE)
    ("PINK1" . SPARSER::PROTEIN) ("tissue-type" . SPARSER::PROTEIN)
    ("Exchange factor" . SPARSER::EXCHANGE-FACTOR) ("STK11" . SPARSER::PROTEIN)
    ("Serine/threonine kinase 11" . SPARSER::PROTEIN)
    ("acetyltransferase activity" . SPARSER::PROTEIN)
    ("creatine kinase" . SPARSER::PROTEIN) ("COX IV" . SPARSER::PROTEIN)
    ("Cytochrome c Oxidase subunit IV" . SPARSER::PROTEIN)
    ("GSK3β" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("PARP-1" . SPARSER::PROTEIN) ("ADP-ribose" . SPARSER::MOLECULE)
    ("Foxo3a" . SPARSER::PROTEIN) ("p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ADP-ribosyltransferase" . SPARSER::PROTEIN)
    ("amino acid" . SPARSER::AMINO-ACID) ("AKT/protein" . SPARSER::PROTEIN)
    ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GCN5" . SPARSER::PROTEIN)
    ("amino acid synthesis" . SPARSER::PROTEIN-FAMILY)
    ("PGC-1β" . SPARSER::PROTEIN) ("PGC-1" . SPARSER::PROTEIN)
    ("PGC - 1α" . SPARSER::PROTEIN)
    ("transcription factor A" . SPARSER::PROTEIN)
    ("transcription factor" . SPARSER::PROTEIN)
    ("fatty acid" . SPARSER::MOLECULE) ("acetyl-CoA" . SPARSER::MOLECULE)
    ("PI3 kinase" . SPARSER::PROTEIN) ("IGF-1" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("SUV39H1" . SPARSER::PROTEIN) ("methyl-transferase" . SPARSER::PROTEIN)
    ("histone deacetylase" . SPARSER::PROTEIN) ("SIRT1" . SPARSER::PROTEIN)
    ("Sirt5" . SPARSER::PROTEIN) ("Sirt4" . SPARSER::PROTEIN)
    ("Sirt3" . SPARSER::PROTEIN)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PPARγ" . SPARSER::PROTEIN)
    ("Peroxisome Proliferator-Activated Receptor gamma" . SPARSER::PROTEIN)
    ("NF-κB" . SPARSER::PROTEIN) ("class O" . SPARSER::PROTEIN)
    ("TP53" . SPARSER::PROTEIN) ("SRT1720" . SPARSER::DRUG)
    ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sir-2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("or 2" . SPARSER::MOLECULE)
    ("O-acetyl-ADP-ribose" . SPARSER::MOLECULE) ("NAD +" . SPARSER::MOLECULE)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("S. cerevisiae" . SPARSER::PROTEIN)
    ("SIR2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HDAC11" . SPARSER::PROTEIN)
    ("Histone DeAcetylase 1" . SPARSER::PROTEIN) ("RPD3" . SPARSER::PROTEIN)
    ("Class I" . SPARSER::PROTEIN) ("PGC-1α" . SPARSER::PROTEIN)
    (NIL . SPARSER::PROTEIN)
    ("Peroxisome proliferator-activated receptor Gamma" . SPARSER::PROTEIN)))